Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000051.4(ATM):c.7375C>G (p.Arg2459Gly)	ATM|C11orf65	R2459G	Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome|not provided	Uncertain significance(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000181982	11	108201008	11	108330281	181982	180503	rs730881383	NC_000011.10:108330280:C:G
NM_001374258.1(BRAF):c.316G>A (p.Gly106Arg)	BRAF	G106R, G54R, G72R	LEOPARD syndrome 3|Noonan syndrome 7|not specified|Rasopathy	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505121	7	140534597	7	140834797	505121	496489	rs749247588	NC_000007.14:140834796:C:T
NM_000051.4(ATM):c.7999A>G (p.Met2667Val)	C11orf65|ATM	M2667V	Hereditary cancer-predisposing syndrome|not provided|Ataxia-telangiectasia syndrome	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141559	11	108204684	11	108333957	141559	151273	rs34099398	NC_000011.10:108333956:A:G
NM_031443.4(CCM2):c.638T>C (p.Leu213Pro)	CCM2	L213P, L234P, L155P	Cerebral cavernous malformation|Cerebral cavernous malformations 2	Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2020)	criteria provided, conflicting interpretations	VCV000655527	7	45109453	7	45069854	655527	636173	rs1583983649	NC_000007.14:45069853:T:C
NM_002890.3(RASA1):c.669G>C (p.Gln223His)	CCNH|RASA1	Q223H, Q46H	not provided	Uncertain significance(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000561692	5	86627294	5	87331477	561692	552576	rs1252085868	NC_000005.10:87331476:G:C
NM_001042492.3(NF1):c.4836-21229G>C	EVI2B|NF1	P340R	Neurofibromatosis, type 1|not provided	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235483	17	29631609	17	31304591	235483	237165	rs17884293	NC_000017.11:31304590:G:C
NM_001130682.3(GUCY1A1):c.1550G>A (p.Cys517Tyr)	GUCY1A1	C517Y, C282Y, C348Y	Moyamoya disease 1|Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559597	4	156634713	4	155713561	559597	550318	rs751701114	NC_000004.12:155713560:G:A
NM_001130682.3(GUCY1A1):c.1258C>T (p.Arg420Ter)	GUCY1A1	R420*, R185*, R251*	Moyamoya disease 1|Moyamoya disease 6 with achalasia	Pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	VCV000559596	4	156634421	4	155713269	559596	550317	rs373182378	NC_000004.12:155713268:C:T
NM_001042492.3(NF1):c.-272G>A	LOC111811965|NF1		Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV001013130	17	29422056	17	31095038	1013130	1001002		NC_000017.11:31095037:G:A
NM_001042492.3(NF1):c.-251C>T	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891892	17	29422077	17	31095059	891892	877178		NC_000017.11:31095058:C:T
NM_001042492.3(NF1):c.-166T>C	LOC111811965|NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000890701	17	29422162	17	31095144	890701	877179		NC_000017.11:31095143:T:C
NM_000267.3(NF1):c.-363T>C	LOC111811965|NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890653	17	29421965	17	31094947	890653	877176		NC_000017.11:31094946:T:C
NM_001042492.3(NF1):c.-51C>T	LOC111811965|NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889509	17	29422277	17	31095259	889509	877180		NC_000017.11:31095258:C:T
NM_001042492.3(NF1):c.44G>A (p.Ser15Asn)	LOC111811965|NF1	S15N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000659045	17	29422371	17	31095353	659045	645435	rs1598173852	NC_000017.11:31095352:G:A
NM_001042492.3(NF1):c.7G>A (p.Ala3Thr)	LOC111811965|NF1	A3T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000658636	17	29422334	17	31095316	658636	645434	rs1598173770	NC_000017.11:31095315:G:A
NM_001042492.3(NF1):c.51C>G (p.Phe17Leu)	LOC111811965|NF1	F17L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 1, 2018)	criteria provided, single submitter	VCV000651327	17	29422378	17	31095360	651327	645436	rs1369290988	NC_000017.11:31095359:C:G
NM_001042492.3(NF1):c.3G>A (p.Met1Ile)	LOC111811965|NF1	M1I	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000647845	17	29422330	17	31095312	647845	645433	rs1598173737	NC_000017.11:31095311:G:A
NM_001042492.3(NF1):c.55G>A (p.Glu19Lys)	LOC111811965|NF1	E19K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000582267	17	29422382	17	31095364	582267	570916	rs786203307	NC_000017.11:31095363:G:A
NM_001042492.3(NF1):c.15G>T (p.Arg5Ser)	LOC111811965|NF1	R5S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000578123	17	29422342	17	31095324	578123	574342	rs1567786804	NC_000017.11:31095323:G:T
NM_001042492.3(NF1):c.26G>A (p.Trp9Ter)	LOC111811965|NF1	W9*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000567193	17	29422353	17	31095335	567193	570915	rs1567786829	NC_000017.11:31095334:G:A
NM_001042492.3(NF1):c.2T>A (p.Met1Lys)	LOC111811965|NF1	M1K	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547562	17	29422329	17	31095311	547562	538099	rs886041346	NC_000017.11:31095310:T:A
NM_001042492.3(NF1):c.36C>A (p.Ala12=)	LOC111811965|NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000527624	17	29422363	17	31095345	527624	530820	rs786203866	NC_000017.11:31095344:C:A
NM_001042492.3(NF1):c.47G>C (p.Arg16Pro)	LOC111811965|NF1	R16P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481953	17	29422374	17	31095356	481953	478010	rs1555594493	NC_000017.11:31095355:G:C
NM_001042492.3(NF1):c.48C>T (p.Arg16=)	LOC111811965|NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000457731	17	29422375	17	31095357	457731	467216	rs1315327163	NC_000017.11:31095356:C:T
NM_001042492.3(NF1):c.2T>G (p.Met1Arg)	LOC111811965|NF1	M1R	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426634	17	29422329	17	31095311	426634	415542	rs886041346	NC_000017.11:31095310:T:G
NM_001042492.3(NF1):c.37G>A (p.Val13Met)	LOC111811965|NF1	V13M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000404442	17	29422364	17	31095346	404442	402080	rs1060500261	NC_000017.11:31095345:G:A
NM_001042492.3(NF1):c.1A>G (p.Met1Val)	LOC111811965|NF1	M1V	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404429	17	29422328	17	31095310	404429	401594	rs1060500252	NC_000017.11:31095309:A:G
NM_001042492.3(NF1):c.46C>T (p.Arg16Cys)	LOC111811965|NF1	R16C	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000378270	17	29422373	17	31095355	378270	375835	rs1057520334	NC_000017.11:31095354:C:T
NM_001042492.3(NF1):c.-73G>T	LOC111811965|NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322565	17	29422255	17	31095237	322565	345442	rs886052795	NC_000017.11:31095236:G:T
NM_001042492.3(NF1):c.-84C>T	LOC111811965|NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322564	17	29422244	17	31095226	322564	327955	rs886052794	NC_000017.11:31095225:C:T
NM_001042492.3(NF1):c.-115T>C	LOC111811965|NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322563	17	29422213	17	31095195	322563	344027	rs886052793	NC_000017.11:31095194:T:C
NM_001042492.3(NF1):c.-173C>G	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322561	17	29422155	17	31095137	322561	344023	rs886052791	NC_000017.11:31095136:C:G
NM_001042492.3(NF1):c.-209C>A	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322560	17	29422119	17	31095101	322560	345441	rs886052790	NC_000017.11:31095100:C:A
NM_001042492.3(NF1):c.-229C>G	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322559	17	29422099	17	31095081	322559	345440	rs886052789	NC_000017.11:31095080:C:G
NM_001042492.3(NF1):c.-237C>T	LOC111811965|NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322558	17	29422091	17	31095073	322558	345439	rs878967255	NC_000017.11:31095072:C:T
NM_001042492.3(NF1):c.-322G>A	LOC111811965|NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322553	17	29422006	17	31094988	322553	345438	rs886052785	NC_000017.11:31094987:G:A
NM_001042492.3(NF1):c.2T>C (p.Met1Thr)	LOC111811965|NF1	M1T	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280054	17	29422329	17	31095311	280054	265013	rs886041346	NC_000017.11:31095310:T:C
NM_001042492.3(NF1):c.-22G>C	LOC111811965|NF1		not specified|not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal	Benign/Likely benign(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000257274	17	29422306	17	31095288	257274	256113	rs556823296	NC_000017.11:31095287:G:C
NM_001042492.3(NF1):c.6C>T (p.Ala2=)	LOC111811965|NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233007	17	29422333	17	31095315	233007	235494	rs876660128	NC_000017.11:31095314:C:T
NM_000267.3(NF1):c.31C>T (p.Gln11Ter)	LOC111811965|NF1	Q11*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230597	17	29422358	17	31095340	230597	231989	rs876658658	NC_000017.11:31095339:C:T
NM_001042492.3(NF1):c.-8G>A	LOC111811965|NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000219977	17	29422320	17	31095302	219977	222562	rs864622331	NC_000017.11:31095301:G:A
NM_001042492.3(NF1):c.17C>T (p.Pro6Leu)	LOC111811965|NF1	P6L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219691	17	29422344	17	31095326	219691	222563	rs864622210	NC_000017.11:31095325:C:T
NM_001042492.3(NF1):c.36C>T (p.Ala12=)	LOC111811965|NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187615	17	29422363	17	31095345	187615	184495	rs786203866	NC_000017.11:31095344:C:T
NM_001042492.3(NF1):c.55G>T (p.Glu19Ter)	LOC111811965|NF1	E19*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186896	17	29422382	17	31095364	186896	184496	rs786203307	NC_000017.11:31095363:G:T
NM_030662.4(MAP2K2):c.274A>G (p.Arg92Gly)	MAP2K2	R92G	Neurofibromatosis-Noonan syndrome|not specified|Rasopathy	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2020)	criteria provided, conflicting interpretations	VCV000040772	19	4117446	19	4117448	40772	49242	rs759061964	NC_000019.10:4117447:T:C
NM_000249.4(MLH1):c.1942C>T (p.Pro648Ser)	MLH1	P648S, P307S, P407S, P290S, P615S, P550S, P593S	Lynch syndrome|Turcot syndrome|Lynch syndrome II|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017097	3	37090053	3	37048562	17097	32136	rs63750899	NC_000003.12:37048561:C:T
NM_000249.4(MLH1):c.199G>T (p.Gly67Trp)	MLH1	G67W	Lynch syndrome II|Turcot syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017088	3	37038192	3	36996701	17088	32127	rs63750206	NC_000003.12:36996700:G:T
NM_000249.4(MLH1):c.676C>T (p.Arg226Ter)	MLH1	R226*, R128*, R193*	not provided|Lynch syndrome|Lynch syndrome I|Turcot syndrome|Lynch syndrome II|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017087	3	37053589	3	37012098	17087	32126	rs63751615	NC_000003.12:37012097:C:T
NM_000251.3(MSH2):c.1906G>C (p.Ala636Pro)	MSH2	A636P, A570P	not provided|Carcinoma of colon|Lynch syndrome|Muir-Torré syndrome|Turcot syndrome|Lynch syndrome I|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome I|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000001764	2	47702310	2	47475171	1764	16803	rs63750875	NC_000002.12:47475170:G:C
NM_000179.3(MSH6):c.3020G>A (p.Trp1007Ter)	MSH6	W1007*, W705*, W877*	Mismatch repair cancer syndrome 3|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089331	2	48028142	2	47801003	89331	94805	rs587779252	NC_000002.12:47801002:G:A
NM_130439.3(MXI1):c.362C>T (p.Ala121Val)	MXI1	A54V, A121V, A18V	Neurofibrosarcoma	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000009537	10	111988034	10	110228276	9537	24576	rs137852604	NC_000010.11:110228275:C:T
NM_001042492.3(NF1):c.3296A>C (p.Lys1099Thr)	NF1	K1099T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319471	17	29559189	17	31232171	1319471	1309724		NC_000017.11:31232170:A:C
NM_001042492.3(NF1):c.6820-6T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319468	17	29665716	17	31338698	1319468	1309721		NC_000017.11:31338697:T:C
NM_001042492.3(NF1):c.7523A>T (p.Tyr2508Phe)	NF1	Y2487F, Y2508F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319467	17	29679340	17	31352322	1319467	1309720		NC_000017.11:31352321:A:T
NM_001042492.3(NF1):c.8377+1659C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319466	17	29689380	17	31362362	1319466	1309719		NC_000017.11:31362361:C:T
NM_001042492.3(NF1):c.563C>A (p.Ala188Glu)	NF1	A188E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319350	17	29496992	17	31169974	1319350	1309603		NC_000017.11:31169973:C:A
NM_001042492.3(NF1):c.1316T>C (p.Leu439Pro)	NF1	L439P	not provided	Uncertain significance(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV001318774	17	29533313	17	31206295	1318774	1307286		NC_000017.11:31206294:T:C
NM_001042492.3(NF1):c.3251C>G (p.Pro1084Arg)	NF1	P1084R	not provided	Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001199076	17	29559144	17	31232126	1199076	1188513		NC_000017.11:31232125:C:G
NM_001042492.3(NF1):c.7457+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic	no assertion criteria provided	VCV001184517	17	29677338	17	31350320	1184517	1174358		NC_000017.11:31350319:T:G
NM_001042492.3(NF1):c.654+28A>G	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV001170338	17	29508535	17	31181517	1170338	1157927		NC_000017.11:31181516:A:G
NM_001042492.3(NF1):c.3864T>C (p.Cys1288=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV001161844	17	29562784	17	31235766	1161844	1146980		NC_000017.11:31235765:T:C
NM_001042492.3(NF1):c.7190-8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV001161706	17	29676130	17	31349112	1161706	1147014		NC_000017.11:31349111:T:G
NM_001042492.3(NF1):c.4545G>A (p.Gln1515=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV001161145	17	29587501	17	31260483	1161145	1146985		NC_000017.11:31260482:G:A
NM_001042492.3(NF1):c.5484G>A (p.Arg1828=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001160935	17	29654732	17	31327714	1160935	1146998		NC_000017.11:31327713:G:A
NM_001042492.3(NF1):c.2193C>G (p.Leu731=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001159282	17	29553644	17	31226626	1159282	1146966		NC_000017.11:31226625:C:G
NM_001042492.3(NF1):c.586+9A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV001158776	17	29497024	17	31170006	1158776	1146947		NC_000017.11:31170005:A:G
NM_001042492.3(NF1):c.2817T>C (p.Asn939=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001158699	17	29556450	17	31229432	1158699	1146970		NC_000017.11:31229431:T:C
NM_001042492.3(NF1):c.609C>T (p.Ala203=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001158493	17	29508462	17	31181444	1158493	1146948		NC_000017.11:31181443:C:T
NM_001042492.3(NF1):c.7557G>A (p.Arg2519=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV001158232	17	29679374	17	31352356	1158232	1147016		NC_000017.11:31352355:G:A
NM_001042492.3(NF1):c.2991-8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001158126	17	29557270	17	31230252	1158126	1146972		NC_000017.11:31230251:C:T
NM_001042492.3(NF1):c.7947G>C (p.Val2649=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001157719	17	29684364	17	31357346	1157719	1147018		NC_000017.11:31357345:G:C
NM_001042492.3(NF1):c.8160+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001157705	17	29686043	17	31359025	1157705	1147022		NC_000017.11:31359024:T:C
NM_001042492.3(NF1):c.4242C>T (p.Ile1414=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV001157650	17	29585430	17	31258412	1157650	1146983		NC_000017.11:31258411:C:T
NM_001042492.3(NF1):c.3699T>C (p.Cys1233=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001156959	17	29560222	17	31233204	1156959	1146979		NC_000017.11:31233203:T:C
NM_001042492.3(NF1):c.8472A>G (p.Gln2824=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV001156937	17	29701125	17	31374107	1156937	1147026		NC_000017.11:31374106:A:G
NM_001042492.3(NF1):c.2412T>C (p.Ala804=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001156797	17	29556045	17	31229027	1156797	1146968		NC_000017.11:31229026:T:C
NM_001042492.3(NF1):c.4950T>G (p.Pro1650=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV001156628	17	29652952	17	31325934	1156628	1146991		NC_000017.11:31325933:T:G
NM_001042492.3(NF1):c.289-8T>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001155863	17	29490196	17	31163178	1155863	1146944		NC_000017.11:31163177:T:A
NM_001042492.3(NF1):c.687T>C (p.Asp229=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV001155714	17	29508760	17	31181742	1155714	1146951		NC_000017.11:31181741:T:C
NM_001042492.3(NF1):c.1506A>G (p.Ala502=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001155634	17	29541582	17	31214564	1155634	1146960		NC_000017.11:31214563:A:G
NM_001042492.3(NF1):c.3009G>A (p.Gly1003=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV001155313	17	29557296	17	31230278	1155313	1146973		NC_000017.11:31230277:G:A
NM_001042492.3(NF1):c.6627G>A (p.Leu2209=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001155200	17	29664585	17	31337567	1155200	1147009		NC_000017.11:31337566:G:A
NM_001042492.3(NF1):c.1080A>G (p.Pro360=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001154948	17	29528072	17	31201054	1154948	1146956		NC_000017.11:31201053:A:G
NM_001042492.3(NF1):c.318A>G (p.Glu106=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001154495	17	29490233	17	31163215	1154495	1146946		NC_000017.11:31163214:A:G
NM_001042492.3(NF1):c.6336C>T (p.Ala2112=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV001154100	17	29663841	17	31336823	1154100	1147005		NC_000017.11:31336822:C:T
NM_001042492.3(NF1):c.5253C>A (p.Thr1751=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, single submitter	VCV001153903	17	29653255	17	31326237	1153903	1146994		NC_000017.11:31326236:C:A
NM_001042492.3(NF1):c.678T>C (p.Asn226=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV001153761	17	29508751	17	31181733	1153761	1146950		NC_000017.11:31181732:T:C
NM_001042492.3(NF1):c.5181T>C (p.Pro1727=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 10, 2020)	criteria provided, single submitter	VCV001153366	17	29653183	17	31326165	1153366	1146993		NC_000017.11:31326164:T:C
NM_001042492.3(NF1):c.3198-7T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV001153017	17	29559084	17	31232066	1153017	1146975		NC_000017.11:31232065:T:G
NM_001042492.3(NF1):c.1221C>T (p.His407=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV001153012	17	29528464	17	31201446	1153012	1146959		NC_000017.11:31201445:C:T
NM_001042492.3(NF1):c.8427C>T (p.Asn2809=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001152677	17	29701080	17	31374062	1152677	1147024		NC_000017.11:31374061:C:T
NM_001042492.3(NF1):c.1528-8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV001152641	17	29546015	17	31218997	1152641	1146961		NC_000017.11:31218996:C:T
NM_001042492.3(NF1):c.7992G>A (p.Lys2664=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001152422	17	29685519	17	31358501	1152422	1147019		NC_000017.11:31358500:G:A
NM_001042492.3(NF1):c.5022C>A (p.Val1674=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV001152319	17	29653024	17	31326006	1152319	1146992		NC_000017.11:31326005:C:A
NM_001042492.3(NF1):c.4824T>C (p.Tyr1608=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV001151785	17	29592346	17	31265328	1151785	1146988		NC_000017.11:31265327:T:C
NM_001042492.3(NF1):c.4577+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV001151705	17	29587540	17	31260522	1151705	1146986		NC_000017.11:31260521:T:C
NM_001042492.3(NF1):c.6309C>T (p.Leu2103=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001151328	17	29663814	17	31336796	1151328	1147004		NC_000017.11:31336795:C:T
NM_001042492.3(NF1):c.8067G>T (p.Val2689=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV001151153	17	29685594	17	31358576	1151153	1147021		NC_000017.11:31358575:G:T
NM_001042492.3(NF1):c.948G>C (p.Leu316=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001150934	17	29527499	17	31200481	1150934	1146953		NC_000017.11:31200480:G:C
NM_001042492.3(NF1):c.6870G>A (p.Leu2290=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001150837	17	29665772	17	31338754	1150837	1147011		NC_000017.11:31338753:G:A
NM_001042492.3(NF1):c.7024C>T (p.Leu2342=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001150019	17	29667625	17	31340607	1150019	1147012		NC_000017.11:31340606:C:T
NM_001042492.3(NF1):c.1155T>C (p.Arg385=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001149973	17	29528147	17	31201129	1149973	1146958		NC_000017.11:31201128:T:C
NM_001042492.3(NF1):c.5271T>C (p.Val1757=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001149440	17	29654519	17	31327501	1149440	1146995		NC_000017.11:31327500:T:C
NM_001042492.3(NF1):c.1659T>C (p.His553=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV001149286	17	29548885	17	31221867	1149286	1146962		NC_000017.11:31221866:T:C
NM_001042492.3(NF1):c.8004G>C (p.Leu2668=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV001149258	17	29685531	17	31358513	1149258	1147020		NC_000017.11:31358512:G:C
NM_001042492.3(NF1):c.648G>A (p.Leu216=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV001148748	17	29508501	17	31181483	1148748	1146949		NC_000017.11:31181482:G:A
NM_001042492.3(NF1):c.3636C>T (p.Val1212=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV001148745	17	29560159	17	31233141	1148745	1146978		NC_000017.11:31233140:C:T
NM_001042492.3(NF1):c.2850+9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001148681	17	29556492	17	31229474	1148681	1146971		NC_000017.11:31229473:T:C
NM_001042492.3(NF1):c.4430+8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001148426	17	29586155	17	31259137	1148426	1146984		NC_000017.11:31259136:T:C
NM_001042492.3(NF1):c.5637C>T (p.Ala1879=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV001148361	17	29657341	17	31330323	1148361	1147000		NC_000017.11:31330322:C:T
NM_001042492.3(NF1):c.3222A>G (p.Glu1074=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, single submitter	VCV001147369	17	29559115	17	31232097	1147369	1146976		NC_000017.11:31232096:A:G
NM_001042492.3(NF1):c.3974+7C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001147134	17	29563046	17	31236028	1147134	1146981		NC_000017.11:31236027:C:T
NM_001042492.3(NF1):c.4896G>A (p.Lys1632=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV001146913	17	29652898	17	31325880	1146913	1146990		NC_000017.11:31325879:G:A
NM_001042492.3(NF1):c.2373C>T (p.Ile791=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001146300	17	29554588	17	31227570	1146300	1146967		NC_000017.11:31227569:C:T
NM_001042492.3(NF1):c.3354T>C (p.Ser1118=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 17, 2019)	criteria provided, single submitter	VCV001146161	17	29559757	17	31232739	1146161	1146977		NC_000017.11:31232738:T:C
NM_001042492.3(NF1):c.1101C>G (p.Gly367=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001145305	17	29528093	17	31201075	1145305	1146957		NC_000017.11:31201074:C:G
NM_001042492.3(NF1):c.5679A>G (p.Leu1893=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001144581	17	29657383	17	31330365	1144581	1147001		NC_000017.11:31330364:A:G
NM_001042492.3(NF1):c.4035G>A (p.Lys1345=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV001144520	17	29576062	17	31249044	1144520	1146982		NC_000017.11:31249043:G:A
NM_001042492.3(NF1):c.6120T>C (p.Ser2040=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001144454	17	29663464	17	31336446	1144454	1147003		NC_000017.11:31336445:T:C
NM_001042492.3(NF1):c.1071T>G (p.Leu357=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV001144182	17	29528063	17	31201045	1144182	1146955		NC_000017.11:31201044:T:G
NM_001042492.3(NF1):c.228A>G (p.Glu76=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV001143773	17	29486051	17	31159033	1143773	1146943		NC_000017.11:31159032:A:G
NM_001042492.3(NF1):c.5406C>A (p.Thr1802=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001143716	17	29654654	17	31327636	1143716	1146996		NC_000017.11:31327635:C:A
NM_001042492.3(NF1):c.5457C>T (p.Ala1819=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001143685	17	29654705	17	31327687	1143685	1146997		NC_000017.11:31327686:C:T
NM_001042492.3(NF1):c.6428-7C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001143634	17	29664379	17	31337361	1143634	1147006		NC_000017.11:31337360:C:T
NM_001042492.3(NF1):c.4636C>T (p.Leu1546=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 18, 2020)	criteria provided, single submitter	VCV001143498	17	29588787	17	31261769	1143498	1146987		NC_000017.11:31261768:C:T
NM_001042492.3(NF1):c.7812C>A (p.Leu2604=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001143471	17	29684051	17	31357033	1143471	1147017		NC_000017.11:31357032:C:A
NM_001042492.3(NF1):c.1968C>T (p.Ala656=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001143461	17	29552235	17	31225217	1143461	1146963		NC_000017.11:31225216:C:T
NM_001042492.3(NF1):c.5772A>G (p.Leu1924=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV001143312	17	29657476	17	31330458	1143312	1147002		NC_000017.11:31330457:A:G
NM_001042492.3(NF1):c.828G>A (p.Leu276=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV001143088	17	29509623	17	31182605	1143088	1146952		NC_000017.11:31182604:G:A
NM_001042492.3(NF1):c.7389T>C (p.Leu2463=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV001143009	17	29677268	17	31350250	1143009	1147015		NC_000017.11:31350249:T:C
NM_001042492.3(NF1):c.2190C>T (p.Asn730=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001142811	17	29553641	17	31226623	1142811	1146965		NC_000017.11:31226622:C:T
NM_001042492.3(NF1):c.7155C>T (p.Asn2385=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV001142714	17	29670119	17	31343101	1142714	1147013		NC_000017.11:31343100:C:T
NM_001042492.3(NF1):c.5538G>A (p.Arg1846=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001142683	17	29654786	17	31327768	1142683	1146999		NC_000017.11:31327767:G:A
NM_001042492.3(NF1):c.8161-4A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001142392	17	29687501	17	31360483	1142392	1147023		NC_000017.11:31360482:A:G
NM_001042492.3(NF1):c.289-4T>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV001142026	17	29490200	17	31163182	1142026	1146945		NC_000017.11:31163181:T:A
NM_001042492.3(NF1):c.6594T>C (p.Ala2198=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001141840	17	29664552	17	31337534	1141840	1147008		NC_000017.11:31337533:T:C
NM_001042492.3(NF1):c.2496C>T (p.Asp832=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001141809	17	29556129	17	31229111	1141809	1146969		NC_000017.11:31229110:C:T
NM_001042492.3(NF1):c.6C>G (p.Ala2=)	NF1|LOC111811965		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV001141694	17	29422333	17	31095315	1141694	1146942		NC_000017.11:31095314:C:G
NM_001042492.3(NF1):c.8469G>A (p.Lys2823=)	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)	criteria provided, conflicting interpretations	VCV001141489	17	29701122	17	31374104	1141489	1147025		NC_000017.11:31374103:G:A
NM_001042492.3(NF1):c.6704+10A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV001141419	17	29664908	17	31337890	1141419	1147010		NC_000017.11:31337889:A:G
NM_001042492.3(NF1):c.6453C>T (p.Leu2151=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV001141393	17	29664411	17	31337393	1141393	1147007		NC_000017.11:31337392:C:T
NM_001042492.3(NF1):c.4926A>G (p.Val1642=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV001140991	17	29652928	17	31325910	1140991	1126094		NC_000017.11:31325909:A:G
NM_001042492.3(NF1):c.7615+9A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001140877	17	29679441	17	31352423	1140877	1126119		NC_000017.11:31352422:A:G
NM_001042492.3(NF1):c.2694G>A (p.Leu898=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV001140766	17	29556327	17	31229309	1140766	1126070		NC_000017.11:31229308:G:A
NM_001042492.3(NF1):c.2850+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV001140721	17	29556490	17	31229472	1140721	1126074		NC_000017.11:31229471:T:C
NM_001042492.3(NF1):c.6708T>C (p.Phe2236=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV001140694	17	29665046	17	31338028	1140694	1126111		NC_000017.11:31338027:T:C
NM_001042492.3(NF1):c.8055G>T (p.Val2685=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001140522	17	29685582	17	31358564	1140522	1126120		NC_000017.11:31358563:G:T
NM_001042492.3(NF1):c.2400A>G (p.Glu800=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV001140255	17	29554615	17	31227597	1140255	1126067		NC_000017.11:31227596:A:G
NM_001042492.3(NF1):c.2577C>A (p.Gly859=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 19, 2020)	criteria provided, single submitter	VCV001140176	17	29556210	17	31229192	1140176	1126069		NC_000017.11:31229191:C:A
NM_001042492.3(NF1):c.2158C>A (p.Arg720=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV001140066	17	29553609	17	31226591	1140066	1126063		NC_000017.11:31226590:C:A
NM_001042492.3(NF1):c.5541A>G (p.Pro1847=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV001139730	17	29654789	17	31327771	1139730	1126099		NC_000017.11:31327770:A:G
NM_001042492.3(NF1):c.36C>G (p.Ala12=)	NF1|LOC111811965		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 28, 2020)	criteria provided, single submitter	VCV001139725	17	29422363	17	31095345	1139725	1126039		NC_000017.11:31095344:C:G
NM_001042492.3(NF1):c.5685A>G (p.Thr1895=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV001139462	17	29657389	17	31330371	1139462	1126100		NC_000017.11:31330370:A:G
NM_001042492.3(NF1):c.4731G>A (p.Gln1577=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV001139112	17	29592253	17	31265235	1139112	1126091		NC_000017.11:31265234:G:A
NM_001042492.3(NF1):c.4044T>C (p.His1348=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001138885	17	29576071	17	31249053	1138885	1126086		NC_000017.11:31249052:T:C
NM_001042492.3(NF1):c.600A>G (p.Lys200=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV001138721	17	29508453	17	31181435	1138721	1126047		NC_000017.11:31181434:A:G
NM_001042492.3(NF1):c.1056T>C (p.Asp352=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001138513	17	29527607	17	31200589	1138513	1126056		NC_000017.11:31200588:T:C
NM_001042492.3(NF1):c.426A>G (p.Leu142=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001137862	17	29490341	17	31163323	1137862	1126043		NC_000017.11:31163322:A:G
NM_001042492.3(NF1):c.5373C>T (p.Ile1791=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001137550	17	29654621	17	31327603	1137550	1126096		NC_000017.11:31327602:C:T
NM_001042492.3(NF1):c.3252T>C (p.Pro1084=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV001136489	17	29559145	17	31232127	1136489	1126081		NC_000017.11:31232126:T:C
NM_001042492.3(NF1):c.5718C>G (p.Leu1906=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV001136031	17	29657422	17	31330404	1136031	1126101		NC_000017.11:31330403:C:G
NM_001042492.3(NF1):c.3138A>G (p.Thr1046=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV001135761	17	29557884	17	31230866	1135761	1126080		NC_000017.11:31230865:A:G
NM_001042492.3(NF1):c.2991-8C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001135210	17	29557270	17	31230252	1135210	1126077		NC_000017.11:31230251:C:G
NM_001042492.3(NF1):c.4680C>T (p.Ser1560=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001135041	17	29588831	17	31261813	1135041	1126090		NC_000017.11:31261812:C:T
NM_001042492.3(NF1):c.5821T>C (p.Leu1941=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001134809	17	29661864	17	31334846	1134809	1126102		NC_000017.11:31334845:T:C
NM_001042492.3(NF1):c.657A>G (p.Ala219=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001134572	17	29508730	17	31181712	1134572	1126048		NC_000017.11:31181711:A:G
NM_001042492.3(NF1):c.2346A>G (p.Ala782=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV001134539	17	29554561	17	31227543	1134539	1126066		NC_000017.11:31227542:A:G
NM_001042492.3(NF1):c.7457+7G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV001134507	17	29677343	17	31350325	1134507	1126117		NC_000017.11:31350324:G:A
NM_001042492.3(NF1):c.4809T>C (p.Asn1603=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001134491	17	29592331	17	31265313	1134491	1126092		NC_000017.11:31265312:T:C
NM_001042492.3(NF1):c.587-5T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001134259	17	29508435	17	31181417	1134259	1126046		NC_000017.11:31181416:T:C
NM_001042492.3(NF1):c.1626T>C (p.Ala542=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001134249	17	29546121	17	31219103	1134249	1126060		NC_000017.11:31219102:T:C
NM_001042492.3(NF1):c.4620A>G (p.Ala1540=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001134228	17	29588771	17	31261753	1134228	1126089		NC_000017.11:31261752:A:G
NM_001042492.3(NF1):c.3114-10C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001133940	17	29557850	17	31230832	1133940	1126078		NC_000017.11:31230831:C:T
NM_001042492.3(NF1):c.5445G>A (p.Gln1815=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV001133545	17	29654693	17	31327675	1133545	1126098		NC_000017.11:31327674:G:A
NM_001042492.3(NF1):c.5862A>C (p.Ser1954=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV001133544	17	29661905	17	31334887	1133544	1126103		NC_000017.11:31334886:A:C
NM_001042492.3(NF1):c.4104A>G (p.Leu1368=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001133506	17	29576131	17	31249113	1133506	1126087		NC_000017.11:31249112:A:G
NM_001042492.3(NF1):c.2251+10A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001133350	17	29553712	17	31226694	1133350	1126065		NC_000017.11:31226693:A:C
NM_001042492.3(NF1):c.60+8G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV001133246	17	29422395	17	31095377	1133246	1126040		NC_000017.11:31095376:G:A
NM_001042492.3(NF1):c.7521C>T (p.Thr2507=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV001133210	17	29679338	17	31352320	1133210	1126118		NC_000017.11:31352319:C:T
NM_001042492.3(NF1):c.8298G>A (p.Leu2766=)	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2020)	criteria provided, conflicting interpretations	VCV001132814	17	29687642	17	31360624	1132814	1126123		NC_000017.11:31360623:G:A
NM_001042492.3(NF1):c.2892C>G (p.Thr964=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001132349	17	29556894	17	31229876	1132349	1126076		NC_000017.11:31229875:C:G
NM_001042492.3(NF1):c.672A>G (p.Val224=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001131669	17	29508745	17	31181727	1131669	1126049		NC_000017.11:31181726:A:G
NM_001042492.3(NF1):c.5997C>T (p.Ser1999=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV001131499	17	29662040	17	31335022	1131499	1126104		NC_000017.11:31335021:C:T
NM_001042492.3(NF1):c.3600A>G (p.Val1200=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001131026	17	29560123	17	31233105	1131026	1126084		NC_000017.11:31233104:A:G
NM_001042492.3(NF1):c.6993T>C (p.Tyr2331=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV001130959	17	29667594	17	31340576	1130959	1126115		NC_000017.11:31340575:T:C
NM_001042492.3(NF1):c.6720T>C (p.Tyr2240=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV001130856	17	29665058	17	31338040	1130856	1126112		NC_000017.11:31338039:T:C
NM_001042492.3(NF1):c.4890T>C (p.Thr1630=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001130809	17	29652892	17	31325874	1130809	1126093		NC_000017.11:31325873:T:C
NM_001042492.3(NF1):c.754T>C (p.Leu252=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV001130766	17	29509549	17	31182531	1130766	1126051		NC_000017.11:31182530:T:C
NM_001042492.3(NF1):c.4368A>G (p.Thr1456=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001130574	17	29586085	17	31259067	1130574	1126088		NC_000017.11:31259066:A:G
NM_001042492.3(NF1):c.2784T>C (p.Ala928=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV001130522	17	29556417	17	31229399	1130522	1126073		NC_000017.11:31229398:T:C
NM_001042492.3(NF1):c.587-6T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001130315	17	29508434	17	31181416	1130315	1126045		NC_000017.11:31181415:T:C
NM_001042492.3(NF1):c.783A>G (p.Lys261=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001130031	17	29509578	17	31182560	1130031	1126052		NC_000017.11:31182559:A:G
NM_001042492.3(NF1):c.6609A>G (p.Glu2203=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001130018	17	29664567	17	31337549	1130018	1126109		NC_000017.11:31337548:A:G
NM_001042492.3(NF1):c.1017C>T (p.Asn339=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV001129888	17	29527568	17	31200550	1129888	1126055		NC_000017.11:31200549:C:T
NM_001042492.3(NF1):c.888+9G>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001129279	17	29509692	17	31182674	1129279	1126053		NC_000017.11:31182673:G:C
NM_001042492.3(NF1):c.2721G>A (p.Glu907=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV001129254	17	29556354	17	31229336	1129254	1126072		NC_000017.11:31229335:G:A
NM_001042492.3(NF1):c.6558A>G (p.Ser2186=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV001129253	17	29664516	17	31337498	1129253	1126108		NC_000017.11:31337497:A:G
NM_001042492.3(NF1):c.327G>A (p.Leu109=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001128657	17	29490242	17	31163224	1128657	1126042		NC_000017.11:31163223:G:A
NM_001042492.3(NF1):c.6870G>C (p.Leu2290=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV001128607	17	29665772	17	31338754	1128607	1126113		NC_000017.11:31338753:G:C
NM_001042492.3(NF1):c.1992C>T (p.Asn664=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001128104	17	29552259	17	31225241	1128104	1126061		NC_000017.11:31225240:C:T
NM_001042492.3(NF1):c.2703A>G (p.Leu901=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV001128014	17	29556336	17	31229318	1128014	1126071		NC_000017.11:31229317:A:G
NM_001042492.3(NF1):c.2410-8G>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001127794	17	29556035	17	31229017	1127794	1126068		NC_000017.11:31229016:G:C
NM_001042492.3(NF1):c.5337A>G (p.Leu1779=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 3, 2019)	criteria provided, single submitter	VCV001127648	17	29654585	17	31327567	1127648	1126095		NC_000017.11:31327566:A:G
NM_001042492.3(NF1):c.3497-9C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001126408	17	29560011	17	31232993	1126408	1126083		NC_000017.11:31232992:C:T
NM_001042492.3(NF1):c.8463G>A (p.Val2821=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV001125956	17	29701116	17	31374098	1125956	1126124		NC_000017.11:31374097:G:A
NM_001042492.3(NF1):c.5388G>A (p.Glu1796=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001125633	17	29654636	17	31327618	1125633	1126097		NC_000017.11:31327617:G:A
NM_001042492.3(NF1):c.1611C>T (p.His537=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV001125182	17	29546106	17	31219088	1125182	1126059		NC_000017.11:31219087:C:T
NM_001042492.3(NF1):c.3622T>C (p.Leu1208=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001125181	17	29560145	17	31233127	1125181	1126085		NC_000017.11:31233126:T:C
NM_001042492.3(NF1):c.3454T>C (p.Leu1152=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV001124572	17	29559857	17	31232839	1124572	1126082		NC_000017.11:31232838:T:C
NM_001042492.3(NF1):c.2851-6C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV001124411	17	29556847	17	31229829	1124411	1126075		NC_000017.11:31229828:C:T
NM_001042492.3(NF1):c.999C>T (p.Tyr333=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001123999	17	29527550	17	31200532	1123999	1126054		NC_000017.11:31200531:C:T
NM_001042492.3(NF1):c.6428-9C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001123786	17	29664377	17	31337359	1123786	1126106		NC_000017.11:31337358:C:T
NM_001042492.3(NF1):c.1401A>G (p.Thr467=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV001123670	17	29541477	17	31214459	1123670	1126057		NC_000017.11:31214458:A:G
NM_001042492.3(NF1):c.6471A>G (p.Ser2157=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV001123546	17	29664429	17	31337411	1123546	1126107		NC_000017.11:31337410:A:G
NM_001042492.3(NF1):c.2052G>A (p.Gln684=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001123484	17	29553503	17	31226485	1123484	1126062		NC_000017.11:31226484:G:A
NM_001042492.3(NF1):c.6705-7A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001123461	17	29665036	17	31338018	1123461	1126110		NC_000017.11:31338017:A:T
NM_001042492.3(NF1):c.7290A>G (p.Glu2430=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001123409	17	29676238	17	31349220	1123409	1126116		NC_000017.11:31349219:A:G
NM_001042492.3(NF1):c.2169G>A (p.Val723=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001123093	17	29553620	17	31226602	1123093	1126064		NC_000017.11:31226601:G:A
NM_001042492.3(NF1):c.480-8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV001122791	17	29496901	17	31169883	1122791	1126044		NC_000017.11:31169882:C:T
NM_001042492.3(NF1):c.8166A>G (p.Thr2722=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001122703	17	29687510	17	31360492	1122703	1126122		NC_000017.11:31360491:A:G
NM_001042492.3(NF1):c.711C>A (p.Ile237=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV001122418	17	29508784	17	31181766	1122418	1126050		NC_000017.11:31181765:C:A
NM_001042492.3(NF1):c.6333A>T (p.Val2111=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001122399	17	29663838	17	31336820	1122399	1126105		NC_000017.11:31336819:A:T
NM_001042492.3(NF1):c.1594C>T (p.Leu532=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001122237	17	29546089	17	31219071	1122237	1126058		NC_000017.11:31219070:C:T
NM_001042492.3(NF1):c.8088A>C (p.Pro2696=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV001121745	17	29685615	17	31358597	1121745	1126121		NC_000017.11:31358596:A:C
NM_001042492.3(NF1):c.3126A>G (p.Val1042=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV001120856	17	29557872	17	31230854	1120856	1126079		NC_000017.11:31230853:A:G
NM_001042492.3(NF1):c.210A>T (p.Ile70=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV001120581	17	29486033	17	31159015	1120581	1126041		NC_000017.11:31159014:A:T
NM_001042492.3(NF1):c.3093T>C (p.Phe1031=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001119869	17	29557380	17	31230362	1119869	1104655		NC_000017.11:31230361:T:C
NM_001042492.3(NF1):c.2586C>T (p.Thr862=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV001119788	17	29556219	17	31229201	1119788	1104650		NC_000017.11:31229200:C:T
NM_001042492.3(NF1):c.1092C>T (p.Phe364=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV001119774	17	29528084	17	31201066	1119774	1104626		NC_000017.11:31201065:C:T
NM_001042492.3(NF1):c.4482T>C (p.His1494=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV001119773	17	29587438	17	31260420	1119773	1104666		NC_000017.11:31260419:T:C
NM_001042492.3(NF1):c.2199C>T (p.Pro733=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001119276	17	29553650	17	31226632	1119276	1104642		NC_000017.11:31226631:C:T
NM_001042492.3(NF1):c.4835+10A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001119175	17	29592367	17	31265349	1119175	1104670		NC_000017.11:31265348:A:G
NM_001042492.3(NF1):c.6067T>C (p.Leu2023=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV001118858	17	29663411	17	31336393	1118858	1104682		NC_000017.11:31336392:T:C
NM_001042492.3(NF1):c.6060A>C (p.Thr2020=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV001118807	17	29663404	17	31336386	1118807	1104681		NC_000017.11:31336385:A:C
NM_001042492.3(NF1):c.3876T>C (p.Tyr1292=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001118493	17	29562941	17	31235923	1118493	1104659		NC_000017.11:31235922:T:C
NM_001042492.3(NF1):c.4575C>T (p.Asn1525=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001117963	17	29587531	17	31260513	1117963	1104667		NC_000017.11:31260512:C:T
NM_001042492.3(NF1):c.4935T>C (p.Leu1645=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001117933	17	29652937	17	31325919	1117933	1104671		NC_000017.11:31325918:T:C
NM_001042492.3(NF1):c.1584G>T (p.Gly528=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV001117560	17	29546079	17	31219061	1117560	1104629		NC_000017.11:31219060:G:T
NM_001042492.3(NF1):c.8223G>T (p.Thr2741=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001117355	17	29687567	17	31360549	1117355	1104706		NC_000017.11:31360548:G:T
NM_001042492.3(NF1):c.132C>A (p.Ile44=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV001117188	17	29483072	17	31156054	1117188	1104619		NC_000017.11:31156053:C:A
NM_001042492.3(NF1):c.6231T>C (p.Asp2077=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 14, 2019)	criteria provided, single submitter	VCV001117182	17	29663736	17	31336718	1117182	1104684		NC_000017.11:31336717:T:C
NM_001042492.3(NF1):c.2454C>G (p.Ser818=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001117113	17	29556087	17	31229069	1117113	1104645		NC_000017.11:31229068:C:G
NM_001042492.3(NF1):c.2634T>A (p.Ile878=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001117057	17	29556267	17	31229249	1117057	1104651		NC_000017.11:31229248:T:A
NM_001042492.3(NF1):c.5916T>C (p.Thr1972=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001116838	17	29661959	17	31334941	1116838	1104679		NC_000017.11:31334940:T:C
NM_001042492.3(NF1):c.4431-4G>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, single submitter	VCV001116444	17	29587383	17	31260365	1116444	1104665		NC_000017.11:31260364:G:C
NM_001042492.3(NF1):c.3279G>A (p.Val1093=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001116263	17	29559172	17	31232154	1116263	1104657		NC_000017.11:31232153:G:A
NM_001042492.3(NF1):c.4009C>A (p.Arg1337=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV001116202	17	29576036	17	31249018	1116202	1104661		NC_000017.11:31249017:C:A
NM_001042492.3(NF1):c.2499C>A (p.Ser833=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 27, 2019)	criteria provided, single submitter	VCV001115939	17	29556132	17	31229114	1115939	1104648		NC_000017.11:31229113:C:A
NM_001042492.3(NF1):c.8250C>T (p.Thr2750=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001115707	17	29687594	17	31360576	1115707	1104708		NC_000017.11:31360575:C:T
NM_001042492.3(NF1):c.6573C>T (p.Ser2191=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001115590	17	29664531	17	31337513	1115590	1104686		NC_000017.11:31337512:C:T
NM_001042492.3(NF1):c.7099C>T (p.Leu2367=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001115580	17	29670063	17	31343045	1115580	1104693		NC_000017.11:31343044:C:T
NM_001042492.3(NF1):c.1721+8T>G	NF1	Y577D	Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001115019	17	29548955	17	31221937	1115019	1104633		NC_000017.11:31221936:T:G
NM_001042492.3(NF1):c.1767A>G (p.Gln589=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 3, 2019)	criteria provided, single submitter	VCV001114860	17	29550507	17	31223489	1114860	1104635		NC_000017.11:31223488:A:G
NM_001042492.3(NF1):c.7701C>G (p.Pro2567=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001114720	17	29683563	17	31356545	1114720	1104699		NC_000017.11:31356544:C:G
NM_001042492.3(NF1):c.3162C>T (p.Asn1054=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001114719	17	29557908	17	31230890	1114719	1104656		NC_000017.11:31230889:C:T
NM_001042492.3(NF1):c.1920C>T (p.Thr640=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001114323	17	29552187	17	31225169	1114323	1104639		NC_000017.11:31225168:C:T
NM_001042492.3(NF1):c.7971-9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV001114217	17	29685489	17	31358471	1114217	1104704		NC_000017.11:31358470:T:C
NM_001042492.3(NF1):c.7738+10A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV001113557	17	29683610	17	31356592	1113557	1104700		NC_000017.11:31356591:A:T
NM_001042492.3(NF1):c.5697T>C (p.Cys1899=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV001113519	17	29657401	17	31330383	1113519	1104678		NC_000017.11:31330382:T:C
NM_001042492.3(NF1):c.204+7A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001113333	17	29483151	17	31156133	1113333	1104620		NC_000017.11:31156132:A:G
NM_001042492.3(NF1):c.5136T>G (p.Pro1712=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001113292	17	29653138	17	31326120	1113292	1104675		NC_000017.11:31326119:T:G
NM_001042492.3(NF1):c.2475C>T (p.Ser825=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV001113101	17	29556108	17	31229090	1113101	1104647		NC_000017.11:31229089:C:T
NM_001042492.3(NF1):c.1890A>G (p.Val630=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001112729	17	29552157	17	31225139	1112729	1104638		NC_000017.11:31225138:A:G
NM_001042492.3(NF1):c.8262C>A (p.Ser2754=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001112715	17	29687606	17	31360588	1112715	1104709		NC_000017.11:31360587:C:A
NM_001042492.3(NF1):c.6138T>C (p.Val2046=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV001112141	17	29663482	17	31336464	1112141	1104683		NC_000017.11:31336463:T:C
NM_001042492.3(NF1):c.1545G>C (p.Gly515=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001112067	17	29546040	17	31219022	1112067	1104628		NC_000017.11:31219021:G:C
NM_001042492.3(NF1):c.2251+9G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV001111648	17	29553711	17	31226693	1111648	1104643		NC_000017.11:31226692:G:A
NM_001042492.3(NF1):c.2472A>T (p.Gly824=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001111412	17	29556105	17	31229087	1111412	1104646		NC_000017.11:31229086:A:T
NM_001042492.3(NF1):c.6705-8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV001110695	17	29665035	17	31338017	1110695	1104687		NC_000017.11:31338016:A:G
NM_001042492.3(NF1):c.1722-10G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001110684	17	29550452	17	31223434	1110684	1104634		NC_000017.11:31223433:G:A
NM_001042492.3(NF1):c.8226C>T (p.Tyr2742=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV001110284	17	29687570	17	31360552	1110284	1104707		NC_000017.11:31360551:C:T
NM_001042492.3(NF1):c.7503A>G (p.Glu2501=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001110254	17	29679320	17	31352302	1110254	1104695		NC_000017.11:31352301:A:G
NM_001042492.3(NF1):c.1698T>C (p.Pro566=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, single submitter	VCV001110106	17	29548924	17	31221906	1110106	1104632		NC_000017.11:31221905:T:C
NM_001042492.3(NF1):c.7908A>G (p.Gln2636=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001110081	17	29684325	17	31357307	1110081	1104702		NC_000017.11:31357306:A:G
NM_001042492.3(NF1):c.5083C>A (p.Arg1695=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001110063	17	29653085	17	31326067	1110063	1104674		NC_000017.11:31326066:C:A
NM_001042492.3(NF1):c.655-8A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV001110006	17	29508720	17	31181702	1110006	1104622		NC_000017.11:31181701:A:C
NM_001042492.3(NF1):c.5061G>A (p.Arg1687=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV001109943	17	29653063	17	31326045	1109943	1104673		NC_000017.11:31326044:G:A
NM_001042492.3(NF1):c.1590C>T (p.Val530=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV001109858	17	29546085	17	31219067	1109858	1104630		NC_000017.11:31219066:C:T
NM_001042492.3(NF1):c.7014T>C (p.Leu2338=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001109651	17	29667615	17	31340597	1109651	1104690		NC_000017.11:31340596:T:C
NM_001042492.3(NF1):c.5307A>G (p.Arg1769=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001109461	17	29654555	17	31327537	1109461	1104677		NC_000017.11:31327536:A:G
NM_001042492.3(NF1):c.2773T>C (p.Leu925=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001109395	17	29556406	17	31229388	1109395	1104652		NC_000017.11:31229387:T:C
NM_001042492.3(NF1):c.2892C>A (p.Thr964=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001108977	17	29556894	17	31229876	1108977	1104653		NC_000017.11:31229875:C:A
NM_001042492.3(NF1):c.2002-5C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001108678	17	29553448	17	31226430	1108678	1104641		NC_000017.11:31226429:C:T
NM_001042492.3(NF1):c.8289T>G (p.Pro2763=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV001108607	17	29687633	17	31360615	1108607	1104710		NC_000017.11:31360614:T:G
NM_001042492.3(NF1):c.8466G>A (p.Gln2822=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV001108092	17	29701119	17	31374101	1108092	1104711		NC_000017.11:31374100:G:A
NM_001042492.3(NF1):c.8514C>T (p.Ile2838=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV001107647	17	29701167	17	31374149	1107647	1104712		NC_000017.11:31374148:C:T
NM_001042492.3(NF1):c.2499C>T (p.Ser833=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV001107428	17	29556132	17	31229114	1107428	1104649		NC_000017.11:31229113:C:T
NM_001042492.3(NF1):c.4200C>T (p.Asn1400=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001107042	17	29585388	17	31258370	1107042	1104663		NC_000017.11:31258369:C:T
NM_001042492.3(NF1):c.4671A>T (p.Thr1557=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001106830	17	29588822	17	31261804	1106830	1104668		NC_000017.11:31261803:A:T
NM_001042492.3(NF1):c.6282T>G (p.Leu2094=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV001106806	17	29663787	17	31336769	1106806	1104685		NC_000017.11:31336768:T:G
NM_001042492.3(NF1):c.6933G>A (p.Leu2311=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001106758	17	29667534	17	31340516	1106758	1104689		NC_000017.11:31340515:G:A
NM_001042492.3(NF1):c.2448A>C (p.Arg816=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV001106404	17	29556081	17	31229063	1106404	1104644		NC_000017.11:31229062:A:C
NM_001042492.3(NF1):c.7656G>A (p.Lys2552=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001106378	17	29683518	17	31356500	1106378	1104697		NC_000017.11:31356499:G:A
NM_001042492.3(NF1):c.594A>G (p.Ala198=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV001105976	17	29508447	17	31181429	1105976	1104621		NC_000017.11:31181428:A:G
NM_001042492.3(NF1):c.6756T>C (p.Phe2252=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001105871	17	29665094	17	31338076	1105871	1104688		NC_000017.11:31338075:T:C
NM_001042492.3(NF1):c.831T>C (p.Cys277=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV001105794	17	29509626	17	31182608	1105794	1104623		NC_000017.11:31182607:T:C
NM_001042492.3(NF1):c.888+10G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001105716	17	29509693	17	31182675	1105716	1104624		NC_000017.11:31182674:G:A
NM_001042492.3(NF1):c.5244C>T (p.His1748=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001105155	17	29653246	17	31326228	1105155	1104676		NC_000017.11:31326227:C:T
NM_001042492.3(NF1):c.1650G>A (p.Leu550=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001104816	17	29548876	17	31221858	1104816	1104631		NC_000017.11:31221857:G:A
NM_001042492.3(NF1):c.3497-6C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV001104716	17	29560014	17	31232996	1104716	1104658		NC_000017.11:31232995:C:T
NM_001042492.3(NF1):c.4430+8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001104207	17	29586155	17	31259137	1104207	1104664		NC_000017.11:31259136:T:G
NM_001042492.3(NF1):c.1845+9A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV001104173	17	29550594	17	31223576	1104173	1104637		NC_000017.11:31223575:A:G
NM_001042492.3(NF1):c.7689C>A (p.Ile2563=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001104137	17	29683551	17	31356533	1104137	1104698		NC_000017.11:31356532:C:A
NM_001042492.3(NF1):c.5001T>C (p.Pro1667=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001104116	17	29653003	17	31325985	1104116	1104672		NC_000017.11:31325984:T:C
NM_001042492.3(NF1):c.5967C>T (p.Tyr1989=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV001103728	17	29662010	17	31334992	1103728	1104680		NC_000017.11:31334991:C:T
NM_001042492.3(NF1):c.1812G>A (p.Leu604=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001103573	17	29550552	17	31223534	1103573	1104636		NC_000017.11:31223533:G:A
NM_001042492.3(NF1):c.7458-4T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001103088	17	29679271	17	31352253	1103088	1104694		NC_000017.11:31352252:T:C
NM_001042492.3(NF1):c.2002-8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV001102801	17	29553445	17	31226427	1102801	1104640		NC_000017.11:31226426:A:G
NM_001042492.3(NF1):c.4017C>A (p.Leu1339=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV001102791	17	29576044	17	31249026	1102791	1104662		NC_000017.11:31249025:C:A
NM_001042492.3(NF1):c.8142T>C (p.Phe2714=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV001102415	17	29686015	17	31358997	1102415	1104705		NC_000017.11:31358996:T:C
NM_001042492.3(NF1):c.7533C>G (p.Val2511=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001102244	17	29679350	17	31352332	1102244	1104696		NC_000017.11:31352331:C:G
NM_001042492.3(NF1):c.1149C>T (p.Cys383=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV001101143	17	29528141	17	31201123	1101143	1104627		NC_000017.11:31201122:C:T
NM_001042492.3(NF1):c.2937C>T (p.Ser979=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001101142	17	29556939	17	31229921	1101142	1104654		NC_000017.11:31229920:C:T
NM_001042492.3(NF1):c.3978A>G (p.Leu1326=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001100331	17	29576005	17	31248987	1100331	1104660		NC_000017.11:31248986:A:G
NM_001042492.3(NF1):c.7063-4A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV001099862	17	29670023	17	31343005	1099862	1104692		NC_000017.11:31343004:A:T
NM_001042492.3(NF1):c.1062+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001099593	17	29527623	17	31200605	1099593	1104625		NC_000017.11:31200604:T:C
NM_001042492.3(NF1):c.7743T>C (p.Thr2581=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV001099465	17	29683982	17	31356964	1099465	1104701		NC_000017.11:31356963:T:C
NM_001042492.3(NF1):c.7965T>G (p.Pro2655=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV001099406	17	29684382	17	31357364	1099406	1104703		NC_000017.11:31357363:T:G
NM_001042492.3(NF1):c.2103A>G (p.Glu701=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV001098093	17	29553554	17	31226536	1098093	1082847		NC_000017.11:31226535:A:G
NM_001042492.3(NF1):c.642T>C (p.Asn214=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV001098062	17	29508495	17	31181477	1098062	1082834		NC_000017.11:31181476:T:C
NM_001042492.3(NF1):c.480-7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV001097886	17	29496902	17	31169884	1097886	1082831		NC_000017.11:31169883:T:C
NM_001042492.3(NF1):c.6625T>C (p.Leu2209=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001096877	17	29664583	17	31337565	1096877	1082895		NC_000017.11:31337564:T:C
NM_001042492.3(NF1):c.60+10C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV001096741	17	29422397	17	31095379	1096741	1082820		NC_000017.11:31095378:C:G
NM_001042492.3(NF1):c.8343C>A (p.Ser2781=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV001096714	17	29687687	17	31360669	1096714	1082915		NC_000017.11:31360668:C:A
NM_001042492.3(NF1):c.7191G>T (p.Gly2397=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV001096684	17	29676139	17	31349121	1096684	1082903		NC_000017.11:31349120:G:T
NM_001042492.3(NF1):c.3186A>G (p.Lys1062=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV001096511	17	29557932	17	31230914	1096511	1082858		NC_000017.11:31230913:A:G
NM_001042492.3(NF1):c.5601G>T (p.Pro1867=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV001096419	17	29654849	17	31327831	1096419	1082885		NC_000017.11:31327830:G:T
NM_001042492.3(NF1):c.480-10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV001096129	17	29496899	17	31169881	1096129	1082830		NC_000017.11:31169880:T:C
NM_001042492.3(NF1):c.438C>T (p.Ser146=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001095536	17	29490353	17	31163335	1095536	1082828		NC_000017.11:31163334:C:T
NM_001042492.3(NF1):c.5526C>T (p.His1842=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV001095116	17	29654774	17	31327756	1095116	1082884		NC_000017.11:31327755:C:T
NM_001042492.3(NF1):c.7869+8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV001094802	17	29684116	17	31357098	1094802	1082910		NC_000017.11:31357097:T:G
NM_001042492.3(NF1):c.61-8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001093986	17	29482993	17	31155975	1093986	1082821		NC_000017.11:31155974:T:C
NM_001042492.3(NF1):c.2410-4T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001093592	17	29556039	17	31229021	1093592	1082851		NC_000017.11:31229020:T:G
NM_001042492.3(NF1):c.2851-7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001092954	17	29556846	17	31229828	1092954	1082852		NC_000017.11:31229827:T:C
NM_001042492.3(NF1):c.3198-8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001092728	17	29559083	17	31232065	1092728	1082859		NC_000017.11:31232064:T:G
NM_001042492.3(NF1):c.4623A>C (p.Thr1541=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV001092704	17	29588774	17	31261756	1092704	1082874		NC_000017.11:31261755:A:C
NM_001042492.3(NF1):c.5325A>G (p.Gln1775=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001091976	17	29654573	17	31327555	1091976	1082883		NC_000017.11:31327554:A:G
NM_001042492.3(NF1):c.6007-7C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001091814	17	29663344	17	31336326	1091814	1082889		NC_000017.11:31336325:C:T
NM_001042492.3(NF1):c.378A>G (p.Glu126=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV001091813	17	29490293	17	31163275	1091813	1082825		NC_000017.11:31163274:A:G
NM_001042492.3(NF1):c.2409+8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001091640	17	29554632	17	31227614	1091640	1082850		NC_000017.11:31227613:T:G
NM_001042492.3(NF1):c.1950A>G (p.Leu650=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001091544	17	29552217	17	31225199	1091544	1082846		NC_000017.11:31225198:A:G
NM_001042492.3(NF1):c.3231T>A (p.Val1077=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV001091457	17	29559124	17	31232106	1091457	1082860		NC_000017.11:31232105:T:A
NM_001042492.3(NF1):c.5184T>C (p.Ala1728=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV001091155	17	29653186	17	31326168	1091155	1082880		NC_000017.11:31326167:T:C
NM_001042492.3(NF1):c.4380T>C (p.His1460=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV001090887	17	29586097	17	31259079	1090887	1082869		NC_000017.11:31259078:T:C
NM_001042492.3(NF1):c.5133T>C (p.Cys1711=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV001090511	17	29653135	17	31326117	1090511	1082878		NC_000017.11:31326116:T:C
NM_001042492.3(NF1):c.3267A>G (p.Glu1089=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV001089516	17	29559160	17	31232142	1089516	1082861		NC_000017.11:31232141:A:G
NM_001042492.3(NF1):c.396T>C (p.Ala132=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001089494	17	29490311	17	31163293	1089494	1082826		NC_000017.11:31163292:T:C
NM_001042492.3(NF1):c.8107C>T (p.Leu2703=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV001089268	17	29685634	17	31358616	1089268	1082914		NC_000017.11:31358615:C:T
NM_001042492.3(NF1):c.432T>C (p.Ser144=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV001089249	17	29490347	17	31163329	1089249	1082827		NC_000017.11:31163328:T:C
NM_001042492.3(NF1):c.1267T>C (p.Leu423=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001089047	17	29533264	17	31206246	1089047	1082840		NC_000017.11:31206245:T:C
NM_001042492.3(NF1):c.5010T>C (p.Ala1670=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001088991	17	29653012	17	31325994	1088991	1082876		NC_000017.11:31325993:T:C
NM_001042492.3(NF1):c.7458-9A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001088809	17	29679266	17	31352248	1088809	1082909		NC_000017.11:31352247:A:C
NM_001042492.3(NF1):c.1063-10G>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV001088603	17	29528045	17	31201027	1088603	1082837		NC_000017.11:31201026:G:T
NM_001042492.3(NF1):c.1341T>A (p.Leu447=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV001088496	17	29533338	17	31206320	1088496	1082841		NC_000017.11:31206319:T:A
NM_001042492.3(NF1):c.288+10T>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV001088213	17	29486121	17	31159103	1088213	1082823		NC_000017.11:31159102:T:A
NM_001042492.3(NF1):c.543G>A (p.Gln181=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001088179	17	29496972	17	31169954	1088179	1082832		NC_000017.11:31169953:G:A
NM_001042492.3(NF1):c.2252-10A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV001088111	17	29554226	17	31227208	1088111	1082849		NC_000017.11:31227207:A:G
NM_001042492.3(NF1):c.5100C>G (p.Leu1700=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001088024	17	29653102	17	31326084	1088024	1082877		NC_000017.11:31326083:C:G
NM_001042492.3(NF1):c.3183A>G (p.Val1061=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV001087889	17	29557929	17	31230911	1087889	1082857		NC_000017.11:31230910:A:G
NM_001042492.3(NF1):c.6570C>T (p.Gly2190=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV001087157	17	29664528	17	31337510	1087157	1082894		NC_000017.11:31337509:C:T
NM_001042492.3(NF1):c.1528-7C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001086288	17	29546016	17	31218998	1086288	1082843		NC_000017.11:31218997:C:G
NM_001042492.3(NF1):c.6726A>C (p.Pro2242=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001086281	17	29665064	17	31338046	1086281	1082896		NC_000017.11:31338045:A:C
NM_001042492.3(NF1):c.2990+7A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001086264	17	29556999	17	31229981	1086264	1082854		NC_000017.11:31229980:A:C
NM_001042492.3(NF1):c.5721T>C (p.Phe1907=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV001086186	17	29657425	17	31330407	1086186	1082887		NC_000017.11:31330406:T:C
NM_001042492.3(NF1):c.3084C>T (p.Asp1028=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV001085865	17	29557371	17	31230353	1085865	1082856		NC_000017.11:31230352:C:T
NM_001042492.3(NF1):c.1014T>C (p.Asp338=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001085830	17	29527565	17	31200547	1085830	1082836		NC_000017.11:31200546:T:C
NM_001042492.3(NF1):c.5148T>C (p.Ala1716=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001085370	17	29653150	17	31326132	1085370	1082879		NC_000017.11:31326131:T:C
NM_001042492.3(NF1):c.279T>C (p.Cys93=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001085343	17	29486102	17	31159084	1085343	1082822		NC_000017.11:31159083:T:C
NM_001042492.3(NF1):c.4476A>C (p.Val1492=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001085292	17	29587432	17	31260414	1085292	1082871		NC_000017.11:31260413:A:C
NM_001042492.3(NF1):c.2251+8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 12, 2020)	criteria provided, single submitter	VCV001085254	17	29553710	17	31226692	1085254	1082848		NC_000017.11:31226691:T:G
NM_001042492.3(NF1):c.3315-6T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV001085201	17	29559712	17	31232694	1085201	1082862		NC_000017.11:31232693:T:C
NM_001042492.3(NF1):c.7053C>T (p.Phe2351=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001085144	17	29667654	17	31340636	1085144	1082899		NC_000017.11:31340635:C:T
NM_001042492.3(NF1):c.7457+8G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV001085116	17	29677344	17	31350326	1085116	1082908		NC_000017.11:31350325:G:A
NM_001042492.3(NF1):c.8460A>G (p.Gln2820=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001084984	17	29701113	17	31374095	1084984	1082916		NC_000017.11:31374094:A:G
NM_001042492.3(NF1):c.5898C>G (p.Ala1966=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001084313	17	29661941	17	31334923	1084313	1082888		NC_000017.11:31334922:C:G
NM_001042492.3(NF1):c.4174-8G>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV001084254	17	29585354	17	31258336	1084254	1082868		NC_000017.11:31258335:G:T
NM_001042492.3(NF1):c.4725-7C>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001084103	17	29592240	17	31265222	1084103	1082875		NC_000017.11:31265221:C:A
NM_001042492.3(NF1):c.1908T>C (p.Ser636=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV001083934	17	29552175	17	31225157	1083934	1082845		NC_000017.11:31225156:T:C
NM_001042492.3(NF1):c.3453C>T (p.Asn1151=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV001083270	17	29559856	17	31232838	1083270	1082864		NC_000017.11:31232837:C:T
NM_001042492.3(NF1):c.5208C>T (p.Asp1736=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV001083007	17	29653210	17	31326192	1083007	1082881		NC_000017.11:31326191:C:T
NM_001042492.3(NF1):c.7870-10A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV001082950	17	29684277	17	31357259	1082950	1082911		NC_000017.11:31357258:A:C
NM_001042492.3(NF1):c.327G>T (p.Leu109=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001082602	17	29490242	17	31163224	1082602	1082824		NC_000017.11:31163223:G:T
NM_001042492.3(NF1):c.1260+10A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV001082274	17	29528513	17	31201495	1082274	1082839		NC_000017.11:31201494:A:C
NM_001042492.3(NF1):c.3974+8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV001082239	17	29563047	17	31236029	1082239	1082865		NC_000017.11:31236028:A:G
NM_001042492.3(NF1):c.7149C>T (p.Asn2383=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001082103	17	29670113	17	31343095	1082103	1082900		NC_000017.11:31343094:C:T
NM_001042492.3(NF1):c.7189+10C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001081694	17	29670163	17	31343145	1081694	1082902		NC_000017.11:31343144:C:G
NM_001042492.3(NF1):c.7281C>T (p.Asp2427=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV001081661	17	29676229	17	31349211	1081661	1082905		NC_000017.11:31349210:C:T
NM_001042492.3(NF1):c.6531C>T (p.Ala2177=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001081656	17	29664489	17	31337471	1081656	1082893		NC_000017.11:31337470:C:T
NM_001042492.3(NF1):c.4431-6T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001081376	17	29587381	17	31260363	1081376	1082870		NC_000017.11:31260362:T:C
NM_001042492.3(NF1):c.7989T>A (p.Ser2663=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV001081289	17	29685516	17	31358498	1081289	1082913		NC_000017.11:31358497:T:A
NM_001042492.3(NF1):c.849T>C (p.Asp283=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001081132	17	29509644	17	31182626	1081132	1082835		NC_000017.11:31182625:T:C
NM_001042492.3(NF1):c.6969G>A (p.Leu2323=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001081120	17	29667570	17	31340552	1081120	1082898		NC_000017.11:31340551:G:A
NM_001042492.3(NF1):c.1674T>C (p.Ile558=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001081114	17	29548900	17	31221882	1081114	1082844		NC_000017.11:31221881:T:C
NM_001042492.3(NF1):c.4551A>G (p.Lys1517=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV001080905	17	29587507	17	31260489	1080905	1082873		NC_000017.11:31260488:A:G
NM_001042492.3(NF1):c.4062C>G (p.Ser1354=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV001080716	17	29576089	17	31249071	1080716	1082866		NC_000017.11:31249070:C:G
NM_001042492.3(NF1):c.462T>C (p.Phe154=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001080617	17	29490377	17	31163359	1080617	1082829		NC_000017.11:31163358:T:C
NM_001042492.3(NF1):c.1146T>G (p.Ser382=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV001080408	17	29528138	17	31201120	1080408	1082838		NC_000017.11:31201119:T:G
NM_001042492.3(NF1):c.2994T>C (p.Tyr998=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001080337	17	29557281	17	31230263	1080337	1082855		NC_000017.11:31230262:T:C
NM_001042492.3(NF1):c.7870-7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV001079953	17	29684280	17	31357262	1079953	1082912		NC_000017.11:31357261:T:C
NM_001042492.3(NF1):c.4533C>G (p.Leu1511=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV001079942	17	29587489	17	31260471	1079942	1082872		NC_000017.11:31260470:C:G
NM_001042492.3(NF1):c.636T>C (p.Val212=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001079750	17	29508489	17	31181471	1079750	1082833		NC_000017.11:31181470:T:C
NM_001042492.3(NF1):c.7272A>G (p.Arg2424=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001079512	17	29676220	17	31349202	1079512	1082904		NC_000017.11:31349201:A:G
NM_001042492.3(NF1):c.4174-10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV001079093	17	29585352	17	31258334	1079093	1082867		NC_000017.11:31258333:T:C
NM_001042492.3(NF1):c.3405T>G (p.Ser1135=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV001079092	17	29559808	17	31232790	1079092	1082863		NC_000017.11:31232789:T:G
NM_001042492.3(NF1):c.2857T>C (p.Leu953=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001078863	17	29556859	17	31229841	1078863	1082853		NC_000017.11:31229840:T:C
NM_001042492.3(NF1):c.6117T>C (p.Ala2039=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001078827	17	29663461	17	31336443	1078827	1082890		NC_000017.11:31336442:T:C
NM_001042492.3(NF1):c.7401A>G (p.Ser2467=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV001078706	17	29677280	17	31350262	1078706	1082907		NC_000017.11:31350261:A:G
NM_001042492.3(NF1):c.6783T>C (p.His2261=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV001078643	17	29665121	17	31338103	1078643	1082897		NC_000017.11:31338102:T:C
NM_001042492.3(NF1):c.6525C>T (p.Val2175=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001077596	17	29664483	17	31337465	1077596	1082892		NC_000017.11:31337464:C:T
NM_001042492.3(NF1):c.5268+8C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001077531	17	29653278	17	31326260	1077531	1082882		NC_000017.11:31326259:C:G
NM_001042492.3(NF1):c.5610-5C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001077369	17	29657309	17	31330291	1077369	1082886		NC_000017.11:31330290:C:T
NM_001042492.3(NF1):c.7322-7C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV001077348	17	29677194	17	31350176	1077348	1082906		NC_000017.11:31350175:C:T
NM_001042492.3(NF1):c.2409+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001076968	17	29554626	17	31227608	1076968	1063955		NC_000017.11:31227607:T:A
NM_001042492.3(NF1):c.7405G>T (p.Glu2469Ter)	NF1	E2448*, E2469*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001076950	17	29677284	17	31350266	1076950	1064109		NC_000017.11:31350265:G:T
NM_001042492.3(NF1):c.6705-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001076270	17	29665041	17	31338023	1076270	1064086		NC_000017.11:31338022:A:G
NM_001042492.3(NF1):c.586+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2014)	criteria provided, single submitter	VCV001076152	17	29497016	17	31169998	1076152	1063896		NC_000017.11:31169997:G:T
NM_001042492.3(NF1):c.5349T>G (p.Tyr1783Ter)	NF1	Y1762*, Y1783*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001076066	17	29654597	17	31327579	1076066	1064055		NC_000017.11:31327578:T:G
NM_001042492.3(NF1):c.5198T>G (p.Leu1733Ter)	NF1	L1712*, L1733*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 25, 2020)	criteria provided, single submitter	VCV001076065	17	29653200	17	31326182	1076065	1064048		NC_000017.11:31326181:T:G
NM_001042492.3(NF1):c.2326-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001076019	17	29554539	17	31227521	1076019	1063952		NC_000017.11:31227520:A:C
NM_001042492.3(NF1):c.7247T>C (p.Leu2416Pro)	NF1	L2395P, L2416P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001075890	17	29676195	17	31349177	1075890	1064104		NC_000017.11:31349176:T:C
NM_001042492.3(NF1):c.3888T>G (p.Tyr1296Ter)	NF1	Y1296*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001075772	17	29562953	17	31235935	1075772	1064006		NC_000017.11:31235934:T:G
NM_001042492.3(NF1):c.3197+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001075712	17	29557945	17	31230927	1075712	1063984		NC_000017.11:31230926:T:G
NM_001042492.3(NF1):c.739G>T (p.Glu247Ter)	NF1	E247*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001075677	17	29509534	17	31182516	1075677	1063901		NC_000017.11:31182515:G:T
NM_001042492.3(NF1):c.3158C>A (p.Ser1053Ter)	NF1	S1053*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001075651	17	29557904	17	31230886	1075651	1063983		NC_000017.11:31230885:C:A
NM_001042492.3(NF1):c.1682G>A (p.Trp561Ter)	NF1	W561*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001075405	17	29548908	17	31221890	1075405	1063930		NC_000017.11:31221889:G:A
NM_001042492.3(NF1):c.1481T>A (p.Leu494Ter)	NF1	L494*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001075404	17	29541557	17	31214539	1075404	1063924		NC_000017.11:31214538:T:A
NM_001042492.3(NF1):c.3544G>C (p.Val1182Leu)	NF1	V1182L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001075346	17	29560067	17	31233049	1075346	1063992		NC_000017.11:31233048:G:C
NM_001042492.3(NF1):c.5268+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001075148	17	29653272	17	31326254	1075148	1064054		NC_000017.11:31326253:T:C
NM_001042492.3(NF1):c.655-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV001075101	17	29508727	17	31181709	1075101	1063897		NC_000017.11:31181708:G:A
NM_001042492.3(NF1):c.346G>T (p.Glu116Ter)	NF1	E116*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001074966	17	29490261	17	31163243	1074966	1063892		NC_000017.11:31163242:G:T
NM_001042492.3(NF1):c.1642-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001074691	17	29548866	17	31221848	1074691	1063927		NC_000017.11:31221847:A:G
NM_001042492.3(NF1):c.7682C>G (p.Ser2561Ter)	NF1	S2540*, S2561*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001074475	17	29683544	17	31356526	1074475	1064121		NC_000017.11:31356525:C:G
NM_001042492.3(NF1):c.7615+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001074474	17	29679433	17	31352415	1074474	1064117		NC_000017.11:31352414:G:A
NM_001042492.3(NF1):c.2648C>A (p.Ser883Ter)	NF1	S883*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001074410	17	29556281	17	31229263	1074410	1063962		NC_000017.11:31229262:C:A
NM_001042492.3(NF1):c.3301C>T (p.Gln1101Ter)	NF1	Q1101*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001074271	17	29559194	17	31232176	1074271	1063985		NC_000017.11:31232175:C:T
NM_001042492.3(NF1):c.6224G>A (p.Trp2075Ter)	NF1	W2054*, W2075*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001074137	17	29663729	17	31336711	1074137	1064074		NC_000017.11:31336710:G:A
NM_001042492.3(NF1):c.6007-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV001074136	17	29663350	17	31336332	1074136	1064066		NC_000017.11:31336331:G:T
NM_001042492.3(NF1):c.3113+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV001074026	17	29557402	17	31230384	1074026	1063979		NC_000017.11:31230383:T:A
NM_001042492.3(NF1):c.2410-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, single submitter	VCV001073903	17	29556041	17	31229023	1073903	1063957		NC_000017.11:31229022:A:G
NM_001042492.3(NF1):c.4725-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001073883	17	29592245	17	31265227	1073883	1064029		NC_000017.11:31265226:A:G
NM_001042492.3(NF1):c.4006C>T (p.Gln1336Ter)	NF1	Q1336*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 30, 2020)	criteria provided, single submitter	VCV001073775	17	29576033	17	31249015	1073775	1064013		NC_000017.11:31249014:C:T
NM_001042492.3(NF1):c.3975-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001073774	17	29576001	17	31248983	1073774	1064012		NC_000017.11:31248982:G:A
NM_001042492.3(NF1):c.3974+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001073773	17	29563040	17	31236022	1073773	1064011		NC_000017.11:31236021:G:T
NM_001042492.3(NF1):c.6643-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV001073530	17	29664836	17	31337818	1073530	1064084		NC_000017.11:31337817:G:C
NM_001042492.3(NF1):c.1261-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001073144	17	29533257	17	31206239	1073144	1063916		NC_000017.11:31206238:G:A
NM_001042492.3(NF1):c.731-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001073116	17	29509525	17	31182507	1073116	1063900		NC_000017.11:31182506:G:C
NM_001042492.3(NF1):c.139T>C (p.Ser47Pro)	NF1	S47P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001073012	17	29483079	17	31156061	1073012	1063885		NC_000017.11:31156060:T:C
NM_001042492.3(NF1):c.1747A>T (p.Lys583Ter)	NF1	K583*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001072955	17	29550487	17	31223469	1072955	1063935		NC_000017.11:31223468:A:T
NM_001042492.3(NF1):c.4333-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV001072744	17	29586049	17	31259031	1072744	1064020		NC_000017.11:31259030:G:T
NM_001042492.3(NF1):c.7359C>A (p.Cys2453Ter)	NF1	C2432*, C2453*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001072587	17	29677238	17	31350220	1072587	1064107		NC_000017.11:31350219:C:A
NM_001042492.3(NF1):c.1949T>G (p.Leu650Ter)	NF1	L650*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV001072477	17	29552216	17	31225198	1072477	1063939		NC_000017.11:31225197:T:G
NM_001042492.3(NF1):c.6720T>G (p.Tyr2240Ter)	NF1	Y2219*, Y2240*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001072469	17	29665058	17	31338040	1072469	1064087		NC_000017.11:31338039:T:G
NM_001042492.3(NF1):c.5040T>G (p.Tyr1680Ter)	NF1	Y1659*, Y1680*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001072455	17	29653042	17	31326024	1072455	1064044		NC_000017.11:31326023:T:G
NM_001042492.3(NF1):c.5854T>A (p.Trp1952Arg)	NF1	W1931R, W1952R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001072274	17	29661897	17	31334879	1072274	1064064		NC_000017.11:31334878:T:A
NM_001042492.3(NF1):c.5812+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001072273	17	29657518	17	31330500	1072273	1064062		NC_000017.11:31330499:T:G
NM_001042492.3(NF1):c.2410-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001072206	17	29556041	17	31229023	1072206	1063956		NC_000017.11:31229022:A:C
NM_001042492.3(NF1):c.4782C>A (p.Tyr1594Ter)	NF1	Y1573*, Y1594*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001071847	17	29592304	17	31265286	1071847	1064030		NC_000017.11:31265285:C:A
NM_001042492.3(NF1):c.2314G>T (p.Gly772Ter)	NF1	G772*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001071781	17	29554298	17	31227280	1071781	1063950		NC_000017.11:31227279:G:T
NM_001042492.3(NF1):c.1740C>G (p.Tyr580Ter)	NF1	Y580*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001071492	17	29550480	17	31223462	1071492	1063933		NC_000017.11:31223461:C:G
NM_001042492.3(NF1):c.7869+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001071331	17	29684110	17	31357092	1071331	1064127		NC_000017.11:31357091:T:C
NM_001042492.3(NF1):c.4107C>A (p.Tyr1369Ter)	NF1	Y1369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001071205	17	29576134	17	31249116	1071205	1064014		NC_000017.11:31249115:C:A
NM_001042492.3(NF1):c.5585T>G (p.Leu1862Ter)	NF1	L1841*, L1862*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001070937	17	29654833	17	31327815	1070937	1064057		NC_000017.11:31327814:T:G
NM_001042492.3(NF1):c.7300C>T (p.Gln2434Ter)	NF1	Q2413*, Q2434*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001070744	17	29676248	17	31349230	1070744	1064106		NC_000017.11:31349229:C:T
NM_001042492.3(NF1):c.7869+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001070509	17	29684110	17	31357092	1070509	1064126		NC_000017.11:31357091:T:A
NM_001042492.3(NF1):c.7802C>G (p.Ser2601Ter)	NF1	S2580*, S2601*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001070508	17	29684041	17	31357023	1070508	1064125		NC_000017.11:31357022:C:G
NM_001042492.3(NF1):c.4300A>T (p.Arg1434Ter)	NF1	R1413*, R1434*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV001070436	17	29585488	17	31258470	1070436	1064019		NC_000017.11:31258469:A:T
NM_001042492.3(NF1):c.7063-1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV001070419	17	29670026	17	31343008	1070419	1064098		NC_000017.11:31343007:G:A
NM_001042492.3(NF1):c.7013T>C (p.Leu2338Pro)	NF1	L2317P, L2338P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001070418	17	29667614	17	31340596	1070418	1064094		NC_000017.11:31340595:T:C
NM_001042492.3(NF1):c.6643-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001070318	17	29664835	17	31337817	1070318	1064083		NC_000017.11:31337816:A:C
NM_001042492.3(NF1):c.6473T>A (p.Leu2158Ter)	NF1	L2137*, L2158*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001070317	17	29664431	17	31337413	1070317	1064077		NC_000017.11:31337412:T:A
NM_001042492.3(NF1):c.5609G>T (p.Arg1870Leu)	NF1	R1849L, R1870L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001070186	17	29654857	17	31327839	1070186	1064058		NC_000017.11:31327838:G:T
NM_001042492.3(NF1):c.6147+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001070078	17	29663493	17	31336475	1070078	1064071		NC_000017.11:31336474:T:G
NM_001042492.3(NF1):c.4875C>A (p.Tyr1625Ter)	NF1	Y1604*, Y1625*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001070051	17	29652877	17	31325859	1070051	1064036		NC_000017.11:31325858:C:A
NM_001042492.3(NF1):c.4835+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001070050	17	29592359	17	31265341	1070050	1064033		NC_000017.11:31265340:T:G
NM_001042492.3(NF1):c.6642+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001069903	17	29664601	17	31337583	1069903	1064082		NC_000017.11:31337582:G:C
NM_001042492.3(NF1):c.6993T>A (p.Tyr2331Ter)	NF1	Y2310*, Y2331*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001069788	17	29667594	17	31340576	1069788	1064093		NC_000017.11:31340575:T:A
NM_001042492.3(NF1):c.3708+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001069723	17	29560232	17	31233214	1069723	1064000		NC_000017.11:31233213:G:C
NM_001042492.3(NF1):c.3628G>T (p.Glu1210Ter)	NF1	E1210*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001069722	17	29560151	17	31233133	1069722	1063998		NC_000017.11:31233132:G:T
NM_001042492.3(NF1):c.3616G>T (p.Glu1206Ter)	NF1	E1206*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001069720	17	29560139	17	31233121	1069720	1063997		NC_000017.11:31233120:G:T
NM_001042492.3(NF1):c.3028C>T (p.Gln1010Ter)	NF1	Q1010*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV001069645	17	29557315	17	31230297	1069645	1063975		NC_000017.11:31230296:C:T
NM_001042492.3(NF1):c.4578-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001069443	17	29588728	17	31261710	1069443	1064026		NC_000017.11:31261709:G:T
NM_001042492.3(NF1):c.60+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001069238	17	29422389	17	31095371	1069238	1063883		NC_000017.11:31095370:T:C
NM_001042492.3(NF1):c.3602T>A (p.Leu1201Ter)	NF1	L1201*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001069219	17	29560125	17	31233107	1069219	1063995		NC_000017.11:31233106:T:A
NM_001042492.3(NF1):c.2398G>T (p.Glu800Ter)	NF1	E800*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 19, 2020)	criteria provided, single submitter	VCV001069058	17	29554613	17	31227595	1069058	1063954		NC_000017.11:31227594:G:T
NM_001042492.3(NF1):c.288+5G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV001069051	17	29486116	17	31159098	1069051	1063891		NC_000017.11:31159097:G:C
NM_001042492.3(NF1):c.2614G>T (p.Glu872Ter)	NF1	E872*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001068661	17	29556247	17	31229229	1068661	1063961		NC_000017.11:31229228:G:T
NM_001042492.3(NF1):c.2353G>T (p.Glu785Ter)	NF1	E785*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001068657	17	29554568	17	31227550	1068657	1063953		NC_000017.11:31227549:G:T
NM_001042492.3(NF1):c.6186C>A (p.Cys2062Ter)	NF1	C2041*, C2062*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001068554	17	29663691	17	31336673	1068554	1064072		NC_000017.11:31336672:C:A
NM_001042492.3(NF1):c.888+2T>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV001068415	17	29509685	17	31182667	1068415	1056388		NC_000017.11:31182666:T:A
NM_001042492.3(NF1):c.6427+1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001068190	17	29663933	17	31336915	1068190	1056404		NC_000017.11:31336914:G:A
NM_001042492.3(NF1):c.3623T>G (p.Leu1208Trp)	NF1	L1208W	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001068122	17	29560146	17	31233128	1068122	1056395		NC_000017.11:31233127:T:G
NM_001042492.3(NF1):c.3572C>G (p.Thr1191Arg)	NF1	T1191R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001067806	17	29560095	17	31233077	1067806	1056392		NC_000017.11:31233076:C:G
NM_001042492.3(NF1):c.888+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001067639	17	29509685	17	31182667	1067639	1056389		NC_000017.11:31182666:T:C
NM_001042492.3(NF1):c.3578T>A (p.Phe1193Tyr)	NF1	F1193Y	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001067371	17	29560101	17	31233083	1067371	1056394		NC_000017.11:31233082:T:A
NM_001042492.3(NF1):c.6819+1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV001067342	17	29665158	17	31338140	1067342	1056405		NC_000017.11:31338139:G:C
NM_001042492.3(NF1):c.4243A>T (p.Asn1415Tyr)	NF1	N1394Y, N1415Y	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001067196	17	29585431	17	31258413	1067196	1056397		NC_000017.11:31258412:A:T
NM_001042492.3(NF1):c.7457+1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV001067139	17	29677337	17	31350319	1067139	1056409		NC_000017.11:31350318:G:T
NM_001042492.3(NF1):c.3577T>A (p.Phe1193Ile)	NF1	F1193I	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001067009	17	29560100	17	31233082	1067009	1056393		NC_000017.11:31233081:T:A
NM_001042492.3(NF1):c.4786G>C (p.Ala1596Pro)	NF1	A1575P, A1596P	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001066896	17	29592308	17	31265290	1066896	1056400		NC_000017.11:31265289:G:C
NM_001042492.3(NF1):c.7457+1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001066702	17	29677337	17	31350319	1066702	1056408		NC_000017.11:31350318:G:A
NM_001042492.3(NF1):c.173T>G (p.Leu58Arg)	NF1	L58R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001066638	17	29483113	17	31156095	1066638	1056386		NC_000017.11:31156094:T:G
NM_001042492.3(NF1):c.7001G>A (p.Gly2334Asp)	NF1	G2313D, G2334D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV001066467	17	29667602	17	31340584	1066467	1056407		NC_000017.11:31340583:G:A
NM_001042492.3(NF1):c.6944T>G (p.Leu2315Arg)	NF1	L2294R, L2315R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001066466	17	29667545	17	31340527	1066466	1056406		NC_000017.11:31340526:T:G
NM_001042492.3(NF1):c.6148-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001066465	17	29663652	17	31336634	1066465	1056403		NC_000017.11:31336633:G:A
NM_001042492.3(NF1):c.5498T>C (p.Leu1833Pro)	NF1	L1812P, L1833P	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV001066464	17	29654746	17	31327728	1066464	1056401		NC_000017.11:31327727:T:C
NM_001042492.3(NF1):c.4577+1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV001066182	17	29587534	17	31260516	1066182	1056398		NC_000017.11:31260515:G:C
NM_001042492.3(NF1):c.1808T>A (p.Ile603Lys)	NF1	I603K	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001065928	17	29550548	17	31223530	1065928	1056391		NC_000017.11:31223529:T:A
NM_001042492.3(NF1):c.889A>T (p.Lys297Ter)	NF1	K297*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, single submitter	VCV001064551	17	29527440	17	31200422	1064551	1052789		NC_000017.11:31200421:A:T
NM_001042492.3(NF1):c.5361A>C (p.Glu1787Asp)	NF1	E1766D, E1787D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001063729	17	29654609	17	31327591	1063729	1050164		NC_000017.11:31327590:A:C
NM_001042492.3(NF1):c.962C>T (p.Ala321Val)	NF1	A321V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001063697	17	29527513	17	31200495	1063697	1050123		NC_000017.11:31200494:C:T
NM_001042492.3(NF1):c.8188C>T (p.Leu2730Phe)	NF1	L2709F, L2730F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001063666	17	29687532	17	31360514	1063666	1050190		NC_000017.11:31360513:C:T
NM_001042492.3(NF1):c.7727A>G (p.Asp2576Gly)	NF1	D2555G, D2576G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001063647	17	29683589	17	31356571	1063647	1050182		NC_000017.11:31356570:A:G
NM_001042492.3(NF1):c.7172T>C (p.Val2391Ala)	NF1	V2370A, V2391A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001063567	17	29670136	17	31343118	1063567	1050178		NC_000017.11:31343117:T:C
NM_001042492.3(NF1):c.7822G>A (p.Glu2608Lys)	NF1	E2587K, E2608K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001063417	17	29684061	17	31357043	1063417	1050184		NC_000017.11:31357042:G:A
NM_001042492.3(NF1):c.8129G>T (p.Gly2710Val)	NF1	G2689V, G2710V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001063396	17	29686002	17	31358984	1063396	1050187		NC_000017.11:31358983:G:T
NM_001042492.3(NF1):c.644G>A (p.Ser215Asn)	NF1	S215N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001063387	17	29508497	17	31181479	1063387	1050119		NC_000017.11:31181478:G:A
NM_001042492.3(NF1):c.7999A>G (p.Thr2667Ala)	NF1	T2646A, T2667A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001063304	17	29685526	17	31358508	1063304	1050185		NC_000017.11:31358507:A:G
NM_001042492.3(NF1):c.8445C>A (p.His2815Gln)	NF1	H2794Q, H2815Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001063241	17	29701098	17	31374080	1063241	1050195		NC_000017.11:31374079:C:A
NM_001042492.3(NF1):c.7478C>T (p.Pro2493Leu)	NF1	P2472L, P2493L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 25, 2020)	criteria provided, single submitter	VCV001062874	17	29679295	17	31352277	1062874	1050180		NC_000017.11:31352276:C:T
NM_001042492.3(NF1):c.59A>G (p.Gln20Arg)	NF1	Q20R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 23, 2020)	criteria provided, single submitter	VCV001062479	17	29422386	17	31095368	1062479	1050114		NC_000017.11:31095367:A:G
NM_001042492.3(NF1):c.1711T>A (p.Trp571Arg)	NF1	W571R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001062333	17	29548937	17	31221919	1062333	1050132		NC_000017.11:31221918:T:A
NM_001042492.3(NF1):c.3884C>T (p.Thr1295Ile)	NF1	T1295I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001062323	17	29562949	17	31235931	1062323	1050149		NC_000017.11:31235930:C:T
NM_001042492.3(NF1):c.4358T>C (p.Val1453Ala)	NF1	V1432A, V1453A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001062187	17	29586075	17	31259057	1062187	1050154		NC_000017.11:31259056:T:C
NM_001042492.3(NF1):c.2936G>A (p.Ser979Asn)	NF1	S979N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001062159	17	29556938	17	31229920	1062159	1050141		NC_000017.11:31229919:G:A
NM_001042492.3(NF1):c.2290A>T (p.Arg764Trp)	NF1	R764W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV001062158	17	29554274	17	31227256	1062158	1050138		NC_000017.11:31227255:A:T
NM_001042492.3(NF1):c.5505G>T (p.Gln1835His)	NF1	Q1814H, Q1835H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001062041	17	29654753	17	31327735	1062041	1050165		NC_000017.11:31327734:G:T
NM_001042492.3(NF1):c.5813-5T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001061939	17	29661851	17	31334833	1061939	1050167		NC_000017.11:31334832:T:C
NM_001042492.3(NF1):c.1230G>A (p.Leu410=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001061676	17	29528473	17	31201455	1061676	1050125		NC_000017.11:31201454:G:A
NM_001042492.3(NF1):c.7062+6C>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001061637	17	29667669	17	31340651	1061637	1050177		NC_000017.11:31340650:C:G
NM_001042492.3(NF1):c.640A>C (p.Asn214His)	NF1	N214H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001061379	17	29508493	17	31181475	1061379	1050117		NC_000017.11:31181474:A:C
NM_001042492.3(NF1):c.643A>T (p.Ser215Cys)	NF1	S215C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001060989	17	29508496	17	31181478	1060989	1050118		NC_000017.11:31181477:A:T
NM_001042492.3(NF1):c.3850A>G (p.Ile1284Val)	NF1	I1284V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001060870	17	29562770	17	31235752	1060870	1050148		NC_000017.11:31235751:A:G
NM_001042492.3(NF1):c.6302C>T (p.Pro2101Leu)	NF1	P2080L, P2101L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001060058	17	29663807	17	31336789	1060058	1050170		NC_000017.11:31336788:C:T
NM_001042492.3(NF1):c.877A>G (p.Asn293Asp)	NF1	N293D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001060050	17	29509672	17	31182654	1060050	1050122		NC_000017.11:31182653:A:G
NM_001042492.3(NF1):c.6921+6T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001059509	17	29665829	17	31338811	1059509	1050175		NC_000017.11:31338810:T:C
NM_001042492.3(NF1):c.6908C>T (p.Pro2303Leu)	NF1	P2282L, P2303L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001059178	17	29665810	17	31338792	1059178	1050174		NC_000017.11:31338791:C:T
NM_001042492.3(NF1):c.6262C>G (p.Leu2088Val)	NF1	L2067V, L2088V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001059120	17	29663767	17	31336749	1059120	1050168		NC_000017.11:31336748:C:G
NM_001042492.3(NF1):c.4862A>C (p.Asp1621Ala)	NF1	D1600A, D1621A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001059119	17	29652864	17	31325846	1059119	1050160		NC_000017.11:31325845:A:C
NM_001042492.3(NF1):c.6268T>C (p.Phe2090Leu)	NF1	F2069L, F2090L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001059001	17	29663773	17	31336755	1059001	1050169		NC_000017.11:31336754:T:C
NM_001042492.3(NF1):c.6811C>T (p.Leu2271Phe)	NF1	L2250F, L2271F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001058883	17	29665149	17	31338131	1058883	1050172		NC_000017.11:31338130:C:T
NM_001042492.3(NF1):c.5801T>G (p.Phe1934Cys)	NF1	F1913C, F1934C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001058629	17	29657505	17	31330487	1058629	1050166		NC_000017.11:31330486:T:G
NM_001042492.3(NF1):c.8398G>A (p.Glu2800Lys)	NF1	E2779K, E2800K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001058187	17	29701051	17	31374033	1058187	1050194		NC_000017.11:31374032:G:A
NM_001042492.3(NF1):c.8261C>T (p.Ser2754Phe)	NF1	S2733F, S2754F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001058027	17	29687605	17	31360587	1058027	1050192		NC_000017.11:31360586:C:T
NM_001042492.3(NF1):c.2375T>C (p.Leu792Pro)	NF1	L792P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001057498	17	29554590	17	31227572	1057498	1050139		NC_000017.11:31227571:T:C
NM_001042492.3(NF1):c.750T>A (p.Phe250Leu)	NF1	F250L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001057392	17	29509545	17	31182527	1057392	1050121		NC_000017.11:31182526:T:A
NM_001042492.3(NF1):c.3033A>G (p.Ile1011Met)	NF1	I1011M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV001057242	17	29557320	17	31230302	1057242	1050143		NC_000017.11:31230301:A:G
NM_001042492.3(NF1):c.1941T>G (p.His647Gln)	NF1	H647Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV001057097	17	29552208	17	31225190	1057097	1050136		NC_000017.11:31225189:T:G
NM_001042492.3(NF1):c.1265C>T (p.Ala422Val)	NF1	A422V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001057017	17	29533262	17	31206244	1057017	1050126		NC_000017.11:31206243:C:T
NM_001042492.3(NF1):c.3004C>G (p.Leu1002Val)	NF1	L1002V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001056949	17	29557291	17	31230273	1056949	1050142		NC_000017.11:31230272:C:G
NM_001042492.3(NF1):c.4523A>T (p.His1508Leu)	NF1	H1487L, H1508L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001056824	17	29587479	17	31260461	1056824	1050156		NC_000017.11:31260460:A:T
NM_001042492.3(NF1):c.109G>A (p.Glu37Lys)	NF1	E37K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001056629	17	29483049	17	31156031	1056629	1050115		NC_000017.11:31156030:G:A
NM_001042492.3(NF1):c.3473A>G (p.Asp1158Gly)	NF1	D1158G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001056467	17	29559876	17	31232858	1056467	1050144		NC_000017.11:31232857:A:G
NM_001042492.3(NF1):c.8148A>T (p.Gly2716=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001056425	17	29686021	17	31359003	1056425	1050189		NC_000017.11:31359002:A:T
NM_001042492.3(NF1):c.1407A>G (p.Lys469=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001056403	17	29541483	17	31214465	1056403	1050129		NC_000017.11:31214464:A:G
NM_001042492.3(NF1):c.1888G>T (p.Val630Leu)	NF1	V630L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001056254	17	29552155	17	31225137	1056254	1050135		NC_000017.11:31225136:G:T
NM_001042492.3(NF1):c.8209G>A (p.Ala2737Thr)	NF1	A2716T, A2737T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001056214	17	29687553	17	31360535	1056214	1050191		NC_000017.11:31360534:G:A
NM_001042492.3(NF1):c.7246C>G (p.Leu2416Val)	NF1	L2395V, L2416V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001056093	17	29676194	17	31349176	1056093	1050179		NC_000017.11:31349175:C:G
NM_001042492.3(NF1):c.1672A>G (p.Ile558Val)	NF1	I558V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001055849	17	29548898	17	31221880	1055849	1050131		NC_000017.11:31221879:A:G
NM_001042492.3(NF1):c.1770G>C (p.Met590Ile)	NF1	M590I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001055798	17	29550510	17	31223492	1055798	1050133		NC_000017.11:31223491:G:C
NM_001042492.3(NF1):c.3712G>C (p.Glu1238Gln)	NF1	E1238Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001055730	17	29562632	17	31235614	1055730	1050146		NC_000017.11:31235613:G:C
NM_001042492.3(NF1):c.4640G>A (p.Gly1547Asp)	NF1	G1526D, G1547D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001055431	17	29588791	17	31261773	1055431	1050158		NC_000017.11:31261772:G:A
NM_001042492.3(NF1):c.4560G>C (p.Gln1520His)	NF1	Q1499H, Q1520H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 24, 2018)	criteria provided, single submitter	VCV001055421	17	29587516	17	31260498	1055421	1050157		NC_000017.11:31260497:G:C
NM_001042492.3(NF1):c.4915T>A (p.Tyr1639Asn)	NF1	Y1618N, Y1639N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001055262	17	29652917	17	31325899	1055262	1050161		NC_000017.11:31325898:T:A
NM_001042492.3(NF1):c.1347A>C (p.Lys449Asn)	NF1	K449N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001055071	17	29533344	17	31206326	1055071	1050127		NC_000017.11:31206325:A:C
NM_001042492.3(NF1):c.7709G>A (p.Arg2570Lys)	NF1	R2549K, R2570K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001055053	17	29683571	17	31356553	1055053	1050181		NC_000017.11:31356552:G:A
NM_001042492.3(NF1):c.7783A>G (p.Lys2595Glu)	NF1	K2574E, K2595E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001054714	17	29684022	17	31357004	1054714	1050183		NC_000017.11:31357003:A:G
NM_001042492.3(NF1):c.4984T>A (p.Trp1662Arg)	NF1	W1641R, W1662R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001054633	17	29652986	17	31325968	1054633	1050162		NC_000017.11:31325967:T:A
NM_001042492.3(NF1):c.3551C>G (p.Thr1184Arg)	NF1	T1184R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001054420	17	29560074	17	31233056	1054420	1050145		NC_000017.11:31233055:C:G
NM_001042492.3(NF1):c.1076A>T (p.Asn359Ile)	NF1	N359I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2020)	criteria provided, single submitter	VCV001054283	17	29528068	17	31201050	1054283	1050124		NC_000017.11:31201049:A:T
NM_001042492.3(NF1):c.1805A>T (p.Glu602Val)	NF1	E602V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001054174	17	29550545	17	31223527	1054174	1050134		NC_000017.11:31223526:A:T
NM_001042492.3(NF1):c.8141T>A (p.Phe2714Tyr)	NF1	F2693Y, F2714Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001054117	17	29686014	17	31358996	1054117	1050188		NC_000017.11:31358995:T:A
NM_001042492.3(NF1):c.3806A>G (p.Asp1269Gly)	NF1	D1269G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001053768	17	29562726	17	31235708	1053768	1050147		NC_000017.11:31235707:A:G
NM_001042492.3(NF1):c.1361G>A (p.Cys454Tyr)	NF1	C454Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001053512	17	29533358	17	31206340	1053512	1050128		NC_000017.11:31206339:G:A
NM_001042492.3(NF1):c.655-3T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001053396	17	29508725	17	31181707	1053396	1050120		NC_000017.11:31181706:T:G
NM_001042492.3(NF1):c.220G>T (p.Ala74Ser)	NF1	A74S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001053323	17	29486043	17	31159025	1053323	1050116		NC_000017.11:31159024:G:T
NM_001042492.3(NF1):c.4448C>G (p.Ala1483Gly)	NF1	A1462G, A1483G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2020)	criteria provided, single submitter	VCV001053270	17	29587404	17	31260386	1053270	1050155		NC_000017.11:31260385:C:G
NM_001042492.3(NF1):c.8090A>C (p.Gln2697Pro)	NF1	Q2676P, Q2697P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001053216	17	29685617	17	31358599	1053216	1050186		NC_000017.11:31358598:A:C
NM_001042492.3(NF1):c.1421G>A (p.Ser474Asn)	NF1	S474N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001053215	17	29541497	17	31214479	1053215	1050130		NC_000017.11:31214478:G:A
NM_001042492.3(NF1):c.6622G>A (p.Ala2208Thr)	NF1	A2187T, A2208T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001053149	17	29664580	17	31337562	1053149	1050171		NC_000017.11:31337561:G:A
NM_001042492.3(NF1):c.2050C>G (p.Gln684Glu)	NF1	Q684E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001052632	17	29553501	17	31226483	1052632	1050137		NC_000017.11:31226482:C:G
NM_001042492.3(NF1):c.6889G>A (p.Ala2297Thr)	NF1	A2276T, A2297T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001052128	17	29665791	17	31338773	1052128	1050173		NC_000017.11:31338772:G:A
NM_001042492.3(NF1):c.8366A>G (p.Gln2789Arg)	NF1	Q2768R, Q2789R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001052054	17	29687710	17	31360692	1052054	1050193		NC_000017.11:31360691:A:G
NM_001042492.3(NF1):c.4228T>A (p.Phe1410Ile)	NF1	F1389I, F1410I	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2021)	criteria provided, conflicting interpretations	VCV001051970	17	29585416	17	31258398	1051970	1050150		NC_000017.11:31258397:T:A
NM_001042492.3(NF1):c.4282G>T (p.Asp1428Tyr)	NF1	D1407Y, D1428Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001051858	17	29585470	17	31258452	1051858	1050152		NC_000017.11:31258451:G:T
NM_001042492.3(NF1):c.4300A>G (p.Arg1434Gly)	NF1	R1413G, R1434G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001051836	17	29585488	17	31258470	1051836	1050153		NC_000017.11:31258469:A:G
NM_001042492.3(NF1):c.4681A>T (p.Ser1561Cys)	NF1	S1540C, S1561C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001051534	17	29588832	17	31261814	1051534	1050159		NC_000017.11:31261813:A:T
NM_001042492.3(NF1):c.5051C>G (p.Ser1684Cys)	NF1	S1663C, S1684C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001050987	17	29653053	17	31326035	1050987	1050163		NC_000017.11:31326034:C:G
NM_001042492.3(NF1):c.5609+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048749	17	29654858	17	31327840	1048749	1036820		NC_000017.11:31327839:G:T
NM_001042492.3(NF1):c.385C>T (p.Gln129Ter)	NF1	Q129*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048748	17	29490300	17	31163282	1048748	1036763		NC_000017.11:31163281:C:T
NM_001042492.3(NF1):c.376G>T (p.Glu126Ter)	NF1	E126*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048744	17	29490291	17	31163273	1048744	1036762		NC_000017.11:31163272:G:T
NM_001042492.3(NF1):c.586G>T (p.Glu196Ter)	NF1	E196*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048743	17	29497015	17	31169997	1048743	1036767		NC_000017.11:31169996:G:T
NM_001042492.3(NF1):c.7000G>C (p.Gly2334Arg)	NF1	G2313R, G2334R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048740	17	29667601	17	31340583	1048740	1036832		NC_000017.11:31340582:G:C
NM_001042492.3(NF1):c.7739-3C>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048736	17	29683975	17	31356957	1048736	1036837		NC_000017.11:31356956:C:A
NM_001042492.3(NF1):c.654+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV001048732	17	29508509	17	31181491	1048732	1036768		NC_000017.11:31181490:T:C
NM_001042492.3(NF1):c.4563T>G (p.Tyr1521Ter)	NF1	Y1500*, Y1521*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048729	17	29587519	17	31260501	1048729	1036807		NC_000017.11:31260500:T:G
NM_001042492.3(NF1):c.6820-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048727	17	29665720	17	31338702	1048727	1036831		NC_000017.11:31338701:A:C
NM_001042492.3(NF1):c.4981A>T (p.Lys1661Ter)	NF1	K1640*, K1661*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048726	17	29652983	17	31325965	1048726	1036813		NC_000017.11:31325964:A:T
NM_001042492.3(NF1):c.3236T>C (p.Leu1079Pro)	NF1	L1079P	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048725	17	29559129	17	31232111	1048725	1036792		NC_000017.11:31232110:T:C
NM_001042492.3(NF1):c.4578-3T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048721	17	29588726	17	31261708	1048721	1036809		NC_000017.11:31261707:T:A
NM_001042492.3(NF1):c.4836G>C (p.Arg1612Ser)	NF1	R1591S, R1612S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048720	17	29652838	17	31325820	1048720	1036812		NC_000017.11:31325819:G:C
NM_001042492.3(NF1):c.2858T>A (p.Leu953Ter)	NF1	L953*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048719	17	29556860	17	31229842	1048719	1036785		NC_000017.11:31229841:T:A
NM_001042492.3(NF1):c.5652T>G (p.Phe1884Leu)	NF1	F1863L, F1884L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 5, 2020)	criteria provided, single submitter	VCV001048718	17	29657356	17	31330338	1048718	1036821		NC_000017.11:31330337:T:G
NM_001042492.3(NF1):c.4986G>A (p.Trp1662Ter)	NF1	W1641*, W1662*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV001048716	17	29652988	17	31325970	1048716	1036814		NC_000017.11:31325969:G:A
NM_001042492.3(NF1):c.4619C>A (p.Ala1540Glu)	NF1	A1519E, A1540E	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2020)	criteria provided, single submitter	VCV001048712	17	29588770	17	31261752	1048712	1036811		NC_000017.11:31261751:C:A
NM_001042492.3(NF1):c.3142T>C (p.Trp1048Arg)	NF1	W1048R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048711	17	29557888	17	31230870	1048711	1036790		NC_000017.11:31230869:T:C
NM_001042492.3(NF1):c.3176A>G (p.Asp1059Gly)	NF1	D1059G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048710	17	29557922	17	31230904	1048710	1036791		NC_000017.11:31230903:A:G
NM_001042492.3(NF1):c.7060A>T (p.Lys2354Ter)	NF1	K2333*, K2354*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048709	17	29667661	17	31340643	1048709	1036834		NC_000017.11:31340642:A:T
NM_001042492.3(NF1):c.6022G>C (p.Asp2008His)	NF1	D1987H, D2008H	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048707	17	29663366	17	31336348	1048707	1036823		NC_000017.11:31336347:G:C
NM_001042492.3(NF1):c.501T>A (p.Cys167Ter)	NF1	C167*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048706	17	29496930	17	31169912	1048706	1036764		NC_000017.11:31169911:T:A
NM_001042492.3(NF1):c.6052A>C (p.Ser2018Arg)	NF1	S1997R, S2018R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048699	17	29663396	17	31336378	1048699	1036824		NC_000017.11:31336377:A:C
NM_001042492.3(NF1):c.5040T>A (p.Tyr1680Ter)	NF1	Y1659*, Y1680*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048698	17	29653042	17	31326024	1048698	1036815		NC_000017.11:31326023:T:A
NM_001042492.3(NF1):c.5270T>G (p.Val1757Gly)	NF1	V1736G, V1757G	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048697	17	29654518	17	31327500	1048697	1036816		NC_000017.11:31327499:T:G
NM_001042492.3(NF1):c.3302A>T (p.Gln1101Leu)	NF1	Q1101L	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048692	17	29559195	17	31232177	1048692	1036793		NC_000017.11:31232176:A:T
NM_001042492.3(NF1):c.3574G>T (p.Glu1192Ter)	NF1	E1192*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV001048690	17	29560097	17	31233079	1048690	1036795		NC_000017.11:31233078:G:T
NM_001042492.3(NF1):c.4578-9T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001048689	17	29588720	17	31261702	1048689	1036808		NC_000017.11:31261701:T:A
NM_001042492.3(NF1):c.3114-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048680	17	29557859	17	31230841	1048680	1036789		NC_000017.11:31230840:G:C
NM_001042492.3(NF1):c.5398A>C (p.Thr1800Pro)	NF1	T1779P, T1800P	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048675	17	29654646	17	31327628	1048675	1036818		NC_000017.11:31327627:A:C
NM_001042492.3(NF1):c.5861C>T (p.Ser1954Leu)	NF1	S1954L, S1933L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, single submitter	VCV001047829	17	29661904	17	31334886	1047829	1033203		NC_000017.11:31334885:C:T
NM_001042492.3(NF1):c.7190G>A (p.Gly2397Glu)	NF1	G2397E, G2376E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001047705	17	29676138	17	31349120	1047705	1033216		NC_000017.11:31349119:G:A
NM_001042492.3(NF1):c.3980A>G (p.Glu1327Gly)	NF1	E1327G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 4, 2020)	criteria provided, single submitter	VCV001047381	17	29576007	17	31248989	1047381	1033184		NC_000017.11:31248988:A:G
NM_001042492.3(NF1):c.2381A>C (p.Tyr794Ser)	NF1	Y794S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001047075	17	29554596	17	31227578	1047075	1033163		NC_000017.11:31227577:A:C
NM_001042492.3(NF1):c.4008G>T (p.Gln1336His)	NF1	Q1336H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001046737	17	29576035	17	31249017	1046737	1033186		NC_000017.11:31249016:G:T
NM_001042492.3(NF1):c.2498C>T (p.Ser833Phe)	NF1	S833F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001046295	17	29556131	17	31229113	1046295	1033166		NC_000017.11:31229112:C:T
NM_001042492.3(NF1):c.4683C>G (p.Ser1561Arg)	NF1	S1561R, S1540R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2020)	criteria provided, single submitter	VCV001046281	17	29588834	17	31261816	1046281	1033191		NC_000017.11:31261815:C:G
NM_001042492.3(NF1):c.7036G>A (p.Asp2346Asn)	NF1	D2325N, D2346N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001046096	17	29667637	17	31340619	1046096	1033213		NC_000017.11:31340618:G:A
NM_001042492.3(NF1):c.2326G>T (p.Ala776Ser)	NF1	A776S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001046074	17	29554541	17	31227523	1046074	1033159		NC_000017.11:31227522:G:T
NM_001042492.3(NF1):c.5548G>A (p.Val1850Ile)	NF1	V1850I, V1829I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001045995	17	29654796	17	31327778	1045995	1033197		NC_000017.11:31327777:G:A
NM_001042492.3(NF1):c.116A>G (p.Asn39Ser)	NF1	N39S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001045948	17	29483056	17	31156038	1045948	1033129		NC_000017.11:31156037:A:G
NM_001042492.3(NF1):c.3442G>C (p.Ala1148Pro)	NF1	A1148P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001045831	17	29559845	17	31232827	1045831	1033173		NC_000017.11:31232826:G:C
NM_001042492.3(NF1):c.6785G>A (p.Gly2262Glu)	NF1	G2241E, G2262E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001045685	17	29665123	17	31338105	1045685	1033208		NC_000017.11:31338104:G:A
NM_001042492.3(NF1):c.1963G>C (p.Gly655Arg)	NF1	G655R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001045644	17	29552230	17	31225212	1045644	1033150		NC_000017.11:31225211:G:C
NM_001042492.3(NF1):c.2251+6T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001045508	17	29553708	17	31226690	1045508	1033156		NC_000017.11:31226689:T:A
NM_001042492.3(NF1):c.3436G>C (p.Val1146Leu)	NF1	V1146L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001045470	17	29559839	17	31232821	1045470	1033172		NC_000017.11:31232820:G:C
NM_001042492.3(NF1):c.415T>G (p.Ser139Ala)	NF1	S139A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001044998	17	29490330	17	31163312	1044998	1033132		NC_000017.11:31163311:T:G
NM_001042492.3(NF1):c.7097C>G (p.Pro2366Arg)	NF1	P2366R, P2345R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001044996	17	29670061	17	31343043	1044996	1033214		NC_000017.11:31343042:C:G
NM_001042492.3(NF1):c.4931A>C (p.Asp1644Ala)	NF1	D1623A, D1644A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001044895	17	29652933	17	31325915	1044895	1033192		NC_000017.11:31325914:A:C
NM_001042492.3(NF1):c.1873C>A (p.Leu625Ile)	NF1	L625I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV001044778	17	29552140	17	31225122	1044778	1033148		NC_000017.11:31225121:C:A
NM_001042492.3(NF1):c.6821C>G (p.Ala2274Gly)	NF1	A2253G, A2274G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001044696	17	29665723	17	31338705	1044696	1033209		NC_000017.11:31338704:C:G
NM_001042492.3(NF1):c.6928C>T (p.Pro2310Ser)	NF1	P2310S, P2289S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001044480	17	29667529	17	31340511	1044480	1033210		NC_000017.11:31340510:C:T
NM_001042492.3(NF1):c.5807A>G (p.Lys1936Arg)	NF1	K1936R, K1915R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001044469	17	29657511	17	31330493	1044469	1033202		NC_000017.11:31330492:A:G
NM_001042492.3(NF1):c.3505T>C (p.Tyr1169His)	NF1	Y1169H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001044448	17	29560028	17	31233010	1044448	1033176		NC_000017.11:31233009:T:C
NM_001042492.3(NF1):c.262G>C (p.Asp88His)	NF1	D88H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001044401	17	29486085	17	31159067	1044401	1033131		NC_000017.11:31159066:G:C
NM_001042492.3(NF1):c.3119A>G (p.Lys1040Arg)	NF1	K1040R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001044174	17	29557865	17	31230847	1044174	1033168		NC_000017.11:31230846:A:G
NM_001042492.3(NF1):c.2327C>A (p.Ala776Asp)	NF1	A776D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001043621	17	29554542	17	31227524	1043621	1033160		NC_000017.11:31227523:C:A
NM_001042492.3(NF1):c.5752A>C (p.Asn1918His)	NF1	N1897H, N1918H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001043338	17	29657456	17	31330438	1043338	1033200		NC_000017.11:31330437:A:C
NM_001042492.3(NF1):c.7494A>C (p.Lys2498Asn)	NF1	K2498N, K2477N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001043326	17	29679311	17	31352293	1043326	1033217		NC_000017.11:31352292:A:C
NM_001042492.3(NF1):c.3880G>A (p.Ala1294Thr)	NF1	A1294T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001043321	17	29562945	17	31235927	1043321	1033182		NC_000017.11:31235926:G:A
NM_001042492.3(NF1):c.725T>G (p.Met242Arg)	NF1	M242R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001042977	17	29508798	17	31181780	1042977	1033136		NC_000017.11:31181779:T:G
NM_001042492.3(NF1):c.8210C>A (p.Ala2737Asp)	NF1	A2716D, A2737D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001042910	17	29687554	17	31360536	1042910	1033221		NC_000017.11:31360535:C:A
NM_001042492.3(NF1):c.1721+542A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001042708	17	29549489	17	31222471	1042708	1033143		NC_000017.11:31222470:A:G
NM_001042492.3(NF1):c.2409+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001042578	17	29554628	17	31227610	1042578	1033165		NC_000017.11:31227609:A:G
NM_001042492.3(NF1):c.6217C>T (p.Leu2073Phe)	NF1	L2073F, L2052F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001042577	17	29663722	17	31336704	1042577	1033205		NC_000017.11:31336703:C:T
NM_001042492.3(NF1):c.3496G>T (p.Gly1166Cys)	NF1	G1166C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV001042357	17	29559899	17	31232881	1042357	1033175		NC_000017.11:31232880:G:T
NM_001042492.3(NF1):c.7174G>C (p.Gly2392Arg)	NF1	G2371R, G2392R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV001042142	17	29670138	17	31343120	1042142	1033215		NC_000017.11:31343119:G:C
NM_001042492.3(NF1):c.6298C>A (p.Leu2100Ile)	NF1	L2100I, L2079I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001042112	17	29663803	17	31336785	1042112	1033206		NC_000017.11:31336784:C:A
NM_001042492.3(NF1):c.1069C>A (p.Leu357Ile)	NF1	L357I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2020)	criteria provided, single submitter	VCV001042031	17	29528061	17	31201043	1042031	1033139		NC_000017.11:31201042:C:A
NM_001042492.3(NF1):c.1735T>C (p.Phe579Leu)	NF1	F579L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2020)	criteria provided, single submitter	VCV001042030	17	29550475	17	31223457	1042030	1033144		NC_000017.11:31223456:T:C
NM_001042492.3(NF1):c.2162G>T (p.Cys721Phe)	NF1	C721F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001041795	17	29553613	17	31226595	1041795	1033153		NC_000017.11:31226594:G:T
NM_001042492.3(NF1):c.8420A>T (p.His2807Leu)	NF1	H2786L, H2807L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001041792	17	29701073	17	31374055	1041792	1033222		NC_000017.11:31374054:A:T
NM_001042492.3(NF1):c.3484A>T (p.Met1162Leu)	NF1	M1162L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001041775	17	29559887	17	31232869	1041775	1033174		NC_000017.11:31232868:A:T
NM_001042492.3(NF1):c.5061G>C (p.Arg1687Ser)	NF1	R1666S, R1687S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001041668	17	29653063	17	31326045	1041668	1033194		NC_000017.11:31326044:G:C
NM_001042492.3(NF1):c.6344C>T (p.Pro2115Leu)	NF1	P2094L, P2115L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001041292	17	29663849	17	31336831	1041292	1033207		NC_000017.11:31336830:C:T
NM_001042492.3(NF1):c.8092T>C (p.Tyr2698His)	NF1	Y2698H, Y2677H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001041266	17	29685619	17	31358601	1041266	1033220		NC_000017.11:31358600:T:C
NM_001042492.3(NF1):c.2266C>G (p.Gln756Glu)	NF1	Q756E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001041196	17	29554250	17	31227232	1041196	1033157		NC_000017.11:31227231:C:G
NM_001042492.3(NF1):c.4214T>C (p.Val1405Ala)	NF1	V1384A, V1405A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001041126	17	29585402	17	31258384	1041126	1033187		NC_000017.11:31258383:T:C
NM_001042492.3(NF1):c.4450T>C (p.Ser1484Pro)	NF1	S1484P, S1463P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001040864	17	29587406	17	31260388	1040864	1033190		NC_000017.11:31260387:T:C
NM_001042492.3(NF1):c.1744T>C (p.Cys582Arg)	NF1	C582R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001040545	17	29550484	17	31223466	1040545	1033145		NC_000017.11:31223465:T:C
NM_001042492.3(NF1):c.3643A>G (p.Met1215Val)	NF1	M1215V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001040466	17	29560166	17	31233148	1040466	1033179		NC_000017.11:31233147:A:G
NM_001042492.3(NF1):c.1716G>T (p.Glu572Asp)	NF1	E572D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001040319	17	29548942	17	31221924	1040319	1033142		NC_000017.11:31221923:G:T
NM_001042492.3(NF1):c.4447G>T (p.Ala1483Ser)	NF1	A1483S, A1462S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 23, 2020)	criteria provided, single submitter	VCV001040315	17	29587403	17	31260385	1040315	1033189		NC_000017.11:31260384:G:T
NM_001042492.3(NF1):c.7034T>C (p.Leu2345Ser)	NF1	L2324S, L2345S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001040043	17	29667635	17	31340617	1040043	1033212		NC_000017.11:31340616:T:C
NM_001042492.3(NF1):c.2746A>G (p.Asn916Asp)	NF1	N916D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV001040009	17	29556379	17	31229361	1040009	1033167		NC_000017.11:31229360:A:G
NM_001042492.3(NF1):c.1624G>T (p.Ala542Ser)	NF1	A542S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV001039983	17	29546119	17	31219101	1039983	1033141		NC_000017.11:31219100:G:T
NM_001042492.3(NF1):c.2196G>T (p.Leu732Phe)	NF1	L732F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001039563	17	29553647	17	31226629	1039563	1033154		NC_000017.11:31226628:G:T
NM_001042492.3(NF1):c.5928C>G (p.Asp1976Glu)	NF1	D1955E, D1976E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV001039455	17	29661971	17	31334953	1039455	1033204		NC_000017.11:31334952:C:G
NM_001042492.3(NF1):c.2140T>A (p.Cys714Ser)	NF1	C714S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001039287	17	29553591	17	31226573	1039287	1033152		NC_000017.11:31226572:T:A
NM_001042492.3(NF1):c.2396T>C (p.Met799Thr)	NF1	M799T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001039260	17	29554611	17	31227593	1039260	1033164		NC_000017.11:31227592:T:C
NM_001042492.3(NF1):c.3708+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001039165	17	29560235	17	31233217	1039165	1033180		NC_000017.11:31233216:A:G
NM_001042492.3(NF1):c.542A>G (p.Gln181Arg)	NF1	Q181R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001039009	17	29496971	17	31169953	1039009	1033133		NC_000017.11:31169952:A:G
NM_001042492.3(NF1):c.56A>C (p.Glu19Ala)	NF1|LOC111811965	E19A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV001038222	17	29422383	17	31095365	1038222	1033128		NC_000017.11:31095364:A:C
NM_001042492.3(NF1):c.3946C>T (p.His1316Tyr)	NF1	H1316Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001038122	17	29563011	17	31235993	1038122	1033183		NC_000017.11:31235992:C:T
NM_001042492.3(NF1):c.1745G>C (p.Cys582Ser)	NF1	C582S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV001038073	17	29550485	17	31223467	1038073	1033146		NC_000017.11:31223466:G:C
NM_001042492.3(NF1):c.2132G>C (p.Arg711Pro)	NF1	R711P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001038014	17	29553583	17	31226565	1038014	1033151		NC_000017.11:31226564:G:C
NM_001042492.3(NF1):c.4333-3T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001037998	17	29586047	17	31259029	1037998	1033188		NC_000017.11:31259028:T:C
NM_001042492.3(NF1):c.1778G>A (p.Ser593Asn)	NF1	S593N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001037990	17	29550518	17	31223500	1037990	1033147		NC_000017.11:31223499:G:A
NM_001042492.3(NF1):c.2324A>C (p.Glu775Ala)	NF1	E775A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001037719	17	29554308	17	31227290	1037719	1033158		NC_000017.11:31227289:A:C
NM_001042492.3(NF1):c.2341C>T (p.His781Tyr)	NF1	H781Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001037652	17	29554556	17	31227538	1037652	1033161		NC_000017.11:31227537:C:T
NM_001042492.3(NF1):c.3859T>G (p.Phe1287Val)	NF1	F1287V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV001037602	17	29562779	17	31235761	1037602	1033181		NC_000017.11:31235760:T:G
NM_001042492.3(NF1):c.5363T>C (p.Ile1788Thr)	NF1	I1767T, I1788T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV001037462	17	29654611	17	31327593	1037462	1033195		NC_000017.11:31327592:T:C
NM_001042492.3(NF1):c.8C>G (p.Ala3Gly)	NF1|LOC111811965	A3G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV001037115	17	29422335	17	31095317	1037115	1033126		NC_000017.11:31095316:C:G
NM_001042492.3(NF1):c.7676T>C (p.Met2559Thr)	NF1	M2538T, M2559T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 27, 2020)	criteria provided, single submitter	VCV001037045	17	29683538	17	31356520	1037045	1033218		NC_000017.11:31356519:T:C
NM_001042492.3(NF1):c.3544G>A (p.Val1182Ile)	NF1	V1182I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001037040	17	29560067	17	31233049	1037040	1033177		NC_000017.11:31233048:G:A
NM_001042492.3(NF1):c.1960C>A (p.Pro654Thr)	NF1	P654T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001036838	17	29552227	17	31225209	1036838	1033149		NC_000017.11:31225208:C:A
NM_001042492.3(NF1):c.698A>G (p.Lys233Arg)	NF1	K233R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001036749	17	29508771	17	31181753	1036749	1033135		NC_000017.11:31181752:A:G
NM_001042492.3(NF1):c.5788T>A (p.Cys1930Ser)	NF1	C1930S, C1909S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001036636	17	29657492	17	31330474	1036636	1033201		NC_000017.11:31330473:T:A
NM_001042492.3(NF1):c.3244G>C (p.Gly1082Arg)	NF1	G1082R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001036430	17	29559137	17	31232119	1036430	1033170		NC_000017.11:31232118:G:C
NM_001042492.3(NF1):c.2220G>T (p.Glu740Asp)	NF1	E740D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001036343	17	29553671	17	31226653	1036343	1033155		NC_000017.11:31226652:G:T
NM_001042492.3(NF1):c.2359G>A (p.Ala787Thr)	NF1	A787T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001036218	17	29554574	17	31227556	1036218	1033162		NC_000017.11:31227555:G:A
NM_001042492.3(NF1):c.5539C>G (p.Pro1847Ala)	NF1	P1826A, P1847A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001036210	17	29654787	17	31327769	1036210	1033196		NC_000017.11:31327768:C:G
NM_001042492.3(NF1):c.3586C>T (p.Leu1196Phe)	NF1	L1196F	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2021)	criteria provided, conflicting interpretations	VCV001036158	17	29560109	17	31233091	1036158	1033178		NC_000017.11:31233090:C:T
NM_001042492.3(NF1):c.5665G>A (p.Glu1889Lys)	NF1	E1889K, E1868K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001035978	17	29657369	17	31330351	1035978	1033198		NC_000017.11:31330350:G:A
NM_001042492.3(NF1):c.810A>G (p.Gln270=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001035890	17	29509605	17	31182587	1035890	1033137		NC_000017.11:31182586:A:G
NM_001042492.3(NF1):c.938G>C (p.Ser313Thr)	NF1	S313T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001035814	17	29527489	17	31200471	1035814	1033138		NC_000017.11:31200470:G:C
NM_001042492.3(NF1):c.4005C>G (p.Asn1335Lys)	NF1	N1335K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001035806	17	29576032	17	31249014	1035806	1033185		NC_000017.11:31249013:C:G
NM_001042492.3(NF1):c.6951G>C (p.Trp2317Cys)	NF1	W2317C, W2296C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001035609	17	29667552	17	31340534	1035609	1033211		NC_000017.11:31340533:G:C
NM_001042492.3(NF1):c.1077T>A (p.Asn359Lys)	NF1	N359K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV001035542	17	29528069	17	31201051	1035542	1033140		NC_000017.11:31201050:T:A
NM_001042492.3(NF1):c.5750C>G (p.Ala1917Gly)	NF1	A1896G, A1917G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001035120	17	29657454	17	31330436	1035120	1033199		NC_000017.11:31330435:C:G
NM_001042492.3(NF1):c.7757C>T (p.Ser2586Leu)	NF1	S2586L, S2565L	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001034916	17	29683996	17	31356978	1034916	1033219		NC_000017.11:31356977:C:T
NM_001042492.3(NF1):c.26G>T (p.Trp9Leu)	NF1|LOC111811965	W9L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV001034566	17	29422353	17	31095335	1034566	1033127		NC_000017.11:31095334:G:T
NM_001042492.3(NF1):c.6229G>T (p.Asp2077Tyr)	NF1	D2056Y, D2077Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001027242	17	29663734	17	31336716	1027242	1012689		NC_000017.11:31336715:G:T
NM_001042492.3(NF1):c.1642-3C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001027176	17	29548865	17	31221847	1027176	1012649		NC_000017.11:31221846:C:T
NM_001042492.3(NF1):c.3430T>C (p.Cys1144Arg)	NF1	C1144R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001026889	17	29559833	17	31232815	1026889	1012667		NC_000017.11:31232814:T:C
NM_001042492.3(NF1):c.6141A>C (p.Ser2047=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001026724	17	29663485	17	31336467	1026724	1012687		NC_000017.11:31336466:A:C
NM_001042492.3(NF1):c.1696C>G (p.Pro566Ala)	NF1	P566A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001026584	17	29548922	17	31221904	1026584	1012650		NC_000017.11:31221903:C:G
NM_001042492.3(NF1):c.6581G>A (p.Arg2194Lys)	NF1	R2173K, R2194K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001026202	17	29664539	17	31337521	1026202	1012693		NC_000017.11:31337520:G:A
NM_001042492.3(NF1):c.8160G>A (p.Lys2720=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001026167	17	29686033	17	31359015	1026167	1012703		NC_000017.11:31359014:G:A
NM_001042492.3(NF1):c.2866A>G (p.Thr956Ala)	NF1	T956A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001026106	17	29556868	17	31229850	1026106	1012664		NC_000017.11:31229849:A:G
NM_001042492.3(NF1):c.50T>G (p.Phe17Cys)	NF1|LOC111811965	F17C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001026095	17	29422377	17	31095359	1026095	1012632		NC_000017.11:31095358:T:G
NM_001042492.3(NF1):c.4453G>T (p.Asp1485Tyr)	NF1	D1464Y, D1485Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001025866	17	29587409	17	31260391	1025866	1012680		NC_000017.11:31260390:G:T
NM_001042492.3(NF1):c.2812A>G (p.Lys938Glu)	NF1	K938E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001025543	17	29556445	17	31229427	1025543	1012662		NC_000017.11:31229426:A:G
NM_001042492.3(NF1):c.5591G>A (p.Ser1864Asn)	NF1	S1843N, S1864N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001025211	17	29654839	17	31327821	1025211	1012686		NC_000017.11:31327820:G:A
NM_001042492.3(NF1):c.2293C>T (p.Arg765Cys)	NF1	R765C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001024989	17	29554277	17	31227259	1024989	1012658		NC_000017.11:31227258:C:T
NM_001042492.3(NF1):c.1261T>A (p.Ser421Thr)	NF1	S421T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001024900	17	29533258	17	31206240	1024900	1012645		NC_000017.11:31206239:T:A
NM_001042492.3(NF1):c.206G>T (p.Arg69Ile)	NF1	R69I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV001024021	17	29486029	17	31159011	1024021	1012634		NC_000017.11:31159010:G:T
NM_001042492.3(NF1):c.694A>G (p.Thr232Ala)	NF1	T232A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 29, 2018)	criteria provided, single submitter	VCV001023987	17	29508767	17	31181749	1023987	1012637		NC_000017.11:31181748:A:G
NM_001042492.3(NF1):c.1183A>G (p.Lys395Glu)	NF1	K395E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001023560	17	29528175	17	31201157	1023560	1012643		NC_000017.11:31201156:A:G
NM_001042492.3(NF1):c.1291G>A (p.Ala431Thr)	NF1	A431T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001023534	17	29533288	17	31206270	1023534	1012646		NC_000017.11:31206269:G:A
NM_001042492.3(NF1):c.5473A>G (p.Ile1825Val)	NF1	I1804V, I1825V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001023372	17	29654721	17	31327703	1023372	1012685		NC_000017.11:31327702:A:G
NM_001042492.3(NF1):c.3878G>A (p.Gly1293Asp)	NF1	G1293D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001023305	17	29562943	17	31235925	1023305	1012674		NC_000017.11:31235924:G:A
NM_001042492.3(NF1):c.427T>C (p.Phe143Leu)	NF1	F143L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001022911	17	29490342	17	31163324	1022911	1012635		NC_000017.11:31163323:T:C
NM_001042492.3(NF1):c.3719C>T (p.Ala1240Val)	NF1	A1240V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001022774	17	29562639	17	31235621	1022774	1012670		NC_000017.11:31235620:C:T
NM_001042492.3(NF1):c.7083G>A (p.Met2361Ile)	NF1	M2340I, M2361I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001022670	17	29670047	17	31343029	1022670	1012696		NC_000017.11:31343028:G:A
NM_001042492.3(NF1):c.5212A>G (p.Lys1738Glu)	NF1	K1717E, K1738E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001022373	17	29653214	17	31326196	1022373	1012684		NC_000017.11:31326195:A:G
NM_001042492.3(NF1):c.4061C>T (p.Ser1354Phe)	NF1	S1354F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001021612	17	29576088	17	31249070	1021612	1012677		NC_000017.11:31249069:C:T
NM_001042492.3(NF1):c.3462T>A (p.Asn1154Lys)	NF1	N1154K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001021607	17	29559865	17	31232847	1021607	1012669		NC_000017.11:31232846:T:A
NM_001042492.3(NF1):c.763G>A (p.Gly255Ser)	NF1	G255S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001021356	17	29509558	17	31182540	1021356	1012638		NC_000017.11:31182539:G:A
NM_001042492.3(NF1):c.4578-8G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001021326	17	29588721	17	31261703	1021326	1012682		NC_000017.11:31261702:G:A
NM_001042492.3(NF1):c.7382T>A (p.Leu2461His)	NF1	L2440H, L2461H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001021194	17	29677261	17	31350243	1021194	1012699		NC_000017.11:31350242:T:A
NM_001042492.3(NF1):c.7162T>C (p.Phe2388Leu)	NF1	F2367L, F2388L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001021192	17	29670126	17	31343108	1021192	1012697		NC_000017.11:31343107:T:C
NM_001042492.3(NF1):c.1258A>C (p.Asn420His)	NF1	N420H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 5, 2020)	criteria provided, single submitter	VCV001021185	17	29528501	17	31201483	1021185	1012644		NC_000017.11:31201482:A:C
NM_001042492.3(NF1):c.6154G>A (p.Gly2052Arg)	NF1	G2031R, G2052R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001021169	17	29663659	17	31336641	1021169	1012688		NC_000017.11:31336640:G:A
NM_001042492.3(NF1):c.1062+3A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001021084	17	29527616	17	31200598	1021084	1012640		NC_000017.11:31200597:A:C
NM_001042492.3(NF1):c.3784T>G (p.Ser1262Ala)	NF1	S1262A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001020769	17	29562704	17	31235686	1020769	1012672		NC_000017.11:31235685:T:G
NM_001042492.3(NF1):c.2534G>T (p.Cys845Phe)	NF1	C845F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001020598	17	29556167	17	31229149	1020598	1012660		NC_000017.11:31229148:G:T
NM_001042492.3(NF1):c.6643-3T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV001020570	17	29664834	17	31337816	1020570	1012694		NC_000017.11:31337815:T:G
NM_001042492.3(NF1):c.4430G>A (p.Arg1477Lys)	NF1	R1456K, R1477K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001020388	17	29586147	17	31259129	1020388	1012678		NC_000017.11:31259128:G:A
NM_001042492.3(NF1):c.2552G>T (p.Cys851Phe)	NF1	C851F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001020124	17	29556185	17	31229167	1020124	1012661		NC_000017.11:31229166:G:T
NM_001042492.3(NF1):c.1062+6A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001020120	17	29527619	17	31200601	1020120	1012641		NC_000017.11:31200600:A:C
NM_001042492.3(NF1):c.7972C>A (p.His2658Asn)	NF1	H2637N, H2658N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001020047	17	29685499	17	31358481	1020047	1012701		NC_000017.11:31358480:C:A
NM_001042492.3(NF1):c.1084A>G (p.Lys362Glu)	NF1	K362E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001020023	17	29528076	17	31201058	1020023	1012642		NC_000017.11:31201057:A:G
NM_001042492.3(NF1):c.7295A>G (p.Asn2432Ser)	NF1	N2411S, N2432S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001019808	17	29676243	17	31349225	1019808	1012698		NC_000017.11:31349224:A:G
NM_001042492.3(NF1):c.3906T>A (p.Asp1302Glu)	NF1	D1302E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001019392	17	29562971	17	31235953	1019392	1012676		NC_000017.11:31235952:T:A
NM_001042492.3(NF1):c.4445T>G (p.Ile1482Arg)	NF1	I1461R, I1482R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001019079	17	29587401	17	31260383	1019079	1012679		NC_000017.11:31260382:T:G
NM_001042492.3(NF1):c.2059C>G (p.Leu687Val)	NF1	L687V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001019047	17	29553510	17	31226492	1019047	1012655		NC_000017.11:31226491:C:G
NM_001042492.3(NF1):c.3760T>C (p.Tyr1254His)	NF1	Y1254H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001019044	17	29562680	17	31235662	1019044	1012671		NC_000017.11:31235661:T:C
NM_001042492.3(NF1):c.607G>A (p.Ala203Thr)	NF1	A203T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001018931	17	29508460	17	31181442	1018931	1012636		NC_000017.11:31181441:G:A
NM_001042492.3(NF1):c.8137C>T (p.Arg2713Trp)	NF1	R2692W, R2713W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001018686	17	29686010	17	31358992	1018686	1012702		NC_000017.11:31358991:C:T
NM_001042492.3(NF1):c.6388A>C (p.Ile2130Leu)	NF1	I2109L, I2130L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001018478	17	29663893	17	31336875	1018478	1012691		NC_000017.11:31336874:A:C
NM_001042492.3(NF1):c.6556T>C (p.Ser2186Pro)	NF1	S2165P, S2186P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001018343	17	29664514	17	31337496	1018343	1012692		NC_000017.11:31337495:T:C
NM_001042492.3(NF1):c.3328T>A (p.Phe1110Ile)	NF1	F1110I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 15, 2020)	criteria provided, single submitter	VCV001018320	17	29559731	17	31232713	1018320	1012666		NC_000017.11:31232712:T:A
NM_001042492.3(NF1):c.4549A>G (p.Lys1517Glu)	NF1	K1496E, K1517E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001018221	17	29587505	17	31260487	1018221	1012681		NC_000017.11:31260486:A:G
NM_001042492.3(NF1):c.2512A>G (p.Ile838Val)	NF1	I838V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001017913	17	29556145	17	31229127	1017913	1012659		NC_000017.11:31229126:A:G
NM_001042492.3(NF1):c.3895A>C (p.Lys1299Gln)	NF1	K1299Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001017505	17	29562960	17	31235942	1017505	1012675		NC_000017.11:31235941:A:C
NM_001042492.3(NF1):c.6338C>A (p.Thr2113Lys)	NF1	T2092K, T2113K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001017498	17	29663843	17	31336825	1017498	1012690		NC_000017.11:31336824:C:A
NM_001042492.3(NF1):c.204G>A (p.Met68Ile)	NF1	M68I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001017372	17	29483144	17	31156126	1017372	1012633		NC_000017.11:31156125:G:A
NM_001042492.3(NF1):c.6748G>A (p.Val2250Ile)	NF1	V2229I, V2250I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001017258	17	29665086	17	31338068	1017258	1012695		NC_000017.11:31338067:G:A
NM_001042492.3(NF1):c.2046A>G (p.Gln682=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001016882	17	29553497	17	31226479	1016882	1012654		NC_000017.11:31226478:A:G
NM_001042492.3(NF1):c.1463G>A (p.Ser488Asn)	NF1	S488N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001016467	17	29541539	17	31214521	1016467	1012648		NC_000017.11:31214520:G:A
NM_001042492.3(NF1):c.8509A>C (p.Lys2837Gln)	NF1	K2816Q, K2837Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001016465	17	29701162	17	31374144	1016465	1012704		NC_000017.11:31374143:A:C
NM_001042492.3(NF1):c.930T>G (p.His310Gln)	NF1	H310Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001016336	17	29527481	17	31200463	1016336	1012639		NC_000017.11:31200462:T:G
NM_001042492.3(NF1):c.1393-592A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001016082	17	29540877	17	31213859	1016082	1012647		NC_000017.11:31213858:A:G
NM_001042492.3(NF1):c.5068A>C (p.Thr1690Pro)	NF1	T1669P, T1690P	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV001016049	17	29653070	17	31326052	1016049	1012683		NC_000017.11:31326051:A:C
NM_001042492.3(NF1):c.3815A>G (p.Gln1272Arg)	NF1	Q1272R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001015931	17	29562735	17	31235717	1015931	1012673		NC_000017.11:31235716:A:G
NM_001042492.3(NF1):c.1765C>A (p.Gln589Lys)	NF1	Q589K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001015592	17	29550505	17	31223487	1015592	1012651		NC_000017.11:31223486:C:A
NM_001042492.3(NF1):c.2190C>A (p.Asn730Lys)	NF1	N730K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV001015366	17	29553641	17	31226623	1015366	1012657		NC_000017.11:31226622:C:A
NM_001042492.3(NF1):c.1940A>G (p.His647Arg)	NF1	H647R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001014352	17	29552207	17	31225189	1014352	1012652		NC_000017.11:31225188:A:G
NM_001042492.3(NF1):c.2818A>G (p.Thr940Ala)	NF1	T940A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001014272	17	29556451	17	31229433	1014272	1012663		NC_000017.11:31229432:A:G
NM_001042492.3(NF1):c.2002G>A (p.Asp668Asn)	NF1	D668N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001014107	17	29553453	17	31226435	1014107	1012653		NC_000017.11:31226434:G:A
NM_001042492.3(NF1):c.2877A>G (p.Gln959=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001013776	17	29556879	17	31229861	1013776	1012665		NC_000017.11:31229860:A:G
NM_001042492.3(NF1):c.598A>T (p.Lys200Ter)	NF1	K200*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV001012199	17	29508451	17	31181433	1012199	999965		NC_000017.11:31181432:A:T
NM_001042492.3(NF1):c.6787C>A (p.Gln2263Lys)	NF1	Q2242K, Q2263K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 27, 2020)	criteria provided, single submitter	VCV001012133	17	29665125	17	31338107	1012133	997472		NC_000017.11:31338106:C:A
NM_001042492.3(NF1):c.4775T>C (p.Ile1592Thr)	NF1	I1571T, I1592T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001012106	17	29592297	17	31265279	1012106	997451		NC_000017.11:31265278:T:C
NM_001042492.3(NF1):c.4197G>C (p.Gln1399His)	NF1	Q1378H, Q1399H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001011694	17	29585385	17	31258367	1011694	997439		NC_000017.11:31258366:G:C
NM_001042492.3(NF1):c.1981G>A (p.Gly661Arg)	NF1	G661R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001011493	17	29552248	17	31225230	1011493	997419		NC_000017.11:31225229:G:A
NM_001042492.3(NF1):c.7036G>C (p.Asp2346His)	NF1	D2325H, D2346H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV001010838	17	29667637	17	31340619	1010838	997476		NC_000017.11:31340618:G:C
NM_001042492.3(NF1):c.4316T>G (p.Leu1439Trp)	NF1	L1418W, L1439W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001010353	17	29585504	17	31258486	1010353	997444		NC_000017.11:31258485:T:G
NM_001042492.3(NF1):c.8395G>C (p.Val2799Leu)	NF1	V2778L, V2799L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001010306	17	29701048	17	31374030	1010306	997493		NC_000017.11:31374029:G:C
NM_001042492.3(NF1):c.7204T>G (p.Ser2402Ala)	NF1	S2381A, S2402A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV001010168	17	29676152	17	31349134	1010168	997480		NC_000017.11:31349133:T:G
NM_001042492.3(NF1):c.3475A>G (p.Ser1159Gly)	NF1	S1159G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001010091	17	29559878	17	31232860	1010091	997429		NC_000017.11:31232859:A:G
NM_001042492.3(NF1):c.101T>C (p.Val34Ala)	NF1	V34A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001009951	17	29483041	17	31156023	1009951	997398		NC_000017.11:31156022:T:C
NM_001042492.3(NF1):c.3338T>C (p.Leu1113Pro)	NF1	L1113P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001009869	17	29559741	17	31232723	1009869	997427		NC_000017.11:31232722:T:C
NM_001042492.3(NF1):c.4286A>G (p.Lys1429Arg)	NF1	K1408R, K1429R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001009689	17	29585474	17	31258456	1009689	997443		NC_000017.11:31258455:A:G
NM_001042492.3(NF1):c.3695C>T (p.Pro1232Leu)	NF1	P1232L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV001009543	17	29560218	17	31233200	1009543	997432		NC_000017.11:31233199:C:T
NM_001042492.3(NF1):c.3988G>C (p.Glu1330Gln)	NF1	E1330Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 19, 2020)	criteria provided, single submitter	VCV001009326	17	29576015	17	31248997	1009326	997438		NC_000017.11:31248996:G:C
NM_001042492.3(NF1):c.5419G>A (p.Gly1807Ser)	NF1	G1786S, G1807S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV001009308	17	29654667	17	31327649	1009308	997457		NC_000017.11:31327648:G:A
NM_001042492.3(NF1):c.6861T>G (p.Ser2287Arg)	NF1	S2266R, S2287R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001009231	17	29665763	17	31338745	1009231	997473		NC_000017.11:31338744:T:G
NM_001042492.3(NF1):c.6292G>A (p.Ala2098Thr)	NF1	A2077T, A2098T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001009223	17	29663797	17	31336779	1009223	997465		NC_000017.11:31336778:G:A
NM_001042492.3(NF1):c.61C>G (p.Leu21Val)	NF1	L21V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001009132	17	29483001	17	31155983	1009132	997397		NC_000017.11:31155982:C:G
NM_001042492.3(NF1):c.1222T>G (p.Tyr408Asp)	NF1	Y408D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001009113	17	29528465	17	31201447	1009113	997410		NC_000017.11:31201446:T:G
NM_001042492.3(NF1):c.2254A>G (p.Arg752Gly)	NF1	R752G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001008922	17	29554238	17	31227220	1008922	997420		NC_000017.11:31227219:A:G
NM_001042492.3(NF1):c.4267G>A (p.Glu1423Lys)	NF1	E1402K, E1423K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001008786	17	29585455	17	31258437	1008786	997442		NC_000017.11:31258436:G:A
NM_001042492.3(NF1):c.1073T>A (p.Phe358Tyr)	NF1	F358Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001008294	17	29528065	17	31201047	1008294	997406		NC_000017.11:31201046:T:A
NM_001042492.3(NF1):c.4390T>C (p.Phe1464Leu)	NF1	F1443L, F1464L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001008291	17	29586107	17	31259089	1008291	997446		NC_000017.11:31259088:T:C
NM_001042492.3(NF1):c.230A>C (p.Lys77Thr)	NF1	K77T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001008150	17	29486053	17	31159035	1008150	997400		NC_000017.11:31159034:A:C
NM_001042492.3(NF1):c.6548G>A (p.Arg2183Gln)	NF1	R2162Q, R2183Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001008114	17	29664506	17	31337488	1008114	997467		NC_000017.11:31337487:G:A
NM_001042492.3(NF1):c.3387C>T (p.Gly1129=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001008058	17	29559790	17	31232772	1008058	997428		NC_000017.11:31232771:C:T
NM_001042492.3(NF1):c.4531C>G (p.Leu1511Val)	NF1	L1490V, L1511V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001007821	17	29587487	17	31260469	1007821	997448		NC_000017.11:31260468:C:G
NM_001042492.3(NF1):c.2822T>C (p.Ile941Thr)	NF1	I941T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001007726	17	29556455	17	31229437	1007726	997424		NC_000017.11:31229436:T:C
NM_001042492.3(NF1):c.5831T>C (p.Leu1944Pro)	NF1	L1923P, L1944P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001007597	17	29661874	17	31334856	1007597	997460		NC_000017.11:31334855:T:C
NM_001042492.3(NF1):c.7072G>C (p.Glu2358Gln)	NF1	E2337Q, E2358Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001007531	17	29670036	17	31343018	1007531	997478		NC_000017.11:31343017:G:C
NM_001042492.3(NF1):c.1183A>C (p.Lys395Gln)	NF1	K395Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001007112	17	29528175	17	31201157	1007112	997408		NC_000017.11:31201156:A:C
NM_001042492.3(NF1):c.3971C>T (p.Thr1324Ile)	NF1	T1324I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001006988	17	29563036	17	31236018	1006988	997437		NC_000017.11:31236017:C:T
NM_001042492.3(NF1):c.1746C>G (p.Cys582Trp)	NF1	C582W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001006747	17	29550486	17	31223468	1006747	997413		NC_000017.11:31223467:C:G
NM_001042492.3(NF1):c.5564T>C (p.Leu1855Pro)	NF1	L1834P, L1855P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV001006552	17	29654812	17	31327794	1006552	997458		NC_000017.11:31327793:T:C
NM_001042492.3(NF1):c.4828G>A (p.Ala1610Thr)	NF1	A1589T, A1610T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001006225	17	29592350	17	31265332	1006225	997453		NC_000017.11:31265331:G:A
NM_001042492.3(NF1):c.769G>C (p.Ala257Pro)	NF1	A257P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001006219	17	29509564	17	31182546	1006219	997405		NC_000017.11:31182545:G:C
NM_001042492.3(NF1):c.6781C>G (p.His2261Asp)	NF1	H2240D, H2261D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV001006103	17	29665119	17	31338101	1006103	997471		NC_000017.11:31338100:C:G
NM_001042492.3(NF1):c.8237T>C (p.Ile2746Thr)	NF1	I2725T, I2746T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001006086	17	29687581	17	31360563	1006086	997492		NC_000017.11:31360562:T:C
NM_001042492.3(NF1):c.4221T>G (p.Ser1407Arg)	NF1	S1386R, S1407R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001006015	17	29585409	17	31258391	1006015	997440		NC_000017.11:31258390:T:G
NM_001042492.3(NF1):c.7374A>C (p.Arg2458Ser)	NF1	R2437S, R2458S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001005725	17	29677253	17	31350235	1005725	997483		NC_000017.11:31350234:A:C
NM_001042492.3(NF1):c.3598G>T (p.Val1200Leu)	NF1	V1200L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV001005591	17	29560121	17	31233103	1005591	997431		NC_000017.11:31233102:G:T
NM_001042492.3(NF1):c.4247C>G (p.Pro1416Arg)	NF1	P1395R, P1416R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001005475	17	29585435	17	31258417	1005475	997441		NC_000017.11:31258416:C:G
NM_001042492.3(NF1):c.1940A>C (p.His647Pro)	NF1	H647P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001005455	17	29552207	17	31225189	1005455	997417		NC_000017.11:31225188:A:C
NM_001042492.3(NF1):c.5816T>G (p.Ile1939Ser)	NF1	I1918S, I1939S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001005316	17	29661859	17	31334841	1005316	997459		NC_000017.11:31334840:T:G
NM_001042492.3(NF1):c.508G>T (p.Asp170Tyr)	NF1	D170Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001005302	17	29496937	17	31169919	1005302	997401		NC_000017.11:31169918:G:T
NM_001042492.3(NF1):c.1955G>T (p.Arg652Leu)	NF1	R652L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001005065	17	29552222	17	31225204	1005065	997418		NC_000017.11:31225203:G:T
NM_001042492.3(NF1):c.562G>A (p.Ala188Thr)	NF1	A188T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001005064	17	29496991	17	31169973	1005064	997402		NC_000017.11:31169972:G:A
NM_001042492.3(NF1):c.6044T>C (p.Ile2015Thr)	NF1	I1994T, I2015T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001005000	17	29663388	17	31336370	1005000	997462		NC_000017.11:31336369:T:C
NM_001042492.3(NF1):c.7540A>G (p.Thr2514Ala)	NF1	T2493A, T2514A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV001004756	17	29679357	17	31352339	1004756	997486		NC_000017.11:31352338:A:G
NM_001042492.3(NF1):c.7526C>G (p.Pro2509Arg)	NF1	P2488R, P2509R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001004375	17	29679343	17	31352325	1004375	997485		NC_000017.11:31352324:C:G
NM_001042492.3(NF1):c.172C>T (p.Leu58Phe)	NF1	L58F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001004269	17	29483112	17	31156094	1004269	997399		NC_000017.11:31156093:C:T
NM_001042492.3(NF1):c.7496G>C (p.Gly2499Ala)	NF1	G2478A, G2499A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001004202	17	29679313	17	31352295	1004202	997484		NC_000017.11:31352294:G:C
NM_001042492.3(NF1):c.1762C>A (p.His588Asn)	NF1	H588N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001004034	17	29550502	17	31223484	1004034	997414		NC_000017.11:31223483:C:A
NM_001042492.3(NF1):c.3539T>G (p.Met1180Arg)	NF1	M1180R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001004008	17	29560062	17	31233044	1004008	997430		NC_000017.11:31233043:T:G
NM_001042492.3(NF1):c.3709-3C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV001003964	17	29562626	17	31235608	1003964	997434		NC_000017.11:31235607:C:T
NM_001042492.3(NF1):c.730+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001003818	17	29508807	17	31181789	1003818	997404		NC_000017.11:31181788:A:G
NM_001042492.3(NF1):c.5997C>A (p.Ser1999Arg)	NF1	S1978R, S1999R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001003594	17	29662040	17	31335022	1003594	997461		NC_000017.11:31335021:C:A
NM_001042492.3(NF1):c.6566C>T (p.Pro2189Leu)	NF1	P2168L, P2189L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV001003484	17	29664524	17	31337506	1003484	997468		NC_000017.11:31337505:C:T
NM_001042492.3(NF1):c.3757C>T (p.Leu1253Phe)	NF1	L1253F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001003270	17	29562677	17	31235659	1003270	997435		NC_000017.11:31235658:C:T
NM_001042492.3(NF1):c.6242T>C (p.Leu2081Ser)	NF1	L2060S, L2081S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001003217	17	29663747	17	31336729	1003217	997464		NC_000017.11:31336728:T:C
NM_001042492.3(NF1):c.4471G>A (p.Ala1491Thr)	NF1	A1470T, A1491T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 23, 2020)	criteria provided, single submitter	VCV001002863	17	29587427	17	31260409	1002863	997447		NC_000017.11:31260408:G:A
NM_001042492.3(NF1):c.2409+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001002598	17	29554629	17	31227611	1002598	997421		NC_000017.11:31227610:G:C
NM_001042492.3(NF1):c.6147+5T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001002286	17	29663496	17	31336478	1002286	997463		NC_000017.11:31336477:T:C
NM_001042492.3(NF1):c.6642+6G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001002219	17	29664606	17	31337588	1002219	997470		NC_000017.11:31337587:G:A
NM_001042492.3(NF1):c.5015A>G (p.Asp1672Gly)	NF1	D1651G, D1672G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001002183	17	29653017	17	31325999	1002183	997455		NC_000017.11:31325998:A:G
NM_001042492.3(NF1):c.2705T>G (p.Met902Arg)	NF1	M902R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001002156	17	29556338	17	31229320	1002156	997423		NC_000017.11:31229319:T:G
NM_001042492.3(NF1):c.7241A>C (p.His2414Pro)	NF1	H2393P, H2414P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001002141	17	29676189	17	31349171	1002141	997481		NC_000017.11:31349170:A:C
NM_001042492.3(NF1):c.6398T>C (p.Leu2133Pro)	NF1	L2112P, L2133P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001002112	17	29663903	17	31336885	1002112	997466		NC_000017.11:31336884:T:C
NM_001042492.3(NF1):c.5270T>A (p.Val1757Asp)	NF1	V1736D, V1757D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001002111	17	29654518	17	31327500	1002111	997456		NC_000017.11:31327499:T:A
NM_001042492.3(NF1):c.4931A>G (p.Asp1644Gly)	NF1	D1623G, D1644G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001002110	17	29652933	17	31325915	1002110	997454		NC_000017.11:31325914:A:G
NM_001042492.3(NF1):c.4808A>G (p.Asn1603Ser)	NF1	N1582S, N1603S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2020)	criteria provided, single submitter	VCV001002109	17	29592330	17	31265312	1002109	997452		NC_000017.11:31265311:A:G
NM_001042492.3(NF1):c.7685G>T (p.Gly2562Val)	NF1	G2541V, G2562V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001001908	17	29683547	17	31356529	1001908	997487		NC_000017.11:31356528:G:T
NM_001042492.3(NF1):c.3708+3A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001001317	17	29560234	17	31233216	1001317	997433		NC_000017.11:31233215:A:G
NM_001042492.3(NF1):c.8182G>A (p.Ala2728Thr)	NF1	A2707T, A2728T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001001184	17	29687526	17	31360508	1001184	997491		NC_000017.11:31360507:G:A
NM_001042492.3(NF1):c.3064A>G (p.Met1022Val)	NF1	M1022V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001001163	17	29557351	17	31230333	1001163	997426		NC_000017.11:31230332:A:G
NM_001042492.3(NF1):c.8443C>T (p.His2815Tyr)	NF1	H2794Y, H2815Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV001000709	17	29701096	17	31374078	1000709	997494		NC_000017.11:31374077:C:T
NM_001042492.3(NF1):c.7144T>A (p.Phe2382Ile)	NF1	F2361I, F2382I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001000664	17	29670108	17	31343090	1000664	997479		NC_000017.11:31343089:T:A
NM_001042492.3(NF1):c.4682G>C (p.Ser1561Thr)	NF1	S1540T, S1561T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001000652	17	29588833	17	31261815	1000652	997450		NC_000017.11:31261814:G:C
NM_001042492.3(NF1):c.3833A>G (p.Asn1278Ser)	NF1	N1278S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001000531	17	29562753	17	31235735	1000531	997436		NC_000017.11:31235734:A:G
NM_001042492.3(NF1):c.7049T>A (p.Ile2350Lys)	NF1	I2329K, I2350K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001000212	17	29667650	17	31340632	1000212	997477		NC_000017.11:31340631:T:A
NM_001042492.3(NF1):c.4540A>C (p.Asn1514His)	NF1	N1493H, N1514H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001000208	17	29587496	17	31260478	1000208	997449		NC_000017.11:31260477:A:C
NM_001042492.3(NF1):c.1339C>G (p.Leu447Val)	NF1	L447V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001000129	17	29533336	17	31206318	1000129	997411		NC_000017.11:31206317:C:G
NM_001042492.3(NF1):c.1141G>T (p.Val381Phe)	NF1	V381F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV000999852	17	29528133	17	31201115	999852	997407		NC_000017.11:31201114:G:T
NM_001042492.3(NF1):c.586+3A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV000999732	17	29497018	17	31170000	999732	997403		NC_000017.11:31169999:A:G
NM_001042492.3(NF1):c.2471G>A (p.Gly824Glu)	NF1	G824E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000999565	17	29556104	17	31229086	999565	997422		NC_000017.11:31229085:G:A
NM_001042492.3(NF1):c.1677T>A (p.Asp559Glu)	NF1	D559E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000999457	17	29548903	17	31221885	999457	997412		NC_000017.11:31221884:T:A
NM_001042492.3(NF1):c.4361T>C (p.Leu1454Pro)	NF1	L1433P, L1454P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000999339	17	29586078	17	31259060	999339	997445		NC_000017.11:31259059:T:C
NM_001042492.3(NF1):c.8161C>G (p.Gln2721Glu)	NF1	Q2700E, Q2721E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000999217	17	29687505	17	31360487	999217	997490		NC_000017.11:31360486:C:G
NM_001042492.3(NF1):c.7738+6A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV000999013	17	29683606	17	31356588	999013	997488		NC_000017.11:31356587:A:T
NM_001042492.3(NF1):c.7873A>G (p.Thr2625Ala)	NF1	T2604A, T2625A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000998874	17	29684290	17	31357272	998874	997489		NC_000017.11:31357271:A:G
NM_001042492.3(NF1):c.7316T>C (p.Leu2439Ser)	NF1	L2418S, L2439S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000998798	17	29676264	17	31349246	998798	997482		NC_000017.11:31349245:T:C
NM_001042492.3(NF1):c.1200G>C (p.Gln400His)	NF1	Q400H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV000998795	17	29528443	17	31201425	998795	997409		NC_000017.11:31201424:G:C
NM_001042492.3(NF1):c.61-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	no assertion criteria provided	VCV000998047	17	29482999	17	31155981	998047	985764		NC_000017.11:31155980:A:C
NM_001042492.3(NF1):c.1639G>T (p.Glu547Ter)	NF1	E547*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	no assertion criteria provided	VCV000998043	17	29546134	17	31219116	998043	985765		NC_000017.11:31219115:G:T
NM_001042492.3(NF1):c.1322A>G (p.Asn441Ser)	NF1	N441S	not specified	Uncertain significance(Last reviewed: Feb 12, 2021)	criteria provided, single submitter	VCV000997877	17	29533319	17	31206301	997877	985643		NC_000017.11:31206300:A:G
NM_001042492.3(NF1):c.4460C>T (p.Pro1487Leu)	NF1	P1466L, P1487L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996533	17	29587416	17	31260398	996533	984171		NC_000017.11:31260397:C:T
NM_001042492.3(NF1):c.2026A>C (p.Thr676Pro)	NF1	T676P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996532	17	29553477	17	31226459	996532	984117		NC_000017.11:31226458:A:C
NM_001042492.3(NF1):c.6953T>C (p.Val2318Ala)	NF1	V2297A, V2318A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996530	17	29667554	17	31340536	996530	984226		NC_000017.11:31340535:T:C
NM_001042492.3(NF1):c.5281G>C (p.Ala1761Pro)	NF1	A1740P, A1761P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996529	17	29654529	17	31327511	996529	984190		NC_000017.11:31327510:G:C
NM_001042492.3(NF1):c.6427+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996528	17	29663937	17	31336919	996528	984217		NC_000017.11:31336918:G:C
NM_001042492.3(NF1):c.6374T>G (p.Leu2125Arg)	NF1	L2104R, L2125R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996527	17	29663879	17	31336861	996527	984216		NC_000017.11:31336860:T:G
NM_001042492.3(NF1):c.1722-2A>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996525	17	29550460	17	31223442	996525	984111		NC_000017.11:31223441:A:C
NM_001042492.3(NF1):c.3911T>G (p.Leu1304Ter)	NF1	L1304*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996521	17	29562976	17	31235958	996521	984158		NC_000017.11:31235957:T:G
NM_001042492.3(NF1):c.3211G>C (p.Ala1071Pro)	NF1	A1071P	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996519	17	29559104	17	31232086	996519	984146		NC_000017.11:31232085:G:C
NM_001042492.3(NF1):c.731-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996510	17	29509525	17	31182507	996510	984092		NC_000017.11:31182506:G:T
NM_001042492.3(NF1):c.7682C>A (p.Ser2561Ter)	NF1	S2540*, S2561*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996509	17	29683544	17	31356526	996509	984244		NC_000017.11:31356525:C:A
NM_001042492.3(NF1):c.3876T>G (p.Tyr1292Ter)	NF1	Y1292*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996508	17	29562941	17	31235923	996508	984157		NC_000017.11:31235922:T:G
NM_001042492.3(NF1):c.6682C>T (p.Gln2228Ter)	NF1	Q2207*, Q2228*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996507	17	29664876	17	31337858	996507	984220		NC_000017.11:31337857:C:T
NM_001042492.3(NF1):c.3562C>T (p.Gln1188Ter)	NF1	Q1188*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996506	17	29560085	17	31233067	996506	984152		NC_000017.11:31233066:C:T
NM_001042492.3(NF1):c.7063-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996501	17	29670026	17	31343008	996501	984231		NC_000017.11:31343007:G:C
NM_001042492.3(NF1):c.999C>A (p.Tyr333Ter)	NF1	Y333*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996500	17	29527550	17	31200532	996500	984098		NC_000017.11:31200531:C:A
NM_001042492.3(NF1):c.2685G>A (p.Met895Ile)	NF1	M895I	Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996499	17	29556318	17	31229300	996499	984125		NC_000017.11:31229299:G:A
NM_001042492.3(NF1):c.821T>C (p.Leu274Pro)	NF1	L274P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996495	17	29509616	17	31182598	996495	984095		NC_000017.11:31182597:T:C
NM_001042492.3(NF1):c.5933T>G (p.Leu1978Arg)	NF1	L1957R, L1978R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996493	17	29661976	17	31334958	996493	984210		NC_000017.11:31334957:T:G
NM_001042492.3(NF1):c.761A>G (p.Asp254Gly)	NF1	D254G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996492	17	29509556	17	31182538	996492	984094		NC_000017.11:31182537:A:G
NM_001042492.3(NF1):c.5310A>C (p.Thr1770=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996491	17	29654558	17	31327540	996491	984192		NC_000017.11:31327539:A:C
NM_001042492.3(NF1):c.4796C>A (p.Ser1599Tyr)	NF1	S1578Y, S1599Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996490	17	29592318	17	31265300	996490	984180		NC_000017.11:31265299:C:A
NM_001042492.3(NF1):c.5668G>C (p.Gly1890Arg)	NF1	G1869R, G1890R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996486	17	29657372	17	31330354	996486	984203		NC_000017.11:31330353:G:C
NM_001042492.3(NF1):c.7537C>T (p.Gln2513Ter)	NF1	Q2492*, Q2513*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996485	17	29679354	17	31352336	996485	984240		NC_000017.11:31352335:C:T
NM_001042492.3(NF1):c.4110+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996478	17	29576138	17	31249120	996478	984165		NC_000017.11:31249119:G:C
NM_001042492.3(NF1):c.3151G>T (p.Gly1051Ter)	NF1	G1051*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996475	17	29557897	17	31230879	996475	984136		NC_000017.11:31230878:G:T
NM_001042492.3(NF1):c.5268+1G>T	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996474	17	29653271	17	31326253	996474	984189		NC_000017.11:31326252:G:T
NM_001042492.3(NF1):c.4753A>T (p.Lys1585Ter)	NF1	K1564*, K1585*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996473	17	29592275	17	31265257	996473	984178		NC_000017.11:31265256:A:T
NM_001042492.3(NF1):c.4676G>A (p.Trp1559Ter)	NF1	W1538*, W1559*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996467	17	29588827	17	31261809	996467	984177		NC_000017.11:31261808:G:A
NM_001042492.3(NF1):c.1655T>C (p.Leu552Pro)	NF1	L552P	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000996460	17	29548881	17	31221863	996460	984110		NC_000017.11:31221862:T:C
NM_001042492.3(NF1):c.3545T>C (p.Val1182Ala)	NF1	V1182A	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996459	17	29560068	17	31233050	996459	984151		NC_000017.11:31233049:T:C
NM_001042492.3(NF1):c.174C>T (p.Leu58=)	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000996458	17	29483114	17	31156096	996458	984086		NC_000017.11:31156095:C:T
NM_001042492.3(NF1):c.6704+5G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996457	17	29664903	17	31337885	996457	984221		NC_000017.11:31337884:G:A
NM_001042492.3(NF1):c.3171A>G (p.Ala1057=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996456	17	29557917	17	31230899	996456	984137		NC_000017.11:31230898:A:G
NM_001042492.3(NF1):c.4349C>A (p.Ala1450Asp)	NF1	A1429D, A1450D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996455	17	29586066	17	31259048	996455	984169		NC_000017.11:31259047:C:A
NM_001042492.3(NF1):c.3655G>C (p.Gly1219Arg)	NF1	G1219R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996453	17	29560178	17	31233160	996453	984154		NC_000017.11:31233159:G:C
NM_001042492.3(NF1):c.1185+5G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996452	17	29528182	17	31201164	996452	984103		NC_000017.11:31201163:G:A
NM_001042492.3(NF1):c.1241T>G (p.Leu414Arg)	NF1	L414R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996451	17	29528484	17	31201466	996451	984104		NC_000017.11:31201465:T:G
NM_001042492.3(NF1):c.3310C>G (p.Leu1104Val)	NF1	L1104V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996450	17	29559203	17	31232185	996450	984148		NC_000017.11:31232184:C:G
NM_001042492.3(NF1):c.6147+1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996449	17	29663492	17	31336474	996449	984212		NC_000017.11:31336473:G:C
NM_001042492.3(NF1):c.2251+1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996448	17	29553703	17	31226685	996448	984119		NC_000017.11:31226684:G:T
NM_001042492.3(NF1):c.6148-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996440	17	29663651	17	31336633	996440	984213		NC_000017.11:31336632:A:G
NM_001042492.3(NF1):c.4535G>A (p.Trp1512Ter)	NF1	W1491*, W1512*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996438	17	29587491	17	31260473	996438	984174		NC_000017.11:31260472:G:A
NM_001042492.3(NF1):c.2990+1G>C	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jan 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000996434	17	29556993	17	31229975	996434	984132		NC_000017.11:31229974:G:C
NM_001042492.3(NF1):c.7106G>A (p.Trp2369Ter)	NF1	W2348*, W2369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996432	17	29670070	17	31343052	996432	984232		NC_000017.11:31343051:G:A
NM_001042492.3(NF1):c.5464C>T (p.Gln1822Ter)	NF1	Q1801*, Q1822*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996430	17	29654712	17	31327694	996430	984196		NC_000017.11:31327693:C:T
NM_001042492.3(NF1):c.3256C>T (p.Gln1086Ter)	NF1	Q1086*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996428	17	29559149	17	31232131	996428	984147		NC_000017.11:31232130:C:T
NM_001042492.3(NF1):c.205-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996426	17	29486026	17	31159008	996426	984087		NC_000017.11:31159007:A:C
NM_001042492.3(NF1):c.1641+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996419	17	29546137	17	31219119	996419	984109		NC_000017.11:31219118:G:C
NM_001042492.3(NF1):c.737C>A (p.Ala246Glu)	NF1	A246E	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996418	17	29509532	17	31182514	996418	984093		NC_000017.11:31182513:C:A
NM_001042492.3(NF1):c.4011G>C (p.Arg1337=)	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000996416	17	29576038	17	31249020	996416	984161		NC_000017.11:31249019:G:C
NM_001042492.3(NF1):c.5561T>A (p.Leu1854Gln)	NF1	L1833Q, L1854Q	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996414	17	29654809	17	31327791	996414	984197		NC_000017.11:31327790:T:A
NM_001042492.3(NF1):c.5746G>C (p.Ala1916Pro)	NF1	A1895P, A1916P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996413	17	29657450	17	31330432	996413	984205		NC_000017.11:31330431:G:C
NM_001042492.3(NF1):c.7546C>T (p.Pro2516Ser)	NF1	P2495S, P2516S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996412	17	29679363	17	31352345	996412	984242		NC_000017.11:31352344:C:T
NM_001042492.3(NF1):c.4522C>G (p.His1508Asp)	NF1	H1487D, H1508D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996411	17	29587478	17	31260460	996411	984173		NC_000017.11:31260459:C:G
NM_001042492.3(NF1):c.7970+5G>A	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000996409	17	29684392	17	31357374	996409	984247		NC_000017.11:31357373:G:A
NM_001042492.3(NF1):c.899T>C (p.Leu300Pro)	NF1	L300P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996408	17	29527450	17	31200432	996408	984096		NC_000017.11:31200431:T:C
NM_001042492.3(NF1):c.2989A>T (p.Arg997Trp)	NF1	R997W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996407	17	29556991	17	31229973	996407	984131		NC_000017.11:31229972:A:T
NM_001042492.3(NF1):c.2350T>A (p.Trp784Arg)	NF1	W784R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996401	17	29554565	17	31227547	996401	984122		NC_000017.11:31227546:T:A
NM_001042492.3(NF1):c.6252C>A (p.Tyr2084Ter)	NF1	Y2063*, Y2084*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000996395	17	29663757	17	31336739	996395	984215		NC_000017.11:31336738:C:A
NM_001042492.3(NF1):c.6006+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000996372	17	29662050	17	31335032	996372	984211		NC_000017.11:31335031:G:T
NM_001042492.3(NF1):c.1720A>C (p.Ser574Arg)	NF1	S574R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, single submitter	VCV000996216	17	29548946	17	31221928	996216	983929		NC_000017.11:31221927:A:C
NM_001042492.3(NF1):c.1139T>G (p.Leu380Arg)	NF1	L380R	none provided	Uncertain significance(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV000993576	17	29528131	17	31201113	993576	982079		NC_000017.11:31201112:T:G
NM_001042492.3(NF1):c.5675T>A (p.Leu1892Ter)	NF1	L1871*, L1892*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000992627	17	29657379	17	31330361	992627	980552		NC_000017.11:31330360:T:A
NM_001042492.3(NF1):c.4285A>G (p.Lys1429Glu)	NF1	K1408E, K1429E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000988013	17	29585473	17	31258455	988013	975951		NC_000017.11:31258454:A:G
NM_001042492.3(NF1):c.5287C>T (p.Gln1763Ter)	NF1	Q1742*, Q1763*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000987429	17	29654535	17	31327517	987429	975472		NC_000017.11:31327516:C:T
NM_001042492.3(NF1):c.2991-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000987118	17	29557276	17	31230258	987118	975470		NC_000017.11:31230257:A:G
NM_001042492.3(NF1):c.8378-13T>C	NF1		not specified	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000984500	17	29701018	17	31374000	984500	972602		NC_000017.11:31373999:T:C
NM_001042492.3(NF1):c.3520C>T (p.Gln1174Ter)	NF1	Q1174*	Neurofibromatosis, type 1|Rhabdomyosarcoma	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000978806	17	29560043	17	31233025	978806	966887		NC_000017.11:31233024:C:T
NM_001042492.3(NF1):c.4110+945A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000978032	17	29577082	17	31250064	978032	966166		NC_000017.11:31250063:A:G
NM_001042492.3(NF1):c.487G>T (p.Glu163Ter)	NF1	E163*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000977199	17	29496916	17	31169898	977199	965335		NC_000017.11:31169897:G:T
NM_001042492.3(NF1):c.4738G>T (p.Glu1580Ter)	NF1	E1559*, E1580*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000976344	17	29592260	17	31265242	976344	964475		NC_000017.11:31265241:G:T
NM_001042492.3(NF1):c.3448T>C (p.Ser1150Pro)	NF1	S1150P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000976302	17	29559851	17	31232833	976302	964474		NC_000017.11:31232832:T:C
NM_001042492.3(NF1):c.3113+1G>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000976156	17	29557401	17	31230383	976156	964689		NC_000017.11:31230382:G:C
NM_001042492.3(NF1):c.1969T>G (p.Ser657Ala)	NF1	S657A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000972593	17	29552236	17	31225218	972593	958036		NC_000017.11:31225217:T:G
NM_001042492.3(NF1):c.3993C>G (p.Ser1331Arg)	NF1	S1331R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000972571	17	29576020	17	31249002	972571	958049		NC_000017.11:31249001:C:G
NM_001042492.3(NF1):c.2251+4A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000972509	17	29553706	17	31226688	972509	960879		NC_000017.11:31226687:A:T
NM_001042492.3(NF1):c.7080T>A (p.Phe2360Leu)	NF1	F2339L, F2360L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000972409	17	29670044	17	31343026	972409	958071		NC_000017.11:31343025:T:A
NM_001042492.3(NF1):c.7189+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000972406	17	29670154	17	31343136	972406	960881		NC_000017.11:31343135:G:T
NM_001042492.3(NF1):c.4747G>T (p.Glu1583Ter)	NF1	E1583*, E1562*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000971976	17	29592269	17	31265251	971976	958053		NC_000017.11:31265250:G:T
NM_001042492.3(NF1):c.5788T>C (p.Cys1930Arg)	NF1	C1909R, C1930R	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000971853	17	29657492	17	31330474	971853	958063		NC_000017.11:31330473:T:C
NM_001042492.3(NF1):c.1062+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000971802	17	29527615	17	31200597	971802	960876		NC_000017.11:31200596:T:G
NM_001042492.3(NF1):c.2939C>T (p.Ser980Phe)	NF1	S980F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000971657	17	29556941	17	31229923	971657	958045		NC_000017.11:31229922:C:T
NM_001042492.3(NF1):c.5198T>A (p.Leu1733Ter)	NF1	L1712*, L1733*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000971282	17	29653200	17	31326182	971282	958059		NC_000017.11:31326181:T:A
NM_001042492.3(NF1):c.7543A>G (p.Ser2515Gly)	NF1	S2515G, S2494G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000971239	17	29679360	17	31352342	971239	958078		NC_000017.11:31352341:A:G
NM_001042492.3(NF1):c.4934T>C (p.Leu1645Pro)	NF1	L1624P, L1645P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000971132	17	29652936	17	31325918	971132	958054		NC_000017.11:31325917:T:C
NM_001042492.3(NF1):c.3328T>C (p.Phe1110Leu)	NF1	F1110L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000970972	17	29559731	17	31232713	970972	958047		NC_000017.11:31232712:T:C
NM_001042492.3(NF1):c.854C>T (p.Ser285Phe)	NF1	S285F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000970468	17	29509649	17	31182631	970468	958023		NC_000017.11:31182630:C:T
NM_001042492.3(NF1):c.2565A>C (p.Arg855Ser)	NF1	R855S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000970407	17	29556198	17	31229180	970407	958042		NC_000017.11:31229179:A:C
NM_001042492.3(NF1):c.5166A>T (p.Glu1722Asp)	NF1	E1701D, E1722D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000970221	17	29653168	17	31326150	970221	958058		NC_000017.11:31326149:A:T
NM_001042492.3(NF1):c.319A>G (p.Thr107Ala)	NF1	T107A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000969681	17	29490234	17	31163216	969681	958022		NC_000017.11:31163215:A:G
NM_001042492.3(NF1):c.2002-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 5, 2020)	criteria provided, single submitter	VCV000969514	17	29553451	17	31226433	969514	960878		NC_000017.11:31226432:A:G
NM_001042492.3(NF1):c.6013G>C (p.Asp2005His)	NF1	D2005H, D1984H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000969138	17	29663357	17	31336339	969138	958064		NC_000017.11:31336338:G:C
NM_001042492.3(NF1):c.8396T>C (p.Val2799Ala)	NF1	V2778A, V2799A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000969110	17	29701049	17	31374031	969110	958083		NC_000017.11:31374030:T:C
NM_001042492.3(NF1):c.5443C>T (p.Gln1815Ter)	NF1	Q1794*, Q1815*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV000968835	17	29654691	17	31327673	968835	958061		NC_000017.11:31327672:C:T
NM_001042492.3(NF1):c.7869+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000968591	17	29684109	17	31357091	968591	960882		NC_000017.11:31357090:G:C
NM_001042492.3(NF1):c.1362T>A (p.Cys454Ter)	NF1	C454*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, single submitter	VCV000968428	17	29533359	17	31206341	968428	958029		NC_000017.11:31206340:T:A
NM_001042492.3(NF1):c.4292C>T (p.Pro1431Leu)	NF1	P1431L, P1410L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV000968300	17	29585480	17	31258462	968300	958052		NC_000017.11:31258461:C:T
NM_001042492.3(NF1):c.4043A>T (p.His1348Leu)	NF1	H1348L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000967918	17	29576070	17	31249052	967918	958050		NC_000017.11:31249051:A:T
NM_001042492.3(NF1):c.7448C>G (p.Pro2483Arg)	NF1	P2483R, P2462R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000967537	17	29677327	17	31350309	967537	958076		NC_000017.11:31350308:C:G
NM_001042492.3(NF1):c.8220C>G (p.Asp2740Glu)	NF1	D2719E, D2740E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000967402	17	29687564	17	31360546	967402	958082		NC_000017.11:31360545:C:G
NM_001042492.3(NF1):c.3198-3C>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000967374	17	29559088	17	31232070	967374	960880		NC_000017.11:31232069:C:A
NM_001042492.3(NF1):c.2422C>T (p.Leu808Phe)	NF1	L808F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000967307	17	29556055	17	31229037	967307	958040		NC_000017.11:31229036:C:T
NM_001042492.3(NF1):c.6377T>G (p.Val2126Gly)	NF1	V2105G, V2126G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000967292	17	29663882	17	31336864	967292	958067		NC_000017.11:31336863:T:G
NM_001042492.3(NF1):c.4108C>T (p.Gln1370Ter)	NF1	Q1370*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000967072	17	29576135	17	31249117	967072	958051		NC_000017.11:31249116:C:T
NM_001042492.3(NF1):c.5108G>C (p.Ser1703Thr)	NF1	S1703T, S1682T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000966983	17	29653110	17	31326092	966983	958057		NC_000017.11:31326091:G:C
NM_001042492.3(NF1):c.977A>G (p.Lys326Arg)	NF1	K326R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000966790	17	29527528	17	31200510	966790	958024		NC_000017.11:31200509:A:G
NM_001042492.3(NF1):c.5030T>C (p.Val1677Ala)	NF1	V1656A, V1677A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000966492	17	29653032	17	31326014	966492	958056		NC_000017.11:31326013:T:C
NM_001042492.3(NF1):c.7194C>G (p.Tyr2398Ter)	NF1	Y2377*, Y2398*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000966483	17	29676142	17	31349124	966483	958074		NC_000017.11:31349123:C:G
NM_001042492.3(NF1):c.1687C>T (p.Pro563Ser)	NF1	P563S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000966412	17	29548913	17	31221895	966412	958032		NC_000017.11:31221894:C:T
NM_001042492.3(NF1):c.7089C>G (p.Ile2363Met)	NF1	I2363M, I2342M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000966274	17	29670053	17	31343035	966274	958072		NC_000017.11:31343034:C:G
NM_001042492.3(NF1):c.3129A>C (p.Glu1043Asp)	NF1	E1043D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000966168	17	29557875	17	31230857	966168	958046		NC_000017.11:31230856:A:C
NM_001042492.3(NF1):c.5582A>T (p.Asn1861Ile)	NF1	N1840I, N1861I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000966109	17	29654830	17	31327812	966109	958062		NC_000017.11:31327811:A:T
NM_001042492.3(NF1):c.2064A>T (p.Glu688Asp)	NF1	E688D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000966108	17	29553515	17	31226497	966108	958038		NC_000017.11:31226496:A:T
NM_001042492.3(NF1):c.7179C>A (p.His2393Gln)	NF1	H2372Q, H2393Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000965911	17	29670143	17	31343125	965911	958073		NC_000017.11:31343124:C:A
NM_001042492.3(NF1):c.60G>C (p.Gln20His)	NF1	Q20H	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000965727	17	29422387	17	31095369	965727	958021		NC_000017.11:31095368:G:C
NM_001042492.3(NF1):c.7003A>C (p.Thr2335Pro)	NF1	T2314P, T2335P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000965665	17	29667604	17	31340586	965665	958070		NC_000017.11:31340585:A:C
NM_001042492.3(NF1):c.1115A>T (p.Asp372Val)	NF1	D372V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000965619	17	29528107	17	31201089	965619	958025		NC_000017.11:31201088:A:T
NM_001042492.3(NF1):c.2774T>A (p.Leu925Ter)	NF1	L925*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000965045	17	29556407	17	31229389	965045	958043		NC_000017.11:31229388:T:A
NM_001042492.3(NF1):c.1270G>A (p.Asp424Asn)	NF1	D424N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000965007	17	29533267	17	31206249	965007	958027		NC_000017.11:31206248:G:A
NM_001042492.3(NF1):c.2914C>A (p.Leu972Ile)	NF1	L972I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000964946	17	29556916	17	31229898	964946	958044		NC_000017.11:31229897:C:A
NM_001042492.3(NF1):c.8065G>A (p.Val2689Met)	NF1	V2689M, V2668M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000964721	17	29685592	17	31358574	964721	958081		NC_000017.11:31358573:G:A
NM_001042492.3(NF1):c.2050C>T (p.Gln684Ter)	NF1	Q684*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV000964637	17	29553501	17	31226483	964637	958037		NC_000017.11:31226482:C:T
NM_001042492.3(NF1):c.803C>T (p.Pro268Leu)	NF1	P268L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000964609	17	29509598	17	31182580	964609	949762		NC_000017.11:31182579:C:T
NM_001042492.3(NF1):c.5625T>A (p.Asn1875Lys)	NF1	N1854K, N1875K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000964566	17	29657329	17	31330311	964566	949827		NC_000017.11:31330310:T:A
NM_001042492.3(NF1):c.1207C>T (p.Pro403Ser)	NF1	P403S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000964555	17	29528450	17	31201432	964555	949770		NC_000017.11:31201431:C:T
NM_001042492.3(NF1):c.987A>G (p.Lys329=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000964493	17	29527538	17	31200520	964493	949764		NC_000017.11:31200519:A:G
NM_001042492.3(NF1):c.4578-7T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000964230	17	29588722	17	31261704	964230	960205		NC_000017.11:31261703:T:A
NM_001042492.3(NF1):c.5491T>C (p.Trp1831Arg)	NF1	W1831R, W1810R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 17, 2019)	criteria provided, single submitter	VCV000964207	17	29654739	17	31327721	964207	949825		NC_000017.11:31327720:T:C
NM_001042492.3(NF1):c.164T>A (p.Ile55Lys)	NF1	I55K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000964155	17	29483104	17	31156086	964155	949753		NC_000017.11:31156085:T:A
NM_001042492.3(NF1):c.7823A>G (p.Glu2608Gly)	NF1	E2608G, E2587G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000963975	17	29684062	17	31357044	963975	949866		NC_000017.11:31357043:A:G
NM_001042492.3(NF1):c.3975-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000963827	17	29576000	17	31248982	963827	960204		NC_000017.11:31248981:A:T
NM_001042492.3(NF1):c.245C>A (p.Ser82Tyr)	NF1	S82Y	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000963679	17	29486068	17	31159050	963679	949755		NC_000017.11:31159049:C:A
NM_001042492.3(NF1):c.4835+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000963576	17	29592359	17	31265341	963576	960207		NC_000017.11:31265340:T:A
NM_001042492.3(NF1):c.1144T>C (p.Ser382Pro)	NF1	S382P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000963410	17	29528136	17	31201118	963410	949769		NC_000017.11:31201117:T:C
NM_001042492.3(NF1):c.4371A>G (p.Lys1457=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000963393	17	29586088	17	31259070	963393	949813		NC_000017.11:31259069:A:G
NM_001042492.3(NF1):c.8086C>A (p.Pro2696Thr)	NF1	P2675T, P2696T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000963371	17	29685613	17	31358595	963371	949868		NC_000017.11:31358594:C:A
NM_001042492.3(NF1):c.6548G>C (p.Arg2183Pro)	NF1	R2162P, R2183P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000963300	17	29664506	17	31337488	963300	949847		NC_000017.11:31337487:G:C
NM_001042492.3(NF1):c.7120A>G (p.Met2374Val)	NF1	M2374V, M2353V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000963287	17	29670084	17	31343066	963287	949856		NC_000017.11:31343065:A:G
NM_001042492.3(NF1):c.8094C>A (p.Tyr2698Ter)	NF1	Y2677*, Y2698*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000963283	17	29685621	17	31358603	963283	949869		NC_000017.11:31358602:C:A
NM_001042492.3(NF1):c.2927C>T (p.Thr976Ile)	NF1	T976I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000963208	17	29556929	17	31229911	963208	949791		NC_000017.11:31229910:C:T
NM_001042492.3(NF1):c.4243A>G (p.Asn1415Asp)	NF1	N1415D, N1394D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000963146	17	29585431	17	31258413	963146	949810		NC_000017.11:31258412:A:G
NM_001042492.3(NF1):c.6536G>T (p.Arg2179Leu)	NF1	R2179L, R2158L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000963058	17	29664494	17	31337476	963058	949845		NC_000017.11:31337475:G:T
NM_001042492.3(NF1):c.2273G>C (p.Arg758Thr)	NF1	R758T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000963032	17	29554257	17	31227239	963032	949784		NC_000017.11:31227238:G:C
NM_001042492.3(NF1):c.5531A>G (p.Lys1844Arg)	NF1	K1823R, K1844R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000962955	17	29654779	17	31327761	962955	949826		NC_000017.11:31327760:A:G
NM_001042492.3(NF1):c.5825A>G (p.Lys1942Arg)	NF1	K1921R, K1942R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000962825	17	29661868	17	31334850	962825	949832		NC_000017.11:31334849:A:G
NM_001042492.3(NF1):c.3140A>T (p.Asp1047Val)	NF1	D1047V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000962738	17	29557886	17	31230868	962738	949792		NC_000017.11:31230867:A:T
NM_001042492.3(NF1):c.1185+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000962619	17	29528178	17	31201160	962619	960197		NC_000017.11:31201159:G:T
NM_001042492.3(NF1):c.8395G>T (p.Val2799Phe)	NF1	V2799F, V2778F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000962510	17	29701048	17	31374030	962510	949872		NC_000017.11:31374029:G:T
NM_001042492.3(NF1):c.6704G>T (p.Arg2235Ile)	NF1	R2214I, R2235I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV000962380	17	29664898	17	31337880	962380	949849		NC_000017.11:31337879:G:T
NM_001042492.3(NF1):c.6160A>T (p.Met2054Leu)	NF1	M2054L, M2033L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000961967	17	29663665	17	31336647	961967	949839		NC_000017.11:31336646:A:T
NM_001042492.3(NF1):c.397G>A (p.Glu133Lys)	NF1	E133K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000961804	17	29490312	17	31163294	961804	949757		NC_000017.11:31163293:G:A
NM_001042492.3(NF1):c.1741A>G (p.Ile581Val)	NF1	I581V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000961540	17	29550481	17	31223463	961540	949776		NC_000017.11:31223462:A:G
NM_001042492.3(NF1):c.5282C>G (p.Ala1761Gly)	NF1	A1740G, A1761G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000961470	17	29654530	17	31327512	961470	949821		NC_000017.11:31327511:C:G
NM_001042492.3(NF1):c.1321A>G (p.Asn441Asp)	NF1	N441D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000961434	17	29533318	17	31206300	961434	949771		NC_000017.11:31206299:A:G
NM_001042492.3(NF1):c.6010A>T (p.Thr2004Ser)	NF1	T2004S, T1983S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000961411	17	29663354	17	31336336	961411	949837		NC_000017.11:31336335:A:T
NM_001042492.3(NF1):c.2161T>A (p.Cys721Ser)	NF1	C721S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000961370	17	29553612	17	31226594	961370	949781		NC_000017.11:31226593:T:A
NM_001042492.3(NF1):c.4073C>T (p.Pro1358Leu)	NF1	P1358L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000961194	17	29576100	17	31249082	961194	949807		NC_000017.11:31249081:C:T
NM_001042492.3(NF1):c.6292G>C (p.Ala2098Pro)	NF1	A2077P, A2098P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000961157	17	29663797	17	31336779	961157	949841		NC_000017.11:31336778:G:C
NM_001042492.3(NF1):c.6545A>G (p.Tyr2182Cys)	NF1	Y2182C, Y2161C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000960848	17	29664503	17	31337485	960848	949846		NC_000017.11:31337484:A:G
NM_001042492.3(NF1):c.5702C>T (p.Pro1901Leu)	NF1	P1880L, P1901L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000960765	17	29657406	17	31330388	960765	949829		NC_000017.11:31330387:C:T
NM_001042492.3(NF1):c.1528-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000960524	17	29546021	17	31219003	960524	960200		NC_000017.11:31219002:A:G
NM_001042492.3(NF1):c.5275T>C (p.Ser1759Pro)	NF1	S1759P, S1738P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 11, 2020)	criteria provided, single submitter	VCV000960410	17	29654523	17	31327505	960410	949820		NC_000017.11:31327504:T:C
NM_001042492.3(NF1):c.5957A>G (p.Lys1986Arg)	NF1	K1986R, K1965R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000960186	17	29662000	17	31334982	960186	949836		NC_000017.11:31334981:A:G
NM_001042492.3(NF1):c.3820C>T (p.Leu1274Phe)	NF1	L1274F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000960033	17	29562740	17	31235722	960033	949804		NC_000017.11:31235721:C:T
NM_001042492.3(NF1):c.5327C>G (p.Ser1776Ter)	NF1	S1776*, S1755*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000960019	17	29654575	17	31327557	960019	949822		NC_000017.11:31327556:C:G
NM_001042492.3(NF1):c.781A>G (p.Lys261Glu)	NF1	K261E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV000960018	17	29509576	17	31182558	960018	949761		NC_000017.11:31182557:A:G
NM_001042492.3(NF1):c.6642+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000959944	17	29664602	17	31337584	959944	960210		NC_000017.11:31337583:T:C
NM_001042492.3(NF1):c.3253C>G (p.Leu1085Val)	NF1	L1085V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2019)	criteria provided, single submitter	VCV000959889	17	29559146	17	31232128	959889	949795		NC_000017.11:31232127:C:G
NM_001042492.3(NF1):c.2105C>T (p.Ala702Val)	NF1	A702V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000959614	17	29553556	17	31226538	959614	949780		NC_000017.11:31226537:C:T
NM_001042492.3(NF1):c.2256A>T (p.Arg752Ser)	NF1	R752S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000959529	17	29554240	17	31227222	959529	949782		NC_000017.11:31227221:A:T
NM_001042492.3(NF1):c.7603A>T (p.Lys2535Ter)	NF1	K2514*, K2535*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000959456	17	29679420	17	31352402	959456	949863		NC_000017.11:31352401:A:T
NM_001042492.3(NF1):c.5609+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000959407	17	29654862	17	31327844	959407	960209		NC_000017.11:31327843:G:C
NM_001042492.3(NF1):c.5434T>C (p.Phe1812Leu)	NF1	F1791L, F1812L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000959392	17	29654682	17	31327664	959392	949824		NC_000017.11:31327663:T:C
NM_001042492.3(NF1):c.8312G>C (p.Ser2771Thr)	NF1	S2771T, S2750T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000959347	17	29687656	17	31360638	959347	949871		NC_000017.11:31360637:G:C
NM_001042492.3(NF1):c.4578G>A (p.Arg1526=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000959080	17	29588729	17	31261711	959080	949815		NC_000017.11:31261710:G:A
NM_001042492.3(NF1):c.4979C>G (p.Ser1660Cys)	NF1	S1660C, S1639C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000958846	17	29652981	17	31325963	958846	949818		NC_000017.11:31325962:C:G
NM_001042492.3(NF1):c.6165C>A (p.Cys2055Ter)	NF1	C2055*, C2034*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000958733	17	29663670	17	31336652	958733	949840		NC_000017.11:31336651:C:A
NM_001042492.3(NF1):c.1788T>G (p.Ile596Met)	NF1	I596M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000958510	17	29550528	17	31223510	958510	949777		NC_000017.11:31223509:T:G
NM_001042492.3(NF1):c.7971-321C>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000958469	17	29685177	17	31358159	958469	960212		NC_000017.11:31358158:C:G
NM_001042492.3(NF1):c.5740A>C (p.Thr1914Pro)	NF1	T1893P, T1914P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000958318	17	29657444	17	31330426	958318	949830		NC_000017.11:31330425:A:C
NM_001042492.3(NF1):c.6308T>A (p.Leu2103His)	NF1	L2082H, L2103H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000958074	17	29663813	17	31336795	958074	949842		NC_000017.11:31336794:T:A
NM_001042492.3(NF1):c.4226T>G (p.Met1409Arg)	NF1	M1388R, M1409R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000957853	17	29585414	17	31258396	957853	949808		NC_000017.11:31258395:T:G
NM_001042492.3(NF1):c.3659A>C (p.Glu1220Ala)	NF1	E1220A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000957649	17	29560182	17	31233164	957649	949799		NC_000017.11:31233163:A:C
NM_001042492.3(NF1):c.7481G>A (p.Trp2494Ter)	NF1	W2494*, W2473*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000957460	17	29679298	17	31352280	957460	949862		NC_000017.11:31352279:G:A
NM_001042492.3(NF1):c.65C>T (p.Pro22Leu)	NF1	P22L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000957418	17	29483005	17	31155987	957418	949752		NC_000017.11:31155986:C:T
NM_001042492.3(NF1):c.4280T>G (p.Leu1427Ter)	NF1	L1406*, L1427*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000957201	17	29585468	17	31258450	957201	949812		NC_000017.11:31258449:T:G
NM_001042492.3(NF1):c.3765A>C (p.Gln1255His)	NF1	Q1255H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 14, 2019)	criteria provided, single submitter	VCV000957131	17	29562685	17	31235667	957131	949801		NC_000017.11:31235666:A:C
NM_001042492.3(NF1):c.2276T>C (p.Val759Ala)	NF1	V759A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000957032	17	29554260	17	31227242	957032	949785		NC_000017.11:31227241:T:C
NM_001042492.3(NF1):c.3233C>G (p.Ser1078Ter)	NF1	S1078*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000956966	17	29559126	17	31232108	956966	949794		NC_000017.11:31232107:C:G
NM_001042492.3(NF1):c.1062+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000956905	17	29527615	17	31200597	956905	960196		NC_000017.11:31200596:T:C
NM_001042492.3(NF1):c.2706G>A (p.Met902Ile)	NF1	M902I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000956842	17	29556339	17	31229321	956842	949790		NC_000017.11:31229320:G:A
NM_001042492.3(NF1):c.705C>A (p.Tyr235Ter)	NF1	Y235*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000956712	17	29508778	17	31181760	956712	949759		NC_000017.11:31181759:C:A
NM_001042492.3(NF1):c.235T>G (p.Leu79Val)	NF1	L79V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000956611	17	29486058	17	31159040	956611	949754		NC_000017.11:31159039:T:G
NM_001042492.3(NF1):c.6976G>A (p.Asp2326Asn)	NF1	D2305N, D2326N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000956591	17	29667577	17	31340559	956591	949855		NC_000017.11:31340558:G:A
NM_001042492.3(NF1):c.2001+1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000956590	17	29552269	17	31225251	956590	960201		NC_000017.11:31225250:G:A
NM_001042492.3(NF1):c.3523A>G (p.Thr1175Ala)	NF1	T1175A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000956580	17	29560046	17	31233028	956580	949798		NC_000017.11:31233027:A:G
NM_001042492.3(NF1):c.3708+5G>A	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000956531	17	29560236	17	31233218	956531	960203		NC_000017.11:31233217:G:A
NM_001042492.3(NF1):c.7644A>G (p.Ile2548Met)	NF1	I2527M, I2548M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 19, 2020)	criteria provided, single submitter	VCV000956506	17	29683506	17	31356488	956506	949865		NC_000017.11:31356487:A:G
NM_001042492.3(NF1):c.757G>A (p.Val253Met)	NF1	V253M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000956351	17	29509552	17	31182534	956351	949760		NC_000017.11:31182533:G:A
NM_001042492.3(NF1):c.1139T>A (p.Leu380His)	NF1	L380H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000956350	17	29528131	17	31201113	956350	949768		NC_000017.11:31201112:T:A
NM_001042492.3(NF1):c.7125T>A (p.Asp2375Glu)	NF1	D2375E, D2354E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2019)	criteria provided, single submitter	VCV000956319	17	29670089	17	31343071	956319	949857		NC_000017.11:31343070:T:A
NM_001042492.3(NF1):c.6922G>A (p.Asp2308Asn)	NF1	D2287N, D2308N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV000956134	17	29667523	17	31340505	956134	949852		NC_000017.11:31340504:G:A
NM_001042492.3(NF1):c.4883T>G (p.Leu1628Ter)	NF1	L1628*, L1607*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000956108	17	29652885	17	31325867	956108	949817		NC_000017.11:31325866:T:G
NM_001042492.3(NF1):c.2518A>C (p.Met840Leu)	NF1	M840L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000956004	17	29556151	17	31229133	956004	949788		NC_000017.11:31229132:A:C
NM_001042492.3(NF1):c.5785G>A (p.Glu1929Lys)	NF1	E1929K, E1908K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000955823	17	29657489	17	31330471	955823	949831		NC_000017.11:31330470:G:A
NM_001042492.3(NF1):c.4232T>C (p.Leu1411Pro)	NF1	L1390P, L1411P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000955704	17	29585420	17	31258402	955704	949809		NC_000017.11:31258401:T:C
NM_001042492.3(NF1):c.4428C>T (p.Arg1476=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000955676	17	29586145	17	31259127	955676	949814		NC_000017.11:31259126:C:T
NM_001042492.3(NF1):c.2267A>G (p.Gln756Arg)	NF1	Q756R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000955675	17	29554251	17	31227233	955675	949783		NC_000017.11:31227232:A:G
NM_001042492.3(NF1):c.3494T>C (p.Ile1165Thr)	NF1	I1165T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV000955671	17	29559897	17	31232879	955671	949797		NC_000017.11:31232878:T:C
NM_001042492.3(NF1):c.4578-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000955585	17	29588727	17	31261709	955585	960206		NC_000017.11:31261708:A:C
NM_001042492.3(NF1):c.6943C>G (p.Leu2315Val)	NF1	L2294V, L2315V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000955259	17	29667544	17	31340526	955259	949854		NC_000017.11:31340525:C:G
NM_001042492.3(NF1):c.3437T>A (p.Val1146Asp)	NF1	V1146D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000955254	17	29559840	17	31232822	955254	949796		NC_000017.11:31232821:T:A
NM_001042492.3(NF1):c.58C>G (p.Gln20Glu)	NF1	Q20E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000955226	17	29422385	17	31095367	955226	949751		NC_000017.11:31095366:C:G
NM_001042492.3(NF1):c.5413A>G (p.Asn1805Asp)	NF1	N1784D, N1805D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000955071	17	29654661	17	31327643	955071	949823		NC_000017.11:31327642:A:G
NM_001042492.3(NF1):c.5034T>G (p.Tyr1678Ter)	NF1	Y1657*, Y1678*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV000954811	17	29653036	17	31326018	954811	949819		NC_000017.11:31326017:T:G
NM_001042492.3(NF1):c.7429C>T (p.Pro2477Ser)	NF1	P2456S, P2477S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000954665	17	29677308	17	31350290	954665	949861		NC_000017.11:31350289:C:T
NM_001042492.3(NF1):c.2471G>T (p.Gly824Val)	NF1	G824V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000954602	17	29556104	17	31229086	954602	949786		NC_000017.11:31229085:G:T
NM_001042492.3(NF1):c.3757C>G (p.Leu1253Val)	NF1	L1253V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV000954572	17	29562677	17	31235659	954572	949800		NC_000017.11:31235658:C:G
NM_001042492.3(NF1):c.6644C>T (p.Ala2215Val)	NF1	A2215V, A2194V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000954558	17	29664838	17	31337820	954558	949848		NC_000017.11:31337819:C:T
NM_001042492.3(NF1):c.5933T>C (p.Leu1978Pro)	NF1	L1978P, L1957P	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000954354	17	29661976	17	31334958	954354	949834		NC_000017.11:31334957:T:C
NM_001042492.3(NF1):c.6508G>A (p.Val2170Ile)	NF1	V2149I, V2170I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000954205	17	29664466	17	31337448	954205	949844		NC_000017.11:31337447:G:A
NM_001042492.3(NF1):c.418G>A (p.Gly140Arg)	NF1	G140R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000954180	17	29490333	17	31163315	954180	949758		NC_000017.11:31163314:G:A
NM_001042492.3(NF1):c.1967C>A (p.Ala656Asp)	NF1	A656D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000954132	17	29552234	17	31225216	954132	949779		NC_000017.11:31225215:C:A
NM_001042492.3(NF1):c.1337C>T (p.Thr446Ile)	NF1	T446I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000953156	17	29533334	17	31206316	953156	949772		NC_000017.11:31206315:C:T
NM_001042492.3(NF1):c.7174G>T (p.Gly2392Ter)	NF1	G2392*, G2371*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000953148	17	29670138	17	31343120	953148	949858		NC_000017.11:31343119:G:T
NM_001042492.3(NF1):c.3506A>C (p.Tyr1169Ser)	NF1	Y1169S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000952935	17	29560029	17	31233011	952935	928148		NC_000017.11:31233010:A:C
NM_001042492.3(NF1):c.3328T>G (p.Phe1110Val)	NF1	F1110V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000952889	17	29559731	17	31232713	952889	928146		NC_000017.11:31232712:T:G
NM_001042492.3(NF1):c.830G>A (p.Cys277Tyr)	NF1	C277Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000952879	17	29509625	17	31182607	952879	928102		NC_000017.11:31182606:G:A
NM_001042492.3(NF1):c.1260+4A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000952686	17	29528507	17	31201489	952686	941167		NC_000017.11:31201488:A:T
NM_001042492.3(NF1):c.6148G>T (p.Val2050Phe)	NF1	V2029F, V2050F	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000952648	17	29663653	17	31336635	952648	928189		NC_000017.11:31336634:G:T
NM_001042492.3(NF1):c.3336C>G (p.Asn1112Lys)	NF1	N1112K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000952627	17	29559739	17	31232721	952627	928147		NC_000017.11:31232720:C:G
NM_001042492.3(NF1):c.8423G>C (p.Cys2808Ser)	NF1	C2787S, C2808S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000952528	17	29701076	17	31374058	952528	928220		NC_000017.11:31374057:G:C
NM_001042492.3(NF1):c.2330G>A (p.Trp777Ter)	NF1	W777*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000952296	17	29554545	17	31227527	952296	928127		NC_000017.11:31227526:G:A
NM_001042492.3(NF1):c.1924C>T (p.Gln642Ter)	NF1	Q642*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000952282	17	29552191	17	31225173	952282	928118		NC_000017.11:31225172:C:T
NM_001042492.3(NF1):c.3299C>A (p.Ser1100Ter)	NF1	S1100*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000952266	17	29559192	17	31232174	952266	928143		NC_000017.11:31232173:C:A
NM_001042492.3(NF1):c.5812+3A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000952250	17	29657519	17	31330501	952250	941173		NC_000017.11:31330500:A:C
NM_001042492.3(NF1):c.5858T>G (p.Leu1953Arg)	NF1	L1953R, L1932R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000952228	17	29661901	17	31334883	952228	928184		NC_000017.11:31334882:T:G
NM_001042492.3(NF1):c.6694C>G (p.Leu2232Val)	NF1	L2232V, L2211V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000952092	17	29664888	17	31337870	952092	928196		NC_000017.11:31337869:C:G
NM_001042492.3(NF1):c.5273G>A (p.Gly1758Asp)	NF1	G1758D, G1737D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000951949	17	29654521	17	31327503	951949	928175		NC_000017.11:31327502:G:A
NM_001042492.3(NF1):c.3859T>C (p.Phe1287Leu)	NF1	F1287L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV000951938	17	29562779	17	31235761	951938	928156		NC_000017.11:31235760:T:C
NM_001042492.3(NF1):c.4828G>T (p.Ala1610Ser)	NF1	A1610S, A1589S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000951873	17	29592350	17	31265332	951873	928167		NC_000017.11:31265331:G:T
NM_001042492.3(NF1):c.690A>C (p.Glu230Asp)	NF1	E230D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV000951802	17	29508763	17	31181745	951802	928099		NC_000017.11:31181744:A:C
NM_001042492.3(NF1):c.7292T>G (p.Val2431Gly)	NF1	V2410G, V2431G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000951727	17	29676240	17	31349222	951727	928207		NC_000017.11:31349221:T:G
NM_001042492.3(NF1):c.8239G>A (p.Asp2747Asn)	NF1	D2726N, D2747N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000951648	17	29687583	17	31360565	951648	928218		NC_000017.11:31360564:G:A
NM_001042492.3(NF1):c.7499C>A (p.Ser2500Tyr)	NF1	S2479Y, S2500Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000951553	17	29679316	17	31352298	951553	928212		NC_000017.11:31352297:C:A
NM_001042492.3(NF1):c.3155C>T (p.Thr1052Ile)	NF1	T1052I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000951552	17	29557901	17	31230883	951552	928140		NC_000017.11:31230882:C:T
NM_001042492.3(NF1):c.6527T>C (p.Ile2176Thr)	NF1	I2155T, I2176T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV000951497	17	29664485	17	31337467	951497	928194		NC_000017.11:31337466:T:C
NM_001042492.3(NF1):c.7189+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000951449	17	29670154	17	31343136	951449	941176		NC_000017.11:31343135:G:C
NM_001042492.3(NF1):c.5285T>C (p.Val1762Ala)	NF1	V1741A, V1762A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000951354	17	29654533	17	31327515	951354	928176		NC_000017.11:31327514:T:C
NM_001042492.3(NF1):c.7256T>G (p.Leu2419Arg)	NF1	L2398R, L2419R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000951205	17	29676204	17	31349186	951205	928205		NC_000017.11:31349185:T:G
NM_001042492.3(NF1):c.8C>T (p.Ala3Val)	NF1|LOC111811965	A3V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV000951161	17	29422335	17	31095317	951161	928093		NC_000017.11:31095316:C:T
NM_001042492.3(NF1):c.1641+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000951144	17	29546141	17	31219123	951144	941168		NC_000017.11:31219122:G:C
NM_001042492.3(NF1):c.888+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000951075	17	29509685	17	31182667	951075	941165		NC_000017.11:31182666:T:G
NM_001042492.3(NF1):c.6023A>G (p.Asp2008Gly)	NF1	D1987G, D2008G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000950973	17	29663367	17	31336349	950973	928188		NC_000017.11:31336348:A:G
NM_001042492.3(NF1):c.7670A>C (p.Gln2557Pro)	NF1	Q2536P, Q2557P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000950933	17	29683532	17	31356514	950933	928213		NC_000017.11:31356513:A:C
NM_001042492.3(NF1):c.6428-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000950753	17	29664385	17	31337367	950753	941174		NC_000017.11:31337366:G:A
NM_001042492.3(NF1):c.910C>G (p.Arg304Gly)	NF1	R304G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000950672	17	29527461	17	31200443	950672	928106		NC_000017.11:31200442:C:G
NM_001042492.3(NF1):c.3752A>C (p.His1251Pro)	NF1	H1251P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000950635	17	29562672	17	31235654	950635	928152		NC_000017.11:31235653:A:C
NM_001042492.3(NF1):c.848A>T (p.Asp283Val)	NF1	D283V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000950631	17	29509643	17	31182625	950631	928104		NC_000017.11:31182624:A:T
NM_001042492.3(NF1):c.4985G>C (p.Trp1662Ser)	NF1	W1641S, W1662S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000950590	17	29652987	17	31325969	950590	928169		NC_000017.11:31325968:G:C
NM_001042492.3(NF1):c.6819+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000950585	17	29665159	17	31338141	950585	941175		NC_000017.11:31338140:T:G
NM_001042492.3(NF1):c.5882A>G (p.Lys1961Arg)	NF1	K1940R, K1961R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000950551	17	29661925	17	31334907	950551	928186		NC_000017.11:31334906:A:G
NM_001042492.3(NF1):c.7067C>A (p.Pro2356Gln)	NF1	P2335Q, P2356Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000950512	17	29670031	17	31343013	950512	928201		NC_000017.11:31343012:C:A
NM_001042492.3(NF1):c.4333-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000950496	17	29586049	17	31259031	950496	941171		NC_000017.11:31259030:G:C
NM_001042492.3(NF1):c.4371A>T (p.Lys1457Asn)	NF1	K1436N, K1457N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000950400	17	29586088	17	31259070	950400	928161		NC_000017.11:31259069:A:T
NM_001042492.3(NF1):c.4473A>G (p.Ala1491=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000950306	17	29587429	17	31260411	950306	928164		NC_000017.11:31260410:A:G
NM_001042492.3(NF1):c.1854T>G (p.Asp618Glu)	NF1	D618E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000950182	17	29552121	17	31225103	950182	928116		NC_000017.11:31225102:T:G
NM_001042492.3(NF1):c.3977T>G (p.Leu1326Ter)	NF1	L1326*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000949855	17	29576004	17	31248986	949855	928158		NC_000017.11:31248985:T:G
NM_001042492.3(NF1):c.3131A>G (p.Tyr1044Cys)	NF1	Y1044C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000949833	17	29557877	17	31230859	949833	928139		NC_000017.11:31230858:A:G
NM_001042492.3(NF1):c.7463T>C (p.Leu2488Pro)	NF1	L2467P, L2488P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000949815	17	29679280	17	31352262	949815	928210		NC_000017.11:31352261:T:C
NM_001042492.3(NF1):c.4330A>T (p.Lys1444Ter)	NF1	K1444*, K1423*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000949779	17	29585518	17	31258500	949779	928160		NC_000017.11:31258499:A:T
NM_001042492.3(NF1):c.479+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000949678	17	29490395	17	31163377	949678	941163		NC_000017.11:31163376:G:C
NM_001042492.3(NF1):c.5885A>C (p.His1962Pro)	NF1	H1941P, H1962P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000949508	17	29661928	17	31334910	949508	928187		NC_000017.11:31334909:A:C
NM_001042492.3(NF1):c.1235A>G (p.Asn412Ser)	NF1	N412S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV000949487	17	29528478	17	31201460	949487	928109		NC_000017.11:31201459:A:G
NM_001042492.3(NF1):c.2464G>A (p.Gly822Arg)	NF1	G822R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000949206	17	29556097	17	31229079	949206	928130		NC_000017.11:31229078:G:A
NM_001042492.3(NF1):c.8374C>T (p.Pro2792Ser)	NF1	P2771S, P2792S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000948965	17	29687718	17	31360700	948965	928219		NC_000017.11:31360699:C:T
NM_001042492.3(NF1):c.655-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000948962	17	29508726	17	31181708	948962	941164		NC_000017.11:31181707:A:G
NM_001042492.3(NF1):c.95C>A (p.Thr32Asn)	NF1	T32N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000948830	17	29483035	17	31156017	948830	928094		NC_000017.11:31156016:C:A
NM_001042492.3(NF1):c.3220G>T (p.Glu1074Ter)	NF1	E1074*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000948826	17	29559113	17	31232095	948826	928141		NC_000017.11:31232094:G:T
NM_001042492.3(NF1):c.4578-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV000948667	17	29588728	17	31261710	948667	941172		NC_000017.11:31261709:G:A
NM_001042492.3(NF1):c.1846-1G>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000948410	17	29552112	17	31225094	948410	941169		NC_000017.11:31225093:G:T
NM_001042492.3(NF1):c.7258G>C (p.Val2420Leu)	NF1	V2399L, V2420L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000948369	17	29676206	17	31349188	948369	928206		NC_000017.11:31349187:G:C
NM_001042492.3(NF1):c.5180C>G (p.Pro1727Arg)	NF1	P1706R, P1727R	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000948364	17	29653182	17	31326164	948364	928173		NC_000017.11:31326163:C:G
NM_001042492.3(NF1):c.5539C>A (p.Pro1847Thr)	NF1	P1847T, P1826T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000947921	17	29654787	17	31327769	947921	928179		NC_000017.11:31327768:C:A
NM_001042492.3(NF1):c.1942G>T (p.Glu648Ter)	NF1	E648*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000947858	17	29552209	17	31225191	947858	928119		NC_000017.11:31225190:G:T
NM_001042492.3(NF1):c.4429A>G (p.Arg1477Gly)	NF1	R1456G, R1477G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000947841	17	29586146	17	31259128	947841	928162		NC_000017.11:31259127:A:G
NM_001042492.3(NF1):c.3096C>A (p.Cys1032Ter)	NF1	C1032*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000947778	17	29557383	17	31230365	947778	928138		NC_000017.11:31230364:C:A
NM_001042492.3(NF1):c.3299C>T (p.Ser1100Leu)	NF1	S1100L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000947775	17	29559192	17	31232174	947775	928144		NC_000017.11:31232173:C:T
NM_001042492.3(NF1):c.2894T>A (p.Ile965Lys)	NF1	I965K	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000947673	17	29556896	17	31229878	947673	928137		NC_000017.11:31229877:T:A
NM_001042492.3(NF1):c.5362A>G (p.Ile1788Val)	NF1	I1788V, I1767V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000947659	17	29654610	17	31327592	947659	928177		NC_000017.11:31327591:A:G
NM_001042492.3(NF1):c.5870T>C (p.Val1957Ala)	NF1	V1936A, V1957A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000947647	17	29661913	17	31334895	947647	928185		NC_000017.11:31334894:T:C
NM_001042492.3(NF1):c.4466G>A (p.Ser1489Asn)	NF1	S1489N, S1468N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000947570	17	29587422	17	31260404	947570	928163		NC_000017.11:31260403:G:A
NM_001042492.3(NF1):c.2623G>C (p.Gly875Arg)	NF1	G875R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000947561	17	29556256	17	31229238	947561	928132		NC_000017.11:31229237:G:C
NM_001042492.3(NF1):c.2078T>C (p.Met693Thr)	NF1	M693T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000947489	17	29553529	17	31226511	947489	928121		NC_000017.11:31226510:T:C
NM_001042492.3(NF1):c.7078T>G (p.Phe2360Val)	NF1	F2339V, F2360V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000947220	17	29670042	17	31343024	947220	928202		NC_000017.11:31343023:T:G
NM_001042492.3(NF1):c.6845C>T (p.Pro2282Leu)	NF1	P2261L, P2282L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000947202	17	29665747	17	31338729	947202	928198		NC_000017.11:31338728:C:T
NM_001042492.3(NF1):c.7487C>T (p.Ser2496Phe)	NF1	S2475F, S2496F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000947131	17	29679304	17	31352286	947131	928211		NC_000017.11:31352285:C:T
NM_001042492.3(NF1):c.6764T>G (p.Ile2255Ser)	NF1	I2234S, I2255S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000947035	17	29665102	17	31338084	947035	928197		NC_000017.11:31338083:T:G
NM_001042492.3(NF1):c.5142A>C (p.Lys1714Asn)	NF1	K1693N, K1714N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000946790	17	29653144	17	31326126	946790	928172		NC_000017.11:31326125:A:C
NM_001042492.3(NF1):c.655G>C (p.Ala219Pro)	NF1	A219P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000946783	17	29508728	17	31181710	946783	928097		NC_000017.11:31181709:G:C
NM_001042492.3(NF1):c.7951C>T (p.Pro2651Ser)	NF1	P2630S, P2651S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000946699	17	29684368	17	31357350	946699	928215		NC_000017.11:31357349:C:T
NM_001042492.3(NF1):c.6412C>T (p.Gln2138Ter)	NF1	Q2117*, Q2138*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000946672	17	29663917	17	31336899	946672	928192		NC_000017.11:31336898:C:T
NM_001042492.3(NF1):c.5141A>C (p.Lys1714Thr)	NF1	K1693T, K1714T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000946296	17	29653143	17	31326125	946296	928171		NC_000017.11:31326124:A:C
NM_001042492.3(NF1):c.2464G>T (p.Gly822Ter)	NF1	G822*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000946222	17	29556097	17	31229079	946222	928131		NC_000017.11:31229078:G:T
NM_001042492.3(NF1):c.2371A>G (p.Ile791Val)	NF1	I791V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000946221	17	29554586	17	31227568	946221	928128		NC_000017.11:31227567:A:G
NM_001042492.3(NF1):c.3708G>A (p.Trp1236Ter)	NF1	W1236*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000946140	17	29560231	17	31233213	946140	928150		NC_000017.11:31233212:G:A
NM_001042492.3(NF1):c.8143G>A (p.Ala2715Thr)	NF1	A2694T, A2715T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000946137	17	29686016	17	31358998	946137	928217		NC_000017.11:31358997:G:A
NM_001042492.3(NF1):c.2099C>G (p.Thr700Ser)	NF1	T700S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000946062	17	29553550	17	31226532	946062	928122		NC_000017.11:31226531:C:G
NM_001042492.3(NF1):c.7802C>A (p.Ser2601Ter)	NF1	S2580*, S2601*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000945791	17	29684041	17	31357023	945791	928214		NC_000017.11:31357022:C:A
NM_001042492.3(NF1):c.60+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV000945776	17	29422391	17	31095373	945776	941162		NC_000017.11:31095372:A:G
NM_001042492.3(NF1):c.7970+6T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 22, 2019)	criteria provided, single submitter	VCV000945724	17	29684393	17	31357375	945724	941178		NC_000017.11:31357374:T:C
NM_001042492.3(NF1):c.2783C>T (p.Ala928Val)	NF1	A928V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000945666	17	29556416	17	31229398	945666	928136		NC_000017.11:31229397:C:T
NM_001042492.3(NF1):c.5768C>A (p.Thr1923Lys)	NF1	T1923K, T1902K	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000945629	17	29657472	17	31330454	945629	928183		NC_000017.11:31330453:C:A
NM_001042492.3(NF1):c.1879T>A (p.Phe627Ile)	NF1	F627I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000945618	17	29552146	17	31225128	945618	928117		NC_000017.11:31225127:T:A
NM_001042492.3(NF1):c.7190-10T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000945511	17	29676128	17	31349110	945511	941177		NC_000017.11:31349109:T:G
NM_001042492.3(NF1):c.4670C>A (p.Thr1557Lys)	NF1	T1536K, T1557K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000945493	17	29588821	17	31261803	945493	928166		NC_000017.11:31261802:C:A
NM_001042492.3(NF1):c.1007G>A (p.Trp336Ter)	NF1	W336*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV000945440	17	29527558	17	31200540	945440	928107		NC_000017.11:31200539:G:A
NM_001042492.3(NF1):c.2638G>A (p.Val880Met)	NF1	V880M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000945416	17	29556271	17	31229253	945416	928133		NC_000017.11:31229252:G:A
NM_001042492.3(NF1):c.7459A>G (p.Thr2487Ala)	NF1	T2466A, T2487A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000945355	17	29679276	17	31352258	945355	928209		NC_000017.11:31352257:A:G
NM_001042492.3(NF1):c.3967C>T (p.Pro1323Ser)	NF1	P1323S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000945186	17	29563032	17	31236014	945186	928157		NC_000017.11:31236013:C:T
NM_001042492.3(NF1):c.3725T>G (p.Val1242Gly)	NF1	V1242G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000945105	17	29562645	17	31235627	945105	928151		NC_000017.11:31235626:T:G
NM_001042492.3(NF1):c.1421G>C (p.Ser474Thr)	NF1	S474T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000945063	17	29541497	17	31214479	945063	928113		NC_000017.11:31214478:G:C
NM_001042492.3(NF1):c.5630T>G (p.Leu1877Arg)	NF1	L1877R, L1856R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000944817	17	29657334	17	31330316	944817	928180		NC_000017.11:31330315:T:G
NM_001042492.3(NF1):c.5245A>G (p.Lys1749Glu)	NF1	K1728E, K1749E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV000944691	17	29653247	17	31326229	944691	928174		NC_000017.11:31326228:A:G
NM_001042492.3(NF1):c.685G>C (p.Asp229His)	NF1	D229H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000944530	17	29508758	17	31181740	944530	928098		NC_000017.11:31181739:G:C
NM_001042492.3(NF1):c.3832A>T (p.Asn1278Tyr)	NF1	N1278Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000944500	17	29562752	17	31235734	944500	928154		NC_000017.11:31235733:A:T
NM_001042492.3(NF1):c.120G>C (p.Lys40Asn)	NF1	K40N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000944433	17	29483060	17	31156042	944433	928095		NC_000017.11:31156041:G:C
NM_001042492.3(NF1):c.5537G>A (p.Arg1846Gln)	NF1	R1846Q, R1825Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV000944389	17	29654785	17	31327767	944389	928178		NC_000017.11:31327766:G:A
NM_001042492.3(NF1):c.1263C>A (p.Ser421=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000944051	17	29533260	17	31206242	944051	928110		NC_000017.11:31206241:C:A
NM_001042492.3(NF1):c.6327C>G (p.Phe2109Leu)	NF1	F2088L, F2109L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000944039	17	29663832	17	31336814	944039	928190		NC_000017.11:31336813:C:G
NM_001042492.3(NF1):c.2176G>T (p.Val726Leu)	NF1	V726L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000943986	17	29553627	17	31226609	943986	928123		NC_000017.11:31226608:G:T
NM_001042492.3(NF1):c.2470G>A (p.Gly824Arg)	NF1	G824R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000943805	17	29556103	17	31229085	943805	937789		NC_000017.11:31229084:G:A
NM_001042492.3(NF1):c.3949G>A (p.Val1317Ile)	NF1	V1317I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000943779	17	29563014	17	31235996	943779	937823		NC_000017.11:31235995:G:A
NM_001042492.3(NF1):c.7048A>C (p.Ile2350Leu)	NF1	I2329L, I2350L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000943671	17	29667649	17	31340631	943671	937869		NC_000017.11:31340630:A:C
NM_001042492.3(NF1):c.602T>G (p.Phe201Cys)	NF1	F201C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000943581	17	29508455	17	31181437	943581	937765		NC_000017.11:31181436:T:G
NM_001042492.3(NF1):c.3278T>C (p.Val1093Ala)	NF1	V1093A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000943414	17	29559171	17	31232153	943414	937805		NC_000017.11:31232152:T:C
NM_001042492.3(NF1):c.147C>G (p.Tyr49Ter)	NF1	Y49*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000943309	17	29483087	17	31156069	943309	937761		NC_000017.11:31156068:C:G
NM_001042492.3(NF1):c.3814C>T (p.Gln1272Ter)	NF1	Q1272*	Inborn genetic diseases|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000943279	17	29562734	17	31235716	943279	937817		NC_000017.11:31235715:C:T
NM_001042492.3(NF1):c.61-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000943213	17	29483000	17	31155982	943213	940390		NC_000017.11:31155981:G:A
NM_001042492.3(NF1):c.5194G>A (p.Ala1732Thr)	NF1	A1711T, A1732T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000943103	17	29653196	17	31326178	943103	937847		NC_000017.11:31326177:G:A
NM_001042492.3(NF1):c.3803C>G (p.Ala1268Gly)	NF1	A1268G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000942792	17	29562723	17	31235705	942792	937815		NC_000017.11:31235704:C:G
NM_001042492.3(NF1):c.3124G>A (p.Val1042Ile)	NF1	V1042I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000942471	17	29557870	17	31230852	942471	937801		NC_000017.11:31230851:G:A
NM_001042492.3(NF1):c.288+3A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000942422	17	29486114	17	31159096	942422	940391		NC_000017.11:31159095:A:T
NM_001042492.3(NF1):c.776G>A (p.Ser259Asn)	NF1	S259N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000942268	17	29509571	17	31182553	942268	937767		NC_000017.11:31182552:G:A
NM_001042492.3(NF1):c.3526A>G (p.Arg1176Gly)	NF1	R1176G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000942184	17	29560049	17	31233031	942184	937809		NC_000017.11:31233030:A:G
NM_001042492.3(NF1):c.4772G>C (p.Ser1591Thr)	NF1	S1570T, S1591T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000942069	17	29592294	17	31265276	942069	937836		NC_000017.11:31265275:G:C
NM_001042492.3(NF1):c.5609+4G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000942068	17	29654861	17	31327843	942068	940400		NC_000017.11:31327842:G:C
NM_001042492.3(NF1):c.5158G>T (p.Glu1720Ter)	NF1	E1720*, E1699*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000941924	17	29653160	17	31326142	941924	937846		NC_000017.11:31326141:G:T
NM_001042492.3(NF1):c.2303A>T (p.His768Leu)	NF1	H768L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000941913	17	29554287	17	31227269	941913	937783		NC_000017.11:31227268:A:T
NM_001042492.3(NF1):c.2301G>T (p.Glu767Asp)	NF1	E767D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000941912	17	29554285	17	31227267	941912	937782		NC_000017.11:31227266:G:T
NM_001042492.3(NF1):c.3803C>T (p.Ala1268Val)	NF1	A1268V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000941695	17	29562723	17	31235705	941695	937816		NC_000017.11:31235704:C:T
NM_001042492.3(NF1):c.5038T>G (p.Tyr1680Asp)	NF1	Y1680D, Y1659D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000941694	17	29653040	17	31326022	941694	937842		NC_000017.11:31326021:T:G
NM_001042492.3(NF1):c.6428-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000941637	17	29664385	17	31337367	941637	940403		NC_000017.11:31337366:G:T
NM_001042492.3(NF1):c.4245T>G (p.Asn1415Lys)	NF1	N1394K, N1415K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000941609	17	29585433	17	31258415	941609	937827		NC_000017.11:31258414:T:G
NM_001042492.3(NF1):c.4560G>T (p.Gln1520His)	NF1	Q1520H, Q1499H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000941548	17	29587516	17	31260498	941548	937829		NC_000017.11:31260497:G:T
NM_001042492.3(NF1):c.2972T>G (p.Met991Arg)	NF1	M991R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000941469	17	29556974	17	31229956	941469	937795		NC_000017.11:31229955:T:G
NM_001042492.3(NF1):c.2981A>G (p.Asn994Ser)	NF1	N994S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000941297	17	29556983	17	31229965	941297	937796		NC_000017.11:31229964:A:G
NM_001042492.3(NF1):c.2850+6G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000941175	17	29556489	17	31229471	941175	940395		NC_000017.11:31229470:G:A
NM_001042492.3(NF1):c.1058T>C (p.Leu353Pro)	NF1	L353P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000940935	17	29527609	17	31200591	940935	937775		NC_000017.11:31200590:T:C
NM_001042492.3(NF1):c.4700C>A (p.Ser1567Ter)	NF1	S1546*, S1567*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000940807	17	29588851	17	31261833	940807	937834		NC_000017.11:31261832:C:A
NM_001042492.3(NF1):c.1018T>G (p.Ser340Ala)	NF1	S340A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000940725	17	29527569	17	31200551	940725	937774		NC_000017.11:31200550:T:G
NM_001042492.3(NF1):c.5224A>G (p.Asn1742Asp)	NF1	N1742D, N1721D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000940684	17	29653226	17	31326208	940684	937848		NC_000017.11:31326207:A:G
NM_001042492.3(NF1):c.6160A>G (p.Met2054Val)	NF1	M2033V, M2054V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000940627	17	29663665	17	31336647	940627	937858		NC_000017.11:31336646:A:G
NM_001042492.3(NF1):c.3047G>A (p.Cys1016Tyr)	NF1	C1016Y	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Aug 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000940554	17	29557334	17	31230316	940554	937798		NC_000017.11:31230315:G:A
NM_001042492.3(NF1):c.6959T>C (p.Val2320Ala)	NF1	V2299A, V2320A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000940274	17	29667560	17	31340542	940274	937868		NC_000017.11:31340541:T:C
NM_001042492.3(NF1):c.5455G>A (p.Ala1819Thr)	NF1	A1798T, A1819T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000940023	17	29654703	17	31327685	940023	937850		NC_000017.11:31327684:G:A
NM_001042492.3(NF1):c.5928C>A (p.Asp1976Glu)	NF1	D1955E, D1976E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 2, 2019)	criteria provided, single submitter	VCV000939927	17	29661971	17	31334953	939927	937856		NC_000017.11:31334952:C:A
NM_001042492.3(NF1):c.5446G>T (p.Glu1816Ter)	NF1	E1795*, E1816*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 12, 2019)	criteria provided, single submitter	VCV000939892	17	29654694	17	31327676	939892	937849		NC_000017.11:31327675:G:T
NM_001042492.3(NF1):c.7063-3T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000939889	17	29670024	17	31343006	939889	940404		NC_000017.11:31343005:T:C
NM_001042492.3(NF1):c.1793A>C (p.Lys598Thr)	NF1	K598T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000939835	17	29550533	17	31223515	939835	937778		NC_000017.11:31223514:A:C
NM_001042492.3(NF1):c.7190-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV000939750	17	29676137	17	31349119	939750	940406		NC_000017.11:31349118:G:A
NM_001042492.3(NF1):c.7060A>G (p.Lys2354Glu)	NF1	K2354E, K2333E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000939690	17	29667661	17	31340643	939690	937870		NC_000017.11:31340642:A:G
NM_001042492.3(NF1):c.3905A>G (p.Asp1302Gly)	NF1	D1302G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000939566	17	29562970	17	31235952	939566	937821		NC_000017.11:31235951:A:G
NM_001042492.3(NF1):c.1324A>G (p.Met442Val)	NF1	M442V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000939488	17	29533321	17	31206303	939488	937776		NC_000017.11:31206302:A:G
NM_001042492.3(NF1):c.7930G>C (p.Ala2644Pro)	NF1	A2644P, A2623P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000939215	17	29684347	17	31357329	939215	937878		NC_000017.11:31357328:G:C
NM_001042492.3(NF1):c.961G>C (p.Ala321Pro)	NF1	A321P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000939172	17	29527512	17	31200494	939172	937771		NC_000017.11:31200493:G:C
NM_001042492.3(NF1):c.3516T>A (p.Asp1172Glu)	NF1	D1172E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000939137	17	29560039	17	31233021	939137	937808		NC_000017.11:31233020:T:A
NM_001042492.3(NF1):c.2991G>A (p.Arg997=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV000938882	17	29557278	17	31230260	938882	937797		NC_000017.11:31230259:G:A
NM_001042492.3(NF1):c.5059A>G (p.Arg1687Gly)	NF1	R1666G, R1687G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000938775	17	29653061	17	31326043	938775	937843		NC_000017.11:31326042:A:G
NM_001042492.3(NF1):c.5998C>T (p.Leu2000Phe)	NF1	L1979F, L2000F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000938717	17	29662041	17	31335023	938717	937857		NC_000017.11:31335022:C:T
NM_001042492.3(NF1):c.4038C>A (p.Phe1346Leu)	NF1	F1346L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000938693	17	29576065	17	31249047	938693	937824		NC_000017.11:31249046:C:A
NM_001042492.3(NF1):c.5549T>G (p.Val1850Gly)	NF1	V1850G, V1829G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000938664	17	29654797	17	31327779	938664	937852		NC_000017.11:31327778:T:G
NM_001042492.3(NF1):c.1260+3A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000938646	17	29528506	17	31201488	938646	940393		NC_000017.11:31201487:A:C
NM_001042492.3(NF1):c.2611A>G (p.Ser871Gly)	NF1	S871G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000938584	17	29556244	17	31229226	938584	937790		NC_000017.11:31229225:A:G
NM_001042492.3(NF1):c.3943C>T (p.Gln1315Ter)	NF1	Q1315*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000938573	17	29563008	17	31235990	938573	937822		NC_000017.11:31235989:C:T
NM_001042492.3(NF1):c.3610C>A (p.Arg1204=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000938473	17	29560133	17	31233115	938473	937811		NC_000017.11:31233114:C:A
NM_001042492.3(NF1):c.4823A>C (p.Tyr1608Ser)	NF1	Y1608S, Y1587S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000938399	17	29592345	17	31265327	938399	937839		NC_000017.11:31265326:A:C
NM_001042492.3(NF1):c.3086T>C (p.Leu1029Pro)	NF1	L1029P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000938133	17	29557373	17	31230355	938133	937800		NC_000017.11:31230354:T:C
NM_001042492.3(NF1):c.7190-3T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 17, 2019)	criteria provided, single submitter	VCV000938123	17	29676135	17	31349117	938123	940405		NC_000017.11:31349116:T:C
NM_001042492.3(NF1):c.5911G>A (p.Val1971Ile)	NF1	V1950I, V1971I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000938010	17	29661954	17	31334936	938010	937855		NC_000017.11:31334935:G:A
NM_001042492.3(NF1):c.980T>G (p.Leu327Arg)	NF1	L327R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000937848	17	29527531	17	31200513	937848	937772		NC_000017.11:31200512:T:G
NM_001042492.3(NF1):c.3709-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000937830	17	29562627	17	31235609	937830	940398		NC_000017.11:31235608:A:G
NM_001042492.3(NF1):c.7566G>A (p.Met2522Ile)	NF1	M2501I, M2522I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000937477	17	29679383	17	31352365	937477	937876		NC_000017.11:31352364:G:A
NM_001042492.3(NF1):c.3698G>C (p.Cys1233Ser)	NF1	C1233S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000937405	17	29560221	17	31233203	937405	937813		NC_000017.11:31233202:G:C
NM_001042492.3(NF1):c.3791A>G (p.Glu1264Gly)	NF1	E1264G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000937360	17	29562711	17	31235693	937360	937814		NC_000017.11:31235692:A:G
NM_001042492.3(NF1):c.2991-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000937354	17	29557277	17	31230259	937354	940396		NC_000017.11:31230258:G:T
NM_001042492.3(NF1):c.4562A>G (p.Tyr1521Cys)	NF1	Y1500C, Y1521C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000937346	17	29587518	17	31260500	937346	937830		NC_000017.11:31260499:A:G
NM_001042492.3(NF1):c.4621A>G (p.Thr1541Ala)	NF1	T1520A, T1541A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000937233	17	29588772	17	31261754	937233	937831		NC_000017.11:31261753:A:G
NM_001042492.3(NF1):c.3196A>G (p.Arg1066Gly)	NF1	R1066G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000937204	17	29557942	17	31230924	937204	937803		NC_000017.11:31230923:A:G
NM_001042492.3(NF1):c.4475T>C (p.Val1492Ala)	NF1	V1492A, V1471A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000937195	17	29587431	17	31260413	937195	937828		NC_000017.11:31260412:T:C
NM_001042492.3(NF1):c.4694C>G (p.Thr1565Ser)	NF1	T1565S, T1544S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000937080	17	29588845	17	31261827	937080	937833		NC_000017.11:31261826:C:G
NM_001042492.3(NF1):c.2325G>C (p.Glu775Asp)	NF1	E775D	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000937015	17	29554309	17	31227291	937015	937784		NC_000017.11:31227290:G:C
NM_001042492.3(NF1):c.3854T>G (p.Met1285Arg)	NF1	M1285R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000936861	17	29562774	17	31235756	936861	937818		NC_000017.11:31235755:T:G
NM_001042492.3(NF1):c.3148A>G (p.Met1050Val)	NF1	M1050V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000936842	17	29557894	17	31230876	936842	937802		NC_000017.11:31230875:A:G
NM_001042492.3(NF1):c.4904A>T (p.Tyr1635Phe)	NF1	Y1614F, Y1635F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000936824	17	29652906	17	31325888	936824	937841		NC_000017.11:31325887:A:T
NM_001042492.3(NF1):c.6526A>G (p.Ile2176Val)	NF1	I2155V, I2176V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000936694	17	29664484	17	31337466	936694	937860		NC_000017.11:31337465:A:G
NM_001042492.3(NF1):c.4649A>G (p.Glu1550Gly)	NF1	E1529G, E1550G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000936666	17	29588800	17	31261782	936666	937832		NC_000017.11:31261781:A:G
NM_001042492.3(NF1):c.224C>G (p.Ala75Gly)	NF1	A75G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000936646	17	29486047	17	31159029	936646	937762		NC_000017.11:31159028:C:G
NM_001042492.3(NF1):c.8192T>C (p.Ile2731Thr)	NF1	I2710T, I2731T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV000936582	17	29687536	17	31360518	936582	937881		NC_000017.11:31360517:T:C
NM_001042492.3(NF1):c.6280C>T (p.Leu2094Phe)	NF1	L2073F, L2094F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000936356	17	29663785	17	31336767	936356	937859		NC_000017.11:31336766:C:T
NM_001042492.3(NF1):c.6680A>T (p.Asp2227Val)	NF1	D2227V, D2206V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000936229	17	29664874	17	31337856	936229	937863		NC_000017.11:31337855:A:T
NM_001042492.3(NF1):c.3198-314G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000936187	17	29558777	17	31231759	936187	940397		NC_000017.11:31231758:G:A
NM_001042492.3(NF1):c.5750C>A (p.Ala1917Asp)	NF1	A1896D, A1917D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000936166	17	29657454	17	31330436	936166	937854		NC_000017.11:31330435:C:A
NM_001042492.3(NF1):c.3049C>T (p.Gln1017Ter)	NF1	Q1017*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000935938	17	29557336	17	31230318	935938	937799		NC_000017.11:31230317:C:T
NM_001042492.3(NF1):c.7739-3C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 17, 2019)	criteria provided, single submitter	VCV000935613	17	29683975	17	31356957	935613	940407		NC_000017.11:31356956:C:T
NM_001042492.3(NF1):c.5491T>G (p.Trp1831Gly)	NF1	W1831G, W1810G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000935460	17	29654739	17	31327721	935460	937851		NC_000017.11:31327720:T:G
NM_001042492.3(NF1):c.5077C>A (p.His1693Asn)	NF1	H1672N, H1693N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000935401	17	29653079	17	31326061	935401	937844		NC_000017.11:31326060:C:A
NM_001042492.3(NF1):c.888+6G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000935291	17	29509689	17	31182671	935291	940392		NC_000017.11:31182670:G:A
NM_001042492.3(NF1):c.35C>T (p.Ala12Val)	NF1|LOC111811965	A12V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000935275	17	29422362	17	31095344	935275	937760		NC_000017.11:31095343:C:T
NM_001042492.3(NF1):c.997T>C (p.Tyr333His)	NF1	Y333H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000935028	17	29527548	17	31200530	935028	937773		NC_000017.11:31200529:T:C
NM_001042492.3(NF1):c.7274A>G (p.Asn2425Ser)	NF1	N2404S, N2425S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000934924	17	29676222	17	31349204	934924	937872		NC_000017.11:31349203:A:G
NM_001042492.3(NF1):c.451A>G (p.Asn151Asp)	NF1	N151D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000934687	17	29490366	17	31163348	934687	937763		NC_000017.11:31163347:A:G
NM_001042492.3(NF1):c.8420A>G (p.His2807Arg)	NF1	H2786R, H2807R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000934589	17	29701073	17	31374055	934589	937884		NC_000017.11:31374054:A:G
NM_001042492.3(NF1):c.8259A>C (p.Glu2753Asp)	NF1	E2732D, E2753D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000934523	17	29687603	17	31360585	934523	937882		NC_000017.11:31360584:A:C
NM_001042492.3(NF1):c.1641+4A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000934364	17	29546140	17	31219122	934364	940394		NC_000017.11:31219121:A:C
NM_001042492.3(NF1):c.4220G>A (p.Ser1407Asn)	NF1	S1386N, S1407N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000934258	17	29585408	17	31258390	934258	937826		NC_000017.11:31258389:G:A
NM_001042492.3(NF1):c.4769T>A (p.Leu1590Ter)	NF1	L1590*, L1569*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000934165	17	29592291	17	31265273	934165	937835		NC_000017.11:31265272:T:A
NM_001042492.3(NF1):c.8011T>A (p.Leu2671Met)	NF1	L2671M, L2650M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV000934013	17	29685538	17	31358520	934013	937879		NC_000017.11:31358519:T:A
NM_001042492.3(NF1):c.781A>C (p.Lys261Gln)	NF1	K261Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000933893	17	29509576	17	31182558	933893	937768		NC_000017.11:31182557:A:C
NM_001042492.3(NF1):c.6955G>C (p.Ala2319Pro)	NF1	A2319P, A2298P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000933812	17	29667556	17	31340538	933812	937867		NC_000017.11:31340537:G:C
NM_001042492.3(NF1):c.7420G>T (p.Asp2474Tyr)	NF1	D2453Y, D2474Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000933778	17	29677299	17	31350281	933778	937875		NC_000017.11:31350280:G:T
NM_001042492.3(NF1):c.3198A>T (p.Arg1066Ser)	NF1	R1066S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000933765	17	29559091	17	31232073	933765	937804		NC_000017.11:31232072:A:T
NM_001042492.3(NF1):c.6819G>C (p.Lys2273Asn)	NF1	K2273N, K2252N	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV000933505	17	29665157	17	31338139	933505	937865		NC_000017.11:31338138:G:C
NM_001042492.3(NF1):c.8287C>A (p.Pro2763Thr)	NF1	P2763T, P2742T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000933469	17	29687631	17	31360613	933469	937883		NC_000017.11:31360612:C:A
NM_001042492.3(NF1):c.1156A>G (p.Ile386Val)	NF1	I386V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000931989	17	29528148	17	31201130	931989	919719		NC_000017.11:31201129:A:G
NM_001042492.3(NF1):c.7310C>A (p.Ala2437Asp)	NF1	A2416D, A2437D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000931870	17	29676258	17	31349240	931870	919724		NC_000017.11:31349239:C:A
NM_001042492.3(NF1):c.7322-14C>T	NF1		none provided|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000931812	17	29677187	17	31350169	931812	920370		NC_000017.11:31350168:C:T
NM_001042492.3(NF1):c.2506G>T (p.Glu836Ter)	NF1	E836*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000931332	17	29556139	17	31229121	931332	919720		NC_000017.11:31229120:G:T
NM_001042492.3(NF1):c.479+5G>T	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000931310	17	29490399	17	31163381	931310	920369		NC_000017.11:31163380:G:T
NM_001042492.3(NF1):c.279T>G (p.Cys93Trp)	NF1	C93W	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV000930967	17	29486102	17	31159084	930967	919718		NC_000017.11:31159083:T:G
NM_001042492.3(NF1):c.4744G>T (p.Glu1582Ter)	NF1	E1561*, E1582*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000930310	17	29592266	17	31265248	930310	919722		NC_000017.11:31265247:G:T
NM_001042492.3(NF1):c.7846C>T (p.Gln2616Ter)	NF1	Q2595*, Q2616*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000928869	17	29684085	17	31357067	928869	917232		NC_000017.11:31357066:C:T
NM_001042492.3(NF1):c.4790G>T (p.Gly1597Val)	NF1	G1576V, G1597V	not specified	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000928592	17	29592312	17	31265294	928592	917230		NC_000017.11:31265293:G:T
NM_001042492.3(NF1):c.1969T>A (p.Ser657Thr)	NF1	S657T	not specified	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000928591	17	29552236	17	31225218	928591	917228		NC_000017.11:31225217:T:A
NM_001042492.3(NF1):c.827T>A (p.Leu276Ter)	NF1	L276*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000915297	17	29509622	17	31182604	915297	903617		NC_000017.11:31182603:T:A
NM_001042492.3(NF1):c.*194A>C	NF1		Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892503	17	29701367	17	31374349	892503	877186		NC_000017.11:31374348:A:C
NM_001042492.3(NF1):c.*160A>T	NF1		Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892502	17	29701333	17	31374315	892502	877185		NC_000017.11:31374314:A:T
NM_001042492.3(NF1):c.*2777C>T	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000891893	17	29703950	17	31376932	891893	877204		NC_000017.11:31376931:C:T
NM_001042492.3(NF1):c.-265G>C	NF1|LOC111811965		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891891	17	29422063	17	31095045	891891	877177		NC_000017.11:31095044:G:C
NM_001042492.3(NF1):c.*1481A>G	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000891756	17	29702654	17	31375636	891756	877199		NC_000017.11:31375635:A:G
NM_001042492.3(NF1):c.*1150C>T	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000891683	17	29702323	17	31375305	891683	877195		NC_000017.11:31375304:C:T
NM_001042492.3(NF1):c.*585G>A	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891622	17	29701758	17	31374740	891622	877191		NC_000017.11:31374739:G:A
NM_001042492.3(NF1):c.*1479A>C	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000891509	17	29702652	17	31375634	891509	877198		NC_000017.11:31375633:A:C
NM_001042492.3(NF1):c.*971T>A	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891431	17	29702144	17	31375126	891431	877194		NC_000017.11:31375125:T:A
NM_001042492.3(NF1):c.*887C>G	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891430	17	29702060	17	31375042	891430	877193		NC_000017.11:31375041:C:G
NM_001042492.3(NF1):c.*584G>C	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)	criteria provided, conflicting interpretations	VCV000891376	17	29701757	17	31374739	891376	877190		NC_000017.11:31374738:G:C
NM_001042492.3(NF1):c.*582T>G	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891375	17	29701755	17	31374737	891375	877189		NC_000017.11:31374736:T:G
NM_001042492.3(NF1):c.*126G>A	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000891306	17	29701299	17	31374281	891306	877184		NC_000017.11:31374280:G:A
NM_001042492.3(NF1):c.*124C>T	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891305	17	29701297	17	31374279	891305	877183		NC_000017.11:31374278:C:T
NM_001042492.3(NF1):c.1392+6A>T	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000890836	17	29533395	17	31206377	890836	880495		NC_000017.11:31206376:A:T
NM_001042492.3(NF1):c.270G>A (p.Leu90=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000890752	17	29486093	17	31159075	890752	877181		NC_000017.11:31159074:G:A
NM_001042492.3(NF1):c.*3227A>G	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890703	17	29704400	17	31377382	890703	877206		NC_000017.11:31377381:A:G
NM_001042492.3(NF1):c.*3189G>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000890702	17	29704362	17	31377344	890702	877205		NC_000017.11:31377343:G:A
NM_001042492.3(NF1):c.3975-12A>G	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890433	17	29575990	17	31248972	890433	880497		NC_000017.11:31248971:A:G
NM_001042492.3(NF1):c.*3514G>T	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890172	17	29704687	17	31377669	890172	877208		NC_000017.11:31377668:G:T
NM_001042492.3(NF1):c.*2540T>G	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890073	17	29703713	17	31376695	890073	877203		NC_000017.11:31376694:T:G
NM_001042492.3(NF1):c.*2073T>C	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000890012	17	29703246	17	31376228	890012	877201		NC_000017.11:31376227:T:C
NM_001042492.3(NF1):c.*1208C>T	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889951	17	29702381	17	31375363	889951	877197		NC_000017.11:31375362:C:T
NM_001042492.3(NF1):c.*541G>A	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889821	17	29701714	17	31374696	889821	877188		NC_000017.11:31374695:G:A
NM_001042492.3(NF1):c.*101T>C	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889769	17	29701274	17	31374256	889769	877182		NC_000017.11:31374255:T:C
NM_001042492.3(NF1):c.7616-15A>C	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000889704	17	29683463	17	31356445	889704	880499		NC_000017.11:31356444:A:C
NM_001042492.3(NF1):c.*3514G>A	NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889510	17	29704687	17	31377669	889510	877207		NC_000017.11:31377668:G:A
NM_001042492.3(NF1):c.*2247T>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889384	17	29703420	17	31376402	889384	877202		NC_000017.11:31376401:T:C
NM_001042492.3(NF1):c.*2010A>G	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889330	17	29703183	17	31376165	889330	877200		NC_000017.11:31376164:A:G
NM_001042492.3(NF1):c.*1187C>A	NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889264	17	29702360	17	31375342	889264	877196		NC_000017.11:31375341:C:A
NM_001042492.3(NF1):c.*585G>T	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889206	17	29701758	17	31374740	889206	877192		NC_000017.11:31374739:G:T
NM_001042492.3(NF1):c.*385C>T	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889139	17	29701558	17	31374540	889139	877187		NC_000017.11:31374539:C:T
NM_001042492.3(NF1):c.6643-13T>C	NF1		not provided|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2021)	criteria provided, conflicting interpretations	VCV000888951	17	29664824	17	31337806	888951	880498		NC_000017.11:31337805:T:C
NM_001042492.3(NF1):c.2409+15T>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000888673	17	29554639	17	31227621	888673	880496		NC_000017.11:31227620:T:C
NM_001042492.3(NF1):c.7063-4A>G	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2020)	criteria provided, conflicting interpretations	VCV000873037	17	29670023	17	31343005	873037	861167		NC_000017.11:31343004:A:G
NM_001042492.3(NF1):c.1722-11T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000873035	17	29550451	17	31223433	873035	861165		NC_000017.11:31223432:T:G
NM_001042492.3(NF1):c.289-6T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000873034	17	29490198	17	31163180	873034	861164		NC_000017.11:31163179:T:G
NM_001042492.3(NF1):c.6675G>A (p.Trp2225Ter)	NF1	W2225*, W2204*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000872184	17	29664869	17	31337851	872184	860371		NC_000017.11:31337850:G:A
NM_001042492.3(NF1):c.8048G>A (p.Gly2683Glu)	NF1	G2683E, G2662E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000864478	17	29685575	17	31358557	864478	845189		NC_000017.11:31358556:G:A
NM_001042492.3(NF1):c.4577+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000864398	17	29587535	17	31260517	864398	852181		NC_000017.11:31260516:T:G
NM_001042492.3(NF1):c.7330A>G (p.Thr2444Ala)	NF1	T2423A, T2444A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000864360	17	29677209	17	31350191	864360	845157		NC_000017.11:31350190:A:G
NM_001042492.3(NF1):c.2942A>G (p.Glu981Gly)	NF1	E981G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV000864160	17	29556944	17	31229926	864160	844966		NC_000017.11:31229925:A:G
NM_001042492.3(NF1):c.5578C>G (p.Leu1860Val)	NF1	L1839V, L1860V	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000864045	17	29654826	17	31327808	864045	845074		NC_000017.11:31327807:C:G
NM_001042492.3(NF1):c.5558C>G (p.Thr1853Arg)	NF1	T1832R, T1853R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000864044	17	29654806	17	31327788	864044	845071		NC_000017.11:31327787:C:G
NM_001042492.3(NF1):c.3194C>A (p.Thr1065Lys)	NF1	T1065K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000864028	17	29557940	17	31230922	864028	844979		NC_000017.11:31230921:C:A
NM_001042492.3(NF1):c.5639T>G (p.Leu1880Ter)	NF1	L1859*, L1880*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000863800	17	29657343	17	31330325	863800	845078		NC_000017.11:31330324:T:G
NM_001042492.3(NF1):c.288+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000863797	17	29486112	17	31159094	863797	852165		NC_000017.11:31159093:G:A
NM_001042492.3(NF1):c.3870+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000863762	17	29562791	17	31235773	863762	852713		NC_000017.11:31235772:G:C
NM_001042492.3(NF1):c.1355A>T (p.Gln452Leu)	NF1	Q452L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000863715	17	29533352	17	31206334	863715	844894		NC_000017.11:31206333:A:T
NM_001042492.3(NF1):c.2305C>T (p.Pro769Ser)	NF1	P769S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000863640	17	29554289	17	31227271	863640	844941		NC_000017.11:31227270:C:T
NM_001042492.3(NF1):c.7231A>T (p.Arg2411Ter)	NF1	R2411*, R2390*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000863490	17	29676179	17	31349161	863490	845147		NC_000017.11:31349160:A:T
NM_001042492.3(NF1):c.6147+3A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV000863430	17	29663494	17	31336476	863430	852726		NC_000017.11:31336475:A:G
NM_001042492.3(NF1):c.8404T>C (p.Ser2802Pro)	NF1	S2781P, S2802P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000863359	17	29701057	17	31374039	863359	845200		NC_000017.11:31374038:T:C
NM_001042492.3(NF1):c.7458-3C>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000863338	17	29679272	17	31352254	863338	852190		NC_000017.11:31352253:C:A
NM_001042492.3(NF1):c.7387C>G (p.Leu2463Val)	NF1	L2442V, L2463V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000863335	17	29677266	17	31350248	863335	845158		NC_000017.11:31350247:C:G
NM_001042492.3(NF1):c.2693T>G (p.Leu898Arg)	NF1	L898R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2019)	criteria provided, single submitter	VCV000863165	17	29556326	17	31229308	863165	844955		NC_000017.11:31229307:T:G
NM_001042492.3(NF1):c.7138C>T (p.Leu2380Phe)	NF1	L2380F, L2359F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000863019	17	29670102	17	31343084	863019	845138		NC_000017.11:31343083:C:T
NM_001042492.3(NF1):c.6055G>C (p.Ala2019Pro)	NF1	A1998P, A2019P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000862931	17	29663399	17	31336381	862931	845091		NC_000017.11:31336380:G:C
NM_001042492.3(NF1):c.851T>C (p.Ile284Thr)	NF1	I284T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000862916	17	29509646	17	31182628	862916	844876		NC_000017.11:31182627:T:C
NM_001042492.3(NF1):c.7876C>A (p.Leu2626Met)	NF1	L2626M, L2605M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000862896	17	29684293	17	31357275	862896	845183		NC_000017.11:31357274:C:A
NM_001042492.3(NF1):c.5571C>A (p.Ile1857=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000862800	17	29654819	17	31327801	862800	845073		NC_000017.11:31327800:C:A
NM_001042492.3(NF1):c.3190C>T (p.Leu1064Phe)	NF1	L1064F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000862794	17	29557936	17	31230918	862794	844978		NC_000017.11:31230917:C:T
NM_001042492.3(NF1):c.7228G>C (p.Val2410Leu)	NF1	V2389L, V2410L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV000862703	17	29676176	17	31349158	862703	845146		NC_000017.11:31349157:G:C
NM_001042492.3(NF1):c.348A>C (p.Glu116Asp)	NF1	E116D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 12, 2019)	criteria provided, single submitter	VCV000862539	17	29490263	17	31163245	862539	844855		NC_000017.11:31163244:A:C
NM_001042492.3(NF1):c.404G>T (p.Arg135Leu)	NF1	R135L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000862514	17	29490319	17	31163301	862514	844859		NC_000017.11:31163300:G:T
NM_001042492.3(NF1):c.1573T>A (p.Leu525Ile)	NF1	L525I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000862461	17	29546068	17	31219050	862461	844907		NC_000017.11:31219049:T:A
NM_001042492.3(NF1):c.3967C>G (p.Pro1323Ala)	NF1	P1323A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000862143	17	29563032	17	31236014	862143	845014		NC_000017.11:31236013:C:G
NM_001042492.3(NF1):c.7465A>T (p.Lys2489Ter)	NF1	K2468*, K2489*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000861961	17	29679282	17	31352264	861961	845164		NC_000017.11:31352263:A:T
NM_001042492.3(NF1):c.7705A>G (p.Met2569Val)	NF1	M2569V, M2548V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000861933	17	29683567	17	31356549	861933	845178		NC_000017.11:31356548:A:G
NM_001042492.3(NF1):c.7421A>G (p.Asp2474Gly)	NF1	D2453G, D2474G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000861892	17	29677300	17	31350282	861892	845160		NC_000017.11:31350281:A:G
NM_001042492.3(NF1):c.2995G>A (p.Val999Ile)	NF1	V999I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000861887	17	29557282	17	31230264	861887	844969		NC_000017.11:31230263:G:A
NM_001042492.3(NF1):c.6119C>T (p.Ser2040Phe)	NF1	S2019F, S2040F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000861870	17	29663463	17	31336445	861870	845093		NC_000017.11:31336444:C:T
NM_001042492.3(NF1):c.1960C>G (p.Pro654Ala)	NF1	P654A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000861844	17	29552227	17	31225209	861844	844926		NC_000017.11:31225208:C:G
NM_001042492.3(NF1):c.3479G>A (p.Gly1160Asp)	NF1	G1160D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000861799	17	29559882	17	31232864	861799	844995		NC_000017.11:31232863:G:A
NM_001042492.3(NF1):c.8126A>G (p.Asn2709Ser)	NF1	N2688S, N2709S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000861752	17	29685999	17	31358981	861752	845194		NC_000017.11:31358980:A:G
NM_001042492.3(NF1):c.637A>G (p.Ile213Val)	NF1	I213V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000861456	17	29508490	17	31181472	861456	844867		NC_000017.11:31181471:A:G
NM_001042492.3(NF1):c.7509C>G (p.Tyr2503Ter)	NF1	Y2482*, Y2503*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000861417	17	29679326	17	31352308	861417	845167		NC_000017.11:31352307:C:G
NM_001042492.3(NF1):c.2345C>G (p.Ala782Gly)	NF1	A782G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000861382	17	29554560	17	31227542	861382	844942		NC_000017.11:31227541:C:G
NM_001042492.3(NF1):c.6034G>C (p.Asp2012His)	NF1	D1991H, D2012H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000861249	17	29663378	17	31336360	861249	845089		NC_000017.11:31336359:G:C
NM_001042492.3(NF1):c.6805C>G (p.Arg2269Gly)	NF1	R2248G, R2269G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000861230	17	29665143	17	31338125	861230	845122		NC_000017.11:31338124:C:G
NM_001042492.3(NF1):c.1207C>A (p.Pro403Thr)	NF1	P403T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000861051	17	29528450	17	31201432	861051	844891		NC_000017.11:31201431:C:A
NM_001042492.3(NF1):c.7240C>T (p.His2414Tyr)	NF1	H2393Y, H2414Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000860996	17	29676188	17	31349170	860996	845148		NC_000017.11:31349169:C:T
NM_001042492.3(NF1):c.4531C>T (p.Leu1511Phe)	NF1	L1490F, L1511F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000860648	17	29587487	17	31260469	860648	845044		NC_000017.11:31260468:C:T
NM_001042492.3(NF1):c.2999G>C (p.Arg1000Pro)	NF1	R1000P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000860498	17	29557286	17	31230268	860498	844970		NC_000017.11:31230267:G:C
NM_001042492.3(NF1):c.6515C>G (p.Ser2172Ter)	NF1	S2151*, S2172*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000860326	17	29664473	17	31337455	860326	845110		NC_000017.11:31337454:C:G
NM_001042492.3(NF1):c.6276T>G (p.Asn2092Lys)	NF1	N2071K, N2092K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000860221	17	29663781	17	31336763	860221	845097		NC_000017.11:31336762:T:G
NM_001042492.3(NF1):c.8357C>T (p.Ala2786Val)	NF1	A2786V, A2765V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000860086	17	29687701	17	31360683	860086	845198		NC_000017.11:31360682:C:T
NM_001042492.3(NF1):c.3920T>G (p.Ile1307Ser)	NF1	I1307S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000859957	17	29562985	17	31235967	859957	845009		NC_000017.11:31235966:T:G
NM_001042492.3(NF1):c.7870-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000859845	17	29684285	17	31357267	859845	852193		NC_000017.11:31357266:A:G
NM_001042492.3(NF1):c.7477C>T (p.Pro2493Ser)	NF1	P2472S, P2493S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000859783	17	29679294	17	31352276	859783	845165		NC_000017.11:31352275:C:T
NM_001042492.3(NF1):c.4255G>A (p.Val1419Ile)	NF1	V1398I, V1419I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000859706	17	29585443	17	31258425	859706	845030		NC_000017.11:31258424:G:A
NM_001042492.3(NF1):c.4895A>G (p.Lys1632Arg)	NF1	K1611R, K1632R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000859654	17	29652897	17	31325879	859654	845051		NC_000017.11:31325878:A:G
NM_001042492.3(NF1):c.4381A>G (p.Met1461Val)	NF1	M1461V, M1440V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000859637	17	29586098	17	31259080	859637	845038		NC_000017.11:31259079:A:G
NM_001042492.3(NF1):c.3892C>T (p.Gln1298Ter)	NF1	Q1298*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000859602	17	29562957	17	31235939	859602	845007		NC_000017.11:31235938:C:T
NM_001042492.3(NF1):c.3497-3T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000859583	17	29560017	17	31232999	859583	852177		NC_000017.11:31232998:T:C
NM_001042492.3(NF1):c.4026G>A (p.Met1342Ile)	NF1	M1342I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000859582	17	29576053	17	31249035	859582	845017		NC_000017.11:31249034:G:A
NM_001042492.3(NF1):c.6890C>G (p.Ala2297Gly)	NF1	A2297G, A2276G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000859564	17	29665792	17	31338774	859564	845124		NC_000017.11:31338773:C:G
NM_001042492.3(NF1):c.2671G>A (p.Val891Ile)	NF1	V891I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000859263	17	29556304	17	31229286	859263	844951		NC_000017.11:31229285:G:A
NM_001042492.3(NF1):c.261G>C (p.Leu87Phe)	NF1	L87F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 25, 2019)	criteria provided, single submitter	VCV000859254	17	29486084	17	31159066	859254	844849		NC_000017.11:31159065:G:C
NM_001042492.3(NF1):c.5494G>T (p.Glu1832Ter)	NF1	E1811*, E1832*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000859126	17	29654742	17	31327724	859126	845066		NC_000017.11:31327723:G:T
NM_001042492.3(NF1):c.1845+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000859076	17	29550587	17	31223569	859076	852173		NC_000017.11:31223568:T:A
NM_001042492.3(NF1):c.5610-3T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000858970	17	29657311	17	31330293	858970	852724		NC_000017.11:31330292:T:C
NM_001042492.3(NF1):c.5609+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000858870	17	29654859	17	31327841	858870	852183		NC_000017.11:31327840:T:G
NM_001042492.3(NF1):c.1789C>T (p.Leu597Phe)	NF1	L597F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000858550	17	29550529	17	31223511	858550	844917		NC_000017.11:31223510:C:T
NM_001042492.3(NF1):c.450C>A (p.Phe150Leu)	NF1	F150L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000858257	17	29490365	17	31163347	858257	844864		NC_000017.11:31163346:C:A
NM_001042492.3(NF1):c.7160A>C (p.Asn2387Thr)	NF1	N2366T, N2387T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000858139	17	29670124	17	31343106	858139	845141		NC_000017.11:31343105:A:C
NM_001042492.3(NF1):c.5268+5G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000857985	17	29653275	17	31326257	857985	851705		NC_000017.11:31326256:G:C
NM_001042492.3(NF1):c.5687C>A (p.Ser1896Ter)	NF1	S1875*, S1896*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2019)	criteria provided, single submitter	VCV000857730	17	29657391	17	31330373	857730	845080		NC_000017.11:31330372:C:A
NM_001042492.3(NF1):c.2447G>C (p.Arg816Pro)	NF1	R816P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000857606	17	29556080	17	31229062	857606	844944		NC_000017.11:31229061:G:C
NM_001042492.3(NF1):c.338T>A (p.Leu113Ter)	NF1	L113*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000857599	17	29490253	17	31163235	857599	844853		NC_000017.11:31163234:T:A
NM_001042492.3(NF1):c.711C>G (p.Ile237Met)	NF1	I237M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000857596	17	29508784	17	31181766	857596	844870		NC_000017.11:31181765:C:G
NM_001042492.3(NF1):c.2588A>G (p.Tyr863Cys)	NF1	Y863C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV000857456	17	29556221	17	31229203	857456	844948		NC_000017.11:31229202:A:G
NM_001042492.3(NF1):c.6486C>G (p.Tyr2162Ter)	NF1	Y2162*, Y2141*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000857333	17	29664444	17	31337426	857333	845106		NC_000017.11:31337425:C:G
NM_001042492.3(NF1):c.269T>C (p.Leu90Pro)	NF1	L90P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000857101	17	29486092	17	31159074	857101	844850		NC_000017.11:31159073:T:C
NM_001042492.3(NF1):c.8002C>A (p.Leu2668Met)	NF1	L2668M, L2647M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000856676	17	29685529	17	31358511	856676	845187		NC_000017.11:31358510:C:A
NM_001042492.3(NF1):c.4271C>A (p.Ala1424Glu)	NF1	A1403E, A1424E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000856529	17	29585459	17	31258441	856529	845031		NC_000017.11:31258440:C:A
NM_001042492.3(NF1):c.1759A>G (p.Ser587Gly)	NF1	S587G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000856418	17	29550499	17	31223481	856418	844915		NC_000017.11:31223480:A:G
NM_001042492.3(NF1):c.5493G>A (p.Trp1831Ter)	NF1	W1810*, W1831*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000856332	17	29654741	17	31327723	856332	845064		NC_000017.11:31327722:G:A
NM_001042492.3(NF1):c.6841G>T (p.Gly2281Ter)	NF1	G2260*, G2281*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000856272	17	29665743	17	31338725	856272	845123		NC_000017.11:31338724:G:T
NM_001042492.3(NF1):c.2932G>A (p.Gly978Ser)	NF1	G978S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000856252	17	29556934	17	31229916	856252	844964		NC_000017.11:31229915:G:A
NM_001042492.3(NF1):c.6717A>G (p.Gln2239=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 9, 2019)	criteria provided, single submitter	VCV000856177	17	29665055	17	31338037	856177	845118		NC_000017.11:31338036:A:G
NM_001042492.3(NF1):c.6704+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000856149	17	29664899	17	31337881	856149	852730		NC_000017.11:31337880:G:C
NM_001042492.3(NF1):c.4298C>G (p.Pro1433Arg)	NF1	P1412R, P1433R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000856126	17	29585486	17	31258468	856126	845034		NC_000017.11:31258467:C:G
NM_001042492.3(NF1):c.6191C>T (p.Ser2064Phe)	NF1	S2064F, S2043F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000856068	17	29663696	17	31336678	856068	845095		NC_000017.11:31336677:C:T
NM_001042492.3(NF1):c.2092C>G (p.Pro698Ala)	NF1	P698A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000856055	17	29553543	17	31226525	856055	844933		NC_000017.11:31226524:C:G
NM_001042492.3(NF1):c.1275G>A (p.Trp425Ter)	NF1	W425*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000855972	17	29533272	17	31206254	855972	844893		NC_000017.11:31206253:G:A
NM_001042492.3(NF1):c.958G>C (p.Ala320Pro)	NF1	A320P	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000855966	17	29527509	17	31200491	855966	844881		NC_000017.11:31200490:G:C
NM_001042492.3(NF1):c.4762A>G (p.Lys1588Glu)	NF1	K1588E, K1567E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000855939	17	29592284	17	31265266	855939	845046		NC_000017.11:31265265:A:G
NM_001042492.3(NF1):c.6421T>G (p.Phe2141Val)	NF1	F2120V, F2141V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000855936	17	29663926	17	31336908	855936	845102		NC_000017.11:31336907:T:G
NM_001042492.3(NF1):c.166A>G (p.Ser56Gly)	NF1	S56G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000855908	17	29483106	17	31156088	855908	844847		NC_000017.11:31156087:A:G
NM_001042492.3(NF1):c.5534T>C (p.Ile1845Thr)	NF1	I1824T, I1845T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000855874	17	29654782	17	31327764	855874	845069		NC_000017.11:31327763:T:C
NM_001042492.3(NF1):c.4501G>A (p.Asp1501Asn)	NF1	D1501N, D1480N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000855828	17	29587457	17	31260439	855828	845042		NC_000017.11:31260438:G:A
NM_001042492.3(NF1):c.416C>T (p.Ser139Phe)	NF1	S139F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000855761	17	29490331	17	31163313	855761	844861		NC_000017.11:31163312:C:T
NM_001042492.3(NF1):c.1261-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000855635	17	29533256	17	31206238	855635	851699		NC_000017.11:31206237:A:G
NM_001042492.3(NF1):c.4349C>T (p.Ala1450Val)	NF1	A1429V, A1450V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000855377	17	29586066	17	31259048	855377	845036		NC_000017.11:31259047:C:T
NM_001042492.3(NF1):c.1376C>T (p.Ala459Val)	NF1	A459V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000855319	17	29533373	17	31206355	855319	844895		NC_000017.11:31206354:C:T
NM_001042492.3(NF1):c.4213G>A (p.Val1405Ile)	NF1	V1405I, V1384I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000855260	17	29585401	17	31258383	855260	845026		NC_000017.11:31258382:G:A
NM_001042492.3(NF1):c.4110+6C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000855216	17	29576143	17	31249125	855216	852179		NC_000017.11:31249124:C:T
NM_001042492.3(NF1):c.3532A>T (p.Thr1178Ser)	NF1	T1178S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000855188	17	29560055	17	31233037	855188	844996		NC_000017.11:31233036:A:T
NM_001042492.3(NF1):c.2145G>A (p.Glu715=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000854768	17	29553596	17	31226578	854768	844934		NC_000017.11:31226577:G:A
NM_001042492.3(NF1):c.8059A>T (p.Ser2687Cys)	NF1	S2687C, S2666C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000854761	17	29685586	17	31358568	854761	845190		NC_000017.11:31358567:A:T
NM_001042492.3(NF1):c.6431A>G (p.Glu2144Gly)	NF1	E2123G, E2144G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000854643	17	29664389	17	31337371	854643	845103		NC_000017.11:31337370:A:G
NM_001042492.3(NF1):c.679T>C (p.Tyr227His)	NF1	Y227H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000854550	17	29508752	17	31181734	854550	844868		NC_000017.11:31181733:T:C
NM_001042492.3(NF1):c.7306G>C (p.Val2436Leu)	NF1	V2415L, V2436L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000854442	17	29676254	17	31349236	854442	845155		NC_000017.11:31349235:G:C
NM_001042492.3(NF1):c.5073G>C (p.Lys1691Asn)	NF1	K1670N, K1691N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000854417	17	29653075	17	31326057	854417	845056		NC_000017.11:31326056:G:C
NM_001042492.3(NF1):c.8084C>T (p.Pro2695Leu)	NF1	P2674L, P2695L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000854100	17	29685611	17	31358593	854100	845193		NC_000017.11:31358592:C:T
NM_001042492.3(NF1):c.454G>A (p.Ala152Thr)	NF1	A152T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000853732	17	29490369	17	31163351	853732	844865		NC_000017.11:31163350:G:A
NM_001042492.3(NF1):c.901G>A (p.Asp301Asn)	NF1	D301N	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000853674	17	29527452	17	31200434	853674	844877		NC_000017.11:31200433:G:A
NM_001042492.3(NF1):c.1845+3A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000853611	17	29550588	17	31223570	853611	852175		NC_000017.11:31223569:A:C
NM_001042492.3(NF1):c.7178A>G (p.His2393Arg)	NF1	H2372R, H2393R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000853509	17	29670142	17	31343124	853509	845143		NC_000017.11:31343123:A:G
NM_001042492.3(NF1):c.3163C>G (p.Gln1055Glu)	NF1	Q1055E	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Dec 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000853508	17	29557909	17	31230891	853508	844976		NC_000017.11:31230890:C:G
NM_001042492.3(NF1):c.6761G>A (p.Cys2254Tyr)	NF1	C2254Y, C2233Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV000853017	17	29665099	17	31338081	853017	845120		NC_000017.11:31338080:G:A
NM_001042492.3(NF1):c.1997C>T (p.Ser666Phe)	NF1	S666F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000852948	17	29552264	17	31225246	852948	844928		NC_000017.11:31225245:C:T
NM_001042492.3(NF1):c.7322-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000852863	17	29677200	17	31350182	852863	852189		NC_000017.11:31350181:G:C
NM_001042492.3(NF1):c.4237T>C (p.Phe1413Leu)	NF1	F1392L, F1413L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000852824	17	29585425	17	31258407	852824	845028		NC_000017.11:31258406:T:C
NM_001042492.3(NF1):c.5785G>T (p.Glu1929Ter)	NF1	E1908*, E1929*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000852822	17	29657489	17	31330471	852822	845083		NC_000017.11:31330470:G:T
NM_001042492.3(NF1):c.6571T>C (p.Ser2191Pro)	NF1	S2191P, S2170P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000852744	17	29664529	17	31337511	852744	845113		NC_000017.11:31337510:T:C
NM_001042492.3(NF1):c.6020T>G (p.Leu2007Arg)	NF1	L2007R, L1986R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000852685	17	29663364	17	31336346	852685	845087		NC_000017.11:31336345:T:G
NM_001042492.3(NF1):c.5503C>T (p.Gln1835Ter)	NF1	Q1814*, Q1835*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000852381	17	29654751	17	31327733	852381	845067		NC_000017.11:31327732:C:T
NM_001042492.3(NF1):c.205-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000852374	17	29486027	17	31159009	852374	852163		NC_000017.11:31159008:G:A
NM_001042492.3(NF1):c.2837A>G (p.Asp946Gly)	NF1	D946G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000852362	17	29556470	17	31229452	852362	844961		NC_000017.11:31229451:A:G
NM_001042492.3(NF1):c.366C>G (p.His122Gln)	NF1	H122Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000851999	17	29490281	17	31163263	851999	844856		NC_000017.11:31163262:C:G
NM_001042492.3(NF1):c.3743A>G (p.Asp1248Gly)	NF1	D1248G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000851959	17	29562663	17	31235645	851959	845000		NC_000017.11:31235644:A:G
NM_001042492.3(NF1):c.1793A>G (p.Lys598Arg)	NF1	K598R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000851833	17	29550533	17	31223515	851833	844918		NC_000017.11:31223514:A:G
NM_001042492.3(NF1):c.4378C>A (p.His1460Asn)	NF1	H1460N, H1439N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 3, 2019)	criteria provided, single submitter	VCV000851817	17	29586095	17	31259077	851817	845037		NC_000017.11:31259076:C:A
NM_001042492.3(NF1):c.6576T>A (p.Tyr2192Ter)	NF1	Y2171*, Y2192*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000851779	17	29664534	17	31337516	851779	845114		NC_000017.11:31337515:T:A
NM_001042492.3(NF1):c.5096G>A (p.Gly1699Asp)	NF1	G1678D, G1699D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000851754	17	29653098	17	31326080	851754	845057		NC_000017.11:31326079:G:A
NM_001042492.3(NF1):c.10C>A (p.His4Asn)	NF1|LOC111811965	H4N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000851752	17	29422337	17	31095319	851752	844841		NC_000017.11:31095318:C:A
NM_001042492.3(NF1):c.688G>T (p.Glu230Ter)	NF1	E230*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000851567	17	29508761	17	31181743	851567	844869		NC_000017.11:31181742:G:T
NM_001042492.3(NF1):c.6147+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000851432	17	29663492	17	31336474	851432	852868		NC_000017.11:31336473:G:T
NM_001042492.3(NF1):c.1431T>A (p.Phe477Leu)	NF1	F477L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000850959	17	29541507	17	31214489	850959	844898		NC_000017.11:31214488:T:A
NM_001042492.3(NF1):c.7869+5G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000850895	17	29684113	17	31357095	850895	852732		NC_000017.11:31357094:G:A
NM_001042492.3(NF1):c.4939C>T (p.His1647Tyr)	NF1	H1626Y, H1647Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 16, 2020)	criteria provided, single submitter	VCV000850763	17	29652941	17	31325923	850763	845052		NC_000017.11:31325922:C:T
NM_001042492.3(NF1):c.4387C>A (p.Pro1463Thr)	NF1	P1442T, P1463T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000850721	17	29586104	17	31259086	850721	845040		NC_000017.11:31259085:C:A
NM_001042492.3(NF1):c.6714C>A (p.Phe2238Leu)	NF1	F2238L, F2217L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000850627	17	29665052	17	31338034	850627	845117		NC_000017.11:31338033:C:A
NM_001042492.3(NF1):c.4822T>G (p.Tyr1608Asp)	NF1	Y1608D, Y1587D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000850565	17	29592344	17	31265326	850565	845048		NC_000017.11:31265325:T:G
NM_001042492.3(NF1):c.6486C>A (p.Tyr2162Ter)	NF1	Y2162*, Y2141*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000850401	17	29664444	17	31337426	850401	845105		NC_000017.11:31337425:C:A
NM_001042492.3(NF1):c.6520G>A (p.Ala2174Thr)	NF1	A2153T, A2174T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV000850260	17	29664478	17	31337460	850260	845111		NC_000017.11:31337459:G:A
NM_001042492.3(NF1):c.3656G>A (p.Gly1219Glu)	NF1	G1219E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000850167	17	29560179	17	31233161	850167	844998		NC_000017.11:31233160:G:A
NM_001042492.3(NF1):c.3467A>C (p.Asn1156Thr)	NF1	N1156T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000849941	17	29559870	17	31232852	849941	844994		NC_000017.11:31232851:A:C
NM_001042492.3(NF1):c.412G>A (p.Ala138Thr)	NF1	A138T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000849841	17	29490327	17	31163309	849841	844860		NC_000017.11:31163308:G:A
NM_001042492.3(NF1):c.5746G>T (p.Ala1916Ser)	NF1	A1916S, A1895S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV000849721	17	29657450	17	31330432	849721	845081		NC_000017.11:31330431:G:T
NM_001042492.3(NF1):c.3942G>A (p.Trp1314Ter)	NF1	W1314*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000849712	17	29563007	17	31235989	849712	845012		NC_000017.11:31235988:G:A
NM_001042492.3(NF1):c.6922-6T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000849704	17	29667517	17	31340499	849704	852869		NC_000017.11:31340498:T:G
NM_001042492.3(NF1):c.4333-9A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV000849602	17	29586041	17	31259023	849602	852716		NC_000017.11:31259022:A:T
NM_001042492.3(NF1):c.2989A>G (p.Arg997Gly)	NF1	R997G	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000849592	17	29556991	17	31229973	849592	844968		NC_000017.11:31229972:A:G
NM_001042492.3(NF1):c.7113C>A (p.Cys2371Ter)	NF1	C2350*, C2371*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000849556	17	29670077	17	31343059	849556	845134		NC_000017.11:31343058:C:A
NM_001042492.3(NF1):c.1057C>G (p.Leu353Val)	NF1	L353V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000849548	17	29527608	17	31200590	849548	844886		NC_000017.11:31200589:C:G
NM_001042492.3(NF1):c.8161-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000849315	17	29687504	17	31360486	849315	852734		NC_000017.11:31360485:G:A
NM_001042492.3(NF1):c.2686G>T (p.Asp896Tyr)	NF1	D896Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000848950	17	29556319	17	31229301	848950	844954		NC_000017.11:31229300:G:T
NM_001042492.3(NF1):c.6950G>A (p.Trp2317Ter)	NF1	W2296*, W2317*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000848870	17	29667551	17	31340533	848870	845129		NC_000017.11:31340532:G:A
NM_001042492.3(NF1):c.1260+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000848717	17	29528504	17	31201486	848717	852699		NC_000017.11:31201485:G:C
NM_001042492.3(NF1):c.3559C>T (p.Leu1187Phe)	NF1	L1187F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV000848620	17	29560082	17	31233064	848620	844997		NC_000017.11:31233063:C:T
NM_001042492.3(NF1):c.4811C>G (p.Pro1604Arg)	NF1	P1604R, P1583R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 3, 2019)	criteria provided, single submitter	VCV000848494	17	29592333	17	31265315	848494	845047		NC_000017.11:31265314:C:G
NM_001042492.3(NF1):c.4107C>G (p.Tyr1369Ter)	NF1	Y1369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000848486	17	29576134	17	31249116	848486	845024		NC_000017.11:31249115:C:G
NM_001042492.3(NF1):c.3314+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV000848281	17	29559209	17	31232191	848281	852710		NC_000017.11:31232190:T:G
NM_001042492.3(NF1):c.1426A>G (p.Lys476Glu)	NF1	K476E	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000848259	17	29541502	17	31214484	848259	844897		NC_000017.11:31214483:A:G
NM_001042492.3(NF1):c.5999T>C (p.Leu2000Pro)	NF1	L2000P, L1979P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000848044	17	29662042	17	31335024	848044	845086		NC_000017.11:31335023:T:C
NM_001042492.3(NF1):c.1906T>C (p.Ser636Pro)	NF1	S636P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV000848034	17	29552173	17	31225155	848034	844923		NC_000017.11:31225154:T:C
NM_001042492.3(NF1):c.19G>A (p.Val7Met)	NF1|LOC111811965	V7M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000847843	17	29422346	17	31095328	847843	844842		NC_000017.11:31095327:G:A
NM_001042492.3(NF1):c.7018C>T (p.Gln2340Ter)	NF1	Q2340*, Q2319*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000847696	17	29667619	17	31340601	847696	845131		NC_000017.11:31340600:C:T
NM_001042492.3(NF1):c.7910G>T (p.Arg2637Leu)	NF1	R2616L, R2637L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000847496	17	29684327	17	31357309	847496	845184		NC_000017.11:31357308:G:T
NM_001042492.3(NF1):c.2681T>C (p.Phe894Ser)	NF1	F894S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000847299	17	29556314	17	31229296	847299	844953		NC_000017.11:31229295:T:C
NM_001042492.3(NF1):c.2618G>T (p.Arg873Leu)	NF1	R873L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000846726	17	29556251	17	31229233	846726	844950		NC_000017.11:31229232:G:T
NM_001042492.3(NF1):c.431C>T (p.Ser144Phe)	NF1	S144F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000846508	17	29490346	17	31163328	846508	844862		NC_000017.11:31163327:C:T
NM_001042492.3(NF1):c.74C>G (p.Thr25Arg)	NF1	T25R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000846275	17	29483014	17	31155996	846275	844845		NC_000017.11:31155995:C:G
NM_001042492.3(NF1):c.7249C>G (p.Leu2417Val)	NF1	L2396V, L2417V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000846034	17	29676197	17	31349179	846034	845150		NC_000017.11:31349178:C:G
NM_001042492.3(NF1):c.7964C>T (p.Pro2655Leu)	NF1	P2634L, P2655L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000845875	17	29684381	17	31357363	845875	845186		NC_000017.11:31357362:C:T
NM_001042492.3(NF1):c.844C>A (p.Gln282Lys)	NF1	Q282K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000845857	17	29509639	17	31182621	845857	844875		NC_000017.11:31182620:C:A
NM_001042492.3(NF1):c.7031C>T (p.Thr2344Ile)	NF1	T2323I, T2344I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV000845721	17	29667632	17	31340614	845721	845132		NC_000017.11:31340613:C:T
NM_001042492.3(NF1):c.8249C>G (p.Thr2750Ser)	NF1	T2750S, T2729S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000845540	17	29687593	17	31360575	845540	845196		NC_000017.11:31360574:C:G
NM_001042492.3(NF1):c.7970+5G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV000845459	17	29684392	17	31357374	845459	851711		NC_000017.11:31357373:G:C
NM_001042492.3(NF1):c.7593G>C (p.Gln2531His)	NF1	Q2510H, Q2531H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000845411	17	29679410	17	31352392	845411	845173		NC_000017.11:31352391:G:C
NM_001042492.3(NF1):c.5494G>A (p.Glu1832Lys)	NF1	E1832K, E1811K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000845410	17	29654742	17	31327724	845410	845065		NC_000017.11:31327723:G:A
NM_001042492.3(NF1):c.3460A>G (p.Asn1154Asp)	NF1	N1154D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000845339	17	29559863	17	31232845	845339	844993		NC_000017.11:31232844:A:G
NM_001042492.3(NF1):c.3975G>T (p.Arg1325Ser)	NF1	R1325S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000845334	17	29576002	17	31248984	845334	845016		NC_000017.11:31248983:G:T
NM_001042492.3(NF1):c.480-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV000845305	17	29496908	17	31169890	845305	852857		NC_000017.11:31169889:G:A
NM_001042492.3(NF1):c.7539G>C (p.Gln2513His)	NF1	Q2492H, Q2513H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000845285	17	29679356	17	31352338	845285	845170		NC_000017.11:31352337:G:C
NM_001042492.3(NF1):c.8482G>A (p.Gly2828Ser)	NF1	G2828S, G2807S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000845261	17	29701135	17	31374117	845261	845205		NC_000017.11:31374116:G:A
NM_001042492.3(NF1):c.8074G>T (p.Glu2692Ter)	NF1	E2671*, E2692*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000845204	17	29685601	17	31358583	845204	845192		NC_000017.11:31358582:G:T
NM_001042492.3(NF1):c.7172T>A (p.Val2391Asp)	NF1	V2391D, V2370D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000845183	17	29670136	17	31343118	845183	845142		NC_000017.11:31343117:T:A
NM_001042492.3(NF1):c.1988G>A (p.Gly663Glu)	NF1	G663E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000845131	17	29552255	17	31225237	845131	844927		NC_000017.11:31225236:G:A
NM_001042492.3(NF1):c.1527+3A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000844804	17	29541606	17	31214588	844804	852171		NC_000017.11:31214587:A:C
NM_001042492.3(NF1):c.6902T>G (p.Leu2301Ter)	NF1	L2301*, L2280*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000844773	17	29665804	17	31338786	844773	845126		NC_000017.11:31338785:T:G
NM_001042492.3(NF1):c.3855G>T (p.Met1285Ile)	NF1	M1285I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000844732	17	29562775	17	31235757	844732	845004		NC_000017.11:31235756:G:T
NM_001042492.3(NF1):c.6499A>C (p.Ile2167Leu)	NF1	I2146L, I2167L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000844679	17	29664457	17	31337439	844679	845109		NC_000017.11:31337438:A:C
NM_001042492.3(NF1):c.1224T>G (p.Tyr408Ter)	NF1	Y408*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000844580	17	29528467	17	31201449	844580	844892		NC_000017.11:31201448:T:G
NM_001042492.3(NF1):c.4724+6G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000844384	17	29588881	17	31261863	844384	852723		NC_000017.11:31261862:G:A
NM_001042492.3(NF1):c.3391A>C (p.Lys1131Gln)	NF1	K1131Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000844067	17	29559794	17	31232776	844067	844989		NC_000017.11:31232775:A:C
NM_001042492.3(NF1):c.91C>G (p.His31Asp)	NF1	H31D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000844050	17	29483031	17	31156013	844050	844846		NC_000017.11:31156012:C:G
NM_001042492.3(NF1):c.7608G>T (p.Lys2536Asn)	NF1	K2536N, K2515N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000843995	17	29679425	17	31352407	843995	845175		NC_000017.11:31352406:G:T
NM_001042492.3(NF1):c.4963A>T (p.Lys1655Ter)	NF1	K1634*, K1655*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000843916	17	29652965	17	31325947	843916	845053		NC_000017.11:31325946:A:T
NM_001042492.3(NF1):c.4577+6A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000843891	17	29587539	17	31260521	843891	852722		NC_000017.11:31260520:A:G
NM_001042492.3(NF1):c.3179A>G (p.Asp1060Gly)	NF1	D1060G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000843728	17	29557925	17	31230907	843728	844977		NC_000017.11:31230906:A:G
NM_001042492.3(NF1):c.5275T>G (p.Ser1759Ala)	NF1	S1738A, S1759A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000843694	17	29654523	17	31327505	843694	845059		NC_000017.11:31327504:T:G
NM_001042492.3(NF1):c.3662T>G (p.Leu1221Arg)	NF1	L1221R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000843506	17	29560185	17	31233167	843506	844999		NC_000017.11:31233166:T:G
NM_001042492.3(NF1):c.2230G>C (p.Val744Leu)	NF1	V744L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000843426	17	29553681	17	31226663	843426	844936		NC_000017.11:31226662:G:C
NM_001042492.3(NF1):c.1406A>G (p.Lys469Arg)	NF1	K469R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000843186	17	29541482	17	31214464	843186	844896		NC_000017.11:31214463:A:G
NM_001042492.3(NF1):c.2991-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000843158	17	29557276	17	31230258	843158	851701		NC_000017.11:31230257:A:T
NM_001042492.3(NF1):c.7458G>A (p.Arg2486=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000843065	17	29679275	17	31352257	843065	845162		NC_000017.11:31352256:G:A
NM_001042492.3(NF1):c.8450C>T (p.Ser2817Phe)	NF1	S2817F, S2796F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000842822	17	29701103	17	31374085	842822	845204		NC_000017.11:31374084:C:T
NM_001042492.3(NF1):c.1721+4T>A	NF1	Y575*	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000842793	17	29548951	17	31221933	842793	852707		NC_000017.11:31221932:T:A
NM_001042492.3(NF1):c.2577C>T (p.Gly859=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000842775	17	29556210	17	31229192	842775	844947		NC_000017.11:31229191:C:T
NM_001042492.3(NF1):c.803C>A (p.Pro268Gln)	NF1	P268Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000842647	17	29509598	17	31182580	842647	844874		NC_000017.11:31182579:C:A
NM_001042492.3(NF1):c.7870G>C (p.Ala2624Pro)	NF1	A2603P, A2624P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000842594	17	29684287	17	31357269	842594	845182		NC_000017.11:31357268:G:C
NM_001042492.3(NF1):c.6053G>A (p.Ser2018Asn)	NF1	S2018N, S1997N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000842511	17	29663397	17	31336379	842511	845090		NC_000017.11:31336378:G:A
NM_001042492.3(NF1):c.758T>A (p.Val253Glu)	NF1	V253E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000842322	17	29509553	17	31182535	842322	844872		NC_000017.11:31182534:T:A
NM_001042492.3(NF1):c.1465T>G (p.Tyr489Asp)	NF1	Y489D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000842198	17	29541541	17	31214523	842198	844899		NC_000017.11:31214522:T:G
NM_001042492.3(NF1):c.1712G>A (p.Trp571Ter)	NF1	W571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000842188	17	29548938	17	31221920	842188	844913		NC_000017.11:31221919:G:A
NM_001042492.3(NF1):c.3449C>T (p.Ser1150Leu)	NF1	S1150L	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2021)	criteria provided, conflicting interpretations	VCV000842050	17	29559852	17	31232834	842050	844992		NC_000017.11:31232833:C:T
NM_001042492.3(NF1):c.1636A>G (p.Met546Val)	NF1	M546V	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000841928	17	29546131	17	31219113	841928	844910		NC_000017.11:31219112:A:G
NM_001042492.3(NF1):c.275A>G (p.Lys92Arg)	NF1	K92R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000841794	17	29486098	17	31159080	841794	844851		NC_000017.11:31159079:A:G
NM_001042492.3(NF1):c.4216G>T (p.Gly1406Ter)	NF1	G1406*, G1385*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000841676	17	29585404	17	31258386	841676	845027		NC_000017.11:31258385:G:T
NM_001042492.3(NF1):c.8448A>G (p.Gly2816=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000841607	17	29701101	17	31374083	841607	845203		NC_000017.11:31374082:A:G
NM_001042492.3(NF1):c.7718C>A (p.Ala2573Glu)	NF1	A2573E, A2552E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000841490	17	29683580	17	31356562	841490	845179		NC_000017.11:31356561:C:A
NM_001042492.3(NF1):c.5783A>G (p.Glu1928Gly)	NF1	E1907G, E1928G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000841365	17	29657487	17	31330469	841365	845082		NC_000017.11:31330468:A:G
NM_001042492.3(NF1):c.6468C>G (p.Phe2156Leu)	NF1	F2135L, F2156L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000841354	17	29664426	17	31337408	841354	845104		NC_000017.11:31337407:C:G
NM_001042492.3(NF1):c.3755T>A (p.Leu1252Ter)	NF1	L1252*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000841346	17	29562675	17	31235657	841346	845001		NC_000017.11:31235656:T:A
NM_001042492.3(NF1):c.1721+2T>A	NF1	Y575N	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000841342	17	29548949	17	31221931	841342	852703		NC_000017.11:31221930:T:A
NM_001042492.3(NF1):c.499T>G (p.Cys167Gly)	NF1	C167G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000841326	17	29496928	17	31169910	841326	844866		NC_000017.11:31169909:T:G
NM_001042492.3(NF1):c.5304G>C (p.Glu1768Asp)	NF1	E1747D, E1768D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000841205	17	29654552	17	31327534	841205	845060		NC_000017.11:31327533:G:C
NM_001042492.3(NF1):c.3406C>T (p.Arg1136Trp)	NF1	R1136W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000841037	17	29559809	17	31232791	841037	844990		NC_000017.11:31232790:C:T
NM_001042492.3(NF1):c.7657G>T (p.Ala2553Ser)	NF1	A2553S, A2532S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000841022	17	29683519	17	31356501	841022	845177		NC_000017.11:31356500:G:T
NM_001042492.3(NF1):c.169G>T (p.Gly57Cys)	NF1	G57C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000840951	17	29483109	17	31156091	840951	844848		NC_000017.11:31156090:G:T
NM_001042492.3(NF1):c.1024A>G (p.Ile342Val)	NF1	I342V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000840945	17	29527575	17	31200557	840945	844885		NC_000017.11:31200556:A:G
NM_001042492.3(NF1):c.1185+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000840905	17	29528179	17	31201161	840905	852696		NC_000017.11:31201160:T:C
NM_001042492.3(NF1):c.721G>A (p.Asp241Asn)	NF1	D241N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000840582	17	29508794	17	31181776	840582	844871		NC_000017.11:31181775:G:A
NM_001042492.3(NF1):c.1931C>G (p.Ser644Cys)	NF1	S644C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000840413	17	29552198	17	31225180	840413	844924		NC_000017.11:31225179:C:G
NM_001042492.3(NF1):c.7870-3C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000840408	17	29684284	17	31357266	840408	852871		NC_000017.11:31357265:C:T
NM_001042492.3(NF1):c.1078C>A (p.Pro360Thr)	NF1	P360T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV000840036	17	29528070	17	31201052	840036	844887		NC_000017.11:31201051:C:A
NM_001042492.3(NF1):c.8198A>C (p.Lys2733Thr)	NF1	K2712T, K2733T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000839956	17	29687542	17	31360524	839956	845195		NC_000017.11:31360523:A:C
NM_001042492.3(NF1):c.1513A>G (p.Lys505Glu)	NF1	K505E	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000839760	17	29541589	17	31214571	839760	844902		NC_000017.11:31214570:A:G
NM_001042492.3(NF1):c.968C>A (p.Ala323Asp)	NF1	A323D	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000839743	17	29527519	17	31200501	839743	844882		NC_000017.11:31200500:C:A
NM_001042492.3(NF1):c.3058G>T (p.Glu1020Ter)	NF1	E1020*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000839592	17	29557345	17	31230327	839592	844974		NC_000017.11:31230326:G:T
NM_001042492.3(NF1):c.7283A>T (p.Lys2428Ile)	NF1	K2407I, K2428I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000839486	17	29676231	17	31349213	839486	845154		NC_000017.11:31349212:A:T
NM_001042492.3(NF1):c.1607C>T (p.Ser536Leu)	NF1	S536L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV000839398	17	29546102	17	31219084	839398	844908		NC_000017.11:31219083:C:T
NM_001042492.3(NF1):c.2006G>A (p.Ser669Asn)	NF1	S669N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000839192	17	29553457	17	31226439	839192	844929		NC_000017.11:31226438:G:A
NM_001042492.3(NF1):c.3250C>G (p.Pro1084Ala)	NF1	P1084A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000839012	17	29559143	17	31232125	839012	844983		NC_000017.11:31232124:C:G
NM_001042492.3(NF1):c.288G>T (p.Gly96=)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000838808	17	29486111	17	31159093	838808	844852		NC_000017.11:31159092:G:T
NM_001042492.3(NF1):c.7114A>T (p.Lys2372Ter)	NF1	K2351*, K2372*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000838652	17	29670078	17	31343060	838652	845135		NC_000017.11:31343059:A:T
NM_001042492.3(NF1):c.6977A>T (p.Asp2326Val)	NF1	D2305V, D2326V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000838630	17	29667578	17	31340560	838630	845130		NC_000017.11:31340559:A:T
NM_001042492.3(NF1):c.2935A>G (p.Ser979Gly)	NF1	S979G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000838517	17	29556937	17	31229919	838517	844965		NC_000017.11:31229918:A:G
NM_001042492.3(NF1):c.6410C>A (p.Ser2137Ter)	NF1	S2116*, S2137*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000838504	17	29663915	17	31336897	838504	845101		NC_000017.11:31336896:C:A
NM_001042492.3(NF1):c.3974G>A (p.Arg1325Lys)	NF1	R1325K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000838318	17	29563039	17	31236021	838318	845015		NC_000017.11:31236020:G:A
NM_001042492.3(NF1):c.6238A>G (p.Ile2080Val)	NF1	I2059V, I2080V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000838238	17	29663743	17	31336725	838238	845096		NC_000017.11:31336724:A:G
NM_001042492.3(NF1):c.2980A>T (p.Asn994Tyr)	NF1	N994Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000838135	17	29556982	17	31229964	838135	844967		NC_000017.11:31229963:A:T
NM_001042492.3(NF1):c.1555C>T (p.Gln519Ter)	NF1	Q519*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000837847	17	29546050	17	31219032	837847	844905		NC_000017.11:31219031:C:T
NM_001042492.3(NF1):c.3929C>T (p.Thr1310Ile)	NF1	T1310I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000837643	17	29562994	17	31235976	837643	845011		NC_000017.11:31235975:C:T
NM_001042492.3(NF1):c.7646C>A (p.Ser2549Ter)	NF1	S2528*, S2549*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000837583	17	29683508	17	31356490	837583	845176		NC_000017.11:31356489:C:A
NM_001042492.3(NF1):c.2069C>T (p.Ala690Val)	NF1	A690V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000837483	17	29553520	17	31226502	837483	844932		NC_000017.11:31226501:C:T
NM_001042492.3(NF1):c.5563C>T (p.Leu1855Phe)	NF1	L1834F, L1855F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000837447	17	29654811	17	31327793	837447	845072		NC_000017.11:31327792:C:T
NM_001042492.3(NF1):c.4382T>G (p.Met1461Arg)	NF1	M1440R, M1461R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000837385	17	29586099	17	31259081	837385	845039		NC_000017.11:31259080:T:G
NM_001042492.3(NF1):c.64C>G (p.Pro22Ala)	NF1	P22A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000837341	17	29483004	17	31155986	837341	844844		NC_000017.11:31155985:C:G
NM_001042492.3(NF1):c.3099A>G (p.Gln1033=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000837186	17	29557386	17	31230368	837186	844975		NC_000017.11:31230367:A:G
NM_001042492.3(NF1):c.7460C>T (p.Thr2487Ile)	NF1	T2466I, T2487I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 2, 2019)	criteria provided, single submitter	VCV000837158	17	29679277	17	31352259	837158	845163		NC_000017.11:31352258:C:T
NM_001042492.3(NF1):c.6488T>C (p.Leu2163Ser)	NF1	L2163S, L2142S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000837147	17	29664446	17	31337428	837147	845108		NC_000017.11:31337427:T:C
NM_001042492.3(NF1):c.911G>T (p.Arg304Leu)	NF1	R304L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000837075	17	29527462	17	31200444	837075	844879		NC_000017.11:31200443:G:T
NM_001042492.3(NF1):c.3305T>G (p.Leu1102Ter)	NF1	L1102*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000836913	17	29559198	17	31232180	836913	844986		NC_000017.11:31232179:T:G
NM_001042492.3(NF1):c.8383G>A (p.Asp2795Asn)	NF1	D2795N, D2774N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000836852	17	29701036	17	31374018	836852	845199		NC_000017.11:31374017:G:A
NM_001042492.3(NF1):c.6705-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000836704	17	29665042	17	31338024	836704	851709		NC_000017.11:31338023:G:T
NM_001042492.3(NF1):c.7582C>T (p.Gln2528Ter)	NF1	Q2507*, Q2528*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000836626	17	29679399	17	31352381	836626	845172		NC_000017.11:31352380:C:T
NM_001042492.3(NF1):c.1260+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000836228	17	29528505	17	31201487	836228	852700		NC_000017.11:31201486:T:C
NM_001042492.3(NF1):c.6488T>A (p.Leu2163Ter)	NF1	L2163*, L2142*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000836119	17	29664446	17	31337428	836119	845107		NC_000017.11:31337427:T:A
NM_001042492.3(NF1):c.7400C>A (p.Ser2467Ter)	NF1	S2446*, S2467*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000836114	17	29677279	17	31350261	836114	845159		NC_000017.11:31350260:C:A
NM_001042492.3(NF1):c.796G>A (p.Val266Ile)	NF1	V266I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000836005	17	29509591	17	31182573	836005	844873		NC_000017.11:31182572:G:A
NM_001042492.3(NF1):c.1261-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000835846	17	29533256	17	31206238	835846	852858		NC_000017.11:31206237:A:T
NM_001042492.3(NF1):c.3947A>T (p.His1316Leu)	NF1	H1316L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000835768	17	29563012	17	31235994	835768	845013		NC_000017.11:31235993:A:T
NM_001042492.3(NF1):c.4431-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000835743	17	29587386	17	31260368	835743	852720		NC_000017.11:31260367:G:A
NM_001042492.3(NF1):c.6921+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000835698	17	29665824	17	31338806	835698	852185		NC_000017.11:31338805:G:C
NM_001042492.3(NF1):c.38T>C (p.Val13Ala)	NF1|LOC111811965	V13A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000835685	17	29422365	17	31095347	835685	844843		NC_000017.11:31095346:T:C
NM_001042492.3(NF1):c.5812+4A>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000835679	17	29657520	17	31330502	835679	852867		NC_000017.11:31330501:A:C
NM_001042492.3(NF1):c.8161-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000835670	17	29687503	17	31360485	835670	852733		NC_000017.11:31360484:A:T
NM_001042492.3(NF1):c.1499T>A (p.Ile500Asn)	NF1	I500N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000835342	17	29541575	17	31214557	835342	844901		NC_000017.11:31214556:T:A
NM_001042492.3(NF1):c.5536C>T (p.Arg1846Trp)	NF1	R1846W, R1825W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000835306	17	29654784	17	31327766	835306	845070		NC_000017.11:31327765:C:T
NM_001042492.3(NF1):c.3496+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000835181	17	29559900	17	31232882	835181	852711		NC_000017.11:31232881:G:C
NM_001042492.3(NF1):c.4090G>A (p.Val1364Met)	NF1	V1364M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000835168	17	29576117	17	31249099	835168	845023		NC_000017.11:31249098:G:A
NM_001042492.3(NF1):c.7321+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV000835149	17	29676271	17	31349253	835149	852187		NC_000017.11:31349252:T:C
NM_001042492.3(NF1):c.3846T>G (p.Ser1282Arg)	NF1	S1282R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000834998	17	29562766	17	31235748	834998	845003		NC_000017.11:31235747:T:G
NM_001042492.3(NF1):c.2810T>A (p.Leu937Ter)	NF1	L937*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000834980	17	29556443	17	31229425	834980	844959		NC_000017.11:31229424:T:A
NM_001042492.3(NF1):c.3034A>T (p.Lys1012Ter)	NF1	K1012*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000834887	17	29557321	17	31230303	834887	844971		NC_000017.11:31230302:A:T
NM_001042492.3(NF1):c.8438C>G (p.Thr2813Ser)	NF1	T2813S, T2792S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000834806	17	29701091	17	31374073	834806	845202		NC_000017.11:31374072:C:G
NM_001042492.3(NF1):c.6697G>A (p.Ala2233Thr)	NF1	A2212T, A2233T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000834694	17	29664891	17	31337873	834694	845116		NC_000017.11:31337872:G:A
NM_001042492.3(NF1):c.5861C>G (p.Ser1954Ter)	NF1	S1933*, S1954*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000834435	17	29661904	17	31334886	834435	845085		NC_000017.11:31334885:C:G
NM_001042492.3(NF1):c.6938A>G (p.Lys2313Arg)	NF1	K2292R, K2313R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000834314	17	29667539	17	31340521	834314	845128		NC_000017.11:31340520:A:G
NM_001042492.3(NF1):c.1642G>T (p.Ala548Ser)	NF1	A548S	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000834162	17	29548868	17	31221850	834162	844912		NC_000017.11:31221849:G:T
NM_001042492.3(NF1):c.5409T>G (p.Ile1803Met)	NF1	I1782M, I1803M	Neurofibromatosis, type 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000830272	17	29654657	17	31327639	830272	818703		NC_000017.11:31327638:T:G
NM_001042492.3(NF1):c.2351G>C (p.Trp784Ser)	NF1	W784S	Neurofibromatosis, type 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000830270	17	29554566	17	31227548	830270	818701		NC_000017.11:31227547:G:C
NM_001042492.3(NF1):c.8318C>T (p.Thr2773Ile)	NF1	T2752I, T2773I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827535	17	29687662	17	31360644	827535	813530	rs1597870290	NC_000017.11:31360643:C:T
NM_001042492.3(NF1):c.8227C>G (p.Leu2743Val)	NF1	L2722V, L2743V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827485	17	29687571	17	31360553	827485	813526	rs1597870180	NC_000017.11:31360552:C:G
NM_001042492.3(NF1):c.812T>C (p.Ile271Thr)	NF1	I271T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827472	17	29509607	17	31182589	827472	813109	rs1597659948	NC_000017.11:31182588:T:C
NM_001042492.3(NF1):c.8137C>A (p.Arg2713=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827433	17	29686010	17	31358992	827433	813523	rs757391670	NC_000017.11:31358991:C:A
NM_001042492.3(NF1):c.8057A>G (p.Gln2686Arg)	NF1	Q2686R, Q2665R	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000827374	17	29685584	17	31358566	827374	813517	rs890017184	NC_000017.11:31358565:A:G
NM_001042492.3(NF1):c.8029T>C (p.Leu2677=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827363	17	29685556	17	31358538	827363	813514	rs1207400434	NC_000017.11:31358537:T:C
NM_001042492.3(NF1):c.7955A>G (p.Lys2652Arg)	NF1	K2631R, K2652R	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827314	17	29684372	17	31357354	827314	813509	rs1597866986	NC_000017.11:31357353:A:G
NM_001042492.3(NF1):c.7781G>T (p.Arg2594Leu)	NF1	R2594L, R2573L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827218	17	29684020	17	31357002	827218	813496	rs774781617	NC_000017.11:31357001:G:T
NM_001042492.3(NF1):c.7667G>T (p.Arg2556Met)	NF1	R2556M, R2535M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827152	17	29683529	17	31356511	827152	813489	rs1597865787	NC_000017.11:31356510:G:T
NM_001042492.3(NF1):c.7616G>C (p.Gly2539Ala)	NF1	G2518A, G2539A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827120	17	29683478	17	31356460	827120	813488	rs1597865736	NC_000017.11:31356459:G:C
NM_001042492.3(NF1):c.753C>T (p.Asp251=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827107	17	29509548	17	31182530	827107	813106	rs1567826636	NC_000017.11:31182529:C:T
NM_001042492.3(NF1):c.7523A>G (p.Tyr2508Cys)	NF1	Y2508C, Y2487C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827067	17	29679340	17	31352322	827067	813484	rs762169098	NC_000017.11:31352321:A:G
NM_001042492.3(NF1):c.7510C>A (p.Leu2504Ile)	NF1	L2483I, L2504I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827050	17	29679327	17	31352309	827050	813482	rs876658333	NC_000017.11:31352308:C:A
NM_001042492.3(NF1):c.7506A>T (p.Gly2502=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000827049	17	29679323	17	31352305	827049	813481	rs775258088	NC_000017.11:31352304:A:T
NM_001042492.3(NF1):c.7496G>T (p.Gly2499Val)	NF1	G2499V, G2478V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000827045	17	29679313	17	31352295	827045	813480	rs375176282	NC_000017.11:31352294:G:T
NM_001042492.3(NF1):c.731-5T>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2020)	criteria provided, conflicting interpretations	VCV000826961	17	29509521	17	31182503	826961	815646	rs1597659721	NC_000017.11:31182502:T:C
NM_001042492.3(NF1):c.7335G>A (p.Val2445=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826941	17	29677214	17	31350196	826941	813478	rs1333741084	NC_000017.11:31350195:G:A
NM_001042492.3(NF1):c.7315T>C (p.Leu2439=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826934	17	29676263	17	31349245	826934	813476	rs1597858629	NC_000017.11:31349244:T:C
NM_001042492.3(NF1):c.7297A>G (p.Thr2433Ala)	NF1	T2433A, T2412A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826923	17	29676245	17	31349227	826923	813474	rs1597858568	NC_000017.11:31349226:A:G
NM_001042492.3(NF1):c.7226C>T (p.Thr2409Ile)	NF1	T2388I, T2409I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826875	17	29676174	17	31349156	826875	813470	rs1597858415	NC_000017.11:31349155:C:T
NM_001042492.3(NF1):c.7201C>T (p.Pro2401Ser)	NF1	P2401S, P2380S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826861	17	29676149	17	31349131	826861	813468	rs1597858372	NC_000017.11:31349130:C:T
NM_001042492.3(NF1):c.7190-4G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826855	17	29676134	17	31349116	826855	815663	rs1414521347	NC_000017.11:31349115:G:A
NM_001042492.3(NF1):c.7185A>G (p.Leu2395=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826852	17	29670149	17	31343131	826852	813466	rs1172296616	NC_000017.11:31343130:A:G
NM_001042492.3(NF1):c.7169T>G (p.Leu2390Trp)	NF1	L2369W, L2390W	Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000826843	17	29670133	17	31343115	826843	813465	rs1597851443	NC_000017.11:31343114:T:G
NM_001042492.3(NF1):c.6882A>G (p.Thr2294=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826641	17	29665784	17	31338766	826641	813443	rs766889312	NC_000017.11:31338765:A:G
NM_001042492.3(NF1):c.6849C>T (p.Asp2283=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826619	17	29665751	17	31338733	826619	813442	rs1597845951	NC_000017.11:31338732:C:T
NM_001042492.3(NF1):c.6701A>G (p.Gln2234Arg)	NF1	Q2234R, Q2213R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826523	17	29664895	17	31337877	826523	813435	rs1597844689	NC_000017.11:31337876:A:G
NM_001042492.3(NF1):c.6687G>A (p.Trp2229Ter)	NF1	W2229*, W2208*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000826516	17	29664881	17	31337863	826516	813432	rs1597844653	NC_000017.11:31337862:G:A
NM_001042492.3(NF1):c.6611C>T (p.Thr2204Ile)	NF1	T2183I, T2204I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826474	17	29664569	17	31337551	826474	813429	rs1597843996	NC_000017.11:31337550:C:T
NM_001042492.3(NF1):c.6583G>C (p.Glu2195Gln)	NF1	E2174Q, E2195Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826461	17	29664541	17	31337523	826461	813427	rs1597843959	NC_000017.11:31337522:G:C
NM_001042492.3(NF1):c.6574T>C (p.Tyr2192His)	NF1	Y2171H, Y2192H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826457	17	29664532	17	31337514	826457	813426	rs267606598	NC_000017.11:31337513:T:C
NM_001042492.3(NF1):c.646C>T (p.Leu216=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826422	17	29508499	17	31181481	826422	813103	rs1597658201	NC_000017.11:31181480:C:T
NM_001042492.3(NF1):c.6437A>G (p.Lys2146Arg)	NF1	K2125R, K2146R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826361	17	29664395	17	31337377	826361	813420	rs1597843678	NC_000017.11:31337376:A:G
NM_001042492.3(NF1):c.6428-5T>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2019)	criteria provided, conflicting interpretations	VCV000826352	17	29664381	17	31337363	826352	815661	rs1597843627	NC_000017.11:31337362:T:C
NM_001042492.3(NF1):c.603T>C (p.Phe201=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826152	17	29508456	17	31181438	826152	813102	rs1597658060	NC_000017.11:31181437:T:C
NM_001042492.3(NF1):c.6058A>G (p.Thr2020Ala)	NF1	T1999A, T2020A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826104	17	29663402	17	31336384	826104	813404	rs1597842258	NC_000017.11:31336383:A:G
NM_001042492.3(NF1):c.5989T>C (p.Trp1997Arg)	NF1	W1997R, W1976R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000826061	17	29662032	17	31335014	826061	813400	rs1597840306	NC_000017.11:31335013:T:C
NM_001042492.3(NF1):c.5902C>A (p.Arg1968=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825999	17	29661945	17	31334927	825999	813397	rs137854552	NC_000017.11:31334926:C:A
NM_001042492.3(NF1):c.5867T>G (p.Leu1956Arg)	NF1	L1956R, L1935R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825985	17	29661910	17	31334892	825985	813396	rs1597840087	NC_000017.11:31334891:T:G
NM_001042492.3(NF1):c.5820A>G (p.Glu1940=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825944	17	29661863	17	31334845	825944	813392	rs1387817581	NC_000017.11:31334844:A:G
NM_001042492.3(NF1):c.5690G>T (p.Gly1897Val)	NF1	G1876V, G1897V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825855	17	29657394	17	31330376	825855	813386	rs1597834751	NC_000017.11:31330375:G:T
NM_001042492.3(NF1):c.5631G>T (p.Leu1877=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825831	17	29657335	17	31330317	825831	813383	rs1555533844	NC_000017.11:31330316:G:T
NM_001042492.3(NF1):c.5571C>G (p.Ile1857Met)	NF1	I1857M, I1836M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825789	17	29654819	17	31327801	825789	813381	rs771837192	NC_000017.11:31327800:C:G
NM_001042492.3(NF1):c.5536C>G (p.Arg1846Gly)	NF1	R1846G, R1825G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825761	17	29654784	17	31327766	825761	813380	rs769843989	NC_000017.11:31327765:C:G
NM_001042492.3(NF1):c.5461G>C (p.Val1821Leu)	NF1	V1821L, V1800L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825698	17	29654709	17	31327691	825698	813374	rs1597832135	NC_000017.11:31327690:G:C
NM_001042492.3(NF1):c.5450G>A (p.Cys1817Tyr)	NF1	C1817Y, C1796Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825693	17	29654698	17	31327680	825693	813373	rs1555533589	NC_000017.11:31327679:G:A
NM_001042492.3(NF1):c.5385T>G (p.Asp1795Glu)	NF1	D1774E, D1795E	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000825651	17	29654633	17	31327615	825651	813372	rs1135402870	NC_000017.11:31327614:T:G
NM_001042492.3(NF1):c.5351A>G (p.Tyr1784Cys)	NF1	Y1763C, Y1784C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825620	17	29654599	17	31327581	825620	813368	rs1060500280	NC_000017.11:31327580:A:G
NM_001042492.3(NF1):c.5348A>G (p.Tyr1783Cys)	NF1	Y1783C, Y1762C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000825618	17	29654596	17	31327578	825618	813367	rs1597831963	NC_000017.11:31327577:A:G
NM_001042492.3(NF1):c.5167C>G (p.Gln1723Glu)	NF1	Q1723E, Q1702E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000825451	17	29653169	17	31326151	825451	813361	rs766727694	NC_000017.11:31326150:C:G
NM_001042492.3(NF1):c.4956T>C (p.Asn1652=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825263	17	29652958	17	31325940	825263	813345	rs1597829740	NC_000017.11:31325939:T:C
NM_001042492.3(NF1):c.4956T>A (p.Asn1652Lys)	NF1	N1631K, N1652K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825262	17	29652958	17	31325940	825262	813344	rs1597829740	NC_000017.11:31325939:T:A
NM_001042492.3(NF1):c.480G>T (p.Arg160Ser)	NF1	R160S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825193	17	29496909	17	31169891	825193	813096	rs1555607071	NC_000017.11:31169890:G:T
NM_001042492.3(NF1):c.4854C>T (p.Ile1618=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825173	17	29652856	17	31325838	825173	813338	rs1268872486	NC_000017.11:31325837:C:T
NM_001042492.3(NF1):c.4830A>G (p.Ala1610=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825154	17	29592352	17	31265334	825154	813337	rs552732964	NC_000017.11:31265333:A:G
NM_001042492.3(NF1):c.4796C>T (p.Ser1599Phe)	NF1	S1599F, S1578F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000825131	17	29592318	17	31265300	825131	813334	rs1555619407	NC_000017.11:31265299:C:T
NM_001042492.3(NF1):c.4737T>C (p.His1579=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825088	17	29592259	17	31265241	825088	813332	rs1233883371	NC_000017.11:31265240:T:C
NM_001042492.3(NF1):c.4732G>A (p.Val1578Ile)	NF1	V1557I, V1578I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825083	17	29592254	17	31265236	825083	813331	rs1597753156	NC_000017.11:31265235:G:A
NM_001042492.3(NF1):c.4554T>C (p.Ile1518=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824936	17	29587510	17	31260492	824936	813323	rs1597747129	NC_000017.11:31260491:T:C
NM_001042492.3(NF1):c.4449A>T (p.Ala1483=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824849	17	29587405	17	31260387	824849	813318	rs1237298231	NC_000017.11:31260386:A:T
NM_001042492.3(NF1):c.4365C>T (p.Phe1455=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000824774	17	29586082	17	31259064	824774	813313	rs1597745625	NC_000017.11:31259063:C:T
NM_001042492.3(NF1):c.4333-4G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2020)	criteria provided, conflicting interpretations	VCV000824742	17	29586046	17	31259028	824742	815653	rs372709098	NC_000017.11:31259027:G:A
NM_001042492.3(NF1):c.4296A>G (p.Pro1432=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000824703	17	29585484	17	31258466	824703	813307	rs864622492	NC_000017.11:31258465:A:G
NM_001042492.3(NF1):c.4203C>T (p.Ser1401=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000824623	17	29585391	17	31258373	824623	813300	rs991237227	NC_000017.11:31258372:C:T
NM_001042492.3(NF1):c.4185G>A (p.Gln1395=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000824608	17	29585373	17	31258355	824608	813299	rs775206746	NC_000017.11:31258354:G:A
NM_001042492.3(NF1):c.410C>G (p.Ser137Cys)	NF1	S137C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000824600	17	29490325	17	31163307	824600	813094	rs1597635932	NC_000017.11:31163306:C:G
NM_001042492.3(NF1):c.4103T>C (p.Leu1368Ser)	NF1	L1368S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000824597	17	29576130	17	31249112	824597	813296	rs1597735265	NC_000017.11:31249111:T:C
NM_001042492.3(NF1):c.4069T>A (p.Phe1357Ile)	NF1	F1357I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824562	17	29576096	17	31249078	824562	813293	rs1207255352	NC_000017.11:31249077:T:A
NM_001042492.3(NF1):c.4046C>T (p.Ala1349Val)	NF1	A1349V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824536	17	29576073	17	31249055	824536	813291	rs1229215269	NC_000017.11:31249054:C:T
NM_001042492.3(NF1):c.3G>C (p.Met1Ile)	NF1|LOC111811965	M1I	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000824485	17	29422330	17	31095312	824485	813072	rs1598173737	NC_000017.11:31095311:G:C
NM_001042492.3(NF1):c.3948T>A (p.His1316Gln)	NF1	H1316Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824414	17	29563013	17	31235995	824414	813282	rs1418340346	NC_000017.11:31235994:T:A
NM_001042492.3(NF1):c.3945A>G (p.Gln1315=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2019)	criteria provided, conflicting interpretations	VCV000824408	17	29563010	17	31235992	824408	813280	rs1365148212	NC_000017.11:31235991:A:G
NM_001042492.3(NF1):c.3904G>A (p.Asp1302Asn)	NF1	D1302N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824367	17	29562969	17	31235951	824367	813276	rs1597722958	NC_000017.11:31235950:G:A
NM_001042492.3(NF1):c.3890T>C (p.Leu1297Pro)	NF1	L1297P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824344	17	29562955	17	31235937	824344	813275	rs1597722927	NC_000017.11:31235936:T:C
NM_001042492.3(NF1):c.3873A>G (p.Val1291=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2019)	criteria provided, conflicting interpretations	VCV000824325	17	29562938	17	31235920	824325	813274	rs1250496630	NC_000017.11:31235919:A:G
NM_001042492.3(NF1):c.3861C>T (p.Phe1287=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824315	17	29562781	17	31235763	824315	813273	rs749107019	NC_000017.11:31235762:C:T
NM_001042492.3(NF1):c.3808T>A (p.Ser1270Thr)	NF1	S1270T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000824244	17	29562728	17	31235710	824244	813270	rs1597722567	NC_000017.11:31235709:T:A
NM_001042492.3(NF1):c.3774G>C (p.Trp1258Cys)	NF1	W1258C	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000824192	17	29562694	17	31235676	824192	813269	rs1597722516	NC_000017.11:31235675:G:C
NM_001042492.3(NF1):c.3611G>A (p.Arg1204Gln)	NF1	R1204Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2021)	criteria provided, conflicting interpretations	VCV000823990	17	29560134	17	31233116	823990	813258	rs1057521848	NC_000017.11:31233115:G:A
NM_001042492.3(NF1):c.3509A>T (p.His1170Leu)	NF1	H1170L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2020)	criteria provided, conflicting interpretations	VCV000823864	17	29560032	17	31233014	823864	813253	rs1597719889	NC_000017.11:31233013:A:T
NM_001042492.3(NF1):c.3492C>T (p.Ser1164=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000823837	17	29559895	17	31232877	823837	813251	rs370206701	NC_000017.11:31232876:C:T
NM_001042492.3(NF1):c.975C>T (p.Val325=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000823463	17	29527526	17	31200508	823463	813120	rs747954452	NC_000017.11:31200507:C:T
NM_001042492.3(NF1):c.928C>T (p.His310Tyr)	NF1	H310Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000823142	17	29527479	17	31200461	823142	813118	rs1597680837	NC_000017.11:31200460:C:T
NM_001042492.3(NF1):c.888+744A>G	NF1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000822795	17	29510427	17	31183409	822795	815647	rs1597660915	NC_000017.11:31183408:A:G
NM_001042492.3(NF1):c.3051A>G (p.Gln1017=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2020)	criteria provided, conflicting interpretations	VCV000822734	17	29557338	17	31230320	822734	813228	rs201891488	NC_000017.11:31230319:A:G
NM_001042492.3(NF1):c.2984T>C (p.Leu995Pro)	NF1	L995P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2021)	criteria provided, conflicting interpretations	VCV000822432	17	29556986	17	31229968	822432	813225	rs1597716466	NC_000017.11:31229967:T:C
NM_001042492.3(NF1):c.294A>G (p.Pro98=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000822342	17	29490209	17	31163191	822342	813087	rs1445884708	NC_000017.11:31163190:A:G
NM_001042492.3(NF1):c.8378G>C (p.Gly2793Ala)	NF1	G2793A, G2772A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000822288	17	29701031	17	31374013	822288	813534	rs1275285522	NC_000017.11:31374012:G:C
NM_001042492.3(NF1):c.8377+4A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000822287	17	29687725	17	31360707	822287	815671	rs1224454019	NC_000017.11:31360706:A:G
NM_001042492.3(NF1):c.1037T>C (p.Val346Ala)	NF1	V346A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000822061	17	29527588	17	31200570	822061	813121	rs1597681117	NC_000017.11:31200569:T:C
NM_001042492.3(NF1):c.288G>A (p.Gly96=)	NF1		Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000821948	17	29486111	17	31159093	821948	813085	rs1430988476	NC_000017.11:31159092:G:A
NM_001042492.3(NF1):c.284C>G (p.Ala95Gly)	NF1	A95G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000821901	17	29486107	17	31159089	821901	813083	rs1567816119	NC_000017.11:31159088:C:G
NM_001042492.3(NF1):c.2851-1G>T	NF1		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000821889	17	29556852	17	31229834	821889	815652	rs1597716274	NC_000017.11:31229833:G:T
NM_001042492.3(NF1):c.2584A>G (p.Thr862Ala)	NF1	T862A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000821519	17	29556217	17	31229199	821519	813212	rs1597715417	NC_000017.11:31229198:A:G
NM_001042492.3(NF1):c.2394A>G (p.Lys798=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000821202	17	29554609	17	31227591	821202	813196	rs1597713814	NC_000017.11:31227590:A:G
NM_001042492.3(NF1):c.2344G>T (p.Ala782Ser)	NF1	A782S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000821128	17	29554559	17	31227541	821128	813193	rs1352143970	NC_000017.11:31227540:G:T
NM_001042492.3(NF1):c.2322T>C (p.Thr774=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000821099	17	29554306	17	31227288	821099	813192	rs770111990	NC_000017.11:31227287:T:C
NM_001042492.3(NF1):c.2353G>A (p.Glu785Lys)	NF1	E785K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000821065	17	29554568	17	31227550	821065	813194	rs1597713756	NC_000017.11:31227549:G:A
NM_001042492.3(NF1):c.2281G>A (p.Ala761Thr)	NF1	A761T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000821025	17	29554265	17	31227247	821025	813190	rs786202504	NC_000017.11:31227246:G:A
NM_001042492.3(NF1):c.2260G>A (p.Ala754Thr)	NF1	A754T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820980	17	29554244	17	31227226	820980	813189	rs1597713272	NC_000017.11:31227225:G:A
NM_001042492.3(NF1):c.2241G>A (p.Met747Ile)	NF1	M747I	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000820951	17	29553692	17	31226674	820951	813188	rs1597712751	NC_000017.11:31226673:G:A
NM_001042492.3(NF1):c.2132G>A (p.Arg711His)	NF1	R711H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820780	17	29553583	17	31226565	820780	813186	rs1479669686	NC_000017.11:31226564:G:A
NM_001042492.3(NF1):c.2080T>C (p.Phe694Leu)	NF1	F694L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820675	17	29553531	17	31226513	820675	813183	rs1597712476	NC_000017.11:31226512:T:C
NM_001042492.3(NF1):c.2061A>C (p.Leu687=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820628	17	29553512	17	31226494	820628	813181	rs143671377	NC_000017.11:31226493:A:C
NM_001042492.3(NF1):c.2059C>T (p.Leu687=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820620	17	29553510	17	31226492	820620	813180	rs1597712422	NC_000017.11:31226491:C:T
NM_001042492.3(NF1):c.2062G>C (p.Glu688Gln)	NF1	E688Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820596	17	29553513	17	31226495	820596	813182	rs1555613784	NC_000017.11:31226494:G:C
NM_001042492.3(NF1):c.2027C>T (p.Thr676Ile)	NF1	T676I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820550	17	29553478	17	31226460	820550	813175	rs1294581001	NC_000017.11:31226459:C:T
NM_001042492.3(NF1):c.1995C>T (p.Ser665=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820495	17	29552262	17	31225244	820495	813174	rs1352726800	NC_000017.11:31225243:C:T
NM_001042492.3(NF1):c.1818C>T (p.Cys606=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820132	17	29550558	17	31223540	820132	813159	rs1567845937	NC_000017.11:31223539:C:T
NM_001042492.3(NF1):c.1801C>A (p.Arg601=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000820104	17	29550541	17	31223523	820104	813158	rs587782592	NC_000017.11:31223522:C:A
NM_001042492.3(NF1):c.1791C>G (p.Leu597=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820086	17	29550531	17	31223513	820086	813157	rs1597708736	NC_000017.11:31223512:C:G
NM_001042492.3(NF1):c.1755A>G (p.Leu585=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820011	17	29550495	17	31223477	820011	813156	rs1597708685	NC_000017.11:31223476:A:G
NM_001042492.3(NF1):c.1668T>C (p.Asp556=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819775	17	29548894	17	31221876	819775	813153	rs1597706678	NC_000017.11:31221875:T:C
NM_001042492.3(NF1):c.1526G>A (p.Cys509Tyr)	NF1	C509Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819456	17	29541602	17	31214584	819456	813149	rs1597698521	NC_000017.11:31214583:G:A
NM_001042492.3(NF1):c.1408G>T (p.Glu470Ter)	NF1	E470*	Neurofibromatosis, type 1|Rasopathy|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819135	17	29541484	17	31214466	819135	813143	rs1597698330	NC_000017.11:31214465:G:T
NM_001042492.3(NF1):c.1381C>A (p.Arg461=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819061	17	29533378	17	31206360	819061	813142	rs878853865	NC_000017.11:31206359:C:A
NM_001042492.3(NF1):c.1367C>T (p.Ala456Val)	NF1	A456V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000819018	17	29533364	17	31206346	819018	813140	rs1597688962	NC_000017.11:31206345:C:T
NM_001042492.3(NF1):c.1329T>C (p.Phe443=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818950	17	29533326	17	31206308	818950	813137	rs1597688853	NC_000017.11:31206307:T:C
NM_001042492.3(NF1):c.130A>G (p.Ile44Val)	NF1	I44V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818866	17	29483070	17	31156052	818866	813076	rs1597625982	NC_000017.11:31156051:A:G
NM_001042492.3(NF1):c.1231G>A (p.Val411Ile)	NF1	V411I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000818658	17	29528474	17	31201456	818658	813133	rs199703072	NC_000017.11:31201455:G:A
NM_001042492.3(NF1):c.5697T>A (p.Cys1899Ter)	NF1	C1878*, C1899*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818197	17	29657401	17	31330383	818197	806400	rs1597834760	NC_000017.11:31330382:T:A
NM_001042492.3(NF1):c.5392C>T (p.Gln1798Ter)	NF1	Q1777*, Q1798*	Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000818196	17	29654640	17	31327622	818196	806399	rs1597832043	NC_000017.11:31327621:C:T
NM_001042492.3(NF1):c.289C>T (p.Gln97Ter)	NF1	Q97*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818189	17	29490204	17	31163186	818189	806386	rs1597635615	NC_000017.11:31163185:C:T
NM_001042492.3(NF1):c.2044C>T (p.Gln682Ter)	NF1	Q682*	Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818186	17	29553495	17	31226477	818186	806392	rs1597712392	NC_000017.11:31226476:C:T
NM_001042492.3(NF1):c.2019C>A (p.Cys673Ter)	NF1	C673*	Neurofibromatosis, type 1|Tibial pseudoarthrosis	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000818185	17	29553470	17	31226452	818185	806391	rs146624509	NC_000017.11:31226451:C:A
NM_001042492.3(NF1):c.1198C>T (p.Gln400Ter)	NF1	Q400*	Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Feb 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818183	17	29528441	17	31201423	818183	806389	rs1597682751	NC_000017.11:31201422:C:T
NM_001042492.3(NF1):c.731-2A>C	NF1		Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000818181	17	29509524	17	31182506	818181	806405	rs1555608924	NC_000017.11:31182505:A:C
NM_001042492.3(NF1):c.6596T>A (p.Leu2199Ter)	NF1	L2178*, L2199*	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000816958	17	29664554	17	31337536	816958	805944	rs1597843979	NC_000017.11:31337535:T:A
NM_001042492.3(NF1):c.8161-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816777	17	29687502	17	31360484	816777	804980	rs786203684	NC_000017.11:31360483:C:G
NM_001042492.3(NF1):c.7063-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816776	17	29670024	17	31343006	816776	804974	rs1241158120	NC_000017.11:31343005:T:G
NM_001042492.3(NF1):c.6428-3C>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000816775	17	29664383	17	31337365	816775	804967	rs374014162	NC_000017.11:31337364:C:G
NM_001042492.3(NF1):c.3114-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816774	17	29557857	17	31230839	816774	804952	rs773097190	NC_000017.11:31230838:T:G
NM_001042492.3(NF1):c.1063-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816773	17	29528052	17	31201034	816773	804933	rs758206740	NC_000017.11:31201033:T:G
NM_001042492.3(NF1):c.7870-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816772	17	29684284	17	31357266	816772	804979	rs1597866792	NC_000017.11:31357265:C:G
NM_001042492.3(NF1):c.7739-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816771	17	29683975	17	31356957	816771	804977	rs747382969	NC_000017.11:31356956:C:G
NM_001042492.3(NF1):c.6148-3C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816769	17	29663650	17	31336632	816769	804966	rs1597842697	NC_000017.11:31336631:C:A
NM_001042492.3(NF1):c.4578-3T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816768	17	29588726	17	31261708	816768	804960	rs1597748656	NC_000017.11:31261707:T:G
NM_001042492.3(NF1):c.3315-3C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000816766	17	29559715	17	31232697	816766	804954	rs752318318	NC_000017.11:31232696:C:G
NM_001042492.3(NF1):c.2410-3T>G	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2020)	criteria provided, conflicting interpretations	VCV000816765	17	29556040	17	31229022	816765	804949	rs1450743199	NC_000017.11:31229021:T:G
NM_001042492.3(NF1):c.1722-3C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816764	17	29550459	17	31223441	816764	804942	rs770211384	NC_000017.11:31223440:C:A
NM_001042492.3(NF1):c.4431-9T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816763	17	29587378	17	31260360	816763	804957	rs1597746884	NC_000017.11:31260359:T:G
NM_001042492.3(NF1):c.3975-11T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816762	17	29575991	17	31248973	816762	804956	rs1597734976	NC_000017.11:31248972:T:G
NM_001042492.3(NF1):c.3114-8T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816761	17	29557852	17	31230834	816761	804951	rs1597717471	NC_000017.11:31230833:T:G
NM_001042492.3(NF1):c.2410-9T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816759	17	29556034	17	31229016	816759	804948	rs1597715061	NC_000017.11:31229015:T:A
NM_001042492.3(NF1):c.2410-14A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816758	17	29556029	17	31229011	816758	804947	rs773710071	NC_000017.11:31229010:A:G
NM_001042492.3(NF1):c.2410-15A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816757	17	29556028	17	31229010	816757	804946	rs1597715031	NC_000017.11:31229009:A:G
NM_001042492.3(NF1):c.1642-7A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816756	17	29548861	17	31221843	816756	804938	rs1597706592	NC_000017.11:31221842:A:G
NM_001042492.3(NF1):c.1642-10A>G	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000816755	17	29548858	17	31221840	816755	804937	rs1597706578	NC_000017.11:31221839:A:G
NM_001042492.3(NF1):c.1261-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816754	17	29533245	17	31206227	816754	804936	rs1597688674	NC_000017.11:31206226:T:A
NM_001042492.3(NF1):c.1261-19G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000816753	17	29533239	17	31206221	816753	804935	rs1597688663	NC_000017.11:31206220:G:A
NM_001042492.3(NF1):c.1261-21T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816752	17	29533237	17	31206219	816752	804934	rs1597688656	NC_000017.11:31206218:T:G
NM_001042492.3(NF1):c.1063-14T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816751	17	29528041	17	31201023	816751	804932	rs538708444	NC_000017.11:31201022:T:A
NM_001042492.3(NF1):c.205-6T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816750	17	29486022	17	31159004	816750	804925	rs1243948503	NC_000017.11:31159003:T:A
NM_001042492.3(NF1):c.7190-12T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816741	17	29676126	17	31349108	816741	804976	rs1597858284	NC_000017.11:31349107:T:A
NM_001042492.3(NF1):c.7190-20T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816740	17	29676118	17	31349100	816740	804975	rs1597858261	NC_000017.11:31349099:T:A
NM_001042492.3(NF1):c.7063-10T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816739	17	29670017	17	31342999	816739	804973	rs1597851210	NC_000017.11:31342998:T:G
NM_001042492.3(NF1):c.6820-9T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816738	17	29665713	17	31338695	816738	804972	rs1597845886	NC_000017.11:31338694:T:G
NM_001042492.3(NF1):c.6820-10T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816737	17	29665712	17	31338694	816737	804971	rs1597845883	NC_000017.11:31338693:T:G
NM_001042492.3(NF1):c.6705-6T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816736	17	29665037	17	31338019	816736	804969	rs1597844950	NC_000017.11:31338018:T:G
NM_001042492.3(NF1):c.6705-5T>G	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000816735	17	29665038	17	31338020	816735	804970	rs1597844956	NC_000017.11:31338019:T:G
NM_001042492.3(NF1):c.6148-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816734	17	29663640	17	31336622	816734	804965	rs1411146465	NC_000017.11:31336621:T:A
NM_001042492.3(NF1):c.6148-16T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816733	17	29663637	17	31336619	816733	804964	rs769223408	NC_000017.11:31336618:T:G
NM_001042492.3(NF1):c.5269-19C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816732	17	29654498	17	31327480	816732	804962	rs755620051	NC_000017.11:31327479:C:A
NM_001042492.3(NF1):c.4578-21T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816731	17	29588708	17	31261690	816731	804958	rs1597748607	NC_000017.11:31261689:T:C
NM_001042492.3(NF1):c.3871-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816730	17	29562923	17	31235905	816730	804955	rs1597722866	NC_000017.11:31235904:T:A
NM_001042492.3(NF1):c.3315-8T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816729	17	29559710	17	31232692	816729	804953	rs764783865	NC_000017.11:31232691:T:G
NM_001042492.3(NF1):c.2326-6T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000816728	17	29554535	17	31227517	816728	804945	rs1597713670	NC_000017.11:31227516:T:G
NM_001042492.3(NF1):c.2252-13T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816727	17	29554223	17	31227205	816727	804944	rs778325867	NC_000017.11:31227204:T:A
NM_001042492.3(NF1):c.1722-26T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816726	17	29550436	17	31223418	816726	804939	rs1597708542	NC_000017.11:31223417:T:C
NM_001042492.3(NF1):c.889-21C>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816725	17	29527419	17	31200401	816725	804931	rs753797445	NC_000017.11:31200400:C:A
NM_001042492.3(NF1):c.731-14T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816724	17	29509512	17	31182494	816724	804930	rs1597659694	NC_000017.11:31182493:T:G
NM_001042492.3(NF1):c.587-14T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816723	17	29508426	17	31181408	816723	804928	rs940581106	NC_000017.11:31181407:T:A
NM_001042492.3(NF1):c.480-8C>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816722	17	29496901	17	31169883	816722	804926	rs1597643692	NC_000017.11:31169882:C:G
NM_001042492.3(NF1):c.205-19T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000816721	17	29486009	17	31158991	816721	804924	rs1597629649	NC_000017.11:31158990:T:A
NM_001042492.2(NF1):c.[6708delT;6710C>G]	NF1	F2215fs, F2236fs, A2216G, A2237G	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000812142	17|17	29665044	17|17	31338026	812142	904244|904246		NC_000017.11:31338025:TTT:TT|NC_000017.11:31338029:C:G
NM_001042492.3(NF1):c.*29A>G	NF1		not specified|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811498	17	29701202	17	31374184	811498	800027	rs139147882	NC_000017.11:31374183:A:G
NM_001042492.3(NF1):c.7895A>G (p.Asp2632Gly)	NF1	D2611G, D2632G	not specified	Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000811226	17	29684312	17	31357294	811226	800025	rs1597866846	NC_000017.11:31357293:A:G
NM_001042492.3(NF1):c.4700C>G (p.Ser1567Ter)	NF1	S1546*, S1567*	Hereditary cancer-predisposing syndrome|not specified	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000811172	17	29588851	17	31261833	811172	800019	rs1555619051	NC_000017.11:31261832:C:G
NM_001042492.3(NF1):c.2553C>A (p.Cys851Ter)	NF1	C851*	not specified	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000811157	17	29556186	17	31229168	811157	800013	rs2230852	NC_000017.11:31229167:C:A
NM_001042492.3(NF1):c.5609+5G>T	NF1		Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000810859	17	29654862	17	31327844	810859	800020	rs1597832498	NC_000017.11:31327843:G:T
NM_001042492.3(NF1):c.2678A>G (p.Lys893Arg)	NF1	K893R	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000808249	17	29556311	17	31229293	808249	797515	rs1597715604	NC_000017.11:31229292:A:G
NM_001042492.3(NF1):c.731-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000805084	17	29509524	17	31182506	805084	794063	rs1555608924	NC_000017.11:31182505:A:G
NM_001042492.3(NF1):c.5548G>T (p.Val1850Phe)	NF1	V1829F, V1850F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 25, 2019)	criteria provided, single submitter	VCV000804227	17	29654796	17	31327778	804227	792584	rs1597832397	NC_000017.11:31327777:G:T
NM_001042492.3(NF1):c.2410-13A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000804167	17	29556030	17	31229012	804167	792537	rs1567848711	NC_000017.11:31229011:A:G
NM_001042492.3(NF1):c.8377+6509A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803380	17	29694230	17	31367212	803380	791733	rs1343721620	NC_000017.11:31367211:A:T
NM_001042492.3(NF1):c.7971-1G>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803379	17	29685497	17	31358479	803379	791732	rs1417908560	NC_000017.11:31358478:G:T
NM_001042492.3(NF1):c.7062+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803375	17	29667664	17	31340646	803375	791728	rs863224492	NC_000017.11:31340645:G:T
NM_001042492.3(NF1):c.6642+42T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803374	17	29664642	17	31337624	803374	791727	rs760581466	NC_000017.11:31337623:T:C
NM_001042492.3(NF1):c.6546C>G (p.Tyr2182Ter)	NF1	Y2182*, Y2161*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803373	17	29664504	17	31337486	803373	791726	rs876659768	NC_000017.11:31337485:C:G
NM_001042492.3(NF1):c.5815A>T (p.Ile1939Phe)	NF1	I1918F, I1939F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803370	17	29661858	17	31334840	803370	791723	rs1173859882	NC_000017.11:31334839:A:T
NM_001042492.3(NF1):c.5711A>C (p.Asn1904Thr)	NF1	N1883T, N1904T	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 9, 2020)	criteria provided, conflicting interpretations	VCV000803368	17	29657415	17	31330397	803368	791721	rs864622647	NC_000017.11:31330396:A:C
NM_001042492.3(NF1):c.4577+2T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803361	17	29587535	17	31260517	803361	791714	rs1597747184	NC_000017.11:31260516:T:C
NM_001042492.3(NF1):c.4431-1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803359	17	29587386	17	31260368	803359	791712	rs1597746891	NC_000017.11:31260367:G:T
NM_001042492.3(NF1):c.4285A>T (p.Lys1429Ter)	NF1	K1408*, K1429*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803356	17	29585473	17	31258455	803356	791709	rs758915600	NC_000017.11:31258454:A:T
NM_001042492.3(NF1):c.3974+23A>T	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803355	17	29563062	17	31236044	803355	791708	rs376217184	NC_000017.11:31236043:A:T
NM_001042492.3(NF1):c.3831C>T (p.Gly1277=)	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000803354	17	29562751	17	31235733	803354	791707	rs1597722611	NC_000017.11:31235732:C:T
NM_001042492.3(NF1):c.3204G>T (p.Leu1068Phe)	NF1	L1068F	Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803352	17	29559097	17	31232079	803352	791705	rs1258842007	NC_000017.11:31232078:G:T
NM_001042492.3(NF1):c.3199G>T (p.Asp1067Tyr)	NF1	D1067Y	Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803351	17	29559092	17	31232074	803351	791704	rs1597718721	NC_000017.11:31232073:G:T
NM_001042492.3(NF1):c.3112A>T (p.Arg1038Trp)	NF1	R1038W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803348	17	29557399	17	31230381	803348	791701	rs1597717017	NC_000017.11:31230380:A:T
NM_001042492.3(NF1):c.2850+17T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803347	17	29556500	17	31229482	803347	791700	rs1410636379	NC_000017.11:31229481:T:C
NM_001042492.3(NF1):c.1186-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803341	17	29528428	17	31201410	803341	791694	rs876660782	NC_000017.11:31201409:G:A
NM_001042492.3(NF1):c.888+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803340	17	29509684	17	31182666	803340	791693	rs1135402799	NC_000017.11:31182665:G:T
NM_001042492.3(NF1):c.269T>A (p.Leu90Gln)	NF1	L90Q	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803337	17	29486092	17	31159074	803337	791690	rs1555605393	NC_000017.11:31159073:T:A
NM_001042492.3(NF1):c.64C>T (p.Pro22Ser)	NF1	P22S	Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803336	17	29483004	17	31155986	803336	791689	rs1597625794	NC_000017.11:31155985:C:T
NM_001042492.3(NF1):c.61-1G>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803335	17	29483000	17	31155982	803335	791688	rs1263745475	NC_000017.11:31155981:G:T
NM_001042492.3(NF1):c.730+8T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000800144	17	29508811	17	31181793	800144	788133	rs1555608771	NC_000017.11:31181792:T:G
NM_001042492.3(NF1):c.2851-10C>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000799987	17	29556843	17	31229825	799987	788222	rs1555614412	NC_000017.11:31229824:C:A
NM_001042492.3(NF1):c.5400C>G (p.Thr1800=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000799954	17	29654648	17	31327630	799954	785512	rs1597832051	NC_000017.11:31327629:C:G
NM_001042492.3(NF1):c.7854G>C (p.Leu2618=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000799934	17	29684093	17	31357075	799934	785533	rs1597866574	NC_000017.11:31357074:G:C
NM_001042492.3(NF1):c.6348C>T (p.Leu2116=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000799750	17	29663853	17	31336835	799750	785517	rs748725395	NC_000017.11:31336834:C:T
NM_001042492.3(NF1):c.3708+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000799639	17	29560241	17	31233223	799639	788228	rs757762958	NC_000017.11:31233222:T:C
NM_001042492.3(NF1):c.6912T>A (p.Leu2304=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000799549	17	29665814	17	31338796	799549	785521	rs1597846097	NC_000017.11:31338795:T:A
NM_001042492.3(NF1):c.7590T>C (p.Ser2530=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000799544	17	29679407	17	31352389	799544	785526	rs1597862243	NC_000017.11:31352388:T:C
NM_001042492.3(NF1):c.654+10A>T	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000799340	17	29508517	17	31181499	799340	788116	rs1597658231	NC_000017.11:31181498:A:T
NM_001042492.3(NF1):c.4803T>G (p.Ala1601=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000799147	17	29592325	17	31265307	799147	785508	rs148662566	NC_000017.11:31265306:T:G
NM_001042492.3(NF1):c.4578-8G>C	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000798947	17	29588721	17	31261703	798947	788136	rs375758486	NC_000017.11:31261702:G:C
NM_001042492.3(NF1):c.5209C>T (p.Leu1737=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000798829	17	29653211	17	31326193	798829	785510	rs1341372934	NC_000017.11:31326192:C:T
NM_001042492.3(NF1):c.8013G>A (p.Leu2671=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000798621	17	29685540	17	31358522	798621	785536	rs769548773	NC_000017.11:31358521:G:A
NM_001042492.3(NF1):c.7254T>G (p.Thr2418=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000798504	17	29676202	17	31349184	798504	785523	rs1597858465	NC_000017.11:31349183:T:G
NM_001042492.3(NF1):c.6428-4A>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000798500	17	29664382	17	31337364	798500	788142	rs1597843630	NC_000017.11:31337363:A:G
NM_001042492.3(NF1):c.4374A>G (p.Glu1458=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV000797956	17	29586091	17	31259073	797956	785505	rs1597745662	NC_000017.11:31259072:A:G
NM_001042492.3(NF1):c.8377+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV000797912	17	29687731	17	31360713	797912	787945	rs1321286725	NC_000017.11:31360712:T:C
NM_001042492.3(NF1):c.5143C>T (p.Leu1715=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000797825	17	29653145	17	31326127	797825	785509	rs1597830104	NC_000017.11:31326126:C:T
NM_001042492.3(NF1):c.4530A>C (p.Leu1510=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000797537	17	29587486	17	31260468	797537	785507	rs876660089	NC_000017.11:31260467:A:C
NM_001042492.3(NF1):c.7008A>G (p.Ala2336=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 25, 2018)	criteria provided, single submitter	VCV000797414	17	29667609	17	31340591	797414	785522	rs201153017	NC_000017.11:31340590:A:G
NM_001042492.3(NF1):c.5517C>T (p.Ile1839=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000797413	17	29654765	17	31327747	797413	785514	rs865839207	NC_000017.11:31327746:C:T
NM_001042492.3(NF1):c.7683A>G (p.Ser2561=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000797364	17	29683545	17	31356527	797364	785529	rs1555536646	NC_000017.11:31356526:A:G
NM_001042492.3(NF1):c.5970A>C (p.Pro1990=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV000796931	17	29662013	17	31334995	796931	785515	rs876658601	NC_000017.11:31334994:A:C
NM_001042492.3(NF1):c.5295T>C (p.Thr1765=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000796524	17	29654543	17	31327525	796524	785511	rs1286956337	NC_000017.11:31327524:T:C
NM_001042492.3(NF1):c.1977G>A (p.Arg659=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000795815	17	29552244	17	31225226	795815	785500	rs1597710788	NC_000017.11:31225225:G:A
NM_001042492.3(NF1):c.4836-7T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000795814	17	29652831	17	31325813	795814	788113	rs1597829481	NC_000017.11:31325812:T:C
NM_001042492.3(NF1):c.6513G>A (p.Lys2171=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000795601	17	29664471	17	31337453	795601	785518	rs1597843784	NC_000017.11:31337452:G:A
NM_001042492.3(NF1):c.5502A>G (p.Ser1834=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000795600	17	29654750	17	31327732	795600	785513	rs747487014	NC_000017.11:31327731:A:G
NM_001042492.3(NF1):c.6705-4G>T	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000795354	17	29665039	17	31338021	795354	788145	rs1597844961	NC_000017.11:31338020:G:T
NM_001042492.3(NF1):c.8004G>A (p.Leu2668=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000795020	17	29685531	17	31358513	795020	785535	rs1597868098	NC_000017.11:31358512:G:A
NM_001042492.3(NF1):c.3426G>A (p.Arg1142=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000795017	17	29559829	17	31232811	795017	785504	rs1597719572	NC_000017.11:31232810:G:A
NM_001042492.3(NF1):c.6777G>A (p.Val2259=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000794866	17	29665115	17	31338097	794866	785520	rs1281405147	NC_000017.11:31338096:G:A
NM_001042492.3(NF1):c.7852C>T (p.Leu2618=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000794631	17	29684091	17	31357073	794631	785532	rs1175965670	NC_000017.11:31357072:C:T
NM_001042492.3(NF1):c.3420A>T (p.Ser1140=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000794591	17	29559823	17	31232805	794591	785503	rs1555614961	NC_000017.11:31232804:A:T
NM_001042492.3(NF1):c.360T>C (p.Phe120=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000794506	17	29490275	17	31163257	794506	785492	rs1597635781	NC_000017.11:31163256:T:C
NM_001042492.3(NF1):c.1587C>G (p.Leu529=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV000794157	17	29546082	17	31219064	794157	785496	rs786203041	NC_000017.11:31219063:C:G
NM_001042492.3(NF1):c.1335A>G (p.Glu445=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000794152	17	29533332	17	31206314	794152	785494	rs1597688882	NC_000017.11:31206313:A:G
NM_001042492.3(NF1):c.6262C>T (p.Leu2088=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000793952	17	29663767	17	31336749	793952	785516	rs752569823	NC_000017.11:31336748:C:T
NM_001042492.3(NF1):c.60+8G>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000793948	17	29422395	17	31095377	793948	788220	rs1598173934	NC_000017.11:31095376:G:C
NM_001042492.3(NF1):c.4333-10T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000793946	17	29586040	17	31259022	793946	788111	rs1254791952	NC_000017.11:31259021:T:C
NM_001042492.3(NF1):c.7791A>T (p.Ser2597=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000793907	17	29684030	17	31357012	793907	785530	rs1597866426	NC_000017.11:31357011:A:T
NM_001042492.3(NF1):c.1086G>A (p.Lys362=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000793840	17	29528078	17	31201060	793840	785493	rs1597681929	NC_000017.11:31201059:G:A
NM_001042492.3(NF1):c.1632A>G (p.Glu544=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000793711	17	29546127	17	31219109	793711	785498	rs1597703585	NC_000017.11:31219108:A:G
NM_001042492.3(NF1):c.7611G>A (p.Leu2537=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000793640	17	29679428	17	31352410	793640	785527	rs1597862289	NC_000017.11:31352409:G:A
NM_001042492.3(NF1):c.7341A>G (p.Glu2447=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000793264	17	29677220	17	31350202	793264	785525	rs878853915	NC_000017.11:31350201:A:G
NM_001042492.3(NF1):c.7923A>G (p.Glu2641=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000793262	17	29684340	17	31357322	793262	785534	rs1597866925	NC_000017.11:31357321:A:G
NM_001042492.3(NF1):c.7738+10A>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000793200	17	29683610	17	31356592	793200	788232	rs759661081	NC_000017.11:31356591:A:G
NM_001042492.3(NF1):c.7323T>C (p.Ala2441=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV000793121	17	29677202	17	31350184	793121	785524	rs765750009	NC_000017.11:31350183:T:C
NM_001042492.3(NF1):c.6753C>A (p.Val2251=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000793120	17	29665091	17	31338073	793120	785519	rs1597845047	NC_000017.11:31338072:C:A
NM_001042492.3(NF1):c.4497A>T (p.Ile1499=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000793118	17	29587453	17	31260435	793118	785506	rs1597747016	NC_000017.11:31260434:A:T
NM_001042492.3(NF1):c.1422C>T (p.Ser474=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV000793027	17	29541498	17	31214480	793027	785495	rs1597698349	NC_000017.11:31214479:C:T
NM_001042492.3(NF1):c.7639T>C (p.Leu2547=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV000792946	17	29683501	17	31356483	792946	785528	rs1597865750	NC_000017.11:31356482:T:C
NM_001042492.3(NF1):c.1893A>T (p.Gly631=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000792655	17	29552160	17	31225142	792655	785499	rs1597710471	NC_000017.11:31225141:A:T
NM_001042492.3(NF1):c.2034G>T (p.Pro678=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000792592	17	29553485	17	31226467	792592	785501	rs2285892	NC_000017.11:31226466:G:T
NM_001042492.3(NF1):c.1602T>C (p.Pro534=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000792542	17	29546097	17	31219079	792542	785497	rs1205604823	NC_000017.11:31219078:T:C
NM_001042492.3(NF1):c.2232C>T (p.Val744=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000792504	17	29553683	17	31226665	792504	785502	rs748865537	NC_000017.11:31226664:C:T
NM_001042492.3(NF1):c.6696A>C (p.Leu2232=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000784805	17	29664890	17	31337872	784805	715357	rs1265616273	NC_000017.11:31337871:A:C
NM_001042492.3(NF1):c.7870-8C>T	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV000775382	17	29684279	17	31357261	775382	778372	rs372441422	NC_000017.11:31357260:C:T
NM_001042492.3(NF1):c.1185+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000774061	17	29528187	17	31201169	774061	778337	rs759048037	NC_000017.11:31201168:T:C
NM_001042492.3(NF1):c.5268+9C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000772827	17	29653279	17	31326261	772827	778467	rs956188716	NC_000017.11:31326260:C:T
NM_001042492.3(NF1):c.8286C>T (p.Tyr2762=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000772617	17	29687630	17	31360612	772617	704075	rs1597870245	NC_000017.11:31360611:C:T
NM_001042492.3(NF1):c.3678T>C (p.Ala1226=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000772327	17	29560201	17	31233183	772327	704074	rs776473273	NC_000017.11:31233182:T:C
NM_001042492.3(NF1):c.2001+9C>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000772211	17	29552277	17	31225259	772211	778463	rs755501652	NC_000017.11:31225258:C:G
NM_001042492.3(NF1):c.387G>A (p.Gln129=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000767563	17	29490302	17	31163284	767563	704073	rs1390215440	NC_000017.11:31163283:G:A
NM_001042492.3(NF1):c.8301G>A (p.Gln2767=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000766747	17	29687645	17	31360627	766747	771427	rs1597870264	NC_000017.11:31360626:G:A
NM_001042492.3(NF1):c.3276T>G (p.Gly1092=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000766695	17	29559169	17	31232151	766695	771379	rs763555840	NC_000017.11:31232150:T:G
NM_001042492.3(NF1):c.4107C>T (p.Tyr1369=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000766405	17	29576134	17	31249116	766405	771390	rs1597735272	NC_000017.11:31249115:C:T
NM_001042492.3(NF1):c.2160G>A (p.Arg720=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000766319	17	29553611	17	31226593	766319	771368	rs765339408	NC_000017.11:31226592:G:A
NM_001042492.3(NF1):c.1506A>C (p.Ala502=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000766315	17	29541582	17	31214564	766315	771359	rs1597698488	NC_000017.11:31214563:A:C
NM_001042492.3(NF1):c.1134C>T (p.Asp378=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000766126	17	29528126	17	31201108	766126	771357	rs781367679	NC_000017.11:31201107:C:T
NM_001042492.3(NF1):c.2136C>T (p.His712=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000765858	17	29553587	17	31226569	765858	771367	rs1597712580	NC_000017.11:31226568:C:T
NM_001042492.3(NF1):c.6472T>C (p.Leu2158=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000765790	17	29664430	17	31337412	765790	771409	rs1597843758	NC_000017.11:31337411:T:C
NM_001042492.3(NF1):c.2868C>T (p.Thr956=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000765646	17	29556870	17	31229852	765646	771372	rs1597716290	NC_000017.11:31229851:C:T
NM_001042492.3(NF1):c.6148-5T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000765554	17	29663648	17	31336630	765554	776296	rs1597842678	NC_000017.11:31336629:T:C
NM_001042492.3(NF1):c.618G>A (p.Lys206=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000765500	17	29508471	17	31181453	765500	771348	rs1567825917	NC_000017.11:31181452:G:A
NM_001042492.3(NF1):c.6912T>G (p.Leu2304=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000765404	17	29665814	17	31338796	765404	771413	rs1597846097	NC_000017.11:31338795:T:G
NM_001042492.3(NF1):c.3870+7A>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000765358	17	29562797	17	31235779	765358	776273	rs774649948	NC_000017.11:31235778:A:G
NM_001042492.3(NF1):c.8379A>G (p.Gly2793=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV000765239	17	29701032	17	31374014	765239	771428	rs1597882952	NC_000017.11:31374013:A:G
NM_001042492.3(NF1):c.7758A>T (p.Ser2586=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000765226	17	29683997	17	31356979	765226	771419	rs876658564	NC_000017.11:31356978:A:T
NM_001042492.3(NF1):c.6643-10C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000764785	17	29664827	17	31337809	764785	776637	rs1597844527	NC_000017.11:31337808:C:T
NM_001042492.3(NF1):c.6453C>A (p.Leu2151=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 15, 2020)	criteria provided, single submitter	VCV000764780	17	29664411	17	31337393	764780	771408	rs1597843719	NC_000017.11:31337392:C:A
NM_001042492.3(NF1):c.289-7A>G	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2021)	criteria provided, conflicting interpretations	VCV000764648	17	29490197	17	31163179	764648	776440	rs751506868	NC_000017.11:31163178:A:G
NM_001042492.3(NF1):c.3885C>T (p.Thr1295=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000764475	17	29562950	17	31235932	764475	771387	rs773942090	NC_000017.11:31235931:C:T
NM_001042492.3(NF1):c.6148-9T>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000764215	17	29663644	17	31336626	764215	776635	rs1597842660	NC_000017.11:31336625:T:G
NM_001042492.3(NF1):c.6820-6T>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000763867	17	29665716	17	31338698	763867	776472	rs1597845896	NC_000017.11:31338697:T:A
NM_001042492.3(NF1):c.205-7C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000763557	17	29486021	17	31159003	763557	776435	rs1597629659	NC_000017.11:31159002:C:T
NM_001042492.3(NF1):c.2820C>T (p.Thr940=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000763552	17	29556453	17	31229435	763552	771371	rs1597715827	NC_000017.11:31229434:C:T
NM_001042492.3(NF1):c.960T>G (p.Ala320=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000763521	17	29527511	17	31200493	763521	771353	rs376447070	NC_000017.11:31200492:T:G
NM_001042492.3(NF1):c.4710G>A (p.Glu1570=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 22, 2018)	criteria provided, single submitter	VCV000763470	17	29588861	17	31261843	763470	771393	rs1597748978	NC_000017.11:31261842:G:A
NM_001042492.3(NF1):c.7380A>G (p.Ser2460=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000763237	17	29677259	17	31350241	763237	771416	rs1597859662	NC_000017.11:31350240:A:G
NM_001042492.3(NF1):c.5232C>G (p.Leu1744=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000762720	17	29653234	17	31326216	762720	771402	rs1597830268	NC_000017.11:31326215:C:G
NM_001042492.3(NF1):c.4356T>C (p.His1452=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000762652	17	29586073	17	31259055	762652	771391	rs1391955681	NC_000017.11:31259054:T:C
NM_001042492.3(NF1):c.2880T>C (p.Phe960=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000762212	17	29556882	17	31229864	762212	771373	rs1377177645	NC_000017.11:31229863:T:C
NM_001042492.3(NF1):c.1962T>C (p.Pro654=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000762196	17	29552229	17	31225211	762196	771365	rs1555613595	NC_000017.11:31225210:T:C
NM_001042492.3(NF1):c.1224T>C (p.Tyr408=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000762002	17	29528467	17	31201449	762002	771358	rs1555611089	NC_000017.11:31201448:T:C
NM_001042492.3(NF1):c.3441T>C (p.Leu1147=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV000761989	17	29559844	17	31232826	761989	771383	rs747330799	NC_000017.11:31232825:T:C
NM_001042492.3(NF1):c.825C>T (p.Ile275=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000761889	17	29509620	17	31182602	761889	771352	rs1597659985	NC_000017.11:31182601:C:T
NM_001042492.3(NF1):c.6183A>T (p.Thr2061=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000761872	17	29663688	17	31336670	761872	771406	rs1225702258	NC_000017.11:31336669:A:T
NM_001042492.3(NF1):c.2895A>C (p.Ile965=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000761809	17	29556897	17	31229879	761809	771374	rs1597716325	NC_000017.11:31229878:A:C
NM_001042492.3(NF1):c.7233A>G (p.Arg2411=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000761808	17	29676181	17	31349163	761808	771415	rs1597858430	NC_000017.11:31349162:A:G
NM_001042492.3(NF1):c.1581A>G (p.Thr527=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000761679	17	29546076	17	31219058	761679	771360	rs1060503907	NC_000017.11:31219057:A:G
NM_001042492.3(NF1):c.744G>A (p.Lys248=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000761174	17	29509539	17	31182521	761174	771350	rs1597659771	NC_000017.11:31182520:G:A
NM_001042492.3(NF1):c.5751C>G (p.Ala1917=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000760894	17	29657455	17	31330437	760894	771405	rs1597834874	NC_000017.11:31330436:C:G
NM_001042492.3(NF1):c.8114-7G>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000760827	17	29685980	17	31358962	760827	776310	rs763549780	NC_000017.11:31358961:G:A
NM_001042492.3(NF1):c.6729C>G (p.Ser2243=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000760665	17	29665067	17	31338049	760665	771411	rs1337738132	NC_000017.11:31338048:C:G
NM_001042492.3(NF1):c.1641+7G>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000760657	17	29546143	17	31219125	760657	776270	rs1060503887	NC_000017.11:31219124:G:A
NM_001042492.3(NF1):c.399A>G (p.Glu133=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000760637	17	29490314	17	31163296	760637	771346	rs1597635911	NC_000017.11:31163295:A:G
NM_001042492.3(NF1):c.8211C>G (p.Ala2737=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000760504	17	29687555	17	31360537	760504	771426	rs1597870152	NC_000017.11:31360536:C:G
NM_001042492.3(NF1):c.1185+8C>G	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2020)	criteria provided, conflicting interpretations	VCV000760479	17	29528185	17	31201167	760479	776264	rs1041153819	NC_000017.11:31201166:C:G
NM_001042492.3(NF1):c.1749G>A (p.Lys583=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000760433	17	29550489	17	31223471	760433	771361	rs1597708670	NC_000017.11:31223470:G:A
NM_001042492.3(NF1):c.1261-5T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000760375	17	29533253	17	31206235	760375	776627	rs1597688687	NC_000017.11:31206234:T:C
NM_001042492.3(NF1):c.5609+8T>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000760373	17	29654865	17	31327847	760373	776283	rs753289678	NC_000017.11:31327846:T:A
NM_001042492.3(NF1):c.3129A>G (p.Glu1043=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000760123	17	29557875	17	31230857	760123	771376	rs1597717530	NC_000017.11:31230856:A:G
NM_001042492.3(NF1):c.5812+9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV000760033	17	29657525	17	31330507	760033	776289	rs1324552702	NC_000017.11:31330506:T:C
NM_001042492.3(NF1):c.6303C>T (p.Pro2101=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000759805	17	29663808	17	31336790	759805	771407	rs1161009317	NC_000017.11:31336789:C:T
NM_001042492.3(NF1):c.3684C>T (p.Ala1228=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000759706	17	29560207	17	31233189	759706	771386	rs200276071	NC_000017.11:31233188:C:T
NM_001042492.3(NF1):c.303A>G (p.Thr101=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000759635	17	29490218	17	31163200	759635	771345	rs1597635650	NC_000017.11:31163199:A:G
NM_001042492.3(NF1):c.7980G>A (p.Leu2660=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000759605	17	29685507	17	31358489	759605	771423	rs758573977	NC_000017.11:31358488:G:A
NM_001042492.3(NF1):c.30C>G (p.Val10=)	NF1|LOC111811965		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000759525	17	29422357	17	31095339	759525	771342	rs1033348008	NC_000017.11:31095338:C:G
NM_001042492.3(NF1):c.81G>A (p.Gln27=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000759242	17	29483021	17	31156003	759242	771343	rs1597625846	NC_000017.11:31156002:G:A
NM_001042492.3(NF1):c.5046T>C (p.Cys1682=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 26, 2020)	criteria provided, single submitter	VCV000759196	17	29653048	17	31326030	759196	771399	rs1597829912	NC_000017.11:31326029:T:C
NM_001042492.3(NF1):c.3238C>T (p.Leu1080=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2018)	criteria provided, single submitter	VCV000759048	17	29559131	17	31232113	759048	771377	rs1555614832	NC_000017.11:31232112:C:T
NM_001042492.3(NF1):c.7739-5T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 15, 2020)	criteria provided, conflicting interpretations	VCV000759024	17	29683973	17	31356955	759024	776303	rs1156443249	NC_000017.11:31356954:T:C
NM_001042492.3(NF1):c.289-4T>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 30, 2019)	criteria provided, conflicting interpretations	VCV000758705	17	29490200	17	31163182	758705	776251	rs1258767746	NC_000017.11:31163181:T:G
NM_001042492.3(NF1):c.8082C>T (p.Ser2694=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000758609	17	29685609	17	31358591	758609	771424	rs1597868236	NC_000017.11:31358590:C:T
NM_001042492.3(NF1):c.2500C>T (p.Leu834=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000758606	17	29556133	17	31229115	758606	771370	rs1597715242	NC_000017.11:31229114:C:T
NM_001042492.3(NF1):c.731-8T>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000758592	17	29509518	17	31182500	758592	776262	rs1597659705	NC_000017.11:31182499:T:G
NM_001042492.3(NF1):c.1956T>G (p.Arg652=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV000758486	17	29552223	17	31225205	758486	771364	rs1429522155	NC_000017.11:31225204:T:G
NM_001042492.3(NF1):c.5812+7A>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000758306	17	29657523	17	31330505	758306	776282	rs1597835005	NC_000017.11:31330504:A:C
NM_001042492.3(NF1):c.3660A>G (p.Glu1220=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000758281	17	29560183	17	31233165	758281	771385	rs1597720161	NC_000017.11:31233164:A:G
NM_001042492.3(NF1):c.1261-7T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000758109	17	29533251	17	31206233	758109	776622	rs1597688681	NC_000017.11:31206232:T:C
NM_001042492.3(NF1):c.3366T>C (p.Asp1122=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV000758108	17	29559769	17	31232751	758108	771380	rs1597719465	NC_000017.11:31232750:T:C
NM_001042492.3(NF1):c.3390G>A (p.Arg1130=)	NF1		Neurofibromatosis, type 1|none provided|not provided	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000758061	17	29559793	17	31232775	758061	771381	rs999720392	NC_000017.11:31232774:G:A
NM_001042492.3(NF1):c.3497-8C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000757935	17	29560012	17	31232994	757935	776634	rs1339536459	NC_000017.11:31232993:C:G
NM_001042492.3(NF1):c.7512T>A (p.Leu2504=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000757708	17	29679329	17	31352311	757708	771417	rs1597862110	NC_000017.11:31352310:T:A
NM_001042492.3(NF1):c.1941T>C (p.His647=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000757319	17	29552208	17	31225190	757319	771363	rs1397958327	NC_000017.11:31225189:T:C
NM_001042492.3(NF1):c.6739A>C (p.Arg2247=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV000757317	17	29665077	17	31338059	757317	771412	rs1597845024	NC_000017.11:31338058:A:C
NM_001042492.3(NF1):c.4062C>T (p.Ser1354=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000757179	17	29576089	17	31249071	757179	771389	rs1597735169	NC_000017.11:31249070:C:T
NM_001042492.3(NF1):c.3273T>C (p.Asp1091=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV000757166	17	29559166	17	31232148	757166	771378	rs1131691124	NC_000017.11:31232147:T:C
NM_001042492.3(NF1):c.420G>A (p.Gly140=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000757049	17	29490335	17	31163317	757049	771347	rs1597635982	NC_000017.11:31163316:G:A
NM_001042492.3(NF1):c.7812C>T (p.Leu2604=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000757041	17	29684051	17	31357033	757041	771420	rs1555536702	NC_000017.11:31357032:C:T
NM_001042492.3(NF1):c.3045G>C (p.Leu1015=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000756966	17	29557332	17	31230314	756966	771375	rs926335233	NC_000017.11:31230313:G:C
NM_001042492.3(NF1):c.5145G>A (p.Leu1715=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV000756657	17	29653147	17	31326129	756657	771400	rs762436173	NC_000017.11:31326128:G:A
NM_001042492.3(NF1):c.480-4T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000756598	17	29496905	17	31169887	756598	776259	rs1597643710	NC_000017.11:31169886:T:C
NM_001042492.3(NF1):c.4430+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000756514	17	29586157	17	31259139	756514	776279	rs1597745779	NC_000017.11:31259138:T:C
NM_001042492.3(NF1):c.5317C>T (p.Leu1773=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000756407	17	29654565	17	31327547	756407	771404	rs1597831909	NC_000017.11:31327546:C:T
NM_001042492.3(NF1):c.3483C>A (p.Leu1161=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000756396	17	29559886	17	31232868	756396	771384	rs1597719677	NC_000017.11:31232867:C:A
NM_001042492.3(NF1):c.8113+10T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000756018	17	29685650	17	31358632	756018	776306	rs1336997870	NC_000017.11:31358631:T:C
NM_001042492.3(NF1):c.3900C>T (p.Leu1300=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000755943	17	29562965	17	31235947	755943	771388	rs1597722945	NC_000017.11:31235946:C:T
NM_001042492.3(NF1):c.7869+9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV000755771	17	29684117	17	31357099	755771	776646	rs940367528	NC_000017.11:31357098:T:C
NM_001042492.3(NF1):c.1098A>G (p.Arg366=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000755663	17	29528090	17	31201072	755663	771356	rs1597681964	NC_000017.11:31201071:A:G
NM_001042492.3(NF1):c.5813-9T>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000755653	17	29661847	17	31334829	755653	776466	rs778521387	NC_000017.11:31334828:T:G
NM_001042492.3(NF1):c.5028A>G (p.Ala1676=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000755622	17	29653030	17	31326012	755622	771398	rs778817599	NC_000017.11:31326011:A:G
NM_001042492.3(NF1):c.4950T>C (p.Pro1650=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000754945	17	29652952	17	31325934	754945	771396	rs1396903872	NC_000017.11:31325933:T:C
NM_001042492.3(NF1):c.822T>C (p.Leu274=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000754866	17	29509617	17	31182599	754866	771351	rs1597659964	NC_000017.11:31182598:T:C
NM_001042492.3(NF1):c.2251+9G>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000754468	17	29553711	17	31226693	754468	776275	rs772014402	NC_000017.11:31226692:G:C
NM_001042492.3(NF1):c.5269-4C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV000754408	17	29654513	17	31327495	754408	776452	rs1555533547	NC_000017.11:31327494:C:T
NM_001042492.3(NF1):c.7608G>A (p.Lys2536=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000754362	17	29679425	17	31352407	754362	771418	rs1597862283	NC_000017.11:31352406:G:A
NM_001042492.3(NF1):c.645C>T (p.Ser215=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV000754349	17	29508498	17	31181480	754349	771349	rs746163138	NC_000017.11:31181479:C:T
NM_001042492.3(NF1):c.150G>A (p.Lys50=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000754118	17	29483090	17	31156072	754118	771344	rs1597626037	NC_000017.11:31156071:G:A
NM_001042492.3(NF1):c.7872T>A (p.Ala2624=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV000753467	17	29684289	17	31357271	753467	771421	rs1399938334	NC_000017.11:31357270:T:A
NM_001042492.3(NF1):c.1893A>C (p.Gly631=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000753432	17	29552160	17	31225142	753432	771362	rs1597710471	NC_000017.11:31225141:A:C
NM_001042492.3(NF1):c.2211A>G (p.Thr737=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000753154	17	29553662	17	31226644	753154	771369	rs1178560430	NC_000017.11:31226643:A:G
NM_001042492.3(NF1):c.5154C>T (p.His1718=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000753096	17	29653156	17	31326138	753096	771401	rs1597830130	NC_000017.11:31326137:C:T
NM_001042492.3(NF1):c.6704+8C>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000753073	17	29664906	17	31337888	753073	776294	rs770797478	NC_000017.11:31337887:C:A
NM_001042492.3(NF1):c.2850+8G>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000752973	17	29556491	17	31229473	752973	776266	rs780608020	NC_000017.11:31229472:G:A
NM_001042492.3(NF1):c.5292A>G (p.Val1764=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000752972	17	29654540	17	31327522	752972	771403	rs1597831870	NC_000017.11:31327521:A:G
NM_001042492.3(NF1):c.4980T>G (p.Ser1660=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000752831	17	29652982	17	31325964	752831	771397	rs1597829786	NC_000017.11:31325963:T:G
NM_001042492.3(NF1):c.4891T>C (p.Leu1631=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000752621	17	29652893	17	31325875	752621	771395	rs1455791933	NC_000017.11:31325874:T:C
NM_001042492.3(NF1):c.480-6T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000752405	17	29496903	17	31169885	752405	776253	rs1597643699	NC_000017.11:31169884:T:C
NM_001042492.3(NF1):c.1185+7G>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000752399	17	29528184	17	31201166	752399	776620	rs1322791959	NC_000017.11:31201165:G:T
NM_001042492.3(NF1):c.8175A>G (p.Pro2725=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV000751964	17	29687519	17	31360501	751964	771425	rs1597870102	NC_000017.11:31360500:A:G
NM_001042492.3(NF1):c.1095A>T (p.Ser365=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000751629	17	29528087	17	31201069	751629	771355	rs150814769	NC_000017.11:31201068:A:T
NM_001042492.3(NF1):c.7190-6T>C	NF1		Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2020)	criteria provided, conflicting interpretations	VCV000751423	17	29676132	17	31349114	751423	776643	rs1597858313	NC_000017.11:31349113:T:C
NM_001042492.3(NF1):c.7128T>C (p.His2376=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000751419	17	29670092	17	31343074	751419	771414	rs1597851346	NC_000017.11:31343073:T:C
NM_001042492.3(NF1):c.4845T>C (p.Thr1615=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000751191	17	29652847	17	31325829	751191	771394	rs753606794	NC_000017.11:31325828:T:C
NM_001042492.3(NF1):c.888+8G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000751146	17	29509691	17	31182673	751146	776617	rs772234682	NC_000017.11:31182672:G:A
NM_001042492.3(NF1):c.2007T>C (p.Ser669=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV000751091	17	29553458	17	31226440	751091	771366	rs750622783	NC_000017.11:31226439:T:C
NM_001042492.3(NF1):c.3423G>C (p.Leu1141=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000750926	17	29559826	17	31232808	750926	771382	rs748691653	NC_000017.11:31232807:G:C
NM_001042492.3(NF1):c.3871-10A>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000750643	17	29562926	17	31235908	750643	760530	rs1597722878	NC_000017.11:31235907:A:G
NM_001042492.3(NF1):c.2977T>C (p.Leu993=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000750506	17	29556979	17	31229961	750506	755748	rs1597716461	NC_000017.11:31229960:T:C
NM_001042492.3(NF1):c.435C>G (p.Leu145=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000750213	17	29490350	17	31163332	750213	755741	rs876659818	NC_000017.11:31163331:C:G
NM_001042492.3(NF1):c.4338T>G (p.Leu1446=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000749766	17	29586055	17	31259037	749766	755749	rs1597745572	NC_000017.11:31259036:T:G
NM_001042492.3(NF1):c.4569C>G (p.Ser1523=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000749135	17	29587525	17	31260507	749135	755751	rs1597747154	NC_000017.11:31260506:C:G
NM_001042492.3(NF1):c.1846-10T>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000749096	17	29552103	17	31225085	749096	760526	rs1597710285	NC_000017.11:31225084:T:G
NM_001042492.3(NF1):c.7878G>A (p.Leu2626=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000748768	17	29684295	17	31357277	748768	755762	rs1022364851	NC_000017.11:31357276:G:A
NM_001042492.3(NF1):c.2745C>A (p.Thr915=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	VCV000748528	17	29556378	17	31229360	748528	755746	rs759465116	NC_000017.11:31229359:C:A
NM_001042492.3(NF1):c.1185+9A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000748168	17	29528186	17	31201168	748168	760399	rs776421322	NC_000017.11:31201167:A:T
NM_001042492.3(NF1):c.717G>A (p.Gln239=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 25, 2020)	criteria provided, single submitter	VCV000747937	17	29508790	17	31181772	747937	755742	rs1597658684	NC_000017.11:31181771:G:A
NM_001042492.3(NF1):c.2799A>G (p.Leu933=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000745528	17	29556432	17	31229414	745528	755747	rs1597715783	NC_000017.11:31229413:A:G
NM_001042492.3(NF1):c.4512G>T (p.Val1504=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000745517	17	29587468	17	31260450	745517	755750	rs1597747038	NC_000017.11:31260449:G:T
NM_001042492.3(NF1):c.234T>C (p.Asn78=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000745514	17	29486057	17	31159039	745514	755740	rs876658354	NC_000017.11:31159038:T:C
NM_001042492.3(NF1):c.6891A>G (p.Ala2297=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000745506	17	29665793	17	31338775	745506	755759	rs776626153	NC_000017.11:31338774:A:G
NM_001042492.3(NF1):c.1257C>G (p.Thr419=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000745441	17	29528500	17	31201482	745441	755744	rs774269651	NC_000017.11:31201481:C:G
NM_001042492.3(NF1):c.7560A>G (p.Lys2520=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV000745275	17	29679377	17	31352359	745275	755760	rs1597862203	NC_000017.11:31352358:A:G
NM_001042492.3(NF1):c.6750T>A (p.Val2250=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV000744808	17	29665088	17	31338070	744808	755758	rs762075320	NC_000017.11:31338069:T:A
NM_001042492.3(NF1):c.730+10C>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000744476	17	29508813	17	31181795	744476	760522	rs750468471	NC_000017.11:31181794:C:A
NM_001042492.3(NF1):c.7899G>A (p.Glu2633=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000744397	17	29684316	17	31357298	744397	755763	rs1597866857	NC_000017.11:31357297:G:A
NM_001042492.3(NF1):c.3315-5C>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 28, 2020)	criteria provided, conflicting interpretations	VCV000743890	17	29559713	17	31232695	743890	760528	rs1266211447	NC_000017.11:31232694:C:T
NM_001042492.3(NF1):c.6567T>C (p.Pro2189=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000743854	17	29664525	17	31337507	743854	755757	rs1597843915	NC_000017.11:31337506:T:C
NM_001042492.3(NF1):c.8283T>G (p.Pro2761=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000743830	17	29687627	17	31360609	743830	755766	rs1597870236	NC_000017.11:31360608:T:G
NM_001042492.3(NF1):c.8196T>G (p.Val2732=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000743829	17	29687540	17	31360522	743829	755765	rs1597870128	NC_000017.11:31360521:T:G
NM_001042492.3(NF1):c.6642+7A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000743774	17	29664607	17	31337589	743774	760535	rs1597844162	NC_000017.11:31337588:A:G
NM_001042492.3(NF1):c.1689T>C (p.Pro563=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000743725	17	29548915	17	31221897	743725	755745	rs1445925500	NC_000017.11:31221896:T:C
NM_001042492.3(NF1):c.879C>T (p.Asn293=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000743429	17	29509674	17	31182656	743429	755743	rs1597660105	NC_000017.11:31182655:C:T
NM_001042492.3(NF1):c.8114-9T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000743247	17	29685978	17	31358960	743247	760558	rs1597868711	NC_000017.11:31358959:T:C
NM_001042492.3(NF1):c.7321+9A>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000743155	17	29676278	17	31349260	743155	760577	rs779562583	NC_000017.11:31349259:A:G
NM_001042492.3(NF1):c.6428-7C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000743088	17	29664379	17	31337361	743088	760553	rs1597843613	NC_000017.11:31337360:C:G
NM_001042492.3(NF1):c.4905T>C (p.Tyr1635=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000742830	17	29652907	17	31325889	742830	755754	rs948982039	NC_000017.11:31325888:T:C
NM_001042492.3(NF1):c.7616-5T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000742671	17	29683473	17	31356455	742671	760539	rs1597865732	NC_000017.11:31356454:T:C
NM_001042492.3(NF1):c.5190C>T (p.Thr1730=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000741740	17	29653192	17	31326174	741740	755756	rs143230984	NC_000017.11:31326173:C:T
NM_001042492.3(NF1):c.7599C>T (p.Asn2533=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV000741717	17	29679416	17	31352398	741717	755761	rs1597862269	NC_000017.11:31352397:C:T
NM_001042492.3(NF1):c.5022C>T (p.Val1674=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000739772	17	29653024	17	31326006	739772	755755	rs1597829853	NC_000017.11:31326005:C:T
NM_001042492.3(NF1):c.7071G>A (p.Glu2357=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000733046	17	29670035	17	31343017	733046	740679	rs1368077280	NC_000017.11:31343016:G:A
NM_001042492.3(NF1):c.3315-10T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000732832	17	29559708	17	31232690	732832	744957	rs759279011	NC_000017.11:31232689:T:C
NM_001042492.3(NF1):c.3113+9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000730810	17	29557409	17	31230391	730810	744952	rs1181782378	NC_000017.11:31230390:T:C
NM_001042492.3(NF1):c.7911A>T (p.Arg2637=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000729422	17	29684328	17	31357310	729422	740680	rs1597866885	NC_000017.11:31357309:A:T
NM_001042492.3(NF1):c.1257C>A (p.Thr419=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000728399	17	29528500	17	31201482	728399	740675	rs774269651	NC_000017.11:31201481:C:A
NM_001042492.3(NF1):c.4899A>T (p.Pro1633=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000725814	17	29652901	17	31325883	725814	740677	rs876658422	NC_000017.11:31325882:A:T
NM_001042492.3(NF1):c.1623T>A (p.Ile541=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000725207	17	29546118	17	31219100	725207	740676	rs1597703569	NC_000017.11:31219099:T:A
NM_001042492.3(NF1):c.8106C>T (p.Tyr2702=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000724937	17	29685633	17	31358615	724937	740681	rs754271057	NC_000017.11:31358614:C:T
NM_001042492.3(NF1):c.6942C>T (p.Ala2314=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV000722516	17	29667543	17	31340525	722516	740678	rs1597847931	NC_000017.11:31340524:C:T
NM_001042492.3(NF1):c.7953C>T (p.Pro2651=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV000719565	17	29684370	17	31357352	719565	727098	rs779167139	NC_000017.11:31357351:C:T
NM_001042492.3(NF1):c.8151G>C (p.Pro2717=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 13, 2017)	criteria provided, single submitter	VCV000717796	17	29686024	17	31359006	717796	727099	rs2285895	NC_000017.11:31359005:G:C
NM_001042492.3(NF1):c.5073G>A (p.Lys1691=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000715140	17	29653075	17	31326057	715140	727096	rs1597829953	NC_000017.11:31326056:G:A
NM_001042492.3(NF1):c.3285G>A (p.Leu1095=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000707737	17	29559178	17	31232160	707737	694070	rs774759676	NC_000017.11:31232159:G:A
NM_001042492.3(NF1):c.7959C>T (p.Val2653=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000707372	17	29684376	17	31357358	707372	694076	rs1555536767	NC_000017.11:31357357:C:T
NM_001042492.3(NF1):c.5427G>A (p.Pro1809=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000707105	17	29654675	17	31327657	707105	694071	rs1281695642	NC_000017.11:31327656:G:A
NM_001042492.3(NF1):c.6183A>G (p.Thr2061=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000706834	17	29663688	17	31336670	706834	694072	rs1225702258	NC_000017.11:31336669:A:G
NM_001042492.3(NF1):c.3180T>C (p.Asp1060=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000706508	17	29557926	17	31230908	706508	694069	rs1555614646	NC_000017.11:31230907:T:C
NM_001042492.3(NF1):c.414C>G (p.Ala138=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000706225	17	29490329	17	31163311	706225	694064	rs1597635949	NC_000017.11:31163310:C:G
NM_001042492.3(NF1):c.3709-5C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000706185	17	29562624	17	31235606	706185	695737	rs1390680821	NC_000017.11:31235605:C:T
NM_001042492.3(NF1):c.8445C>T (p.His2815=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000705923	17	29701098	17	31374080	705923	694079	rs1597883082	NC_000017.11:31374079:C:T
NM_001042492.3(NF1):c.2364A>G (p.Thr788=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV000705570	17	29554579	17	31227561	705570	694068	rs1240233000	NC_000017.11:31227560:A:G
NM_001042492.3(NF1):c.1290T>C (p.Asp430=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000705533	17	29533287	17	31206269	705533	694065	rs766688203	NC_000017.11:31206268:T:C
NM_001042492.3(NF1):c.7995C>T (p.Ile2665=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000705070	17	29685522	17	31358504	705070	694077	rs1037082087	NC_000017.11:31358503:C:T
NM_001042492.3(NF1):c.5610-7C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV000704426	17	29657307	17	31330289	704426	695740	rs553657123	NC_000017.11:31330288:C:T
NM_001042492.3(NF1):c.1578T>A (p.Ile526=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000704311	17	29546073	17	31219055	704311	694066	rs1597703458	NC_000017.11:31219054:T:A
NM_001042492.3(NF1):c.5269-6T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 5, 2018)	criteria provided, single submitter	VCV000704237	17	29654511	17	31327493	704237	695739	rs1597831812	NC_000017.11:31327492:T:C
NM_001042492.3(NF1):c.147C>T (p.Tyr49=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000704219	17	29483087	17	31156069	704219	694063	rs1597626026	NC_000017.11:31156068:C:T
NM_001042492.3(NF1):c.8100A>G (p.Thr2700=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000704097	17	29685627	17	31358609	704097	694078	rs1597868278	NC_000017.11:31358608:A:G
NM_001042492.3(NF1):c.6438G>A (p.Lys2146=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000703978	17	29664396	17	31337378	703978	694073	rs1172220920	NC_000017.11:31337377:G:A
NM_001042492.3(NF1):c.7461A>T (p.Thr2487=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703681	17	29679278	17	31352260	703681	694075	rs149924365	NC_000017.11:31352259:A:T
NM_001042492.3(NF1):c.2002-8A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000703625	17	29553445	17	31226427	703625	695733	rs1318674321	NC_000017.11:31226426:A:T
NM_001042492.3(NF1):c.3496+8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV000703603	17	29559907	17	31232889	703603	695736	rs754087844	NC_000017.11:31232888:C:T
NM_001042492.3(NF1):c.3114-4A>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000703390	17	29557856	17	31230838	703390	695734	rs201550230	NC_000017.11:31230837:A:C
NM_001042492.3(NF1):c.6465G>A (p.Glu2155=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000702905	17	29664423	17	31337405	702905	694074	rs1394945517	NC_000017.11:31337404:G:A
NM_001042492.3(NF1):c.5328A>G (p.Ser1776=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000701899	17	29654576	17	31327558	701899	688759	rs759639187	NC_000017.11:31327557:A:G
NM_001042492.3(NF1):c.7870-10A>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000701431	17	29684277	17	31357259	701431	690174	rs1597866772	NC_000017.11:31357258:A:G
NM_001042492.3(NF1):c.2589T>C (p.Tyr863=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000700428	17	29556222	17	31229204	700428	688758	rs587782814	NC_000017.11:31229203:T:C
NM_001042492.3(NF1):c.6207A>G (p.Leu2069=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV000699713	17	29663712	17	31336694	699713	688760	rs1597842793	NC_000017.11:31336693:A:G
NM_001042492.3(NF1):c.1186-7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 19, 2020)	criteria provided, single submitter	VCV000699539	17	29528422	17	31201404	699539	690171	rs1597682676	NC_000017.11:31201403:T:C
NM_001042492.3(NF1):c.8206G>A (p.Asp2736Asn)	NF1	D2715N, D2736N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000699036	17	29687550	17	31360532	699036	688761	rs1597870148	NC_000017.11:31360531:G:A
NM_001042492.3(NF1):c.7615+7T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000698959	17	29679439	17	31352421	698959	690173	rs779078444	NC_000017.11:31352420:T:C
NM_001042492.3(NF1):c.7827A>G (p.Val2609=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000696535	17	29684066	17	31357048	696535	684670	rs1597866497	NC_000017.11:31357047:A:G
NM_001042492.3(NF1):c.4331A>T (p.Lys1444Met)	NF1	K1423M, K1444M	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2019)	criteria provided, conflicting interpretations	VCV000694609	17	29585519	17	31258501	694609	682682	rs199474781	NC_000017.11:31258500:A:T
NM_001042492.3(NF1):c.3827G>T (p.Arg1276Leu)	NF1	R1276L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000694608	17	29562747	17	31235729	694608	682681	rs137854556	NC_000017.11:31235728:G:T
NM_001042492.3(NF1):c.2536G>C (p.Ala846Pro)	NF1	A846P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694607	17	29556169	17	31229151	694607	682680	rs1555614226	NC_000017.11:31229150:G:C
NM_001042492.3(NF1):c.2531T>A (p.Leu844His)	NF1	L844H	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000694605	17	29556164	17	31229146	694605	682679	rs137854566	NC_000017.11:31229145:T:A
NM_001042492.3(NF1):c.3579T>G (p.Phe1193Leu)	NF1	F1193L	Neurofibromatosis, type 1	Pathogenic	criteria provided, single submitter	VCV000694510	17	29560102	17	31233084	694510	682497		NC_000017.11:31233083:T:G
NM_001042492.3(NF1):c.2521A>C (p.Thr841Pro)	NF1	T841P	Neurofibromatosis, type 1	Likely pathogenic	criteria provided, single submitter	VCV000694508	17	29556154	17	31229136	694508	682495		NC_000017.11:31229135:A:C
NM_001042492.3(NF1):c.1A>C (p.Met1Leu)	NF1|LOC111811965	M1L	Neurofibromatosis, type 1	Likely pathogenic	criteria provided, single submitter	VCV000694505	17	29422328	17	31095310	694505	682492		NC_000017.11:31095309:A:C
NM_001042492.3(NF1):c.7186A>T (p.Lys2396Ter)	NF1	K2375*, K2396*	Neurofibromatosis, type 1|Ewing sarcoma	Pathogenic(Last reviewed: Sep 4, 2018)	no assertion criteria provided	VCV000690368	17	29670150	17	31343132	690368	678053	rs1597851489	NC_000017.11:31343131:A:T
NM_001042492.3(NF1):c.590C>G (p.Thr197Arg)	NF1	T197R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000666568	17	29508443	17	31181425	666568	654140	rs1597658021	NC_000017.11:31181424:C:G
NM_001042492.3(NF1):c.97A>T (p.Lys33Ter)	NF1	K33*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000666183	17	29483037	17	31156019	666183	645439	rs1060500324	NC_000017.11:31156018:A:T
NM_001042492.3(NF1):c.1756A>G (p.Thr586Ala)	NF1	T586A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000666086	17	29550496	17	31223478	666086	645513	rs876659242	NC_000017.11:31223477:A:G
NM_001042492.3(NF1):c.586+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000665960	17	29497019	17	31170001	665960	653391	rs1597644028	NC_000017.11:31170000:A:G
NM_001042492.3(NF1):c.3158C>G (p.Ser1053Ter)	NF1	S1053*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000665851	17	29557904	17	31230886	665851	645576	rs1597717610	NC_000017.11:31230885:C:G
NM_001042492.3(NF1):c.2342A>G (p.His781Arg)	NF1	H781R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000665791	17	29554557	17	31227539	665791	645542	rs199474763	NC_000017.11:31227538:A:G
NM_001042492.3(NF1):c.4529T>C (p.Leu1510Pro)	NF1	L1489P, L1510P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000665580	17	29587485	17	31260467	665580	645637	rs1597747078	NC_000017.11:31260466:T:C
NM_001042492.3(NF1):c.3223G>T (p.Ala1075Ser)	NF1	A1075S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000665518	17	29559116	17	31232098	665518	645582	rs1597718763	NC_000017.11:31232097:G:T
NM_001042492.3(NF1):c.2375T>A (p.Leu792His)	NF1	L792H	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000665425	17	29554590	17	31227572	665425	645543	rs1597713777	NC_000017.11:31227571:T:A
NM_001042492.3(NF1):c.3149T>A (p.Met1050Lys)	NF1	M1050K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000665339	17	29557895	17	31230877	665339	645574	rs1597717585	NC_000017.11:31230876:T:A
NM_001042492.3(NF1):c.3368A>G (p.Glu1123Gly)	NF1	E1123G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000665327	17	29559771	17	31232753	665327	645585	rs1410465727	NC_000017.11:31232752:A:G
NM_001042492.3(NF1):c.4085G>T (p.Arg1362Leu)	NF1	R1362L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000665110	17	29576112	17	31249094	665110	645617	rs540108477	NC_000017.11:31249093:G:T
NM_001042492.3(NF1):c.2851-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000665079	17	29556852	17	31229834	665079	653237	rs1597716274	NC_000017.11:31229833:G:A
NM_001042492.3(NF1):c.6076A>G (p.Ile2026Val)	NF1	I2026V, I2005V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV000665076	17	29663420	17	31336402	665076	645696	rs1376868609	NC_000017.11:31336401:A:G
NM_001042492.3(NF1):c.3053T>A (p.Leu1018Ter)	NF1	L1018*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000664969	17	29557340	17	31230322	664969	645569	rs1597716924	NC_000017.11:31230321:T:A
NM_001042492.3(NF1):c.6439C>T (p.Gln2147Ter)	NF1	Q2147*, Q2126*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000664810	17	29664397	17	31337379	664810	645707	rs1555534859	NC_000017.11:31337378:C:T
NM_001042492.3(NF1):c.7831A>G (p.Thr2611Ala)	NF1	T2611A, T2590A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000664602	17	29684070	17	31357052	664602	645761	rs759424718	NC_000017.11:31357051:A:G
NM_001042492.3(NF1):c.888+789A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000664551	17	29510472	17	31183454	664551	652913	rs1597660974	NC_000017.11:31183453:A:G
NM_001042492.3(NF1):c.706C>G (p.Gln236Glu)	NF1	Q236E	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000664248	17	29508779	17	31181761	664248	645469	rs1597658664	NC_000017.11:31181760:C:G
NM_001042492.3(NF1):c.808C>T (p.Gln270Ter)	NF1	Q270*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000664218	17	29509603	17	31182585	664218	645476	rs1555608970	NC_000017.11:31182584:C:T
NM_001042492.3(NF1):c.4244A>G (p.Asn1415Ser)	NF1	N1394S, N1415S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000663890	17	29585432	17	31258414	663890	645622	rs1406169018	NC_000017.11:31258413:A:G
NM_001042492.3(NF1):c.5668G>T (p.Gly1890Cys)	NF1	G1869C, G1890C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000663647	17	29657372	17	31330354	663647	645683	rs1597834706	NC_000017.11:31330353:G:T
NM_001042492.3(NF1):c.7177C>T (p.His2393Tyr)	NF1	H2393Y, H2372Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000663626	17	29670141	17	31343123	663626	645735	rs1597851468	NC_000017.11:31343122:C:T
NM_001042492.3(NF1):c.4332+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000663586	17	29585521	17	31258503	663586	652754	rs1555618572	NC_000017.11:31258502:G:T
NM_001042492.3(NF1):c.4333-2A>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000663523	17	29586048	17	31259030	663523	652928	rs1555618634	NC_000017.11:31259029:A:C
NM_001042492.3(NF1):c.7199A>G (p.His2400Arg)	NF1	H2379R, H2400R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000663441	17	29676147	17	31349129	663441	645736	rs1597858362	NC_000017.11:31349128:A:G
NM_001042492.3(NF1):c.1340T>C (p.Leu447Pro)	NF1	L447P	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000663394	17	29533337	17	31206319	663394	645501	rs1597688896	NC_000017.11:31206318:T:C
NM_001042492.3(NF1):c.5842T>C (p.Tyr1948His)	NF1	Y1927H, Y1948H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000663229	17	29661885	17	31334867	663229	645690	rs1057520575	NC_000017.11:31334866:T:C
NM_001042492.3(NF1):c.60+1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000663201	17	29422388	17	31095370	663201	652903	rs1555594500	NC_000017.11:31095369:G:C
NM_001042492.3(NF1):c.3530C>T (p.Ala1177Val)	NF1	A1177V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000662684	17	29560053	17	31233035	662684	645595	rs1597719920	NC_000017.11:31233034:C:T
NM_001042492.3(NF1):c.3849A>T (p.Lys1283Asn)	NF1	K1283N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000662638	17	29562769	17	31235751	662638	645609	rs1597722644	NC_000017.11:31235750:A:T
NM_001042492.3(NF1):c.972T>A (p.Cys324Ter)	NF1	C324*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000662589	17	29527523	17	31200505	662589	645484	rs1597680938	NC_000017.11:31200504:T:A
NM_001042492.3(NF1):c.5815A>G (p.Ile1939Val)	NF1	I1939V, I1918V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV000662344	17	29661858	17	31334840	662344	645689	rs1173859882	NC_000017.11:31334839:A:G
NM_001042492.3(NF1):c.1871T>C (p.Phe624Ser)	NF1	F624S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000662272	17	29552138	17	31225120	662272	645521	rs1597710397	NC_000017.11:31225119:T:C
NM_001042492.3(NF1):c.3614T>G (p.Phe1205Cys)	NF1	F1205C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000662269	17	29560137	17	31233119	662269	645599	rs1597720068	NC_000017.11:31233118:T:G
NM_001042492.3(NF1):c.1238C>A (p.Ser413Ter)	NF1	S413*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000662203	17	29528481	17	31201463	662203	645497	rs1241533665	NC_000017.11:31201462:C:A
NM_001042492.3(NF1):c.1642-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000661992	17	29548866	17	31221848	661992	652722	rs1597706620	NC_000017.11:31221847:A:T
NM_001042492.3(NF1):c.3974+1G>A	NF1		not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000661977	17	29563040	17	31236022	661977	653248	rs1567852849	NC_000017.11:31236021:G:A
NM_001042492.3(NF1):c.599A>T (p.Lys200Ile)	NF1	K200I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000661939	17	29508452	17	31181434	661939	645464	rs1597658055	NC_000017.11:31181433:A:T
NM_001042492.3(NF1):c.6716A>T (p.Gln2239Leu)	NF1	Q2218L, Q2239L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000661786	17	29665054	17	31338036	661786	645717	rs1597844989	NC_000017.11:31338035:A:T
NM_001042492.3(NF1):c.6643-3T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000661717	17	29664834	17	31337816	661717	652767	rs1326745383	NC_000017.11:31337815:T:A
NM_001042492.3(NF1):c.593C>T (p.Ala198Val)	NF1	A198V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000661602	17	29508446	17	31181428	661602	645463	rs863224663	NC_000017.11:31181427:C:T
NM_001042492.3(NF1):c.5606T>G (p.Leu1869Ter)	NF1	L1848*, L1869*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000661533	17	29654854	17	31327836	661533	645679	rs1597832482	NC_000017.11:31327835:T:G
NM_001042492.3(NF1):c.2101G>A (p.Glu701Lys)	NF1	E701K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000661244	17	29553552	17	31226534	661244	645529	rs1597712510	NC_000017.11:31226533:G:A
NM_001042492.3(NF1):c.3464C>G (p.Ala1155Gly)	NF1	A1155G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000661116	17	29559867	17	31232849	661116	645593	rs1597719654	NC_000017.11:31232848:C:G
NM_001042492.3(NF1):c.1118T>C (p.Val373Ala)	NF1	V373A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000661072	17	29528110	17	31201092	661072	645493	rs1597682016	NC_000017.11:31201091:T:C
NM_001042492.3(NF1):c.6434C>T (p.Thr2145Ile)	NF1	T2124I, T2145I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000660949	17	29664392	17	31337374	660949	645705	rs1597843658	NC_000017.11:31337373:C:T
NM_001042492.3(NF1):c.4264T>C (p.Tyr1422His)	NF1	Y1401H, Y1422H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV000660933	17	29585452	17	31258434	660933	645623	rs17884349	NC_000017.11:31258433:T:C
NM_001042492.3(NF1):c.4847G>A (p.Gly1616Asp)	NF1	G1616D, G1595D	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660894	17	29652849	17	31325831	660894	645647	rs1597829516	NC_000017.11:31325830:G:A
NM_001042492.3(NF1):c.518A>T (p.Asp173Val)	NF1	D173V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000660881	17	29496947	17	31169929	660881	645459	rs1597643820	NC_000017.11:31169928:A:T
NM_001042492.3(NF1):c.5140A>G (p.Lys1714Glu)	NF1	K1693E, K1714E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000660851	17	29653142	17	31326124	660851	645661	rs1597830089	NC_000017.11:31326123:A:G
NM_001042492.3(NF1):c.6374T>C (p.Leu2125Pro)	NF1	L2104P, L2125P	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660822	17	29663879	17	31336861	660822	645704	rs1597843129	NC_000017.11:31336860:T:C
NM_001042492.3(NF1):c.3446T>C (p.Met1149Thr)	NF1	M1149T	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2019)	criteria provided, conflicting interpretations	VCV000660819	17	29559849	17	31232831	660819	645589	rs1131691121	NC_000017.11:31232830:T:C
NM_001042492.3(NF1):c.3721C>G (p.Arg1241Gly)	NF1	R1241G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000660755	17	29562641	17	31235623	660755	645602	rs137854562	NC_000017.11:31235622:C:G
NM_001042492.3(NF1):c.4478A>G (p.Asn1493Ser)	NF1	N1493S, N1472S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000660382	17	29587434	17	31260416	660382	645633	rs1597746976	NC_000017.11:31260415:A:G
NM_001042492.3(NF1):c.3215G>A (p.Ser1072Asn)	NF1	S1072N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000660292	17	29559108	17	31232090	660292	645581	rs1597718741	NC_000017.11:31232089:G:A
NM_001042492.3(NF1):c.1062+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000660278	17	29527614	17	31200596	660278	652918	rs1597681200	NC_000017.11:31200595:G:A
NM_001042492.3(NF1):c.2275G>T (p.Val759Leu)	NF1	V759L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000659900	17	29554259	17	31227241	659900	645537	rs978948341	NC_000017.11:31227240:G:T
NM_001042492.3(NF1):c.2850+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000659863	17	29556485	17	31229467	659863	653235	rs1597715880	NC_000017.11:31229466:T:G
NM_001042492.3(NF1):c.2932G>T (p.Gly978Cys)	NF1	G978C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000659862	17	29556934	17	31229916	659862	645559	rs1597716367	NC_000017.11:31229915:G:T
NM_001042492.3(NF1):c.7700C>A (p.Pro2567His)	NF1	P2567H, P2546H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000659616	17	29683562	17	31356544	659616	645756	rs754511534	NC_000017.11:31356543:C:A
NM_001042492.3(NF1):c.1826A>G (p.Lys609Arg)	NF1	K609R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000659559	17	29550566	17	31223548	659559	645517	rs1597708810	NC_000017.11:31223547:A:G
NM_001042492.3(NF1):c.7919A>G (p.Tyr2640Cys)	NF1	Y2640C, Y2619C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000659509	17	29684336	17	31357318	659509	645768	rs1597866901	NC_000017.11:31357317:A:G
NM_001042492.3(NF1):c.3054A>C (p.Leu1018Phe)	NF1	L1018F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000659441	17	29557341	17	31230323	659441	645570	rs1237938582	NC_000017.11:31230322:A:C
NM_001042492.3(NF1):c.5458A>G (p.Ile1820Val)	NF1	I1799V, I1820V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000659283	17	29654706	17	31327688	659283	645668	rs786202459	NC_000017.11:31327687:A:G
NM_001042492.3(NF1):c.2702T>G (p.Leu901Ter)	NF1	L901*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000659214	17	29556335	17	31229317	659214	645551	rs1597715649	NC_000017.11:31229316:T:G
NM_001042492.3(NF1):c.974T>G (p.Val325Gly)	NF1	V325G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000659113	17	29527525	17	31200507	659113	645485	rs1422095982	NC_000017.11:31200506:T:G
NM_001042492.3(NF1):c.809A>G (p.Gln270Arg)	NF1	Q270R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000659075	17	29509604	17	31182586	659075	645477	rs1597659939	NC_000017.11:31182585:A:G
NM_001042492.3(NF1):c.7223G>A (p.Arg2408Lys)	NF1	R2408K, R2387K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000658849	17	29676171	17	31349153	658849	645737	rs1597858407	NC_000017.11:31349152:G:A
NM_001042492.3(NF1):c.7907A>C (p.Gln2636Pro)	NF1	Q2615P, Q2636P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000658821	17	29684324	17	31357306	658821	645765	rs1597866867	NC_000017.11:31357305:A:C
NM_001042492.3(NF1):c.8002C>G (p.Leu2668Val)	NF1	L2647V, L2668V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000658806	17	29685529	17	31358511	658806	645776	rs1060503905	NC_000017.11:31358510:C:G
NM_001042492.3(NF1):c.5102A>T (p.Lys1701Ile)	NF1	K1701I, K1680I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000658675	17	29653104	17	31326086	658675	645658	rs1597830021	NC_000017.11:31326085:A:T
NM_001042492.3(NF1):c.5588G>A (p.Gly1863Asp)	NF1	G1863D, G1842D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000658564	17	29654836	17	31327818	658564	645678	rs1597832460	NC_000017.11:31327817:G:A
NM_001042492.3(NF1):c.3104T>A (p.Met1035Lys)	NF1	M1035K	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000658527	17	29557391	17	31230373	658527	645573	rs137854553	NC_000017.11:31230372:T:A
NM_001042492.3(NF1):c.549C>G (p.Ile183Met)	NF1	I183M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000658522	17	29496978	17	31169960	658522	645461	rs1597643884	NC_000017.11:31169959:C:G
NM_001042492.3(NF1):c.715C>T (p.Gln239Ter)	NF1	Q239*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000658113	17	29508788	17	31181770	658113	645471	rs1597658676	NC_000017.11:31181769:C:T
NM_001042492.3(NF1):c.2001G>A (p.Met667Ile)	NF1	M667I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 8, 2018)	criteria provided, single submitter	VCV000657759	17	29552268	17	31225250	657759	645527	rs1597710853	NC_000017.11:31225249:G:A
NM_001042492.3(NF1):c.3315-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000657669	17	29559717	17	31232699	657669	653242	rs1567850984	NC_000017.11:31232698:G:A
NM_001042492.3(NF1):c.1886G>T (p.Gly629Val)	NF1	G629V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000657597	17	29552153	17	31225135	657597	645522	rs1597710440	NC_000017.11:31225134:G:T
NM_001042492.3(NF1):c.7931C>G (p.Ala2644Gly)	NF1	A2623G, A2644G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000657485	17	29684348	17	31357330	657485	645769	rs766494934	NC_000017.11:31357329:C:G
NM_001042492.3(NF1):c.5270T>C (p.Val1757Ala)	NF1	V1757A, V1736A	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000657452	17	29654518	17	31327500	657452	645663	rs1021835871	NC_000017.11:31327499:T:C
NM_001042492.3(NF1):c.7391C>T (p.Thr2464Ile)	NF1	T2443I, T2464I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000657313	17	29677270	17	31350252	657313	645747	rs1597859696	NC_000017.11:31350251:C:T
NM_001042492.3(NF1):c.6733C>T (p.Gln2245Ter)	NF1	Q2224*, Q2245*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000657256	17	29665071	17	31338053	657256	645718	rs1597845013	NC_000017.11:31338052:C:T
NM_001042492.3(NF1):c.707A>G (p.Gln236Arg)	NF1	Q236R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000657228	17	29508780	17	31181762	657228	645470	rs1321998864	NC_000017.11:31181761:A:G
NM_001042492.3(NF1):c.6164G>C (p.Cys2055Ser)	NF1	C2034S, C2055S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000657125	17	29663669	17	31336651	657125	645698	rs1597842735	NC_000017.11:31336650:G:C
NM_001042492.3(NF1):c.5373C>G (p.Ile1791Met)	NF1	I1770M, I1791M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000657101	17	29654621	17	31327603	657101	645667	rs1597831996	NC_000017.11:31327602:C:G
NM_001042492.3(NF1):c.4433T>G (p.Phe1478Cys)	NF1	F1478C, F1457C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000657078	17	29587389	17	31260371	657078	645631	rs1597746900	NC_000017.11:31260370:T:G
NM_001042492.3(NF1):c.6227A>G (p.Asp2076Gly)	NF1	D2055G, D2076G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000656973	17	29663732	17	31336714	656973	645701	rs1597842820	NC_000017.11:31336713:A:G
NM_001042492.3(NF1):c.2274A>T (p.Arg758Ser)	NF1	R758S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000656909	17	29554258	17	31227240	656909	645536	rs1597713310	NC_000017.11:31227239:A:T
NM_001042492.3(NF1):c.4334T>G (p.Ile1445Arg)	NF1	I1424R, I1445R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 12, 2020)	criteria provided, single submitter	VCV000656881	17	29586051	17	31259033	656881	645625	rs1597745565	NC_000017.11:31259032:T:G
NM_001042492.3(NF1):c.2915T>C (p.Leu972Pro)	NF1	L972P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000656765	17	29556917	17	31229899	656765	645558	rs1597716348	NC_000017.11:31229898:T:C
NM_001042492.3(NF1):c.6658A>C (p.Ile2220Leu)	NF1	I2199L, I2220L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000656655	17	29664852	17	31337834	656655	645715	rs781284066	NC_000017.11:31337833:A:C
NM_001042492.3(NF1):c.681T>G (p.Tyr227Ter)	NF1	Y227*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000656641	17	29508754	17	31181736	656641	645468	rs745804540	NC_000017.11:31181735:T:G
NM_001042492.3(NF1):c.3871-5T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000656635	17	29562931	17	31235913	656635	652751	rs1597722882	NC_000017.11:31235912:T:G
NM_001042492.3(NF1):c.7343A>C (p.Glu2448Ala)	NF1	E2448A, E2427A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000656596	17	29677222	17	31350204	656596	645745	rs1597859599	NC_000017.11:31350203:A:C
NM_001042492.3(NF1):c.8497A>G (p.Asn2833Asp)	NF1	N2833D, N2812D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000656487	17	29701150	17	31374132	656487	645789	rs786202863	NC_000017.11:31374131:A:G
NM_001042492.3(NF1):c.4431G>A (p.Arg1477=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000656349	17	29587387	17	31260369	656349	645630	rs181462219	NC_000017.11:31260368:G:A
NM_001042492.3(NF1):c.7712G>A (p.Arg2571Lys)	NF1	R2550K, R2571K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000656251	17	29683574	17	31356556	656251	645757	rs1597865842	NC_000017.11:31356555:G:A
NM_001042492.3(NF1):c.1892G>C (p.Gly631Ala)	NF1	G631A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2018)	criteria provided, single submitter	VCV000656247	17	29552159	17	31225141	656247	645523	rs876660272	NC_000017.11:31225140:G:C
NM_001042492.3(NF1):c.3169G>A (p.Ala1057Thr)	NF1	A1057T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2019)	criteria provided, conflicting interpretations	VCV000656225	17	29557915	17	31230897	656225	645577	rs1367746167	NC_000017.11:31230896:G:A
NM_001042492.3(NF1):c.4201A>G (p.Ser1401Gly)	NF1	S1380G, S1401G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000656201	17	29585389	17	31258371	656201	645619	rs1060500310	NC_000017.11:31258370:A:G
NM_001042492.3(NF1):c.4831C>A (p.Arg1611=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000656152	17	29592353	17	31265335	656152	645645	rs1060500316	NC_000017.11:31265334:C:A
NM_001042492.3(NF1):c.1274G>C (p.Trp425Ser)	NF1	W425S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000656118	17	29533271	17	31206253	656118	645498	rs1597688734	NC_000017.11:31206252:G:C
NM_001042492.3(NF1):c.5116C>T (p.Leu1706Phe)	NF1	L1685F, L1706F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000656005	17	29653118	17	31326100	656005	645659	rs769087878	NC_000017.11:31326099:C:T
NM_001042492.3(NF1):c.1744T>G (p.Cys582Gly)	NF1	C582G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000656004	17	29550484	17	31223466	656004	645512	rs1597708661	NC_000017.11:31223465:T:G
NM_001042492.3(NF1):c.7447C>T (p.Pro2483Ser)	NF1	P2462S, P2483S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV000655887	17	29677326	17	31350308	655887	645752	rs1291550449	NC_000017.11:31350307:C:T
NM_001042492.3(NF1):c.6830G>A (p.Ser2277Asn)	NF1	S2256N, S2277N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000655846	17	29665732	17	31338714	655846	645719	rs1597845918	NC_000017.11:31338713:G:A
NM_001042492.3(NF1):c.6635T>A (p.Ile2212Asn)	NF1	I2191N, I2212N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000655783	17	29664593	17	31337575	655783	645712	rs1597844075	NC_000017.11:31337574:T:A
NM_001042492.3(NF1):c.5049C>G (p.Asn1683Lys)	NF1	N1662K, N1683K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000655745	17	29653051	17	31326033	655745	645656	rs140994965	NC_000017.11:31326032:C:G
NM_001042492.3(NF1):c.3154A>G (p.Thr1052Ala)	NF1	T1052A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000655658	17	29557900	17	31230882	655658	645575	rs1597717598	NC_000017.11:31230881:A:G
NM_001042492.3(NF1):c.1783G>T (p.Glu595Ter)	NF1	E595*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000655568	17	29550523	17	31223505	655568	645515	rs1597708728	NC_000017.11:31223504:G:T
NM_001042492.3(NF1):c.3852A>G (p.Ile1284Met)	NF1	I1284M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000655513	17	29562772	17	31235754	655513	645610	rs1597722650	NC_000017.11:31235753:A:G
NM_001042492.3(NF1):c.4901A>G (p.Tyr1634Cys)	NF1	Y1634C, Y1613C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000655453	17	29652903	17	31325885	655453	645650	rs1597829621	NC_000017.11:31325884:A:G
NM_001042492.3(NF1):c.4454A>G (p.Asp1485Gly)	NF1	D1464G, D1485G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000655394	17	29587410	17	31260392	655394	645632	rs1279391103	NC_000017.11:31260391:A:G
NM_001042492.3(NF1):c.236T>G (p.Leu79Ter)	NF1	L79*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655362	17	29486059	17	31159041	655362	645444	rs1597629765	NC_000017.11:31159040:T:G
NM_001042492.3(NF1):c.4736A>C (p.His1579Pro)	NF1	H1558P, H1579P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000655293	17	29592258	17	31265240	655293	645642	rs1275751975	NC_000017.11:31265239:A:C
NM_001042492.3(NF1):c.7724C>T (p.Thr2575Ile)	NF1	T2575I, T2554I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000655149	17	29683586	17	31356568	655149	645758	rs1597865850	NC_000017.11:31356567:C:T
NM_001042492.3(NF1):c.2251G>A (p.Gly751Arg)	NF1	G751R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000655108	17	29553702	17	31226684	655108	645534	rs1567847681	NC_000017.11:31226683:G:A
NM_001042492.3(NF1):c.3772T>C (p.Trp1258Arg)	NF1	W1258R	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000655055	17	29562692	17	31235674	655055	645606	rs1597722508	NC_000017.11:31235673:T:C
NM_001042492.3(NF1):c.3595A>G (p.Thr1199Ala)	NF1	T1199A	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655052	17	29560118	17	31233100	655052	645597	rs1453504440	NC_000017.11:31233099:A:G
NM_001042492.3(NF1):c.5368G>T (p.Glu1790Ter)	NF1	E1790*, E1769*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000654733	17	29654616	17	31327598	654733	645666	rs1597831990	NC_000017.11:31327597:G:T
NM_001042492.3(NF1):c.3011A>G (p.Asn1004Ser)	NF1	N1004S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000654535	17	29557298	17	31230280	654535	645564	rs1475800240	NC_000017.11:31230279:A:G
NM_001042492.3(NF1):c.279T>A (p.Cys93Ter)	NF1	C93*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000654518	17	29486102	17	31159084	654518	645449	rs1597629882	NC_000017.11:31159083:T:A
NM_001042492.3(NF1):c.1185+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000654452	17	29528182	17	31201164	654452	652716	rs1597682182	NC_000017.11:31201163:G:C
NM_001042492.3(NF1):c.2734C>T (p.Gln912Ter)	NF1	Q912*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654419	17	29556367	17	31229349	654419	645552	rs1597715673	NC_000017.11:31229348:C:T
NM_001042492.3(NF1):c.2990G>A (p.Arg997Lys)	NF1	R997K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654334	17	29556992	17	31229974	654334	645562	rs1555614462	NC_000017.11:31229973:G:A
NM_001042492.3(NF1):c.1692T>G (p.Asp564Glu)	NF1	D564E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000654055	17	29548918	17	31221900	654055	645509	rs1597706718	NC_000017.11:31221899:T:G
NM_001042492.3(NF1):c.2410-12T>G	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 28, 2021)	criteria provided, conflicting interpretations	VCV000653976	17	29556031	17	31229013	653976	652738	rs876657932	NC_000017.11:31229012:T:G
NM_001042492.3(NF1):c.3275G>A (p.Gly1092Asp)	NF1	G1092D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000653835	17	29559168	17	31232150	653835	645584	rs1597718838	NC_000017.11:31232149:G:A
NM_001042492.3(NF1):c.3863G>A (p.Cys1288Tyr)	NF1	C1288Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000653694	17	29562783	17	31235765	653694	645611	rs1597722661	NC_000017.11:31235764:G:A
NM_001042492.3(NF1):c.5680G>T (p.Glu1894Ter)	NF1	E1894*, E1873*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000653673	17	29657384	17	31330366	653673	645684	rs774893767	NC_000017.11:31330365:G:T
NM_001042492.3(NF1):c.581T>C (p.Leu194Pro)	NF1	L194P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000653665	17	29497010	17	31169992	653665	645462	rs199474753	NC_000017.11:31169991:T:C
NM_001042492.3(NF1):c.4207G>C (p.Gly1403Arg)	NF1	G1382R, G1403R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000653561	17	29585395	17	31258377	653561	645620	rs138227618	NC_000017.11:31258376:G:C
NM_001042492.3(NF1):c.3598G>A (p.Val1200Ile)	NF1	V1200I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000653329	17	29560121	17	31233103	653329	645598	rs1597720021	NC_000017.11:31233102:G:A
NM_001042492.3(NF1):c.5609+5G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000653133	17	29654862	17	31327844	653133	652758	rs1597832498	NC_000017.11:31327843:G:A
NM_001042492.3(NF1):c.205-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000652752	17	29486026	17	31159008	652752	652701	rs1597629679	NC_000017.11:31159007:A:G
NM_001042492.3(NF1):c.787A>G (p.Lys263Glu)	NF1	K263E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000652545	17	29509582	17	31182564	652545	645474	rs1597659883	NC_000017.11:31182563:A:G
NM_001042492.3(NF1):c.8144C>T (p.Ala2715Val)	NF1	A2715V, A2694V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000652495	17	29686017	17	31358999	652495	645781	rs1597868802	NC_000017.11:31358998:C:T
NM_001042492.3(NF1):c.6643-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000652474	17	29664835	17	31337817	652474	653262	rs1597844547	NC_000017.11:31337816:A:G
NM_001042492.3(NF1):c.244T>C (p.Ser82Pro)	NF1	S82P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000652365	17	29486067	17	31159049	652365	645446	rs1597629813	NC_000017.11:31159048:T:C
NM_001042492.3(NF1):c.2329T>C (p.Trp777Arg)	NF1	W777R	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000652361	17	29554544	17	31227526	652361	645541	rs876658853	NC_000017.11:31227525:T:C
NM_001042492.3(NF1):c.8020G>A (p.Asp2674Asn)	NF1	D2653N, D2674N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000652324	17	29685547	17	31358529	652324	645777	rs1597868123	NC_000017.11:31358528:G:A
NM_001042492.3(NF1):c.911G>A (p.Arg304Gln)	NF1	R304Q	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000652291	17	29527462	17	31200444	652291	645482	rs76015786	NC_000017.11:31200443:G:A
NM_001042492.3(NF1):c.2156T>C (p.Ile719Thr)	NF1	I719T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000652214	17	29553607	17	31226589	652214	645531	rs754025938	NC_000017.11:31226588:T:C
NM_001042492.3(NF1):c.4949C>T (p.Pro1650Leu)	NF1	P1629L, P1650L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000652212	17	29652951	17	31325933	652212	645653	rs1597829723	NC_000017.11:31325932:C:T
NM_001042492.3(NF1):c.3716T>G (p.Leu1239Arg)	NF1	L1239R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000652134	17	29562636	17	31235618	652134	645601	rs1597722390	NC_000017.11:31235617:T:G
NM_001042492.3(NF1):c.888G>A (p.Lys296=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000652012	17	29509683	17	31182665	652012	645481	rs1597660134	NC_000017.11:31182664:G:A
NM_001042492.3(NF1):c.5732T>A (p.Ile1911Asn)	NF1	I1911N, I1890N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2018)	criteria provided, single submitter	VCV000652007	17	29657436	17	31330418	652007	645686	rs1597834839	NC_000017.11:31330417:T:A
NM_001042492.3(NF1):c.5974A>T (p.Ile1992Phe)	NF1	I1992F, I1971F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000651925	17	29662017	17	31334999	651925	645695	rs1597840279	NC_000017.11:31334998:A:T
NM_001042492.3(NF1):c.7976A>C (p.Asn2659Thr)	NF1	N2638T, N2659T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000651836	17	29685503	17	31358485	651836	645775	rs1597868051	NC_000017.11:31358484:A:C
NM_001042492.3(NF1):c.6338C>T (p.Thr2113Ile)	NF1	T2113I, T2092I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000651560	17	29663843	17	31336825	651560	645702	rs768982249	NC_000017.11:31336824:C:T
NM_001042492.3(NF1):c.730+6G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000651228	17	29508809	17	31181791	651228	653226	rs1444298546	NC_000017.11:31181790:G:C
NM_001042492.3(NF1):c.1307C>T (p.Ser436Leu)	NF1	S436L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000651225	17	29533304	17	31206286	651225	645500	rs755190083	NC_000017.11:31206285:C:T
NM_001042492.3(NF1):c.78A>T (p.Gly26=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 30, 2018)	criteria provided, conflicting interpretations	VCV000651212	17	29483018	17	31156000	651212	645438	rs748018099	NC_000017.11:31155999:A:T
NM_001042492.3(NF1):c.6918T>A (p.Asn2306Lys)	NF1	N2285K, N2306K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000651198	17	29665820	17	31338802	651198	645722	rs1597846111	NC_000017.11:31338801:T:A
NM_001042492.3(NF1):c.5572G>T (p.Ala1858Ser)	NF1	A1837S, A1858S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000651169	17	29654820	17	31327802	651169	645677	rs786203416	NC_000017.11:31327801:G:T
NM_001042492.3(NF1):c.3496G>A (p.Gly1166Ser)	NF1	G1166S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000651126	17	29559899	17	31232881	651126	645594	rs1597719704	NC_000017.11:31232880:G:A
NM_001042492.3(NF1):c.412G>C (p.Ala138Pro)	NF1	A138P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV000651033	17	29490327	17	31163309	651033	645456	rs1597635936	NC_000017.11:31163308:G:C
NM_001042492.3(NF1):c.5646T>G (p.Cys1882Trp)	NF1	C1882W, C1861W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000650987	17	29657350	17	31330332	650987	645681	rs1597834659	NC_000017.11:31330331:T:G
NM_001042492.3(NF1):c.59A>C (p.Gln20Pro)	NF1	Q20P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000650986	17	29422386	17	31095368	650986	645437	rs1598173901	NC_000017.11:31095367:A:C
NM_001042492.3(NF1):c.1078C>T (p.Pro360Ser)	NF1	P360S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000650890	17	29528070	17	31201052	650890	645490	rs1597681902	NC_000017.11:31201051:C:T
NM_001042492.3(NF1):c.7897G>A (p.Glu2633Lys)	NF1	E2612K, E2633K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000650807	17	29684314	17	31357296	650807	645763	rs750754640	NC_000017.11:31357295:G:A
NM_001042492.3(NF1):c.3753T>A (p.His1251Gln)	NF1	H1251Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000650763	17	29562673	17	31235655	650763	645604	rs1597722470	NC_000017.11:31235654:T:A
NM_001042492.3(NF1):c.6488T>G (p.Leu2163Trp)	NF1	L2142W, L2163W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000650746	17	29664446	17	31337428	650746	645708	rs1353492847	NC_000017.11:31337427:T:G
NM_001042492.3(NF1):c.5918C>G (p.Ala1973Gly)	NF1	A1952G, A1973G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000650651	17	29661961	17	31334943	650651	645693	rs1597840153	NC_000017.11:31334942:C:G
NM_001042492.3(NF1):c.3400A>G (p.Met1134Val)	NF1	M1134V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000650592	17	29559803	17	31232785	650592	645587	rs1597719532	NC_000017.11:31232784:A:G
NM_001042492.3(NF1):c.204+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000650586	17	29483146	17	31156128	650586	653214	rs1597626161	NC_000017.11:31156127:T:G
NM_001042492.3(NF1):c.2325G>T (p.Glu775Asp)	NF1	E775D	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000650391	17	29554309	17	31227291	650391	645540	rs1555613932	NC_000017.11:31227290:G:T
NM_001042492.3(NF1):c.7321+6A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2018)	criteria provided, single submitter	VCV000650076	17	29676275	17	31349257	650076	652933	rs1597858669	NC_000017.11:31349256:A:G
NM_001042492.3(NF1):c.866T>C (p.Val289Ala)	NF1	V289A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV000650039	17	29509661	17	31182643	650039	645480	rs749251299	NC_000017.11:31182642:T:C
NM_001042492.3(NF1):c.2990+3A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000649964	17	29556995	17	31229977	649964	652745	rs1597716487	NC_000017.11:31229976:A:T
NM_001042492.3(NF1):c.2759T>A (p.Leu920Gln)	NF1	L920Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000649957	17	29556392	17	31229374	649957	645554	rs199474775	NC_000017.11:31229373:T:A
NM_001042492.3(NF1):c.5771T>A (p.Leu1924Ter)	NF1	L1924*, L1903*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000649928	17	29657475	17	31330457	649928	645687	rs1198491194	NC_000017.11:31330456:T:A
NM_001042492.3(NF1):c.1372C>G (p.Pro458Ala)	NF1	P458A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000649828	17	29533369	17	31206351	649828	645503	rs1597688990	NC_000017.11:31206350:C:G
NM_001042492.3(NF1):c.2991G>C (p.Arg997Ser)	NF1	R997S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV000649695	17	29557278	17	31230260	649695	645563	rs755501749	NC_000017.11:31230259:G:C
NM_001042492.3(NF1):c.5269-8C>G	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000649676	17	29654509	17	31327491	649676	652929	rs1597831805	NC_000017.11:31327490:C:G
NM_001042492.3(NF1):c.2851G>A (p.Val951Ile)	NF1	V951I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000649656	17	29556853	17	31229835	649656	645555	rs1597716277	NC_000017.11:31229834:G:A
NM_001042492.3(NF1):c.6648C>A (p.Cys2216Ter)	NF1	C2195*, C2216*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000649614	17	29664842	17	31337824	649614	645714	rs1597844556	NC_000017.11:31337823:C:A
NM_001042492.3(NF1):c.3568G>A (p.Gly1190Ser)	NF1	G1190S	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2019)	criteria provided, conflicting interpretations	VCV000649604	17	29560091	17	31233073	649604	645596	rs1597719982	NC_000017.11:31233072:G:A
NM_001042492.3(NF1):c.4783C>T (p.Gln1595Ter)	NF1	Q1595*, Q1574*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000649568	17	29592305	17	31265287	649568	645644	rs1597753263	NC_000017.11:31265286:C:T
NM_001042492.3(NF1):c.2991-3T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000649473	17	29557275	17	31230257	649473	653417	rs1597716778	NC_000017.11:31230256:T:G
NM_001042492.3(NF1):c.7012C>G (p.Leu2338Val)	NF1	L2338V, L2317V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000649434	17	29667613	17	31340595	649434	645726	rs1597848149	NC_000017.11:31340594:C:G
NM_001042492.3(NF1):c.4321T>A (p.Leu1441Ile)	NF1	L1420I, L1441I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000649377	17	29585509	17	31258491	649377	645624	rs786201458	NC_000017.11:31258490:T:A
NM_001042492.3(NF1):c.2287C>G (p.Leu763Val)	NF1	L763V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000649337	17	29554271	17	31227253	649337	645538	rs1597713340	NC_000017.11:31227252:C:G
NM_001042492.3(NF1):c.173T>C (p.Leu58Pro)	NF1	L58P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000649283	17	29483113	17	31156095	649283	645441	rs1597626094	NC_000017.11:31156094:T:C
NM_001042492.3(NF1):c.7090C>T (p.Arg2364Trp)	NF1	R2364W, R2343W	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000648933	17	29670054	17	31343036	648933	645729	rs1567620403	NC_000017.11:31343035:C:T
NM_001042492.3(NF1):c.1379T>C (p.Ile460Thr)	NF1	I460T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000648920	17	29533376	17	31206358	648920	645504	rs147417054	NC_000017.11:31206357:T:C
NM_001042492.3(NF1):c.7544G>T (p.Ser2515Ile)	NF1	S2494I, S2515I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000648877	17	29679361	17	31352343	648877	645754	rs1597862174	NC_000017.11:31352342:G:T
NM_001042492.3(NF1):c.1457C>T (p.Thr486Ile)	NF1	T486I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000648843	17	29541533	17	31214515	648843	645506	rs1019393337	NC_000017.11:31214514:C:T
NM_001042492.3(NF1):c.1642-3C>G	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000648709	17	29548865	17	31221847	648709	653403	rs1597706610	NC_000017.11:31221846:C:G
NM_001042492.3(NF1):c.647T>G (p.Leu216Arg)	NF1	L216R	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2018)	criteria provided, conflicting interpretations	VCV000648671	17	29508500	17	31181482	648671	645465	rs199474756	NC_000017.11:31181481:T:G
NM_001042492.3(NF1):c.289-3T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV000648591	17	29490201	17	31163183	648591	652710	rs1461646186	NC_000017.11:31163182:T:C
NM_001042492.3(NF1):c.2161T>C (p.Cys721Arg)	NF1	C721R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000648462	17	29553612	17	31226594	648462	645533	rs1597712637	NC_000017.11:31226593:T:C
NM_001042492.3(NF1):c.736G>T (p.Ala246Ser)	NF1	A246S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000648450	17	29509531	17	31182513	648450	645472	rs1597659751	NC_000017.11:31182512:G:T
NM_001042492.3(NF1):c.7162T>A (p.Phe2388Ile)	NF1	F2388I, F2367I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 23, 2018)	criteria provided, single submitter	VCV000648366	17	29670126	17	31343108	648366	645734	rs1425642121	NC_000017.11:31343107:T:A
NM_001042492.3(NF1):c.3037A>C (p.Thr1013Pro)	NF1	T1013P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000648338	17	29557324	17	31230306	648338	645566	rs1597716888	NC_000017.11:31230305:A:C
NM_001042492.3(NF1):c.2867C>T (p.Thr956Ile)	NF1	T956I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000648324	17	29556869	17	31229851	648324	645556	rs1323973848	NC_000017.11:31229850:C:T
NM_001042492.3(NF1):c.6643-2A>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000648314	17	29664835	17	31337817	648314	652931	rs1597844547	NC_000017.11:31337816:A:T
NM_001042492.3(NF1):c.5459T>C (p.Ile1820Thr)	NF1	I1820T, I1799T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000648166	17	29654707	17	31327689	648166	645669	rs1597832129	NC_000017.11:31327688:T:C
NM_001042492.3(NF1):c.2409+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000648121	17	29554625	17	31227607	648121	653416	rs1555614022	NC_000017.11:31227606:G:A
NM_001042492.3(NF1):c.999C>G (p.Tyr333Ter)	NF1	Y333*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000647719	17	29527550	17	31200532	647719	645487	rs1466912192	NC_000017.11:31200531:C:G
NM_001042492.3(NF1):c.768T>G (p.Phe256Leu)	NF1	F256L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000647653	17	29509563	17	31182545	647653	645473	rs1597659838	NC_000017.11:31182544:T:G
NM_001042492.3(NF1):c.5189C>T (p.Thr1730Ile)	NF1	T1730I, T1709I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000647410	17	29653191	17	31326173	647410	645662	rs772831692	NC_000017.11:31326172:C:T
NM_001042492.3(NF1):c.6158G>C (p.Arg2053Thr)	NF1	R2053T, R2032T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000647367	17	29663663	17	31336645	647367	645697	rs1060500289	NC_000017.11:31336644:G:C
NM_001042492.3(NF1):c.8072A>G (p.His2691Arg)	NF1	H2691R, H2670R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000647245	17	29685599	17	31358581	647245	645779	rs1597868213	NC_000017.11:31358580:A:G
NM_001042492.3(NF1):c.5501C>G (p.Ser1834Ter)	NF1	S1834*, S1813*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000647087	17	29654749	17	31327731	647087	645674	rs1597832235	NC_000017.11:31327730:C:G
NM_001042492.3(NF1):c.3709-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000647016	17	29562627	17	31235609	647016	652926	rs1597722374	NC_000017.11:31235608:A:T
NM_001042492.3(NF1):c.6212A>G (p.Gln2071Arg)	NF1	Q2071R, Q2050R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000646852	17	29663717	17	31336699	646852	645700	rs1597842800	NC_000017.11:31336698:A:G
NM_001042492.3(NF1):c.824T>C (p.Ile275Thr)	NF1	I275T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000646833	17	29509619	17	31182601	646833	645478	rs1406698961	NC_000017.11:31182600:T:C
NM_001042492.3(NF1):c.6179A>G (p.Lys2060Arg)	NF1	K2060R, K2039R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000646795	17	29663684	17	31336666	646795	645699	rs1597842757	NC_000017.11:31336665:A:G
NM_001042492.3(NF1):c.4690C>T (p.Leu1564Phe)	NF1	L1564F, L1543F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000646583	17	29588841	17	31261823	646583	645641	rs1427435078	NC_000017.11:31261822:C:T
NM_001042492.3(NF1):c.1717A>G (p.Ile573Val)	NF1	I573V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000646490	17	29548943	17	31221925	646490	645511	rs1597706766	NC_000017.11:31221924:A:G
NM_001042492.3(NF1):c.6973C>A (p.Leu2325Ile)	NF1	L2304I, L2325I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000646296	17	29667574	17	31340556	646296	645723	rs1597848038	NC_000017.11:31340555:C:A
NM_001042492.3(NF1):c.5845A>T (p.Met1949Leu)	NF1	M1949L, M1928L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 5, 2018)	criteria provided, single submitter	VCV000646265	17	29661888	17	31334870	646265	645691	rs1597840049	NC_000017.11:31334869:A:T
NM_001042492.3(NF1):c.8422T>C (p.Cys2808Arg)	NF1	C2808R, C2787R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000646131	17	29701075	17	31374057	646131	645788	rs1597883056	NC_000017.11:31374056:T:C
NM_001042492.3(NF1):c.1703A>G (p.Glu568Gly)	NF1	E568G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000646112	17	29548929	17	31221911	646112	645510	rs1597706730	NC_000017.11:31221910:A:G
NM_001042492.3(NF1):c.7267C>T (p.His2423Tyr)	NF1	H2402Y, H2423Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000646107	17	29676215	17	31349197	646107	645741	rs761299521	NC_000017.11:31349196:C:T
NM_001042492.3(NF1):c.1112C>T (p.Ala371Val)	NF1	A371V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000645986	17	29528104	17	31201086	645986	645492	rs1597681991	NC_000017.11:31201085:C:T
NM_001042492.3(NF1):c.223G>A (p.Ala75Thr)	NF1	A75T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000645770	17	29486046	17	31159028	645770	645443	rs1597629733	NC_000017.11:31159027:G:A
NM_001042492.3(NF1):c.3017T>C (p.Val1006Ala)	NF1	V1006A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000645652	17	29557304	17	31230286	645652	645565	rs755636107	NC_000017.11:31230285:T:C
NM_001042492.3(NF1):c.7415C>T (p.Pro2472Leu)	NF1	P2451L, P2472L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000645606	17	29677294	17	31350276	645606	645750	rs786202184	NC_000017.11:31350275:C:T
NM_001042492.3(NF1):c.3708+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000645590	17	29560236	17	31233218	645590	653423	rs1597720280	NC_000017.11:31233217:G:C
NM_001042492.3(NF1):c.5072A>C (p.Lys1691Thr)	NF1	K1670T, K1691T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000645527	17	29653074	17	31326056	645527	645657	rs863224661	NC_000017.11:31326055:A:C
NM_001042492.3(NF1):c.511A>C (p.Asn171His)	NF1	N171H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000645515	17	29496940	17	31169922	645515	645457	rs1597643796	NC_000017.11:31169921:A:C
NM_001042492.3(NF1):c.3658G>A (p.Glu1220Lys)	NF1	E1220K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000645400	17	29560181	17	31233163	645400	645600	rs1597720155	NC_000017.11:31233162:G:A
NM_001042492.3(NF1):c.7969G>C (p.Val2657Leu)	NF1	V2636L, V2657L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000645302	17	29684386	17	31357368	645302	645774	rs1597867034	NC_000017.11:31357367:G:C
NM_001042492.3(NF1):c.390T>A (p.His130Gln)	NF1	H130Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000645168	17	29490305	17	31163287	645168	645454	rs1597635884	NC_000017.11:31163286:T:A
NM_001042492.3(NF1):c.4375G>T (p.Glu1459Ter)	NF1	E1438*, E1459*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000645094	17	29586092	17	31259074	645094	645627	rs1597745663	NC_000017.11:31259073:G:T
NM_001042492.3(NF1):c.7914T>G (p.Ile2638Met)	NF1	I2617M, I2638M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000644976	17	29684331	17	31357313	644976	645766	rs1597866892	NC_000017.11:31357312:T:G
NM_001042492.3(NF1):c.5812+4A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000644875	17	29657520	17	31330502	644875	652762	rs1597834988	NC_000017.11:31330501:A:T
NM_001042492.3(NF1):c.5315T>A (p.Val1772Asp)	NF1	V1772D, V1751D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000644781	17	29654563	17	31327545	644781	645665	rs1209831572	NC_000017.11:31327544:T:A
NM_001042492.3(NF1):c.5482C>G (p.Arg1828Gly)	NF1	R1807G, R1828G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000644770	17	29654730	17	31327712	644770	645672	rs1555533609	NC_000017.11:31327711:C:G
NM_001042492.3(NF1):c.8158A>G (p.Lys2720Glu)	NF1	K2720E, K2699E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000644614	17	29686031	17	31359013	644614	645782	rs1597868832	NC_000017.11:31359012:A:G
NM_001042492.3(NF1):c.6646T>A (p.Cys2216Ser)	NF1	C2195S, C2216S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000644567	17	29664840	17	31337822	644567	645713	rs757736155	NC_000017.11:31337821:T:A
NM_001042492.3(NF1):c.7455T>A (p.Tyr2485Ter)	NF1	Y2464*, Y2485*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000644466	17	29677334	17	31350316	644466	645753	rs1597859871	NC_000017.11:31350315:T:A
NM_001042492.3(NF1):c.1510C>A (p.Pro504Thr)	NF1	P504T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000644431	17	29541586	17	31214568	644431	645507	rs1597698495	NC_000017.11:31214567:C:A
NM_001042492.3(NF1):c.3204G>C (p.Leu1068Phe)	NF1	L1068F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000644421	17	29559097	17	31232079	644421	645579	rs1258842007	NC_000017.11:31232078:G:C
NM_001042492.3(NF1):c.1148G>T (p.Cys383Phe)	NF1	C383F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000644336	17	29528140	17	31201122	644336	645494	rs1597682085	NC_000017.11:31201121:G:T
NM_001042492.3(NF1):c.5873G>T (p.Arg1958Leu)	NF1	R1937L, R1958L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000644154	17	29661916	17	31334898	644154	645692	rs1296862549	NC_000017.11:31334897:G:T
NM_001042492.3(NF1):c.847G>A (p.Asp283Asn)	NF1	D283N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 18, 2018)	criteria provided, single submitter	VCV000644018	17	29509642	17	31182624	644018	645479	rs200572531	NC_000017.11:31182623:G:A
NM_001042492.3(NF1):c.7945G>C (p.Val2649Leu)	NF1	V2649L, V2628L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000643926	17	29684362	17	31357344	643926	645770	rs1555536761	NC_000017.11:31357343:G:C
NM_001042492.3(NF1):c.3964G>A (p.Asp1322Asn)	NF1	D1322N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000643890	17	29563029	17	31236011	643890	645612	rs1597723042	NC_000017.11:31236010:G:A
NM_001042492.3(NF1):c.1061A>C (p.Lys354Thr)	NF1	K354T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000643849	17	29527612	17	31200594	643849	645488	rs1135402801	NC_000017.11:31200593:A:C
NM_001042492.3(NF1):c.5123T>G (p.Phe1708Cys)	NF1	F1687C, F1708C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000643793	17	29653125	17	31326107	643793	645660	rs1597830056	NC_000017.11:31326106:T:G
NM_001042492.3(NF1):c.2757T>A (p.Asp919Glu)	NF1	D919E	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000643555	17	29556390	17	31229372	643555	645553	rs1131691110	NC_000017.11:31229371:T:A
NM_001042492.3(NF1):c.1957A>G (p.Thr653Ala)	NF1	T653A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000643514	17	29552224	17	31225206	643514	645525	rs1597710712	NC_000017.11:31225205:A:G
NM_001042492.3(NF1):c.8362T>G (p.Ser2788Ala)	NF1	S2788A, S2767A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000643491	17	29687706	17	31360688	643491	645787	rs374004608	NC_000017.11:31360687:T:G
NM_001042492.3(NF1):c.5546A>T (p.Asp1849Val)	NF1	D1849V, D1828V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000643423	17	29654794	17	31327776	643423	645676	rs1170679293	NC_000017.11:31327775:A:T
NM_001042492.3(NF1):c.6658A>G (p.Ile2220Val)	NF1	I2199V, I2220V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000643254	17	29664852	17	31337834	643254	645716	rs781284066	NC_000017.11:31337833:A:G
NM_001042492.3(NF1):c.5645G>A (p.Cys1882Tyr)	NF1	C1861Y, C1882Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000643136	17	29657349	17	31330331	643136	645680	rs1597834656	NC_000017.11:31330330:G:A
NM_001042492.3(NF1):c.7156T>G (p.Phe2386Val)	NF1	F2386V, F2365V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000642993	17	29670120	17	31343102	642993	645732	rs1597851418	NC_000017.11:31343101:T:G
NM_001042492.3(NF1):c.247C>T (p.Gln83Ter)	NF1	Q83*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000642883	17	29486070	17	31159052	642883	645447	rs746824139	NC_000017.11:31159051:C:T
NM_001042492.3(NF1):c.520G>A (p.Val174Ile)	NF1	V174I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000642860	17	29496949	17	31169931	642860	645460	rs1555607084	NC_000017.11:31169930:G:A
NM_001042492.3(NF1):c.3078A>C (p.Arg1026Ser)	NF1	R1026S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000642809	17	29557365	17	31230347	642809	645571	rs1597716965	NC_000017.11:31230346:A:C
NM_001042492.3(NF1):c.4914A>G (p.Pro1638=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 16, 2020)	criteria provided, conflicting interpretations	VCV000642789	17	29652916	17	31325898	642789	645651	rs186482097	NC_000017.11:31325897:A:G
NM_001042492.3(NF1):c.288+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000642767	17	29486112	17	31159094	642767	653217	rs1567816131	NC_000017.11:31159093:G:C
NM_001042492.3(NF1):c.288+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000642764	17	29486116	17	31159098	642764	652705	rs1555605409	NC_000017.11:31159097:G:A
NM_001042492.3(NF1):c.2479G>A (p.Asp827Asn)	NF1	D827N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000642693	17	29556112	17	31229094	642693	645546	rs1597715215	NC_000017.11:31229093:G:A
NM_001042492.3(NF1):c.8158A>T (p.Lys2720Ter)	NF1	K2720*, K2699*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000642603	17	29686031	17	31359013	642603	645783	rs1597868832	NC_000017.11:31359012:A:T
NM_001042492.3(NF1):c.2441A>T (p.Lys814Met)	NF1	K814M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000642522	17	29556074	17	31229056	642522	645544	rs1555614185	NC_000017.11:31229055:A:T
NM_001042492.3(NF1):c.1850C>A (p.Ala617Glu)	NF1	A617E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000642480	17	29552117	17	31225099	642480	645519	rs1461412558	NC_000017.11:31225098:C:A
NM_001042492.3(NF1):c.7258G>A (p.Val2420Ile)	NF1	V2399I, V2420I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000642416	17	29676206	17	31349188	642416	645739	rs1597858484	NC_000017.11:31349187:G:A
NM_001042492.3(NF1):c.3974+3T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000642373	17	29563042	17	31236024	642373	653427	rs1597723069	NC_000017.11:31236023:T:G
NM_001042492.3(NF1):c.2549T>C (p.Val850Ala)	NF1	V850A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000642273	17	29556182	17	31229164	642273	645549	rs1424956205	NC_000017.11:31229163:T:C
NM_001042492.3(NF1):c.2326-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000642179	17	29554540	17	31227522	642179	653408	rs1567848100	NC_000017.11:31227521:G:A
NM_001042492.3(NF1):c.976A>G (p.Lys326Glu)	NF1	K326E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000642154	17	29527527	17	31200509	642154	645486	rs1597680956	NC_000017.11:31200508:A:G
NM_001042492.3(NF1):c.349A>G (p.Ile117Val)	NF1	I117V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000642103	17	29490264	17	31163246	642103	645451	rs1597635759	NC_000017.11:31163245:A:G
NM_001042492.3(NF1):c.4051A>C (p.Ile1351Leu)	NF1	I1351L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000642076	17	29576078	17	31249060	642076	645614	rs1233135542	NC_000017.11:31249059:A:C
NM_001042492.3(NF1):c.248A>C (p.Gln83Pro)	NF1	Q83P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000641956	17	29486071	17	31159053	641956	645448	rs1060500360	NC_000017.11:31159052:A:C
NM_001042492.3(NF1):c.4379A>G (p.His1460Arg)	NF1	H1439R, H1460R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000641811	17	29586096	17	31259078	641811	645628	rs748990989	NC_000017.11:31259077:A:G
NM_001042492.3(NF1):c.7856T>G (p.Leu2619Arg)	NF1	L2598R, L2619R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000641712	17	29684095	17	31357077	641712	645762	rs916881278	NC_000017.11:31357076:T:G
NM_001042492.3(NF1):c.1846-3T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000641613	17	29552110	17	31225092	641613	652726	rs1555613541	NC_000017.11:31225091:T:A
NM_001042492.3(NF1):c.1260+5G>A	NF1		Neurofibromatosis, type 1|Midaortic syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000641476	17	29528508	17	31201490	641476	653401	rs1060500253	NC_000017.11:31201489:G:A
NM_001042492.3(NF1):c.6986A>G (p.Asn2329Ser)	NF1	N2308S, N2329S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000641385	17	29667587	17	31340569	641385	645724	rs1597848079	NC_000017.11:31340568:A:G
NM_001042492.3(NF1):c.7949T>G (p.Phe2650Cys)	NF1	F2650C, F2629C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000641323	17	29684366	17	31357348	641323	645771	rs754443238	NC_000017.11:31357347:T:G
NM_001042492.3(NF1):c.1759A>C (p.Ser587Arg)	NF1	S587R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000641296	17	29550499	17	31223481	641296	645514	rs1597708695	NC_000017.11:31223480:A:C
NM_001042492.3(NF1):c.1642-9A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000641286	17	29548859	17	31221841	641286	652921	rs1597706581	NC_000017.11:31221840:A:G
NM_001042492.3(NF1):c.6850A>G (p.Thr2284Ala)	NF1	T2284A, T2263A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000641220	17	29665752	17	31338734	641220	645721	rs1597845953	NC_000017.11:31338733:A:G
NM_001042492.3(NF1):c.5479A>G (p.Ile1827Val)	NF1	I1806V, I1827V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000641217	17	29654727	17	31327709	641217	645671	rs1299780528	NC_000017.11:31327708:A:G
NM_001042492.3(NF1):c.1984A>T (p.Lys662Ter)	NF1	K662*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000641164	17	29552251	17	31225233	641164	645526	rs1597710793	NC_000017.11:31225232:A:T
NM_001042492.3(NF1):c.60+3A>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000641143	17	29422390	17	31095372	641143	653213	rs1598173910	NC_000017.11:31095371:A:T
NM_001042492.3(NF1):c.1522C>T (p.Leu508Phe)	NF1	L508F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000641036	17	29541598	17	31214580	641036	645508	rs1597698512	NC_000017.11:31214579:C:T
NM_001042492.3(NF1):c.1280C>T (p.Pro427Leu)	NF1	P427L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000641025	17	29533277	17	31206259	641025	645499	rs1597688746	NC_000017.11:31206258:C:T
NM_001042492.3(NF1):c.4490C>T (p.Ser1497Phe)	NF1	S1476F, S1497F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000640749	17	29587446	17	31260428	640749	645635	rs1597746999	NC_000017.11:31260427:C:T
NM_001042492.3(NF1):c.7054A>G (p.Asn2352Asp)	NF1	N2352D, N2331D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000640605	17	29667655	17	31340637	640605	645728	rs1441937734	NC_000017.11:31340636:A:G
NM_001042492.3(NF1):c.3813G>C (p.Met1271Ile)	NF1	M1271I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 16, 2018)	criteria provided, single submitter	VCV000640576	17	29562733	17	31235715	640576	645607	rs876658565	NC_000017.11:31235714:G:C
NM_001042492.3(NF1):c.2915T>A (p.Leu972Gln)	NF1	L972Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000640479	17	29556917	17	31229899	640479	645557	rs1597716348	NC_000017.11:31229898:T:A
NM_001042492.3(NF1):c.6147+5T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000640467	17	29663496	17	31336478	640467	652764	rs1597842332	NC_000017.11:31336477:T:A
NM_001042492.3(NF1):c.7381C>T (p.Leu2461Phe)	NF1	L2440F, L2461F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000640439	17	29677260	17	31350242	640439	645746	rs1199046022	NC_000017.11:31350241:C:T
NM_001042492.3(NF1):c.368C>A (p.Thr123Asn)	NF1	T123N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000640438	17	29490283	17	31163265	640438	645452	rs878853886	NC_000017.11:31163264:C:A
NM_001042492.3(NF1):c.7423A>G (p.Thr2475Ala)	NF1	T2454A, T2475A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000640408	17	29677302	17	31350284	640408	645751	rs1597859789	NC_000017.11:31350283:A:G
NM_001042492.3(NF1):c.4430+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000640358	17	29586148	17	31259130	640358	653430	rs773151680	NC_000017.11:31259129:G:A
NM_001042492.3(NF1):c.1174C>T (p.Gln392Ter)	NF1	Q392*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000640314	17	29528166	17	31201148	640314	645495	rs1597682137	NC_000017.11:31201147:C:T
NM_001042492.3(NF1):c.2542G>A (p.Gly848Arg)	NF1	G848R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000640216	17	29556175	17	31229157	640216	645548	rs1060500368	NC_000017.11:31229156:G:A
NM_001042492.3(NF1):c.1219C>T (p.His407Tyr)	NF1	H407Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000640138	17	29528462	17	31201444	640138	645496	rs1156614886	NC_000017.11:31201443:C:T
NM_001042492.3(NF1):c.4930G>A (p.Asp1644Asn)	NF1	D1623N, D1644N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000640039	17	29652932	17	31325914	640039	645652	rs1131691123	NC_000017.11:31325913:G:A
NM_001042492.3(NF1):c.7265A>G (p.Lys2422Arg)	NF1	K2422R, K2401R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000639985	17	29676213	17	31349195	639985	645740	rs1597858501	NC_000017.11:31349194:A:G
NM_001042492.3(NF1):c.4236A>C (p.Arg1412Ser)	NF1	R1391S, R1412S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000639692	17	29585424	17	31258406	639692	645621	rs137854554	NC_000017.11:31258405:A:C
NM_001042492.3(NF1):c.512A>C (p.Asn171Thr)	NF1	N171T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000639534	17	29496941	17	31169923	639534	645458	rs767500770	NC_000017.11:31169922:A:C
NM_001042492.3(NF1):c.669G>T (p.Trp223Cys)	NF1	W223C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000639518	17	29508742	17	31181724	639518	645467	rs1057517967	NC_000017.11:31181723:G:T
NM_001042492.3(NF1):c.3964G>C (p.Asp1322His)	NF1	D1322H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000639471	17	29563029	17	31236011	639471	645613	rs1597723042	NC_000017.11:31236010:G:C
NM_001042492.3(NF1):c.3079G>A (p.Asp1027Asn)	NF1	D1027N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000639288	17	29557366	17	31230348	639288	645572	rs774066804	NC_000017.11:31230347:G:A
NM_001042492.3(NF1):c.6547C>A (p.Arg2183=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000639287	17	29664505	17	31337487	639287	645711	rs760177417	NC_000017.11:31337486:C:A
NM_001042492.3(NF1):c.4339C>G (p.Gln1447Glu)	NF1	Q1447E, Q1426E	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 15, 2020)	criteria provided, single submitter	VCV000639280	17	29586056	17	31259038	639280	645626	rs1135402857	NC_000017.11:31259037:C:G
NM_001042492.3(NF1):c.1352T>G (p.Val451Gly)	NF1	V451G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000639255	17	29533349	17	31206331	639255	645502	rs747466938	NC_000017.11:31206330:T:G
NM_001042492.3(NF1):c.3815A>T (p.Gln1272Leu)	NF1	Q1272L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000639218	17	29562735	17	31235717	639218	645608	rs1597722580	NC_000017.11:31235716:A:T
NM_001042492.3(NF1):c.2272A>T (p.Arg758Ter)	NF1	R758*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000639102	17	29554256	17	31227238	639102	645535	rs777759192	NC_000017.11:31227237:A:T
NM_001042492.3(NF1):c.6436A>T (p.Lys2146Ter)	NF1	K2125*, K2146*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 22, 2019)	criteria provided, single submitter	VCV000639020	17	29664394	17	31337376	639020	645706	rs1597843675	NC_000017.11:31337375:A:T
NM_001042492.3(NF1):c.7901T>C (p.Phe2634Ser)	NF1	F2613S, F2634S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000638984	17	29684318	17	31357300	638984	645764	rs756567782	NC_000017.11:31357299:T:C
NM_001042492.3(NF1):c.5044T>C (p.Cys1682Arg)	NF1	C1682R, C1661R	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000638839	17	29653046	17	31326028	638839	645655	rs1597829901	NC_000017.11:31326027:T:C
NM_001042492.3(NF1):c.844C>T (p.Gln282Ter)	NF1	Q282*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000637000	17	29509639	17	31182621	637000	624623	rs753054046	NC_000017.11:31182620:C:T
NM_001042492.3(NF1):c.61-7486G>T	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2020)	criteria provided, conflicting interpretations	VCV000636832	17	29475515	17	31148497	636832	624813	rs1597617010	NC_000017.11:31148496:G:T
NM_001042492.3(NF1):c.1919C>T (p.Thr640Ile)	NF1	T640I	Hereditary cancer-predisposing syndrome|Neurofibroma|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635821	17	29552186	17	31225168	635821	623635	rs1555613573	NC_000017.11:31225167:C:T
NM_001042492.3(NF1):c.7063-2A>G	NF1		Neurofibroma|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000635820	17	29670025	17	31343007	635820	623637	rs1597851255	NC_000017.11:31343006:A:G
NM_001042492.3(NF1):c.7458-1G>C	NF1		Neurofibroma|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000635818	17	29679274	17	31352256	635818	623638	rs1597862012	NC_000017.11:31352255:G:C
NM_001042492.3(NF1):c.2329T>G (p.Trp777Gly)	NF1	W777G	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV000635519	17	29554544	17	31227526	635519	623344	rs876658853	NC_000017.11:31227525:T:G
NM_001042492.3(NF1):c.3708+1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 1, 2019)	no assertion criteria provided	VCV000635478	17	29560232	17	31233214	635478	623346	rs1420779915	NC_000017.11:31233213:G:A
NM_001042492.3(NF1):c.4069T>C (p.Phe1357Leu)	NF1	F1357L	not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633339	17	29576096	17	31249078	633339	621557	rs1207255352	NC_000017.11:31249077:T:C
NM_001042492.3(NF1):c.3679C>G (p.Leu1227Val)	NF1	L1227V	not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633337	17	29560202	17	31233184	633337	621556	rs876660431	NC_000017.11:31233183:C:G
NM_001042492.3(NF1):c.5134C>A (p.Pro1712Thr)	NF1	P1691T, P1712T	not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000633336	17	29653136	17	31326118	633336	621558	rs1567611556	NC_000017.11:31326117:C:A
NM_001042492.3(NF1):c.441C>A (p.Cys147Ter)	NF1	C147*	Neurofibromatosis, type 1	risk factor	no assertion criteria provided	VCV000631512	17	29490356	17	31163338	631512	619899	rs1597636022	NC_000017.11:31163337:C:A
NM_001042492.3(NF1):c.7278T>A (p.Cys2426Ter)	NF1	C2405*, C2426*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000627518	17	29676226	17	31349208	627518	615874	rs1567623508	NC_000017.11:31349207:T:A
NM_001042492.3(NF1):c.4316T>A (p.Leu1439Ter)	NF1	L1418*, L1439*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000623196	17	29585504	17	31258486	623196	612164	rs1567862071	NC_000017.11:31258485:T:A
NM_001042492.3(NF1):c.3106A>T (p.Lys1036Ter)	NF1	K1036*	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000620488	17	29557393	17	31230375	620488	611848	rs1567849891	NC_000017.11:31230374:A:T
NM_001042492.3(NF1):c.5959C>T (p.Gln1987Ter)	NF1	Q1966*, Q1987*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620128	17	29662002	17	31334984	620128	611851	rs876659070	NC_000017.11:31334983:C:T
NM_001042492.3(NF1):c.746T>C (p.Leu249Pro)	NF1	L249P	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618755	17	29509541	17	31182523	618755	610070	rs1567826623	NC_000017.11:31182522:T:C
NM_001042492.3(NF1):c.5855G>A (p.Trp1952Ter)	NF1	W1931*, W1952*	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000618754	17	29661898	17	31334880	618754	610078	rs1567615766	NC_000017.11:31334879:G:A
NM_001042492.3(NF1):c.2509T>C (p.Trp837Arg)	NF1	W837R	not specified|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 12, 2020)	criteria provided, conflicting interpretations	VCV000618753	17	29556142	17	31229124	618753	610074	rs587781747	NC_000017.11:31229123:T:C
NM_001042492.3(NF1):c.556G>T (p.Asp186Tyr)	NF1	D186Y	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618253	17	29496985	17	31169967	618253	610069	rs1567820765	NC_000017.11:31169966:G:T
NM_001042492.3(NF1):c.7334T>G (p.Val2445Gly)	NF1	V2424G, V2445G	not provided	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000618251	17	29677213	17	31350195	618251	610080	rs1567623931	NC_000017.11:31350194:T:G
NM_001042492.3(NF1):c.2842C>T (p.Gln948Ter)	NF1	Q948*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618249	17	29556475	17	31229457	618249	610075	rs1567849237	NC_000017.11:31229456:C:T
NM_001042492.3(NF1):c.7982T>A (p.Leu2661Ter)	NF1	L2640*, L2661*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000617614	17	29685509	17	31358491	617614	609010	rs1567627709	NC_000017.11:31358490:T:A
NM_001042492.3(NF1):c.3646G>T (p.Gly1216Cys)	NF1	G1216C	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000591153	17	29560169	17	31233151	591153	582147	rs1567851424	NC_000017.11:31233150:G:T
NM_001042492.3(NF1):c.7458-17T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000586981	17	29679258	17	31352240	586981	578027		NC_000017.11:31352239:T:G
NM_001042492.3(NF1):c.122A>T (p.Glu41Val)	NF1	E41V	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2020)	criteria provided, conflicting interpretations	VCV000586954	17	29483062	17	31156044	586954	578002		NC_000017.11:31156043:A:T
NM_001042492.3(NF1):c.913A>G (p.Lys305Glu)	NF1	K305E	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586174	17	29527464	17	31200446	586174	577620	rs1567835041	NC_000017.11:31200445:A:G
NM_001042492.3(NF1):c.3317A>G (p.Tyr1106Cys)	NF1	Y1106C	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)	criteria provided, conflicting interpretations	VCV000586172	17	29559720	17	31232702	586172	577625	rs1567850987	NC_000017.11:31232701:A:G
NM_001042492.3(NF1):c.2827A>T (p.Lys943Ter)	NF1	K943*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585292	17	29556460	17	31229442	585292	576343	rs1567849199	NC_000017.11:31229441:A:T
NM_001042492.3(NF1):c.1392+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000585289	17	29533390	17	31206372	585289	576342	rs267604791	NC_000017.11:31206371:G:C
NM_001042492.3(NF1):c.7513G>A (p.Ala2505Thr)	NF1	A2484T, A2505T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584935	17	29679330	17	31352312	584935	575984	rs786202955	NC_000017.11:31352311:G:A
NM_001042492.3(NF1):c.6623C>T (p.Ala2208Val)	NF1	A2187V, A2208V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584934	17	29664581	17	31337563	584934	575983	rs1555534886	NC_000017.11:31337562:C:T
NM_001042492.3(NF1):c.6577G>C (p.Glu2193Gln)	NF1	E2193Q, E2172Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584933	17	29664535	17	31337517	584933	575982	rs1135402891	NC_000017.11:31337516:G:C
NM_001042492.3(NF1):c.5269-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584932	17	29654515	17	31327497	584932	575981	rs1555533548	NC_000017.11:31327496:A:T
NM_001042492.3(NF1):c.4655A>G (p.Lys1552Arg)	NF1	K1531R, K1552R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584931	17	29588806	17	31261788	584931	575980	rs1172780277	NC_000017.11:31261787:A:G
NM_001042492.3(NF1):c.3625G>C (p.Val1209Leu)	NF1	V1209L	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584930	17	29560148	17	31233130	584930	575979	rs1458579232	NC_000017.11:31233129:G:C
NM_001042492.3(NF1):c.2897C>G (p.Ala966Gly)	NF1	A966G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000584929	17	29556899	17	31229881	584929	575978	rs1567849533	NC_000017.11:31229880:C:G
NM_001042492.3(NF1):c.2251G>C (p.Gly751Arg)	NF1	G751R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584927	17	29553702	17	31226684	584927	575976	rs1567847681	NC_000017.11:31226683:G:C
NM_001042492.3(NF1):c.484C>A (p.Gln162Lys)	NF1	Q162K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584926	17	29496913	17	31169895	584926	575975	rs1555607073	NC_000017.11:31169894:C:A
NM_001042492.3(NF1):c.1243C>T (p.His415Tyr)	NF1	H415Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000584539	17	29528486	17	31201468	584539	575603	rs1415155749	NC_000017.11:31201467:C:T
NM_001042492.3(NF1):c.2206A>C (p.Asn736His)	NF1	N736H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000583291	17	29553657	17	31226639	583291	574381	rs1567847621	NC_000017.11:31226638:A:C
NM_001042492.3(NF1):c.1921A>T (p.Ser641Cys)	NF1	S641C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000583284	17	29552188	17	31225170	583284	571007	rs769154907	NC_000017.11:31225169:A:T
NM_001042492.3(NF1):c.3667A>G (p.Ile1223Val)	NF1	I1223V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000583268	17	29560190	17	31233172	583268	568879	rs1567851470	NC_000017.11:31233171:A:G
NM_001042492.3(NF1):c.6249C>G (p.Arg2083=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2019)	criteria provided, conflicting interpretations	VCV000583060	17	29663754	17	31336736	583060	571170	rs1567616975	NC_000017.11:31336735:C:G
NM_001042492.3(NF1):c.1382G>A (p.Arg461Gln)	NF1	R461Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000583040	17	29533379	17	31206361	583040	574372	rs1555611606	NC_000017.11:31206360:G:A
NM_001042492.3(NF1):c.6700C>T (p.Gln2234Ter)	NF1	Q2213*, Q2234*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000583019	17	29664894	17	31337876	583019	571179	rs1567617727	NC_000017.11:31337875:C:T
NM_001042492.3(NF1):c.4016T>C (p.Leu1339Pro)	NF1	L1339P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000583016	17	29576043	17	31249025	583016	574404	rs1567858306	NC_000017.11:31249024:T:C
NM_001042492.3(NF1):c.6470C>T (p.Ser2157Leu)	NF1	S2136L, S2157L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000582941	17	29664428	17	31337410	582941	571034	rs774161532	NC_000017.11:31337409:C:T
NM_001042492.3(NF1):c.8017C>T (p.Gln2673Ter)	NF1	Q2673*, Q2652*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000582838	17	29685544	17	31358526	582838	574434	rs1567627751	NC_000017.11:31358525:C:T
NM_001042492.3(NF1):c.6442G>A (p.Val2148Ile)	NF1	V2148I, V2127I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000582746	17	29664400	17	31337382	582746	571028	rs770993581	NC_000017.11:31337381:G:A
NM_001042492.3(NF1):c.557A>T (p.Asp186Val)	NF1	D186V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000582722	17	29496986	17	31169968	582722	568767	rs1567820771	NC_000017.11:31169967:A:T
NM_001042492.3(NF1):c.732A>C (p.Glu244Asp)	NF1	E244D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000582716	17	29509527	17	31182509	582716	568783	rs1567826603	NC_000017.11:31182508:A:C
NM_001042492.3(NF1):c.778A>G (p.Thr260Ala)	NF1	T260A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000582455	17	29509573	17	31182555	582455	574358	rs1466892954	NC_000017.11:31182554:A:G
NM_001042492.3(NF1):c.4922T>C (p.Ile1641Thr)	NF1	I1641T, I1620T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000582432	17	29652924	17	31325906	582432	574412	rs1567611281	NC_000017.11:31325905:T:C
NM_001042492.3(NF1):c.4523A>G (p.His1508Arg)	NF1	H1487R, H1508R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000582409	17	29587479	17	31260461	582409	571116	rs1254695587	NC_000017.11:31260460:A:G
NM_001042492.3(NF1):c.4110+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582401	17	29576138	17	31249120	582401	574406	rs1555617383	NC_000017.11:31249119:G:T
NM_001042492.3(NF1):c.7869+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000582333	17	29684112	17	31357094	582333	571229	rs1567627046	NC_000017.11:31357093:A:G
NM_001042492.3(NF1):c.7888A>G (p.Thr2630Ala)	NF1	T2609A, T2630A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000582304	17	29684305	17	31357287	582304	574432	rs1567627155	NC_000017.11:31357286:A:G
NM_001042492.3(NF1):c.1529A>C (p.Asn510Thr)	NF1	N510T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000582137	17	29546024	17	31219006	582137	570882	rs876660091	NC_000017.11:31219005:A:C
NM_001042492.3(NF1):c.6819+6T>C	NF1		not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000582025	17	29665163	17	31338145	582025	568970	rs1407700643	NC_000017.11:31338144:T:C
NM_001042492.3(NF1):c.677A>C (p.Asn226Thr)	NF1	N226T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582019	17	29508750	17	31181732	582019	570944	rs770339628	NC_000017.11:31181731:A:C
NM_001042492.3(NF1):c.5384A>G (p.Asp1795Gly)	NF1	D1795G, D1774G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000581986	17	29654632	17	31327614	581986	571133	rs1567612446	NC_000017.11:31327613:A:G
NM_001042492.3(NF1):c.4462A>C (p.Thr1488Pro)	NF1	T1467P, T1488P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000581691	17	29587418	17	31260400	581691	570986	rs876660162	NC_000017.11:31260399:A:C
NM_001042492.3(NF1):c.1185G>A (p.Lys395=)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000581467	17	29528177	17	31201159	581467	574364	rs1567835847	NC_000017.11:31201158:G:A
NM_001042492.3(NF1):c.6679G>A (p.Asp2227Asn)	NF1	D2227N, D2206N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000581211	17	29664873	17	31337855	581211	574421	rs993364800	NC_000017.11:31337854:G:A
NM_001042492.3(NF1):c.7807G>A (p.Val2603Ile)	NF1	V2582I, V2603I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	VCV000581070	17	29684046	17	31357028	581070	571059	rs766135206	NC_000017.11:31357027:G:A
NM_001042492.3(NF1):c.288+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000581065	17	29486113	17	31159095	581065	570850	rs1555605406	NC_000017.11:31159094:T:C
NM_001042492.3(NF1):c.5863A>T (p.Asn1955Tyr)	NF1	N1955Y, N1934Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000581057	17	29661906	17	31334888	581057	571015	rs1567615782	NC_000017.11:31334887:A:T
NM_001042492.3(NF1):c.116A>T (p.Asn39Ile)	NF1	N39I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000581035	17	29483056	17	31156038	581035	574344	rs1567814494	NC_000017.11:31156037:A:T
NM_001042492.3(NF1):c.1846-5T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, single submitter	VCV000581018	17	29552108	17	31225090	581018	570981	rs1567846600	NC_000017.11:31225089:T:C
NM_001042492.3(NF1):c.2326-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000581003	17	29554540	17	31227522	581003	574385	rs1567848100	NC_000017.11:31227521:G:C
NM_001042492.3(NF1):c.7045C>G (p.Arg2349Gly)	NF1	R2328G, R2349G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000580832	17	29667646	17	31340628	580832	568977	rs56013763	NC_000017.11:31340627:C:G
NM_001042492.3(NF1):c.1393-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000580769	17	29541468	17	31214450	580769	574376	rs1131691131	NC_000017.11:31214449:G:A
NM_001042492.3(NF1):c.7009C>T (p.Leu2337Phe)	NF1	L2316F, L2337F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000580678	17	29667610	17	31340592	580678	574425	rs367734104	NC_000017.11:31340591:C:T
NM_001042492.3(NF1):c.6203C>G (p.Thr2068Ser)	NF1	T2047S, T2068S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000580384	17	29663708	17	31336690	580384	571025	rs876659172	NC_000017.11:31336689:C:G
NM_001042492.3(NF1):c.681T>A (p.Tyr227Ter)	NF1	Y227*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000580256	17	29508754	17	31181736	580256	568771	rs745804540	NC_000017.11:31181735:T:A
NM_001042492.3(NF1):c.1797G>A (p.Trp599Ter)	NF1	W599*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000580246	17	29550537	17	31223519	580246	568806	rs1567845906	NC_000017.11:31223518:G:A
NM_001042492.3(NF1):c.7040G>C (p.Ser2347Thr)	NF1	S2347T, S2326T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000580141	17	29667641	17	31340623	580141	571199	rs1567619102	NC_000017.11:31340622:G:C
NM_001042492.3(NF1):c.3992G>C (p.Ser1331Thr)	NF1	S1331T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000580115	17	29576019	17	31249001	580115	568890	rs1567858266	NC_000017.11:31249000:G:C
NM_001042492.3(NF1):c.3596C>T (p.Thr1199Ile)	NF1	T1199I	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: May 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000580044	17	29560119	17	31233101	580044	568871	rs1555615047	NC_000017.11:31233100:C:T
NM_001042492.3(NF1):c.3089C>G (p.Ser1030Ter)	NF1	S1030*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000580002	17	29557376	17	31230358	580002	574399	rs1567849864	NC_000017.11:31230357:C:G
NM_001042492.3(NF1):c.4660G>A (p.Val1554Met)	NF1	V1533M, V1554M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000579911	17	29588811	17	31261793	579911	570996	rs1319687326	NC_000017.11:31261792:G:A
NM_001042492.3(NF1):c.3436G>T (p.Val1146Phe)	NF1	V1146F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000579791	17	29559839	17	31232821	579791	570951	rs201047812	NC_000017.11:31232820:G:T
NM_001042492.3(NF1):c.3911T>C (p.Leu1304Ser)	NF1	L1304S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000579740	17	29562976	17	31235958	579740	568888	rs761512189	NC_000017.11:31235957:T:C
NM_001042492.3(NF1):c.1618G>T (p.Glu540Ter)	NF1	E540*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000579731	17	29546113	17	31219095	579731	570884	rs1567843930	NC_000017.11:31219094:G:T
NM_001042492.3(NF1):c.2410-18C>G	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000579654	17	29556025	17	31229007	579654	574388	rs533210843	NC_000017.11:31229006:C:G
NM_001042492.3(NF1):c.668G>A (p.Trp223Ter)	NF1	W223*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000579648	17	29508741	17	31181723	579648	568769	rs1567826110	NC_000017.11:31181722:G:A
NM_001042492.3(NF1):c.1845+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000579615	17	29550586	17	31223568	579615	568808	rs1567845945	NC_000017.11:31223567:G:A
NM_001042492.3(NF1):c.256A>G (p.Ile86Val)	NF1	I86V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000579548	17	29486079	17	31159061	579548	574348	rs757057811	NC_000017.11:31159060:A:G
NM_001042492.3(NF1):c.7790C>A (p.Ser2597Ter)	NF1	S2576*, S2597*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000579517	17	29684029	17	31357011	579517	574431	rs1567626945	NC_000017.11:31357010:C:A
NM_001042492.3(NF1):c.6368A>T (p.His2123Leu)	NF1	H2102L, H2123L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000579497	17	29663873	17	31336855	579497	571171	rs112546213	NC_000017.11:31336854:A:T
NM_001042492.3(NF1):c.7281C>A (p.Asp2427Glu)	NF1	D2406E, D2427E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000579377	17	29676229	17	31349211	579377	574429	rs1567623519	NC_000017.11:31349210:C:A
NM_001042492.3(NF1):c.3451A>G (p.Asn1151Asp)	NF1	N1151D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000579312	17	29559854	17	31232836	579312	574401	rs1567851125	NC_000017.11:31232835:A:G
NM_001042492.3(NF1):c.852A>G (p.Ile284Met)	NF1	I284M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000579246	17	29509647	17	31182629	579246	568787	rs1567826762	NC_000017.11:31182628:A:G
NM_001042492.3(NF1):c.1670G>A (p.Ser557Asn)	NF1	S557N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000579243	17	29548896	17	31221878	579243	568801	rs1567845046	NC_000017.11:31221877:G:A
NM_001042492.3(NF1):c.175A>G (p.Thr59Ala)	NF1	T59A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000579215	17	29483115	17	31156097	579215	570833	rs1567814586	NC_000017.11:31156096:A:G
NM_001042492.3(NF1):c.7926C>G (p.Tyr2642Ter)	NF1	Y2621*, Y2642*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000579176	17	29684343	17	31357325	579176	574433	rs1567627217	NC_000017.11:31357324:C:G
NM_001042492.3(NF1):c.618G>C (p.Lys206Asn)	NF1	K206N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000579024	17	29508471	17	31181453	579024	570860	rs1567825917	NC_000017.11:31181452:G:C
NM_001042492.3(NF1):c.5132G>T (p.Cys1711Phe)	NF1	C1690F, C1711F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000578980	17	29653134	17	31326116	578980	574413	rs1567611549	NC_000017.11:31326115:G:T
NM_001042492.3(NF1):c.8138G>A (p.Arg2713Gln)	NF1	R2713Q, R2692Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578922	17	29686011	17	31358993	578922	574436	rs1170836879	NC_000017.11:31358992:G:A
NM_001042492.3(NF1):c.7079T>G (p.Phe2360Cys)	NF1	F2339C, F2360C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 13, 2018)	criteria provided, single submitter	VCV000578916	17	29670043	17	31343025	578916	571218	rs1567620390	NC_000017.11:31343024:T:G
NM_001042492.3(NF1):c.3243T>A (p.Ala1081=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2018)	criteria provided, conflicting interpretations	VCV000578896	17	29559136	17	31232118	578896	571046	rs1567850679	NC_000017.11:31232117:T:A
NM_001042492.3(NF1):c.1845G>A (p.Lys615=)	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578879	17	29550585	17	31223567	578879	570901	rs1131691080	NC_000017.11:31223566:G:A
NM_001042492.3(NF1):c.6004C>T (p.Gln2002Ter)	NF1	Q2002*, Q1981*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000578868	17	29662047	17	31335029	578868	574420	rs1567615941	NC_000017.11:31335028:C:T
NM_001042492.3(NF1):c.2809T>G (p.Leu937Val)	NF1	L937V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578678	17	29556442	17	31229424	578678	568853	rs1567849181	NC_000017.11:31229423:T:G
NM_001042492.3(NF1):c.5669G>T (p.Gly1890Val)	NF1	G1869V, G1890V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000578661	17	29657373	17	31330355	578661	568938	rs1567613630	NC_000017.11:31330354:G:T
NM_001042492.3(NF1):c.1751A>T (p.Lys584Ile)	NF1	K584I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000578589	17	29550491	17	31223473	578589	570978	rs1567845855	NC_000017.11:31223472:A:T
NM_001042492.3(NF1):c.4768T>G (p.Leu1590Val)	NF1	L1569V, L1590V	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578543	17	29592290	17	31265272	578543	568919	rs1567865010	NC_000017.11:31265271:T:G
NM_001042492.3(NF1):c.6118T>C (p.Ser2040Pro)	NF1	S2040P, S2019P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000578527	17	29663462	17	31336444	578527	571024	rs1567616704	NC_000017.11:31336443:T:C
NM_001042492.3(NF1):c.4442A>G (p.Asp1481Gly)	NF1	D1460G, D1481G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000578483	17	29587398	17	31260380	578483	574408	rs777229737	NC_000017.11:31260379:A:G
NM_001042492.3(NF1):c.6056C>T (p.Ala2019Val)	NF1	A1998V, A2019V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000578431	17	29663400	17	31336382	578431	571152	rs1567616673	NC_000017.11:31336381:C:T
NM_001042492.3(NF1):c.7189G>C (p.Gly2397Arg)	NF1	G2376R, G2397R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000578365	17	29670153	17	31343135	578365	568989	rs1135402900	NC_000017.11:31343134:G:C
NM_001042492.3(NF1):c.4355A>G (p.His1452Arg)	NF1	H1431R, H1452R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 19, 2018)	criteria provided, single submitter	VCV000578360	17	29586072	17	31259054	578360	568909	rs1567862291	NC_000017.11:31259053:A:G
NM_001042492.3(NF1):c.2954A>T (p.Gln985Leu)	NF1	Q985L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000578168	17	29556956	17	31229938	578168	570931	rs1567849565	NC_000017.11:31229937:A:T
NM_001042492.3(NF1):c.3940T>C (p.Trp1314Arg)	NF1	W1314R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV000577999	17	29563005	17	31235987	577999	571086	rs576687606	NC_000017.11:31235986:T:C
NM_001042492.3(NF1):c.3361G>T (p.Glu1121Ter)	NF1	E1121*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000577899	17	29559764	17	31232746	577899	571066	rs1567851029	NC_000017.11:31232745:G:T
NM_001042492.3(NF1):c.62T>C (p.Leu21Pro)	NF1	L21P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000577584	17	29483002	17	31155984	577584	570924	rs1567814403	NC_000017.11:31155983:T:C
NM_001042492.3(NF1):c.6196A>G (p.Thr2066Ala)	NF1	T2045A, T2066A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000577495	17	29663701	17	31336683	577495	571169	rs1567616928	NC_000017.11:31336682:A:G
NM_001042492.3(NF1):c.1134C>G (p.Asp378Glu)	NF1	D378E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000577232	17	29528126	17	31201108	577232	570867	rs781367679	NC_000017.11:31201107:C:G
NM_001042492.3(NF1):c.7514C>T (p.Ala2505Val)	NF1	A2505V, A2484V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000577228	17	29679331	17	31352313	577228	571057	rs1567625126	NC_000017.11:31352312:C:T
NM_001042492.3(NF1):c.5083C>T (p.Arg1695Trp)	NF1	R1674W, R1695W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000577095	17	29653085	17	31326067	577095	568930	rs1567611500	NC_000017.11:31326066:C:T
NM_001042492.3(NF1):c.4369A>C (p.Lys1457Gln)	NF1	K1436Q, K1457Q	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2021)	criteria provided, conflicting interpretations	VCV000577061	17	29586086	17	31259068	577061	570982	rs878853893	NC_000017.11:31259067:A:C
NM_001042492.3(NF1):c.753C>G (p.Asp251Glu)	NF1	D251E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000576763	17	29509548	17	31182530	576763	570946	rs1567826636	NC_000017.11:31182529:C:G
NM_001042492.3(NF1):c.6038G>A (p.Ser2013Asn)	NF1	S2013N, S1992N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000576732	17	29663382	17	31336364	576732	571151	rs1567616663	NC_000017.11:31336363:G:A
NM_001042492.3(NF1):c.4787C>G (p.Ala1596Gly)	NF1	A1596G, A1575G	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000576579	17	29592309	17	31265291	576579	571126	rs1567865042	NC_000017.11:31265290:C:G
NM_001042492.3(NF1):c.4770A>C (p.Leu1590Phe)	NF1	L1569F, L1590F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV000576533	17	29592292	17	31265274	576533	568921	rs1567865021	NC_000017.11:31265273:A:C
NM_001042492.3(NF1):c.58C>T (p.Gln20Ter)	NF1	Q20*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000576465	17	29422385	17	31095367	576465	574343	rs1567786905	NC_000017.11:31095366:C:T
NM_001042492.3(NF1):c.2266C>T (p.Gln756Ter)	NF1	Q756*	Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000576444	17	29554250	17	31227232	576444	570918	rs1567847905	NC_000017.11:31227231:C:T
NM_001042492.3(NF1):c.4577+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000576239	17	29587534	17	31260516	576239	570994	rs1279529138	NC_000017.11:31260515:G:T
NM_001042492.3(NF1):c.1877T>C (p.Leu626Pro)	NF1	L626P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000576101	17	29552144	17	31225126	576101	568830	rs752591958	NC_000017.11:31225125:T:C
NM_001042492.3(NF1):c.779C>T (p.Thr260Ile)	NF1	T260I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000576092	17	29509574	17	31182556	576092	570953	rs1567826665	NC_000017.11:31182555:C:T
NM_001042492.3(NF1):c.6572C>T (p.Ser2191Phe)	NF1	S2191F, S2170F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000576084	17	29664530	17	31337512	576084	568963	rs765598479	NC_000017.11:31337511:C:T
NM_001042492.3(NF1):c.8421C>A (p.His2807Gln)	NF1	H2786Q, H2807Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000575928	17	29701074	17	31374056	575928	571073	rs1326795798	NC_000017.11:31374055:C:A
NM_001042492.3(NF1):c.2325+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000575838	17	29554310	17	31227292	575838	574384	rs1555613933	NC_000017.11:31227291:G:T
NM_001042492.3(NF1):c.4310G>A (p.Arg1437Lys)	NF1	R1416K, R1437K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000575825	17	29585498	17	31258480	575825	570975	rs1567862061	NC_000017.11:31258479:G:A
NM_001042492.3(NF1):c.2395A>G (p.Met799Val)	NF1	M799V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000575761	17	29554610	17	31227592	575761	571016	rs1060500317	NC_000017.11:31227591:A:G
NM_001042492.3(NF1):c.4711G>T (p.Glu1571Ter)	NF1	E1550*, E1571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000575667	17	29588862	17	31261844	575667	571124	rs1567863648	NC_000017.11:31261843:G:T
NM_001042492.3(NF1):c.1721+2T>G	NF1	Y575D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 31, 2018)	criteria provided, single submitter	VCV000575447	17	29548949	17	31221931	575447	570888	rs1567845116	NC_000017.11:31221930:T:G
NM_001042492.3(NF1):c.6376G>A (p.Val2126Ile)	NF1	V2105I, V2126I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000575421	17	29663881	17	31336863	575421	568954	rs1567617114	NC_000017.11:31336862:G:A
NM_001042492.3(NF1):c.5146G>C (p.Ala1716Pro)	NF1	A1695P, A1716P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV000575185	17	29653148	17	31326130	575185	574414	rs767469374	NC_000017.11:31326129:G:C
NM_001042492.3(NF1):c.276A>T (p.Lys92Asn)	NF1	K92N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000575154	17	29486099	17	31159081	575154	570838	rs1060503900	NC_000017.11:31159080:A:T
NM_001042492.3(NF1):c.1895G>A (p.Cys632Tyr)	NF1	C632Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000575094	17	29552162	17	31225144	575094	571001	rs1567846698	NC_000017.11:31225143:G:A
NM_001042492.3(NF1):c.1579A>T (p.Thr527Ser)	NF1	T527S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000574803	17	29546074	17	31219056	574803	570961	rs1567843874	NC_000017.11:31219055:A:T
NM_001042492.3(NF1):c.7090C>A (p.Arg2364=)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000574345	17	29670054	17	31343036	574345	568979	rs1567620403	NC_000017.11:31343035:C:A
NM_001042492.3(NF1):c.8498A>G (p.Asn2833Ser)	NF1	N2812S, N2833S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000574159	17	29701151	17	31374133	574159	568995	rs1567634576	NC_000017.11:31374132:A:G
NM_001042492.3(NF1):c.8080T>A (p.Ser2694Thr)	NF1	S2694T, S2673T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000574140	17	29685607	17	31358589	574140	574435	rs876658554	NC_000017.11:31358588:T:A
NM_001042492.3(NF1):c.3736C>G (p.Leu1246Val)	NF1	L1246V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000574135	17	29562656	17	31235638	574135	568885	rs1567852501	NC_000017.11:31235637:C:G
NM_001042492.3(NF1):c.2839T>A (p.Ser947Thr)	NF1	S947T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000574058	17	29556472	17	31229454	574058	570928	rs1567849219	NC_000017.11:31229453:T:A
NM_001042492.3(NF1):c.3749G>T (p.Arg1250Leu)	NF1	R1250L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000574021	17	29562669	17	31235651	574021	570967	rs199474765	NC_000017.11:31235650:G:T
NM_001042492.3(NF1):c.3314+1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000573917	17	29559208	17	31232190	573917	571060	rs767805288	NC_000017.11:31232189:G:A
NM_001042492.3(NF1):c.8490C>G (p.Phe2830Leu)	NF1	F2830L, F2809L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000573828	17	29701143	17	31374125	573828	571255	rs760550772	NC_000017.11:31374124:C:G
NM_001042492.3(NF1):c.1907C>A (p.Ser636Tyr)	NF1	S636Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000573787	17	29552174	17	31225156	573787	571004	rs780412565	NC_000017.11:31225155:C:A
NM_001042492.3(NF1):c.1765C>T (p.Gln589Ter)	NF1	Q589*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000573696	17	29550505	17	31223487	573696	568805	rs1282299543	NC_000017.11:31223486:C:T
NM_001042492.3(NF1):c.730+5G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000573582	17	29508808	17	31181790	573582	574354	rs1567826200	NC_000017.11:31181789:G:A
NM_001042492.3(NF1):c.3274G>A (p.Gly1092Ser)	NF1	G1092S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000573545	17	29559167	17	31232149	573545	571051	rs1457169236	NC_000017.11:31232148:G:A
NM_001042492.3(NF1):c.6642+5A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000573534	17	29664605	17	31337587	573534	568965	rs1567617536	NC_000017.11:31337586:A:G
NM_001042492.3(NF1):c.6700C>G (p.Gln2234Glu)	NF1	Q2234E, Q2213E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000573491	17	29664894	17	31337876	573491	574422	rs1567617727	NC_000017.11:31337875:C:G
NM_001042492.3(NF1):c.5900A>G (p.Lys1967Arg)	NF1	K1946R, K1967R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000573447	17	29661943	17	31334925	573447	568940	rs1567615807	NC_000017.11:31334924:A:G
NM_001042492.3(NF1):c.8363C>T (p.Ser2788Phe)	NF1	S2767F, S2788F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000573427	17	29687707	17	31360689	573427	571065	rs1567628713	NC_000017.11:31360688:C:T
NM_001042492.3(NF1):c.5984A>G (p.Lys1995Arg)	NF1	K1974R, K1995R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000573306	17	29662027	17	31335009	573306	568945	rs1567615913	NC_000017.11:31335008:A:G
NM_001042492.3(NF1):c.2540T>G (p.Leu847Arg)	NF1	L847R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000573019	17	29556173	17	31229155	573019	571033	rs199474747	NC_000017.11:31229154:T:G
NM_001042492.3(NF1):c.4985G>A (p.Trp1662Ter)	NF1	W1641*, W1662*	Rhabdomyosarcoma|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000573015	17	29652987	17	31325969	573015	568925	rs1567611375	NC_000017.11:31325968:G:A
NM_001042492.3(NF1):c.6921G>A (p.Lys2307=)	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000572995	17	29665823	17	31338805	572995	571192	rs1057523533	NC_000017.11:31338804:G:A
NM_001042492.3(NF1):c.5720T>A (p.Phe1907Tyr)	NF1	F1886Y, F1907Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000572925	17	29657424	17	31330406	572925	571014	rs1567613677	NC_000017.11:31330405:T:A
NM_001042492.3(NF1):c.5192T>A (p.Leu1731Ter)	NF1	L1710*, L1731*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000572862	17	29653194	17	31326176	572862	571008	rs1567611604	NC_000017.11:31326175:T:A
NM_001042492.3(NF1):c.7588T>C (p.Ser2530Pro)	NF1	S2509P, S2530P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000572859	17	29679405	17	31352387	572859	571058	rs1567625190	NC_000017.11:31352386:T:C
NM_001042492.3(NF1):c.589A>G (p.Thr197Ala)	NF1	T197A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000572839	17	29508442	17	31181424	572839	570934	rs1171626658	NC_000017.11:31181423:A:G
NM_001042492.3(NF1):c.7552G>A (p.Ala2518Thr)	NF1	A2497T, A2518T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000572767	17	29679369	17	31352351	572767	574430	rs1567625163	NC_000017.11:31352350:G:A
NM_001042492.3(NF1):c.7183T>G (p.Leu2395Val)	NF1	L2395V, L2374V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000572751	17	29670147	17	31343129	572751	571219	rs1567620503	NC_000017.11:31343128:T:G
NM_001042492.3(NF1):c.2765G>A (p.Gly922Asp)	NF1	G922D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000572649	17	29556398	17	31229380	572649	574396	rs1378141985	NC_000017.11:31229379:G:A
NM_001042492.3(NF1):c.1818C>A (p.Cys606Ter)	NF1	C606*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000572601	17	29550558	17	31223540	572601	570899	rs1567845937	NC_000017.11:31223539:C:A
NM_001042492.3(NF1):c.2617C>G (p.Arg873Gly)	NF1	R873G	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)	criteria provided, conflicting interpretations	VCV000572485	17	29556250	17	31229232	572485	571038	rs199474739	NC_000017.11:31229231:C:G
NM_001042492.3(NF1):c.2410-16A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000572474	17	29556027	17	31229009	572474	571021	rs1567848704	NC_000017.11:31229008:A:G
NM_001042492.3(NF1):c.2516A>T (p.Asn839Ile)	NF1	N839I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 28, 2018)	criteria provided, single submitter	VCV000572386	17	29556149	17	31229131	572386	571029	rs1567848834	NC_000017.11:31229130:A:T
NM_001042492.3(NF1):c.6749T>C (p.Val2250Ala)	NF1	V2229A, V2250A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000572193	17	29665087	17	31338069	572193	571045	rs1567617869	NC_000017.11:31338068:T:C
NM_001042492.3(NF1):c.5098C>T (p.Leu1700Phe)	NF1	L1679F, L1700F	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572107	17	29653100	17	31326082	572107	571006	rs775786295	NC_000017.11:31326081:C:T
NM_001042492.3(NF1):c.7870-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000572065	17	29684286	17	31357268	572065	571061	rs1567627138	NC_000017.11:31357267:G:A
NM_001042492.3(NF1):c.746T>G (p.Leu249Arg)	NF1	L249R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000572042	17	29509541	17	31182523	572042	574356	rs1567826623	NC_000017.11:31182522:T:G
NM_001042492.3(NF1):c.1603C>T (p.Gln535Ter)	NF1	Q535*	Tibial pseudoarthrosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571976	17	29546098	17	31219080	571976	574378	rs1567843917	NC_000017.11:31219079:C:T
NM_001042492.3(NF1):c.3974+1G>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000571920	17	29563040	17	31236022	571920	570971	rs1567852849	NC_000017.11:31236021:G:C
NM_001042492.3(NF1):c.5540C>T (p.Pro1847Leu)	NF1	P1826L, P1847L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000571903	17	29654788	17	31327770	571903	574418	rs1555533631	NC_000017.11:31327769:C:T
NM_001042492.3(NF1):c.7170G>T (p.Leu2390Phe)	NF1	L2369F, L2390F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000571858	17	29670134	17	31343116	571858	574426	rs751081026	NC_000017.11:31343115:G:T
NM_001042492.3(NF1):c.5528C>T (p.Thr1843Ile)	NF1	T1843I, T1822I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000571804	17	29654776	17	31327758	571804	574416	rs1567612632	NC_000017.11:31327757:C:T
NM_001042492.3(NF1):c.1393-2A>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000571756	17	29541467	17	31214449	571756	568797	rs1555612266	NC_000017.11:31214448:A:T
NM_001042492.3(NF1):c.6101C>T (p.Thr2034Ile)	NF1	T2034I, T2013I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000571753	17	29663445	17	31336427	571753	571160	rs1567616695	NC_000017.11:31336426:C:T
NM_001042492.3(NF1):c.1846-2A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000571696	17	29552111	17	31225093	571696	568827	rs1567846609	NC_000017.11:31225092:A:G
NM_001042492.3(NF1):c.6820-7C>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000571676	17	29665715	17	31338697	571676	574424	rs1555535020	NC_000017.11:31338696:C:A
NM_001042492.3(NF1):c.730G>A (p.Glu244Lys)	NF1	E244K	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2018)	criteria provided, conflicting interpretations	VCV000571661	17	29508803	17	31181785	571661	568776	rs1567826188	NC_000017.11:31181784:G:A
NM_001042492.3(NF1):c.7198C>T (p.His2400Tyr)	NF1	H2379Y, H2400Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000571612	17	29676146	17	31349128	571612	574428	rs1567623421	NC_000017.11:31349127:C:T
NM_001042492.3(NF1):c.3055G>A (p.Val1019Ile)	NF1	V1019I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000571610	17	29557342	17	31230324	571610	570940	rs1567849826	NC_000017.11:31230323:G:A
NM_001042492.3(NF1):c.1643C>T (p.Ala548Val)	NF1	A548V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571565	17	29548869	17	31221851	571565	570885	rs1567844997	NC_000017.11:31221850:C:T
NM_001042492.3(NF1):c.1229T>G (p.Leu410Arg)	NF1	L410R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000571545	17	29528472	17	31201454	571545	574366	rs1376759287	NC_000017.11:31201453:T:G
NM_001042492.3(NF1):c.3926T>A (p.Ile1309Asn)	NF1	I1309N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000571491	17	29562991	17	31235973	571491	571085	rs1567852796	NC_000017.11:31235972:T:A
NM_001042492.3(NF1):c.5610-4C>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571440	17	29657310	17	31330292	571440	568935	rs1419030713	NC_000017.11:31330291:C:G
NM_001042492.3(NF1):c.1319G>A (p.Arg440Gln)	NF1	R440Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000571423	17	29533316	17	31206298	571423	570869	rs1466678870	NC_000017.11:31206297:G:A
NM_001042492.3(NF1):c.6656A>T (p.Asp2219Val)	NF1	D2198V, D2219V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 3, 2018)	criteria provided, single submitter	VCV000571307	17	29664850	17	31337832	571307	571176	rs1567617676	NC_000017.11:31337831:A:T
NM_001042492.3(NF1):c.288+1G>T	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000571198	17	29486112	17	31159094	571198	568760	rs1567816131	NC_000017.11:31159093:G:T
NM_001042492.3(NF1):c.8062G>T (p.Val2688Leu)	NF1	V2688L, V2667L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 15, 2018)	criteria provided, single submitter	VCV000571104	17	29685589	17	31358571	571104	571254	rs1567627780	NC_000017.11:31358570:G:T
NM_001042492.3(NF1):c.3871-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000571095	17	29562935	17	31235917	571095	570968	rs1567852753	NC_000017.11:31235916:G:A
NM_001042492.3(NF1):c.5639T>C (p.Leu1880Ser)	NF1	L1859S, L1880S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000571031	17	29657343	17	31330325	571031	571141	rs1567613595	NC_000017.11:31330324:T:C
NM_001042492.3(NF1):c.670G>C (p.Val224Leu)	NF1	V224L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 17, 2018)	criteria provided, single submitter	VCV000571002	17	29508743	17	31181725	571002	568770	rs1567826116	NC_000017.11:31181724:G:C
NM_001042492.3(NF1):c.3641T>G (p.Met1214Arg)	NF1	M1214R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000570979	17	29560164	17	31233146	570979	568875	rs1567851416	NC_000017.11:31233145:T:G
NM_001042492.3(NF1):c.4543C>T (p.Gln1515Ter)	NF1	Q1494*, Q1515*	Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000570950	17	29587499	17	31260481	570950	570990	rs1567862991	NC_000017.11:31260480:C:T
NM_001042492.3(NF1):c.3752A>G (p.His1251Arg)	NF1	H1251R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000570856	17	29562672	17	31235654	570856	574402	rs1567852526	NC_000017.11:31235653:A:G
NM_001042492.3(NF1):c.1260+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000570670	17	29528504	17	31201486	570670	570960	rs267606603	NC_000017.11:31201485:G:T
NM_001042492.3(NF1):c.6936C>G (p.His2312Gln)	NF1	H2291Q, H2312Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000570613	17	29667537	17	31340519	570613	568972	rs1567618937	NC_000017.11:31340518:C:G
NM_001042492.3(NF1):c.1238C>G (p.Ser413Ter)	NF1	S413*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570504	17	29528481	17	31201463	570504	574368	rs1241533665	NC_000017.11:31201462:C:G
NM_001042492.3(NF1):c.3407G>A (p.Arg1136Gln)	NF1	R1136Q	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570356	17	29559810	17	31232792	570356	571078	rs868407539	NC_000017.11:31232791:G:A
NM_001042492.3(NF1):c.452A>G (p.Asn151Ser)	NF1	N151S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000570300	17	29490367	17	31163349	570300	574350	rs1567817981	NC_000017.11:31163348:A:G
NM_001042492.3(NF1):c.445A>G (p.Asn149Asp)	NF1	N149D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 10, 2018)	criteria provided, single submitter	VCV000570137	17	29490360	17	31163342	570137	570932	rs750974024	NC_000017.11:31163341:A:G
NM_001042492.3(NF1):c.4313G>T (p.Gly1438Val)	NF1	G1417V, G1438V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000570017	17	29585501	17	31258483	570017	570980	rs748901190	NC_000017.11:31258482:G:T
NM_001042492.3(NF1):c.7101G>A (p.Leu2367=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 10, 2018)	criteria provided, single submitter	VCV000569930	17	29670065	17	31343047	569930	568984	rs1567620421	NC_000017.11:31343046:G:A
NM_001042492.3(NF1):c.6794A>G (p.Lys2265Arg)	NF1	K2265R, K2244R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000569818	17	29665132	17	31338114	569818	568966	rs1060500258	NC_000017.11:31338113:A:G
NM_001042492.3(NF1):c.3958G>A (p.Glu1320Lys)	NF1	E1320K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569700	17	29563023	17	31236005	569700	570970	rs1273280025	NC_000017.11:31236004:G:A
NM_001042492.3(NF1):c.5935A>T (p.Ile1979Leu)	NF1	I1958L, I1979L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000569677	17	29661978	17	31334960	569677	571019	rs775480099	NC_000017.11:31334959:A:T
NM_001042492.3(NF1):c.2539C>G (p.Leu847Val)	NF1	L847V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000569665	17	29556172	17	31229154	569665	571031	rs753552408	NC_000017.11:31229153:C:G
NM_001042492.3(NF1):c.219A>T (p.Glu73Asp)	NF1	E73D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000569581	17	29486042	17	31159024	569581	570930	rs1567816022	NC_000017.11:31159023:A:T
NM_001042492.3(NF1):c.4333A>C (p.Ile1445Leu)	NF1	I1445L, I1424L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV000569472	17	29586050	17	31259032	569472	574407	rs1555618637	NC_000017.11:31259031:A:C
NM_001042492.3(NF1):c.567A>G (p.Lys189=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2018)	criteria provided, conflicting interpretations	VCV000569310	17	29496996	17	31169978	569310	570858	rs1567820796	NC_000017.11:31169977:A:G
NM_001042492.3(NF1):c.284C>T (p.Ala95Val)	NF1	A95V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000569188	17	29486107	17	31159089	569188	570845	rs1567816119	NC_000017.11:31159088:C:T
NM_001042492.3(NF1):c.4351A>G (p.Asn1451Asp)	NF1	N1451D, N1430D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000569136	17	29586068	17	31259050	569136	568904	rs1567862283	NC_000017.11:31259049:A:G
NM_001042492.3(NF1):c.4548G>C (p.Glu1516Asp)	NF1	E1495D, E1516D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000568927	17	29587504	17	31260486	568927	570992	rs1567863000	NC_000017.11:31260485:G:C
NM_001042492.3(NF1):c.3134T>C (p.Leu1045Pro)	NF1	L1045P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000568810	17	29557880	17	31230862	568810	570948	rs1567850142	NC_000017.11:31230861:T:C
NM_001042492.3(NF1):c.2325+6C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV000568795	17	29554315	17	31227297	568795	571012	rs1567847979	NC_000017.11:31227296:C:T
NM_001042492.3(NF1):c.1724C>G (p.Ser575Ter)	NF1	S575*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000568718	17	29550464	17	31223446	568718	570898	rs915463951	NC_000017.11:31223445:C:G
NM_001042492.3(NF1):c.2486C>T (p.Ser829Phe)	NF1	S829F	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000568707	17	29556119	17	31229101	568707	574390	rs1567848794	NC_000017.11:31229100:C:T
NM_001042492.3(NF1):c.2271A>T (p.Lys757Asn)	NF1	K757N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000568492	17	29554255	17	31227237	568492	574383	rs1555613916	NC_000017.11:31227236:A:T
NM_001042492.3(NF1):c.3722G>C (p.Arg1241Pro)	NF1	R1241P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000568343	17	29562642	17	31235624	568343	570965	rs543387071	NC_000017.11:31235623:G:C
NM_001042492.3(NF1):c.2990G>C (p.Arg997Thr)	NF1	R997T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000568334	17	29556992	17	31229974	568334	568857	rs1555614462	NC_000017.11:31229973:G:C
NM_001042492.3(NF1):c.4430+6T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000568299	17	29586153	17	31259135	568299	571102	rs1567862378	NC_000017.11:31259134:T:A
NM_001042492.3(NF1):c.1391C>T (p.Pro464Leu)	NF1	P464L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000568213	17	29533388	17	31206370	568213	574374	rs1269425503	NC_000017.11:31206369:C:T
NM_001042492.3(NF1):c.6161T>C (p.Met2054Thr)	NF1	M2054T, M2033T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000568031	17	29663666	17	31336648	568031	571165	rs1555534665	NC_000017.11:31336647:T:C
NM_001042492.3(NF1):c.7970+3A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000568012	17	29684390	17	31357372	568012	571063	rs1567627282	NC_000017.11:31357371:A:G
NM_001042492.3(NF1):c.4897C>A (p.Pro1633Thr)	NF1	P1612T, P1633T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000567918	17	29652899	17	31325881	567918	568923	rs1567611255	NC_000017.11:31325880:C:A
NM_001042492.3(NF1):c.2660C>T (p.Ala887Val)	NF1	A887V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, single submitter	VCV000567890	17	29556293	17	31229275	567890	574393	rs1567849029	NC_000017.11:31229274:C:T
NM_001042492.3(NF1):c.355C>A (p.His119Asn)	NF1	H119N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000567623	17	29490270	17	31163252	567623	570853	rs1555606066	NC_000017.11:31163251:C:A
NM_001042492.3(NF1):c.8461G>A (p.Val2821Met)	NF1	V2821M, V2800M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000567320	17	29701114	17	31374096	567320	571075	rs1567634549	NC_000017.11:31374095:G:A
NM_001042492.3(NF1):c.1069C>G (p.Leu357Val)	NF1	L357V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000567012	17	29528061	17	31201043	567012	574362	rs1567835662	NC_000017.11:31201042:C:G
NM_001042492.3(NF1):c.6647G>T (p.Cys2216Phe)	NF1	C2195F, C2216F	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000566978	17	29664841	17	31337823	566978	571041	rs1567617669	NC_000017.11:31337822:G:T
NM_001042492.3(NF1):c.1722-9T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000566858	17	29550453	17	31223435	566858	570895	rs1567845805	NC_000017.11:31223434:T:G
NM_001042492.3(NF1):c.4245T>A (p.Asn1415Lys)	NF1	N1394K, N1415K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000566848	17	29585433	17	31258415	566848	568896	rs760949880	NC_000017.11:31258414:T:A
NM_001042492.3(NF1):c.2740C>T (p.Arg914Trp)	NF1	R914W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 5, 2018)	criteria provided, single submitter	VCV000566843	17	29556373	17	31229355	566843	574395	rs765848298	NC_000017.11:31229354:C:T
NM_001042492.3(NF1):c.3496+5G>A	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566489	17	29559904	17	31232886	566489	568863	rs786202564	NC_000017.11:31232885:G:A
NM_001042492.3(NF1):c.6427+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000566355	17	29663934	17	31336916	566355	568957	rs1567617158	NC_000017.11:31336915:T:G
NM_001042492.3(NF1):c.2642T>C (p.Met881Thr)	NF1	M881T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566231	17	29556275	17	31229257	566231	574392	rs777868654	NC_000017.11:31229256:T:C
NM_001042492.3(NF1):c.6931C>G (p.Leu2311Val)	NF1	L2290V, L2311V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000566160	17	29667532	17	31340514	566160	571049	rs1044698498	NC_000017.11:31340513:C:G
NM_001042492.3(NF1):c.3447G>C (p.Met1149Ile)	NF1	M1149I	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000566155	17	29559850	17	31232832	566155	570952	rs1064794277	NC_000017.11:31232831:G:C
NM_001042492.3(NF1):c.3673A>G (p.Met1225Val)	NF1	M1225V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000565922	17	29560196	17	31233178	565922	570957	rs770837892	NC_000017.11:31233177:A:G
NM_001042492.3(NF1):c.2725G>T (p.Val909Leu)	NF1	V909L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 15, 2018)	criteria provided, single submitter	VCV000565794	17	29556358	17	31229340	565794	574394	rs1567849105	NC_000017.11:31229339:G:T
NM_001042492.3(NF1):c.2407C>T (p.Gln803Ter)	NF1	Q803*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000565792	17	29554622	17	31227604	565792	574387	rs1567848213	NC_000017.11:31227603:C:T
NM_001042492.3(NF1):c.2963T>C (p.Ile988Thr)	NF1	I988T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000565716	17	29556965	17	31229947	565716	574397	rs746670929	NC_000017.11:31229946:T:C
NM_001042492.3(NF1):c.4000G>T (p.Glu1334Ter)	NF1	E1334*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000565647	17	29576027	17	31249009	565647	568894	rs878853892	NC_000017.11:31249008:G:T
NM_001042492.3(NF1):c.7406A>G (p.Glu2469Gly)	NF1	E2448G, E2469G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000565588	17	29677285	17	31350267	565588	571226	rs1281096294	NC_000017.11:31350266:A:G
NM_001042492.3(NF1):c.7180C>G (p.Leu2394Val)	NF1	L2373V, L2394V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000565569	17	29670144	17	31343126	565569	574427	rs1555535452	NC_000017.11:31343125:C:G
NM_001042492.3(NF1):c.4616T>C (p.Met1539Thr)	NF1	M1539T, M1518T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000565568	17	29588767	17	31261749	565568	571118	rs1567863578	NC_000017.11:31261748:T:C
NM_001042492.3(NF1):c.479+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000565507	17	29490399	17	31163381	565507	570933	rs1567818033	NC_000017.11:31163380:G:A
NM_001042492.3(NF1):c.3870+1G>T	NF1		Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000565498	17	29562791	17	31235773	565498	574403	rs1131691075	NC_000017.11:31235772:G:T
NM_001042492.3(NF1):c.4556G>A (p.Gly1519Glu)	NF1	G1498E, G1519E	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000565475	17	29587512	17	31260494	565475	571117	rs1567863004	NC_000017.11:31260493:G:A
NM_001042492.3(NF1):c.6643-8T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000565441	17	29664829	17	31337811	565441	571036	rs752079977	NC_000017.11:31337810:T:A
NM_001042492.3(NF1):c.3315-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000565393	17	29559717	17	31232699	565393	574400	rs1567850984	NC_000017.11:31232698:G:C
NM_001042492.3(NF1):c.479+1G>T	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561965	17	29490395	17	31163377	561965	552878	rs1555606137	NC_000017.11:31163376:G:T
NM_001042492.3(NF1):c.7458-3C>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561955	17	29679272	17	31352254	561955	552996	rs1158267419	NC_000017.11:31352253:C:G
NM_001042492.3(NF1):c.1754T>G (p.Leu585Ter)	NF1	L585*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000561952	17	29550494	17	31223476	561952	552915	rs775670722	NC_000017.11:31223475:T:G
NM_001042492.3(NF1):c.586+5G>C	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561921	17	29497020	17	31170002	561921	552885	rs1060500284	NC_000017.11:31170001:G:C
NM_001042492.3(NF1):c.1069C>T (p.Leu357Phe)	NF1	L357F	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561903	17	29528061	17	31201043	561903	552896	rs1567835662	NC_000017.11:31201042:C:T
NM_001042492.3(NF1):c.1186-8T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561861	17	29528421	17	31201403	561861	552897	rs921012432	NC_000017.11:31201402:T:C
NM_001042492.3(NF1):c.5967C>G (p.Tyr1989Ter)	NF1	Y1968*, Y1989*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561857	17	29662010	17	31334992	561857	552978	rs1567615902	NC_000017.11:31334991:C:G
NM_001042492.3(NF1):c.3198-5T>G	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561845	17	29559086	17	31232068	561845	552939	rs587782639	NC_000017.11:31232067:T:G
NM_001042492.3(NF1):c.392C>T (p.Ala131Val)	NF1	A131V	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561800	17	29490307	17	31163289	561800	552877	rs1567817930	NC_000017.11:31163288:C:T
NM_001042492.3(NF1):c.2518A>G (p.Met840Val)	NF1	M840V	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561788	17	29556151	17	31229133	561788	552927	rs779931789	NC_000017.11:31229132:A:G
NM_001042492.3(NF1):c.5610-1G>C	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561746	17	29657313	17	31330295	561746	552971	rs1567613569	NC_000017.11:31330294:G:C
NM_001042492.3(NF1):c.1998T>C (p.Ser666=)	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2018)	criteria provided, conflicting interpretations	VCV000561687	17	29552265	17	31225247	561687	552917	rs1567846823	NC_000017.11:31225246:T:C
NM_001042492.3(NF1):c.4721C>T (p.Thr1574Ile)	NF1	T1553I, T1574I	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561685	17	29588872	17	31261854	561685	552956	rs1567863650	NC_000017.11:31261853:C:T
NM_001042492.3(NF1):c.2850G>A (p.Gln950=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561684	17	29556483	17	31229465	561684	552930	rs863224446	NC_000017.11:31229464:G:A
NM_001042492.3(NF1):c.5269-14C>G	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000561680	17	29654503	17	31327485	561680	552965	rs753463683	NC_000017.11:31327484:C:G
NM_001042492.3(NF1):c.3989A>C (p.Glu1330Ala)	NF1	E1330A	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561676	17	29576016	17	31248998	561676	552945	rs1256727206	NC_000017.11:31248997:A:C
NM_001042492.3(NF1):c.527A>G (p.Asp176Gly)	NF1	D176G	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Apr 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561646	17	29496956	17	31169938	561646	552884	rs1567820732	NC_000017.11:31169937:A:G
NM_001042492.3(NF1):c.7970+5G>T	NF1		not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561510	17	29684392	17	31357374	561510	553000	rs1567627286	NC_000017.11:31357373:G:T
NM_001042492.3(NF1):c.3216C>G (p.Ser1072Arg)	NF1	S1072R	not provided	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000561506	17	29559109	17	31232091	561506	552940	rs1567850647	NC_000017.11:31232090:C:G
NM_001042492.3(NF1):c.2325+2T>C	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561504	17	29554311	17	31227293	561504	552923	rs1567847972	NC_000017.11:31227292:T:C
NM_001042492.3(NF1):c.480-2A>G	NF1		not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000561503	17	29496907	17	31169889	561503	552883	rs1567820688	NC_000017.11:31169888:A:G
NM_001042492.3(NF1):c.2510G>A (p.Trp837Ter)	NF1	W837*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000561498	17	29556143	17	31229125	561498	552926	rs1348129244	NC_000017.11:31229124:G:A
NM_001042492.3(NF1):c.6340G>T (p.Gly2114Cys)	NF1	G2093C, G2114C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561056	17	29663845	17	31336827	561056	552201	rs1567617070	NC_000017.11:31336826:G:T
NM_001042492.3(NF1):c.989C>A (p.Ala330Glu)	NF1	A330E	Neurofibromatosis type 6	Uncertain significance	no assertion criteria provided	VCV000560363	17	29527540	17	31200522	560363	551417	rs1555610898	NC_000017.11:31200521:C:A
NM_001042492.3(NF1):c.8222C>A (p.Thr2741Lys)	NF1	T2720K, T2741K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547702	17	29687566	17	31360548	547702	538239	rs144178015	NC_000017.11:31360547:C:A
NM_001042492.3(NF1):c.8160+1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547701	17	29686034	17	31359016	547701	538238	rs1555537032	NC_000017.11:31359015:G:A
NM_001042492.3(NF1):c.7970+6T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547699	17	29684393	17	31357375	547699	538236	rs1555536775	NC_000017.11:31357374:T:G
NM_001042492.3(NF1):c.7906C>T (p.Gln2636Ter)	NF1	Q2615*, Q2636*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547698	17	29684323	17	31357305	547698	538235	rs567988442	NC_000017.11:31357304:C:T
NM_001042492.3(NF1):c.7870-20A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547697	17	29684267	17	31357249	547697	538234	rs574898272	NC_000017.11:31357248:A:G
NM_001042492.3(NF1):c.7619C>A (p.Thr2540Lys)	NF1	T2519K, T2540K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547694	17	29683481	17	31356463	547694	538231	rs1555536633	NC_000017.11:31356462:C:A
NM_001042492.3(NF1):c.7157T>C (p.Phe2386Ser)	NF1	F2365S, F2386S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547692	17	29670121	17	31343103	547692	538229	rs1555535439	NC_000017.11:31343102:T:C
NM_001042492.3(NF1):c.7010T>G (p.Leu2337Arg)	NF1	L2316R, L2337R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547691	17	29667611	17	31340593	547691	538228	rs1555535179	NC_000017.11:31340592:T:G
NM_001042492.3(NF1):c.7006G>C (p.Ala2336Pro)	NF1	A2315P, A2336P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547690	17	29667607	17	31340589	547690	538227	rs587781428	NC_000017.11:31340588:G:C
NM_001042492.3(NF1):c.6921+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547687	17	29665824	17	31338806	547687	538223	rs1060500355	NC_000017.11:31338805:G:T
NM_001042492.3(NF1):c.6921+2T>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547686	17	29665825	17	31338807	547686	538224	rs1555535053	NC_000017.11:31338806:T:A
NM_001042492.3(NF1):c.6921G>C (p.Lys2307Asn)	NF1	K2286N, K2307N	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547685	17	29665823	17	31338805	547685	538222	rs1057523533	NC_000017.11:31338804:G:C
NM_001042492.3(NF1):c.6704+2T>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547681	17	29664900	17	31337882	547681	538218	rs1555534928	NC_000017.11:31337881:T:G
NM_001042492.3(NF1):c.6704+1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Rhabdomyosarcoma|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547680	17	29664899	17	31337881	547680	538217	rs1060500376	NC_000017.11:31337880:G:T
NM_001042492.3(NF1):c.6669C>A (p.Cys2223Ter)	NF1	C2202*, C2223*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547678	17	29664863	17	31337845	547678	538215	rs1555534918	NC_000017.11:31337844:C:A
NM_001042492.3(NF1):c.6642+18A>G	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2021)	criteria provided, conflicting interpretations	VCV000547676	17	29664618	17	31337600	547676	538213	rs1555534893	NC_000017.11:31337599:A:G
NM_001042492.3(NF1):c.6147+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547673	17	29663493	17	31336475	547673	538210	rs1555534621	NC_000017.11:31336474:T:C
NM_001042492.3(NF1):c.6007-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547672	17	29663349	17	31336331	547672	538208	rs1555534595	NC_000017.11:31336330:A:G
NM_001042492.3(NF1):c.6007-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547671	17	29663350	17	31336332	547671	538209	rs1555534596	NC_000017.11:31336331:G:A
NM_001042492.3(NF1):c.5836T>A (p.Leu1946Met)	NF1	L1925M, L1946M	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547670	17	29661879	17	31334861	547670	538207	rs1422333640	NC_000017.11:31334860:T:A
NM_001042492.3(NF1):c.5812+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547669	17	29657518	17	31330500	547669	538206	rs1555533887	NC_000017.11:31330499:T:C
NM_001042492.3(NF1):c.5812+1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547668	17	29657517	17	31330499	547668	538205	rs876658854	NC_000017.11:31330498:G:T
NM_001042492.3(NF1):c.5676A>C (p.Leu1892Phe)	NF1	L1871F, L1892F	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547665	17	29657380	17	31330362	547665	538202	rs876658130	NC_000017.11:31330361:A:C
NM_001042492.3(NF1):c.5624A>G (p.Asn1875Ser)	NF1	N1854S, N1875S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547663	17	29657328	17	31330310	547663	538200	rs1555533843	NC_000017.11:31330309:A:G
NM_001042492.3(NF1):c.5357C>A (p.Ser1786Ter)	NF1	S1765*, S1786*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547660	17	29654605	17	31327587	547660	538197	rs1555533569	NC_000017.11:31327586:C:A
NM_001042492.3(NF1):c.5285T>A (p.Val1762Asp)	NF1	V1741D, V1762D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547659	17	29654533	17	31327515	547659	538196	rs1555533550	NC_000017.11:31327514:T:A
NM_001042492.3(NF1):c.5273G>C (p.Gly1758Ala)	NF1	G1737A, G1758A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547658	17	29654521	17	31327503	547658	538195	rs1358882546	NC_000017.11:31327502:G:C
NM_001042492.3(NF1):c.5269-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547657	17	29654515	17	31327497	547657	538194	rs1555533548	NC_000017.11:31327496:A:G
NM_001042492.3(NF1):c.5268+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547656	17	29653272	17	31326254	547656	538193	rs1555533416	NC_000017.11:31326253:T:G
NM_001042492.3(NF1):c.4934T>G (p.Leu1645Arg)	NF1	L1624R, L1645R	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)	criteria provided, conflicting interpretations	VCV000547653	17	29652936	17	31325918	547653	538190	rs1555533305	NC_000017.11:31325917:T:G
NM_001042492.3(NF1):c.4835+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547652	17	29592358	17	31265340	547652	538189	rs1085307819	NC_000017.11:31265339:G:A
NM_001042492.3(NF1):c.4821T>A (p.Tyr1607Ter)	NF1	Y1586*, Y1607*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547651	17	29592343	17	31265325	547651	538188	rs1555619416	NC_000017.11:31265324:T:A
NM_001042492.3(NF1):c.4635C>G (p.Tyr1545Ter)	NF1	Y1524*, Y1545*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547647	17	29588786	17	31261768	547647	538184	rs754023358	NC_000017.11:31261767:C:G
NM_001042492.3(NF1):c.4586A>G (p.Lys1529Arg)	NF1	K1508R, K1529R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547646	17	29588737	17	31261719	547646	538183	rs1555619001	NC_000017.11:31261718:A:G
NM_001042492.3(NF1):c.4430+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547645	17	29586148	17	31259130	547645	538182	rs773151680	NC_000017.11:31259129:G:C
NM_001042492.3(NF1):c.4306G>T (p.Glu1436Ter)	NF1	E1415*, E1436*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547643	17	29585494	17	31258476	547643	538180	rs876660428	NC_000017.11:31258475:G:T
NM_001042492.3(NF1):c.4231C>G (p.Leu1411Val)	NF1	L1390V, L1411V	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547642	17	29585419	17	31258401	547642	538179	rs199474789	NC_000017.11:31258400:C:G
NM_001042492.3(NF1):c.4183C>T (p.Gln1395Ter)	NF1	Q1374*, Q1395*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547641	17	29585371	17	31258353	547641	538178	rs1555618494	NC_000017.11:31258352:C:T
NM_001042492.3(NF1):c.3864T>A (p.Cys1288Ter)	NF1	C1288*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547638	17	29562784	17	31235766	547638	538175	rs1555615495	NC_000017.11:31235765:T:A
NM_001042492.3(NF1):c.3767T>G (p.Leu1256Arg)	NF1	L1256R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547635	17	29562687	17	31235669	547635	538172	rs1555615457	NC_000017.11:31235668:T:G
NM_001042492.3(NF1):c.3708+3A>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547634	17	29560234	17	31233216	547634	538171	rs1555615114	NC_000017.11:31233215:A:T
NM_001042492.3(NF1):c.3644T>C (p.Met1215Thr)	NF1	M1215T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547631	17	29560167	17	31233149	547631	538168	rs1555615071	NC_000017.11:31233148:T:C
NM_001042492.3(NF1):c.3596C>G (p.Thr1199Arg)	NF1	T1199R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547630	17	29560119	17	31233101	547630	538167	rs1555615047	NC_000017.11:31233100:C:G
NM_001042492.3(NF1):c.3586C>G (p.Leu1196Val)	NF1	L1196V	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2020)	criteria provided, conflicting interpretations	VCV000547629	17	29560109	17	31233091	547629	538166	rs1555615039	NC_000017.11:31233090:C:G
NM_001042492.3(NF1):c.3318C>A (p.Tyr1106Ter)	NF1	Y1106*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547626	17	29559721	17	31232703	547626	538163	rs876659289	NC_000017.11:31232702:C:A
NM_001042492.3(NF1):c.3313A>T (p.Lys1105Ter)	NF1	K1105*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547625	17	29559206	17	31232188	547625	538162	rs1555614867	NC_000017.11:31232187:A:T
NM_001042492.3(NF1):c.3251C>T (p.Pro1084Leu)	NF1	P1084L	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547623	17	29559144	17	31232126	547623	538160	rs1164081667	NC_000017.11:31232125:C:T
NM_001042492.3(NF1):c.3114-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547621	17	29557859	17	31230841	547621	538158	rs1555614611	NC_000017.11:31230840:G:A
NM_001042492.3(NF1):c.2991-2A>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547620	17	29557276	17	31230258	547620	538157	rs1555614495	NC_000017.11:31230257:A:C
NM_001042492.3(NF1):c.2850+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547617	17	29556484	17	31229466	547617	538154	rs1131691122	NC_000017.11:31229465:G:A
NM_001042492.3(NF1):c.2786T>C (p.Leu929Pro)	NF1	L929P	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2020)	criteria provided, conflicting interpretations	VCV000547614	17	29556419	17	31229401	547614	538151	rs1555614338	NC_000017.11:31229400:T:C
NM_001042492.3(NF1):c.2560C>T (p.Gln854Ter)	NF1	Q854*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547612	17	29556193	17	31229175	547612	538149	rs1555614261	NC_000017.11:31229174:C:T
NM_001042492.3(NF1):c.2356C>T (p.Gln786Ter)	NF1	Q786*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547610	17	29554571	17	31227553	547610	538147	rs1555613999	NC_000017.11:31227552:C:T
NM_001042492.3(NF1):c.2269A>T (p.Lys757Ter)	NF1	K757*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547608	17	29554253	17	31227235	547608	538145	rs1270674587	NC_000017.11:31227234:A:T
NM_001042492.3(NF1):c.2252-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547607	17	29554234	17	31227216	547607	538143	rs1131691105	NC_000017.11:31227215:A:C
NM_001042492.3(NF1):c.2252-1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547606	17	29554235	17	31227217	547606	538144	rs587781577	NC_000017.11:31227216:G:T
NM_001042492.3(NF1):c.1846C>T (p.Gln616Ter)	NF1	Q616*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547603	17	29552113	17	31225095	547603	538140	rs1555613543	NC_000017.11:31225094:C:T
NM_001042492.3(NF1):c.1845+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547602	17	29550587	17	31223569	547602	538139	rs1555613430	NC_000017.11:31223568:T:C
NM_001042492.3(NF1):c.1660C>T (p.Gln554Ter)	NF1	Q554*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000547601	17	29548886	17	31221868	547601	538138	rs953440640	NC_000017.11:31221867:C:T
NM_001042492.3(NF1):c.1655T>G (p.Leu552Arg)	NF1	L552R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547600	17	29548881	17	31221863	547600	538137	rs1555613193	NC_000017.11:31221862:T:G
NM_001042492.3(NF1):c.1642-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547599	17	29548867	17	31221849	547599	538136	rs1555613185	NC_000017.11:31221848:G:A
NM_001042492.3(NF1):c.1641+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547598	17	29546138	17	31219120	547598	538135	rs1555612867	NC_000017.11:31219119:T:C
NM_001042492.3(NF1):c.1607C>G (p.Ser536Ter)	NF1	S536*	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547597	17	29546102	17	31219084	547597	538134	rs1555612859	NC_000017.11:31219083:C:G
NM_001042492.3(NF1):c.1607C>A (p.Ser536Ter)	NF1	S536*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547596	17	29546102	17	31219084	547596	538133	rs1555612859	NC_000017.11:31219083:C:A
NM_001042492.3(NF1):c.1598T>G (p.Val533Gly)	NF1	V533G	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547595	17	29546093	17	31219075	547595	538132	rs1555612857	NC_000017.11:31219074:T:G
NM_001042492.3(NF1):c.1540C>T (p.Gln514Ter)	NF1	Q514*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547594	17	29546035	17	31219017	547594	538131	rs1316926587	NC_000017.11:31219016:C:T
NM_001042492.3(NF1):c.1527+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547593	17	29541605	17	31214587	547593	538130	rs1064796700	NC_000017.11:31214586:T:C
NM_001042492.3(NF1):c.1496T>G (p.Leu499Arg)	NF1	L499R	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547592	17	29541572	17	31214554	547592	538129	rs1555612288	NC_000017.11:31214553:T:G
NM_001042492.3(NF1):c.1393-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547589	17	29541468	17	31214450	547589	538126	rs1131691131	NC_000017.11:31214449:G:C
NM_001042492.3(NF1):c.1328T>C (p.Phe443Ser)	NF1	F443S	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2019)	criteria provided, conflicting interpretations	VCV000547588	17	29533325	17	31206307	547588	538125	rs1555611581	NC_000017.11:31206306:T:C
NM_001042492.3(NF1):c.1260+6T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547587	17	29528509	17	31201491	547587	538124	rs1555611111	NC_000017.11:31201490:T:G
NM_001042492.3(NF1):c.1260+6T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547586	17	29528509	17	31201491	547586	538123	rs1555611111	NC_000017.11:31201490:T:C
NM_001042492.3(NF1):c.1237T>C (p.Ser413Pro)	NF1	S413P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547584	17	29528480	17	31201462	547584	538121	rs1555611093	NC_000017.11:31201461:T:C
NM_001042492.3(NF1):c.1063-1G>C	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547580	17	29528054	17	31201036	547580	538117	rs1555610955	NC_000017.11:31201035:G:C
NM_001042492.3(NF1):c.989C>T (p.Ala330Val)	NF1	A330V	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547578	17	29527540	17	31200522	547578	538115	rs1555610898	NC_000017.11:31200521:C:T
NM_001042492.3(NF1):c.980T>C (p.Leu327Pro)	NF1	L327P	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2018)	criteria provided, conflicting interpretations	VCV000547576	17	29527531	17	31200513	547576	538113	rs201624827	NC_000017.11:31200512:T:C
NM_001042492.3(NF1):c.959C>A (p.Ala320Asp)	NF1	A320D	Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	VCV000547575	17	29527510	17	31200492	547575	538112	rs1555610884	NC_000017.11:31200491:C:A
NM_001042492.3(NF1):c.943C>T (p.Gln315Ter)	NF1	Q315*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547574	17	29527494	17	31200476	547574	538111	rs766011053	NC_000017.11:31200475:C:T
NM_001042492.3(NF1):c.888+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547573	17	29509684	17	31182666	547573	538110	rs1135402799	NC_000017.11:31182665:G:A
NM_001042492.3(NF1):c.730+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547571	17	29508804	17	31181786	547571	538108	rs1060500274	NC_000017.11:31181785:G:T
NM_001042492.3(NF1):c.667T>C (p.Trp223Arg)	NF1	W223R	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547570	17	29508740	17	31181722	547570	538107	rs1555608740	NC_000017.11:31181721:T:C
NM_001042492.3(NF1):c.655-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547569	17	29508726	17	31181708	547569	538106	rs1555608734	NC_000017.11:31181707:A:C
NM_001042492.3(NF1):c.586+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547567	17	29497016	17	31169998	547567	538104	rs1555607126	NC_000017.11:31169997:G:A
NM_001042492.3(NF1):c.269T>G (p.Leu90Arg)	NF1	L90R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547566	17	29486092	17	31159074	547566	538103	rs1555605393	NC_000017.11:31159073:T:G
NM_001042492.3(NF1):c.266C>A (p.Thr89Lys)	NF1	T89K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547565	17	29486089	17	31159071	547565	538102	rs1555605392	NC_000017.11:31159070:C:A
NM_001042492.3(NF1):c.205-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547564	17	29486027	17	31159009	547564	538101	rs1555605362	NC_000017.11:31159008:G:C
NM_001042492.3(NF1):c.2325+1G>A	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000546100	17	29554310	17	31227292	546100	536933	rs1555613933	NC_000017.11:31227291:G:A
NM_001042492.3(NF1):c.4305C>T (p.Ile1435=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527680	17	29585493	17	31258475	527680	531060	rs779865988	NC_000017.11:31258474:C:T
NM_001042492.3(NF1):c.1185+7G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000527679	17	29528184	17	31201166	527679	531198	rs1322791959	NC_000017.11:31201165:G:A
NM_001042492.3(NF1):c.6922-5G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527678	17	29667518	17	31340500	527678	530899	rs1555535158	NC_000017.11:31340499:G:A
NM_001042492.3(NF1):c.102C>T (p.Val34=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527677	17	29483042	17	31156024	527677	531184	rs760823948	NC_000017.11:31156023:C:T
NM_001042492.3(NF1):c.1722-6C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000527676	17	29550456	17	31223438	527676	530902	rs878853869	NC_000017.11:31223437:C:T
NM_001042492.3(NF1):c.1374A>G (p.Pro458=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000527675	17	29533371	17	31206353	527675	530951	rs1555611601	NC_000017.11:31206352:A:G
NM_001042492.3(NF1):c.5658A>G (p.Leu1886=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000527674	17	29657362	17	31330344	527674	531336	rs1555533854	NC_000017.11:31330343:A:G
NM_001042492.3(NF1):c.7875A>G (p.Thr2625=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527673	17	29684292	17	31357274	527673	531434	rs763646216	NC_000017.11:31357273:A:G
NM_001042492.3(NF1):c.5609+8T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000527672	17	29654865	17	31327847	527672	531009	rs753289678	NC_000017.11:31327846:T:C
NM_001042492.3(NF1):c.7314C>T (p.Tyr2438=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV000527671	17	29676262	17	31349244	527671	530915	rs1060500385	NC_000017.11:31349243:C:T
NM_001042492.3(NF1):c.6045C>A (p.Ile2015=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527670	17	29663389	17	31336371	527670	531018	rs1433863184	NC_000017.11:31336370:C:A
NM_001042492.3(NF1):c.5286C>T (p.Val1762=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527669	17	29654534	17	31327516	527669	531088	rs748566277	NC_000017.11:31327515:C:T
NM_001042492.3(NF1):c.4671A>G (p.Thr1557=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000527668	17	29588822	17	31261804	527668	531073	rs876658990	NC_000017.11:31261803:A:G
NM_001042492.3(NF1):c.7359C>T (p.Cys2453=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000527667	17	29677238	17	31350220	527667	531390	rs1555536126	NC_000017.11:31350219:C:T
NM_001042492.3(NF1):c.6820-7C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000527666	17	29665715	17	31338697	527666	531035	rs1555535020	NC_000017.11:31338696:C:T
NM_001042492.3(NF1):c.7189+7A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV000527665	17	29670160	17	31343142	527665	531382	rs767151173	NC_000017.11:31343141:A:G
NM_001042492.3(NF1):c.834A>G (p.Pro278=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000527664	17	29509629	17	31182611	527664	530940	rs1318820078	NC_000017.11:31182610:A:G
NM_001042492.3(NF1):c.4647A>G (p.Pro1549=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527663	17	29588798	17	31261780	527663	531290	rs1305841472	NC_000017.11:31261779:A:G
NM_001042492.3(NF1):c.3708+7G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000527662	17	29560238	17	31233220	527662	531025	rs1555615115	NC_000017.11:31233219:G:A
NM_001042492.3(NF1):c.2271A>G (p.Lys757=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000527661	17	29554255	17	31227237	527661	530944	rs1555613916	NC_000017.11:31227236:A:G
NM_001042492.3(NF1):c.96C>G (p.Thr32=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527660	17	29483036	17	31156018	527660	531183	rs1555604886	NC_000017.11:31156017:C:G
NM_001042492.3(NF1):c.4932C>T (p.Asp1644=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000527659	17	29652934	17	31325916	527659	531305	rs1555533304	NC_000017.11:31325915:C:T
NM_001042492.3(NF1):c.771T>C (p.Ala257=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV000527658	17	29509566	17	31182548	527658	530683	rs766932517	NC_000017.11:31182547:T:C
NM_001042492.3(NF1):c.5556G>A (p.Gly1852=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000527657	17	29654804	17	31327786	527657	531330	rs763146785	NC_000017.11:31327785:G:A
NM_001042492.3(NF1):c.7029T>C (p.His2343=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000527656	17	29667630	17	31340612	527656	531116	rs1555535187	NC_000017.11:31340611:T:C
NM_001042492.3(NF1):c.3195A>G (p.Thr1065=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000527655	17	29557941	17	31230923	527655	531002	rs1555614650	NC_000017.11:31230922:A:G
NM_001042492.3(NF1):c.4431-8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000527654	17	29587379	17	31260361	527654	530996	rs1555618801	NC_000017.11:31260360:T:C
NM_001042492.3(NF1):c.450C>T (p.Phe150=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000527653	17	29490365	17	31163347	527653	530670	rs202142624	NC_000017.11:31163346:C:T
NM_001042492.3(NF1):c.1393-9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000527651	17	29541460	17	31214442	527651	530959	rs1314978150	NC_000017.11:31214441:T:C
NM_001042492.3(NF1):c.843C>A (p.Ile281=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000527650	17	29509638	17	31182620	527650	530853	rs146094856	NC_000017.11:31182619:C:A
NM_001042492.3(NF1):c.2928T>C (p.Thr976=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000527649	17	29556930	17	31229912	527649	530767	rs1555614446	NC_000017.11:31229911:T:C
NM_001042492.3(NF1):c.8378-6C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000527648	17	29701025	17	31374007	527648	530938	rs761763159	NC_000017.11:31374006:C:T
NM_001042492.3(NF1):c.1569A>G (p.Ala523=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV000527647	17	29546064	17	31219046	527647	531203	rs1555612830	NC_000017.11:31219045:A:G
NM_001042492.3(NF1):c.1359T>C (p.Gly453=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000527646	17	29533356	17	31206338	527646	530707	rs1555611595	NC_000017.11:31206337:T:C
NM_001042492.3(NF1):c.807A>G (p.Leu269=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527645	17	29509602	17	31182584	527645	530687	rs1333394353	NC_000017.11:31182583:A:G
NM_001042492.3(NF1):c.3045G>A (p.Leu1015=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527644	17	29557332	17	31230314	527644	530982	rs926335233	NC_000017.11:31230313:G:A
NM_001042492.3(NF1):c.5040T>C (p.Tyr1680=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 19, 2017)	criteria provided, single submitter	VCV000527643	17	29653042	17	31326024	527643	530874	rs1555533351	NC_000017.11:31326023:T:C
NM_001042492.3(NF1):c.2781T>G (p.Pro927=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000527642	17	29556414	17	31229396	527642	530753	rs1555614337	NC_000017.11:31229395:T:G
NM_001042492.3(NF1):c.3192T>C (p.Leu1064=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000527641	17	29557938	17	31230920	527641	530955	rs1555614649	NC_000017.11:31230919:T:C
NM_001042492.3(NF1):c.4272A>T (p.Ala1424=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000527640	17	29585460	17	31258442	527640	531049	rs753182376	NC_000017.11:31258441:A:T
NM_001042492.3(NF1):c.2851-10C>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000527639	17	29556843	17	31229825	527639	530975	rs1555614412	NC_000017.11:31229824:C:G
NM_001042492.3(NF1):c.3906T>C (p.Asp1302=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 6, 2018)	criteria provided, single submitter	VCV000527638	17	29562971	17	31235953	527638	531038	rs549058591	NC_000017.11:31235952:T:C
NM_001042492.3(NF1):c.8160+9A>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV000527637	17	29686042	17	31359024	527637	531067	rs997202389	NC_000017.11:31359023:A:C
NM_001042492.3(NF1):c.7794G>A (p.Val2598=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000527636	17	29684033	17	31357015	527636	531137	rs1555536699	NC_000017.11:31357014:G:A
NM_001042492.3(NF1):c.5013C>T (p.Tyr1671=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000527635	17	29653015	17	31325997	527635	531311	rs1060500255	NC_000017.11:31325996:C:T
NM_001042492.3(NF1):c.2550G>A (p.Val850=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527634	17	29556183	17	31229165	527634	530967	rs772148227	NC_000017.11:31229164:G:A
NM_001042492.3(NF1):c.7581G>C (p.Gly2527=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527633	17	29679398	17	31352380	527633	531126	rs1555536369	NC_000017.11:31352379:G:C
NM_001042492.3(NF1):c.7570C>T (p.Leu2524=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527632	17	29679387	17	31352369	527632	530922	rs1555536366	NC_000017.11:31352368:C:T
NM_001042492.3(NF1):c.111G>A (p.Glu37=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000527631	17	29483051	17	31156033	527631	530822	rs1555604893	NC_000017.11:31156032:G:A
NM_001042492.3(NF1):c.5625T>C (p.Asn1875=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000527630	17	29657329	17	31330311	527630	531097	rs1275173622	NC_000017.11:31330310:T:C
NM_001042492.3(NF1):c.2118C>T (p.Ala706=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000527629	17	29553569	17	31226551	527629	530939	rs1156646242	NC_000017.11:31226550:C:T
NM_001042492.3(NF1):c.1887G>A (p.Gly629=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000527628	17	29552154	17	31225136	527628	530932	rs1555613561	NC_000017.11:31225135:G:A
NM_001042492.3(NF1):c.237A>G (p.Leu79=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527627	17	29486060	17	31159042	527627	531186	rs752208826	NC_000017.11:31159041:A:G
NM_001042492.3(NF1):c.6420T>C (p.His2140=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527626	17	29663925	17	31336907	527626	531028	rs762803346	NC_000017.11:31336906:T:C
NM_001042492.3(NF1):c.4869G>A (p.Leu1623=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527625	17	29652871	17	31325853	527625	530857	rs1555533279	NC_000017.11:31325852:G:A
NM_001042492.3(NF1):c.264T>C (p.Asp88=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000527623	17	29486087	17	31159069	527623	531187	rs1359209770	NC_000017.11:31159068:T:C
NM_001042492.3(NF1):c.1545G>T (p.Gly515=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527622	17	29546040	17	31219022	527622	530712	rs876658203	NC_000017.11:31219021:G:T
NM_001042492.3(NF1):c.4188T>A (p.Arg1396=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 10, 2017)	criteria provided, single submitter	VCV000527621	17	29585376	17	31258358	527621	530989	rs1555618496	NC_000017.11:31258357:T:A
NM_001042492.3(NF1):c.6428-6T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000527620	17	29664380	17	31337362	527620	530892	rs772738883	NC_000017.11:31337361:T:C
NM_001042492.3(NF1):c.4263G>T (p.Pro1421=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000527619	17	29585451	17	31258433	527619	530826	rs201648604	NC_000017.11:31258432:G:T
NM_001042492.3(NF1):c.6192T>C (p.Ser2064=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527618	17	29663697	17	31336679	527618	531349	rs765094377	NC_000017.11:31336678:T:C
NM_001042492.3(NF1):c.6892C>T (p.Leu2298=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2017)	criteria provided, single submitter	VCV000527617	17	29665794	17	31338776	527617	531036	rs1555535049	NC_000017.11:31338775:C:T
NM_001042492.3(NF1):c.720T>C (p.Thr240=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527616	17	29508793	17	31181775	527616	530931	rs1555608761	NC_000017.11:31181774:T:C
NM_001042492.3(NF1):c.288+10T>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV000527615	17	29486121	17	31159103	527615	530831	rs1364620059	NC_000017.11:31159102:T:G
NM_001042492.3(NF1):c.7615+8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000527614	17	29679440	17	31352422	527614	531404	rs1555536383	NC_000017.11:31352421:T:C
NM_001042492.3(NF1):c.8040A>T (p.Pro2680=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000527613	17	29685567	17	31358549	527613	531145	rs749163014	NC_000017.11:31358548:A:T
NM_001042492.3(NF1):c.7322-10T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000527612	17	29677191	17	31350173	527612	531386	rs759969966	NC_000017.11:31350172:T:G
NM_001042492.3(NF1):c.6819+7G>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000527611	17	29665164	17	31338146	527611	531032	rs200532525	NC_000017.11:31338145:G:C
NM_001042492.3(NF1):c.2130C>T (p.Phe710=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527610	17	29553581	17	31226563	527610	530718	rs1555613806	NC_000017.11:31226562:C:T
NM_001042492.3(NF1):c.204+9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV000527609	17	29483153	17	31156135	527609	530661	rs771989896	NC_000017.11:31156134:T:C
NM_001042492.3(NF1):c.1527+7A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV000527608	17	29541610	17	31214592	527608	530889	rs1555612295	NC_000017.11:31214591:A:T
NM_001042492.3(NF1):c.3639A>G (p.Thr1213=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000527607	17	29560162	17	31233144	527607	531017	rs1555615069	NC_000017.11:31233143:A:G
NM_001042492.3(NF1):c.2415T>G (p.Ala805=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000527606	17	29556048	17	31229030	527606	530947	rs1555614182	NC_000017.11:31229029:T:G
NM_001042492.3(NF1):c.5490C>T (p.Arg1830=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527605	17	29654738	17	31327720	527605	531095	rs1245095693	NC_000017.11:31327719:C:T
NM_001042492.3(NF1):c.7032T>C (p.Thr2344=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527604	17	29667633	17	31340615	527604	530911	rs1201730858	NC_000017.11:31340614:T:C
NM_001042492.3(NF1):c.8127T>C (p.Asn2709=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527603	17	29686000	17	31358982	527603	530936	rs1555537015	NC_000017.11:31358981:T:C
NM_001042492.3(NF1):c.4077T>C (p.Pro1359=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000527602	17	29576104	17	31249086	527602	531278	rs1555617366	NC_000017.11:31249085:T:C
NM_001042492.3(NF1):c.8050A>C (p.Ile2684Leu)	NF1	I2663L, I2684L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000527601	17	29685577	17	31358559	527601	531146	rs1555536913	NC_000017.11:31358558:A:C
NM_001042492.3(NF1):c.3988G>A (p.Glu1330Lys)	NF1	E1330K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000527600	17	29576015	17	31248997	527600	530988	rs1483311407	NC_000017.11:31248996:G:A
NM_001042492.3(NF1):c.3917G>A (p.Arg1306Gln)	NF1	R1306Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000527599	17	29562982	17	31235964	527599	531262	rs1306237220	NC_000017.11:31235963:G:A
NM_001042492.3(NF1):c.1549G>T (p.Glu517Ter)	NF1	E517*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527597	17	29546044	17	31219026	527597	530901	rs587778548	NC_000017.11:31219025:G:T
NM_001042492.3(NF1):c.3644T>G (p.Met1215Arg)	NF1	M1215R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000527596	17	29560167	17	31233149	527596	531252	rs1555615071	NC_000017.11:31233148:T:G
NM_001042492.3(NF1):c.5146G>A (p.Ala1716Thr)	NF1	A1716T, A1695T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527595	17	29653148	17	31326130	527595	531321	rs767469374	NC_000017.11:31326129:G:A
NM_001042492.3(NF1):c.853T>G (p.Ser285Ala)	NF1	S285A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527593	17	29509648	17	31182630	527593	530690	rs1555608981	NC_000017.11:31182629:T:G
NM_001042492.3(NF1):c.6054T>G (p.Ser2018Arg)	NF1	S1997R, S2018R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000527592	17	29663398	17	31336380	527592	530885	rs1555534600	NC_000017.11:31336379:T:G
NM_001042492.3(NF1):c.2684T>G (p.Met895Arg)	NF1	M895R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000527591	17	29556317	17	31229299	527591	530739	rs1555614301	NC_000017.11:31229298:T:G
NM_001042492.3(NF1):c.7381C>G (p.Leu2461Val)	NF1	L2461V, L2440V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000527590	17	29677260	17	31350242	527590	531394	rs1199046022	NC_000017.11:31350241:C:G
NM_001042492.3(NF1):c.2062G>T (p.Glu688Ter)	NF1	E688*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000527588	17	29553513	17	31226495	527588	531222	rs1555613784	NC_000017.11:31226494:G:T
NM_001042492.3(NF1):c.2393A>C (p.Lys798Thr)	NF1	K798T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000527587	17	29554608	17	31227590	527587	530729	rs745498566	NC_000017.11:31227589:A:C
NM_001042492.3(NF1):c.4371A>C (p.Lys1457Asn)	NF1	K1457N, K1436N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000527586	17	29586088	17	31259070	527586	531282	rs1555618658	NC_000017.11:31259069:A:C
NM_001042492.3(NF1):c.3198-2A>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000527585	17	29559089	17	31232071	527585	531004	rs1131691089	NC_000017.11:31232070:A:T
NM_001042492.3(NF1):c.5443C>G (p.Gln1815Glu)	NF1	Q1794E, Q1815E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000527584	17	29654691	17	31327673	527584	531323	rs1555533587	NC_000017.11:31327672:C:G
NM_001042492.3(NF1):c.4098C>G (p.His1366Gln)	NF1	H1366Q	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527583	17	29576125	17	31249107	527583	530823	rs1555617377	NC_000017.11:31249106:C:G
NM_001042492.3(NF1):c.7717G>A (p.Ala2573Thr)	NF1	A2552T, A2573T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000527582	17	29683579	17	31356561	527582	531129	rs1555536654	NC_000017.11:31356560:G:A
NM_001042492.3(NF1):c.288+2T>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000527581	17	29486113	17	31159095	527581	530916	rs1555605406	NC_000017.11:31159094:T:A
NM_001042492.3(NF1):c.2665A>G (p.Thr889Ala)	NF1	T889A	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527580	17	29556298	17	31229280	527580	530737	rs1314766383	NC_000017.11:31229279:A:G
NM_001042492.3(NF1):c.3947A>G (p.His1316Arg)	NF1	H1316R	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527579	17	29563012	17	31235994	527579	531267	rs751023085	NC_000017.11:31235993:A:G
NM_001042492.3(NF1):c.4256T>A (p.Val1419Asp)	NF1	V1419D, V1398D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000527578	17	29585444	17	31258426	527578	530993	rs1555618528	NC_000017.11:31258425:T:A
NM_001042492.3(NF1):c.237A>T (p.Leu79Phe)	NF1	L79F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527577	17	29486060	17	31159042	527577	530666	rs752208826	NC_000017.11:31159041:A:T
NM_001042492.3(NF1):c.5480T>C (p.Ile1827Thr)	NF1	I1827T, I1806T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000527576	17	29654728	17	31327710	527576	531093	rs1555533605	NC_000017.11:31327709:T:C
NM_001042492.3(NF1):c.695C>T (p.Thr232Ile)	NF1	T232I	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527575	17	29508768	17	31181750	527575	530927	rs769719064	NC_000017.11:31181749:C:T
NM_001042492.3(NF1):c.6368A>G (p.His2123Arg)	NF1	H2102R, H2123R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000527573	17	29663873	17	31336855	527573	531358	rs112546213	NC_000017.11:31336854:A:G
NM_001042492.3(NF1):c.6299T>G (p.Leu2100Arg)	NF1	L2079R, L2100R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527572	17	29663804	17	31336786	527572	531102	rs1555534708	NC_000017.11:31336785:T:G
NM_001042492.3(NF1):c.3501A>C (p.Leu1167Phe)	NF1	L1167F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000527571	17	29560024	17	31233006	527571	531016	rs1555615008	NC_000017.11:31233005:A:C
NM_001042492.3(NF1):c.5992G>A (p.Gly1998Arg)	NF1	G1998R, G1977R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000527570	17	29662035	17	31335017	527570	531011	rs1555534426	NC_000017.11:31335016:G:A
NM_001042492.3(NF1):c.3685A>T (p.Asn1229Tyr)	NF1	N1229Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 18, 2017)	criteria provided, single submitter	VCV000527569	17	29560208	17	31233190	527569	531255	rs1555615102	NC_000017.11:31233189:A:T
NM_001042492.3(NF1):c.3412C>T (p.Leu1138=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000527566	17	29559815	17	31232797	527566	531015	rs1555614958	NC_000017.11:31232796:C:T
NM_001042492.3(NF1):c.3949G>C (p.Val1317Leu)	NF1	V1317L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000527565	17	29563014	17	31235996	527565	530815	rs1555615560	NC_000017.11:31235995:G:C
NM_001042492.3(NF1):c.5512T>C (p.Ser1838Pro)	NF1	S1838P, S1817P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000527564	17	29654760	17	31327742	527564	530883	rs1555533619	NC_000017.11:31327741:T:C
NM_001042492.3(NF1):c.4197G>T (p.Gln1399His)	NF1	Q1399H, Q1378H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000527563	17	29585385	17	31258367	527563	531044	rs1355988609	NC_000017.11:31258366:G:T
NM_001042492.3(NF1):c.2476A>G (p.Ile826Val)	NF1	I826V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000527562	17	29556109	17	31229091	527562	530952	rs767069721	NC_000017.11:31229090:A:G
NM_001042492.3(NF1):c.1405A>G (p.Lys469Glu)	NF1	K469E	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2018)	criteria provided, conflicting interpretations	VCV000527561	17	29541481	17	31214463	527561	530966	rs1555612271	NC_000017.11:31214462:A:G
NM_001042492.3(NF1):c.4430+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000527560	17	29586149	17	31259131	527560	531286	rs1555618693	NC_000017.11:31259130:T:C
NM_001042492.3(NF1):c.4951A>T (p.Ser1651Cys)	NF1	S1630C, S1651C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000527559	17	29652953	17	31325935	527559	530858	rs1555533314	NC_000017.11:31325934:A:T
NM_001042492.3(NF1):c.6314A>C (p.His2105Pro)	NF1	H2105P, H2084P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000527558	17	29663819	17	31336801	527558	531107	rs1555534726	NC_000017.11:31336800:A:C
NM_001042492.3(NF1):c.3197G>T (p.Arg1066Ile)	NF1	R1066I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000527557	17	29557943	17	31230925	527557	531239	rs1555614652	NC_000017.11:31230924:G:T
NM_001042492.3(NF1):c.4379A>T (p.His1460Leu)	NF1	H1460L, H1439L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000527556	17	29586096	17	31259078	527556	530994	rs748990989	NC_000017.11:31259077:A:T
NM_001042492.3(NF1):c.5015A>T (p.Asp1672Val)	NF1	D1672V, D1651V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000527555	17	29653017	17	31325999	527555	531081	rs1555533338	NC_000017.11:31325998:A:T
NM_001042492.3(NF1):c.3623T>C (p.Leu1208Ser)	NF1	L1208S	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Feb 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000527554	17	29560146	17	31233128	527554	531248	rs1060500374	NC_000017.11:31233127:T:C
NM_001042492.3(NF1):c.8392A>T (p.Asn2798Tyr)	NF1	N2777Y, N2798Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000527553	17	29701045	17	31374027	527553	531072	rs1555538514	NC_000017.11:31374026:A:T
NM_001042492.3(NF1):c.2321C>T (p.Thr774Ile)	NF1	T774I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV000527550	17	29554305	17	31227287	527550	530722	rs917302286	NC_000017.11:31227286:C:T
NM_001042492.3(NF1):c.3250C>T (p.Pro1084Ser)	NF1	P1084S	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000527549	17	29559143	17	31232125	527549	530957	rs1555614848	NC_000017.11:31232124:C:T
NM_001042492.3(NF1):c.2251+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527548	17	29553703	17	31226685	527548	531223	rs1555613843	NC_000017.11:31226684:G:C
NM_001042492.3(NF1):c.3245G>C (p.Gly1082Ala)	NF1	G1082A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527547	17	29559138	17	31232120	527547	531013	rs1555614839	NC_000017.11:31232119:G:C
NM_001042492.3(NF1):c.2252-9T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000527546	17	29554227	17	31227209	527546	530943	rs1555613907	NC_000017.11:31227208:T:G
NM_001042492.3(NF1):c.7842G>T (p.Lys2614Asn)	NF1	K2614N, K2593N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000527545	17	29684081	17	31357063	527545	531141	rs1555536710	NC_000017.11:31357062:G:T
NM_001042492.3(NF1):c.467G>A (p.Arg156His)	NF1	R156H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000527544	17	29490382	17	31163364	527544	530923	rs754096545	NC_000017.11:31163363:G:A
NM_001042492.3(NF1):c.3685A>G (p.Asn1229Asp)	NF1	N1229D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000527543	17	29560208	17	31233190	527543	530981	rs1555615102	NC_000017.11:31233189:A:G
NM_001042492.3(NF1):c.7428T>A (p.Tyr2476Ter)	NF1	Y2455*, Y2476*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000527542	17	29677307	17	31350289	527542	530918	rs181397225	NC_000017.11:31350288:T:A
NM_001042492.3(NF1):c.5935A>G (p.Ile1979Val)	NF1	I1958V, I1979V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000527541	17	29661978	17	31334960	527541	531098	rs775480099	NC_000017.11:31334959:A:G
NM_001042492.3(NF1):c.3773G>A (p.Trp1258Ter)	NF1	W1258*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000527540	17	29562693	17	31235675	527540	531033	rs1555615458	NC_000017.11:31235674:G:A
NM_001042492.3(NF1):c.4061C>A (p.Ser1354Tyr)	NF1	S1354Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000527539	17	29576088	17	31249070	527539	530817	rs1555617348	NC_000017.11:31249069:C:A
NM_001042492.3(NF1):c.7189+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000527538	17	29670154	17	31343136	527538	531045	rs1555535455	NC_000017.11:31343135:G:A
NM_001042492.3(NF1):c.6148-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527537	17	29663652	17	31336634	527537	531021	rs1555534661	NC_000017.11:31336633:G:C
NM_001042492.3(NF1):c.3664C>G (p.Pro1222Ala)	NF1	P1222A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527536	17	29560187	17	31233169	527536	530971	rs1555615088	NC_000017.11:31233168:C:G
NM_001042492.3(NF1):c.4328C>T (p.Ser1443Leu)	NF1	S1422L, S1443L	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2020)	criteria provided, conflicting interpretations	VCV000527535	17	29585516	17	31258498	527535	531061	rs1555618566	NC_000017.11:31258497:C:T
NM_001042492.3(NF1):c.7657G>C (p.Ala2553Pro)	NF1	A2532P, A2553P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000527534	17	29683519	17	31356501	527534	531407	rs1555536644	NC_000017.11:31356500:G:C
NM_001042492.3(NF1):c.6997G>T (p.Ala2333Ser)	NF1	A2333S, A2312S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000527533	17	29667598	17	31340580	527533	531372	rs1555535178	NC_000017.11:31340579:G:T
NM_001042492.3(NF1):c.8083C>T (p.Pro2695Ser)	NF1	P2695S, P2674S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000527532	17	29685610	17	31358592	527532	531149	rs772707560	NC_000017.11:31358591:C:T
NM_001042492.3(NF1):c.7064G>A (p.Ser2355Asn)	NF1	S2355N, S2334N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000527529	17	29670028	17	31343010	527529	531040	rs1555535399	NC_000017.11:31343009:G:A
NM_001042492.3(NF1):c.3140A>G (p.Asp1047Gly)	NF1	D1047G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000527527	17	29557886	17	31230868	527527	531237	rs1555614631	NC_000017.11:31230867:A:G
NM_001042492.3(NF1):c.5694A>G (p.Leu1898=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527525	17	29657398	17	31330380	527525	531343	rs1555533863	NC_000017.11:31330379:A:G
NM_001042492.3(NF1):c.785G>A (p.Arg262His)	NF1	R262H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000527524	17	29509580	17	31182562	527524	531194	rs1555608957	NC_000017.11:31182561:G:A
NM_001042492.3(NF1):c.3241G>A (p.Ala1081Thr)	NF1	A1081T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000527523	17	29559134	17	31232116	527523	531241	rs1555614834	NC_000017.11:31232115:G:A
NM_001042492.3(NF1):c.5456C>T (p.Ala1819Val)	NF1	A1819V, A1798V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000527522	17	29654704	17	31327686	527522	530875	rs1555533590	NC_000017.11:31327685:C:T
NM_001042492.3(NF1):c.3468C>A (p.Asn1156Lys)	NF1	N1156K	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000527521	17	29559871	17	31232853	527521	530968	rs147955381	NC_000017.11:31232852:C:A
NM_001042492.3(NF1):c.3533C>A (p.Thr1178Lys)	NF1	T1178K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000527520	17	29560056	17	31233038	527520	530786	rs1555615025	NC_000017.11:31233037:C:A
NM_001042492.3(NF1):c.143A>C (p.Lys48Thr)	NF1	K48T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000527519	17	29483083	17	31156065	527519	530824	rs1555604902	NC_000017.11:31156064:A:C
NM_001042492.3(NF1):c.7091G>A (p.Arg2364Gln)	NF1	R2343Q, R2364Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jun 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000527518	17	29670055	17	31343037	527518	531374	rs1555535407	NC_000017.11:31343036:G:A
NM_001042492.3(NF1):c.3445A>G (p.Met1149Val)	NF1	M1149V	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000527517	17	29559848	17	31232830	527517	530962	rs1187097568	NC_000017.11:31232829:A:G
NM_001042492.3(NF1):c.1045A>G (p.Met349Val)	NF1	M349V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527516	17	29527596	17	31200578	527516	530700	rs776050648	NC_000017.11:31200577:A:G
NM_001042492.3(NF1):c.7615+5G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000527515	17	29679437	17	31352419	527515	530929	rs1555536382	NC_000017.11:31352418:G:A
NM_001042492.3(NF1):c.2786T>G (p.Leu929Arg)	NF1	L929R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000527514	17	29556419	17	31229401	527514	530755	rs1555614338	NC_000017.11:31229400:T:G
NM_001042492.3(NF1):c.60+1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000527513	17	29422388	17	31095370	527513	531173	rs1555594500	NC_000017.11:31095369:G:T
NM_001042492.3(NF1):c.3071C>T (p.Ala1024Val)	NF1	A1024V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000527512	17	29557358	17	31230340	527512	531236	rs1555614525	NC_000017.11:31230339:C:T
NM_001042492.3(NF1):c.6404C>T (p.Thr2135Ile)	NF1	T2114I, T2135I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000527511	17	29663909	17	31336891	527511	531359	rs1555534770	NC_000017.11:31336890:C:T
NM_001042492.3(NF1):c.6312C>G (p.Phe2104Leu)	NF1	F2083L, F2104L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000527510	17	29663817	17	31336799	527510	530888	rs780728198	NC_000017.11:31336798:C:G
NM_001042492.3(NF1):c.5268+4A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000527509	17	29653274	17	31326256	527509	531085	rs1555533418	NC_000017.11:31326255:A:G
NM_001042492.3(NF1):c.3107A>C (p.Lys1036Thr)	NF1	K1036T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000527508	17	29557394	17	31230376	527508	530780	rs1555614540	NC_000017.11:31230375:A:C
NM_001042492.3(NF1):c.5339A>G (p.Asn1780Ser)	NF1	N1759S, N1780S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000527506	17	29654587	17	31327569	527506	531092	rs1411525800	NC_000017.11:31327568:A:G
NM_001042492.3(NF1):c.5152C>T (p.His1718Tyr)	NF1	H1697Y, H1718Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000527505	17	29653154	17	31326136	527505	531083	rs1555533381	NC_000017.11:31326135:C:T
NM_001042492.3(NF1):c.3404C>T (p.Ser1135Phe)	NF1	S1135F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 7, 2018)	criteria provided, single submitter	VCV000527504	17	29559807	17	31232789	527504	531247	rs1555614952	NC_000017.11:31232788:C:T
NM_001042492.3(NF1):c.888+6G>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000527503	17	29509689	17	31182671	527503	530871	rs1555609000	NC_000017.11:31182670:G:T
NM_001042492.3(NF1):c.1496T>C (p.Leu499Pro)	NF1	L499P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527502	17	29541572	17	31214554	527502	530710	rs1555612288	NC_000017.11:31214553:T:C
NM_001042492.3(NF1):c.6278C>G (p.Ser2093Cys)	NF1	S2093C, S2072C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527501	17	29663783	17	31336765	527501	531101	rs1555534698	NC_000017.11:31336764:C:G
NM_001042492.3(NF1):c.4174-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000527498	17	29585361	17	31258343	527498	531279	rs1555618492	NC_000017.11:31258342:G:A
NM_001042492.3(NF1):c.3830G>T (p.Gly1277Val)	NF1	G1277V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000527496	17	29562750	17	31235732	527496	530802	rs1555615480	NC_000017.11:31235731:G:T
NM_001042492.3(NF1):c.814A>G (p.Ile272Val)	NF1	I272V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000527495	17	29509609	17	31182591	527495	530937	rs1555608971	NC_000017.11:31182590:A:G
NM_001042492.3(NF1):c.7074A>G (p.Glu2358=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV000527494	17	29670038	17	31343020	527494	531118	rs1388098913	NC_000017.11:31343019:A:G
NM_001042492.3(NF1):c.2293C>G (p.Arg765Gly)	NF1	R765G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000527493	17	29554277	17	31227259	527493	530720	rs1383770460	NC_000017.11:31227258:C:G
NM_001042492.3(NF1):c.4447G>A (p.Ala1483Thr)	NF1	A1483T, A1462T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000527492	17	29587403	17	31260385	527492	531062	rs1555618808	NC_000017.11:31260384:G:A
NM_001042492.3(NF1):c.6646T>C (p.Cys2216Arg)	NF1	C2195R, C2216R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 24, 2017)	criteria provided, single submitter	VCV000527491	17	29664840	17	31337822	527491	530897	rs757736155	NC_000017.11:31337821:T:C
NM_001042492.3(NF1):c.4578-19A>G	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000527490	17	29588710	17	31261692	527490	530855	rs1555618994	NC_000017.11:31261691:A:G
NM_001042492.3(NF1):c.7889C>G (p.Thr2630Ser)	NF1	T2630S, T2609S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527488	17	29684306	17	31357288	527488	531437	rs1283946778	NC_000017.11:31357287:C:G
NM_001042492.3(NF1):c.1062+5C>T	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000527487	17	29527618	17	31200600	527487	530945	rs1555610916	NC_000017.11:31200599:C:T
NM_001042492.3(NF1):c.4700C>T (p.Ser1567Leu)	NF1	S1546L, S1567L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000527486	17	29588851	17	31261833	527486	531293	rs1555619051	NC_000017.11:31261832:C:T
NM_001042492.3(NF1):c.592G>A (p.Ala198Thr)	NF1	A198T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527485	17	29508445	17	31181427	527485	531188	rs1555608643	NC_000017.11:31181426:G:A
NM_001042492.3(NF1):c.7591C>T (p.Gln2531Ter)	NF1	Q2510*, Q2531*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527484	17	29679408	17	31352390	527484	530926	rs1555536372	NC_000017.11:31352389:C:T
NM_001042492.3(NF1):c.7807G>C (p.Val2603Leu)	NF1	V2603L, V2582L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527482	17	29684046	17	31357028	527482	531430	rs766135206	NC_000017.11:31357027:G:C
NM_001042492.3(NF1):c.7361G>C (p.Ser2454Thr)	NF1	S2433T, S2454T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000527481	17	29677240	17	31350222	527481	531053	rs1555536127	NC_000017.11:31350221:G:C
NM_001042492.3(NF1):c.3346G>C (p.Asp1116His)	NF1	D1116H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000527480	17	29559749	17	31232731	527480	530782	rs1555614932	NC_000017.11:31232730:G:C
NM_001042492.3(NF1):c.4940A>C (p.His1647Pro)	NF1	H1626P, H1647P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000527479	17	29652942	17	31325924	527479	531309	rs1555533307	NC_000017.11:31325923:A:C
NM_001042492.3(NF1):c.5661A>G (p.Lys1887=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000527478	17	29657365	17	31330347	527478	531339	rs149759456	NC_000017.11:31330346:A:G
NM_001042492.3(NF1):c.1145C>T (p.Ser382Phe)	NF1	S382F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000527477	17	29528137	17	31201119	527477	531196	rs1555611016	NC_000017.11:31201118:C:T
NM_001042492.3(NF1):c.3707G>A (p.Trp1236Ter)	NF1	W1236*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000527476	17	29560230	17	31233212	527476	531256	rs1252674239	NC_000017.11:31233211:G:A
NM_001042492.3(NF1):c.3180T>G (p.Asp1060Glu)	NF1	D1060E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000527474	17	29557926	17	31230908	527474	530954	rs1555614646	NC_000017.11:31230907:T:G
NM_001042492.3(NF1):c.3709-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527473	17	29562628	17	31235610	527473	531027	rs1555615431	NC_000017.11:31235609:G:A
NM_001042492.3(NF1):c.4312G>T (p.Gly1438Cys)	NF1	G1417C, G1438C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000527472	17	29585500	17	31258482	527472	530832	rs1555618559	NC_000017.11:31258481:G:T
NM_001042492.3(NF1):c.1260+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000527471	17	29528505	17	31201487	527471	530702	rs1555611110	NC_000017.11:31201486:T:G
NM_001042492.3(NF1):c.2038T>C (p.Cys680Arg)	NF1	C680R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000527468	17	29553489	17	31226471	527468	531218	rs1555613775	NC_000017.11:31226470:T:C
NM_001042492.3(NF1):c.7585C>T (p.Pro2529Ser)	NF1	P2508S, P2529S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000527467	17	29679402	17	31352384	527467	531403	rs1555536370	NC_000017.11:31352383:C:T
NM_001042492.3(NF1):c.2990+5G>A	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2020)	criteria provided, conflicting interpretations	VCV000527465	17	29556997	17	31229979	527465	530771	rs1555614464	NC_000017.11:31229978:G:A
NM_001042492.3(NF1):c.4030G>T (p.Glu1344Ter)	NF1	E1344*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000527464	17	29576057	17	31249039	527464	531042	rs1555617328	NC_000017.11:31249038:G:T
NM_001042492.3(NF1):c.1354C>T (p.Gln452Ter)	NF1	Q452*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000527463	17	29533351	17	31206333	527463	531201	rs1555611590	NC_000017.11:31206332:C:T
NM_001042492.3(NF1):c.1846C>G (p.Gln616Glu)	NF1	Q616E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527462	17	29552113	17	31225095	527462	530903	rs1555613543	NC_000017.11:31225094:C:G
NM_001042492.3(NF1):c.2798T>C (p.Leu933Pro)	NF1	L933P	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2019)	criteria provided, conflicting interpretations	VCV000527461	17	29556431	17	31229413	527461	530973	rs1555614342	NC_000017.11:31229412:T:C
NM_001042492.3(NF1):c.5377C>A (p.Leu1793Ile)	NF1	L1793I, L1772I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000527460	17	29654625	17	31327607	527460	531007	rs761676110	NC_000017.11:31327606:C:A
NM_001042492.3(NF1):c.7465A>G (p.Lys2489Glu)	NF1	K2468E, K2489E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000527459	17	29679282	17	31352264	527459	531396	rs1555536338	NC_000017.11:31352263:A:G
NM_001042492.3(NF1):c.4930G>C (p.Asp1644His)	NF1	D1623H, D1644H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000527458	17	29652932	17	31325914	527458	531080	rs1131691123	NC_000017.11:31325913:G:C
NM_001042492.3(NF1):c.3708+1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527457	17	29560232	17	31233214	527457	531020	rs1420779915	NC_000017.11:31233213:G:T
NM_001042492.3(NF1):c.1331G>A (p.Gly444Asp)	NF1	G444D	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527456	17	29533328	17	31206310	527456	530946	rs1555611582	NC_000017.11:31206309:G:A
NM_001042492.3(NF1):c.5160G>C (p.Glu1720Asp)	NF1	E1699D, E1720D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000527455	17	29653162	17	31326144	527455	531001	rs773378630	NC_000017.11:31326143:G:C
NM_001042492.3(NF1):c.387G>C (p.Gln129His)	NF1	Q129H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527454	17	29490302	17	31163284	527454	530833	rs1390215440	NC_000017.11:31163283:G:C
NM_001042492.3(NF1):c.6643-5T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000527451	17	29664832	17	31337814	527451	531110	rs1555534907	NC_000017.11:31337813:T:G
NM_001042492.3(NF1):c.3332T>C (p.Met1111Thr)	NF1	M1111T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 19, 2017)	criteria provided, single submitter	VCV000527449	17	29559735	17	31232717	527449	530960	rs1555614920	NC_000017.11:31232716:T:C
NM_001042492.3(NF1):c.1357G>A (p.Gly453Ser)	NF1	G453S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527448	17	29533354	17	31206336	527448	530879	rs1273060925	NC_000017.11:31206335:G:A
NM_001042492.3(NF1):c.7825G>C (p.Val2609Leu)	NF1	V2588L, V2609L	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527447	17	29684064	17	31357046	527447	531063	rs786203848	NC_000017.11:31357045:G:C
NM_001042492.3(NF1):c.550A>C (p.Asn184His)	NF1	N184H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527446	17	29496979	17	31169961	527446	530924	rs1555607101	NC_000017.11:31169960:A:C
NM_001042492.3(NF1):c.6439C>A (p.Gln2147Lys)	NF1	Q2147K, Q2126K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000527445	17	29664397	17	31337379	527445	530893	rs1555534859	NC_000017.11:31337378:C:A
NM_001042492.3(NF1):c.5813G>A (p.Ser1938Asn)	NF1	S1938N, S1917N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527444	17	29661856	17	31334838	527444	530884	rs906075234	NC_000017.11:31334837:G:A
NM_001042492.3(NF1):c.3811A>C (p.Met1271Leu)	NF1	M1271L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000527442	17	29562731	17	31235713	527442	530985	rs746583007	NC_000017.11:31235712:A:C
NM_001042492.3(NF1):c.7161C>G (p.Asn2387Lys)	NF1	N2387K, N2366K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000527441	17	29670125	17	31343107	527441	531378	rs1555535444	NC_000017.11:31343106:C:G
NM_001042492.3(NF1):c.1912G>T (p.Gly638Ter)	NF1	G638*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527439	17	29552179	17	31225161	527439	531214	rs1555613567	NC_000017.11:31225160:G:T
NM_001042492.3(NF1):c.845A>G (p.Gln282Arg)	NF1	Q282R	Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527438	17	29509640	17	31182622	527438	530861	rs779034900	NC_000017.11:31182621:A:G
NM_001042492.3(NF1):c.7150T>C (p.Ser2384Pro)	NF1	S2363P, S2384P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000527437	17	29670114	17	31343096	527437	531043	rs1555535429	NC_000017.11:31343095:T:C
NM_001042492.3(NF1):c.7618A>G (p.Thr2540Ala)	NF1	T2519A, T2540A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000527436	17	29683480	17	31356462	527436	531058	rs1555536632	NC_000017.11:31356461:A:G
NM_001042492.3(NF1):c.3991A>G (p.Ser1331Gly)	NF1	S1331G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000527435	17	29576018	17	31249000	527435	531272	rs1411796317	NC_000017.11:31248999:A:G
NM_001042492.3(NF1):c.2020A>G (p.Ser674Gly)	NF1	S674G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527434	17	29553471	17	31226453	527434	530717	rs1555613753	NC_000017.11:31226452:A:G
NM_001042492.3(NF1):c.6820G>T (p.Ala2274Ser)	NF1	A2253S, A2274S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000527433	17	29665722	17	31338704	527433	531365	rs1555535023	NC_000017.11:31338703:G:T
NM_001042492.3(NF1):c.514G>A (p.Val172Ile)	NF1	V172I	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000527432	17	29496943	17	31169925	527432	530839	rs1555607083	NC_000017.11:31169924:G:A
NM_001042492.3(NF1):c.697A>C (p.Lys233Gln)	NF1	K233Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000527431	17	29508770	17	31181752	527431	530850	rs922257267	NC_000017.11:31181751:A:C
NM_001042492.3(NF1):c.4383G>A (p.Met1461Ile)	NF1	M1461I, M1440I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000527430	17	29586100	17	31259082	527430	530851	rs1555618677	NC_000017.11:31259081:G:A
NM_001042492.3(NF1):c.3548T>C (p.Leu1183Pro)	NF1	L1183P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000527427	17	29560071	17	31233053	527427	530789	rs1555615028	NC_000017.11:31233052:T:C
NM_001042492.3(NF1):c.2596C>T (p.Pro866Ser)	NF1	P866S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000527426	17	29556229	17	31229211	527426	530731	rs1555614272	NC_000017.11:31229210:C:T
NM_001042492.3(NF1):c.4290G>T (p.Lys1430Asn)	NF1	K1409N, K1430N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000527425	17	29585478	17	31258460	527425	530828	rs373086572	NC_000017.11:31258459:G:T
NM_001042492.3(NF1):c.2159G>A (p.Arg720Gln)	NF1	R720Q	Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527423	17	29553610	17	31226592	527423	530941	rs1350468182	NC_000017.11:31226591:G:A
NM_001042492.3(NF1):c.3836G>A (p.Ser1279Asn)	NF1	S1279N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000527422	17	29562756	17	31235738	527422	531034	rs1170788683	NC_000017.11:31235737:G:A
NM_001042492.3(NF1):c.8103T>G (p.Ser2701=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000527421	17	29685630	17	31358612	527421	531441	rs1555536935	NC_000017.11:31358611:T:G
NM_001042492.3(NF1):c.4274G>A (p.Gly1425Glu)	NF1	G1404E, G1425E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2017)	criteria provided, single submitter	VCV000527420	17	29585462	17	31258444	527420	531054	rs1555618547	NC_000017.11:31258443:G:A
NM_001042492.3(NF1):c.7534G>A (p.Gly2512Ser)	NF1	G2512S, G2491S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527419	17	29679351	17	31352333	527419	531123	rs766496842	NC_000017.11:31352332:G:A
NM_001042492.3(NF1):c.7454A>G (p.Tyr2485Cys)	NF1	Y2464C, Y2485C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527418	17	29677333	17	31350315	527418	531122	rs1022605462	NC_000017.11:31350314:A:G
NM_001042492.3(NF1):c.6402T>A (p.Cys2134Ter)	NF1	C2113*, C2134*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000527417	17	29663907	17	31336889	527417	531026	rs1555534766	NC_000017.11:31336888:T:A
NM_001042492.3(NF1):c.7700C>G (p.Pro2567Arg)	NF1	P2546R, P2567R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527416	17	29683562	17	31356544	527416	531410	rs754511534	NC_000017.11:31356543:C:G
NM_001042492.3(NF1):c.2326-10T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000527415	17	29554531	17	31227513	527415	531226	rs1555613971	NC_000017.11:31227512:T:G
NM_001042492.3(NF1):c.7804A>T (p.Asn2602Tyr)	NF1	N2602Y, N2581Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527414	17	29684043	17	31357025	527414	531059	rs150657839	NC_000017.11:31357024:A:T
NM_001042492.3(NF1):c.4886T>C (p.Leu1629Pro)	NF1	L1629P, L1608P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000527413	17	29652888	17	31325870	527413	531304	rs1555533288	NC_000017.11:31325869:T:C
NM_001042492.3(NF1):c.2503C>T (p.Gln835Ter)	NF1	Q835*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523904	17	29556136	17	31229118	523904	514712	rs1555614207	NC_000017.11:31229117:C:T
NM_001042492.3(NF1):c.3703C>T (p.Gln1235Ter)	NF1	Q1235*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523788	17	29560226	17	31233208	523788	514714	rs1555615109	NC_000017.11:31233207:C:T
NM_001042492.3(NF1):c.4243A>C (p.Asn1415His)	NF1	N1394H, N1415H	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2021)	criteria provided, conflicting interpretations	VCV000523625	17	29585431	17	31258413	523625	514273	rs1555618518	NC_000017.11:31258412:A:C
NM_001042492.3(NF1):c.3496+53T>C	NF1		Neurofibromatosis type 6|Motor delay|Focal seizures	Uncertain significance(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523397	17	29559952	17	31232934	523397	514074	rs1555614994	NC_000017.11:31232933:T:C
NM_001042492.3(NF1):c.6109G>A (p.Ala2037Thr)	NF1	A2016T, A2037T	Neurofibromatosis, type 1|Premature birth|Infantile muscular hypotonia|Delayed speech and language development|Neurofibromatosis type 6	Uncertain significance(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523348	17	29663453	17	31336435	523348	514079	rs1555534612	NC_000017.11:31336434:G:A
NM_001042492.3(NF1):c.4235G>C (p.Arg1412Thr)	NF1	R1391T, R1412T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis type 6|Neurofibroma|Abnormality of vision	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000523345	17	29585423	17	31258405	523345	514075	rs1555618516	NC_000017.11:31258404:G:C
NM_001042492.3(NF1):c.4875C>G (p.Tyr1625Ter)	NF1	Y1604*, Y1625*	Axillary freckling|Neurofibromatosis type 6|Neurofibroma	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523344	17	29652877	17	31325859	523344	514077	rs1555533285	NC_000017.11:31325858:C:G
NM_001042492.3(NF1):c.6642+1G>A	NF1		Neurofibromatosis, type 1|not provided|Cafe-au-lait spot	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000523343	17	29664601	17	31337583	523343	514080	rs1060500345	NC_000017.11:31337582:G:A
NM_001042492.3(NF1):c.3197+3A>T	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522580	17	29557946	17	31230928	522580	513192	rs1359512152	NC_000017.11:31230927:A:T
NM_001042492.3(NF1):c.5481C>G (p.Ile1827Met)	NF1	I1806M, I1827M	Neurofibromatosis, type 1|not specified	Uncertain significance(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000517503	17	29654729	17	31327711	517503	497566	rs1555533607	NC_000017.11:31327710:C:G
NM_001042492.3(NF1):c.2502A>G (p.Leu834=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000516007	17	29556135	17	31229117	516007	506730	rs953405312	NC_000017.11:31229116:A:G
NM_001042492.3(NF1):c.4725-3T>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2019)	criteria provided, conflicting interpretations	VCV000515863	17	29592244	17	31265226	515863	506748	rs892441625	NC_000017.11:31265225:T:C
NM_001042492.3(NF1):c.7616-9T>C	NF1		not provided|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000515754	17	29683469	17	31356451	515754	505831	rs1555536631	NC_000017.11:31356450:T:C
NM_001042492.3(NF1):c.8378-9T>C	NF1		not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000515675	17	29701022	17	31374004	515675	505836	rs1453787016	NC_000017.11:31374003:T:C
NM_001042492.3(NF1):c.480G>A (p.Arg160=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2020)	criteria provided, conflicting interpretations	VCV000515633	17	29496909	17	31169891	515633	506238	rs1555607071	NC_000017.11:31169890:G:A
NM_001042492.3(NF1):c.7170G>A (p.Leu2390=)	NF1		not specified|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 6, 2020)	criteria provided, conflicting interpretations	VCV000514424	17	29670134	17	31343116	514424	506756	rs751081026	NC_000017.11:31343115:G:A
NM_001042492.3(NF1):c.6922-16A>G	NF1		Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2017)	criteria provided, conflicting interpretations	VCV000512282	17	29667507	17	31340489	512282	505825	rs202158964	NC_000017.11:31340488:A:G
NM_001042492.3(NF1):c.7284A>G (p.Lys2428=)	NF1		not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507079	17	29676232	17	31349214	507079	506760	rs1555536034	NC_000017.11:31349213:A:G
NM_001042492.3(NF1):c.6161T>A (p.Met2054Lys)	NF1	M2033K, M2054K	not specified	Uncertain significance(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000505226	17	29663666	17	31336648	505226	497289	rs1555534665	NC_000017.11:31336647:T:A
NM_001042492.3(NF1):c.4835+3A>G	NF1		not specified|not provided	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000504973	17	29592360	17	31265342	504973	497491	rs1417732851	NC_000017.11:31265341:A:G
NM_001042492.3(NF1):c.7457+5G>A	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504409	17	29677341	17	31350323	504409	495416	rs1555536171	NC_000017.11:31350322:G:A
NM_001042492.3(NF1):c.3197+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503702	17	29557944	17	31230926	503702	495410	rs1555614653	NC_000017.11:31230925:G:A
NM_001042492.3(NF1):c.1527+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000503701	17	29541604	17	31214586	503701	495835	rs1060500331	NC_000017.11:31214585:G:A
NM_001042492.3(NF1):c.730+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503700	17	29508804	17	31181786	503700	495833	rs1060500274	NC_000017.11:31181785:G:A
NM_001042492.3(NF1):c.2978T>G (p.Leu993Ter)	NF1	L993*	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000493211	17	29556980	17	31229962	493211	486174	rs1555614460	NC_000017.11:31229961:T:G
NM_001042492.3(NF1):c.6623C>G (p.Ala2208Gly)	NF1	A2187G, A2208G	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492887	17	29664581	17	31337563	492887	485779	rs1555534886	NC_000017.11:31337562:C:G
NM_001042492.3(NF1):c.4905T>G (p.Tyr1635Ter)	NF1	Y1614*, Y1635*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	VCV000492883	17	29652907	17	31325889	492883	485775	rs948982039	NC_000017.11:31325888:T:G
NM_001042492.3(NF1):c.4631C>A (p.Ala1544Glu)	NF1	A1523E, A1544E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 31, 2015)	no assertion criteria provided	VCV000492882	17	29588782	17	31261764	492882	485774	rs1555619015	NC_000017.11:31261763:C:A
NM_001042492.3(NF1):c.4332+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000492881	17	29585521	17	31258503	492881	485773	rs1555618572	NC_000017.11:31258502:G:A
NM_001042492.3(NF1):c.2511G>A (p.Trp837Ter)	NF1	W837*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 30, 2015)	no assertion criteria provided	VCV000492879	17	29556144	17	31229126	492879	485771	rs1555614211	NC_000017.11:31229125:G:A
NM_001042492.3(NF1):c.2251+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000492878	17	29553703	17	31226685	492878	485770	rs1555613843	NC_000017.11:31226684:G:A
NM_001042492.3(NF1):c.1393-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000492877	17	29541467	17	31214449	492877	485768	rs1555612266	NC_000017.11:31214448:A:G
NM_001042492.3(NF1):c.889-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV000492875	17	29527439	17	31200421	492875	485767	rs587781517	NC_000017.11:31200420:G:C
NM_001042492.3(NF1):c.541C>T (p.Gln181Ter)	NF1	Q181*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000492874	17	29496970	17	31169952	492874	485766	rs753529924	NC_000017.11:31169951:C:T
NM_001042492.3(NF1):c.7615+1G>T	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489226	17	29679433	17	31352415	489226	482132	rs1555536380	NC_000017.11:31352414:G:T
NM_001042492.3(NF1):c.5880C>A (p.Cys1960Ter)	NF1	C1939*, C1960*	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000488978	17	29661923	17	31334905	488978	482127	rs1462287670	NC_000017.11:31334904:C:A
NM_001042492.3(NF1):c.2163T>A (p.Cys721Ter)	NF1	C721*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488882	17	29553614	17	31226596	488882	482124	rs1555613816	NC_000017.11:31226595:T:A
NM_001042492.3(NF1):c.6674G>A (p.Trp2225Ter)	NF1	W2204*, W2225*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488819	17	29664868	17	31337850	488819	482131	rs1193716348	NC_000017.11:31337849:G:A
NM_001042492.3(NF1):c.6428-3C>A	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2020)	criteria provided, conflicting interpretations	VCV000488818	17	29664383	17	31337365	488818	482130	rs374014162	NC_000017.11:31337364:C:A
NM_001042492.3(NF1):c.6006+1G>A	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488817	17	29662050	17	31335032	488817	482128	rs1555534433	NC_000017.11:31335031:G:A
NM_001042492.3(NF1):c.5856G>A (p.Trp1952Ter)	NF1	W1931*, W1952*	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000488816	17	29661899	17	31334881	488816	482126	rs1555534393	NC_000017.11:31334880:G:A
NM_001042492.3(NF1):c.2002-1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488815	17	29553452	17	31226434	488815	482123	rs1555613743	NC_000017.11:31226433:G:A
NM_001042492.3(NF1):c.731-1G>A	NF1		not provided|Neurofibromatosis, type 1|none provided	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488814	17	29509525	17	31182507	488814	482122	rs1555608928	NC_000017.11:31182506:G:A
NM_001042492.3(NF1):c.6006G>C (p.Gln2002His)	NF1	Q1981H, Q2002H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487463	17	29662049	17	31335031	487463	480529	rs1555534432	NC_000017.11:31335030:G:C
NM_001042492.3(NF1):c.1224T>A (p.Tyr408Ter)	NF1	Y408*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000485979	17	29528467	17	31201449	485979	478022	rs1555611089	NC_000017.11:31201448:T:A
NM_001042492.3(NF1):c.7510C>T (p.Leu2504Phe)	NF1	L2504F, L2483F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485976	17	29679327	17	31352309	485976	478361	rs876658333	NC_000017.11:31352308:C:T
NM_001042492.3(NF1):c.632C>T (p.Ala211Val)	NF1	A211V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485973	17	29508485	17	31181467	485973	477998	rs1555608675	NC_000017.11:31181466:C:T
NM_001042492.3(NF1):c.8292T>C (p.Pro2764=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485972	17	29687636	17	31360618	485972	478397	rs1555537246	NC_000017.11:31360617:T:C
NM_001042492.3(NF1):c.5020G>A (p.Val1674Ile)	NF1	V1653I, V1674I	Neurofibromatosis, type 1|Microcephaly|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485969	17	29653022	17	31326004	485969	478363	rs1555533342	NC_000017.11:31326003:G:A
NM_001042492.3(NF1):c.4870A>G (p.Ile1624Val)	NF1	I1603V, I1624V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485968	17	29652872	17	31325854	485968	478220	rs1555533280	NC_000017.11:31325853:A:G
NM_001042492.3(NF1):c.4791G>T (p.Gly1597=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2019)	criteria provided, conflicting interpretations	VCV000485966	17	29592313	17	31265295	485966	478214	rs1412795566	NC_000017.11:31265294:G:T
NM_001042492.3(NF1):c.6399G>A (p.Leu2133=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485965	17	29663904	17	31336886	485965	478440	rs1448544243	NC_000017.11:31336885:G:A
NM_001042492.3(NF1):c.5125A>G (p.Ile1709Val)	NF1	I1709V, I1688V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485964	17	29653127	17	31326109	485964	478927	rs774720054	NC_000017.11:31326108:A:G
NM_001042492.3(NF1):c.2850+5A>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485962	17	29556488	17	31229470	485962	478108	rs864622633	NC_000017.11:31229469:A:T
NM_001042492.3(NF1):c.6642+3A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485961	17	29664603	17	31337585	485961	478970	rs1555534891	NC_000017.11:31337584:A:G
NM_001042492.3(NF1):c.1733T>C (p.Leu578Pro)	NF1	L578P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2019)	criteria provided, conflicting interpretations	VCV000485956	17	29550473	17	31223455	485956	478144	rs199474774	NC_000017.11:31223454:T:C
NM_001042492.3(NF1):c.2325G>A (p.Glu775=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000485955	17	29554309	17	31227291	485955	478061	rs1555613932	NC_000017.11:31227290:G:A
NM_001042492.3(NF1):c.7876C>G (p.Leu2626Val)	NF1	L2605V, L2626V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485954	17	29684293	17	31357275	485954	478355	rs1555536748	NC_000017.11:31357274:C:G
NM_001042492.3(NF1):c.2002-5C>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485953	17	29553448	17	31226430	485953	478733	rs1165625614	NC_000017.11:31226429:C:G
NM_001042492.3(NF1):c.8202T>C (p.Phe2734=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485949	17	29687546	17	31360528	485949	478559	rs764884159	NC_000017.11:31360527:T:C
NM_001042492.3(NF1):c.1113A>G (p.Ala371=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485946	17	29528105	17	31201087	485946	477972	rs786201652	NC_000017.11:31201086:A:G
NM_001042492.3(NF1):c.4800A>G (p.Lys1600=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485944	17	29592322	17	31265304	485944	478206	rs1555619409	NC_000017.11:31265303:A:G
NM_001042492.3(NF1):c.1627C>T (p.Gln543Ter)	NF1	Q543*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485943	17	29546122	17	31219104	485943	478042	rs894292181	NC_000017.11:31219103:C:T
NM_001042492.3(NF1):c.8386A>C (p.Lys2796Gln)	NF1	K2796Q, K2775Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485942	17	29701039	17	31374021	485942	478422	rs1383658117	NC_000017.11:31374020:A:C
NM_001042492.3(NF1):c.7355G>A (p.Arg2452His)	NF1	R2431H, R2452H	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000485941	17	29677234	17	31350216	485941	478516	rs1555536122	NC_000017.11:31350215:G:A
NM_001042492.3(NF1):c.4791G>A (p.Gly1597=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485940	17	29592313	17	31265295	485940	478340	rs1412795566	NC_000017.11:31265294:G:A
NM_001042492.3(NF1):c.5467T>C (p.Ser1823Pro)	NF1	S1823P, S1802P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485939	17	29654715	17	31327697	485939	478384	rs1555533592	NC_000017.11:31327696:T:C
NM_001042492.3(NF1):c.2661A>C (p.Ala887=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485938	17	29556294	17	31229276	485938	478060	rs1555614292	NC_000017.11:31229275:A:C
NM_001042492.3(NF1):c.5482C>T (p.Arg1828Trp)	NF1	R1828W, R1807W	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485936	17	29654730	17	31327712	485936	478244	rs1555533609	NC_000017.11:31327711:C:T
NM_001042492.3(NF1):c.1244A>G (p.His415Arg)	NF1	H415R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000485935	17	29528487	17	31201469	485935	478106	rs1555611097	NC_000017.11:31201468:A:G
NM_001042492.3(NF1):c.4275G>A (p.Gly1425=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485934	17	29585463	17	31258445	485934	478188	rs1555618548	NC_000017.11:31258444:G:A
NM_001042492.3(NF1):c.1846-3T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485933	17	29552110	17	31225092	485933	478049	rs1555613541	NC_000017.11:31225091:T:C
NM_001042492.3(NF1):c.6837A>C (p.Leu2279Phe)	NF1	L2279F, L2258F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000485932	17	29665739	17	31338721	485932	478977	rs144287929	NC_000017.11:31338720:A:C
NM_001042492.3(NF1):c.1153C>T (p.Arg385Cys)	NF1	R385C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485931	17	29528145	17	31201127	485931	477982	rs1322986962	NC_000017.11:31201126:C:T
NM_001042492.3(NF1):c.5553T>C (p.Pro1851=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484158	17	29654801	17	31327783	484158	478938	rs974310759	NC_000017.11:31327782:T:C
NM_001042492.3(NF1):c.7765C>T (p.Gln2589Ter)	NF1	Q2589*, Q2568*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000484156	17	29684004	17	31356986	484156	478369	rs1555536689	NC_000017.11:31356985:C:T
NM_001042492.3(NF1):c.2045A>C (p.Gln682Pro)	NF1	Q682P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484149	17	29553496	17	31226478	484149	478747	rs1304889984	NC_000017.11:31226477:A:C
NM_001042492.3(NF1):c.5155A>G (p.Ile1719Val)	NF1	I1698V, I1719V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484146	17	29653157	17	31326139	484146	478222	rs1434439252	NC_000017.11:31326138:A:G
NM_001042492.3(NF1):c.2623G>A (p.Gly875Ser)	NF1	G875S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484145	17	29556256	17	31229238	484145	478098	rs754734571	NC_000017.11:31229237:G:A
NM_001042492.3(NF1):c.3694C>T (p.Pro1232Ser)	NF1	P1232S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484142	17	29560217	17	31233199	484142	478267	rs1482085668	NC_000017.11:31233198:C:T
NM_001042492.3(NF1):c.7197G>A (p.Arg2399=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000484141	17	29676145	17	31349127	484141	478999	rs1555536017	NC_000017.11:31349126:G:A
NM_001042492.3(NF1):c.5269-4C>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2020)	criteria provided, conflicting interpretations	VCV000484137	17	29654513	17	31327495	484137	478236	rs1555533547	NC_000017.11:31327494:C:G
NM_001042492.3(NF1):c.4601G>A (p.Arg1534Gln)	NF1	R1513Q, R1534Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484135	17	29588752	17	31261734	484135	478896	rs867955218	NC_000017.11:31261733:G:A
NM_001042492.3(NF1):c.4657C>T (p.Pro1553Ser)	NF1	P1532S, P1553S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484130	17	29588808	17	31261790	484130	478906	rs1033427343	NC_000017.11:31261789:C:T
NM_001042492.3(NF1):c.3014T>C (p.Met1005Thr)	NF1	M1005T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484129	17	29557301	17	31230283	484129	478133	rs1555614504	NC_000017.11:31230282:T:C
NM_001042492.3(NF1):c.5857C>T (p.Leu1953=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484127	17	29661900	17	31334882	484127	478402	rs1555534394	NC_000017.11:31334881:C:T
NM_001042492.3(NF1):c.4796C>G (p.Ser1599Cys)	NF1	S1578C, S1599C	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000484126	17	29592318	17	31265300	484126	478215	rs1555619407	NC_000017.11:31265299:C:G
NM_001042492.3(NF1):c.6116C>T (p.Ala2039Val)	NF1	A2039V, A2018V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484122	17	29663460	17	31336442	484122	478955	rs1555534614	NC_000017.11:31336441:C:T
NM_001042492.3(NF1):c.6162G>A (p.Met2054Ile)	NF1	M2054I, M2033I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484119	17	29663667	17	31336649	484119	478289	rs876660651	NC_000017.11:31336648:G:A
NM_001042492.3(NF1):c.1944A>G (p.Glu648=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484118	17	29552211	17	31225193	484118	478150	rs1465016257	NC_000017.11:31225192:A:G
NM_001042492.3(NF1):c.348A>T (p.Glu116Asp)	NF1	E116D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484117	17	29490263	17	31163245	484117	477918	rs1231174547	NC_000017.11:31163244:A:T
NM_001042492.3(NF1):c.1710T>C (p.Phe570=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484115	17	29548936	17	31221918	484115	478120	rs1462741584	NC_000017.11:31221917:T:C
NM_001042492.3(NF1):c.1811T>A (p.Leu604Ter)	NF1	L604*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000484114	17	29550551	17	31223533	484114	478023	rs1555613427	NC_000017.11:31223532:T:A
NM_001042492.3(NF1):c.7837C>T (p.Pro2613Ser)	NF1	P2592S, P2613S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484112	17	29684076	17	31357058	484112	478379	rs138839077	NC_000017.11:31357057:C:T
NM_001042492.3(NF1):c.1429T>C (p.Phe477Leu)	NF1	F477L	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 2, 2020)	criteria provided, conflicting interpretations	VCV000484107	17	29541505	17	31214487	484107	478032	rs1555612276	NC_000017.11:31214486:T:C
NM_001042492.3(NF1):c.2338A>G (p.Thr780Ala)	NF1	T780A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484104	17	29554553	17	31227535	484104	478181	rs1205746953	NC_000017.11:31227534:A:G
NM_001042492.3(NF1):c.6201T>C (p.Pro2067=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484102	17	29663706	17	31336688	484102	478296	rs1555534671	NC_000017.11:31336687:T:C
NM_001042492.3(NF1):c.3582C>T (p.Asp1194=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484099	17	29560105	17	31233087	484099	478820	rs1555615036	NC_000017.11:31233086:C:T
NM_001042492.3(NF1):c.4312G>A (p.Gly1438Ser)	NF1	G1438S, G1417S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484098	17	29585500	17	31258482	484098	478201	rs1555618559	NC_000017.11:31258481:G:A
NM_001042492.3(NF1):c.1907C>G (p.Ser636Cys)	NF1	S636C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484094	17	29552174	17	31225156	484094	478727	rs780412565	NC_000017.11:31225155:C:G
NM_001042492.3(NF1):c.2337T>G (p.Asp779Glu)	NF1	D779E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484093	17	29554552	17	31227534	484093	478063	rs1555613989	NC_000017.11:31227533:T:G
NM_001042492.3(NF1):c.724A>G (p.Met242Val)	NF1	M242V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484089	17	29508797	17	31181779	484089	478663	rs1555608762	NC_000017.11:31181778:A:G
NM_001042492.3(NF1):c.8393A>G (p.Asn2798Ser)	NF1	N2777S, N2798S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484088	17	29701046	17	31374028	484088	478423	rs1555538515	NC_000017.11:31374027:A:G
NM_001042492.3(NF1):c.274A>G (p.Lys92Glu)	NF1	K92E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484087	17	29486097	17	31159079	484087	477979	rs1555605396	NC_000017.11:31159078:A:G
NM_001042492.3(NF1):c.3315-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484086	17	29559716	17	31232698	484086	478125	rs1555614914	NC_000017.11:31232697:A:G
NM_001042492.3(NF1):c.884A>G (p.Asn295Ser)	NF1	N295S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2017)	criteria provided, conflicting interpretations	VCV000484085	17	29509679	17	31182661	484085	478674	rs1555608994	NC_000017.11:31182660:A:G
NM_001042492.3(NF1):c.4336C>T (p.Leu1446Phe)	NF1	L1425F, L1446F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484082	17	29586053	17	31259035	484082	478210	rs1555618639	NC_000017.11:31259034:C:T
NM_001042492.3(NF1):c.5866C>A (p.Leu1956Ile)	NF1	L1956I, L1935I	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000484081	17	29661909	17	31334891	484081	478255	rs747678243	NC_000017.11:31334890:C:A
NM_001042492.3(NF1):c.1413A>G (p.Lys471=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484080	17	29541489	17	31214471	484080	478007	rs1309932338	NC_000017.11:31214470:A:G
NM_001042492.3(NF1):c.5705C>T (p.Ala1902Val)	NF1	A1902V, A1881V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484077	17	29657409	17	31330391	484077	478253	rs1465309384	NC_000017.11:31330390:C:T
NM_001042492.3(NF1):c.663G>A (p.Trp221Ter)	NF1	W221*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000484076	17	29508736	17	31181718	484076	477936	rs1555608737	NC_000017.11:31181717:G:A
NM_001042492.3(NF1):c.8267T>A (p.Leu2756Gln)	NF1	L2735Q, L2756Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484073	17	29687611	17	31360593	484073	478564	rs1555537241	NC_000017.11:31360592:T:A
NM_001042492.3(NF1):c.2999G>A (p.Arg1000His)	NF1	R1000H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484071	17	29557286	17	31230268	484071	478127	rs753082620	NC_000017.11:31230267:G:A
NM_001042492.3(NF1):c.7550G>A (p.Arg2517Gln)	NF1	R2496Q, R2517Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484069	17	29679367	17	31352349	484069	478537	rs755260088	NC_000017.11:31352348:G:A
NM_001042492.3(NF1):c.3133C>T (p.Leu1045=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484068	17	29557879	17	31230861	484068	478114	rs1555614626	NC_000017.11:31230860:C:T
NM_001042492.3(NF1):c.179C>G (p.Thr60Ser)	NF1	T60S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484066	17	29483119	17	31156101	484066	477901	rs1007047958	NC_000017.11:31156100:C:G
NM_001042492.3(NF1):c.1953A>G (p.Leu651=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484065	17	29552220	17	31225202	484065	478151	rs1298717179	NC_000017.11:31225201:A:G
NM_001042492.3(NF1):c.4186C>T (p.Arg1396Cys)	NF1	R1375C, R1396C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484064	17	29585374	17	31258356	484064	478864	rs1555618495	NC_000017.11:31258355:C:T
NM_001042492.3(NF1):c.607G>T (p.Ala203Ser)	NF1	A203S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484063	17	29508460	17	31181442	484063	477987	rs904361724	NC_000017.11:31181441:G:T
NM_001042492.3(NF1):c.4370A>G (p.Lys1457Arg)	NF1	K1436R, K1457R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2020)	criteria provided, conflicting interpretations	VCV000484060	17	29586087	17	31259069	484060	478190	rs1555618656	NC_000017.11:31259068:A:G
NM_001042492.3(NF1):c.7020A>G (p.Gln2340=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2018)	criteria provided, conflicting interpretations	VCV000484059	17	29667621	17	31340603	484059	478986	rs777399429	NC_000017.11:31340602:A:G
NM_001042492.3(NF1):c.3469G>A (p.Val1157Ile)	NF1	V1157I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Mar 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000484058	17	29559872	17	31232854	484058	478154	rs375845704	NC_000017.11:31232853:G:A
NM_001042492.3(NF1):c.7762C>T (p.Gln2588Ter)	NF1	Q2588*, Q2567*	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000484056	17	29684001	17	31356983	484056	479071	rs1555536687	NC_000017.11:31356982:C:T
NM_001042492.3(NF1):c.291A>G (p.Gln97=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 24, 2020)	criteria provided, conflicting interpretations	VCV000484055	17	29490206	17	31163188	484055	477911	rs1555606044	NC_000017.11:31163187:A:G
NM_001042492.3(NF1):c.4022A>T (p.Gln1341Leu)	NF1	Q1341L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484054	17	29576049	17	31249031	484054	478153	rs1555617325	NC_000017.11:31249030:A:T
NM_001042492.3(NF1):c.2440A>G (p.Lys814Glu)	NF1	K814E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484051	17	29556073	17	31229055	484051	478073	rs1555614184	NC_000017.11:31229054:A:G
NM_001042492.3(NF1):c.7812C>G (p.Leu2604=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Feb 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484050	17	29684051	17	31357033	484050	478373	rs1555536702	NC_000017.11:31357032:C:G
NM_001042492.3(NF1):c.117C>T (p.Asn39=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484049	17	29483057	17	31156039	484049	478019	rs1555604894	NC_000017.11:31156038:C:T
NM_001042492.3(NF1):c.1107G>A (p.Gln369=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484046	17	29528099	17	31201081	484046	478016	rs1193249274	NC_000017.11:31201080:G:A
NM_001042492.3(NF1):c.3330T>A (p.Phe1110Leu)	NF1	F1110L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484045	17	29559733	17	31232715	484045	478812	rs1256152851	NC_000017.11:31232714:T:A
NM_001042492.3(NF1):c.7509C>T (p.Tyr2503=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000484043	17	29679326	17	31352308	484043	478359	rs1555536359	NC_000017.11:31352307:C:T
NM_001042492.3(NF1):c.4856A>G (p.Asn1619Ser)	NF1	N1598S, N1619S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484042	17	29652858	17	31325840	484042	478217	rs1466167635	NC_000017.11:31325839:A:G
NM_001042492.3(NF1):c.8026A>G (p.Asn2676Asp)	NF1	N2676D, N2655D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484041	17	29685553	17	31358535	484041	478404	rs1555536902	NC_000017.11:31358534:A:G
NM_001042492.3(NF1):c.4836G>T (p.Arg1612Ser)	NF1	R1591S, R1612S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484040	17	29652838	17	31325820	484040	478347	rs1555533268	NC_000017.11:31325819:G:T
NM_001042492.3(NF1):c.1962T>G (p.Pro654=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484038	17	29552229	17	31225211	484038	478158	rs1555613595	NC_000017.11:31225210:T:G
NM_001042492.3(NF1):c.2409+1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484037	17	29554625	17	31227607	484037	478205	rs1555614022	NC_000017.11:31227606:G:C
NM_001042492.3(NF1):c.537G>A (p.Leu179=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484033	17	29496966	17	31169948	484033	477927	rs1555607095	NC_000017.11:31169947:G:A
NM_001042492.3(NF1):c.2239A>G (p.Met747Val)	NF1	M747V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484030	17	29553690	17	31226672	484030	478058	rs1471232737	NC_000017.11:31226671:A:G
NM_001042492.3(NF1):c.2378A>C (p.Asn793Thr)	NF1	N793T	Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2018)	criteria provided, conflicting interpretations	VCV000484027	17	29554593	17	31227575	484027	478185	rs772543826	NC_000017.11:31227574:A:C
NM_001042492.3(NF1):c.7542C>T (p.Thr2514=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484024	17	29679359	17	31352341	484024	478362	rs1444018213	NC_000017.11:31352340:C:T
NM_001042492.3(NF1):c.585G>A (p.Lys195=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2020)	criteria provided, conflicting interpretations	VCV000484020	17	29497014	17	31169996	484020	478647	rs918734204	NC_000017.11:31169995:G:A
NM_001042492.3(NF1):c.3342G>A (p.Leu1114=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484019	17	29559745	17	31232727	484019	478129	rs1172575807	NC_000017.11:31232726:G:A
NM_001042492.3(NF1):c.1068G>A (p.Leu356=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484016	17	29528060	17	31201042	484016	478697	rs1259636575	NC_000017.11:31201041:G:A
NM_001042492.3(NF1):c.4725-1G>A	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484015	17	29592246	17	31265228	484015	478907	rs1555619391	NC_000017.11:31265227:G:A
NM_001042492.3(NF1):c.7881A>G (p.Val2627=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000484013	17	29684298	17	31357280	484013	479113	rs756880349	NC_000017.11:31357279:A:G
NM_001042492.3(NF1):c.7225A>G (p.Thr2409Ala)	NF1	T2409A, T2388A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484012	17	29676173	17	31349155	484012	479006	rs1555536021	NC_000017.11:31349154:A:G
NM_001042492.3(NF1):c.6591T>C (p.Phe2197=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484011	17	29664549	17	31337531	484011	478968	rs1298866989	NC_000017.11:31337530:T:C
NM_001042492.3(NF1):c.8296C>G (p.Leu2766Val)	NF1	L2766V, L2745V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2019)	criteria provided, conflicting interpretations	VCV000484009	17	29687640	17	31360622	484009	478406	rs749647961	NC_000017.11:31360621:C:G
NM_001042492.3(NF1):c.5631G>A (p.Leu1877=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000484007	17	29657335	17	31330317	484007	478269	rs1555533844	NC_000017.11:31330316:G:A
NM_001042492.3(NF1):c.4110+3A>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484005	17	29576140	17	31249122	484005	478183	rs774669878	NC_000017.11:31249121:A:C
NM_001042492.3(NF1):c.5729C>G (p.Ser1910Cys)	NF1	S1889C, S1910C	Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484003	17	29657433	17	31330415	484003	478388	rs751904277	NC_000017.11:31330414:C:G
NM_001042492.3(NF1):c.5263A>G (p.Ile1755Val)	NF1	I1734V, I1755V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000484002	17	29653265	17	31326247	484002	478223	rs370181275	NC_000017.11:31326246:A:G
NM_001042492.3(NF1):c.7647A>G (p.Ser2549=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000484001	17	29683509	17	31356491	484001	479054	rs750342324	NC_000017.11:31356490:A:G
NM_001042492.3(NF1):c.4174-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481997	17	29585360	17	31258342	481997	478184	rs1555618489	NC_000017.11:31258341:A:G
NM_001042492.3(NF1):c.1652T>C (p.Val551Ala)	NF1	V551A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481995	17	29548878	17	31221860	481995	478017	rs113867817	NC_000017.11:31221859:T:C
NM_001042492.3(NF1):c.3367G>T (p.Glu1123Ter)	NF1	E1123*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481993	17	29559770	17	31232752	481993	478232	rs1555614940	NC_000017.11:31232751:G:T
NM_001042492.3(NF1):c.2457T>C (p.His819=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000481990	17	29556090	17	31229072	481990	478081	rs976466916	NC_000017.11:31229071:T:C
NM_001042492.3(NF1):c.8160G>C (p.Lys2720Asn)	NF1	K2699N, K2720N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481988	17	29686033	17	31359015	481988	478557	rs1555537030	NC_000017.11:31359014:G:C
NM_001042492.3(NF1):c.4657C>G (p.Pro1553Ala)	NF1	P1532A, P1553A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481983	17	29588808	17	31261790	481983	478901	rs1033427343	NC_000017.11:31261789:C:G
NM_001042492.3(NF1):c.6705-3C>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481981	17	29665040	17	31338022	481981	478971	rs1131691079	NC_000017.11:31338021:C:A
NM_001042492.3(NF1):c.4227G>A (p.Met1409Ile)	NF1	M1388I, M1409I	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481977	17	29585415	17	31258397	481977	478279	rs786201895	NC_000017.11:31258396:G:A
NM_001042492.3(NF1):c.2661A>G (p.Ala887=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481976	17	29556294	17	31229276	481976	478213	rs1555614292	NC_000017.11:31229275:A:G
NM_001042492.3(NF1):c.6396T>G (p.Ser2132=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481975	17	29663901	17	31336883	481975	478297	rs1555534764	NC_000017.11:31336882:T:G
NM_001042492.3(NF1):c.4339C>A (p.Gln1447Lys)	NF1	Q1426K, Q1447K	Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000481974	17	29586056	17	31259038	481974	478282	rs1135402857	NC_000017.11:31259037:C:A
NM_001042492.3(NF1):c.107C>T (p.Thr36Ile)	NF1	T36I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481973	17	29483047	17	31156029	481973	478632	rs199966218	NC_000017.11:31156028:C:T
NM_001042492.3(NF1):c.587-3C>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000481968	17	29508437	17	31181419	481968	478070	rs375188075	NC_000017.11:31181418:C:G
NM_001042492.3(NF1):c.5946C>T (p.Thr1982=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481967	17	29661989	17	31334971	481967	478284	rs1555534423	NC_000017.11:31334970:C:T
NM_001042492.3(NF1):c.4722T>G (p.Thr1574=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481966	17	29588873	17	31261855	481966	478211	rs1555619054	NC_000017.11:31261854:T:G
NM_001042492.3(NF1):c.656C>G (p.Ala219Gly)	NF1	A219G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481963	17	29508729	17	31181711	481963	478655	rs1160353919	NC_000017.11:31181710:C:G
NM_001042492.3(NF1):c.7030A>G (p.Thr2344Ala)	NF1	T2344A, T2323A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481960	17	29667631	17	31340613	481960	478473	rs1555535189	NC_000017.11:31340612:A:G
NM_001042492.3(NF1):c.469A>G (p.Ile157Val)	NF1	I157V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481959	17	29490384	17	31163366	481959	478046	rs1555606118	NC_000017.11:31163365:A:G
NM_001042492.3(NF1):c.4350C>T (p.Ala1450=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481957	17	29586067	17	31259049	481957	478180	rs752055412	NC_000017.11:31259048:C:T
NM_001042492.3(NF1):c.7490C>T (p.Pro2497Leu)	NF1	P2476L, P2497L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481955	17	29679307	17	31352289	481955	478525	rs1555536347	NC_000017.11:31352288:C:T
NM_001042492.3(NF1):c.7846C>G (p.Gln2616Glu)	NF1	Q2595E, Q2616E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481954	17	29684085	17	31357067	481954	478381	rs1555536713	NC_000017.11:31357066:C:G
NM_001042492.3(NF1):c.2825G>C (p.Ser942Thr)	NF1	S942T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481951	17	29556458	17	31229440	481951	478072	rs1555614350	NC_000017.11:31229439:G:C
NM_001042492.3(NF1):c.4577+4A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481945	17	29587537	17	31260519	481945	478327	rs1555618863	NC_000017.11:31260518:A:G
NM_001042492.3(NF1):c.2390C>T (p.Ala797Val)	NF1	A797V	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481943	17	29554605	17	31227587	481943	478203	rs1181350360	NC_000017.11:31227586:C:T
NM_001042492.3(NF1):c.4045G>A (p.Ala1349Thr)	NF1	A1349T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481942	17	29576072	17	31249054	481942	478836	rs1555617332	NC_000017.11:31249053:G:A
NM_001042492.3(NF1):c.7148A>G (p.Asn2383Ser)	NF1	N2383S, N2362S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481941	17	29670112	17	31343094	481941	478329	rs146296921	NC_000017.11:31343093:A:G
NM_001042492.3(NF1):c.3506A>G (p.Tyr1169Cys)	NF1	Y1169C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481937	17	29560029	17	31233011	481937	478238	rs1555615014	NC_000017.11:31233010:A:G
NM_001042492.3(NF1):c.907C>G (p.Leu303Val)	NF1	L303V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481935	17	29527458	17	31200440	481935	478003	rs1555610847	NC_000017.11:31200439:C:G
NM_001042492.3(NF1):c.7768C>T (p.His2590Tyr)	NF1	H2569Y, H2590Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481934	17	29684007	17	31356989	481934	479077	rs1555536690	NC_000017.11:31356988:C:T
NM_001042492.3(NF1):c.2856A>C (p.Leu952Phe)	NF1	L952F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481933	17	29556858	17	31229840	481933	478112	rs750488772	NC_000017.11:31229839:A:C
NM_001042492.3(NF1):c.520G>T (p.Val174Phe)	NF1	V174F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481930	17	29496949	17	31169931	481930	477986	rs1555607084	NC_000017.11:31169930:G:T
NM_001042492.3(NF1):c.7044C>T (p.Leu2348=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481929	17	29667645	17	31340627	481929	478332	rs1350755921	NC_000017.11:31340626:C:T
NM_001042492.3(NF1):c.3013A>G (p.Met1005Val)	NF1	M1005V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481926	17	29557300	17	31230282	481926	478131	rs1555614502	NC_000017.11:31230281:A:G
NM_001042492.3(NF1):c.7349G>A (p.Arg2450Gln)	NF1	R2429Q, R2450Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481925	17	29677228	17	31350210	481925	478515	rs533110479	NC_000017.11:31350209:G:A
NM_001042492.3(NF1):c.373C>G (p.Arg125Gly)	NF1	R125G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481924	17	29490288	17	31163270	481924	477981	rs876659418	NC_000017.11:31163269:C:G
NM_001042492.3(NF1):c.5039A>G (p.Tyr1680Cys)	NF1	Y1680C, Y1659C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481920	17	29653041	17	31326023	481920	478915	rs758361270	NC_000017.11:31326022:A:G
NM_001042492.3(NF1):c.3527G>T (p.Arg1176Ile)	NF1	R1176I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481919	17	29560050	17	31233032	481919	478258	rs1227027709	NC_000017.11:31233031:G:T
NM_001042492.3(NF1):c.7190-5T>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000481915	17	29676133	17	31349115	481915	478331	rs748245325	NC_000017.11:31349114:T:G
NM_001042492.3(NF1):c.4277T>C (p.Ile1426Thr)	NF1	I1426T, I1405T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481914	17	29585465	17	31258447	481914	478194	rs1555618549	NC_000017.11:31258446:T:C
NM_001042492.3(NF1):c.464G>A (p.Ser155Asn)	NF1	S155N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481911	17	29490379	17	31163361	481911	477926	rs1555606113	NC_000017.11:31163360:G:A
NM_001042492.3(NF1):c.3975-4G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000481910	17	29575998	17	31248980	481910	478826	rs760207624	NC_000017.11:31248979:G:A
NM_001042492.3(NF1):c.4360C>G (p.Leu1454Val)	NF1	L1454V, L1433V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481907	17	29586077	17	31259059	481907	478182	rs1408832954	NC_000017.11:31259058:C:G
NM_001042492.3(NF1):c.8218G>A (p.Asp2740Asn)	NF1	D2719N, D2740N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481906	17	29687562	17	31360544	481906	478560	rs1555537228	NC_000017.11:31360543:G:A
NM_001042492.3(NF1):c.4344T>C (p.Ser1448=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481905	17	29586061	17	31259043	481905	478288	rs1555618644	NC_000017.11:31259042:T:C
NM_001042492.3(NF1):c.355C>T (p.His119Tyr)	NF1	H119Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481901	17	29490270	17	31163252	481901	477920	rs1555606066	NC_000017.11:31163251:C:T
NM_001042492.3(NF1):c.5741C>A (p.Thr1914Lys)	NF1	T1893K, T1914K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481899	17	29657445	17	31330427	481899	478271	rs1555533873	NC_000017.11:31330426:C:A
NM_001042492.3(NF1):c.7504G>C (p.Gly2502Arg)	NF1	G2481R, G2502R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481894	17	29679321	17	31352303	481894	478351	rs1555536357	NC_000017.11:31352302:G:C
NM_001042492.3(NF1):c.804A>C (p.Pro268=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481893	17	29509599	17	31182581	481893	477951	rs759964997	NC_000017.11:31182580:A:C
NM_001042492.3(NF1):c.2971A>G (p.Met991Val)	NF1	M991V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481890	17	29556973	17	31229955	481890	478088	rs1268543864	NC_000017.11:31229954:A:G
NM_001042492.3(NF1):c.2556C>T (p.Leu852=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481889	17	29556189	17	31229171	481889	478209	rs771308677	NC_000017.11:31229170:C:T
NM_001042492.3(NF1):c.1392+5G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000481888	17	29533394	17	31206376	481888	477993	rs199999754	NC_000017.11:31206375:G:A
NM_001042492.3(NF1):c.4058C>T (p.Ser1353Phe)	NF1	S1353F	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000481887	17	29576085	17	31249067	481887	478839	rs1555617346	NC_000017.11:31249066:C:T
NM_001042492.3(NF1):c.1021G>A (p.Val341Ile)	NF1	V341I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000481886	17	29527572	17	31200554	481886	478090	rs1555610907	NC_000017.11:31200553:G:A
NM_001042492.3(NF1):c.2282C>T (p.Ala761Val)	NF1	A761V	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481883	17	29554266	17	31227248	481883	478043	rs746850653	NC_000017.11:31227247:C:T
NM_001042492.3(NF1):c.484C>T (p.Gln162Ter)	NF1	Q162*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481882	17	29496913	17	31169895	481882	478065	rs1555607073	NC_000017.11:31169894:C:T
NM_001042492.3(NF1):c.7600A>G (p.Thr2534Ala)	NF1	T2513A, T2534A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)	criteria provided, conflicting interpretations	VCV000481881	17	29679417	17	31352399	481881	479051	rs779737221	NC_000017.11:31352398:A:G
NM_001042492.3(NF1):c.4046C>A (p.Ala1349Asp)	NF1	A1349D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481880	17	29576073	17	31249055	481880	478276	rs1229215269	NC_000017.11:31249054:C:A
NM_001042492.3(NF1):c.2328T>G (p.Ala776=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481879	17	29554543	17	31227525	481879	478178	rs1555613978	NC_000017.11:31227524:T:G
NM_001042492.3(NF1):c.2916A>C (p.Leu972=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481878	17	29556918	17	31229900	481878	478087	rs1210119104	NC_000017.11:31229899:A:C
NM_001042492.3(NF1):c.2618G>A (p.Arg873His)	NF1	R873H	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000481877	17	29556251	17	31229233	481877	478091	rs949092641	NC_000017.11:31229232:G:A
NM_001042492.3(NF1):c.3965A>T (p.Asp1322Val)	NF1	D1322V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000481875	17	29563030	17	31236012	481875	478169	rs1555615565	NC_000017.11:31236011:A:T
NM_001042492.3(NF1):c.2385A>G (p.Pro795=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480957	17	29554600	17	31227582	480957	478197	rs1555614009	NC_000017.11:31227581:A:G
NM_001042492.3(NF1):c.4953C>T (p.Ser1651=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480954	17	29652955	17	31325937	480954	478911	rs941643920	NC_000017.11:31325936:C:T
NM_001042492.3(NF1):c.612A>G (p.Leu204=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Aug 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480800	17	29508465	17	31181447	480800	477990	rs1555608658	NC_000017.11:31181446:A:G
NM_001042492.3(NF1):c.6230A>T (p.Asp2077Val)	NF1	D2056V, D2077V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480225	17	29663735	17	31336717	480225	478966	rs1555534684	NC_000017.11:31336716:A:T
NM_001042492.3(NF1):c.4938C>T (p.Thr1646=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480218	17	29652940	17	31325922	480218	478350	rs1555533306	NC_000017.11:31325921:C:T
NM_001042492.3(NF1):c.2769A>G (p.Leu923=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480217	17	29556402	17	31229384	480217	478103	rs1450651152	NC_000017.11:31229383:A:G
NM_001042492.3(NF1):c.680A>T (p.Tyr227Phe)	NF1	Y227F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480216	17	29508753	17	31181735	480216	478076	rs1555608742	NC_000017.11:31181734:A:T
NM_001042492.3(NF1):c.3345T>C (p.Asn1115=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480215	17	29559748	17	31232730	480215	478230	rs1443772199	NC_000017.11:31232729:T:C
NM_001042492.3(NF1):c.3315-3C>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480211	17	29559715	17	31232697	480211	478807	rs752318318	NC_000017.11:31232696:C:T
NM_001042492.3(NF1):c.6082G>A (p.Ala2028Thr)	NF1	A2028T, A2007T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480209	17	29663426	17	31336408	480209	478291	rs767869530	NC_000017.11:31336407:G:A
NM_001042492.3(NF1):c.614A>G (p.Lys205Arg)	NF1	K205R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480207	17	29508467	17	31181449	480207	477995	rs1555608659	NC_000017.11:31181448:A:G
NM_001042492.3(NF1):c.479G>A (p.Arg160Lys)	NF1	R160K	Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000480206	17	29490394	17	31163376	480206	478059	rs199474752	NC_000017.11:31163375:G:A
NM_001042492.3(NF1):c.4078C>T (p.Gln1360Ter)	NF1	Q1360*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480204	17	29576105	17	31249087	480204	478856	rs1555617368	NC_000017.11:31249086:C:T
NM_001042492.3(NF1):c.6012A>G (p.Thr2004=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480200	17	29663356	17	31336338	480200	478412	rs1232336416	NC_000017.11:31336337:A:G
NM_001042492.3(NF1):c.7368A>C (p.Lys2456Asn)	NF1	K2435N, K2456N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480199	17	29677247	17	31350229	480199	479015	rs201287021	NC_000017.11:31350228:A:C
NM_001042492.3(NF1):c.6667T>C (p.Cys2223Arg)	NF1	C2223R, C2202R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480198	17	29664861	17	31337843	480198	478305	rs1192120725	NC_000017.11:31337842:T:C
NM_001042492.3(NF1):c.7400C>T (p.Ser2467Leu)	NF1	S2446L, S2467L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480197	17	29677279	17	31350261	480197	479024	rs1555536135	NC_000017.11:31350260:C:T
NM_001042492.3(NF1):c.4507A>C (p.Asn1503His)	NF1	N1482H, N1503H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480196	17	29587463	17	31260445	480196	478881	rs1555618837	NC_000017.11:31260444:A:C
NM_001042492.3(NF1):c.1392+4A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480194	17	29533393	17	31206375	480194	478724	rs1555611611	NC_000017.11:31206374:A:G
NM_001042492.3(NF1):c.7189+4A>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480192	17	29670157	17	31343139	480192	478505	rs756834212	NC_000017.11:31343138:A:C
NM_001042492.3(NF1):c.3756A>G (p.Leu1252=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480191	17	29562676	17	31235658	480191	478165	rs1298630862	NC_000017.11:31235657:A:G
NM_001042492.3(NF1):c.7675A>G (p.Met2559Val)	NF1	M2559V, M2538V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480190	17	29683537	17	31356519	480190	479060	rs779373258	NC_000017.11:31356518:A:G
NM_001042492.3(NF1):c.7369C>T (p.His2457Tyr)	NF1	H2436Y, H2457Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480189	17	29677248	17	31350230	480189	478517	rs768404575	NC_000017.11:31350229:C:T
NM_001042492.3(NF1):c.8412C>T (p.Thr2804=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2021)	criteria provided, conflicting interpretations	VCV000480188	17	29701065	17	31374047	480188	478426	rs1555538531	NC_000017.11:31374046:C:T
NM_001042492.3(NF1):c.3358G>C (p.Val1120Leu)	NF1	V1120L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480187	17	29559761	17	31232743	480187	478142	rs200594167	NC_000017.11:31232742:G:C
NM_001042492.3(NF1):c.7095T>C (p.Asn2365=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480185	17	29670059	17	31343041	480185	478992	rs981246691	NC_000017.11:31343040:T:C
NM_001042492.3(NF1):c.4495A>C (p.Ile1499Leu)	NF1	I1499L, I1478L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480184	17	29587451	17	31260433	480184	478200	rs764654925	NC_000017.11:31260432:A:C
NM_001042492.3(NF1):c.2326-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480183	17	29554539	17	31227521	480183	478174	rs1555613975	NC_000017.11:31227520:A:G
NM_001042492.3(NF1):c.7774C>A (p.His2592Asn)	NF1	H2592N, H2571N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480182	17	29684013	17	31356995	480182	479098	rs749460130	NC_000017.11:31356994:C:A
NM_001042492.3(NF1):c.1528-1G>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000480181	17	29546022	17	31219004	480181	478014	rs876660595	NC_000017.11:31219003:G:T
NM_001042492.3(NF1):c.2098A>G (p.Thr700Ala)	NF1	T700A	Neurofibromatosis, type 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480180	17	29553549	17	31226531	480180	478030	rs1555613801	NC_000017.11:31226530:A:G
NM_001042492.3(NF1):c.3114G>C (p.Arg1038Ser)	NF1	R1038S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480179	17	29557860	17	31230842	480179	478101	rs1555614616	NC_000017.11:31230841:G:C
NM_001042492.3(NF1):c.1356A>C (p.Gln452His)	NF1	Q452H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480174	17	29533353	17	31206335	480174	477992	rs1324833228	NC_000017.11:31206334:A:C
NM_001042492.3(NF1):c.7867C>G (p.Leu2623Val)	NF1	L2623V, L2602V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480171	17	29684106	17	31357088	480171	479105	rs1555536721	NC_000017.11:31357087:C:G
NM_001042492.3(NF1):c.7780C>T (p.Arg2594Cys)	NF1	R2594C, R2573C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480169	17	29684019	17	31357001	480169	478348	rs372787215	NC_000017.11:31357000:C:T
NM_001042492.3(NF1):c.6704+4T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480166	17	29664902	17	31337884	480166	478307	rs1555534930	NC_000017.11:31337883:T:C
NM_001042492.3(NF1):c.7815G>A (p.Leu2605=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2018)	criteria provided, conflicting interpretations	VCV000480165	17	29684054	17	31357036	480165	478552	rs1555536703	NC_000017.11:31357035:G:A
NM_001042492.3(NF1):c.3062T>G (p.Val1021Gly)	NF1	V1021G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480164	17	29557349	17	31230331	480164	478219	rs1355411201	NC_000017.11:31230330:T:G
NM_001042492.3(NF1):c.2508A>G (p.Glu836=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480163	17	29556141	17	31229123	480163	478773	rs1555614208	NC_000017.11:31229122:A:G
NM_001042492.3(NF1):c.6264G>C (p.Leu2088=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480162	17	29663769	17	31336751	480162	478301	rs762751192	NC_000017.11:31336750:G:C
NM_001042492.3(NF1):c.1764T>C (p.His588=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480160	17	29550504	17	31223486	480160	478146	rs1229784876	NC_000017.11:31223485:T:C
NM_001042492.3(NF1):c.7452C>A (p.Ser2484=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480159	17	29677331	17	31350313	480159	479048	rs764502383	NC_000017.11:31350312:C:A
NM_001042492.3(NF1):c.486G>A (p.Gln162=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480158	17	29496915	17	31169897	480158	478646	rs1555607076	NC_000017.11:31169896:G:A
NM_001042492.3(NF1):c.3960A>G (p.Glu1320=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480156	17	29563025	17	31236007	480156	478148	rs1555615564	NC_000017.11:31236006:A:G
NM_001042492.3(NF1):c.5442C>T (p.His1814=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480153	17	29654690	17	31327672	480153	478240	rs991848606	NC_000017.11:31327671:C:T
NM_001042492.3(NF1):c.8304C>T (p.Ser2768=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480152	17	29687648	17	31360630	480152	478415	rs1555537250	NC_000017.11:31360629:C:T
NM_001042492.3(NF1):c.7963C>G (p.Pro2655Ala)	NF1	P2634A, P2655A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480150	17	29684380	17	31357362	480150	479127	rs587781791	NC_000017.11:31357361:C:G
NM_001042492.3(NF1):c.2160G>T (p.Arg720=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480148	17	29553611	17	31226593	480148	478036	rs765339408	NC_000017.11:31226592:G:T
NM_001042492.3(NF1):c.7959C>A (p.Val2653=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480147	17	29684376	17	31357358	480147	479121	rs1555536767	NC_000017.11:31357357:C:A
NM_001042492.3(NF1):c.5299G>A (p.Ala1767Thr)	NF1	A1767T, A1746T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000480145	17	29654547	17	31327529	480145	478368	rs529905904	NC_000017.11:31327528:G:A
NM_001042492.3(NF1):c.1032A>T (p.Leu344=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480142	17	29527583	17	31200565	480142	477966	rs199832006	NC_000017.11:31200564:A:T
NM_001042492.3(NF1):c.7230C>T (p.Val2410=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480139	17	29676178	17	31349160	480139	479012	rs1555536022	NC_000017.11:31349159:C:T
NM_001042492.3(NF1):c.1910G>C (p.Ser637Thr)	NF1	S637T	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000480138	17	29552177	17	31225159	480138	478029	rs749745247	NC_000017.11:31225158:G:C
NM_001042492.3(NF1):c.6851C>T (p.Thr2284Ile)	NF1	T2263I, T2284I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480135	17	29665753	17	31338735	480135	478319	rs747881072	NC_000017.11:31338734:C:T
NM_001042492.3(NF1):c.2491A>G (p.Thr831Ala)	NF1	T831A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480134	17	29556124	17	31229106	480134	478083	rs1555614204	NC_000017.11:31229105:A:G
NM_001042492.3(NF1):c.1722-5T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2020)	criteria provided, conflicting interpretations	VCV000480133	17	29550457	17	31223439	480133	478136	rs1458980212	NC_000017.11:31223438:T:C
NM_001042492.3(NF1):c.1647G>T (p.Leu549=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480129	17	29548873	17	31221855	480129	478044	rs774627695	NC_000017.11:31221854:G:T
NM_001042492.3(NF1):c.5351A>T (p.Tyr1784Phe)	NF1	Y1784F, Y1763F	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480122	17	29654599	17	31327581	480122	478371	rs1060500280	NC_000017.11:31327580:A:T
NM_001042492.3(NF1):c.5280T>C (p.Thr1760=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480120	17	29654528	17	31327510	480120	478225	rs779104728	NC_000017.11:31327509:T:C
NM_001042492.3(NF1):c.2356C>A (p.Gln786Lys)	NF1	Q786K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480119	17	29554571	17	31227553	480119	478048	rs1555613999	NC_000017.11:31227552:C:A
NM_001042492.3(NF1):c.2637A>G (p.Ser879=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480117	17	29556270	17	31229252	480117	478057	rs1555614288	NC_000017.11:31229251:A:G
NM_001042492.3(NF1):c.6784G>T (p.Gly2262Trp)	NF1	G2241W, G2262W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480114	17	29665122	17	31338104	480114	478314	rs1392981001	NC_000017.11:31338103:G:T
NM_001042492.3(NF1):c.774A>G (p.Glu258=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480113	17	29509569	17	31182551	480113	477950	rs1555608947	NC_000017.11:31182550:A:G
NM_001042492.3(NF1):c.3185A>T (p.Lys1062Ile)	NF1	K1062I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480112	17	29557931	17	31230913	480112	478137	rs1314168961	NC_000017.11:31230912:A:T
NM_001042492.3(NF1):c.5175A>G (p.Lys1725=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480109	17	29653177	17	31326159	480109	478928	rs1372069749	NC_000017.11:31326158:A:G
NM_001042492.3(NF1):c.1920C>G (p.Thr640=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480108	17	29552187	17	31225169	480108	478052	rs1555613574	NC_000017.11:31225168:C:G
NM_001042492.3(NF1):c.8150C>T (p.Pro2717Leu)	NF1	P2696L, P2717L	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480106	17	29686023	17	31359005	480106	478395	rs778799019	NC_000017.11:31359004:C:T
NM_001042492.3(NF1):c.6805C>T (p.Arg2269Cys)	NF1	R2248C, R2269C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480104	17	29665143	17	31338125	480104	478457	rs1555534961	NC_000017.11:31338124:C:T
NM_001042492.3(NF1):c.4867C>T (p.Leu1623=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480103	17	29652869	17	31325851	480103	478349	rs1555533277	NC_000017.11:31325850:C:T
NM_001042492.3(NF1):c.965T>C (p.Ile322Thr)	NF1	I322T	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480101	17	29527516	17	31200498	480101	478006	rs1417994243	NC_000017.11:31200497:T:C
NM_001042492.3(NF1):c.74C>T (p.Thr25Ile)	NF1	T25I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480097	17	29483014	17	31155996	480097	478012	rs1555604874	NC_000017.11:31155995:C:T
NM_001042492.3(NF1):c.4486C>T (p.Leu1496Phe)	NF1	L1475F, L1496F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480096	17	29587442	17	31260424	480096	478196	rs1555618823	NC_000017.11:31260423:C:T
NM_001042492.3(NF1):c.3435G>T (p.Thr1145=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480095	17	29559838	17	31232820	480095	478233	rs772432150	NC_000017.11:31232819:G:T
NM_001042492.3(NF1):c.7594G>A (p.Ala2532Thr)	NF1	A2532T, A2511T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480094	17	29679411	17	31352393	480094	478547	rs1555536373	NC_000017.11:31352392:G:A
NM_001042492.3(NF1):c.7869+1G>A	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480091	17	29684109	17	31357091	480091	478383	rs1329683225	NC_000017.11:31357090:G:A
NM_001042492.3(NF1):c.2466A>C (p.Gly822=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480090	17	29556099	17	31229081	480090	478208	rs1555614200	NC_000017.11:31229080:A:C
NM_001042492.3(NF1):c.978A>G (p.Lys326=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2018)	criteria provided, conflicting interpretations	VCV000480088	17	29527529	17	31200511	480088	477960	rs1555610891	NC_000017.11:31200510:A:G
NM_001042492.3(NF1):c.1371C>A (p.His457Gln)	NF1	H457Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000480087	17	29533368	17	31206350	480087	478025	rs1318894606	NC_000017.11:31206349:C:A
NM_001042492.3(NF1):c.8060G>T (p.Ser2687Ile)	NF1	S2666I, S2687I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000480086	17	29685587	17	31358569	480086	478365	rs1555536916	NC_000017.11:31358568:G:T
NM_001042492.3(NF1):c.1266A>G (p.Ala422=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480085	17	29533263	17	31206245	480085	477985	rs1555611565	NC_000017.11:31206244:A:G
NM_001042492.3(NF1):c.3435G>A (p.Thr1145=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480084	17	29559838	17	31232820	480084	478147	rs772432150	NC_000017.11:31232819:G:A
NM_001042492.3(NF1):c.1330G>C (p.Gly444Arg)	NF1	G444R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480083	17	29533327	17	31206309	480083	477989	rs1162173842	NC_000017.11:31206308:G:C
NM_001042492.3(NF1):c.374G>A (p.Arg125His)	NF1	R125H	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480081	17	29490289	17	31163271	480081	478033	rs149003051	NC_000017.11:31163270:G:A
NM_001042492.3(NF1):c.5058C>T (p.Val1686=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480080	17	29653060	17	31326042	480080	478918	rs1315128684	NC_000017.11:31326041:C:T
NM_001042492.3(NF1):c.3030A>G (p.Gln1010=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2019)	criteria provided, conflicting interpretations	VCV000480079	17	29557317	17	31230299	480079	478096	rs1405071456	NC_000017.11:31230298:A:G
NM_001042492.3(NF1):c.631G>A (p.Ala211Thr)	NF1	A211T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480078	17	29508484	17	31181466	480078	478652	rs781519491	NC_000017.11:31181465:G:A
NM_001042492.3(NF1):c.7023C>T (p.Asn2341=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480077	17	29667624	17	31340606	480077	478330	rs1208205873	NC_000017.11:31340605:C:T
NM_001042492.3(NF1):c.2094T>C (p.Pro698=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480076	17	29553545	17	31226527	480076	478757	rs1555613798	NC_000017.11:31226526:T:C
NM_001042492.3(NF1):c.5238A>G (p.Leu1746=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480074	17	29653240	17	31326222	480074	478932	rs779689556	NC_000017.11:31326221:A:G
NM_001042492.3(NF1):c.4032A>G (p.Glu1344=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480073	17	29576059	17	31249041	480073	478827	rs1555617330	NC_000017.11:31249040:A:G
NM_001042492.3(NF1):c.655-3T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2020)	criteria provided, conflicting interpretations	VCV000480072	17	29508725	17	31181707	480072	478071	rs746584147	NC_000017.11:31181706:T:C
NM_001042492.3(NF1):c.1392+5G>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2018)	criteria provided, conflicting interpretations	VCV000480071	17	29533394	17	31206376	480071	478119	rs199999754	NC_000017.11:31206375:G:T
NM_001042492.3(NF1):c.6834C>T (p.Cys2278=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000480068	17	29665736	17	31338718	480068	478462	rs149603406	NC_000017.11:31338717:C:T
NM_001042492.3(NF1):c.98A>G (p.Lys33Arg)	NF1	K33R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457881	17	29483038	17	31156020	457881	466395	rs1555604887	NC_000017.11:31156019:A:G
NM_001042492.3(NF1):c.930T>C (p.His310=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457879	17	29527481	17	31200463	457879	467410	rs1555610865	NC_000017.11:31200462:T:C
NM_001042492.3(NF1):c.926G>A (p.Gly309Asp)	NF1	G309D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000457878	17	29527477	17	31200459	457878	466420	rs1555610862	NC_000017.11:31200458:G:A
NM_001042492.3(NF1):c.88A>C (p.Thr30Pro)	NF1	T30P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457875	17	29483028	17	31156010	457875	467509	rs1555604881	NC_000017.11:31156009:A:C
NM_001042492.3(NF1):c.873A>C (p.Glu291Asp)	NF1	E291D	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457874	17	29509668	17	31182650	457874	467409	rs754915138	NC_000017.11:31182649:A:C
NM_001042492.3(NF1):c.8469G>T (p.Lys2823Asn)	NF1	K2823N, K2802N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000457873	17	29701122	17	31374104	457873	467788	rs1203883572	NC_000017.11:31374103:G:T
NM_001042492.3(NF1):c.8456G>A (p.Ser2819Asn)	NF1	S2798N, S2819N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457872	17	29701109	17	31374091	457872	467585	rs934837854	NC_000017.11:31374090:G:A
NM_001042492.3(NF1):c.8418C>T (p.Gly2806=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000457871	17	29701071	17	31374053	457871	467920	rs1555538535	NC_000017.11:31374052:C:T
NM_001042492.3(NF1):c.8376A>C (p.Pro2792=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2020)	criteria provided, conflicting interpretations	VCV000457870	17	29687720	17	31360702	457870	466730	rs1028961967	NC_000017.11:31360701:A:C
NM_001042492.3(NF1):c.8323A>T (p.Asn2775Tyr)	NF1	N2754Y, N2775Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000457869	17	29687667	17	31360649	457869	467580	rs1555537252	NC_000017.11:31360648:A:T
NM_001042492.3(NF1):c.8161-8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000457868	17	29687497	17	31360479	457868	467575	rs1425972521	NC_000017.11:31360478:C:T
NM_001042492.3(NF1):c.8161-7A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, single submitter	VCV000457867	17	29687498	17	31360480	457867	467578	rs767623039	NC_000017.11:31360479:A:G
NM_001042492.3(NF1):c.804A>G (p.Pro268=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000457866	17	29509599	17	31182581	457866	467404	rs759964997	NC_000017.11:31182580:A:G
NM_001042492.3(NF1):c.8107C>A (p.Leu2703Met)	NF1	L2703M, L2682M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000457865	17	29685634	17	31358616	457865	467571	rs955074155	NC_000017.11:31358615:C:A
NM_001042492.3(NF1):c.7971-8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000457863	17	29685490	17	31358472	457863	467785	rs766889741	NC_000017.11:31358471:T:C
NM_001042492.3(NF1):c.7971-4T>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2019)	criteria provided, conflicting interpretations	VCV000457862	17	29685494	17	31358476	457862	467918	rs1555536865	NC_000017.11:31358475:T:G
NM_001042492.3(NF1):c.7945G>A (p.Val2649Met)	NF1	V2628M, V2649M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000457860	17	29684362	17	31357344	457860	466729	rs1555536761	NC_000017.11:31357343:G:A
NM_001042492.3(NF1):c.7869+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000457859	17	29684110	17	31357092	457859	466727	rs1555536724	NC_000017.11:31357091:T:G
NM_001042492.3(NF1):c.7844T>A (p.Ile2615Asn)	NF1	I2615N, I2594N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000457858	17	29684083	17	31357065	457858	467780	rs1555536711	NC_000017.11:31357064:T:A
NM_001042492.3(NF1):c.7839G>C (p.Pro2613=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457857	17	29684078	17	31357060	457857	466725	rs752218441	NC_000017.11:31357059:G:C
NM_001042492.3(NF1):c.7839G>A (p.Pro2613=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457856	17	29684078	17	31357060	457856	466720	rs752218441	NC_000017.11:31357059:G:A
NM_001042492.3(NF1):c.7810C>G (p.Leu2604Val)	NF1	L2604V, L2583V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457855	17	29684049	17	31357031	457855	467910	rs776602307	NC_000017.11:31357030:C:G
NM_001042492.3(NF1):c.7793T>C (p.Val2598Ala)	NF1	V2598A, V2577A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457854	17	29684032	17	31357014	457854	467778	rs760531845	NC_000017.11:31357013:T:C
NM_001042492.3(NF1):c.75A>C (p.Thr25=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000457852	17	29483015	17	31155997	457852	467505	rs768754175	NC_000017.11:31155996:A:C
NM_001042492.3(NF1):c.7614T>C (p.Leu2538=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 31, 2017)	criteria provided, conflicting interpretations	VCV000457851	17	29679431	17	31352413	457851	467567	rs1555536374	NC_000017.11:31352412:T:C
NM_001042492.3(NF1):c.7533C>T (p.Val2511=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457850	17	29679350	17	31352332	457850	467774	rs760733171	NC_000017.11:31352331:C:T
NM_001042492.3(NF1):c.7470G>A (p.Glu2490=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000457849	17	29679287	17	31352269	457849	467907	rs1555536339	NC_000017.11:31352268:G:A
NM_001042492.3(NF1):c.7461A>C (p.Thr2487=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000457848	17	29679278	17	31352260	457848	467905	rs149924365	NC_000017.11:31352259:A:C
NM_001042492.3(NF1):c.7457+3A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000457846	17	29677339	17	31350321	457846	466708	rs1555536170	NC_000017.11:31350320:A:G
NM_001042492.3(NF1):c.7456A>G (p.Arg2486Gly)	NF1	R2465G, R2486G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457845	17	29677335	17	31350317	457845	467772	rs752162999	NC_000017.11:31350316:A:G
NM_001042492.3(NF1):c.7437T>C (p.His2479=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Feb 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457844	17	29677316	17	31350298	457844	467903	rs1355368926	NC_000017.11:31350297:T:C
NM_001042492.3(NF1):c.7428T>C (p.Tyr2476=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000457843	17	29677307	17	31350289	457843	467563	rs181397225	NC_000017.11:31350288:T:C
NM_001042492.3(NF1):c.7424C>T (p.Thr2475Ile)	NF1	T2454I, T2475I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457842	17	29677303	17	31350285	457842	467755	rs770532573	NC_000017.11:31350284:C:T
NM_001042492.3(NF1):c.7417A>G (p.Met2473Val)	NF1	M2473V, M2452V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457841	17	29677296	17	31350278	457841	467896	rs1555536144	NC_000017.11:31350277:A:G
NM_001042492.3(NF1):c.7402A>G (p.Met2468Val)	NF1	M2447V, M2468V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jun 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457840	17	29677281	17	31350263	457840	467561	rs151211377	NC_000017.11:31350262:A:G
NM_001042492.3(NF1):c.7397T>C (p.Ile2466Thr)	NF1	I2445T, I2466T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000457839	17	29677276	17	31350258	457839	466706	rs771915484	NC_000017.11:31350257:T:C
NM_001042492.3(NF1):c.7396A>C (p.Ile2466Leu)	NF1	I2445L, I2466L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000457838	17	29677275	17	31350257	457838	467560	rs748027595	NC_000017.11:31350256:A:C
NM_001042492.3(NF1):c.7383T>C (p.Leu2461=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000457837	17	29677262	17	31350244	457837	467556	rs1555536133	NC_000017.11:31350243:T:C
NM_001042492.3(NF1):c.731-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000457836	17	29509524	17	31182506	457836	467242	rs1555608924	NC_000017.11:31182505:A:T
NM_001042492.3(NF1):c.7373G>A (p.Arg2458Lys)	NF1	R2437K, R2458K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457835	17	29677252	17	31350234	457835	467554	rs1555536130	NC_000017.11:31350233:G:A
NM_001042492.3(NF1):c.730+8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000457834	17	29508811	17	31181793	457834	467400	rs1555608771	NC_000017.11:31181792:T:C
NM_001042492.3(NF1):c.7326A>G (p.Leu2442=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2018)	criteria provided, conflicting interpretations	VCV000457833	17	29677205	17	31350187	457833	466697	rs753224880	NC_000017.11:31350186:A:G
NM_001042492.3(NF1):c.7321+8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000457832	17	29676277	17	31349259	457832	467551	rs1555536044	NC_000017.11:31349258:C:T
NM_001042492.3(NF1):c.7303A>G (p.Ser2435Gly)	NF1	S2414G, S2435G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457831	17	29676251	17	31349233	457831	467545	rs1555536038	NC_000017.11:31349232:A:G
NM_001042492.3(NF1):c.7262A>C (p.Asn2421Thr)	NF1	N2400T, N2421T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000457830	17	29676210	17	31349192	457830	466692	rs774339063	NC_000017.11:31349191:A:C
NM_001042492.3(NF1):c.7253C>T (p.Thr2418Ile)	NF1	T2397I, T2418I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457829	17	29676201	17	31349183	457829	467894	rs764022114	NC_000017.11:31349182:C:T
NM_001042492.3(NF1):c.7238T>A (p.Leu2413Ter)	NF1	L2413*, L2392*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000457827	17	29676186	17	31349168	457827	467748	rs775181940	NC_000017.11:31349167:T:A
NM_001042492.3(NF1):c.7211C>T (p.Ala2404Val)	NF1	A2383V, A2404V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457826	17	29676159	17	31349141	457826	467888	rs771706364	NC_000017.11:31349140:C:T
NM_001042492.3(NF1):c.7170G>C (p.Leu2390Phe)	NF1	L2369F, L2390F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000457824	17	29670134	17	31343116	457824	467742	rs751081026	NC_000017.11:31343115:G:C
NM_001042492.3(NF1):c.7167A>C (p.Ala2389=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457823	17	29670131	17	31343113	457823	467740	rs1555535447	NC_000017.11:31343112:A:C
NM_001042492.3(NF1):c.7086A>C (p.Ala2362=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457822	17	29670050	17	31343032	457822	466690	rs1241296625	NC_000017.11:31343031:A:C
NM_001042492.3(NF1):c.7081A>G (p.Met2361Val)	NF1	M2361V, M2340V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000457821	17	29670045	17	31343027	457821	467537	rs1022562410	NC_000017.11:31343026:A:G
NM_001042492.3(NF1):c.7063-9C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV000457820	17	29670018	17	31343000	457820	467525	rs1555535398	NC_000017.11:31342999:C:T
NM_001042492.3(NF1):c.7063-6T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000457819	17	29670021	17	31343003	457819	467737	rs780593077	NC_000017.11:31343002:T:C
NM_001042492.3(NF1):c.7046G>T (p.Arg2349Leu)	NF1	R2328L, R2349L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457817	17	29667647	17	31340629	457817	467882	rs864622065	NC_000017.11:31340628:G:T
NM_001042492.3(NF1):c.697A>G (p.Lys233Glu)	NF1	K233E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	VCV000457816	17	29508770	17	31181752	457816	467540	rs922257267	NC_000017.11:31181751:A:G
NM_001042492.3(NF1):c.6958G>A (p.Val2320Met)	NF1	V2320M, V2299M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000457814	17	29667559	17	31340541	457814	467881	rs766323701	NC_000017.11:31340540:G:A
NM_001042492.3(NF1):c.6921+9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000457813	17	29665832	17	31338814	457813	466685	rs1555535059	NC_000017.11:31338813:T:C
NM_001042492.3(NF1):c.6945C>G (p.Leu2315=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457812	17	29667546	17	31340528	457812	467524	rs751893971	NC_000017.11:31340527:C:G
NM_001042492.3(NF1):c.6839A>G (p.Lys2280Arg)	NF1	K2259R, K2280R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000457809	17	29665741	17	31338723	457809	467723	rs773858629	NC_000017.11:31338722:A:G
NM_001042492.3(NF1):c.6822A>C (p.Ala2274=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000457808	17	29665724	17	31338706	457808	467715	rs1555535025	NC_000017.11:31338705:A:C
NM_001042492.3(NF1):c.6820-5A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000457807	17	29665717	17	31338699	457807	467876	rs1555535022	NC_000017.11:31338698:A:G
NM_001042492.3(NF1):c.6819+4C>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000457806	17	29665161	17	31338143	457806	467711	rs755135948	NC_000017.11:31338142:C:T
NM_001042492.3(NF1):c.6819+3A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000457805	17	29665160	17	31338142	457805	467709	rs1555534966	NC_000017.11:31338141:A:G
NM_001042492.3(NF1):c.6819+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457804	17	29665158	17	31338140	457804	467523	rs1555534964	NC_000017.11:31338139:G:A
NM_001042492.3(NF1):c.6705-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000457803	17	29665042	17	31338024	457803	467708	rs1060500356	NC_000017.11:31338023:G:A
NM_001042492.3(NF1):c.6691G>A (p.Glu2231Lys)	NF1	E2210K, E2231K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457802	17	29664885	17	31337867	457802	467705	rs1024484381	NC_000017.11:31337866:G:A
NM_001042492.3(NF1):c.6681C>T (p.Asp2227=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457801	17	29664875	17	31337857	457801	467700	rs876659371	NC_000017.11:31337856:C:T
NM_001042492.3(NF1):c.6643-8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000457799	17	29664829	17	31337811	457799	467874	rs752079977	NC_000017.11:31337810:T:C
NM_001042492.3(NF1):c.6643-4T>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2019)	criteria provided, conflicting interpretations	VCV000457798	17	29664833	17	31337815	457798	466679	rs1555534908	NC_000017.11:31337814:T:C
NM_001042492.3(NF1):c.6559T>C (p.Phe2187Leu)	NF1	F2187L, F2166L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000457796	17	29664517	17	31337499	457796	467863	rs1555534876	NC_000017.11:31337498:T:C
NM_001042492.3(NF1):c.6536G>A (p.Arg2179His)	NF1	R2158H, R2179H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457795	17	29664494	17	31337476	457795	466671	rs772639479	NC_000017.11:31337475:G:A
NM_001042492.3(NF1):c.6521C>T (p.Ala2174Val)	NF1	A2153V, A2174V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000457794	17	29664479	17	31337461	457794	467698	rs1555534865	NC_000017.11:31337460:C:T
NM_001042492.3(NF1):c.6427G>A (p.Glu2143Lys)	NF1	E2122K, E2143K	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000457793	17	29663932	17	31336914	457793	467693	rs1555534775	NC_000017.11:31336913:G:A
NM_001042492.3(NF1):c.6427+10A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, single submitter	VCV000457792	17	29663942	17	31336924	457792	467696	rs763852229	NC_000017.11:31336923:A:G
NM_001042492.3(NF1):c.6328T>C (p.Leu2110=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457790	17	29663833	17	31336815	457790	467519	rs780230966	NC_000017.11:31336814:T:C
NM_001042492.3(NF1):c.6324T>C (p.Thr2108=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 4, 2017)	criteria provided, single submitter	VCV000457789	17	29663829	17	31336811	457789	467690	rs1555534728	NC_000017.11:31336810:T:C
NM_001042492.3(NF1):c.6316G>A (p.Val2106Ile)	NF1	V2085I, V2106I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457788	17	29663821	17	31336803	457788	467515	rs755791578	NC_000017.11:31336802:G:A
NM_001042492.3(NF1):c.6307C>T (p.Leu2103Phe)	NF1	L2082F, L2103F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000457787	17	29663812	17	31336794	457787	467852	rs1555534719	NC_000017.11:31336793:C:T
NM_001042492.3(NF1):c.6297T>C (p.His2099=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000457786	17	29663802	17	31336784	457786	466665	rs751517473	NC_000017.11:31336783:T:C
NM_001042492.3(NF1):c.6272A>G (p.Asn2091Ser)	NF1	N2091S, N2070S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457785	17	29663777	17	31336759	457785	466664	rs1555534696	NC_000017.11:31336758:A:G
NM_001042492.3(NF1):c.61-9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000457784	17	29482992	17	31155974	457784	466392	rs780956522	NC_000017.11:31155973:T:C
NM_001042492.3(NF1):c.6228T>C (p.Asp2076=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457783	17	29663733	17	31336715	457783	467851	rs1555534682	NC_000017.11:31336714:T:C
NM_001042492.3(NF1):c.61-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457782	17	29482999	17	31155981	457782	466393	rs1131691100	NC_000017.11:31155980:A:G
NM_001042492.3(NF1):c.6186C>T (p.Cys2062=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000457781	17	29663691	17	31336673	457781	467681	rs1555534669	NC_000017.11:31336672:C:T
NM_001042492.3(NF1):c.6147+8C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000457780	17	29663499	17	31336481	457780	467680	rs182709912	NC_000017.11:31336480:C:T
NM_001042492.3(NF1):c.6069G>C (p.Leu2023Phe)	NF1	L2002F, L2023F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000457778	17	29663413	17	31336395	457778	467849	rs1555534607	NC_000017.11:31336394:G:C
NM_001042492.3(NF1):c.60+5C>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2020)	criteria provided, conflicting interpretations	VCV000457777	17	29422392	17	31095374	457777	467217	rs879413062	NC_000017.11:31095373:C:G
NM_001042492.3(NF1):c.6062G>A (p.Gly2021Asp)	NF1	G2021D, G2000D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000457776	17	29663406	17	31336388	457776	467512	rs1555534605	NC_000017.11:31336387:G:A
NM_001042492.3(NF1):c.6033A>C (p.Leu2011=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000457775	17	29663377	17	31336359	457775	467847	rs147995863	NC_000017.11:31336358:A:C
NM_001042492.3(NF1):c.6002G>A (p.Gly2001Glu)	NF1	G2001E, G1980E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000457774	17	29662045	17	31335027	457774	467510	rs878853905	NC_000017.11:31335026:G:A
NM_001042492.3(NF1):c.6001G>C (p.Gly2001Arg)	NF1	G1980R, G2001R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457773	17	29662044	17	31335026	457773	467844	rs199474751	NC_000017.11:31335025:G:C
NM_001042492.3(NF1):c.5958A>G (p.Lys1986=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457772	17	29662001	17	31334983	457772	467843	rs1216926117	NC_000017.11:31334982:A:G
NM_001042492.3(NF1):c.5955A>G (p.Glu1985=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457771	17	29661998	17	31334980	457771	467507	rs369043956	NC_000017.11:31334979:A:G
NM_001042492.3(NF1):c.587-2A>G	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457770	17	29508438	17	31181420	457770	467538	rs1057518360	NC_000017.11:31181419:A:G
NM_001042492.3(NF1):c.5924T>C (p.Leu1975Pro)	NF1	L1975P, L1954P	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457769	17	29661967	17	31334949	457769	467503	rs1555534411	NC_000017.11:31334948:T:C
NM_001042492.3(NF1):c.5885A>G (p.His1962Arg)	NF1	H1962R, H1941R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000457768	17	29661928	17	31334910	457768	466660	rs1555534402	NC_000017.11:31334909:A:G
NM_001042492.3(NF1):c.5851C>G (p.Pro1951Ala)	NF1	P1951A, P1930A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000457767	17	29661894	17	31334876	457767	466658	rs1555534391	NC_000017.11:31334875:C:G
NM_001042492.3(NF1):c.5934G>A (p.Leu1978=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000457766	17	29661977	17	31334959	457766	466661	rs535803385	NC_000017.11:31334958:G:A
NM_001042492.3(NF1):c.5812+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000457764	17	29657521	17	31330503	457764	467501	rs1555533889	NC_000017.11:31330502:G:A
NM_001042492.3(NF1):c.5787G>T (p.Glu1929Asp)	NF1	E1929D, E1908D	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457763	17	29657491	17	31330473	457763	467652	rs786202591	NC_000017.11:31330472:G:T
NM_001042492.3(NF1):c.5769G>A (p.Thr1923=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, single submitter	VCV000457762	17	29657473	17	31330455	457762	466657	rs780145472	NC_000017.11:31330454:G:A
NM_001042492.3(NF1):c.5745G>T (p.Leu1915=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457761	17	29657449	17	31330431	457761	466654	rs1234091349	NC_000017.11:31330430:G:T
NM_001042492.3(NF1):c.5742A>T (p.Thr1914=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457760	17	29657446	17	31330428	457760	467640	rs1555533874	NC_000017.11:31330427:A:T
NM_001042492.3(NF1):c.5680G>C (p.Glu1894Gln)	NF1	E1873Q, E1894Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000457759	17	29657384	17	31330366	457759	467500	rs774893767	NC_000017.11:31330365:G:C
NM_001042492.3(NF1):c.5673G>A (p.Gln1891=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000457758	17	29657377	17	31330359	457758	467498	rs1555533857	NC_000017.11:31330358:G:A
NM_001042492.3(NF1):c.5636C>T (p.Ala1879Val)	NF1	A1879V, A1858V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457757	17	29657340	17	31330322	457757	467631	rs1555533845	NC_000017.11:31330321:C:T
NM_001042492.3(NF1):c.5610-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000457756	17	29657312	17	31330294	457756	467628	rs1135402876	NC_000017.11:31330293:A:G
NM_001042492.3(NF1):c.5517C>A (p.Ile1839=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000457755	17	29654765	17	31327747	457755	467622	rs865839207	NC_000017.11:31327746:C:A
NM_001042492.3(NF1):c.5470A>G (p.Ile1824Val)	NF1	I1803V, I1824V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457753	17	29654718	17	31327700	457753	467615	rs370858405	NC_000017.11:31327699:A:G
NM_001042492.3(NF1):c.5360A>C (p.Glu1787Ala)	NF1	E1766A, E1787A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000457752	17	29654608	17	31327590	457752	467833	rs1555533570	NC_000017.11:31327589:A:C
NM_001042492.3(NF1):c.5357C>T (p.Ser1786Leu)	NF1	S1765L, S1786L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV000457751	17	29654605	17	31327587	457751	466651	rs1555533569	NC_000017.11:31327586:C:T
NM_001042492.3(NF1):c.5344A>G (p.Ile1782Val)	NF1	I1761V, I1782V	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457750	17	29654592	17	31327574	457750	467496	rs1160436761	NC_000017.11:31327573:A:G
NM_001042492.3(NF1):c.5306G>A (p.Arg1769Gln)	NF1	R1769Q, R1748Q	Neurofibromatosis, type 1|Inborn genetic diseases|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457749	17	29654554	17	31327536	457749	467831	rs1555533559	NC_000017.11:31327535:G:A
NM_001042492.3(NF1):c.5290G>T (p.Val1764Leu)	NF1	V1743L, V1764L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000457748	17	29654538	17	31327520	457748	467610	rs778427434	NC_000017.11:31327519:G:T
NM_001042492.3(NF1):c.5268+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000457746	17	29653277	17	31326259	457746	466648	rs772663607	NC_000017.11:31326258:T:C
NM_001042492.3(NF1):c.5230C>T (p.Leu1744Phe)	NF1	L1723F, L1744F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000457745	17	29653232	17	31326214	457745	467608	rs1555533407	NC_000017.11:31326213:C:T
NM_001042492.3(NF1):c.5221C>A (p.His1741Asn)	NF1	H1741N, H1720N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457744	17	29653223	17	31326205	457744	467493	rs780529277	NC_000017.11:31326204:C:A
NM_001042492.3(NF1):c.5183C>T (p.Ala1728Val)	NF1	A1707V, A1728V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000457743	17	29653185	17	31326167	457743	467829	rs1555533395	NC_000017.11:31326166:C:T
NM_001042492.3(NF1):c.5250C>T (p.Asp1750=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457742	17	29653252	17	31326234	457742	466638	rs1210732116	NC_000017.11:31326233:C:T
NM_001042492.3(NF1):c.5142A>G (p.Lys1714=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000457740	17	29653144	17	31326126	457740	467485	rs1555533379	NC_000017.11:31326125:A:G
NM_001042492.3(NF1):c.5107A>G (p.Ser1703Gly)	NF1	S1703G, S1682G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000457739	17	29653109	17	31326091	457739	466635	rs1555533374	NC_000017.11:31326090:A:G
NM_001042492.3(NF1):c.5055G>A (p.Trp1685Ter)	NF1	W1664*, W1685*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457738	17	29653057	17	31326039	457738	466633	rs1555533354	NC_000017.11:31326038:G:A
NM_001042492.3(NF1):c.5033A>G (p.Tyr1678Cys)	NF1	Y1678C, Y1657C	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457737	17	29653035	17	31326017	457737	466631	rs1555533347	NC_000017.11:31326016:A:G
NM_001042492.3(NF1):c.5018A>G (p.Asn1673Ser)	NF1	N1652S, N1673S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457736	17	29653020	17	31326002	457736	467601	rs1201910133	NC_000017.11:31326001:A:G
NM_001042492.3(NF1):c.5014G>A (p.Asp1672Asn)	NF1	D1672N, D1651N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457735	17	29653016	17	31325998	457735	467597	rs1483541195	NC_000017.11:31325997:G:A
NM_001042492.3(NF1):c.494C>G (p.Thr165Ser)	NF1	T165S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457733	17	29496923	17	31169905	457733	467534	rs876660009	NC_000017.11:31169904:C:G
NM_001042492.3(NF1):c.4984T>C (p.Trp1662Arg)	NF1	W1662R, W1641R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000457732	17	29652986	17	31325968	457732	467481	rs1555533328	NC_000017.11:31325967:T:C
NM_001042492.3(NF1):c.4958G>T (p.Arg1653Leu)	NF1	R1653L, R1632L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000457730	17	29652960	17	31325942	457730	467460	rs763413441	NC_000017.11:31325941:G:T
NM_001042492.3(NF1):c.4951A>C (p.Ser1651Arg)	NF1	S1630R, S1651R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000457729	17	29652953	17	31325935	457729	467594	rs1555533314	NC_000017.11:31325934:A:C
NM_001042492.3(NF1):c.484C>G (p.Gln162Glu)	NF1	Q162E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457727	17	29496913	17	31169895	457727	466413	rs1555607073	NC_000017.11:31169894:C:G
NM_001042492.3(NF1):c.4917T>A (p.Tyr1639Ter)	NF1	Y1618*, Y1639*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000457726	17	29652919	17	31325901	457726	467825	rs1555533297	NC_000017.11:31325900:T:A
NM_001042492.3(NF1):c.480-5T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	VCV000457723	17	29496904	17	31169886	457723	466411	rs1555607069	NC_000017.11:31169885:T:C
NM_001042492.3(NF1):c.479+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457722	17	29490395	17	31163377	457722	466407	rs1555606137	NC_000017.11:31163376:G:A
NM_001042492.3(NF1):c.4846G>A (p.Gly1616Ser)	NF1	G1616S, G1595S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457721	17	29652848	17	31325830	457721	467456	rs1555533271	NC_000017.11:31325829:G:A
NM_001042492.3(NF1):c.4836G>A (p.Arg1612=)	NF1		Neurofibromatosis, type 1|Craniopharyngioma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 9, 2017)	criteria provided, conflicting interpretations	VCV000457720	17	29652838	17	31325820	457720	466629	rs1555533268	NC_000017.11:31325819:G:A
NM_001042492.3(NF1):c.4836-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV000457719	17	29652837	17	31325819	457719	467812	rs1057518326	NC_000017.11:31325818:G:C
NM_001042492.3(NF1):c.4823A>G (p.Tyr1608Cys)	NF1	Y1587C, Y1608C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000457718	17	29592345	17	31265327	457718	467451	rs1555619417	NC_000017.11:31265326:A:G
NM_001042492.3(NF1):c.4793C>A (p.Thr1598Asn)	NF1	T1577N, T1598N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457717	17	29592315	17	31265297	457717	467584	rs753453385	NC_000017.11:31265296:C:A
NM_001042492.3(NF1):c.4756G>T (p.Ala1586Ser)	NF1	A1586S, A1565S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457716	17	29592278	17	31265260	457716	467576	rs767438491	NC_000017.11:31265259:G:T
NM_001042492.3(NF1):c.4756G>A (p.Ala1586Thr)	NF1	A1565T, A1586T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000457715	17	29592278	17	31265260	457715	467807	rs767438491	NC_000017.11:31265259:G:A
NM_001042492.3(NF1):c.466C>T (p.Arg156Cys)	NF1	R156C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457714	17	29490381	17	31163363	457714	466404	rs755890242	NC_000017.11:31163362:C:T
NM_001042492.3(NF1):c.4724+1G>A	NF1		Neurofibromatosis, type 1|not specified|Neurofibroma|Aneurysm	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457713	17	29588876	17	31261858	457713	467795	rs1555619056	NC_000017.11:31261857:G:A
NM_001042492.3(NF1):c.4704G>A (p.Lys1568=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457712	17	29588855	17	31261837	457712	467793	rs1424931932	NC_000017.11:31261836:G:A
NM_001042492.3(NF1):c.4695C>T (p.Thr1565=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457710	17	29588846	17	31261828	457710	466625	rs1555619045	NC_000017.11:31261827:C:T
NM_001042492.3(NF1):c.4672C>T (p.His1558Tyr)	NF1	H1558Y, H1537Y	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457709	17	29588823	17	31261805	457709	466623	rs1468638747	NC_000017.11:31261804:C:T
NM_001042492.3(NF1):c.4645C>G (p.Pro1549Ala)	NF1	P1549A, P1528A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000457708	17	29588796	17	31261778	457708	467574	rs1555619025	NC_000017.11:31261777:C:G
NM_001042492.3(NF1):c.4626T>C (p.Leu1542=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457707	17	29588777	17	31261759	457707	467573	rs1555619012	NC_000017.11:31261758:T:C
NM_001042492.3(NF1):c.4593T>C (p.Val1531=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457706	17	29588744	17	31261726	457706	467566	rs773315342	NC_000017.11:31261725:T:C
NM_001042492.3(NF1):c.4578-2A>G	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000457705	17	29588727	17	31261709	457705	466618	rs1555618996	NC_000017.11:31261708:A:G
NM_001042492.3(NF1):c.4560G>A (p.Gln1520=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000457704	17	29587516	17	31260498	457704	467789	rs1555618859	NC_000017.11:31260497:G:A
NM_001042492.3(NF1):c.4538A>G (p.Asn1513Ser)	NF1	N1513S, N1492S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000457703	17	29587494	17	31260476	457703	467783	rs113205862	NC_000017.11:31260475:A:G
NM_001042492.3(NF1):c.4459C>T (p.Pro1487Ser)	NF1	P1466S, P1487S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000457701	17	29587415	17	31260397	457701	466615	rs1265291141	NC_000017.11:31260396:C:T
NM_001042492.3(NF1):c.4434T>C (p.Phe1478=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457700	17	29587390	17	31260372	457700	467775	rs1310523976	NC_000017.11:31260371:T:C
NM_001042492.3(NF1):c.433C>T (p.Leu145Phe)	NF1	L145F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457699	17	29490348	17	31163330	457699	467236	rs786203460	NC_000017.11:31163329:C:T
NM_001042492.3(NF1):c.4382T>A (p.Met1461Lys)	NF1	M1461K, M1440K	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457698	17	29586099	17	31259081	457698	467449	rs754639587	NC_000017.11:31259080:T:A
NM_001042492.3(NF1):c.4381A>T (p.Met1461Leu)	NF1	M1440L, M1461L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000457697	17	29586098	17	31259080	457697	467771	rs1555618675	NC_000017.11:31259079:A:T
NM_001042492.3(NF1):c.4357G>T (p.Val1453Phe)	NF1	V1453F, V1432F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457696	17	29586074	17	31259056	457696	467564	rs199474755	NC_000017.11:31259055:G:T
NM_001042492.3(NF1):c.4352A>T (p.Asn1451Ile)	NF1	N1430I, N1451I	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2018)	criteria provided, conflicting interpretations	VCV000457695	17	29586069	17	31259051	457695	467558	rs199474754	NC_000017.11:31259050:A:T
NM_001042492.3(NF1):c.4344T>G (p.Ser1448Arg)	NF1	S1427R, S1448R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000457694	17	29586061	17	31259043	457694	466614	rs1555618644	NC_000017.11:31259042:T:G
NM_001042492.3(NF1):c.4333A>T (p.Ile1445Leu)	NF1	I1424L, I1445L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000457693	17	29586050	17	31259032	457693	467443	rs1555618637	NC_000017.11:31259031:A:T
NM_001042492.3(NF1):c.4333-1G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000457692	17	29586049	17	31259031	457692	467769	rs1418965797	NC_000017.11:31259030:G:A
NM_001042492.3(NF1):c.4309A>T (p.Arg1437Trp)	NF1	R1416W, R1437W	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000457691	17	29585497	17	31258479	457691	466613	rs1555618558	NC_000017.11:31258478:A:T
NM_001042492.3(NF1):c.4290G>A (p.Lys1430=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457690	17	29585478	17	31258460	457690	467557	rs373086572	NC_000017.11:31258459:G:A
NM_001042492.3(NF1):c.4284T>C (p.Asp1428=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000457689	17	29585472	17	31258454	457689	467549	rs1555618550	NC_000017.11:31258453:T:C
NM_001042492.3(NF1):c.4258T>C (p.Ser1420Pro)	NF1	S1420P, S1399P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000457688	17	29585446	17	31258428	457688	467536	rs1555618533	NC_000017.11:31258427:T:C
NM_001042492.3(NF1):c.4251C>T (p.Ala1417=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000457687	17	29585439	17	31258421	457687	467535	rs1555618524	NC_000017.11:31258420:C:T
NM_001042492.3(NF1):c.4234A>G (p.Arg1412Gly)	NF1	R1391G, R1412G	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457686	17	29585422	17	31258404	457686	467765	rs1555618515	NC_000017.11:31258403:A:G
NM_001042492.3(NF1):c.4226T>C (p.Met1409Thr)	NF1	M1388T, M1409T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457684	17	29585414	17	31258396	457684	467442	rs1555618508	NC_000017.11:31258395:T:C
NM_001042492.3(NF1):c.4217G>T (p.Gly1406Val)	NF1	G1385V, G1406V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000457683	17	29585405	17	31258387	457683	467438	rs1555618505	NC_000017.11:31258386:G:T
NM_001042492.3(NF1):c.4209T>C (p.Gly1403=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000457682	17	29585397	17	31258379	457682	467761	rs761772247	NC_000017.11:31258378:T:C
NM_001042492.3(NF1):c.4190T>A (p.Phe1397Tyr)	NF1	F1376Y, F1397Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457681	17	29585378	17	31258360	457681	466612	rs768223279	NC_000017.11:31258359:T:A
NM_001042492.3(NF1):c.4110+9A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000457680	17	29576146	17	31249128	457680	466606	rs1555617387	NC_000017.11:31249127:A:T
NM_001042492.3(NF1):c.4110+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457679	17	29576138	17	31249120	457679	466602	rs1555617383	NC_000017.11:31249119:G:A
NM_001042492.3(NF1):c.4072C>T (p.Pro1358Ser)	NF1	P1358S	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457677	17	29576099	17	31249081	457677	467436	rs1555617359	NC_000017.11:31249080:C:T
NM_001042492.3(NF1):c.4054A>T (p.Ser1352Cys)	NF1	S1352C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457676	17	29576081	17	31249063	457676	467531	rs1337343400	NC_000017.11:31249062:A:T
NM_001042492.3(NF1):c.3974+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000457675	17	29563041	17	31236023	457675	467754	rs1555615567	NC_000017.11:31236022:T:C
NM_001042492.3(NF1):c.3916C>A (p.Arg1306=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457674	17	29562981	17	31235963	457674	467530	rs376576925	NC_000017.11:31235962:C:A
NM_001042492.3(NF1):c.389A>G (p.His130Arg)	NF1	H130R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457673	17	29490304	17	31163286	457673	467397	rs876660277	NC_000017.11:31163285:A:G
NM_001042492.3(NF1):c.3870G>C (p.Lys1290Asn)	NF1	K1290N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000457672	17	29562790	17	31235772	457672	466593	rs1555615497	NC_000017.11:31235771:G:C
NM_001042492.3(NF1):c.3870+4T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2020)	criteria provided, conflicting interpretations	VCV000457671	17	29562794	17	31235776	457671	466601	rs1555615499	NC_000017.11:31235775:T:C
NM_001042492.3(NF1):c.3811A>G (p.Met1271Val)	NF1	M1271V	Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457669	17	29562731	17	31235713	457669	467751	rs746583007	NC_000017.11:31235712:A:G
NM_001042492.3(NF1):c.3779T>C (p.Met1260Thr)	NF1	M1260T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457668	17	29562699	17	31235681	457668	467435	rs1555615463	NC_000017.11:31235680:T:C
NM_001042492.3(NF1):c.3778A>G (p.Met1260Val)	NF1	M1260V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457667	17	29562698	17	31235680	457667	467529	rs1264981144	NC_000017.11:31235679:A:G
NM_001042492.3(NF1):c.3764A>G (p.Gln1255Arg)	NF1	Q1255R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457666	17	29562684	17	31235666	457666	467432	rs1555615453	NC_000017.11:31235665:A:G
NM_001042492.3(NF1):c.3748C>T (p.Arg1250Trp)	NF1	R1250W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457665	17	29562668	17	31235650	457665	466585	rs1452005208	NC_000017.11:31235649:C:T
NM_001042492.3(NF1):c.372T>C (p.Cys124=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000457664	17	29490287	17	31163269	457664	467532	rs1555606078	NC_000017.11:31163268:T:C
NM_001042492.3(NF1):c.370T>A (p.Cys124Ser)	NF1	C124S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000457663	17	29490285	17	31163267	457663	467395	rs1555606074	NC_000017.11:31163266:T:A
NM_001042492.3(NF1):c.3709-3C>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000457662	17	29562626	17	31235608	457662	467745	rs1555615430	NC_000017.11:31235607:C:A
NM_001042492.3(NF1):c.3708+8A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000457661	17	29560239	17	31233221	457661	466576	rs1173930586	NC_000017.11:31233220:A:G
NM_001042492.3(NF1):c.3625G>T (p.Val1209Leu)	NF1	V1209L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000457660	17	29560148	17	31233130	457660	466571	rs1458579232	NC_000017.11:31233129:G:T
NM_001042492.3(NF1):c.3619A>C (p.Arg1207=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000457659	17	29560142	17	31233124	457659	467527	rs202208560	NC_000017.11:31233123:A:C
NM_001042492.3(NF1):c.3607G>A (p.Asp1203Asn)	NF1	D1203N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000457658	17	29560130	17	31233112	457658	467526	rs1555615051	NC_000017.11:31233111:G:A
NM_001042492.3(NF1):c.3590C>G (p.Ala1197Gly)	NF1	A1197G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457657	17	29560113	17	31233095	457657	467739	rs370820478	NC_000017.11:31233094:C:G
NM_001042492.3(NF1):c.3569G>A (p.Gly1190Asp)	NF1	G1190D	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 7, 2017)	criteria provided, single submitter	VCV000457656	17	29560092	17	31233074	457656	466563	rs1555615032	NC_000017.11:31233073:G:A
NM_001042492.3(NF1):c.3549G>C (p.Leu1183=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000457655	17	29560072	17	31233054	457655	467738	rs1051842	NC_000017.11:31233053:G:C
NM_001042492.3(NF1):c.3544G>T (p.Val1182Phe)	NF1	V1182F	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457654	17	29560067	17	31233049	457654	467729	rs1555615027	NC_000017.11:31233048:G:T
NM_001042492.3(NF1):c.3519C>T (p.Leu1173=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000457653	17	29560042	17	31233024	457653	467728	rs1555615020	NC_000017.11:31233023:C:T
NM_001042492.3(NF1):c.3497-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457652	17	29560019	17	31233001	457652	467721	rs1555615004	NC_000017.11:31233000:G:A
NM_001042492.3(NF1):c.3447G>T (p.Met1149Ile)	NF1	M1149I	Neurofibromatosis, type 1|none provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457650	17	29559850	17	31232832	457650	466548	rs1064794277	NC_000017.11:31232831:G:T
NM_001042492.3(NF1):c.3428A>G (p.His1143Arg)	NF1	H1143R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000457649	17	29559831	17	31232813	457649	466545	rs1555614965	NC_000017.11:31232812:A:G
NM_001042492.3(NF1):c.3427C>T (p.His1143Tyr)	NF1	H1143Y	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457648	17	29559830	17	31232812	457648	467429	rs1555614963	NC_000017.11:31232811:C:T
NM_001042492.3(NF1):c.3417A>T (p.Ala1139=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 1, 2017)	criteria provided, single submitter	VCV000457647	17	29559820	17	31232802	457647	467422	rs864622524	NC_000017.11:31232801:A:T
NM_001042492.3(NF1):c.3416C>A (p.Ala1139Glu)	NF1	A1139E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000457646	17	29559819	17	31232801	457646	467502	rs1555614960	NC_000017.11:31232800:C:A
NM_001042492.3(NF1):c.3420A>G (p.Ser1140=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457645	17	29559823	17	31232805	457645	466542	rs1555614961	NC_000017.11:31232804:A:G
NM_001042492.3(NF1):c.3374C>T (p.Ala1125Val)	NF1	A1125V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457644	17	29559777	17	31232759	457644	467420	rs902739109	NC_000017.11:31232758:C:T
NM_001042492.3(NF1):c.3371G>A (p.Ser1124Asn)	NF1	S1124N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis	Conflicting interpretations of pathogenicity(Last reviewed: Sep 3, 2020)	criteria provided, conflicting interpretations	VCV000457643	17	29559774	17	31232756	457643	467718	rs374472758	NC_000017.11:31232755:G:A
NM_001042492.3(NF1):c.3359T>C (p.Val1120Ala)	NF1	V1120A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457642	17	29559762	17	31232744	457642	467417	rs751571517	NC_000017.11:31232743:T:C
NM_001042492.3(NF1):c.3340T>C (p.Leu1114=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000457641	17	29559743	17	31232725	457641	467490	rs1555614928	NC_000017.11:31232724:T:C
NM_001042492.3(NF1):c.3315A>G (p.Lys1105=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000457640	17	29559718	17	31232700	457640	466541	rs1555614915	NC_000017.11:31232699:A:G
NM_001042492.3(NF1):c.3277G>A (p.Val1093Met)	NF1	V1093M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV000457638	17	29559170	17	31232152	457638	467714	rs1555614858	NC_000017.11:31232151:G:A
NM_001042492.3(NF1):c.3242C>G (p.Ala1081Gly)	NF1	A1081G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)	criteria provided, conflicting interpretations	VCV000457637	17	29559135	17	31232117	457637	466537	rs769941435	NC_000017.11:31232116:C:G
NM_001042492.3(NF1):c.323T>C (p.Met108Thr)	NF1	M108T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457636	17	29490238	17	31163220	457636	467234	rs780233935	NC_000017.11:31163219:T:C
NM_001042492.3(NF1):c.3238C>G (p.Leu1080Val)	NF1	L1080V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000457635	17	29559131	17	31232113	457635	467406	rs1555614832	NC_000017.11:31232112:C:G
NM_001042492.3(NF1):c.3198-3C>T	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2019)	criteria provided, conflicting interpretations	VCV000457630	17	29559088	17	31232070	457630	467707	rs777759972	NC_000017.11:31232069:C:T
NM_001042492.3(NF1):c.3197G>C (p.Arg1066Thr)	NF1	R1066T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	VCV000457629	17	29557943	17	31230925	457629	467392	rs1555614652	NC_000017.11:31230924:G:C
NM_001042492.3(NF1):c.3173A>G (p.Asp1058Gly)	NF1	D1058G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000457628	17	29557919	17	31230901	457628	467694	rs1387858614	NC_000017.11:31230900:A:G
NM_001042492.3(NF1):c.3166G>A (p.Ala1056Thr)	NF1	A1056T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV000457627	17	29557912	17	31230894	457627	467692	rs776907522	NC_000017.11:31230893:G:A
NM_001042492.3(NF1):c.3144G>A (p.Trp1048Ter)	NF1	W1048*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457626	17	29557890	17	31230872	457626	466532	rs1555614635	NC_000017.11:31230871:G:A
NM_001042492.3(NF1):c.3142T>G (p.Trp1048Gly)	NF1	W1048G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000457625	17	29557888	17	31230870	457625	467389	rs1555614634	NC_000017.11:31230869:T:G
NM_001042492.3(NF1):c.3114-4A>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)	criteria provided, conflicting interpretations	VCV000457624	17	29557856	17	31230838	457624	467387	rs201550230	NC_000017.11:31230837:A:T
NM_001042492.3(NF1):c.3114-2A>G	NF1		Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457623	17	29557858	17	31230840	457623	466531	rs1428885377	NC_000017.11:31230839:A:G
NM_001042492.3(NF1):c.3113+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000457622	17	29557405	17	31230387	457622	467386	rs1555614549	NC_000017.11:31230386:G:A
NM_001042492.3(NF1):c.3081T>C (p.Asp1027=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000457621	17	29557368	17	31230350	457621	467382	rs1555614532	NC_000017.11:31230349:T:C
NM_001042492.3(NF1):c.3056T>C (p.Val1019Ala)	NF1	V1019A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000457619	17	29557343	17	31230325	457619	467677	rs1555614520	NC_000017.11:31230324:T:C
NM_001042492.3(NF1):c.304A>G (p.Met102Val)	NF1	M102V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2020)	criteria provided, conflicting interpretations	VCV000457618	17	29490219	17	31163201	457618	467231	rs756370324	NC_000017.11:31163200:A:G
NM_001042492.3(NF1):c.3040A>G (p.Lys1014Glu)	NF1	K1014E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000457617	17	29557327	17	31230309	457617	466526	rs1135402839	NC_000017.11:31230308:A:G
NM_001042492.3(NF1):c.2998C>T (p.Arg1000Cys)	NF1	R1000C	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457616	17	29557285	17	31230267	457616	467377	rs367684252	NC_000017.11:31230266:C:T
NM_001042492.3(NF1):c.2991-6A>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457615	17	29557272	17	31230254	457615	467665	rs1191095886	NC_000017.11:31230253:A:G
NM_001042492.3(NF1):c.2991-4A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2020)	criteria provided, conflicting interpretations	VCV000457614	17	29557274	17	31230256	457614	467371	rs754414489	NC_000017.11:31230255:A:G
NM_001042492.3(NF1):c.2991-1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000457613	17	29557277	17	31230259	457613	467376	rs1060500273	NC_000017.11:31230258:G:C
NM_001042492.3(NF1):c.2990G>T (p.Arg997Met)	NF1	R997M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000457612	17	29556992	17	31229974	457612	467657	rs1555614462	NC_000017.11:31229973:G:T
NM_001042492.3(NF1):c.2990+7A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000457611	17	29556999	17	31229981	457611	467486	rs1555614465	NC_000017.11:31229980:A:T
NM_001042492.3(NF1):c.2990+7A>G	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2017)	criteria provided, conflicting interpretations	VCV000457610	17	29556999	17	31229981	457610	467662	rs1555614465	NC_000017.11:31229980:A:G
NM_001042492.3(NF1):c.2953C>T (p.Gln985Ter)	NF1	Q985*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457608	17	29556955	17	31229937	457608	467482	rs1555614455	NC_000017.11:31229936:C:T
NM_001042492.3(NF1):c.2894T>G (p.Ile965Arg)	NF1	I965R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000457607	17	29556896	17	31229878	457607	467366	rs1555614438	NC_000017.11:31229877:T:G
NM_001042492.3(NF1):c.288+5G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000457605	17	29486116	17	31159098	457605	466402	rs1555605409	NC_000017.11:31159097:G:T
NM_001042492.3(NF1):c.2850+10T>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000457603	17	29556493	17	31229475	457603	467362	rs771916458	NC_000017.11:31229474:T:G
NM_001042492.3(NF1):c.2841C>T (p.Ser947=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000457602	17	29556474	17	31229456	457602	467651	rs1555614355	NC_000017.11:31229455:C:T
NM_001042492.3(NF1):c.2782G>A (p.Ala928Thr)	NF1	A928T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000457600	17	29556415	17	31229397	457600	467637	rs1277935019	NC_000017.11:31229396:G:A
NM_001042492.3(NF1):c.2754G>A (p.Lys918=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000457599	17	29556387	17	31229369	457599	467350	rs1555614330	NC_000017.11:31229368:G:A
NM_001042492.3(NF1):c.2749G>A (p.Val917Ile)	NF1	V917I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457598	17	29556382	17	31229364	457598	466511	rs752455591	NC_000017.11:31229363:G:A
NM_001042492.3(NF1):c.2742G>A (p.Arg914=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000457597	17	29556375	17	31229357	457597	467339	rs1555614324	NC_000017.11:31229356:G:A
NM_001042492.3(NF1):c.2690G>A (p.Arg897Gln)	NF1	R897Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV000457596	17	29556323	17	31229305	457596	467474	rs863224658	NC_000017.11:31229304:G:A
NM_001042492.3(NF1):c.2659G>A (p.Ala887Thr)	NF1	A887T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457595	17	29556292	17	31229274	457595	467472	rs1251621684	NC_000017.11:31229273:G:A
NM_001042492.3(NF1):c.2633T>C (p.Ile878Thr)	NF1	I878T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457594	17	29556266	17	31229248	457594	467338	rs372049168	NC_000017.11:31229247:T:C
NM_001042492.3(NF1):c.2618G>C (p.Arg873Pro)	NF1	R873P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457593	17	29556251	17	31229233	457593	467335	rs949092641	NC_000017.11:31229232:G:C
NM_001042492.3(NF1):c.2592C>T (p.Ser864=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457592	17	29556225	17	31229207	457592	466506	rs761499485	NC_000017.11:31229206:C:T
NM_001042492.3(NF1):c.2581G>A (p.Ala861Thr)	NF1	A861T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000457591	17	29556214	17	31229196	457591	467465	rs768425956	NC_000017.11:31229195:G:A
NM_001042492.3(NF1):c.2539C>T (p.Leu847Phe)	NF1	L847F	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457589	17	29556172	17	31229154	457589	466501	rs753552408	NC_000017.11:31229153:C:T
NM_001042492.3(NF1):c.2537C>A (p.Ala846Asp)	NF1	A846D	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457588	17	29556170	17	31229152	457588	467630	rs1555614229	NC_000017.11:31229151:C:A
NM_001042492.3(NF1):c.2536G>A (p.Ala846Thr)	NF1	A846T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000457587	17	29556169	17	31229151	457587	467334	rs1555614226	NC_000017.11:31229150:G:A
NM_001042492.3(NF1):c.2512A>T (p.Ile838Phe)	NF1	I838F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000457586	17	29556145	17	31229127	457586	467616	rs1555614212	NC_000017.11:31229126:A:T
NM_001042492.3(NF1):c.2445G>A (p.Arg815=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000457585	17	29556078	17	31229060	457585	467614	rs1555614186	NC_000017.11:31229059:G:A
NM_001042492.3(NF1):c.2409+5G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457583	17	29554629	17	31227611	457583	466497	rs763688567	NC_000017.11:31227610:G:A
NM_001042492.3(NF1):c.239A>C (p.Tyr80Ser)	NF1	Y80S	not specified|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457582	17	29486062	17	31159044	457582	467229	rs4795581	NC_000017.11:31159043:A:C
NM_001042492.3(NF1):c.2339C>G (p.Thr780Arg)	NF1	T780R	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457581	17	29554554	17	31227536	457581	467330	rs199474746	NC_000017.11:31227535:C:G
NM_001042492.3(NF1):c.2326-9T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000457580	17	29554532	17	31227514	457580	467321	rs181838967	NC_000017.11:31227513:T:A
NM_001042492.3(NF1):c.2325+7C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000457579	17	29554316	17	31227298	457579	467454	rs1555613937	NC_000017.11:31227297:C:T
NM_001042492.3(NF1):c.2325+4T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457578	17	29554313	17	31227295	457578	466494	rs1555613934	NC_000017.11:31227294:T:C
NM_001042492.3(NF1):c.2261C>G (p.Ala754Gly)	NF1	A754G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000457576	17	29554245	17	31227227	457576	466491	rs1555613912	NC_000017.11:31227226:C:G
NM_001042492.3(NF1):c.2252-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000457575	17	29554235	17	31227217	457575	467605	rs587781577	NC_000017.11:31227216:G:A
NM_001042492.3(NF1):c.2251+9G>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV000457574	17	29553711	17	31226693	457574	466486	rs772014402	NC_000017.11:31226692:G:T
NM_001042492.3(NF1):c.2237A>G (p.Asn746Ser)	NF1	N746S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000457573	17	29553688	17	31226670	457573	466480	rs1176567641	NC_000017.11:31226669:A:G
NM_001042492.3(NF1):c.2211A>T (p.Thr737=)	NF1		Neurofibromatosis, type 1	Benign(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000457572	17	29553662	17	31226644	457572	467309	rs1178560430	NC_000017.11:31226643:A:T
NM_001042492.3(NF1):c.2203T>C (p.Tyr735His)	NF1	Y735H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000457570	17	29553654	17	31226636	457570	467308	rs1555613827	NC_000017.11:31226635:T:C
NM_001042492.3(NF1):c.2199C>A (p.Pro733=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000457569	17	29553650	17	31226632	457569	466479	rs1555613826	NC_000017.11:31226631:C:A
NM_001042492.3(NF1):c.2189A>C (p.Asn730Thr)	NF1	N730T	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: May 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457568	17	29553640	17	31226622	457568	467306	rs778033578	NC_000017.11:31226621:A:C
NM_001042492.3(NF1):c.2181A>G (p.Ser727=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000457567	17	29553632	17	31226614	457567	467305	rs1203116843	NC_000017.11:31226613:A:G
NM_001042492.3(NF1):c.2175A>G (p.Glu725=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000457566	17	29553626	17	31226608	457566	467602	rs1555613817	NC_000017.11:31226607:A:G
NM_001042492.3(NF1):c.2131C>T (p.Arg711Cys)	NF1	R711C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457565	17	29553582	17	31226564	457565	467599	rs1400902839	NC_000017.11:31226563:C:T
NM_001042492.3(NF1):c.2097C>T (p.Asp699=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV000457564	17	29553548	17	31226530	457564	467595	rs547905840	NC_000017.11:31226529:C:T
NM_001042492.3(NF1):c.2077A>G (p.Met693Val)	NF1	M693V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457563	17	29553528	17	31226510	457563	467447	rs1555613794	NC_000017.11:31226509:A:G
NM_001042492.3(NF1):c.2072T>G (p.Leu691Arg)	NF1	L691R	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2020)	criteria provided, conflicting interpretations	VCV000457562	17	29553523	17	31226505	457562	467304	rs1131691132	NC_000017.11:31226504:T:G
NM_001042492.3(NF1):c.204+6T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000457560	17	29483150	17	31156132	457560	467394	rs1555604948	NC_000017.11:31156131:T:G
NM_001042492.3(NF1):c.203T>C (p.Met68Thr)	NF1	M68T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000457559	17	29483143	17	31156125	457559	467522	rs779063198	NC_000017.11:31156124:T:C
NM_001042492.3(NF1):c.2031C>G (p.Pro677=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457558	17	29553482	17	31226464	457558	467591	rs753177596	NC_000017.11:31226463:C:G
NM_001042492.3(NF1):c.1966G>A (p.Ala656Thr)	NF1	A656T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000457557	17	29552233	17	31225215	457557	467300	rs1555613598	NC_000017.11:31225214:G:A
NM_001042492.3(NF1):c.1907C>T (p.Ser636Phe)	NF1	S636F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000457556	17	29552174	17	31225156	457556	466474	rs780412565	NC_000017.11:31225155:C:T
NM_001042492.3(NF1):c.1902T>A (p.Ile634=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000457555	17	29552169	17	31225151	457555	467293	rs1555613566	NC_000017.11:31225150:T:A
NM_001042492.3(NF1):c.1884C>A (p.Tyr628Ter)	NF1	Y628*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457554	17	29552151	17	31225133	457554	467287	rs555635097	NC_000017.11:31225132:C:A
NM_001042492.3(NF1):c.1875C>T (p.Leu625=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457552	17	29552142	17	31225124	457552	467444	rs974172157	NC_000017.11:31225123:C:T
NM_001042492.3(NF1):c.1869C>T (p.His623=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457551	17	29552136	17	31225118	457551	467588	rs1555613556	NC_000017.11:31225117:C:T
NM_001042492.3(NF1):c.1868A>G (p.His623Arg)	NF1	H623R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457550	17	29552135	17	31225117	457550	466473	rs1555613555	NC_000017.11:31225116:A:G
NM_001042492.3(NF1):c.1862C>T (p.Ser621Phe)	NF1	S621F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000457549	17	29552129	17	31225111	457549	467587	rs760346063	NC_000017.11:31225110:C:T
NM_001042492.3(NF1):c.181A>G (p.Ile61Val)	NF1	I61V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2020)	criteria provided, conflicting interpretations	VCV000457548	17	29483121	17	31156103	457548	467517	rs754295034	NC_000017.11:31156102:A:G
NM_001042492.3(NF1):c.178A>G (p.Thr60Ala)	NF1	T60A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457547	17	29483118	17	31156100	457547	467225	rs546729596	NC_000017.11:31156099:A:G
NM_001042492.3(NF1):c.1780A>G (p.Thr594Ala)	NF1	T594A	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457546	17	29550520	17	31223502	457546	467581	rs1555613419	NC_000017.11:31223501:A:G
NM_001042492.3(NF1):c.1721+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457545	17	29548948	17	31221930	457545	467579	rs1131691096	NC_000017.11:31221929:G:A
NM_001042492.3(NF1):c.170G>A (p.Gly57Asp)	NF1	G57D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000457544	17	29483110	17	31156092	457544	467223	rs1555604925	NC_000017.11:31156091:G:A
NM_001042492.3(NF1):c.1699G>A (p.Val567Ile)	NF1	V567I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000457543	17	29548925	17	31221907	457543	467577	rs1555613200	NC_000017.11:31221906:G:A
NM_001042492.3(NF1):c.1677T>C (p.Asp559=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000457542	17	29548903	17	31221885	457542	467570	rs1209447028	NC_000017.11:31221884:T:C
NM_001042492.3(NF1):c.1650G>C (p.Leu550=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457541	17	29548876	17	31221858	457541	467428	rs1555613190	NC_000017.11:31221857:G:C
NM_001042492.3(NF1):c.1641+3A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000457540	17	29546139	17	31219121	457540	466467	rs754159326	NC_000017.11:31219120:A:G
NM_001042492.3(NF1):c.1641+1G>A	NF1		Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457539	17	29546137	17	31219119	457539	466460	rs1555612866	NC_000017.11:31219118:G:A
NM_001042492.3(NF1):c.1600C>T (p.Pro534Ser)	NF1	P534S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000457538	17	29546095	17	31219077	457538	466458	rs1555612858	NC_000017.11:31219076:C:T
NM_001042492.3(NF1):c.1527+5G>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000457537	17	29541608	17	31214590	457537	467282	rs1060500352	NC_000017.11:31214589:G:C
NM_001042492.3(NF1):c.144A>G (p.Lys48=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000457534	17	29483084	17	31156066	457534	467513	rs763375105	NC_000017.11:31156065:A:G
NM_001042492.3(NF1):c.1431T>C (p.Phe477=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000457533	17	29541507	17	31214489	457533	466448	rs1555612278	NC_000017.11:31214488:T:C
NM_001042492.3(NF1):c.1392+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000457532	17	29533391	17	31206373	457532	466447	rs1555611610	NC_000017.11:31206372:T:C
NM_001042492.3(NF1):c.1371C>T (p.His457=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457531	17	29533368	17	31206350	457531	467562	rs1318894606	NC_000017.11:31206349:C:T
NM_001042492.3(NF1):c.1356A>G (p.Gln452=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457530	17	29533353	17	31206335	457530	467427	rs1324833228	NC_000017.11:31206334:A:G
NM_001042492.3(NF1):c.1309G>T (p.Val437Phe)	NF1	V437F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000457529	17	29533306	17	31206288	457529	466438	rs1555611574	NC_000017.11:31206287:G:T
NM_001042492.3(NF1):c.1304A>G (p.His435Arg)	NF1	H435R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000457528	17	29533301	17	31206283	457528	467559	rs1555611571	NC_000017.11:31206282:A:G
NM_001042492.3(NF1):c.128T>C (p.Leu43Pro)	NF1	L43P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457527	17	29483068	17	31156050	457527	467390	rs1555604899	NC_000017.11:31156049:T:C
NM_001042492.3(NF1):c.1259A>G (p.Asn420Ser)	NF1	N420S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457526	17	29528502	17	31201484	457526	467276	rs1555611107	NC_000017.11:31201483:A:G
NM_001042492.3(NF1):c.1248A>T (p.Arg416=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000457525	17	29528491	17	31201473	457525	467423	rs1403345664	NC_000017.11:31201472:A:T
NM_001042492.3(NF1):c.1247G>A (p.Arg416Gln)	NF1	R416Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457524	17	29528490	17	31201472	457524	467275	rs1343309278	NC_000017.11:31201471:G:A
NM_001042492.3(NF1):c.1186A>C (p.Ile396Leu)	NF1	I396L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457523	17	29528429	17	31201411	457523	467550	rs1413735911	NC_000017.11:31201410:A:C
NM_001042492.3(NF1):c.1186-6C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV000457522	17	29528423	17	31201405	457522	467262	rs200684215	NC_000017.11:31201404:C:T
NM_001042492.3(NF1):c.1186-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000457521	17	29528428	17	31201410	457521	466437	rs876660782	NC_000017.11:31201409:G:C
NM_001042492.3(NF1):c.1185+7G>C	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2020)	criteria provided, conflicting interpretations	VCV000457520	17	29528184	17	31201166	457520	467260	rs1322791959	NC_000017.11:31201165:G:C
NM_001042492.3(NF1):c.1170C>T (p.Asn390=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457518	17	29528162	17	31201144	457518	467250	rs769004910	NC_000017.11:31201143:C:T
NM_001042492.3(NF1):c.1154G>A (p.Arg385His)	NF1	R385H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000457517	17	29528146	17	31201128	457517	467421	rs1350329837	NC_000017.11:31201127:G:A
NM_001042492.3(NF1):c.1139T>C (p.Leu380Pro)	NF1	L380P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000457516	17	29528131	17	31201113	457516	467415	rs1555611004	NC_000017.11:31201112:T:C
NM_000267.3(NF1):c.1138C>T (p.Leu380Phe)	NF1	L380F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457515	17	29528130	17	31201112	457515	467247	rs1426127948	NC_000017.11:31201111:C:T
NM_001042492.3(NF1):c.1131T>C (p.Ile377=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV000457514	17	29528123	17	31201105	457514	467414	rs1555610993	NC_000017.11:31201104:T:C
NM_001042492.3(NF1):c.105T>C (p.Ser35=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457513	17	29483045	17	31156027	457513	467221	rs370026303	NC_000017.11:31156026:T:C
NM_001042492.3(NF1):c.1048G>A (p.Val350Met)	NF1	V350M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457512	17	29527599	17	31200581	457512	467413	rs1185636269	NC_000017.11:31200580:G:A
NM_001042492.3(NF1):c.1019C>G (p.Ser340Cys)	NF1	S340C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000457511	17	29527570	17	31200552	457511	467245	rs771089333	NC_000017.11:31200551:C:G
NM_001042492.3(NF1):c.1004A>G (p.Asn335Ser)	NF1	N335S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457510	17	29527555	17	31200537	457510	467546	rs758212945	NC_000017.11:31200536:A:G
NM_001042492.3(NF1):c.1642-1G>T	NF1		not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000453127	17	29548867	17	31221849	453127	445733	rs1555613185	NC_000017.11:31221848:G:T
NM_001042492.3(NF1):c.5812+6T>G	NF1		Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000450744	17	29657522	17	31330504	450744	445750	rs1555533893	NC_000017.11:31330503:T:G
NM_001042492.3(NF1):c.5822T>A (p.Leu1941Ter)	NF1	L1920*, L1941*	not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000449431	17	29661865	17	31334847	449431	445751	rs1555534375	NC_000017.11:31334846:T:A
NM_001042492.3(NF1):c.5552C>T (p.Pro1851Leu)	NF1	P1830L, P1851L	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2021)	criteria provided, conflicting interpretations	VCV000449430	17	29654800	17	31327782	449430	445749	rs1555533638	NC_000017.11:31327781:C:T
NM_001042492.3(NF1):c.5552C>G (p.Pro1851Arg)	NF1	P1830R, P1851R	not provided	Uncertain significance(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000449429	17	29654800	17	31327782	449429	445748	rs1555533638	NC_000017.11:31327781:C:G
NM_001042492.3(NF1):c.4836-2A>C	NF1		not provided	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000449428	17	29652836	17	31325818	449428	445744	rs1555533265	NC_000017.11:31325817:A:C
NM_001042492.3(NF1):c.4333-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449427	17	29586048	17	31259030	449427	445742	rs1555618634	NC_000017.11:31259029:A:G
NM_001042492.3(NF1):c.5297C>G (p.Ser1766Ter)	NF1	S1745*, S1766*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449426	17	29654545	17	31327527	449426	445746	rs1555533555	NC_000017.11:31327526:C:G
NM_001042492.3(NF1):c.3197G>A (p.Arg1066Lys)	NF1	R1066K	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000449425	17	29557943	17	31230925	449425	445738	rs1555614652	NC_000017.11:31230924:G:A
NM_001042492.3(NF1):c.3376C>T (p.Gln1126Ter)	NF1	Q1126*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449424	17	29559779	17	31232761	449424	445739	rs1555614947	NC_000017.11:31232760:C:T
NM_001042492.3(NF1):c.2409+1G>T	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449423	17	29554625	17	31227607	449423	445735	rs1555614022	NC_000017.11:31227606:G:T
NM_001042492.3(NF1):c.277T>C (p.Cys93Arg)	NF1	C93R	not provided	Likely pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000449420	17	29486100	17	31159082	449420	445727	rs1555605398	NC_000017.11:31159081:T:C
NM_001042492.3(NF1):c.204+1G>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449419	17	29483145	17	31156127	449419	445726	rs886039548	NC_000017.11:31156126:G:T
NM_001042492.3(NF1):c.3974+9T>A	NF1		not specified|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000440002	17	29563048	17	31236030	440002	433255	rs368586596	NC_000017.11:31236029:T:A
NM_001042492.3(NF1):c.7117C>T (p.Gln2373Ter)	NF1	Q2352*, Q2373*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000440001	17	29670081	17	31343063	440001	433263	rs1555535417	NC_000017.11:31343062:C:T
NM_001042492.3(NF1):c.7474C>T (p.Gln2492Ter)	NF1	Q2471*, Q2492*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439998	17	29679291	17	31352273	439998	433265	rs1555536340	NC_000017.11:31352272:C:T
NM_001042492.3(NF1):c.4577+1G>A	NF1		Midaortic syndrome|not provided|not specified|Neurofibromatosis, type 1|Optic nerve glioma	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439997	17	29587534	17	31260516	439997	433256	rs1279529138	NC_000017.11:31260515:G:A
NM_001042492.3(NF1):c.3118A>G (p.Lys1040Glu)	NF1	K1040E	not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439996	17	29557864	17	31230846	439996	433249	rs1555614619	NC_000017.11:31230845:A:G
NM_001042492.3(NF1):c.1094C>G (p.Ser365Ter)	NF1	S365*	not specified|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000439995	17	29528086	17	31201068	439995	433241	rs864622107	NC_000017.11:31201067:C:G
NM_001042492.3(NF1):c.3790G>T (p.Glu1264Ter)	NF1	E1264*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439986	17	29562710	17	31235692	439986	433254	rs863224660	NC_000017.11:31235691:G:T
NM_001042492.3(NF1):c.654+1G>A	NF1		Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|not specified	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439982	17	29508508	17	31181490	439982	433236	rs1060500245	NC_000017.11:31181489:G:A
NM_001042492.3(NF1):c.1185+2T>G	NF1		not specified|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439976	17	29528179	17	31201161	439976	433243	rs1555611043	NC_000017.11:31201160:T:G
NM_001042492.3(NF1):c.334C>T (p.Gln112Ter)	NF1	Q112*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439975	17	29490249	17	31163231	439975	433234	rs1555606061	NC_000017.11:31163230:C:T
NM_001042492.3(NF1):c.3076A>T (p.Arg1026Ter)	NF1	R1026*	not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439974	17	29557363	17	31230345	439974	433248	rs1555614529	NC_000017.11:31230344:A:T
NM_001042492.3(NF1):c.6855C>G (p.Tyr2285Ter)	NF1	Y2264*, Y2285*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000439973	17	29665757	17	31338739	439973	433262	rs772295894	NC_000017.11:31338738:C:G
NM_001042492.3(NF1):c.7970+1G>A	NF1		Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439967	17	29684388	17	31357370	439967	433268	rs1555536773	NC_000017.11:31357369:G:A
NM_001042492.3(NF1):c.3250C>A (p.Pro1084Thr)	NF1	P1084T	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2019)	criteria provided, conflicting interpretations	VCV000437407	17	29559143	17	31232125	437407	430967	rs1555614848	NC_000017.11:31232124:C:A
NM_001042492.3(NF1):c.7972C>T (p.His2658Tyr)	NF1	H2637Y, H2658Y	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000433188	17	29685499	17	31358481	433188	426748	rs1555536868	NC_000017.11:31358480:C:T
NM_001042492.3(NF1):c.3449C>G (p.Ser1150Ter)	NF1	S1150*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432961	17	29559852	17	31232834	432961	426216	rs1555614972	NC_000017.11:31232833:C:G
NM_001042492.3(NF1):c.1721G>T (p.Ser574Ile)	NF1	S574I, R574M	not provided	Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000432805	17	29548947	17	31221929	432805	426214	rs1555613206	NC_000017.11:31221928:G:T
NM_001042492.3(NF1):c.3239T>C (p.Leu1080Pro)	NF1	L1080P	not provided	Likely pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000431978	17	29559132	17	31232114	431978	426215	rs1555614833	NC_000017.11:31232113:T:C
NM_001042492.3(NF1):c.6007-1G>C	NF1		not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431977	17	29663350	17	31336332	431977	426217	rs1555534596	NC_000017.11:31336331:G:C
NM_001042492.3(NF1):c.1721G>A (p.Ser574Asn)	NF1	S574N, R574K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis type 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431976	17	29548947	17	31221929	431976	426213	rs1555613206	NC_000017.11:31221928:G:A
NM_001042492.3(NF1):c.1039C>T (p.Gln347Ter)	NF1	Q347*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Sep 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431975	17	29527590	17	31200572	431975	426212	rs1555610910	NC_000017.11:31200571:C:T
NM_001042492.3(NF1):c.569T>G (p.Leu190Ter)	NF1	L190*	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431974	17	29496998	17	31169980	431974	426210	rs1555607112	NC_000017.11:31169979:T:G
NM_001042492.3(NF1):c.8176G>A (p.Asp2726Asn)	NF1	D2705N, D2726N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431696	17	29687520	17	31360502	431696	425201	rs1135402910	NC_000017.11:31360501:G:A
NM_001042492.3(NF1):c.8160+2T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431695	17	29686035	17	31359017	431695	425200	rs1135402909	NC_000017.11:31359016:T:G
NM_001042492.3(NF1):c.7321+1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431689	17	29676270	17	31349252	431689	425194	rs1135402903	NC_000017.11:31349251:G:T
NM_001042492.3(NF1):c.7189G>A (p.Gly2397Arg)	NF1	G2376R, G2397R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000431686	17	29670153	17	31343135	431686	425191	rs1135402900	NC_000017.11:31343134:G:A
NM_001042492.3(NF1):c.7181T>G (p.Leu2394Arg)	NF1	L2373R, L2394R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431685	17	29670145	17	31343127	431685	425190	rs1135402899	NC_000017.11:31343126:T:G
NM_001042492.3(NF1):c.7062+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431684	17	29667665	17	31340647	431684	425189	rs1135402898	NC_000017.11:31340646:T:C
NM_001042492.3(NF1):c.6978T>C (p.Asp2326=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 6, 2020)	criteria provided, conflicting interpretations	VCV000431682	17	29667579	17	31340561	431682	425187	rs1135402896	NC_000017.11:31340560:T:C
NM_001042492.3(NF1):c.6819+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000431680	17	29665159	17	31338141	431680	425185	rs1135402894	NC_000017.11:31338140:T:C
NM_001042492.3(NF1):c.6819G>T (p.Lys2273Asn)	NF1	K2252N, K2273N	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000431679	17	29665157	17	31338139	431679	425184	rs1060500373	NC_000017.11:31338138:G:T
NM_001042492.3(NF1):c.6577G>T (p.Glu2193Ter)	NF1	E2172*, E2193*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431676	17	29664535	17	31337517	431676	425181	rs1135402891	NC_000017.11:31337516:G:T
NM_001042492.3(NF1):c.6428-2A>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000431671	17	29664384	17	31337366	431671	425176	rs1060500312	NC_000017.11:31337365:A:C
NM_001042492.3(NF1):c.6424A>C (p.Ser2142Arg)	NF1	S2121R, S2142R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431670	17	29663929	17	31336911	431670	425175	rs1135402886	NC_000017.11:31336910:A:C
NM_001042492.3(NF1):c.6211C>T (p.Gln2071Ter)	NF1	Q2050*, Q2071*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431668	17	29663716	17	31336698	431668	425173	rs1135402884	NC_000017.11:31336697:C:T
NM_001042492.3(NF1):c.6147G>C (p.Lys2049Asn)	NF1	K2028N, K2049N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000431666	17	29663491	17	31336473	431666	425171	rs1135402882	NC_000017.11:31336472:G:C
NM_001042492.3(NF1):c.5687C>G (p.Ser1896Ter)	NF1	S1875*, S1896*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431663	17	29657391	17	31330373	431663	425168	rs1135402879	NC_000017.11:31330372:C:G
NM_001042492.3(NF1):c.5610-2A>T	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431660	17	29657312	17	31330294	431660	425165	rs1135402876	NC_000017.11:31330293:A:T
NM_001042492.3(NF1):c.5492G>A (p.Trp1831Ter)	NF1	W1810*, W1831*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431656	17	29654740	17	31327722	431656	425161	rs1135402872	NC_000017.11:31327721:G:A
NM_001042492.3(NF1):c.5476C>G (p.His1826Asp)	NF1	H1805D, H1826D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV000431655	17	29654724	17	31327706	431655	425160	rs1135402871	NC_000017.11:31327705:C:G
NM_001042492.3(NF1):c.5385T>A (p.Asp1795Glu)	NF1	D1774E, D1795E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431654	17	29654633	17	31327615	431654	425159	rs1135402870	NC_000017.11:31327614:T:A
NM_001042492.3(NF1):c.5269-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431653	17	29654516	17	31327498	431653	425158	rs876660141	NC_000017.11:31327497:G:C
NM_001042492.3(NF1):c.5062G>T (p.Glu1688Ter)	NF1	E1667*, E1688*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431652	17	29653064	17	31326046	431652	425157	rs1135402869	NC_000017.11:31326045:G:T
NM_001042492.3(NF1):c.4929G>T (p.Val1643=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431649	17	29652931	17	31325913	431649	425154	rs17880521	NC_000017.11:31325912:G:T
NM_001042492.3(NF1):c.4544A>G (p.Gln1515Arg)	NF1	Q1494R, Q1515R	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000431647	17	29587500	17	31260482	431647	425152	rs1135402865	NC_000017.11:31260481:A:G
NM_001042492.3(NF1):c.4532T>G (p.Leu1511Arg)	NF1	L1490R, L1511R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431646	17	29587488	17	31260470	431646	425151	rs1135402864	NC_000017.11:31260469:T:G
NM_001042492.3(NF1):c.4520T>G (p.Leu1507Ter)	NF1	L1486*, L1507*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000431645	17	29587476	17	31260458	431645	425150	rs1135402863	NC_000017.11:31260457:T:G
NM_001042492.3(NF1):c.4498A>G (p.Ser1500Gly)	NF1	S1479G, S1500G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000431644	17	29587454	17	31260436	431644	425149	rs1135402862	NC_000017.11:31260435:A:G
NM_001042492.3(NF1):c.4403T>G (p.Val1468Gly)	NF1	V1447G, V1468G	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431642	17	29586120	17	31259102	431642	425147	rs1135402860	NC_000017.11:31259101:T:G
NM_001042492.3(NF1):c.4382T>C (p.Met1461Thr)	NF1	M1440T, M1461T	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431641	17	29586099	17	31259081	431641	425146	rs754639587	NC_000017.11:31259080:T:C
NM_001042492.3(NF1):c.4372G>A (p.Glu1458Lys)	NF1	E1437K, E1458K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431639	17	29586089	17	31259071	431639	425144	rs1135402858	NC_000017.11:31259070:G:A
NM_001042492.3(NF1):c.4339C>T (p.Gln1447Ter)	NF1	Q1426*, Q1447*	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431638	17	29586056	17	31259038	431638	425143	rs1135402857	NC_000017.11:31259037:C:T
NM_001042492.3(NF1):c.4330A>C (p.Lys1444Gln)	NF1	K1423Q, K1444Q	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431637	17	29585518	17	31258500	431637	425142	rs137854550	NC_000017.11:31258499:A:C
NM_001042492.3(NF1):c.4110G>C (p.Gln1370His)	NF1	Q1370H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431634	17	29576137	17	31249119	431634	425139	rs1135402854	NC_000017.11:31249118:G:C
NM_001042492.3(NF1):c.4109A>C (p.Gln1370Pro)	NF1	Q1370P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431633	17	29576136	17	31249118	431633	425138	rs1135402853	NC_000017.11:31249117:A:C
NM_001042492.3(NF1):c.3834C>G (p.Asn1278Lys)	NF1	N1278K	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431630	17	29562754	17	31235736	431630	425135	rs1135402850	NC_000017.11:31235735:C:G
NM_001042492.3(NF1):c.3651T>G (p.Asp1217Glu)	NF1	D1217E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431626	17	29560174	17	31233156	431626	425131	rs1135402846	NC_000017.11:31233155:T:G
NM_001042492.3(NF1):c.3632T>G (p.Leu1211Arg)	NF1	L1211R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431625	17	29560155	17	31233137	431625	425130	rs1135402845	NC_000017.11:31233136:T:G
NM_001042492.3(NF1):c.3578T>C (p.Phe1193Ser)	NF1	F1193S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431623	17	29560101	17	31233083	431623	425128	rs199474780	NC_000017.11:31233082:T:C
NM_001042492.3(NF1):c.3521A>G (p.Gln1174Arg)	NF1	Q1174R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431622	17	29560044	17	31233026	431622	425127	rs1135402843	NC_000017.11:31233025:A:G
NM_001042492.3(NF1):c.3189T>A (p.Cys1063Ter)	NF1	C1063*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431620	17	29557935	17	31230917	431620	425125	rs1135402841	NC_000017.11:31230916:T:A
NM_001042492.3(NF1):c.3113+2T>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000431619	17	29557402	17	31230384	431619	425124	rs876658997	NC_000017.11:31230383:T:C
NM_001042492.3(NF1):c.3104T>C (p.Met1035Thr)	NF1	M1035T	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431618	17	29557391	17	31230373	431618	425123	rs137854553	NC_000017.11:31230372:T:C
NM_001042492.3(NF1):c.3048T>A (p.Cys1016Ter)	NF1	C1016*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431617	17	29557335	17	31230317	431617	425122	rs1135402840	NC_000017.11:31230316:T:A
NM_001042492.3(NF1):c.3040A>T (p.Lys1014Ter)	NF1	K1014*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431616	17	29557327	17	31230309	431616	425121	rs1135402839	NC_000017.11:31230308:A:T
NM_001042492.3(NF1):c.2990+1G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000431613	17	29556993	17	31229975	431613	425118	rs1135402836	NC_000017.11:31229974:G:A
NM_001042492.3(NF1):c.2870A>T (p.Asn957Ile)	NF1	N957I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 19, 2020)	criteria provided, single submitter	VCV000431611	17	29556872	17	31229854	431611	425116	rs1135402834	NC_000017.11:31229853:A:T
NM_001042492.3(NF1):c.2790T>G (p.Tyr930Ter)	NF1	Y930*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431609	17	29556423	17	31229405	431609	425114	rs1135402832	NC_000017.11:31229404:T:G
NM_001042492.3(NF1):c.2764G>A (p.Gly922Ser)	NF1	G922S	Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431608	17	29556397	17	31229379	431608	425113	rs1135402831	NC_000017.11:31229378:G:A
NM_001042492.3(NF1):c.2392A>C (p.Lys798Gln)	NF1	K798Q	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431607	17	29554607	17	31227589	431607	425112	rs1135402830	NC_000017.11:31227588:A:C
NM_001042492.3(NF1):c.2218G>T (p.Glu740Ter)	NF1	E740*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431604	17	29553669	17	31226651	431604	425109	rs1135402827	NC_000017.11:31226650:G:T
NM_001042492.3(NF1):c.1949T>A (p.Leu650Ter)	NF1	L650*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000431603	17	29552216	17	31225198	431603	425108	rs1135402826	NC_000017.11:31225197:T:A
NM_001042492.3(NF1):c.1889T>A (p.Val630Glu)	NF1	V630E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431601	17	29552156	17	31225138	431601	425106	rs1135402824	NC_000017.11:31225137:T:A
NM_001042492.3(NF1):c.1866T>A (p.Cys622Ter)	NF1	C622*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431599	17	29552133	17	31225115	431599	425104	rs753245823	NC_000017.11:31225114:T:A
NM_001042492.3(NF1):c.1683G>A (p.Trp561Ter)	NF1	W561*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431596	17	29548909	17	31221891	431596	425101	rs1135402820	NC_000017.11:31221890:G:A
NM_001042492.3(NF1):c.1585C>T (p.Leu529Phe)	NF1	L529F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431592	17	29546080	17	31219062	431592	425097	rs1135402816	NC_000017.11:31219061:C:T
NM_001042492.3(NF1):c.1570G>T (p.Glu524Ter)	NF1	E524*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000431591	17	29546065	17	31219047	431591	425096	rs1135402815	NC_000017.11:31219046:G:T
NM_001042492.3(NF1):c.1527+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV000431589	17	29541604	17	31214586	431589	425094	rs1060500331	NC_000017.11:31214585:G:C
NM_001042492.3(NF1):c.1477C>G (p.Leu493Val)	NF1	L493V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431587	17	29541553	17	31214535	431587	425092	rs1135402812	NC_000017.11:31214534:C:G
NM_001042492.3(NF1):c.1460G>A (p.Arg487Lys)	NF1	R487K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431584	17	29541536	17	31214518	431584	425089	rs1135402809	NC_000017.11:31214517:G:A
NM_001042492.3(NF1):c.1061A>G (p.Lys354Arg)	NF1	K354R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431576	17	29527612	17	31200594	431576	425081	rs1135402801	NC_000017.11:31200593:A:G
NM_001042492.3(NF1):c.889-1G>A	NF1		Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431574	17	29527439	17	31200421	431574	425079	rs587781517	NC_000017.11:31200420:G:A
NM_001042492.3(NF1):c.888+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000431573	17	29509684	17	31182666	431573	425078	rs1135402799	NC_000017.11:31182665:G:C
NM_001042492.3(NF1):c.886A>T (p.Lys296Ter)	NF1	K296*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000431572	17	29509681	17	31182663	431572	425077	rs1135402798	NC_000017.11:31182662:A:T
NM_001042492.3(NF1):c.615G>A (p.Lys205=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 19, 2020)	criteria provided, single submitter	VCV000431568	17	29508468	17	31181450	431568	425073	rs1135402794	NC_000017.11:31181449:G:A
NM_001042492.3(NF1):c.586+2T>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000431565	17	29497017	17	31169999	431565	425070	rs1135402791	NC_000017.11:31169998:T:C
NM_001042492.3(NF1):c.1722-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430965	17	29550460	17	31223442	430965	424506	rs763983337	NC_000017.11:31223441:A:G
NM_001042492.3(NF1):c.503C>G (p.Ser168Ter)	NF1	S168*	Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430497	17	29496932	17	31169914	430497	422155	rs1131691994	NC_000017.11:31169913:C:G
NM_001042492.3(NF1):c.1453G>T (p.Glu485Ter)	NF1	E485*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429817	17	29541529	17	31214511	429817	422157	rs1131691610	NC_000017.11:31214510:G:T
NM_001042492.3(NF1):c.204+5G>C	NF1		not provided	Uncertain significance(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000429627	17	29483149	17	31156131	429627	422154	rs1131691499	NC_000017.11:31156130:G:C
NM_001042492.3(NF1):c.6968T>C (p.Leu2323Pro)	NF1	L2302P, L2323P	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429223	17	29667569	17	31340551	429223	422160	rs1131691267	NC_000017.11:31340550:T:C
NM_001042492.3(NF1):c.1849G>A (p.Ala617Thr)	NF1	A617T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429019	17	29552116	17	31225098	429019	420778	rs1131691135	NC_000017.11:31225097:G:A
NM_001042492.3(NF1):c.2072T>C (p.Leu691Pro)	NF1	L691P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429016	17	29553523	17	31226505	429016	420781	rs1131691132	NC_000017.11:31226504:T:C
NM_001042492.3(NF1):c.82C>T (p.Gln28Ter)	NF1	Q28*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429015	17	29483022	17	31156004	429015	420761	rs771764281	NC_000017.11:31156003:C:T
NM_001042492.3(NF1):c.1393-1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429014	17	29541468	17	31214450	429014	420773	rs1131691131	NC_000017.11:31214449:G:T
NM_001042492.3(NF1):c.1796G>A (p.Trp599Ter)	NF1	W599*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429013	17	29550536	17	31223518	429013	420776	rs1131691130	NC_000017.11:31223517:G:A
NM_001042492.3(NF1):c.7988C>G (p.Ser2663Cys)	NF1	S2642C, S2663C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429009	17	29685515	17	31358497	429009	420837	rs786202579	NC_000017.11:31358496:C:G
NM_001042492.3(NF1):c.662G>A (p.Trp221Ter)	NF1	W221*	Hereditary cancer-predisposing syndrome|none provided	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429007	17	29508735	17	31181717	429007	420766	rs1131691126	NC_000017.11:31181716:G:A
NM_001042492.3(NF1):c.2850+1G>T	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000429002	17	29556484	17	31229466	429002	420790	rs1131691122	NC_000017.11:31229465:G:T
NM_001042492.3(NF1):c.1062G>A (p.Lys354=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428998	17	29527613	17	31200595	428998	420767	rs1131691118	NC_000017.11:31200594:G:A
NM_001042492.3(NF1):c.5609+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428997	17	29654858	17	31327840	428997	420812	rs1131691117	NC_000017.11:31327839:G:A
NM_001042492.3(NF1):c.7063-1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428994	17	29670026	17	31343008	428994	420828	rs1131691114	NC_000017.11:31343007:G:T
NM_001042492.3(NF1):c.3044T>C (p.Leu1015Pro)	NF1	L1015P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428992	17	29557331	17	31230313	428992	420791	rs1131691112	NC_000017.11:31230312:T:C
NM_001042492.3(NF1):c.4340A>C (p.Gln1447Pro)	NF1	Q1426P, Q1447P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428987	17	29586057	17	31259039	428987	420804	rs786204157	NC_000017.11:31259038:A:C
NM_001042492.3(NF1):c.2252-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428984	17	29554234	17	31227216	428984	420784	rs1131691105	NC_000017.11:31227215:A:G
NM_001042492.3(NF1):c.3097C>T (p.Gln1033Ter)	NF1	Q1033*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428983	17	29557384	17	31230366	428983	420792	rs1131691104	NC_000017.11:31230365:C:T
NM_001042492.3(NF1):c.5311A>G (p.Lys1771Glu)	NF1	K1750E, K1771E	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000428982	17	29654559	17	31327541	428982	420809	rs1131691103	NC_000017.11:31327540:A:G
NM_001042492.3(NF1):c.61-2A>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000428979	17	29482999	17	31155981	428979	420760	rs1131691100	NC_000017.11:31155980:A:T
NM_001042492.3(NF1):c.1721+1G>T	NF1	R574S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428975	17	29548948	17	31221930	428975	420775	rs1131691096	NC_000017.11:31221929:G:T
NM_001042492.3(NF1):c.2125T>C (p.Cys709Arg)	NF1	C709R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428974	17	29553576	17	31226558	428974	420783	rs1131691095	NC_000017.11:31226557:T:C
NM_001042492.3(NF1):c.6557C>G (p.Ser2186Ter)	NF1	S2165*, S2186*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428969	17	29664515	17	31337497	428969	420819	rs1131691091	NC_000017.11:31337496:C:G
NM_001042492.3(NF1):c.7760C>G (p.Ser2587Ter)	NF1	S2566*, S2587*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000428968	17	29683999	17	31356981	428968	420834	rs1131691090	NC_000017.11:31356980:C:G
NM_001042492.3(NF1):c.3198-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428967	17	29559089	17	31232071	428967	420794	rs1131691089	NC_000017.11:31232070:A:G
NM_001042492.3(NF1):c.1845G>T (p.Lys615Asn)	NF1	K615N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2018)	criteria provided, conflicting interpretations	VCV000428956	17	29550585	17	31223567	428956	420777	rs1131691080	NC_000017.11:31223566:G:T
NM_001042492.3(NF1):c.6705-3C>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000428955	17	29665040	17	31338022	428955	420822	rs1131691079	NC_000017.11:31338021:C:G
NM_001042492.3(NF1):c.3871-2A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428953	17	29562934	17	31235916	428953	420799	rs1131691077	NC_000017.11:31235915:A:G
NM_001042492.3(NF1):c.3870+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428951	17	29562791	17	31235773	428951	420798	rs1131691075	NC_000017.11:31235772:G:A
NM_001042492.3(NF1):c.4635C>A (p.Tyr1545Ter)	NF1	Y1524*, Y1545*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000428949	17	29588786	17	31261768	428949	420806	rs754023358	NC_000017.11:31261767:C:A
NM_001042492.3(NF1):c.6970C>T (p.Gln2324Ter)	NF1	Q2303*, Q2324*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|not provided	Pathogenic(Last reviewed: Jun 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428948	17	29667571	17	31340553	428948	420826	rs1131691073	NC_000017.11:31340552:C:T
NM_001042492.3(NF1):c.6818A>G (p.Lys2273Arg)	NF1	K2252R, K2273R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2020)	criteria provided, conflicting interpretations	VCV000428947	17	29665156	17	31338138	428947	420824	rs1060500344	NC_000017.11:31338137:A:G
NM_001042492.3(NF1):c.4195C>T (p.Gln1399Ter)	NF1	Q1378*, Q1399*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428946	17	29585383	17	31258365	428946	420801	rs1131691072	NC_000017.11:31258364:C:T
NM_001042492.3(NF1):c.1376C>A (p.Ala459Glu)	NF1	A459E	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428944	17	29533373	17	31206355	428944	420772	rs1131691070	NC_000017.11:31206354:C:A
NM_001042492.3(NF1):c.1260+1604A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428941	17	29530107	17	31203089	428941	420770	rs1131691067	NC_000017.11:31203088:A:G
NM_001042492.3(NF1):c.1063-13G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000428940	17	29528042	17	31201024	428940	420768	rs1131691066	NC_000017.11:31201023:G:A
NM_001042492.3(NF1):c.6921+3A>G	NF1		Pre-B-cell acute lymphoblastic leukemia|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 28, 2020)	criteria provided, conflicting interpretations	VCV000426988	17	29665826	17	31338808	426988	415549	rs1085307885	NC_000017.11:31338807:A:G
NM_001042492.3(NF1):c.4835+1G>T	NF1		Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426827	17	29592358	17	31265340	426827	415547	rs1085307819	NC_000017.11:31265339:G:T
NM_001042492.3(NF1):c.2991G>T (p.Arg997Ser)	NF1	R997S	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Sep 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426719	17	29557278	17	31230260	426719	415545	rs755501749	NC_000017.11:31230259:G:T
NM_001042492.3(NF1):c.5358G>A (p.Ser1786=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2020)	criteria provided, conflicting interpretations	VCV000424072	17	29654606	17	31327588	424072	409875	rs373313111	NC_000017.11:31327587:G:A
NM_001042492.3(NF1):c.4332G>A (p.Lys1444=)	NF1		Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2021)	criteria provided, conflicting interpretations	VCV000423536	17	29585520	17	31258502	423536	409873	rs199474750	NC_000017.11:31258501:G:A
NM_001042492.3(NF1):c.6705-17G>A	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2020)	criteria provided, conflicting interpretations	VCV000422739	17	29665026	17	31338008	422739	409880	rs1064795966	NC_000017.11:31338007:G:A
NM_001042492.3(NF1):c.1052T>C (p.Val351Ala)	NF1	V351A	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421102	17	29527603	17	31200585	421102	409861	rs878853861	NC_000017.11:31200584:T:C
NM_001042492.3(NF1):c.6864A>G (p.Gln2288=)	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000420870	17	29665766	17	31338748	420870	409881	rs1064794756	NC_000017.11:31338747:A:G
NM_001042492.3(NF1):c.3447G>A (p.Met1149Ile)	NF1	M1149I	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420079	17	29559850	17	31232832	420079	409869	rs1064794277	NC_000017.11:31232831:G:A
NM_001042492.3(NF1):c.1658A>G (p.His553Arg)	NF1	H553R	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000420076	17	29548884	17	31221866	420076	409863	rs1064794274	NC_000017.11:31221865:A:G
NM_001042492.3(NF1):c.801G>A (p.Trp267Ter)	NF1	W267*	Neurofibromatosis, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000420075	17	29509596	17	31182578	420075	409860	rs1064794273	NC_000017.11:31182577:G:A
NM_001042492.3(NF1):c.2694G>C (p.Leu898=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413038	17	29556327	17	31229309	413038	401696	rs1060503923	NC_000017.11:31229308:G:C
NM_001042492.3(NF1):c.4095C>T (p.Cys1365=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2020)	criteria provided, conflicting interpretations	VCV000413037	17	29576122	17	31249104	413037	401774	rs1060503922	NC_000017.11:31249103:C:T
NM_001042492.3(NF1):c.3496+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, single submitter	VCV000413036	17	29559906	17	31232888	413036	401732	rs1060503921	NC_000017.11:31232887:T:C
NM_001042492.3(NF1):c.7458-7C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Mar 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000413035	17	29679268	17	31352250	413035	401838	rs758106590	NC_000017.11:31352249:C:T
NM_001042492.3(NF1):c.6195A>C (p.Pro2065=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000413034	17	29663700	17	31336682	413034	402484	rs1060503920	NC_000017.11:31336681:A:C
NM_001042492.3(NF1):c.7110C>T (p.His2370=)	NF1		Hereditary cancer-predisposing syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2020)	criteria provided, conflicting interpretations	VCV000413033	17	29670074	17	31343056	413033	402525	rs201881479	NC_000017.11:31343055:C:T
NM_001042492.3(NF1):c.6279C>T (p.Ser2093=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413032	17	29663784	17	31336766	413032	401823	rs1055695069	NC_000017.11:31336765:C:T
NM_001042492.3(NF1):c.5976T>C (p.Ile1992=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413031	17	29662019	17	31335001	413031	402481	rs766233634	NC_000017.11:31335000:T:C
NM_001042492.3(NF1):c.627G>A (p.Gln209=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000413030	17	29508480	17	31181462	413030	401611	rs1060503919	NC_000017.11:31181461:G:A
NM_001042492.3(NF1):c.4110+10C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000413029	17	29576147	17	31249129	413029	402457	rs776277455	NC_000017.11:31249128:C:T
NM_001042492.3(NF1):c.6480A>G (p.Lys2160=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 12, 2020)	criteria provided, single submitter	VCV000413028	17	29664438	17	31337420	413028	402502	rs1060503918	NC_000017.11:31337419:A:G
NM_001042492.3(NF1):c.4668T>C (p.Asp1556=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413027	17	29588819	17	31261801	413027	401781	rs763874870	NC_000017.11:31261800:T:C
NM_001042492.3(NF1):c.8229G>A (p.Leu2743=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000413026	17	29687573	17	31360555	413026	402391	rs1060503917	NC_000017.11:31360554:G:A
NM_001042492.3(NF1):c.1528-9T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV000413025	17	29546014	17	31218996	413025	401644	rs1060503916	NC_000017.11:31218995:T:C
NM_001042492.3(NF1):c.7323T>G (p.Ala2441=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413024	17	29677202	17	31350184	413024	402542	rs765750009	NC_000017.11:31350183:T:G
NM_001042492.3(NF1):c.3300A>G (p.Ser1100=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000413023	17	29559193	17	31232175	413023	401719	rs1060503915	NC_000017.11:31232174:A:G
NM_001042492.3(NF1):c.819C>T (p.Leu273=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413022	17	29509614	17	31182596	413022	402108	rs765595990	NC_000017.11:31182595:C:T
NM_001042492.3(NF1):c.3225A>G (p.Ala1075=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000413021	17	29559118	17	31232100	413021	402230	rs746022492	NC_000017.11:31232099:A:G
NM_001042492.3(NF1):c.5191T>C (p.Leu1731=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000413020	17	29653193	17	31326175	413020	401809	rs876658602	NC_000017.11:31326174:T:C
NM_001042492.3(NF1):c.6600A>C (p.Thr2200=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV000413019	17	29664558	17	31337540	413019	402504	rs747576584	NC_000017.11:31337539:A:C
NM_001042492.3(NF1):c.5574A>G (p.Ala1858=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Likely benign(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413018	17	29654822	17	31327804	413018	401795	rs760561904	NC_000017.11:31327803:A:G
NM_001042492.3(NF1):c.87C>T (p.Asn29=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413017	17	29483027	17	31156009	413017	402084	rs1060503914	NC_000017.11:31156008:C:T
NM_001042492.3(NF1):c.127C>T (p.Leu43=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413016	17	29483067	17	31156049	413016	401602	rs1060503913	NC_000017.11:31156048:C:T
NM_001042492.3(NF1):c.4455T>C (p.Asp1485=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413015	17	29587411	17	31260393	413015	401747	rs186556778	NC_000017.11:31260392:T:C
NM_001042492.3(NF1):c.6549G>A (p.Arg2183=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413014	17	29664507	17	31337489	413014	401862	rs1028183407	NC_000017.11:31337488:G:A
NM_001042492.3(NF1):c.2226C>G (p.Ala742=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000413013	17	29553677	17	31226659	413013	402175	rs1060503912	NC_000017.11:31226658:C:G
NM_001042492.3(NF1):c.6189A>G (p.Leu2063=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413012	17	29663694	17	31336676	413012	401819	rs1060503911	NC_000017.11:31336675:A:G
NM_001042492.3(NF1):c.1062+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV000413010	17	29527620	17	31200602	413010	402132	rs979521240	NC_000017.11:31200601:T:C
NM_001042492.3(NF1):c.7887T>C (p.Tyr2629=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000413009	17	29684304	17	31357286	413009	401842	rs767860040	NC_000017.11:31357285:T:C
NM_001042492.3(NF1):c.6213A>G (p.Gln2071=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000413008	17	29663718	17	31336700	413008	402487	rs1060503910	NC_000017.11:31336699:A:G
NM_001042492.3(NF1):c.479+7G>A	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV000413007	17	29490401	17	31163383	413007	401601	rs778398666	NC_000017.11:31163382:G:A
NM_001042492.3(NF1):c.864G>T (p.Val288=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV000413006	17	29509659	17	31182641	413006	402115	rs201181517	NC_000017.11:31182640:G:T
NM_001042492.3(NF1):c.6456T>C (p.Ser2152=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV000413005	17	29664414	17	31337396	413005	401858	rs776897972	NC_000017.11:31337395:T:C
NM_001042492.3(NF1):c.6820-8C>T	NF1		Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000413004	17	29665714	17	31338696	413004	401869	rs1060503909	NC_000017.11:31338695:C:T
NM_001042492.3(NF1):c.1260+9A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000413003	17	29528512	17	31201494	413003	401638	rs1060503908	NC_000017.11:31201493:A:G
NM_001042492.3(NF1):c.1581A>C (p.Thr527=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000413002	17	29546076	17	31219058	413002	401650	rs1060503907	NC_000017.11:31219057:A:C
NM_001042492.3(NF1):c.7770C>T (p.His2590=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000413001	17	29684009	17	31356991	413001	402388	rs1060503906	NC_000017.11:31356990:C:T
NM_001042492.3(NF1):c.8002C>T (p.Leu2668=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000413000	17	29685529	17	31358511	413000	402389	rs1060503905	NC_000017.11:31358510:C:T
NM_001042492.3(NF1):c.7275T>C (p.Asn2425=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412999	17	29676223	17	31349205	412999	401890	rs1060503904	NC_000017.11:31349204:T:C
NM_001042492.3(NF1):c.7457+8G>T	NF1		not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2020)	criteria provided, conflicting interpretations	VCV000412998	17	29677344	17	31350326	412998	402547	rs376147282	NC_000017.11:31350325:G:T
NM_001042492.3(NF1):c.7332A>G (p.Thr2444=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000412997	17	29677211	17	31350193	412997	401893	rs759005886	NC_000017.11:31350192:A:G
NM_001042492.3(NF1):c.3709-8G>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412996	17	29562621	17	31235603	412996	401763	rs767650263	NC_000017.11:31235602:G:C
NM_001042492.3(NF1):c.4725-5T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000412995	17	29592242	17	31265224	412995	402284	rs1060503903	NC_000017.11:31265223:T:C
NM_001042492.3(NF1):c.1653T>A (p.Val551=)	NF1		not provided|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000412994	17	29548879	17	31221861	412994	402362	rs1060503902	NC_000017.11:31221860:T:A
NM_001042492.3(NF1):c.655-8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000412993	17	29508720	17	31181702	412993	401627	rs758089068	NC_000017.11:31181701:A:G
NM_001042492.3(NF1):c.2235C>T (p.Ser745=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412992	17	29553686	17	31226668	412992	402390	rs1060503901	NC_000017.11:31226667:C:T
NM_001042492.3(NF1):c.369C>T (p.Thr123=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000412991	17	29490284	17	31163266	412991	402090	rs146691765	NC_000017.11:31163265:C:T
NM_001042492.3(NF1):c.8001C>T (p.Thr2667=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412990	17	29685528	17	31358510	412990	401843	rs876658475	NC_000017.11:31358509:C:T
NM_001042492.3(NF1):c.276A>G (p.Lys92=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000412989	17	29486099	17	31159081	412989	402318	rs1060503900	NC_000017.11:31159080:A:G
NM_001042492.3(NF1):c.5256A>G (p.Lys1752=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV000412988	17	29653258	17	31326240	412988	401811	rs1060503899	NC_000017.11:31326239:A:G
NM_001042492.3(NF1):c.6922-8T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000412987	17	29667515	17	31340497	412987	402516	rs191255643	NC_000017.11:31340496:T:C
NM_001042492.3(NF1):c.7190-7T>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000412986	17	29676131	17	31349113	412986	402531	rs779081215	NC_000017.11:31349112:T:G
NM_001042492.3(NF1):c.7189+8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000412985	17	29670161	17	31343143	412985	402528	rs750100211	NC_000017.11:31343142:A:G
NM_001042492.3(NF1):c.8223G>A (p.Thr2741=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412984	17	29687567	17	31360549	412984	401845	rs777755159	NC_000017.11:31360548:G:A
NM_001042492.3(NF1):c.4887G>A (p.Leu1629=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412983	17	29652889	17	31325871	412983	402290	rs368638966	NC_000017.11:31325870:G:A
NM_001042492.3(NF1):c.1641+8G>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000412982	17	29546144	17	31219126	412982	401655	rs758022528	NC_000017.11:31219125:G:C
NM_001042492.3(NF1):c.1707A>G (p.Thr569=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000412981	17	29548933	17	31221915	412981	402369	rs1060503898	NC_000017.11:31221914:A:G
NM_001042492.3(NF1):c.8385C>T (p.Asp2795=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000412980	17	29701038	17	31374020	412980	401847	rs144635489	NC_000017.11:31374019:C:T
NM_001042492.3(NF1):c.6750T>C (p.Val2250=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412979	17	29665088	17	31338070	412979	401866	rs762075320	NC_000017.11:31338069:T:C
NM_001042492.3(NF1):c.3648T>A (p.Gly1216=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000412978	17	29560171	17	31233153	412978	402443	rs1060503897	NC_000017.11:31233152:T:A
NM_001042492.3(NF1):c.1186-4A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412977	17	29528425	17	31201407	412977	401634	rs769295150	NC_000017.11:31201406:A:G
NM_001042492.3(NF1):c.730+10C>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 19, 2020)	criteria provided, single submitter	VCV000412976	17	29508813	17	31181795	412976	402345	rs750468471	NC_000017.11:31181794:C:T
NM_001042492.3(NF1):c.4311G>A (p.Arg1437=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000412975	17	29585499	17	31258481	412975	402279	rs1060503896	NC_000017.11:31258480:G:A
NM_001042492.3(NF1):c.60+7G>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000412974	17	29422394	17	31095376	412974	402082	rs1060503895	NC_000017.11:31095375:G:C
NM_001042492.3(NF1):c.2805C>T (p.Asn935=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000412973	17	29556438	17	31229420	412973	401688	rs1060503894	NC_000017.11:31229419:C:T
NM_001042492.3(NF1):c.5377C>T (p.Leu1793=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000412972	17	29654625	17	31327607	412972	402471	rs761676110	NC_000017.11:31327606:C:T
NM_001042492.3(NF1):c.4632A>G (p.Ala1544=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412970	17	29588783	17	31261765	412970	401772	rs781741727	NC_000017.11:31261764:A:G
NM_001042492.3(NF1):c.6378C>T (p.Val2126=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412969	17	29663883	17	31336865	412969	402342	rs760941036	NC_000017.11:31336864:C:T
NM_001042492.3(NF1):c.1554C>A (p.Thr518=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412968	17	29546049	17	31219031	412968	401645	rs876660849	NC_000017.11:31219030:C:A
NM_001042492.3(NF1):c.5715C>T (p.Thr1905=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412967	17	29657419	17	31330401	412967	401816	rs1060503892	NC_000017.11:31330400:C:T
NM_001042492.3(NF1):c.2583A>G (p.Ala861=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000412966	17	29556216	17	31229198	412966	402430	rs1060503891	NC_000017.11:31229197:A:G
NM_001042492.3(NF1):c.8382C>T (p.Ile2794=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412965	17	29701035	17	31374017	412965	401846	rs1060503890	NC_000017.11:31374016:C:T
NM_001042492.3(NF1):c.2085G>A (p.Leu695=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412964	17	29553536	17	31226518	412964	402383	rs1060503889	NC_000017.11:31226517:G:A
NM_001042492.3(NF1):c.7191G>A (p.Gly2397=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412963	17	29676139	17	31349121	412963	402536	rs773474652	NC_000017.11:31349120:G:A
NM_001042492.3(NF1):c.4479T>C (p.Asn1493=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412962	17	29587435	17	31260417	412962	401753	rs1060503888	NC_000017.11:31260416:T:C
NM_001042492.3(NF1):c.1641+7G>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000412961	17	29546143	17	31219125	412961	402360	rs1060503887	NC_000017.11:31219124:G:C
NM_001042492.3(NF1):c.1392+10A>G	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000412960	17	29533399	17	31206381	412960	402358	rs1060503886	NC_000017.11:31206380:A:G
NM_001042492.3(NF1):c.5951A>G (p.Asn1984Ser)	NF1	N1963S, N1984S	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404620	17	29661994	17	31334976	404620	402322	rs764291252	NC_000017.11:31334975:A:G
NM_001042492.3(NF1):c.5299G>T (p.Ala1767Ser)	NF1	A1746S, A1767S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 17, 2016)	criteria provided, single submitter	VCV000404619	17	29654547	17	31327529	404619	401821	rs529905904	NC_000017.11:31327528:G:T
NM_001042492.3(NF1):c.1299T>G (p.Tyr433Ter)	NF1	Y433*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404617	17	29533296	17	31206278	404617	402352	rs876660099	NC_000017.11:31206277:T:G
NM_001042492.3(NF1):c.7314C>G (p.Tyr2438Ter)	NF1	Y2438*, Y2417*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404615	17	29676262	17	31349244	404615	401832	rs1060500385	NC_000017.11:31349243:C:G
NM_001042492.3(NF1):c.5030T>A (p.Val1677Asp)	NF1	V1656D, V1677D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000404614	17	29653032	17	31326014	404614	402294	rs1060500384	NC_000017.11:31326013:T:A
NM_001042492.3(NF1):c.3016G>A (p.Val1006Ile)	NF1	V1006I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000404613	17	29557303	17	31230285	404613	401700	rs1060500383	NC_000017.11:31230284:G:A
NM_001042492.3(NF1):c.3461A>T (p.Asn1154Ile)	NF1	N1154I	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404612	17	29559864	17	31232846	404612	402439	rs371544233	NC_000017.11:31232845:A:T
NM_001042492.3(NF1):c.6295C>T (p.His2099Tyr)	NF1	H2099Y, H2078Y	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404611	17	29663800	17	31336782	404611	402328	rs1060500382	NC_000017.11:31336781:C:T
NM_001042492.3(NF1):c.4927G>A (p.Val1643Met)	NF1	V1643M, V1622M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000404610	17	29652929	17	31325911	404610	401794	rs1060500381	NC_000017.11:31325910:G:A
NM_001042492.3(NF1):c.7045C>T (p.Arg2349Cys)	NF1	R2328C, R2349C	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404609	17	29667646	17	31340628	404609	401883	rs56013763	NC_000017.11:31340627:C:T
NM_001042492.3(NF1):c.1867C>T (p.His623Tyr)	NF1	H623Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404608	17	29552134	17	31225116	404608	401657	rs759555122	NC_000017.11:31225115:C:T
NM_001042492.3(NF1):c.4555G>A (p.Gly1519Arg)	NF1	G1498R, G1519R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000404607	17	29587511	17	31260493	404607	401779	rs1060500380	NC_000017.11:31260492:G:A
NM_001042492.3(NF1):c.4010G>A (p.Arg1337Gln)	NF1	R1337Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404606	17	29576037	17	31249019	404606	401771	rs1060500379	NC_000017.11:31249018:G:A
NM_001042492.3(NF1):c.988G>C (p.Ala330Pro)	NF1	A330P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000404605	17	29527539	17	31200521	404605	401628	rs199474767	NC_000017.11:31200520:G:C
NM_001042492.3(NF1):c.6921+5T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2020)	criteria provided, conflicting interpretations	VCV000404604	17	29665828	17	31338810	404604	401881	rs370402788	NC_000017.11:31338809:T:C
NM_001042492.3(NF1):c.6175G>A (p.Asp2059Asn)	NF1	D2038N, D2059N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000404603	17	29663680	17	31336662	404603	401844	rs761029453	NC_000017.11:31336661:G:A
NM_001042492.3(NF1):c.4230C>G (p.Phe1410Leu)	NF1	F1389L, F1410L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000404602	17	29585418	17	31258400	404602	402458	rs750213850	NC_000017.11:31258399:C:G
NM_001042492.3(NF1):c.5650T>C (p.Phe1884Leu)	NF1	F1884L, F1863L	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000404601	17	29657354	17	31330336	404601	402477	rs1060500378	NC_000017.11:31330335:T:C
NM_001042492.3(NF1):c.7992G>C (p.Lys2664Asn)	NF1	K2643N, K2664N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2016)	criteria provided, single submitter	VCV000404600	17	29685519	17	31358501	404600	401912	rs1060500377	NC_000017.11:31358500:G:C
NM_001042492.3(NF1):c.6704+1G>A	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404599	17	29664899	17	31337881	404599	402353	rs1060500376	NC_000017.11:31337880:G:A
NM_001042492.3(NF1):c.3517C>T (p.Leu1173Phe)	NF1	L1173F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 20, 2016)	criteria provided, single submitter	VCV000404598	17	29560040	17	31233022	404598	401738	rs1060500375	NC_000017.11:31233021:C:T
NM_001042492.3(NF1):c.1246C>T (p.Arg416Ter)	NF1	R416*	not provided|not specified|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404597	17	29528489	17	31201471	404597	402141	rs764079291	NC_000017.11:31201470:C:T
NM_001042492.3(NF1):c.3623T>A (p.Leu1208Ter)	NF1	L1208*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000404596	17	29560146	17	31233128	404596	401748	rs1060500374	NC_000017.11:31233127:T:A
NM_001042492.3(NF1):c.6790A>T (p.Ile2264Leu)	NF1	I2243L, I2264L	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2020)	criteria provided, conflicting interpretations	VCV000404595	17	29665128	17	31338110	404595	402356	rs761213794	NC_000017.11:31338109:A:T
NM_001042492.3(NF1):c.6819G>A (p.Lys2273=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000404594	17	29665157	17	31338139	404594	401829	rs1060500373	NC_000017.11:31338138:G:A
NM_001042492.3(NF1):c.7228G>A (p.Val2410Ile)	NF1	V2389I, V2410I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV000404593	17	29676176	17	31349158	404593	402382	rs1060500372	NC_000017.11:31349157:G:A
NM_001042492.3(NF1):c.3916C>T (p.Arg1306Ter)	NF1	R1306*	Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404592	17	29562981	17	31235963	404592	401712	rs376576925	NC_000017.11:31235962:C:T
NM_001042492.3(NF1):c.3975-1G>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000404590	17	29576001	17	31248983	404590	401715	rs1060500370	NC_000017.11:31248982:G:T
NM_001042492.3(NF1):c.4225A>G (p.Met1409Val)	NF1	M1409V, M1388V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000404589	17	29585413	17	31258395	404589	401777	rs1060500369	NC_000017.11:31258394:A:G
NM_001042492.3(NF1):c.2542G>C (p.Gly848Arg)	NF1	G848R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404588	17	29556175	17	31229157	404588	402419	rs1060500368	NC_000017.11:31229156:G:C
NM_001042492.3(NF1):c.2534G>A (p.Cys845Tyr)	NF1	C845Y	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404587	17	29556167	17	31229149	404587	401689	rs1060500367	NC_000017.11:31229148:G:A
NM_001042492.3(NF1):c.6006+4T>C	NF1		Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 10, 2020)	criteria provided, conflicting interpretations	VCV000404586	17	29662053	17	31335035	404586	402482	rs754909198	NC_000017.11:31335034:T:C
NM_001042492.3(NF1):c.1615C>G (p.Pro539Ala)	NF1	P539A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000404585	17	29546110	17	31219092	404585	401651	rs1060500366	NC_000017.11:31219091:C:G
NM_001042492.3(NF1):c.712C>G (p.Pro238Ala)	NF1	P238A	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000404584	17	29508785	17	31181767	404584	401615	rs1060500365	NC_000017.11:31181766:C:G
NM_001042492.3(NF1):c.2741G>A (p.Arg914Gln)	NF1	R914Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404583	17	29556374	17	31229356	404583	401680	rs776447057	NC_000017.11:31229355:G:A
NM_001042492.3(NF1):c.79C>T (p.Gln27Ter)	NF1	Q27*	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404581	17	29483019	17	31156001	404581	402309	rs1060500363	NC_000017.11:31156000:C:T
NM_001042492.3(NF1):c.4444A>G (p.Ile1482Val)	NF1	I1482V, I1461V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404580	17	29587400	17	31260382	404580	401746	rs1060500362	NC_000017.11:31260381:A:G
NM_001042492.3(NF1):c.2624G>T (p.Gly875Val)	NF1	G875V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000404579	17	29556257	17	31229239	404579	401674	rs1060500361	NC_000017.11:31229238:G:T
NM_001042492.3(NF1):c.248A>G (p.Gln83Arg)	NF1	Q83R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 12, 2016)	criteria provided, single submitter	VCV000404578	17	29486071	17	31159053	404578	401609	rs1060500360	NC_000017.11:31159052:A:G
NM_001042492.3(NF1):c.2065G>A (p.Val689Met)	NF1	V689M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404577	17	29553516	17	31226498	404577	401675	rs771784652	NC_000017.11:31226497:G:A
NM_001042492.3(NF1):c.7015G>T (p.Glu2339Ter)	NF1	E2318*, E2339*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000404576	17	29667616	17	31340598	404576	402522	rs1060500359	NC_000017.11:31340597:G:T
NM_001042492.3(NF1):c.1063-2A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404575	17	29528053	17	31201035	404575	401633	rs1060500358	NC_000017.11:31201034:A:G
NM_001042492.3(NF1):c.2848C>T (p.Gln950Ter)	NF1	Q950*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404574	17	29556481	17	31229463	404574	402194	rs1060500357	NC_000017.11:31229462:C:T
NM_001042492.3(NF1):c.6705-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 2, 2016)	criteria provided, single submitter	VCV000404573	17	29665042	17	31338024	404573	401826	rs1060500356	NC_000017.11:31338023:G:C
NM_001042492.3(NF1):c.289-6T>C	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV000404572	17	29490198	17	31163180	404572	402335	rs757074803	NC_000017.11:31163179:T:C
NM_001042492.3(NF1):c.6921+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404571	17	29665824	17	31338806	404571	401871	rs1060500355	NC_000017.11:31338805:G:A
NM_001042492.3(NF1):c.145T>A (p.Tyr49Asn)	NF1	Y49N	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404570	17	29483085	17	31156067	404570	401608	rs764367878	NC_000017.11:31156066:T:A
NM_001042492.3(NF1):c.1900A>G (p.Ile634Val)	NF1	I634V	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2021)	criteria provided, conflicting interpretations	VCV000404567	17	29552167	17	31225149	404567	402379	rs745906742	NC_000017.11:31225148:A:G
NM_001042492.3(NF1):c.1527+5G>A	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 21, 2021)	criteria provided, conflicting interpretations	VCV000404566	17	29541608	17	31214590	404566	401646	rs1060500352	NC_000017.11:31214589:G:A
NM_001042492.3(NF1):c.2514C>G (p.Ile838Met)	NF1	I838M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2016)	criteria provided, single submitter	VCV000404565	17	29556147	17	31229129	404565	401666	rs863224352	NC_000017.11:31229128:C:G
NM_001042492.3(NF1):c.3712G>T (p.Glu1238Ter)	NF1	E1238*	Tibial pseudoarthrosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404559	17	29562632	17	31235614	404559	402450	rs1060500346	NC_000017.11:31235613:G:T
NM_001042492.3(NF1):c.6642+1G>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404558	17	29664601	17	31337583	404558	402348	rs1060500345	NC_000017.11:31337582:G:T
NM_001042492.3(NF1):c.1392G>T (p.Pro464=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000404557	17	29533389	17	31206371	404557	401643	rs201604273	NC_000017.11:31206370:G:T
NM_001042492.3(NF1):c.6818A>T (p.Lys2273Met)	NF1	K2252M, K2273M	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000404556	17	29665156	17	31338138	404556	402363	rs1060500344	NC_000017.11:31338137:A:T
NM_001042492.3(NF1):c.3145G>A (p.Val1049Ile)	NF1	V1049I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404555	17	29557891	17	31230873	404555	402209	rs1060500343	NC_000017.11:31230872:G:A
NM_001042492.3(NF1):c.6685T>C (p.Trp2229Arg)	NF1	W2229R, W2208R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404554	17	29664879	17	31337861	404554	402350	rs1060500342	NC_000017.11:31337860:T:C
NM_001042492.3(NF1):c.1771C>G (p.Leu591Val)	NF1	L591V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV000404553	17	29550511	17	31223493	404553	402372	rs767247726	NC_000017.11:31223492:C:G
NM_001042492.3(NF1):c.3842C>G (p.Ala1281Gly)	NF1	A1281G	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404552	17	29562762	17	31235744	404552	402235	rs1060500341	NC_000017.11:31235743:C:G
NM_001042492.3(NF1):c.3671C>T (p.Ala1224Val)	NF1	A1224V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404551	17	29560194	17	31233176	404551	402448	rs1060500340	NC_000017.11:31233175:C:T
NM_001042492.3(NF1):c.5534T>G (p.Ile1845Ser)	NF1	I1845S, I1824S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000404550	17	29654782	17	31327764	404550	402308	rs1060500339	NC_000017.11:31327763:T:G
NM_001042492.3(NF1):c.3962T>C (p.Val1321Ala)	NF1	V1321A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404548	17	29563027	17	31236009	404548	402452	rs1060500337	NC_000017.11:31236008:T:C
NM_001042492.3(NF1):c.5939C>T (p.Thr1980Ile)	NF1	T1959I, T1980I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404547	17	29661982	17	31334964	404547	402320	rs1060500336	NC_000017.11:31334963:C:T
NM_001042492.3(NF1):c.7920T>G (p.Tyr2640Ter)	NF1	Y2619*, Y2640*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000404544	17	29684337	17	31357319	404544	401910	rs1060500333	NC_000017.11:31357318:T:G
NM_001042492.3(NF1):c.5587G>A (p.Gly1863Ser)	NF1	G1842S, G1863S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000404543	17	29654835	17	31327817	404543	401798	rs1060500332	NC_000017.11:31327816:G:A
NM_001042492.3(NF1):c.5115G>C (p.Arg1705Ser)	NF1	R1684S, R1705S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404541	17	29653117	17	31326099	404541	402299	rs749669269	NC_000017.11:31326098:G:C
NM_001042492.3(NF1):c.1527+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000404540	17	29541604	17	31214586	404540	402162	rs1060500331	NC_000017.11:31214585:G:T
NM_001042492.3(NF1):c.5768C>G (p.Thr1923Arg)	NF1	T1902R, T1923R	Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2020)	criteria provided, conflicting interpretations	VCV000404539	17	29657472	17	31330454	404539	401817	rs786203824	NC_000017.11:31330453:C:G
NM_001042492.3(NF1):c.160G>T (p.Val54Phe)	NF1	V54F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000404538	17	29483100	17	31156082	404538	402316	rs1060500330	NC_000017.11:31156081:G:T
NM_001042492.3(NF1):c.2960G>A (p.Ser987Asn)	NF1	S987N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000404537	17	29556962	17	31229944	404537	402196	rs1060500329	NC_000017.11:31229943:G:A
NM_001042492.3(NF1):c.8479G>A (p.Ala2827Thr)	NF1	A2806T, A2827T	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 19, 2020)	criteria provided, conflicting interpretations	VCV000404536	17	29701132	17	31374114	404536	401915	rs199878086	NC_000017.11:31374113:G:A
NM_001042492.3(NF1):c.5465A>C (p.Gln1822Pro)	NF1	Q1822P, Q1801P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404535	17	29654713	17	31327695	404535	402475	rs1060500328	NC_000017.11:31327694:A:C
NM_001042492.3(NF1):c.451A>C (p.Asn151His)	NF1	N151H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404534	17	29490366	17	31163348	404534	402092	rs769391944	NC_000017.11:31163347:A:C
NM_001042492.3(NF1):c.7135G>A (p.Gly2379Arg)	NF1	G2379R, G2358R	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404531	17	29670099	17	31343081	404531	402377	rs775476318	NC_000017.11:31343080:G:A
NM_001042492.3(NF1):c.3383G>A (p.Gly1128Asp)	NF1	G1128D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404530	17	29559786	17	31232768	404530	402435	rs1060500325	NC_000017.11:31232767:G:A
NM_001042492.3(NF1):c.97A>G (p.Lys33Glu)	NF1	K33E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000404529	17	29483037	17	31156019	404529	402310	rs1060500324	NC_000017.11:31156018:A:G
NM_001042492.3(NF1):c.1804G>C (p.Glu602Gln)	NF1	E602Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000404527	17	29550544	17	31223526	404527	402373	rs1060500322	NC_000017.11:31223525:G:C
NM_001042492.3(NF1):c.7190-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000404526	17	29676136	17	31349118	404526	402535	rs772348111	NC_000017.11:31349117:A:G
NM_001042492.3(NF1):c.4202G>T (p.Ser1401Ile)	NF1	S1401I, S1380I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000404523	17	29585390	17	31258372	404523	402257	rs1060500249	NC_000017.11:31258371:G:T
NM_001042492.3(NF1):c.964A>G (p.Ile322Val)	NF1	I322V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404522	17	29527515	17	31200497	404522	402119	rs755007999	NC_000017.11:31200496:A:G
NM_001042492.3(NF1):c.3986C>A (p.Ser1329Ter)	NF1	S1329*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000404521	17	29576013	17	31248995	404521	402247	rs1060500319	NC_000017.11:31248994:C:A
NM_001042492.3(NF1):c.2689C>T (p.Arg897Trp)	NF1	R897W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404520	17	29556322	17	31229304	404520	402192	rs775949348	NC_000017.11:31229303:C:T
NM_001042492.3(NF1):c.7039A>G (p.Ser2347Gly)	NF1	S2347G, S2326G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000404518	17	29667640	17	31340622	404518	402368	rs1060500318	NC_000017.11:31340621:A:G
NM_001042492.3(NF1):c.3358G>T (p.Val1120Phe)	NF1	V1120F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000404517	17	29559761	17	31232743	404517	401705	rs200594167	NC_000017.11:31232742:G:T
NM_001042492.3(NF1):c.2395A>T (p.Met799Leu)	NF1	M799L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000404516	17	29554610	17	31227592	404516	402392	rs1060500317	NC_000017.11:31227591:A:T
NM_001042492.3(NF1):c.4831C>T (p.Arg1611Trp)	NF1	R1590W, R1611W	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404515	17	29592353	17	31265335	404515	401791	rs1060500316	NC_000017.11:31265334:C:T
NM_001042492.3(NF1):c.3683C>T (p.Ala1228Val)	NF1	A1228V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404514	17	29560206	17	31233188	404514	401754	rs1060500315	NC_000017.11:31233187:C:T
NM_001042492.3(NF1):c.2474C>G (p.Ser825Cys)	NF1	S825C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000404513	17	29556107	17	31229089	404513	401663	rs1060500314	NC_000017.11:31229088:C:G
NM_000267.3(NF1):c.2761G>A (p.Val921Met)	NF1	V921M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404512	17	29556394	17	31229376	404512	401698	rs567023433	NC_000017.11:31229375:G:A
NM_001042492.3(NF1):c.3113G>T (p.Arg1038Met)	NF1	R1038M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000404511	17	29557400	17	31230382	404511	401701	rs1060500313	NC_000017.11:31230381:G:T
NM_001042492.3(NF1):c.6428-2A>G	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000404510	17	29664384	17	31337366	404510	402492	rs1060500312	NC_000017.11:31337365:A:G
NM_001042492.3(NF1):c.6427+5G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404509	17	29663937	17	31336919	404509	402490	rs1060500311	NC_000017.11:31336918:G:A
NM_001042492.3(NF1):c.4201A>T (p.Ser1401Cys)	NF1	S1380C, S1401C	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404507	17	29585389	17	31258371	404507	401720	rs1060500310	NC_000017.11:31258370:A:T
NM_001042492.3(NF1):c.5195C>G (p.Ala1732Gly)	NF1	A1711G, A1732G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404506	17	29653197	17	31326179	404506	402470	rs202037436	NC_000017.11:31326178:C:G
NM_001042492.3(NF1):c.563C>T (p.Ala188Val)	NF1	A188V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 11, 2017)	criteria provided, single submitter	VCV000404505	17	29496992	17	31169974	404505	401603	rs1060500309	NC_000017.11:31169973:C:T
NM_001042492.3(NF1):c.3763C>T (p.Gln1255Ter)	NF1	Q1255*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000404504	17	29562683	17	31235665	404504	401707	rs1060500308	NC_000017.11:31235664:C:T
NM_001042492.3(NF1):c.5126T>G (p.Ile1709Arg)	NF1	I1688R, I1709R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000404502	17	29653128	17	31326110	404502	401807	rs876660316	NC_000017.11:31326109:T:G
NM_001042492.3(NF1):c.3857C>T (p.Thr1286Ile)	NF1	T1286I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000404501	17	29562777	17	31235759	404501	401766	rs1060500306	NC_000017.11:31235758:C:T
NM_001042492.3(NF1):c.1456A>T (p.Thr486Ser)	NF1	T486S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000404500	17	29541532	17	31214514	404500	402147	rs1060500305	NC_000017.11:31214513:A:T
NM_001042492.3(NF1):c.6992A>T (p.Tyr2331Phe)	NF1	Y2331F, Y2310F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000404499	17	29667593	17	31340575	404499	402365	rs1060500304	NC_000017.11:31340574:A:T
NM_001042492.3(NF1):c.4781A>G (p.Tyr1594Cys)	NF1	Y1594C, Y1573C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000404498	17	29592303	17	31265285	404498	401783	rs1060500303	NC_000017.11:31265284:A:G
NM_001042492.3(NF1):c.7385T>C (p.Leu2462Pro)	NF1	L2462P, L2441P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000404497	17	29677264	17	31350246	404497	402546	rs1060500302	NC_000017.11:31350245:T:C
NM_001042492.3(NF1):c.2570A>G (p.Asn857Ser)	NF1	N857S	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404494	17	29556203	17	31229185	404494	402425	rs1060500299	NC_000017.11:31229184:A:G
NM_001042492.3(NF1):c.2972T>C (p.Met991Thr)	NF1	M991T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000404493	17	29556974	17	31229956	404493	401691	rs1060500298	NC_000017.11:31229955:T:C
NM_001042492.3(NF1):c.6949T>G (p.Trp2317Gly)	NF1	W2317G, W2296G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 16, 2016)	criteria provided, single submitter	VCV000404492	17	29667550	17	31340532	404492	402519	rs1060500297	NC_000017.11:31340531:T:G
NM_001042492.3(NF1):c.1991A>G (p.Asn664Ser)	NF1	N664S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV000404491	17	29552258	17	31225240	404491	401672	rs756145065	NC_000017.11:31225239:A:G
NM_001042492.3(NF1):c.4801G>A (p.Ala1601Thr)	NF1	A1580T, A1601T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404490	17	29592323	17	31265305	404490	402285	rs754651519	NC_000017.11:31265304:G:A
NM_001042492.3(NF1):c.6147+1G>A	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404489	17	29663492	17	31336474	404489	401837	rs1060500296	NC_000017.11:31336473:G:A
NM_001042492.3(NF1):c.1528-3C>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404487	17	29546020	17	31219002	404487	402166	rs1060500294	NC_000017.11:31219001:C:T
NM_001042492.3(NF1):c.4430G>C (p.Arg1477Thr)	NF1	R1477T, R1456T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404486	17	29586147	17	31259129	404486	401740	rs1060500293	NC_000017.11:31259128:G:C
NM_001042492.3(NF1):c.4332G>C (p.Lys1444Asn)	NF1	K1444N, K1423N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404485	17	29585520	17	31258502	404485	401735	rs199474750	NC_000017.11:31258501:G:C
NM_001042492.3(NF1):c.1062+6A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000404483	17	29527619	17	31200601	404483	402126	rs1060500291	NC_000017.11:31200600:A:G
NM_001042492.3(NF1):c.5489G>A (p.Arg1830His)	NF1	R1830H, R1809H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404482	17	29654737	17	31327719	404482	401793	rs771529172	NC_000017.11:31327718:G:A
NM_001042492.3(NF1):c.5284G>A (p.Val1762Ile)	NF1	V1741I, V1762I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000404481	17	29654532	17	31327514	404481	401789	rs1060500290	NC_000017.11:31327513:G:A
NM_001042492.3(NF1):c.4945G>A (p.Gly1649Arg)	NF1	G1628R, G1649R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404480	17	29652947	17	31325929	404480	402291	rs770124316	NC_000017.11:31325928:G:A
NM_001042492.3(NF1):c.6158G>A (p.Arg2053Lys)	NF1	R2032K, R2053K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000404479	17	29663663	17	31336645	404479	402326	rs1060500289	NC_000017.11:31336644:G:A
NM_001042492.3(NF1):c.1802G>A (p.Arg601Gln)	NF1	R601Q	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404478	17	29550542	17	31223524	404478	401665	rs1060500288	NC_000017.11:31223523:G:A
NM_001042492.3(NF1):c.5293A>G (p.Thr1765Ala)	NF1	T1765A, T1744A	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404477	17	29654541	17	31327523	404477	401820	rs747584987	NC_000017.11:31327522:A:G
NM_001042492.3(NF1):c.3496+3G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000404476	17	29559902	17	31232884	404476	401706	rs1060500287	NC_000017.11:31232883:G:A
NM_001042492.3(NF1):c.7107G>A (p.Trp2369Ter)	NF1	W2348*, W2369*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000404475	17	29670071	17	31343053	404475	401885	rs1060500286	NC_000017.11:31343052:G:A
NM_001042492.3(NF1):c.686A>G (p.Asp229Gly)	NF1	D229G	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404474	17	29508759	17	31181741	404474	401629	rs1060500285	NC_000017.11:31181740:A:G
NM_001042492.3(NF1):c.586+5G>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, single submitter	VCV000404473	17	29497020	17	31170002	404473	401620	rs1060500284	NC_000017.11:31170001:G:A
NM_001042492.3(NF1):c.2495A>G (p.Asp832Gly)	NF1	D832G	Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404472	17	29556128	17	31229110	404472	401685	rs1060500283	NC_000017.11:31229109:A:G
NM_001042492.3(NF1):c.104G>A (p.Ser35Asn)	NF1	S35N	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2016)	criteria provided, single submitter	VCV000404471	17	29483044	17	31156026	404471	402088	rs1060500282	NC_000017.11:31156025:G:A
NM_001042492.3(NF1):c.1135T>C (p.Cys379Arg)	NF1	C379R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000404470	17	29528127	17	31201109	404470	402137	rs1060500281	NC_000017.11:31201108:T:C
NM_001042492.3(NF1):c.5351A>C (p.Tyr1784Ser)	NF1	Y1763S, Y1784S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 19, 2016)	criteria provided, single submitter	VCV000404469	17	29654599	17	31327581	404469	402304	rs1060500280	NC_000017.11:31327580:A:C
NM_001042492.3(NF1):c.5421C>T (p.Gly1807=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000404468	17	29654669	17	31327651	404468	402474	rs1060500279	NC_000017.11:31327650:C:T
NM_001042492.3(NF1):c.1726C>T (p.Gln576Ter)	NF1	Q576*	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404467	17	29550466	17	31223448	404467	401648	rs1060500278	NC_000017.11:31223447:C:T
NM_001042492.3(NF1):c.67A>G (p.Ile23Val)	NF1	I23V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404464	17	29483007	17	31155989	404464	401599	rs542824372	NC_000017.11:31155988:A:G
NM_001042492.3(NF1):c.5642C>T (p.Thr1881Ile)	NF1	T1860I, T1881I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000404463	17	29657346	17	31330328	404463	401804	rs876658349	NC_000017.11:31330327:C:T
NM_001042492.3(NF1):c.1310T>C (p.Val437Ala)	NF1	V437A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404462	17	29533307	17	31206289	404462	401635	rs876658642	NC_000017.11:31206288:T:C
NM_001042492.3(NF1):c.1916A>G (p.Asn639Ser)	NF1	N639S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 4, 2016)	criteria provided, single submitter	VCV000404461	17	29552183	17	31225165	404461	402381	rs1060500275	NC_000017.11:31225164:A:G
NM_001042492.3(NF1):c.1769T>C (p.Met590Thr)	NF1	M590T	Hereditary cancer-predisposing syndrome|not specified|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404460	17	29550509	17	31223491	404460	401653	rs761559887	NC_000017.11:31223490:T:C
NM_001042492.3(NF1):c.730+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000404459	17	29508804	17	31181786	404459	402099	rs1060500274	NC_000017.11:31181785:G:C
NM_001042492.3(NF1):c.2991-1G>A	NF1		none provided|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404458	17	29557277	17	31230259	404458	401699	rs1060500273	NC_000017.11:31230258:G:A
NM_001042492.3(NF1):c.2653G>A (p.Gly885Arg)	NF1	G885R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404457	17	29556286	17	31229268	404457	402183	rs1060500272	NC_000017.11:31229267:G:A
NM_001042492.3(NF1):c.2410-8G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000404455	17	29556035	17	31229017	404455	402414	rs1060500270	NC_000017.11:31229016:G:A
NM_001042492.3(NF1):c.616A>G (p.Lys206Glu)	NF1	K206E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000404454	17	29508469	17	31181451	404454	402098	rs1060500269	NC_000017.11:31181450:A:G
NM_001042492.3(NF1):c.3395G>A (p.Arg1132His)	NF1	R1132H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404453	17	29559798	17	31232780	404453	401728	rs778920556	NC_000017.11:31232779:G:A
NM_001042492.3(NF1):c.288+4A>G	NF1		not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2021)	criteria provided, conflicting interpretations	VCV000404451	17	29486115	17	31159097	404451	402331	rs781459468	NC_000017.11:31159096:A:G
NM_001042492.3(NF1):c.2468G>A (p.Gly823Glu)	NF1	G823E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000404450	17	29556101	17	31229083	404450	401678	rs1060500267	NC_000017.11:31229082:G:A
NM_001042492.3(NF1):c.6820-1G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 30, 2016)	criteria provided, single submitter	VCV000404449	17	29665721	17	31338703	404449	402514	rs1060500266	NC_000017.11:31338702:G:C
NM_001042492.3(NF1):c.757G>T (p.Val253Leu)	NF1	V253L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404448	17	29509552	17	31182534	404448	402346	rs786203607	NC_000017.11:31182533:G:T
NM_001042492.3(NF1):c.7553C>A (p.Ala2518Asp)	NF1	A2497D, A2518D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000404447	17	29679370	17	31352352	404447	401839	rs1060500265	NC_000017.11:31352351:C:A
NM_001042492.3(NF1):c.2668C>T (p.Pro890Ser)	NF1	P890S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000404446	17	29556301	17	31229283	404446	402184	rs771012891	NC_000017.11:31229282:C:T
NM_001042492.3(NF1):c.2641A>G (p.Met881Val)	NF1	M881V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404444	17	29556274	17	31229256	404444	402178	rs1060500263	NC_000017.11:31229255:A:G
NM_001042492.3(NF1):c.3336C>A (p.Asn1112Lys)	NF1	N1112K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000404443	17	29559739	17	31232721	404443	401722	rs1060500262	NC_000017.11:31232720:C:A
NM_001042492.3(NF1):c.2410G>C (p.Ala804Pro)	NF1	A804P	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000404441	17	29556043	17	31229025	404441	402415	rs761109477	NC_000017.11:31229024:G:C
NM_001042492.3(NF1):c.1469A>G (p.Lys490Arg)	NF1	K490R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000404440	17	29541545	17	31214527	404440	402148	rs1060500260	NC_000017.11:31214526:A:G
NM_001042492.3(NF1):c.2569A>C (p.Asn857His)	NF1	N857H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000404439	17	29556202	17	31229184	404439	402177	rs1060500259	NC_000017.11:31229183:A:C
NM_001042492.3(NF1):c.6794A>T (p.Lys2265Met)	NF1	K2244M, K2265M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000404438	17	29665132	17	31338114	404438	402508	rs1060500258	NC_000017.11:31338113:A:T
NM_001042492.3(NF1):c.4262C>T (p.Pro1421Leu)	NF1	P1400L, P1421L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404437	17	29585450	17	31258432	404437	402274	rs753997885	NC_000017.11:31258431:C:T
NM_001042492.3(NF1):c.4211C>T (p.Ala1404Val)	NF1	A1383V, A1404V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000404436	17	29585399	17	31258381	404436	401729	rs1060500257	NC_000017.11:31258380:C:T
NM_001042492.3(NF1):c.2671G>C (p.Val891Leu)	NF1	V891L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404435	17	29556304	17	31229286	404435	401695	rs1060500256	NC_000017.11:31229285:G:C
NM_001042492.3(NF1):c.5013C>A (p.Tyr1671Ter)	NF1	Y1650*, Y1671*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000404434	17	29653015	17	31325997	404434	401802	rs1060500255	NC_000017.11:31325996:C:A
NM_001042492.3(NF1):c.5329G>T (p.Val1777Phe)	NF1	V1777F, V1756F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000404433	17	29654577	17	31327559	404433	402302	rs876658562	NC_000017.11:31327558:G:T
NM_001042492.3(NF1):c.6007-6A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000404432	17	29663345	17	31336327	404432	401836	rs775960363	NC_000017.11:31336326:A:G
NM_001042492.3(NF1):c.2533T>C (p.Cys845Arg)	NF1	C845R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404431	17	29556166	17	31229148	404431	401687	rs1060500254	NC_000017.11:31229147:T:C
NM_001042492.3(NF1):c.1260+5G>C	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000404430	17	29528508	17	31201490	404430	402349	rs1060500253	NC_000017.11:31201489:G:C
NM_001042492.3(NF1):c.6426T>C (p.Ser2142=)	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000404428	17	29663931	17	31336913	404428	401849	rs1060500251	NC_000017.11:31336912:T:C
NM_001042492.3(NF1):c.4384C>T (p.Arg1462Trp)	NF1	R1441W, R1462W	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404427	17	29586101	17	31259083	404427	402460	rs876658127	NC_000017.11:31259082:C:T
NM_001042492.3(NF1):c.386A>G (p.Gln129Arg)	NF1	Q129R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404426	17	29490301	17	31163283	404426	401597	rs1060500250	NC_000017.11:31163282:A:G
NM_001042492.3(NF1):c.4202G>C (p.Ser1401Thr)	NF1	S1401T, S1380T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000404425	17	29585390	17	31258372	404425	402255	rs1060500249	NC_000017.11:31258371:G:C
NM_001042492.3(NF1):c.7006G>T (p.Ala2336Ser)	NF1	A2336S, A2315S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404422	17	29667607	17	31340589	404422	401830	rs587781428	NC_000017.11:31340588:G:T
NM_001042492.3(NF1):c.4577+3A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000404421	17	29587536	17	31260518	404421	402280	rs1060500246	NC_000017.11:31260517:A:G
NM_001042492.3(NF1):c.654+1G>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000404420	17	29508508	17	31181490	404420	402340	rs1060500245	NC_000017.11:31181489:G:T
NM_001042492.3(NF1):c.404G>A (p.Arg135Gln)	NF1	R135Q	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404419	17	29490319	17	31163301	404419	401614	rs1060500244	NC_000017.11:31163300:G:A
NM_001042492.3(NF1):c.3875A>G (p.Tyr1292Cys)	NF1	Y1292C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000404418	17	29562940	17	31235922	404418	401767	rs1060500243	NC_000017.11:31235921:A:G
NM_001042492.3(NF1):c.4558C>T (p.Gln1520Ter)	NF1	Q1520*, Q1499*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000404417	17	29587514	17	31260496	404417	402465	rs1060500242	NC_000017.11:31260495:C:T
NM_001042492.3(NF1):c.681T>C (p.Tyr227=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2020)	criteria provided, conflicting interpretations	VCV000391038	17	29508754	17	31181736	391038	375841	rs745804540	NC_000017.11:31181735:T:C
NM_001042492.3(NF1):c.153T>C (p.Phe51=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000390802	17	29483093	17	31156075	390802	375836	rs1057523892	NC_000017.11:31156074:T:C
NM_001042492.3(NF1):c.8477G>C (p.Ser2826Thr)	NF1	S2805T, S2826T	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000389587	17	29701130	17	31374112	389587	378113	rs1057523477	NC_000017.11:31374111:G:C
NM_001042492.3(NF1):c.1062+3A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000381606	17	29527616	17	31200598	381606	378108	rs1057521098	NC_000017.11:31200597:A:G
NM_001042492.3(NF1):c.311T>G (p.Leu104Ter)	NF1	L104*	not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000381605	17	29490226	17	31163208	381605	374910	rs1057521097	NC_000017.11:31163207:T:G
NM_001042492.3(NF1):c.5842T>G (p.Tyr1948Asp)	NF1	Y1927D, Y1948D	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000379330	17	29661885	17	31334867	379330	375854	rs1057520575	NC_000017.11:31334866:T:G
NM_001042492.3(NF1):c.5813-1G>A	NF1		Neurofibromatosis, type 1|Plexiform neurofibroma|Axillary freckling|Cafe-au-lait spot|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000374204	17	29661855	17	31334837	374204	361013	rs1057518974	NC_000017.11:31334836:G:A
NM_001042492.3(NF1):c.1721+3A>G	NF1	Y575C	Neurofibromatosis type 6|Neurofibroma|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|Optic nerve glioma|Neurofibromatosis type 6	Pathogenic(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374108	17	29548950	17	31221932	374108	361009	rs1057518904	NC_000017.11:31221931:A:G
NM_001042492.3(NF1):c.2252-3T>G	NF1		Neurofibromatosis, type 1|Inguinal freckling|Neurofibromatosis type 6|Axillary freckling|Cafe-au-lait spot|Neurofibroma	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2020)	criteria provided, conflicting interpretations	VCV000374022	17	29554233	17	31227215	374022	361010	rs1057518842	NC_000017.11:31227214:T:G
NM_001042492.3(NF1):c.6904C>T (p.Gln2302Ter)	NF1	Q2281*, Q2302*	Neurofibromatosis type 6|Subcutaneous neurofibromas|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000373973	17	29665806	17	31338788	373973	361014	rs1057518807	NC_000017.11:31338787:C:T
NM_001042492.3(NF1):c.2709G>A (p.Val903=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373958	17	29556342	17	31229324	373958	361012	rs771820789	NC_000017.11:31229323:G:A
NM_001042492.3(NF1):c.2410-1G>A	NF1		Neurofibromatosis type 6|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000373947	17	29556042	17	31229024	373947	361011	rs1057518792	NC_000017.11:31229023:G:A
NM_001042492.3(NF1):c.7915C>G (p.Leu2639Val)	NF1	L2618V, L2639V	Neurofibromatosis, type 1|not specified	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373344	17	29684332	17	31357314	373344	360233	rs1057518362	NC_000017.11:31357313:C:G
NM_001042492.3(NF1):c.587-2A>T	NF1		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000373342	17	29508438	17	31181420	373342	360285	rs1057518360	NC_000017.11:31181419:A:T
NM_001042492.3(NF1):c.4836-1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000373285	17	29652837	17	31325819	373285	360299	rs1057518326	NC_000017.11:31325818:G:A
NM_001042492.3(NF1):c.3911T>A (p.Leu1304Ter)	NF1	L1304*	not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000373284	17	29562976	17	31235958	373284	360330	rs761512189	NC_000017.11:31235957:T:A
NM_001042492.3(NF1):c.669G>A (p.Trp223Ter)	NF1	W223*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372756	17	29508742	17	31181724	372756	360415	rs1057517967	NC_000017.11:31181723:G:A
NM_001042492.3(NF1):c.2325+3A>G	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372550	17	29554312	17	31227294	372550	360327	rs1057517848	NC_000017.11:31227293:A:G
NM_001042492.3(NF1):c.*3514G>C	NF1		Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322609	17	29704687	17	31377669	322609	337823	rs574282086	NC_000017.11:31377668:G:C
NM_001042492.3(NF1):c.*3266G>A	NF1		Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322608	17	29704439	17	31377421	322608	344073	rs548117626	NC_000017.11:31377420:G:A
NM_001042492.3(NF1):c.*3248G>A	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322607	17	29704421	17	31377403	322607	337821	rs527971565	NC_000017.11:31377402:G:A
NM_001042492.3(NF1):c.*3174A>C	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322606	17	29704347	17	31377329	322606	337819	rs886052815	NC_000017.11:31377328:A:C
NM_001042492.3(NF1):c.*3091A>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322605	17	29704264	17	31377246	322605	344072	rs570154156	NC_000017.11:31377245:A:C
NM_001042492.3(NF1):c.*2884T>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322604	17	29704057	17	31377039	322604	344071	rs886052814	NC_000017.11:31377038:T:A
NM_001042492.3(NF1):c.*2829T>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322603	17	29704002	17	31376984	322603	337817	rs1048317	NC_000017.11:31376983:T:C
NM_001042492.3(NF1):c.*2777C>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322602	17	29703950	17	31376932	322602	337815	rs185015732	NC_000017.11:31376931:C:A
NM_001042492.3(NF1):c.*2566C>T	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322600	17	29703739	17	31376721	322600	344066	rs545937364	NC_000017.11:31376720:C:T
NM_001042492.3(NF1):c.*2265C>G	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322599	17	29703438	17	31376420	322599	327986	rs1800845	NC_000017.11:31376419:C:G
NM_001042492.3(NF1):c.*2201G>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322597	17	29703374	17	31376356	322597	345469	rs7406983	NC_000017.11:31376355:G:A
NM_001042492.3(NF1):c.*2132T>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322596	17	29703305	17	31376287	322596	344065	rs551806545	NC_000017.11:31376286:T:C
NM_001042492.3(NF1):c.*2089G>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322595	17	29703262	17	31376244	322595	327983	rs17881973	NC_000017.11:31376243:G:A
NM_001042492.3(NF1):c.*2071G>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322594	17	29703244	17	31376226	322594	345464	rs886052811	NC_000017.11:31376225:G:A
NM_001042492.3(NF1):c.*1987C>T	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322593	17	29703160	17	31376142	322593	345459	rs886052810	NC_000017.11:31376141:C:T
NM_001042492.3(NF1):c.*1899A>G	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322592	17	29703072	17	31376054	322592	327982	rs547663480	NC_000017.11:31376053:A:G
NM_001042492.3(NF1):c.*1446T>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322591	17	29702619	17	31375601	322591	344060	rs886052809	NC_000017.11:31375600:T:C
NM_001042492.3(NF1):c.*1425C>T	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322590	17	29702598	17	31375580	322590	327981	rs886052808	NC_000017.11:31375579:C:T
NM_001042492.3(NF1):c.*1202A>C	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322589	17	29702375	17	31375357	322589	345452	rs886052807	NC_000017.11:31375356:A:C
NM_001042492.3(NF1):c.*1164G>A	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322588	17	29702337	17	31375319	322588	337813	rs140110377	NC_000017.11:31375318:G:A
NM_001042492.3(NF1):c.*875T>A	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322587	17	29702048	17	31375030	322587	345447	rs886052806	NC_000017.11:31375029:T:A
NM_001042492.3(NF1):c.*873A>T	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322586	17	29702046	17	31375028	322586	337811	rs3058624	NC_000017.11:31375027:A:T
NM_001042492.3(NF1):c.*871A>T	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322585	17	29702044	17	31375026	322585	344051	rs568276164	NC_000017.11:31375025:A:T
NM_001042492.3(NF1):c.*584G>T	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322581	17	29701757	17	31374739	322581	337808	rs190144445	NC_000017.11:31374738:G:T
NM_001042492.3(NF1):c.*506T>A	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322580	17	29701679	17	31374661	322580	337806	rs886052804	NC_000017.11:31374660:T:A
NM_001042492.3(NF1):c.*498T>G	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322579	17	29701671	17	31374653	322579	344049	rs9900729	NC_000017.11:31374652:T:G
NM_001042492.3(NF1):c.7525C>T (p.Pro2509Ser)	NF1	P2509S, P2488S	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000322577	17	29679342	17	31352324	322577	344046	rs886052803	NC_000017.11:31352323:C:T
NM_001042492.3(NF1):c.7007C>A (p.Ala2336Glu)	NF1	A2315E, A2336E	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322576	17	29667608	17	31340590	322576	327978	rs886052802	NC_000017.11:31340589:C:A
NM_001042492.3(NF1):c.6630G>A (p.Leu2210=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2019)	criteria provided, conflicting interpretations	VCV000322575	17	29664588	17	31337570	322575	344043	rs886052801	NC_000017.11:31337569:G:A
NM_001042492.3(NF1):c.4530A>G (p.Leu1510=)	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322574	17	29587486	17	31260468	322574	327961	rs876660089	NC_000017.11:31260467:A:G
NM_001042492.3(NF1):c.3891A>G (p.Leu1297=)	NF1		Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2019)	criteria provided, conflicting interpretations	VCV000322573	17	29562956	17	31235938	322573	344038	rs753036396	NC_000017.11:31235937:A:G
NM_001042492.3(NF1):c.2794A>G (p.Met932Val)	NF1	M932V	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000322572	17	29556427	17	31229409	322572	344034	rs886052800	NC_000017.11:31229408:A:G
NM_001042492.3(NF1):c.1846-8T>A	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2020)	criteria provided, conflicting interpretations	VCV000322571	17	29552105	17	31225087	322571	344029	rs886052799	NC_000017.11:31225086:T:A
NM_001042492.3(NF1):c.1649T>C (p.Leu550Pro)	NF1	L550P	Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000322570	17	29548875	17	31221857	322570	327958	rs886052798	NC_000017.11:31221856:T:C
NM_001042492.3(NF1):c.1444A>G (p.Thr482Ala)	NF1	T482A	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000322569	17	29541520	17	31214502	322569	345444	rs770201871	NC_000017.11:31214501:A:G
NM_001042492.3(NF1):c.205-13T>A	NF1		Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000322567	17	29486015	17	31158997	322567	327957	rs886052797	NC_000017.11:31158996:T:A
NM_001042492.3(NF1):c.-148C>A	NF1|LOC111811965		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000322562	17	29422180	17	31095162	322562	327954	rs886052792	NC_000017.11:31095161:C:A
NM_001042492.3(NF1):c.2446C>T (p.Arg816Ter)	NF1	R816*	Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Inguinal freckling|Large cafe-au-lait macules with irregular margins|Axillary freckling|Lisch nodules|Neurofibromatosis type 6|Delayed fine motor development|not provided	Pathogenic(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280055	17	29556079	17	31229061	280055	264844	rs886041347	NC_000017.11:31229060:C:T
NM_001042492.3(NF1):c.204+1G>A	NF1		not provided|Neurofibromatosis, type 1|not specified	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265442	17	29483145	17	31156127	265442	260163	rs886039548	NC_000017.11:31156126:G:A
NM_001042492.3(NF1):c.8478C>T (p.Ser2826=)	NF1		Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257308	17	29701131	17	31374113	257308	256148	rs770148738	NC_000017.11:31374112:C:T
NM_001042492.3(NF1):c.6642+45T>A	NF1		not specified|none provided|Neurofibromatosis, type 1|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257297	17	29664645	17	31337627	257297	256137	rs17883614	NC_000017.11:31337626:T:A
NM_001042492.3(NF1):c.5609+19T>A	NF1		not specified|not provided|Neurofibromatosis, type 1|none provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257294	17	29654876	17	31327858	257294	256135	rs2285894	NC_000017.11:31327857:T:A
NM_001042492.3(NF1):c.4257C>T (p.Val1419=)	NF1		Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257288	17	29585445	17	31258427	257288	256129	rs886038395	NC_000017.11:31258426:C:T
NM_001042492.3(NF1):c.3496+19T>C	NF1		not provided|Neurofibromatosis, type 1|not specified	Benign/Likely benign(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257284	17	29559918	17	31232900	257284	256125	rs9890283	NC_000017.11:31232899:T:C
NM_001042492.3(NF1):c.2851-16T>C	NF1		not provided|not specified	Benign(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257282	17	29556837	17	31229819	257282	256124	rs17880825	NC_000017.11:31229818:T:C
NM_001042492.3(NF1):c.1393-32T>C	NF1		not provided|not specified|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257276	17	29541437	17	31214419	257276	256117	rs2905876	NC_000017.11:31214418:T:C
NM_001042492.3(NF1):c.889-2A>G	NF1		not provided|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000237610	17	29527438	17	31200420	237610	242629	rs878853922	NC_000017.11:31200419:A:G
NM_001042492.3(NF1):c.848A>G (p.Asp283Gly)	NF1	D283G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237609	17	29509643	17	31182625	237609	242628	rs878853921	NC_000017.11:31182624:A:G
NM_001042492.3(NF1):c.8511G>A (p.Lys2837=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237608	17	29701164	17	31374146	237608	242719	rs752398289	NC_000017.11:31374145:G:A
NM_001042492.3(NF1):c.8407C>A (p.Pro2803Thr)	NF1	P2782T, P2803T	Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237607	17	29701060	17	31374042	237607	242718	rs779180729	NC_000017.11:31374041:C:A
NM_001042492.3(NF1):c.8324A>G (p.Asn2775Ser)	NF1	N2754S, N2775S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237606	17	29687668	17	31360650	237606	242717	rs772090874	NC_000017.11:31360649:A:G
NM_001042492.3(NF1):c.8288C>A (p.Pro2763His)	NF1	P2742H, P2763H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	VCV000237605	17	29687632	17	31360614	237605	242716	rs878853920	NC_000017.11:31360613:C:A
NM_001042492.3(NF1):c.8244A>T (p.Glu2748Asp)	NF1	E2727D, E2748D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000237604	17	29687588	17	31360570	237604	242715	rs878853919	NC_000017.11:31360569:A:T
NM_001042492.3(NF1):c.8073T>G (p.His2691Gln)	NF1	H2670Q, H2691Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237603	17	29685600	17	31358582	237603	242714	rs375468032	NC_000017.11:31358581:T:G
NM_001042492.3(NF1):c.7971-7C>A	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237602	17	29685491	17	31358473	237602	242713	rs754359027	NC_000017.11:31358472:C:A
NM_001042492.3(NF1):c.7963C>T (p.Pro2655Ser)	NF1	P2634S, P2655S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: May 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237601	17	29684380	17	31357362	237601	242712	rs587781791	NC_000017.11:31357361:C:T
NM_001042492.3(NF1):c.784C>T (p.Arg262Cys)	NF1	R262C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237599	17	29509579	17	31182561	237599	242627	rs754343223	NC_000017.11:31182560:C:T
NM_001042492.3(NF1):c.7496G>A (p.Gly2499Asp)	NF1	G2478D, G2499D	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237597	17	29679313	17	31352295	237597	242709	rs375176282	NC_000017.11:31352294:G:A
NM_001042492.3(NF1):c.7449T>C (p.Pro2483=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237595	17	29677328	17	31350310	237595	242708	rs878853916	NC_000017.11:31350309:T:C
NM_001042492.3(NF1):c.7341A>C (p.Glu2447Asp)	NF1	E2426D, E2447D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000237594	17	29677220	17	31350202	237594	242707	rs878853915	NC_000017.11:31350201:A:C
NM_001042492.3(NF1):c.7339G>C (p.Glu2447Gln)	NF1	E2426Q, E2447Q	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000237593	17	29677218	17	31350200	237593	242706	rs878853914	NC_000017.11:31350199:G:C
NM_001042492.3(NF1):c.7142A>G (p.Asn2381Ser)	NF1	N2360S, N2381S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000237591	17	29670106	17	31343088	237591	242704	rs878853912	NC_000017.11:31343087:A:G
NM_001042492.3(NF1):c.6879T>C (p.Ala2293=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237590	17	29665781	17	31338763	237590	242703	rs761125983	NC_000017.11:31338762:T:C
NM_001042492.3(NF1):c.6786G>A (p.Gly2262=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000237589	17	29665124	17	31338106	237589	242702	rs878853911	NC_000017.11:31338105:G:A
NM_001042492.3(NF1):c.6744T>A (p.Ala2248=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000237588	17	29665082	17	31338064	237588	242701	rs878853910	NC_000017.11:31338063:T:A
NM_001042492.3(NF1):c.649G>T (p.Glu217Ter)	NF1	E217*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000237587	17	29508502	17	31181484	237587	242626	rs878853909	NC_000017.11:31181483:G:T
NM_001042492.3(NF1):c.6535C>T (p.Arg2179Cys)	NF1	R2158C, R2179C	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237586	17	29664493	17	31337475	237586	242700	rs878853908	NC_000017.11:31337474:C:T
NM_001042492.3(NF1):c.6365C>T (p.Thr2122Ile)	NF1	T2101I, T2122I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237585	17	29663870	17	31336852	237585	242699	rs878853907	NC_000017.11:31336851:C:T
NM_001042492.3(NF1):c.628T>C (p.Leu210=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237584	17	29508481	17	31181463	237584	242625	rs757812365	NC_000017.11:31181462:T:C
NM_001042492.3(NF1):c.6334G>A (p.Ala2112Thr)	NF1	A2091T, A2112T	Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237583	17	29663839	17	31336821	237583	242698	rs749672954	NC_000017.11:31336820:G:A
NM_001042492.3(NF1):c.624G>A (p.Ala208=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237582	17	29508477	17	31181459	237582	242624	rs370184932	NC_000017.11:31181458:G:A
NM_001042492.3(NF1):c.6032T>C (p.Leu2011Pro)	NF1	L1990P, L2011P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000237581	17	29663376	17	31336358	237581	242697	rs878853906	NC_000017.11:31336357:T:C
NM_001042492.3(NF1):c.594A>T (p.Ala198=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237580	17	29508447	17	31181429	237580	242623	rs138411879	NC_000017.11:31181428:A:T
NM_001042492.3(NF1):c.6002G>T (p.Gly2001Val)	NF1	G1980V, G2001V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	VCV000237579	17	29662045	17	31335027	237579	242696	rs878853905	NC_000017.11:31335026:G:T
NM_001042492.3(NF1):c.587-3C>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237578	17	29508437	17	31181419	237578	242622	rs375188075	NC_000017.11:31181418:C:T
NM_001042492.3(NF1):c.5671C>T (p.Gln1891Ter)	NF1	Q1870*, Q1891*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000237577	17	29657375	17	31330357	237577	242695	rs878853904	NC_000017.11:31330356:C:T
NM_001042492.3(NF1):c.5561T>G (p.Leu1854Arg)	NF1	L1833R, L1854R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237576	17	29654809	17	31327791	237576	242694	rs878853903	NC_000017.11:31327790:T:G
NM_001042492.3(NF1):c.5477A>G (p.His1826Arg)	NF1	H1805R, H1826R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237575	17	29654725	17	31327707	237575	242693	rs878853902	NC_000017.11:31327706:A:G
NM_001042492.3(NF1):c.5397C>T (p.Phe1799=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237574	17	29654645	17	31327627	237574	242692	rs878853901	NC_000017.11:31327626:C:T
NM_001042492.3(NF1):c.5227G>C (p.Ala1743Pro)	NF1	A1722P, A1743P	Midaortic syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000237573	17	29653229	17	31326211	237573	242691	rs878853900	NC_000017.11:31326210:G:C
NM_001042492.3(NF1):c.4836-10T>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 30, 2016)	criteria provided, single submitter	VCV000237572	17	29652828	17	31325810	237572	242690	rs878853899	NC_000017.11:31325809:T:G
NM_001042492.3(NF1):c.4834A>C (p.Arg1612=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000237571	17	29592356	17	31265338	237571	242689	rs755137259	NC_000017.11:31265337:A:C
NM_001042492.3(NF1):c.4804G>A (p.Gly1602Arg)	NF1	G1581R, G1602R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237570	17	29592326	17	31265308	237570	242688	rs878853898	NC_000017.11:31265307:G:A
NM_001042492.3(NF1):c.4536G>C (p.Trp1512Cys)	NF1	W1491C, W1512C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237569	17	29587492	17	31260474	237569	242687	rs878853897	NC_000017.11:31260473:G:C
NM_001042492.3(NF1):c.4445T>C (p.Ile1482Thr)	NF1	I1461T, I1482T	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000237567	17	29587401	17	31260383	237567	242685	rs746994734	NC_000017.11:31260382:T:C
NM_001042492.3(NF1):c.4426C>T (p.Arg1476Cys)	NF1	R1455C, R1476C	Hereditary breast and ovarian cancer syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237566	17	29586143	17	31259125	237566	242684	rs771420960	NC_000017.11:31259124:C:T
NM_001042492.3(NF1):c.4396G>T (p.Asp1466Tyr)	NF1	D1445Y, D1466Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000237565	17	29586113	17	31259095	237565	242683	rs878853895	NC_000017.11:31259094:G:T
NM_001042492.3(NF1):c.4373A>G (p.Glu1458Gly)	NF1	E1437G, E1458G	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2021)	criteria provided, conflicting interpretations	VCV000237564	17	29586090	17	31259072	237564	242682	rs878853894	NC_000017.11:31259071:A:G
NM_001042492.3(NF1):c.4369A>G (p.Lys1457Glu)	NF1	K1436E, K1457E	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237563	17	29586086	17	31259068	237563	242681	rs878853893	NC_000017.11:31259067:A:G
NM_001042492.3(NF1):c.4332+8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV000237562	17	29585528	17	31258510	237562	242680	rs773883353	NC_000017.11:31258509:A:G
NM_001042492.3(NF1):c.4318A>G (p.Lys1440Glu)	NF1	K1419E, K1440E	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000237561	17	29585506	17	31258488	237561	242679	rs199474790	NC_000017.11:31258487:A:G
NM_001042492.3(NF1):c.4000G>A (p.Glu1334Lys)	NF1	E1334K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237560	17	29576027	17	31249009	237560	242678	rs878853892	NC_000017.11:31249008:G:A
NM_001042492.3(NF1):c.3881C>T (p.Ala1294Val)	NF1	A1294V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 30, 2015)	criteria provided, single submitter	VCV000237557	17	29562946	17	31235928	237557	242676	rs878853889	NC_000017.11:31235927:C:T
NM_001042492.3(NF1):c.3826C>T (p.Arg1276Ter)	NF1	R1276*	not provided|Rhabdomyosarcoma|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000237556	17	29562746	17	31235728	237556	242675	rs199474742	NC_000017.11:31235727:C:T
NM_001042492.3(NF1):c.3726T>A (p.Val1242=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000237555	17	29562646	17	31235628	237555	242674	rs878853888	NC_000017.11:31235627:T:A
NM_001042492.3(NF1):c.3709-10T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000237554	17	29562619	17	31235601	237554	242673	rs878853887	NC_000017.11:31235600:T:C
NM_001042492.3(NF1):c.368C>T (p.Thr123Ile)	NF1	T123I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000237553	17	29490283	17	31163265	237553	242620	rs878853886	NC_000017.11:31163264:C:T
NM_001042492.3(NF1):c.3656G>T (p.Gly1219Val)	NF1	G1219V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV000237552	17	29560179	17	31233161	237552	242672	rs878853885	NC_000017.11:31233160:G:T
NM_001042492.3(NF1):c.3565C>T (p.Gln1189Ter)	NF1	Q1189*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237551	17	29560088	17	31233070	237551	242671	rs878853884	NC_000017.11:31233069:C:T
NM_001042492.3(NF1):c.3502G>C (p.Gly1168Arg)	NF1	G1168R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2018)	criteria provided, conflicting interpretations	VCV000237550	17	29560025	17	31233007	237550	242670	rs878853883	NC_000017.11:31233006:G:C
NM_001042492.3(NF1):c.3407G>C (p.Arg1136Pro)	NF1	R1136P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	VCV000237549	17	29559810	17	31232792	237549	242669	rs868407539	NC_000017.11:31232791:G:C
NM_001042492.3(NF1):c.3352A>G (p.Ser1118Gly)	NF1	S1118G	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237548	17	29559755	17	31232737	237548	242668	rs201645318	NC_000017.11:31232736:A:G
NM_001042492.3(NF1):c.3315-8T>C	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237547	17	29559710	17	31232692	237547	242667	rs764783865	NC_000017.11:31232691:T:C
NM_001042492.3(NF1):c.3063A>C (p.Val1021=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237544	17	29557350	17	31230332	237544	242664	rs768611775	NC_000017.11:31230331:A:C
NM_001042492.3(NF1):c.3046T>C (p.Cys1016Arg)	NF1	C1016R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237543	17	29557333	17	31230315	237543	242663	rs878853880	NC_000017.11:31230314:T:C
NM_001042492.3(NF1):c.2840C>G (p.Ser947Cys)	NF1	S947C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 13, 2015)	criteria provided, single submitter	VCV000237542	17	29556473	17	31229455	237542	242662	rs878853879	NC_000017.11:31229454:C:G
NM_001042492.3(NF1):c.2819C>G (p.Thr940Ser)	NF1	T940S	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)	criteria provided, conflicting interpretations	VCV000237541	17	29556452	17	31229434	237541	242661	rs368995630	NC_000017.11:31229433:C:G
NM_001042492.3(NF1):c.2709G>T (p.Val903=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV000237540	17	29556342	17	31229324	237540	242660	rs771820789	NC_000017.11:31229323:G:T
NM_001042492.3(NF1):c.2606C>T (p.Pro869Leu)	NF1	P869L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 9, 2016)	criteria provided, single submitter	VCV000237539	17	29556239	17	31229221	237539	242659	rs878853878	NC_000017.11:31229220:C:T
NM_001042492.3(NF1):c.2437G>A (p.Val813Ile)	NF1	V813I	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 16, 2016)	criteria provided, single submitter	VCV000237537	17	29556070	17	31229052	237537	242657	rs878853876	NC_000017.11:31229051:G:A
NM_001042492.3(NF1):c.2352G>A (p.Trp784Ter)	NF1	W784*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000237535	17	29554567	17	31227549	237535	242655	rs199474778	NC_000017.11:31227548:G:A
NM_001042492.3(NF1):c.2326-8C>T	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 10, 2020)	criteria provided, single submitter	VCV000237534	17	29554533	17	31227515	237534	242654	rs878853874	NC_000017.11:31227514:C:T
NM_001042492.3(NF1):c.2257G>A (p.Ala753Thr)	NF1	A753T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237533	17	29554241	17	31227223	237533	242653	rs758325102	NC_000017.11:31227222:G:A
NM_001042492.3(NF1):c.2142T>C (p.Cys714=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237532	17	29553593	17	31226575	237532	242652	rs141382637	NC_000017.11:31226574:T:C
NM_001042492.3(NF1):c.2028C>G (p.Thr676=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Apr 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000237531	17	29553479	17	31226461	237531	242651	rs878853873	NC_000017.11:31226460:C:G
NM_001042492.3(NF1):c.2018G>A (p.Cys673Tyr)	NF1	C673Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000237530	17	29553469	17	31226451	237530	242650	rs878853872	NC_000017.11:31226450:G:A
NM_001042492.3(NF1):c.2001+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, single submitter	VCV000237528	17	29552275	17	31225257	237528	242648	rs878853870	NC_000017.11:31225256:T:C
NM_001042492.3(NF1):c.1985A>G (p.Lys662Arg)	NF1	K662R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237527	17	29552252	17	31225234	237527	242647	rs578141234	NC_000017.11:31225233:A:G
NM_001042492.3(NF1):c.1960C>T (p.Pro654Ser)	NF1	P654S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237526	17	29552227	17	31225209	237526	242646	rs765281937	NC_000017.11:31225208:C:T
NM_001042492.3(NF1):c.1939C>T (p.His647Tyr)	NF1	H647Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237525	17	29552206	17	31225188	237525	242645	rs776251084	NC_000017.11:31225187:C:T
NM_001042492.3(NF1):c.1866T>C (p.Cys622=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|not provided|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2020)	criteria provided, conflicting interpretations	VCV000237524	17	29552133	17	31225115	237524	242644	rs753245823	NC_000017.11:31225114:T:C
NM_001042492.3(NF1):c.171C>A (p.Gly57=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000237523	17	29483111	17	31156093	237523	242619	rs876658709	NC_000017.11:31156092:C:A
NM_001042492.3(NF1):c.169G>A (p.Gly57Ser)	NF1	G57S	Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000237522	17	29483109	17	31156091	237522	242618	rs779727341	NC_000017.11:31156090:G:A
NM_001042492.3(NF1):c.1595T>G (p.Leu532Arg)	NF1	L532R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	VCV000237521	17	29546090	17	31219072	237521	242642	rs199474737	NC_000017.11:31219071:T:G
NM_001042492.3(NF1):c.1593A>C (p.Gln531His)	NF1	Q531H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 21, 2015)	criteria provided, single submitter	VCV000237520	17	29546088	17	31219070	237520	242641	rs773712266	NC_000017.11:31219069:A:C
NM_001042492.3(NF1):c.1722-6C>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000237519	17	29550456	17	31223438	237519	242643	rs878853869	NC_000017.11:31223437:C:G
NM_001042492.3(NF1):c.1527+1159C>T	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Apr 10, 2020)	criteria provided, single submitter	VCV000237518	17	29542762	17	31215744	237518	242640	rs878853868	NC_000017.11:31215743:C:T
NM_001042492.3(NF1):c.1480T>A (p.Leu494Met)	NF1	L494M	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2015)	criteria provided, single submitter	VCV000237517	17	29541556	17	31214538	237517	242639	rs878853867	NC_000017.11:31214537:T:A
NM_001042492.3(NF1):c.1458A>G (p.Thr486=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000237516	17	29541534	17	31214516	237516	242638	rs878853866	NC_000017.11:31214515:A:G
NM_001042492.3(NF1):c.1369C>T (p.His457Tyr)	NF1	H457Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000237515	17	29533366	17	31206348	237515	242636	rs757560526	NC_000017.11:31206347:C:T
NM_001042492.3(NF1):c.1381C>T (p.Arg461Ter)	NF1	R461*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237514	17	29533378	17	31206360	237514	242637	rs878853865	NC_000017.11:31206359:C:T
NM_001042492.3(NF1):c.1261T>G (p.Ser421Ala)	NF1	S421A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237513	17	29533258	17	31206240	237513	242635	rs878853864	NC_000017.11:31206239:T:G
NM_001042492.3(NF1):c.1261-3T>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000237512	17	29533255	17	31206237	237512	242634	rs761761583	NC_000017.11:31206236:T:A
NM_001042492.3(NF1):c.1176A>G (p.Gln392=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237511	17	29528168	17	31201150	237511	242633	rs566220983	NC_000017.11:31201149:A:G
NM_001042492.3(NF1):c.1130T>C (p.Ile377Thr)	NF1	I377T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237510	17	29528122	17	31201104	237510	242632	rs878853863	NC_000017.11:31201103:T:C
NM_001042492.3(NF1):c.1108C>T (p.Pro370Ser)	NF1	P370S	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000237509	17	29528100	17	31201082	237509	242631	rs878853862	NC_000017.11:31201081:C:T
NM_001042492.3(NF1):c.1052T>A (p.Val351Asp)	NF1	V351D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000237508	17	29527603	17	31200585	237508	242630	rs878853861	NC_000017.11:31200584:T:A
NM_001042492.3(NF1):c.7700C>T (p.Pro2567Leu)	NF1	P2546L, P2567L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2020)	criteria provided, conflicting interpretations	VCV000234225	17	29683562	17	31356544	234225	235830	rs754511534	NC_000017.11:31356543:C:T
NM_001042492.3(NF1):c.1358G>T (p.Gly453Val)	NF1	G453V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234194	17	29533355	17	31206337	234194	235550	rs876660915	NC_000017.11:31206336:G:T
NM_001042492.3(NF1):c.4055G>C (p.Ser1352Thr)	NF1	S1352T	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000234185	17	29576082	17	31249064	234185	235675	rs876660908	NC_000017.11:31249063:G:C
NM_001042492.3(NF1):c.1554C>T (p.Thr518=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234101	17	29546049	17	31219031	234101	235557	rs876660849	NC_000017.11:31219030:C:T
NM_001042492.3(NF1):c.7027C>T (p.His2343Tyr)	NF1	H2322Y, H2343Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234095	17	29667628	17	31340610	234095	235802	rs781578248	NC_000017.11:31340609:C:T
NM_001042492.3(NF1):c.3485T>G (p.Met1162Arg)	NF1	M1162R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234094	17	29559888	17	31232870	234094	235639	rs200732832	NC_000017.11:31232869:T:G
NM_001042492.3(NF1):c.923C>G (p.Ala308Gly)	NF1	A308G	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234079	17	29527474	17	31200456	234079	235530	rs876660836	NC_000017.11:31200455:C:G
NM_001042492.3(NF1):c.6060A>G (p.Thr2020=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234052	17	29663404	17	31336386	234052	235761	rs761889172	NC_000017.11:31336385:A:G
NM_001042492.3(NF1):c.3921T>G (p.Ile1307Met)	NF1	I1307M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234032	17	29562986	17	31235968	234032	235665	rs876660805	NC_000017.11:31235967:T:G
NM_001042492.3(NF1):c.633A>G (p.Ala211=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234022	17	29508486	17	31181468	234022	235520	rs876660800	NC_000017.11:31181467:A:G
NM_001042492.3(NF1):c.3903G>A (p.Leu1301=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234003	17	29562968	17	31235950	234003	235664	rs876660789	NC_000017.11:31235949:G:A
NM_001042492.3(NF1):c.1186-1G>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233994	17	29528428	17	31201410	233994	235541	rs876660782	NC_000017.11:31201409:G:T
NM_001042492.3(NF1):c.108T>C (p.Thr36=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233986	17	29483048	17	31156030	233986	235495	rs876660776	NC_000017.11:31156029:T:C
NM_001042492.3(NF1):c.4637T>C (p.Leu1546Pro)	NF1	L1525P, L1546P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233964	17	29588788	17	31261770	233964	235699	rs876660760	NC_000017.11:31261769:T:C
NM_001042492.3(NF1):c.7623G>A (p.Arg2541=)	NF1		not provided|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233929	17	29683485	17	31356467	233929	235827	rs876660737	NC_000017.11:31356466:G:A
NM_001042492.3(NF1):c.3258G>A (p.Gln1086=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233927	17	29559151	17	31232133	233927	235632	rs876660736	NC_000017.11:31232132:G:A
NM_001042492.3(NF1):c.5169A>T (p.Gln1723His)	NF1	Q1702H, Q1723H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233907	17	29653171	17	31326153	233907	235727	rs864622372	NC_000017.11:31326152:A:T
NM_001042492.3(NF1):c.5991G>A (p.Trp1997Ter)	NF1	W1976*, W1997*	Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233869	17	29662034	17	31335016	233869	235758	rs876660696	NC_000017.11:31335015:G:A
NM_001042492.3(NF1):c.4943C>T (p.Thr1648Ile)	NF1	T1627I, T1648I	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000233847	17	29652945	17	31325927	233847	235711	rs376655102	NC_000017.11:31325926:C:T
NM_001042492.3(NF1):c.3246T>C (p.Gly1082=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233833	17	29559139	17	31232121	233833	235631	rs876660670	NC_000017.11:31232120:T:C
NM_001042492.3(NF1):c.2286G>A (p.Leu762=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233761	17	29554270	17	31227252	233761	235589	rs876660624	NC_000017.11:31227251:G:A
NM_001042492.3(NF1):c.7446C>A (p.Asp2482Glu)	NF1	D2461E, D2482E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000233748	17	29677325	17	31350307	233748	235820	rs876660614	NC_000017.11:31350306:C:A
NM_001042492.3(NF1):c.2251+5A>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233732	17	29553707	17	31226689	233732	235588	rs786201934	NC_000017.11:31226688:A:T
NM_001042492.3(NF1):c.6333A>G (p.Val2111=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233717	17	29663838	17	31336820	233717	235771	rs876660592	NC_000017.11:31336819:A:G
NM_001042492.3(NF1):c.366C>T (p.His122=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233681	17	29490281	17	31163263	233681	235505	rs138952888	NC_000017.11:31163262:C:T
NM_001042492.3(NF1):c.3871-4G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2019)	criteria provided, conflicting interpretations	VCV000233616	17	29562932	17	31235914	233616	235662	rs558421445	NC_000017.11:31235913:G:A
NM_001042492.3(NF1):c.1974C>A (p.Leu658=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233597	17	29552241	17	31225223	233597	235574	rs751318331	NC_000017.11:31225222:C:A
NM_001042492.3(NF1):c.3978A>T (p.Leu1326Phe)	NF1	L1326F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233589	17	29576005	17	31248987	233589	235669	rs876660506	NC_000017.11:31248986:A:T
NM_001042492.3(NF1):c.5114G>A (p.Arg1705Lys)	NF1	R1684K, R1705K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233555	17	29653116	17	31326098	233555	235724	rs876660487	NC_000017.11:31326097:G:A
NM_001042492.3(NF1):c.4878T>C (p.His1626=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233512	17	29652880	17	31325862	233512	235708	rs374589653	NC_000017.11:31325861:T:C
NM_001042492.3(NF1):c.2887C>T (p.Gln963Ter)	NF1	Q963*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233495	17	29556889	17	31229871	233495	235619	rs876660444	NC_000017.11:31229870:C:T
NM_001042492.3(NF1):c.417T>C (p.Ser139=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233485	17	29490332	17	31163314	233485	235508	rs762434870	NC_000017.11:31163313:T:C
NM_001042492.3(NF1):c.4306G>A (p.Glu1436Lys)	NF1	E1415K, E1436K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233469	17	29585494	17	31258476	233469	235681	rs876660428	NC_000017.11:31258475:G:A
NM_001042492.3(NF1):c.2643G>A (p.Met881Ile)	NF1	M881I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233450	17	29556276	17	31229258	233450	235607	rs376666221	NC_000017.11:31229257:G:A
NM_001042492.3(NF1):c.3497-5A>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 26, 2020)	criteria provided, conflicting interpretations	VCV000233434	17	29560015	17	31232997	233434	235642	rs876660405	NC_000017.11:31232996:A:G
NM_001042492.3(NF1):c.5322G>T (p.Gly1774=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2020)	criteria provided, conflicting interpretations	VCV000233397	17	29654570	17	31327552	233397	235734	rs201584313	NC_000017.11:31327551:G:T
NM_001042492.3(NF1):c.235T>C (p.Leu79=)	NF1		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233373	17	29486058	17	31159040	233373	235502	rs764855221	NC_000017.11:31159039:T:C
NM_001042492.3(NF1):c.1223A>G (p.Tyr408Cys)	NF1	Y408C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233342	17	29528466	17	31201448	233342	235542	rs876660344	NC_000017.11:31201447:A:G
NM_001042492.3(NF1):c.3749G>A (p.Arg1250Gln)	NF1	R1250Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233335	17	29562669	17	31235651	233335	235654	rs199474765	NC_000017.11:31235650:G:A
NM_001042492.3(NF1):c.5126T>C (p.Ile1709Thr)	NF1	I1688T, I1709T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233296	17	29653128	17	31326110	233296	235725	rs876660316	NC_000017.11:31326109:T:C
NM_001042492.3(NF1):c.529A>G (p.Ile177Val)	NF1	I177V	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233278	17	29496958	17	31169940	233278	235514	rs766213678	NC_000017.11:31169939:A:G
NM_001042492.3(NF1):c.5483G>A (p.Arg1828Gln)	NF1	R1807Q, R1828Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233269	17	29654731	17	31327713	233269	235737	rs876660298	NC_000017.11:31327712:G:A
NM_001042492.3(NF1):c.2668C>A (p.Pro890Thr)	NF1	P890T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233255	17	29556301	17	31229283	233255	235609	rs771012891	NC_000017.11:31229282:C:A
NM_001042492.3(NF1):c.2658C>G (p.Asn886Lys)	NF1	N886K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233252	17	29556291	17	31229273	233252	235608	rs781549970	NC_000017.11:31229272:C:G
NM_001042492.3(NF1):c.2899A>G (p.Ile967Val)	NF1	I967V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233237	17	29556901	17	31229883	233237	235621	rs876660279	NC_000017.11:31229882:A:G
NM_001042492.3(NF1):c.389A>T (p.His130Leu)	NF1	H130L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233235	17	29490304	17	31163286	233235	235507	rs876660277	NC_000017.11:31163285:A:T
NM_001042492.3(NF1):c.1892G>A (p.Gly631Glu)	NF1	G631E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233228	17	29552159	17	31225141	233228	235567	rs876660272	NC_000017.11:31225140:G:A
NM_001042492.3(NF1):c.3513G>A (p.Lys1171=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000233227	17	29560036	17	31233018	233227	235643	rs765438014	NC_000017.11:31233017:G:A
NM_001042492.3(NF1):c.7158T>C (p.Phe2386=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233226	17	29670122	17	31343104	233226	235804	rs876660271	NC_000017.11:31343103:T:C
NM_001042492.3(NF1):c.1870T>C (p.Phe624Leu)	NF1	F624L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|See cases	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233199	17	29552137	17	31225119	233199	235566	rs765060733	NC_000017.11:31225118:T:C
NM_001042492.3(NF1):c.6300T>C (p.Leu2100=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233166	17	29663805	17	31336787	233166	235767	rs876660236	NC_000017.11:31336786:T:C
NM_001042492.3(NF1):c.4341G>C (p.Gln1447His)	NF1	Q1426H, Q1447H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000233115	17	29586058	17	31259040	233115	235682	rs876660206	NC_000017.11:31259039:G:C
NM_001042492.3(NF1):c.872A>C (p.Glu291Ala)	NF1	E291A	Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233074	17	29509667	17	31182649	233074	235528	rs876660171	NC_000017.11:31182648:A:C
NM_001042492.3(NF1):c.3039G>A (p.Thr1013=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233070	17	29557326	17	31230308	233070	235624	rs876660168	NC_000017.11:31230307:G:A
NM_001042492.3(NF1):c.8324A>C (p.Asn2775Thr)	NF1	N2754T, N2775T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2020)	criteria provided, conflicting interpretations	VCV000233062	17	29687668	17	31360650	233062	235850	rs772090874	NC_000017.11:31360649:A:C
NM_001042492.3(NF1):c.4462A>G (p.Thr1488Ala)	NF1	T1467A, T1488A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233057	17	29587418	17	31260400	233057	235692	rs876660162	NC_000017.11:31260399:A:G
NM_001042492.3(NF1):c.5269-1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233026	17	29654516	17	31327498	233026	235732	rs876660141	NC_000017.11:31327497:G:A
NM_001042492.3(NF1):c.6663A>G (p.Pro2221=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000233018	17	29664857	17	31337839	233018	235781	rs876660136	NC_000017.11:31337838:A:G
NM_001042492.3(NF1):c.1082G>C (p.Ser361Thr)	NF1	S361T	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2020)	criteria provided, conflicting interpretations	VCV000232969	17	29528074	17	31201056	232969	235537	rs876660103	NC_000017.11:31201055:G:C
NM_001042492.3(NF1):c.1541A>C (p.Gln514Pro)	NF1	Q514P	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000232968	17	29546036	17	31219018	232968	235555	rs775369084	NC_000017.11:31219017:A:C
NM_001042492.3(NF1):c.467G>T (p.Arg156Leu)	NF1	R156L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Jun 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232959	17	29490382	17	31163364	232959	235510	rs754096545	NC_000017.11:31163363:G:T
NM_001042492.3(NF1):c.1936G>T (p.Asp646Tyr)	NF1	D646Y	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232947	17	29552203	17	31225185	232947	235571	rs142079728	NC_000017.11:31225184:G:T
NM_001042492.3(NF1):c.4409G>A (p.Ser1470Asn)	NF1	S1449N, S1470N	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000232946	17	29586126	17	31259108	232946	235689	rs876660093	NC_000017.11:31259107:G:A
NM_001042492.3(NF1):c.3114-4A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232916	17	29557856	17	31230838	232916	235628	rs201550230	NC_000017.11:31230837:A:G
NM_001042492.3(NF1):c.4670C>G (p.Thr1557Arg)	NF1	T1536R, T1557R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232909	17	29588821	17	31261803	232909	235701	rs876660065	NC_000017.11:31261802:C:G
NM_001042492.3(NF1):c.2238T>C (p.Asn746=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232895	17	29553689	17	31226671	232895	235586	rs768161162	NC_000017.11:31226670:T:C
NM_001042492.3(NF1):c.5719T>C (p.Phe1907Leu)	NF1	F1886L, F1907L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232872	17	29657423	17	31330405	232872	235749	rs876660040	NC_000017.11:31330404:T:C
NM_001042492.3(NF1):c.7344A>G (p.Glu2448=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232860	17	29677223	17	31350205	232860	235816	rs374234848	NC_000017.11:31350204:A:G
NM_001042492.3(NF1):c.694A>T (p.Thr232Ser)	NF1	T232S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232852	17	29508767	17	31181749	232852	235522	rs876660027	NC_000017.11:31181748:A:T
NM_001042492.3(NF1):c.7616-4A>G	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232836	17	29683474	17	31356456	232836	235826	rs761675429	NC_000017.11:31356455:A:G
NM_001042492.3(NF1):c.494C>T (p.Thr165Ile)	NF1	T165I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232819	17	29496923	17	31169905	232819	235512	rs876660009	NC_000017.11:31169904:C:T
NM_001042492.3(NF1):c.6586A>G (p.Thr2196Ala)	NF1	T2175A, T2196A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232814	17	29664544	17	31337526	232814	235778	rs372169109	NC_000017.11:31337525:A:G
NM_001042492.3(NF1):c.6310T>C (p.Phe2104Leu)	NF1	F2083L, F2104L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000232806	17	29663815	17	31336797	232806	235769	rs876660000	NC_000017.11:31336796:T:C
NM_001042492.3(NF1):c.4378C>T (p.His1460Tyr)	NF1	H1439Y, H1460Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232783	17	29586095	17	31259077	232783	235686	rs377295676	NC_000017.11:31259076:C:T
NM_001042492.3(NF1):c.1917T>C (p.Asn639=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232763	17	29552184	17	31225166	232763	235569	rs876659976	NC_000017.11:31225165:T:C
NM_001042492.3(NF1):c.5215G>C (p.Val1739Leu)	NF1	V1718L, V1739L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232734	17	29653217	17	31326199	232734	235730	rs876659956	NC_000017.11:31326198:G:C
NM_001042492.3(NF1):c.3303G>A (p.Gln1101=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000232714	17	29559196	17	31232178	232714	235633	rs876659944	NC_000017.11:31232177:G:A
NM_001042492.3(NF1):c.4957C>T (p.Arg1653Cys)	NF1	R1632C, R1653C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232686	17	29652959	17	31325941	232686	235712	rs876659922	NC_000017.11:31325940:C:T
NM_001042492.3(NF1):c.3711T>G (p.Asp1237Glu)	NF1	D1237E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232680	17	29562631	17	31235613	232680	235652	rs876659917	NC_000017.11:31235612:T:G
NM_001042492.3(NF1):c.4958G>A (p.Arg1653His)	NF1	R1632H, R1653H	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232671	17	29652960	17	31325942	232671	235713	rs763413441	NC_000017.11:31325941:G:A
NM_001042492.3(NF1):c.7311C>T (p.Ala2437=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232642	17	29676259	17	31349241	232642	235813	rs876659893	NC_000017.11:31349240:C:T
NM_001042492.3(NF1):c.7005C>T (p.Thr2335=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232640	17	29667606	17	31340588	232640	235800	rs2040793	NC_000017.11:31340587:C:T
NM_001042492.3(NF1):c.2158C>T (p.Arg720Trp)	NF1	R720W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232635	17	29553609	17	31226591	232635	235584	rs759679443	NC_000017.11:31226590:C:T
NM_001042492.3(NF1):c.2821A>G (p.Ile941Val)	NF1	I941V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232633	17	29556454	17	31229436	232633	235614	rs876659888	NC_000017.11:31229435:A:G
NM_001042492.3(NF1):c.3074G>A (p.Arg1025Lys)	NF1	R1025K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000232617	17	29557361	17	31230343	232617	235626	rs876659876	NC_000017.11:31230342:G:A
NM_001042492.3(NF1):c.7306G>A (p.Val2436Met)	NF1	V2415M, V2436M	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2019)	criteria provided, conflicting interpretations	VCV000232590	17	29676254	17	31349236	232590	235812	rs876659856	NC_000017.11:31349235:G:A
NM_001042492.3(NF1):c.7241A>G (p.His2414Arg)	NF1	H2393R, H2414R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232584	17	29676189	17	31349171	232584	235808	rs876659855	NC_000017.11:31349170:A:G
NM_001042492.3(NF1):c.6975T>C (p.Leu2325=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232577	17	29667576	17	31340558	232577	235799	rs876659851	NC_000017.11:31340557:T:C
NM_001042492.3(NF1):c.551A>G (p.Asn184Ser)	NF1	N184S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232575	17	29496980	17	31169962	232575	235516	rs876659849	NC_000017.11:31169961:A:G
NM_001042492.3(NF1):c.2576G>C (p.Gly859Ala)	NF1	G859A	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232542	17	29556209	17	31229191	232542	235601	rs876659829	NC_000017.11:31229190:G:C
NM_001042492.3(NF1):c.435C>T (p.Leu145=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232520	17	29490350	17	31163332	232520	235509	rs876659818	NC_000017.11:31163331:C:T
NM_001042492.3(NF1):c.1070T>G (p.Leu357Arg)	NF1	L357R	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000232517	17	29528062	17	31201044	232517	235535	rs137854563	NC_000017.11:31201043:T:G
NM_001042492.3(NF1):c.1519T>C (p.Leu507=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232516	17	29541595	17	31214577	232516	235551	rs876659815	NC_000017.11:31214576:T:C
NM_001042492.3(NF1):c.3812T>C (p.Met1271Thr)	NF1	M1271T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232492	17	29562732	17	31235714	232492	235658	rs876659801	NC_000017.11:31235713:T:C
NM_001042492.3(NF1):c.6546C>T (p.Tyr2182=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232443	17	29664504	17	31337486	232443	235776	rs876659768	NC_000017.11:31337485:C:T
NM_001042492.3(NF1):c.2619T>C (p.Arg873=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232417	17	29556252	17	31229234	232417	235605	rs766212733	NC_000017.11:31229233:T:C
NM_001042492.3(NF1):c.4578-5T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232410	17	29588724	17	31261706	232410	235697	rs772759508	NC_000017.11:31261705:T:C
NM_001042492.3(NF1):c.5026G>A (p.Ala1676Thr)	NF1	A1655T, A1676T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000232362	17	29653028	17	31326010	232362	235718	rs756450772	NC_000017.11:31326009:G:A
NM_001042492.3(NF1):c.2674A>T (p.Ser892Cys)	NF1	S892C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232347	17	29556307	17	31229289	232347	235610	rs746324091	NC_000017.11:31229288:A:T
NM_001042492.3(NF1):c.5290G>A (p.Val1764Ile)	NF1	V1743I, V1764I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232345	17	29654538	17	31327520	232345	235733	rs778427434	NC_000017.11:31327519:G:A
NM_001042492.3(NF1):c.7305C>T (p.Ser2435=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232310	17	29676253	17	31349235	232310	235811	rs369754180	NC_000017.11:31349234:C:T
NM_001042492.3(NF1):c.3438C>T (p.Val1146=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232246	17	29559841	17	31232823	232246	235638	rs876659646	NC_000017.11:31232822:C:T
NM_001042492.3(NF1):c.4504G>A (p.Gly1502Ser)	NF1	G1481S, G1502S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232189	17	29587460	17	31260442	232189	235695	rs876659607	NC_000017.11:31260441:G:A
NM_001042492.3(NF1):c.7245A>G (p.Thr2415=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232187	17	29676193	17	31349175	232187	235809	rs539553128	NC_000017.11:31349174:A:G
NM_001042492.3(NF1):c.5091G>C (p.Leu1697=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232161	17	29653093	17	31326075	232161	235719	rs876659589	NC_000017.11:31326074:G:C
NM_001042492.3(NF1):c.2629A>G (p.Met877Val)	NF1	M877V	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232159	17	29556262	17	31229244	232159	235606	rs764950557	NC_000017.11:31229243:A:G
NM_001042492.3(NF1):c.1263C>T (p.Ser421=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000232136	17	29533260	17	31206242	232136	235544	rs767410768	NC_000017.11:31206241:C:T
NM_001042492.3(NF1):c.4368A>T (p.Thr1456=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232135	17	29586085	17	31259067	232135	235685	rs876659577	NC_000017.11:31259066:A:T
NM_001042492.3(NF1):c.200A>G (p.Asn67Ser)	NF1	N67S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232106	17	29483140	17	31156122	232106	235500	rs375038808	NC_000017.11:31156121:A:G
NM_001042492.3(NF1):c.2517C>T (p.Asn839=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 23, 2020)	criteria provided, conflicting interpretations	VCV000232083	17	29556150	17	31229132	232083	235598	rs876659543	NC_000017.11:31229131:C:T
NM_001042492.3(NF1):c.3653A>G (p.Gln1218Arg)	NF1	Q1218R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232081	17	29560176	17	31233158	232081	235648	rs876659541	NC_000017.11:31233157:A:G
NM_001042492.3(NF1):c.7869A>G (p.Leu2623=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232073	17	29684108	17	31357090	232073	235839	rs876659536	NC_000017.11:31357089:A:G
NM_001042492.3(NF1):c.7635T>A (p.Asp2545Glu)	NF1	D2524E, D2545E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000232063	17	29683497	17	31356479	232063	235828	rs876659530	NC_000017.11:31356478:T:A
NM_001042492.3(NF1):c.6585G>A (p.Glu2195=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232036	17	29664543	17	31337525	232036	235777	rs202151774	NC_000017.11:31337524:G:A
NM_001042492.3(NF1):c.6819+5C>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000232021	17	29665162	17	31338144	232021	235793	rs876659499	NC_000017.11:31338143:C:A
NM_001042492.3(NF1):c.6781C>T (p.His2261Tyr)	NF1	H2240Y, H2261Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000232006	17	29665119	17	31338101	232006	235790	rs750869272	NC_000017.11:31338100:C:T
NM_001042492.3(NF1):c.4942A>G (p.Thr1648Ala)	NF1	T1627A, T1648A	Neurofibromatosis, type 1|not provided|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000231988	17	29652944	17	31325926	231988	235710	rs770558820	NC_000017.11:31325925:A:G
NM_001042492.3(NF1):c.4017C>T (p.Leu1339=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231986	17	29576044	17	31249026	231986	235672	rs778993658	NC_000017.11:31249025:C:T
NM_001042492.3(NF1):c.6666G>A (p.Thr2222=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231984	17	29664860	17	31337842	231984	235782	rs780247942	NC_000017.11:31337841:G:A
NM_001042492.3(NF1):c.6922-3C>T	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000231907	17	29667520	17	31340502	231907	235795	rs876659438	NC_000017.11:31340501:C:T
NM_001042492.3(NF1):c.2476A>C (p.Ile826Leu)	NF1	I826L	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231893	17	29556109	17	31229091	231893	235597	rs767069721	NC_000017.11:31229090:A:C
NM_001042492.3(NF1):c.373C>T (p.Arg125Cys)	NF1	R125C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231872	17	29490288	17	31163270	231872	235506	rs876659418	NC_000017.11:31163269:C:T
NM_001042492.3(NF1):c.2957C>T (p.Ala986Val)	NF1	A986V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231871	17	29556959	17	31229941	231871	235622	rs876659417	NC_000017.11:31229940:C:T
NM_001042492.3(NF1):c.3490T>G (p.Ser1164Ala)	NF1	S1164A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000231861	17	29559893	17	31232875	231861	235640	rs750303863	NC_000017.11:31232874:T:G
NM_001042492.3(NF1):c.4212A>G (p.Ala1404=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2018)	criteria provided, conflicting interpretations	VCV000231847	17	29585400	17	31258382	231847	235679	rs376825167	NC_000017.11:31258381:A:G
NM_001042492.3(NF1):c.5007T>C (p.Phe1669=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231833	17	29653009	17	31325991	231833	235715	rs761807609	NC_000017.11:31325990:T:C
NM_001042492.3(NF1):c.6293C>T (p.Ala2098Val)	NF1	A2077V, A2098V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231832	17	29663798	17	31336780	231832	235766	rs764106639	NC_000017.11:31336779:C:T
NM_001042492.3(NF1):c.6801A>G (p.Ile2267Met)	NF1	I2246M, I2267M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231810	17	29665139	17	31338121	231810	235791	rs876659381	NC_000017.11:31338120:A:G
NM_001042492.3(NF1):c.6681C>A (p.Asp2227Glu)	NF1	D2206E, D2227E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231795	17	29664875	17	31337857	231795	235786	rs876659371	NC_000017.11:31337856:C:A
NM_001042492.3(NF1):c.3766C>T (p.Leu1256=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231783	17	29562686	17	31235668	231783	235655	rs876659360	NC_000017.11:31235667:C:T
NM_001042492.3(NF1):c.2032C>G (p.Pro678Ala)	NF1	P678A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231733	17	29553483	17	31226465	231733	235579	rs758691069	NC_000017.11:31226464:C:G
NM_001042492.3(NF1):c.7847A>G (p.Gln2616Arg)	NF1	Q2595R, Q2616R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231702	17	29684086	17	31357068	231702	235837	rs876659308	NC_000017.11:31357067:A:G
NM_001042492.3(NF1):c.3114-3T>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231697	17	29557857	17	31230839	231697	235629	rs773097190	NC_000017.11:31230838:T:C
NM_001042492.3(NF1):c.6758G>A (p.Gly2253Glu)	NF1	G2232E, G2253E	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231680	17	29665096	17	31338078	231680	235787	rs876659295	NC_000017.11:31338077:G:A
NM_001042492.3(NF1):c.8238T>G (p.Ile2746Met)	NF1	I2725M, I2746M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000231655	17	29687582	17	31360564	231655	235849	rs779789452	NC_000017.11:31360563:T:G
NM_001042492.3(NF1):c.3564A>G (p.Gln1188=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231644	17	29560087	17	31233069	231644	235646	rs777859444	NC_000017.11:31233068:A:G
NM_001042492.3(NF1):c.1972C>T (p.Leu658Phe)	NF1	L658F	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000231610	17	29552239	17	31225221	231610	235573	rs763901597	NC_000017.11:31225220:C:T
NM_001042492.3(NF1):c.1756A>C (p.Thr586Pro)	NF1	T586P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231583	17	29550496	17	31223478	231583	235564	rs876659242	NC_000017.11:31223477:A:C
NM_001042492.3(NF1):c.3690G>T (p.Val1230=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231515	17	29560213	17	31233195	231515	235651	rs183296277	NC_000017.11:31233194:G:T
NM_001042492.3(NF1):c.4832G>A (p.Arg1611Gln)	NF1	R1590Q, R1611Q	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231506	17	29592354	17	31265336	231506	235707	rs876659197	NC_000017.11:31265335:G:A
NM_001042492.3(NF1):c.1901T>C (p.Ile634Thr)	NF1	I634T	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231484	17	29552168	17	31225150	231484	235568	rs527563505	NC_000017.11:31225149:T:C
NM_001042492.3(NF1):c.1921A>G (p.Ser641Gly)	NF1	S641G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231483	17	29552188	17	31225170	231483	235570	rs769154907	NC_000017.11:31225169:A:G
NM_001042492.3(NF1):c.5093C>G (p.Thr1698Ser)	NF1	T1677S, T1698S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231471	17	29653095	17	31326077	231471	235721	rs769469854	NC_000017.11:31326076:C:G
NM_001042492.3(NF1):c.2434A>G (p.Ile812Val)	NF1	I812V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000231470	17	29556067	17	31229049	231470	235596	rs587781899	NC_000017.11:31229048:A:G
NM_001042492.3(NF1):c.4352A>G (p.Asn1451Ser)	NF1	N1430S, N1451S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231417	17	29586069	17	31259051	231417	235683	rs199474754	NC_000017.11:31259050:A:G
NM_001042492.3(NF1):c.3727C>T (p.Leu1243=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231393	17	29562647	17	31235629	231393	235653	rs750993436	NC_000017.11:31235628:C:T
NM_001042492.3(NF1):c.2683A>G (p.Met895Val)	NF1	M895V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000231389	17	29556316	17	31229298	231389	235611	rs876659129	NC_000017.11:31229297:A:G
NM_001042492.3(NF1):c.7845C>T (p.Ile2615=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231367	17	29684084	17	31357066	231367	235836	rs876659117	NC_000017.11:31357065:C:T
NM_001042492.3(NF1):c.7981T>C (p.Leu2661=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231350	17	29685508	17	31358490	231350	235841	rs777848844	NC_000017.11:31358489:T:C
NM_001042492.3(NF1):c.586G>A (p.Glu196Lys)	NF1	E196K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 6, 2016)	criteria provided, multiple submitters, no conflicts	VCV000231304	17	29497015	17	31169997	231304	235517	rs876659079	NC_000017.11:31169996:G:A
NM_001042492.3(NF1):c.2597C>T (p.Pro866Leu)	NF1	P866L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231303	17	29556230	17	31229212	231303	235604	rs767159555	NC_000017.11:31229211:C:T
NM_001042492.3(NF1):c.5959C>G (p.Gln1987Glu)	NF1	Q1966E, Q1987E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000231282	17	29662002	17	31334984	231282	235755	rs876659070	NC_000017.11:31334983:C:G
NM_001042492.3(NF1):c.2250A>G (p.Thr750=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000231266	17	29553701	17	31226683	231266	235587	rs876659061	NC_000017.11:31226682:A:G
NM_001042492.3(NF1):c.843C>T (p.Ile281=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231222	17	29509638	17	31182620	231222	235526	rs146094856	NC_000017.11:31182619:C:T
NM_001042492.3(NF1):c.4047C>T (p.Ala1349=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231207	17	29576074	17	31249056	231207	235674	rs752621693	NC_000017.11:31249055:C:T
NM_001042492.3(NF1):c.5092A>T (p.Thr1698Ser)	NF1	T1677S, T1698S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231197	17	29653094	17	31326076	231197	235720	rs876659017	NC_000017.11:31326075:A:T
NM_001042492.3(NF1):c.3672G>A (p.Ala1224=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000231172	17	29560195	17	31233177	231172	235649	rs151293900	NC_000017.11:31233176:G:A
NM_001042492.3(NF1):c.3113+2T>G	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000231169	17	29557402	17	31230384	231169	235627	rs876658997	NC_000017.11:31230383:T:G
NM_001042492.3(NF1):c.6945C>T (p.Leu2315=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231168	17	29667546	17	31340528	231168	235797	rs751893971	NC_000017.11:31340527:C:T
NM_001042492.3(NF1):c.1023C>T (p.Val341=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231159	17	29527574	17	31200556	231159	235534	rs776720136	NC_000017.11:31200555:C:T
NM_001042492.3(NF1):c.4825G>A (p.Val1609Ile)	NF1	V1588I, V1609I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231123	17	29592347	17	31265329	231123	235705	rs876658973	NC_000017.11:31265328:G:A
NM_001042492.3(NF1):c.5025C>T (p.Ser1675=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231121	17	29653027	17	31326009	231121	235717	rs17878418	NC_000017.11:31326008:C:T
NM_001042492.3(NF1):c.1721+5A>G	NF1	M576V	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 18, 2020)	criteria provided, conflicting interpretations	VCV000231104	17	29548952	17	31221934	231104	235562	rs876658961	NC_000017.11:31221933:A:G
NM_001042492.3(NF1):c.2326-3T>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000231081	17	29554538	17	31227520	231081	235591	rs876658946	NC_000017.11:31227519:T:G
NM_001042492.3(NF1):c.862G>A (p.Val288Met)	NF1	V288M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231063	17	29509657	17	31182639	231063	235527	rs755670651	NC_000017.11:31182638:G:A
NM_001042492.3(NF1):c.6323C>T (p.Thr2108Ile)	NF1	T2087I, T2108I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231041	17	29663828	17	31336810	231041	235770	rs876658920	NC_000017.11:31336809:C:T
NM_001042492.3(NF1):c.5160G>T (p.Glu1720Asp)	NF1	E1699D, E1720D	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not specified|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2021)	criteria provided, conflicting interpretations	VCV000231040	17	29653162	17	31326144	231040	235726	rs773378630	NC_000017.11:31326143:G:T
NM_001042492.3(NF1):c.3976T>A (p.Leu1326Ile)	NF1	L1326I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231035	17	29576003	17	31248985	231035	235668	rs765957571	NC_000017.11:31248984:T:A
NM_001042492.3(NF1):c.1662G>T (p.Gln554His)	NF1	Q554H	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2021)	criteria provided, conflicting interpretations	VCV000231024	17	29548888	17	31221870	231024	235560	rs147594815	NC_000017.11:31221869:G:T
NM_001042492.3(NF1):c.6111T>C (p.Ala2037=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231009	17	29663455	17	31336437	231009	235763	rs876658898	NC_000017.11:31336436:T:C
NM_001042492.3(NF1):c.6425G>A (p.Ser2142Asn)	NF1	S2121N, S2142N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231006	17	29663930	17	31336912	231006	235774	rs876658896	NC_000017.11:31336911:G:A
NM_001042492.3(NF1):c.7728T>C (p.Asp2576=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000231000	17	29683590	17	31356572	231000	235831	rs876658892	NC_000017.11:31356571:T:C
NM_001042492.3(NF1):c.936A>C (p.Gly312=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230968	17	29527487	17	31200469	230968	235531	rs876658874	NC_000017.11:31200468:A:C
NM_001042492.3(NF1):c.5812+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230938	17	29657517	17	31330499	230938	235752	rs876658854	NC_000017.11:31330498:G:A
NM_001042492.3(NF1):c.2329T>A (p.Trp777Arg)	NF1	W777R	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230937	17	29554544	17	31227526	230937	235592	rs876658853	NC_000017.11:31227525:T:A
NM_001042492.3(NF1):c.2896G>A (p.Ala966Thr)	NF1	A966T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230931	17	29556898	17	31229880	230931	235620	rs876658849	NC_000017.11:31229879:G:A
NM_001042492.3(NF1):c.3843C>T (p.Ala1281=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230886	17	29562763	17	31235745	230886	235660	rs150426576	NC_000017.11:31235744:C:T
NM_001042492.3(NF1):c.2361A>G (p.Ala787=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230880	17	29554576	17	31227558	230880	235594	rs371589922	NC_000017.11:31227557:A:G
NM_001042492.3(NF1):c.3987A>G (p.Ser1329=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230840	17	29576014	17	31248996	230840	235670	rs753270018	NC_000017.11:31248995:A:G
NM_001042492.3(NF1):c.5649C>T (p.Thr1883=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230807	17	29657353	17	31330335	230807	235746	rs139696493	NC_000017.11:31330334:C:T
NM_001042492.3(NF1):c.948G>A (p.Leu316=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230799	17	29527499	17	31200481	230799	235532	rs876658782	NC_000017.11:31200480:G:A
NM_001042492.3(NF1):c.4446A>G (p.Ile1482Met)	NF1	I1461M, I1482M	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230792	17	29587402	17	31260384	230792	235691	rs876658776	NC_000017.11:31260383:A:G
NM_001042492.3(NF1):c.6779C>T (p.Ser2260Phe)	NF1	S2239F, S2260F	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230791	17	29665117	17	31338099	230791	235789	rs876658775	NC_000017.11:31338098:C:T
NM_001042492.3(NF1):c.6927G>A (p.Ser2309=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230747	17	29667528	17	31340510	230747	235796	rs763028083	NC_000017.11:31340509:G:A
NM_001042492.3(NF1):c.6379A>G (p.Ile2127Val)	NF1	I2106V, I2127V	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2021)	criteria provided, conflicting interpretations	VCV000230714	17	29663884	17	31336866	230714	235773	rs200022550	NC_000017.11:31336865:A:G
NM_001042492.3(NF1):c.747A>G (p.Leu249=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230710	17	29509542	17	31182524	230710	235525	rs761964963	NC_000017.11:31182523:A:G
NM_001042492.3(NF1):c.7429C>G (p.Pro2477Ala)	NF1	P2456A, P2477A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230709	17	29677308	17	31350290	230709	235819	rs876658722	NC_000017.11:31350289:C:G
NM_001042492.3(NF1):c.7609T>C (p.Leu2537=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230704	17	29679426	17	31352408	230704	235824	rs748843392	NC_000017.11:31352407:T:C
NM_001042492.3(NF1):c.3362A>G (p.Glu1121Gly)	NF1	E1121G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230699	17	29559765	17	31232747	230699	235636	rs757222815	NC_000017.11:31232746:A:G
NM_001042492.3(NF1):c.6037A>G (p.Ser2013Gly)	NF1	S1992G, S2013G	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230689	17	29663381	17	31336363	230689	235760	rs876658710	NC_000017.11:31336362:A:G
NM_001042492.3(NF1):c.171C>T (p.Gly57=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230688	17	29483111	17	31156093	230688	235498	rs876658709	NC_000017.11:31156092:C:T
NM_001042492.3(NF1):c.1318C>T (p.Arg440Ter)	NF1	R440*	not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230673	17	29533315	17	31206297	230673	235548	rs778405030	NC_000017.11:31206296:C:T
NM_001042492.3(NF1):c.623C>T (p.Ala208Val)	NF1	A208V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2020)	criteria provided, conflicting interpretations	VCV000230640	17	29508476	17	31181458	230640	235518	rs758624540	NC_000017.11:31181457:C:T
NM_001042492.3(NF1):c.2023G>A (p.Gly675Arg)	NF1	G675R	Hereditary cancer-predisposing syndrome|not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230614	17	29553474	17	31226456	230614	235578	rs779546178	NC_000017.11:31226455:G:A
NM_001042492.3(NF1):c.1120G>A (p.Asp374Asn)	NF1	D374N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230609	17	29528112	17	31201094	230609	235538	rs876658666	NC_000017.11:31201093:G:A
NM_001042492.3(NF1):c.1310T>A (p.Val437Asp)	NF1	V437D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230574	17	29533307	17	31206289	230574	235547	rs876658642	NC_000017.11:31206288:T:A
NM_001042492.3(NF1):c.504A>G (p.Ser168=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000230565	17	29496933	17	31169915	230565	235513	rs876658638	NC_000017.11:31169914:A:G
NM_001042492.3(NF1):c.3871-4G>C	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230555	17	29562932	17	31235914	230555	235663	rs558421445	NC_000017.11:31235913:G:C
NM_001042492.3(NF1):c.2355A>G (p.Glu785=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230539	17	29554570	17	31227552	230539	235593	rs876658622	NC_000017.11:31227551:A:G
NM_001042492.3(NF1):c.1938T>C (p.Asp646=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230533	17	29552205	17	31225187	230533	235572	rs876658620	NC_000017.11:31225186:T:C
NM_001042492.3(NF1):c.5191T>G (p.Leu1731Val)	NF1	L1710V, L1731V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230506	17	29653193	17	31326175	230506	235729	rs876658602	NC_000017.11:31326174:T:G
NM_001042492.3(NF1):c.5970A>G (p.Pro1990=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230505	17	29662013	17	31334995	230505	235756	rs876658601	NC_000017.11:31334994:A:G
NM_001042492.3(NF1):c.7549C>T (p.Arg2517Ter)	NF1	R2496*, R2517*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Pathogenic(Last reviewed: Jan 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230467	17	29679366	17	31352348	230467	235823	rs866445127	NC_000017.11:31352347:C:T
NM_001042492.3(NF1):c.7758A>C (p.Ser2586=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230434	17	29683997	17	31356979	230434	235832	rs876658564	NC_000017.11:31356978:A:C
NM_001042492.3(NF1):c.8080T>C (p.Ser2694Pro)	NF1	S2673P, S2694P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230419	17	29685607	17	31358589	230419	235845	rs876658554	NC_000017.11:31358588:T:C
NM_001042492.3(NF1):c.4489T>C (p.Ser1497Pro)	NF1	S1476P, S1497P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000230418	17	29587445	17	31260427	230418	235694	rs763266925	NC_000017.11:31260426:T:C
NM_001042492.3(NF1):c.7986C>T (p.Asp2662=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230409	17	29685513	17	31358495	230409	235842	rs876658550	NC_000017.11:31358494:C:T
NM_001042492.3(NF1):c.4071C>T (p.Phe1357=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230408	17	29576098	17	31249080	230408	235676	rs747272290	NC_000017.11:31249079:C:T
NM_001042492.3(NF1):c.8183C>T (p.Ala2728Val)	NF1	A2707V, A2728V	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000230400	17	29687527	17	31360509	230400	235848	rs760973918	NC_000017.11:31360508:C:T
NM_001042492.3(NF1):c.6772C>T (p.Arg2258Ter)	NF1	R2237*, R2258*	Hereditary cancer-predisposing syndrome|Tibial pseudoarthrosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000230389	17	29665110	17	31338092	230389	235788	rs876658541	NC_000017.11:31338091:C:T
NM_001042492.3(NF1):c.7781G>A (p.Arg2594His)	NF1	R2573H, R2594H	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230365	17	29684020	17	31357002	230365	235833	rs774781617	NC_000017.11:31357001:G:A
NM_001042492.3(NF1):c.4767G>A (p.Thr1589=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230351	17	29592289	17	31265271	230351	235703	rs376659579	NC_000017.11:31265270:G:A
NM_001042492.3(NF1):c.2581G>C (p.Ala861Pro)	NF1	A861P	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2020)	criteria provided, conflicting interpretations	VCV000230343	17	29556214	17	31229196	230343	235602	rs768425956	NC_000017.11:31229195:G:C
NM_001042492.3(NF1):c.2856A>G (p.Leu952=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jun 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230333	17	29556858	17	31229840	230333	235617	rs750488772	NC_000017.11:31229839:A:G
NM_001042492.3(NF1):c.5947A>G (p.Ile1983Val)	NF1	I1962V, I1983V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230286	17	29661990	17	31334972	230286	235754	rs876658484	NC_000017.11:31334971:A:G
NM_001042492.3(NF1):c.8001C>A (p.Thr2667=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230272	17	29685528	17	31358510	230272	235843	rs876658475	NC_000017.11:31358509:C:A
NM_001042492.3(NF1):c.8091A>G (p.Gln2697=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2020)	criteria provided, conflicting interpretations	VCV000230262	17	29685618	17	31358600	230262	235846	rs760433938	NC_000017.11:31358599:A:G
NM_001042492.3(NF1):c.6672G>A (p.Lys2224=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230228	17	29664866	17	31337848	230228	235784	rs771835288	NC_000017.11:31337847:G:A
NM_001042492.3(NF1):c.1352T>C (p.Val451Ala)	NF1	V451A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230227	17	29533349	17	31206331	230227	235549	rs747466938	NC_000017.11:31206330:T:C
NM_001042492.3(NF1):c.3417A>G (p.Ala1139=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230182	17	29559820	17	31232802	230182	235637	rs864622524	NC_000017.11:31232801:A:G
NM_001042492.3(NF1):c.297G>A (p.Lys99=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230171	17	29490212	17	31163194	230171	235504	rs876658428	NC_000017.11:31163193:G:A
NM_001042492.3(NF1):c.4899A>G (p.Pro1633=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230164	17	29652901	17	31325883	230164	235709	rs876658422	NC_000017.11:31325882:A:G
NM_001042492.3(NF1):c.4635C>T (p.Tyr1545=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230136	17	29588786	17	31261768	230136	235698	rs754023358	NC_000017.11:31261767:C:T
NM_001042492.3(NF1):c.4110+3A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2020)	criteria provided, conflicting interpretations	VCV000230135	17	29576140	17	31249122	230135	235677	rs774669878	NC_000017.11:31249121:A:G
NM_001042492.3(NF1):c.2550G>T (p.Val850=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230110	17	29556183	17	31229165	230110	235599	rs772148227	NC_000017.11:31229164:G:T
NM_001042492.3(NF1):c.*1A>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000230101	17	29701174	17	31374156	230101	235853	rs876658388	NC_000017.11:31374155:A:C
NM_001042492.3(NF1):c.234T>A (p.Asn78Lys)	NF1	N78K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230049	17	29486057	17	31159039	230049	235501	rs876658354	NC_000017.11:31159038:T:A
NM_001042492.3(NF1):c.4472C>T (p.Ala1491Val)	NF1	A1470V, A1491V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000230021	17	29587428	17	31260410	230021	235693	rs876658334	NC_000017.11:31260409:C:T
NM_001042492.3(NF1):c.7851G>T (p.Ala2617=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000230003	17	29684090	17	31357072	230003	235838	rs751273275	NC_000017.11:31357071:G:T
NM_001042492.3(NF1):c.2188A>C (p.Asn730His)	NF1	N730H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000229999	17	29553639	17	31226621	229999	235585	rs758893131	NC_000017.11:31226620:A:C
NM_001042492.3(NF1):c.2747A>G (p.Asn916Ser)	NF1	N916S	Neurofibromatosis, type 1|Acute monocytic leukemia|Acute monoblastic leukemia|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229977	17	29556380	17	31229362	229977	235612	rs765043916	NC_000017.11:31229361:A:G
NM_001042492.3(NF1):c.2968A>C (p.Thr990Pro)	NF1	T990P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229956	17	29556970	17	31229952	229956	235623	rs876658299	NC_000017.11:31229951:A:C
NM_001042492.3(NF1):c.6082G>C (p.Ala2028Pro)	NF1	A2007P, A2028P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229949	17	29663426	17	31336408	229949	235762	rs767869530	NC_000017.11:31336407:G:C
NM_001042492.3(NF1):c.2301G>A (p.Glu767=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229923	17	29554285	17	31227267	229923	235590	rs746127097	NC_000017.11:31227266:G:A
NM_001042492.3(NF1):c.6360T>C (p.Ala2120=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2020)	criteria provided, conflicting interpretations	VCV000229911	17	29663865	17	31336847	229911	235772	rs371578074	NC_000017.11:31336846:T:C
NM_001042492.3(NF1):c.6649A>G (p.Met2217Val)	NF1	M2196V, M2217V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229892	17	29664843	17	31337825	229892	235780	rs876658255	NC_000017.11:31337824:A:G
NM_001042492.3(NF1):c.4412A>G (p.Asn1471Ser)	NF1	N1450S, N1471S	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229884	17	29586129	17	31259111	229884	235690	rs876658250	NC_000017.11:31259110:A:G
NM_001042492.3(NF1):c.5523A>G (p.Gln1841=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2021)	criteria provided, conflicting interpretations	VCV000229853	17	29654771	17	31327753	229853	235740	rs151046636	NC_000017.11:31327752:A:G
NM_001042492.3(NF1):c.5423C>T (p.Thr1808Met)	NF1	T1787M, T1808M	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229848	17	29654671	17	31327653	229848	235736	rs760649828	NC_000017.11:31327652:C:T
NM_001042492.3(NF1):c.2838C>T (p.Asp946=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Likely benign(Last reviewed: Apr 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229844	17	29556471	17	31229453	229844	235615	rs147188807	NC_000017.11:31229452:C:T
NM_001042492.3(NF1):c.2116G>A (p.Ala706Thr)	NF1	A706T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229841	17	29553567	17	31226549	229841	235583	rs876658232	NC_000017.11:31226548:G:A
NM_001042492.3(NF1):c.3534A>G (p.Thr1178=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229808	17	29560057	17	31233039	229808	235645	rs876658210	NC_000017.11:31233038:A:G
NM_001042492.3(NF1):c.1545G>A (p.Gly515=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229800	17	29546040	17	31219022	229800	235556	rs876658203	NC_000017.11:31219021:G:A
NM_001042492.3(NF1):c.134A>G (p.Asn45Ser)	NF1	N45S	Hereditary cancer-predisposing syndrome|none provided|not specified|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229787	17	29483074	17	31156056	229787	235496	rs753189381	NC_000017.11:31156055:A:G
NM_001042492.3(NF1):c.2054C>G (p.Thr685Ser)	NF1	T685S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229779	17	29553505	17	31226487	229779	235580	rs876658190	NC_000017.11:31226486:C:G
NM_001042492.3(NF1):c.7838C>T (p.Pro2613Leu)	NF1	P2592L, P2613L	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000229734	17	29684077	17	31357059	229734	235835	rs750972729	NC_000017.11:31357058:C:T
NM_001042492.3(NF1):c.5004C>G (p.Gly1668=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229699	17	29653006	17	31325988	229699	235714	rs751603479	NC_000017.11:31325987:C:G
NM_001042492.3(NF1):c.4357G>A (p.Val1453Ile)	NF1	V1432I, V1453I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229695	17	29586074	17	31259056	229695	235684	rs199474755	NC_000017.11:31259055:G:A
NM_001042492.3(NF1):c.8440C>T (p.Arg2814Cys)	NF1	R2793C, R2814C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229682	17	29701093	17	31374075	229682	235852	rs876658139	NC_000017.11:31374074:C:T
NM_001042492.3(NF1):c.5676A>G (p.Leu1892=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229667	17	29657380	17	31330362	229667	235748	rs876658130	NC_000017.11:31330361:A:G
NM_001042492.3(NF1):c.6676C>T (p.Leu2226=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229666	17	29664870	17	31337852	229666	235785	rs876658129	NC_000017.11:31337851:C:T
NM_001042492.3(NF1):c.1734T>C (p.Leu578=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229665	17	29550474	17	31223456	229665	235563	rs876658128	NC_000017.11:31223455:T:C
NM_001042492.3(NF1):c.1296G>A (p.Val432=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2021)	criteria provided, conflicting interpretations	VCV000229664	17	29533293	17	31206275	229664	235545	rs371599283	NC_000017.11:31206274:G:A
NM_001042492.3(NF1):c.7092G>A (p.Arg2364=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229662	17	29670056	17	31343038	229662	235803	rs762081710	NC_000017.11:31343037:G:A
NM_001042492.3(NF1):c.5664C>T (p.Ile1888=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229660	17	29657368	17	31330350	229660	235747	rs373685150	NC_000017.11:31330349:C:T
NM_001042492.3(NF1):c.3631C>T (p.Leu1211=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229659	17	29560154	17	31233136	229659	235647	rs876658125	NC_000017.11:31233135:C:T
NM_001042492.3(NF1):c.5550C>T (p.Val1850=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000229658	17	29654798	17	31327780	229658	235742	rs876658124	NC_000017.11:31327779:C:T
NM_001042492.3(NF1):c.8162A>G (p.Gln2721Arg)	NF1	Q2700R, Q2721R	not specified|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229065	17	29687506	17	31360488	229065	230774	rs876657933	NC_000017.11:31360487:A:G
NM_001042492.3(NF1):c.7439A>G (p.His2480Arg)	NF1	H2459R, H2480R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000229064	17	29677318	17	31350300	229064	230773	rs371151718	NC_000017.11:31350299:A:G
NM_001042492.3(NF1):c.5509G>A (p.Asp1837Asn)	NF1	D1816N, D1837N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2019)	criteria provided, conflicting interpretations	VCV000229063	17	29654757	17	31327739	229063	230768	rs771597781	NC_000017.11:31327738:G:A
NM_001042492.3(NF1):c.2410-12T>C	NF1		Neurofibromatosis, type 1|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2019)	criteria provided, conflicting interpretations	VCV000229062	17	29556031	17	31229013	229062	230761	rs876657932	NC_000017.11:31229012:T:C
NM_001042492.3(NF1):c.5305C>T (p.Arg1769Ter)	NF1	R1748*, R1769*	not provided|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000228381	17	29654553	17	31327535	228381	230767	rs876657714	NC_000017.11:31327534:C:T
NM_001042492.3(NF1):c.6366A>G (p.Thr2122=)	NF1		Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000227745	17	29663871	17	31336853	227745	230769	rs876657547	NC_000017.11:31336852:A:G
NM_001042492.3(NF1):c.5229T>C (p.Ala1743=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|not specified	Likely benign(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000227744	17	29653231	17	31326213	227744	230766	rs876657546	NC_000017.11:31326212:T:C
NM_001042492.3(NF1):c.4752C>T (p.Phe1584=)	NF1		not specified|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000227743	17	29592274	17	31265256	227743	230765	rs876657545	NC_000017.11:31265255:C:T
NM_001042492.3(NF1):c.4724+11A>G	NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2018)	criteria provided, conflicting interpretations	VCV000227742	17	29588886	17	31261868	227742	230764	rs368649260	NC_000017.11:31261867:A:G
NM_001042492.3(NF1):c.4577+11C>G	NF1		Neurofibromatosis, type 1|not provided|not specified	Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000227741	17	29587544	17	31260526	227741	230762	rs190614908	NC_000017.11:31260525:C:G
NM_001042492.3(NF1):c.1450C>T (p.Leu484=)	NF1		not provided|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000227740	17	29541526	17	31214508	227740	230758	rs876657544	NC_000017.11:31214507:C:T
NM_001042492.3(NF1):c.1845+13A>T	NF1		not provided|not specified	Benign(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000226850	17	29550598	17	31223580	226850	230760	rs17885739	NC_000017.11:31223579:A:T
NM_001042492.3(NF1):c.4860T>C (p.Gly1620=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000221100	17	29652862	17	31325844	221100	222610	rs864622747	NC_000017.11:31325843:T:C
NM_001042492.3(NF1):c.7426T>C (p.Tyr2476His)	NF1	Y2476H, Y2455H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000221093	17	29677305	17	31350287	221093	222634	rs864622745	NC_000017.11:31350286:T:C
NM_001042492.3(NF1):c.2599A>G (p.Met867Val)	NF1	M867V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000220990	17	29556232	17	31229214	220990	222584	rs864622715	NC_000017.11:31229213:A:G
NM_001042492.3(NF1):c.1392+7T>C	NF1		Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000220921	17	29533396	17	31206378	220921	222574	rs773017698	NC_000017.11:31206377:T:C
NM_001042492.3(NF1):c.2447G>A (p.Arg816Gln)	NF1	R816Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000220840	17	29556080	17	31229062	220840	222582	rs762709897	NC_000017.11:31229061:G:A
NM_001042492.3(NF1):c.7322-17C>T	NF1		Neurofibromatosis, type 1|not provided|not specified	Benign(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220819	17	29677184	17	31350166	220819	222632	rs17884859	NC_000017.11:31350165:C:T
NM_001042492.3(NF1):c.5711A>G (p.Asn1904Ser)	NF1	N1904S, N1883S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000220757	17	29657415	17	31330397	220757	222619	rs864622647	NC_000017.11:31330396:A:G
NM_001042492.3(NF1):c.5322G>A (p.Gly1774=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220747	17	29654570	17	31327552	220747	222615	rs201584313	NC_000017.11:31327551:G:A
NM_001042492.3(NF1):c.5436C>T (p.Phe1812=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220720	17	29654684	17	31327666	220720	222616	rs864622640	NC_000017.11:31327665:C:T
NM_001042492.3(NF1):c.2850+5A>G	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 25, 2015)	criteria provided, single submitter	VCV000220708	17	29556488	17	31229470	220708	222586	rs864622633	NC_000017.11:31229469:A:G
NM_001042492.3(NF1):c.2666C>G (p.Thr889Arg)	NF1	T889R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220707	17	29556299	17	31229281	220707	222585	rs369912079	NC_000017.11:31229280:C:G
NM_001042492.3(NF1):c.2284C>T (p.Leu762=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220620	17	29554268	17	31227250	220620	222581	rs370762336	NC_000017.11:31227249:C:T
NM_001042492.3(NF1):c.6427+8C>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000220602	17	29663940	17	31336922	220602	222620	rs864622598	NC_000017.11:31336921:C:T
NM_001042492.3(NF1):c.5268+5G>A	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000220498	17	29653275	17	31326257	220498	222614	rs864622551	NC_000017.11:31326256:G:A
NM_001042492.3(NF1):c.2126G>A (p.Cys709Tyr)	NF1	C709Y	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000220491	17	29553577	17	31226559	220491	222578	rs864622547	NC_000017.11:31226558:G:A
NM_001042492.3(NF1):c.7026G>T (p.Leu2342=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220479	17	29667627	17	31340609	220479	222625	rs371581213	NC_000017.11:31340608:G:T
NM_001042492.3(NF1):c.456A>C (p.Ala152=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220456	17	29490371	17	31163353	220456	222565	rs377481833	NC_000017.11:31163352:A:C
NM_001042492.3(NF1):c.3417A>C (p.Ala1139=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220435	17	29559820	17	31232802	220435	222593	rs864622524	NC_000017.11:31232801:A:C
NM_001042492.3(NF1):c.7596C>T (p.Ala2532=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV000220415	17	29679413	17	31352395	220415	222637	rs864622517	NC_000017.11:31352394:C:T
NM_001042492.3(NF1):c.6922-2A>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000220397	17	29667521	17	31340503	220397	222624	rs864622509	NC_000017.11:31340502:A:G
NM_001042492.3(NF1):c.4296A>C (p.Pro1432=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, single submitter	VCV000220361	17	29585484	17	31258466	220361	222603	rs864622492	NC_000017.11:31258465:A:C
NM_001042492.3(NF1):c.7262A>G (p.Asn2421Ser)	NF1	N2421S, N2400S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000220340	17	29676210	17	31349192	220340	222631	rs774339063	NC_000017.11:31349191:A:G
NM_001042492.3(NF1):c.7870-8C>A	NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2020)	criteria provided, conflicting interpretations	VCV000220337	17	29684279	17	31357261	220337	222641	rs372441422	NC_000017.11:31357260:C:A
NM_001042492.3(NF1):c.5521C>T (p.Gln1841Ter)	NF1	Q1841*, Q1820*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220317	17	29654769	17	31327751	220317	222618	rs786203570	NC_000017.11:31327750:C:T
NM_001042492.3(NF1):c.3198A>G (p.Arg1066=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV000220302	17	29559091	17	31232073	220302	222592	rs864622469	NC_000017.11:31232072:A:G
NM_001042492.3(NF1):c.7062+8A>G	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000220301	17	29667671	17	31340653	220301	222628	rs864622468	NC_000017.11:31340652:A:G
NM_001042492.3(NF1):c.703T>C (p.Tyr235His)	NF1	Y235H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220294	17	29508776	17	31181758	220294	222566	rs864622465	NC_000017.11:31181757:T:C
NM_001042492.3(NF1):c.2232C>G (p.Val744=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000220274	17	29553683	17	31226665	220274	222579	rs748865537	NC_000017.11:31226664:C:G
NM_001042492.3(NF1):c.3103A>G (p.Met1035Val)	NF1	M1035V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Jan 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000220267	17	29557390	17	31230372	220267	222588	rs771694969	NC_000017.11:31230371:A:G
NM_001042492.3(NF1):c.3975-2A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220232	17	29576000	17	31248982	220232	222596	rs864622431	NC_000017.11:31248981:A:G
NM_001042492.3(NF1):c.1479C>G (p.Leu493=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220187	17	29541555	17	31214537	220187	222575	rs139653388	NC_000017.11:31214536:C:G
NM_001042492.3(NF1):c.7354C>T (p.Arg2452Cys)	NF1	R2452C, R2431C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|none provided|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000220184	17	29677233	17	31350215	220184	222633	rs377662483	NC_000017.11:31350214:C:T
NM_001042492.3(NF1):c.4724+3A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220183	17	29588878	17	31261860	220183	222608	rs781147524	NC_000017.11:31261859:A:G
NM_001042492.3(NF1):c.403C>T (p.Arg135Trp)	NF1	R135W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220180	17	29490318	17	31163300	220180	222564	rs775191883	NC_000017.11:31163299:C:T
NM_001042492.3(NF1):c.4206C>T (p.Ile1402=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220165	17	29585394	17	31258376	220165	222602	rs864622406	NC_000017.11:31258375:C:T
NM_001042492.3(NF1):c.4540A>G (p.Asn1514Asp)	NF1	N1514D, N1493D	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 5, 2015)	criteria provided, single submitter	VCV000220163	17	29587496	17	31260478	220163	222606	rs864622404	NC_000017.11:31260477:A:G
NM_001042492.3(NF1):c.4600C>T (p.Arg1534Ter)	NF1	R1534*, R1513*	Subcutaneous neurofibromas|Thoracic scoliosis|Neurofibromatosis type 6|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|not specified	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000220152	17	29588751	17	31261733	220152	222607	rs760703505	NC_000017.11:31261732:C:T
NM_001042492.3(NF1):c.1888G>A (p.Val630Ile)	NF1	V630I	Neurofibromatosis, type 1|Diffuse intrinsic pontine glioma|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220148	17	29552155	17	31225137	220148	222576	rs751795238	NC_000017.11:31225136:G:A
NM_001042492.3(NF1):c.740A>G (p.Glu247Gly)	NF1	E247G	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000220110	17	29509535	17	31182517	220110	222567	rs864622385	NC_000017.11:31182516:A:G
NM_001042492.3(NF1):c.2002-9G>T	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220104	17	29553444	17	31226426	220104	222577	rs376197466	NC_000017.11:31226425:G:T
NM_001042492.3(NF1):c.5255A>G (p.Lys1752Arg)	NF1	K1752R, K1731R	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Retinoblastoma	Uncertain significance(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000220078	17	29653257	17	31326239	220078	222613	rs864622373	NC_000017.11:31326238:A:G
NM_001042492.3(NF1):c.5169A>G (p.Gln1723=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220077	17	29653171	17	31326153	220077	222611	rs864622372	NC_000017.11:31326152:A:G
NM_001042492.3(NF1):c.7789T>C (p.Ser2597Pro)	NF1	S2597P, S2576P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000220062	17	29684028	17	31357010	220062	222639	rs864622364	NC_000017.11:31357009:T:C
NM_001042492.3(NF1):c.6816C>T (p.Ser2272=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 2, 2016)	criteria provided, conflicting interpretations	VCV000220055	17	29665154	17	31338136	220055	222622	rs864622360	NC_000017.11:31338135:C:T
NM_001042492.3(NF1):c.4525C>T (p.Arg1509Cys)	NF1	R1509C, R1488C	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000220020	17	29587481	17	31260463	220020	222605	rs864622348	NC_000017.11:31260462:C:T
NM_001042492.3(NF1):c.3000T>C (p.Arg1000=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219976	17	29557287	17	31230269	219976	222587	rs764332485	NC_000017.11:31230268:T:C
NM_001042492.3(NF1):c.6637A>G (p.Met2213Val)	NF1	M2213V, M2192V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jul 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000219972	17	29664595	17	31337577	219972	222621	rs864622330	NC_000017.11:31337576:A:G
NM_001042492.3(NF1):c.3939T>C (p.Asp1313=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000219962	17	29563004	17	31235986	219962	222595	rs864622325	NC_000017.11:31235985:T:C
NM_001042492.3(NF1):c.7479A>G (p.Pro2493=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219947	17	29679296	17	31352278	219947	222636	rs144957306	NC_000017.11:31352277:A:G
NM_001042492.3(NF1):c.7869+6G>A	NF1		Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV000219941	17	29684114	17	31357096	219941	222640	rs864622318	NC_000017.11:31357095:G:A
NM_001042492.3(NF1):c.885T>A (p.Asn295Lys)	NF1	N295K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219894	17	29509680	17	31182662	219894	222568	rs864622300	NC_000017.11:31182661:T:A
NM_001042492.3(NF1):c.4193C>T (p.Pro1398Leu)	NF1	P1398L, P1377L	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000219893	17	29585381	17	31258363	219893	222601	rs864622299	NC_000017.11:31258362:C:T
NM_001042492.3(NF1):c.4362C>T (p.Leu1454=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|not specified	Likely benign(Last reviewed: Jun 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000219892	17	29586079	17	31259061	219892	222604	rs864622298	NC_000017.11:31259060:C:T
NM_001042492.3(NF1):c.7055A>G (p.Asn2352Ser)	NF1	N2352S, N2331S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000219867	17	29667656	17	31340638	219867	222627	rs763082717	NC_000017.11:31340637:A:G
NM_001042492.3(NF1):c.7643T>G (p.Ile2548Arg)	NF1	I2548R, I2527R	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000219822	17	29683505	17	31356487	219822	222638	rs864622266	NC_000017.11:31356486:T:G
NM_001042492.3(NF1):c.7466A>G (p.Lys2489Arg)	NF1	K2489R, K2468R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219783	17	29679283	17	31352265	219783	222635	rs864622249	NC_000017.11:31352264:A:G
NM_001042492.3(NF1):c.1389A>G (p.Ala463=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV000219762	17	29533386	17	31206368	219762	222573	rs1131923	NC_000017.11:31206367:A:G
NM_001042492.3(NF1):c.3484A>G (p.Met1162Val)	NF1	M1162V	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000219750	17	29559887	17	31232869	219750	222594	rs773968270	NC_000017.11:31232868:A:G
NM_001042492.3(NF1):c.5497C>T (p.Leu1833=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219722	17	29654745	17	31327727	219722	222617	rs372932380	NC_000017.11:31327726:C:T
NM_001042492.3(NF1):c.5225A>G (p.Asn1742Ser)	NF1	N1742S, N1721S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219686	17	29653227	17	31326209	219686	222612	rs745407845	NC_000017.11:31326208:A:G
NM_001042492.3(NF1):c.4012A>C (p.Asn1338His)	NF1	N1338H	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000219670	17	29576039	17	31249021	219670	222597	rs864622202	NC_000017.11:31249020:A:C
NM_001042492.3(NF1):c.4724+7T>C	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000219606	17	29588882	17	31261864	219606	222609	rs864622178	NC_000017.11:31261863:T:C
NM_001042492.3(NF1):c.1185+1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219572	17	29528178	17	31201160	219572	222572	rs864622161	NC_000017.11:31201159:G:A
NM_001042492.3(NF1):c.2251+2T>G	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000219531	17	29553704	17	31226686	219531	222580	rs864622142	NC_000017.11:31226685:T:G
NM_001042492.3(NF1):c.1094C>A (p.Ser365Ter)	NF1	S365*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	VCV000219467	17	29528086	17	31201068	219467	222571	rs864622107	NC_000017.11:31201067:C:A
NM_001042492.3(NF1):c.4085G>A (p.Arg1362Gln)	NF1	R1362Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219443	17	29576112	17	31249094	219443	222598	rs540108477	NC_000017.11:31249093:G:A
NM_001042492.3(NF1):c.2541T>C (p.Leu847=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|not specified	Benign/Likely benign(Last reviewed: May 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000219435	17	29556174	17	31229156	219435	222583	rs147433258	NC_000017.11:31229155:T:C
NM_001042492.3(NF1):c.4187G>A (p.Arg1396His)	NF1	R1396H, R1375H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219424	17	29585375	17	31258357	219424	222600	rs368685980	NC_000017.11:31258356:G:A
NM_001042492.3(NF1):c.7046G>A (p.Arg2349His)	NF1	R2349H, R2328H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219389	17	29667647	17	31340629	219389	222626	rs864622065	NC_000017.11:31340628:G:A
NM_001042492.3(NF1):c.1042T>C (p.Ser348Pro)	NF1	S348P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000219385	17	29527593	17	31200575	219385	222570	rs864622064	NC_000017.11:31200574:T:C
NM_001042492.3(NF1):c.823A>T (p.Ile275Phe)	NF1	I275F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000216415	17	29509618	17	31182600	216415	213247	rs786202464	NC_000017.11:31182599:A:T
NM_001042492.3(NF1):c.8222C>T (p.Thr2741Met)	NF1	T2720M, T2741M	Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216414	17	29687566	17	31360548	216414	213302	rs144178015	NC_000017.11:31360547:C:T
NM_001042492.3(NF1):c.8139G>A (p.Arg2713=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216413	17	29686012	17	31358994	216413	213301	rs139527415	NC_000017.11:31358993:G:A
NM_001042492.3(NF1):c.7432A>G (p.Ile2478Val)	NF1	I2457V, I2478V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216412	17	29677311	17	31350293	216412	213297	rs759307070	NC_000017.11:31350292:A:G
NM_001042492.3(NF1):c.7396A>G (p.Ile2466Val)	NF1	I2445V, I2466V	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2020)	criteria provided, conflicting interpretations	VCV000216411	17	29677275	17	31350257	216411	213296	rs748027595	NC_000017.11:31350256:A:G
NM_001042492.3(NF1):c.7370A>G (p.His2457Arg)	NF1	H2436R, H2457R	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216410	17	29677249	17	31350231	216410	213295	rs863224664	NC_000017.11:31350230:A:G
NM_001042492.3(NF1):c.6952G>T (p.Val2318Leu)	NF1	V2297L, V2318L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216409	17	29667553	17	31340535	216409	213293	rs760528229	NC_000017.11:31340534:G:T
NM_001042492.3(NF1):c.593C>A (p.Ala198Glu)	NF1	A198E	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000216408	17	29508446	17	31181428	216408	213245	rs863224663	NC_000017.11:31181427:C:A
NM_001042492.3(NF1):c.5662A>T (p.Ile1888Phe)	NF1	I1867F, I1888F	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000216407	17	29657366	17	31330348	216407	213283	rs863224662	NC_000017.11:31330347:A:T
NM_001042492.3(NF1):c.5072A>G (p.Lys1691Arg)	NF1	K1670R, K1691R	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000216406	17	29653074	17	31326056	216406	213280	rs863224661	NC_000017.11:31326055:A:G
NM_001042492.3(NF1):c.4766C>T (p.Thr1589Met)	NF1	T1568M, T1589M	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal	Uncertain significance(Last reviewed: Mar 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216405	17	29592288	17	31265270	216405	213278	rs185660700	NC_000017.11:31265269:C:T
NM_001042492.3(NF1):c.4682G>A (p.Ser1561Asn)	NF1	S1540N, S1561N	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2021)	criteria provided, conflicting interpretations	VCV000216404	17	29588833	17	31261815	216404	213277	rs751414513	NC_000017.11:31261814:G:A
NM_001042492.3(NF1):c.4185G>T (p.Gln1395His)	NF1	Q1374H, Q1395H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216403	17	29585373	17	31258355	216403	213275	rs775206746	NC_000017.11:31258354:G:T
NM_001042492.3(NF1):c.3790G>A (p.Glu1264Lys)	NF1	E1264K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216402	17	29562710	17	31235692	216402	213269	rs863224660	NC_000017.11:31235691:G:A
NM_001042492.3(NF1):c.3590C>T (p.Ala1197Val)	NF1	A1197V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000216401	17	29560113	17	31233095	216401	213268	rs370820478	NC_000017.11:31233094:C:T
NM_001042492.3(NF1):c.3287T>C (p.Met1096Thr)	NF1	M1096T	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 16, 2015)	criteria provided, single submitter	VCV000216400	17	29559180	17	31232162	216400	213266	rs863224659	NC_000017.11:31232161:T:C
NM_001042492.3(NF1):c.2690G>C (p.Arg897Pro)	NF1	R897P	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000216399	17	29556323	17	31229305	216399	213262	rs863224658	NC_000017.11:31229304:G:C
NM_001042492.3(NF1):c.2342A>T (p.His781Leu)	NF1	H781L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216398	17	29554557	17	31227539	216398	213259	rs199474763	NC_000017.11:31227538:A:T
NM_001042492.3(NF1):c.2297T>G (p.Ile766Ser)	NF1	I766S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000216397	17	29554281	17	31227263	216397	213258	rs863224657	NC_000017.11:31227262:T:G
NM_001042492.3(NF1):c.2288T>G (p.Leu763Arg)	NF1	L763R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216396	17	29554272	17	31227254	216396	213257	rs199474762	NC_000017.11:31227253:T:G
NM_001042492.3(NF1):c.1661A>G (p.Gln554Arg)	NF1	Q554R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216395	17	29548887	17	31221869	216395	213252	rs863224656	NC_000017.11:31221868:A:G
NM_001042492.3(NF1):c.1642-449A>G	NF1		not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216394	17	29548419	17	31221401	216394	213251	rs863224655	NC_000017.11:31221400:A:G
NM_001042492.3(NF1):c.7482G>A (p.Trp2494Ter)	NF1	W2473*, W2494*	Neurofibromatosis, type 1|Axillary freckling|Familial predisposition|Cafe-au-lait spot|Delayed speech and language development|Specific learning disability|Inguinal freckling|Inguinal hernia	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000216067	17	29679299	17	31352281	216067	213298	rs863224493	NC_000017.11:31352280:G:A
NM_001042492.3(NF1):c.7062+1G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000216066	17	29667664	17	31340646	216066	213294	rs863224492	NC_000017.11:31340645:G:A
NM_001042492.3(NF1):c.5812+332A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216065	17	29657848	17	31330830	216065	213285	rs863224491	NC_000017.11:31330829:A:G
NM_001042492.3(NF1):c.4546G>T (p.Glu1516Ter)	NF1	E1495*, E1516*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000216064	17	29587502	17	31260484	216064	213276	rs786203390	NC_000017.11:31260483:G:T
NM_001042492.3(NF1):c.3113+1G>T	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216062	17	29557401	17	31230383	216062	213264	rs267606599	NC_000017.11:31230382:G:T
NM_001042492.3(NF1):c.1713G>A (p.Trp571Ter)	NF1	W571*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216061	17	29548939	17	31221921	216061	213253	rs863224489	NC_000017.11:31221920:G:A
NM_001042492.3(NF1):c.3974G>C (p.Arg1325Thr)	NF1	R1325T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215990	17	29563039	17	31236021	215990	213270	rs863224447	NC_000017.11:31236020:G:C
NM_001042492.3(NF1):c.2850G>C (p.Gln950His)	NF1	Q950H	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000215989	17	29556483	17	31229465	215989	213263	rs863224446	NC_000017.11:31229464:G:C
NM_001042492.3(NF1):c.3314+2T>A	NF1		Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000215988	17	29559209	17	31232191	215988	213267	rs863224445	NC_000017.11:31232190:T:A
NM_001042492.3(NF1):c.8114-70A>T	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000215726	17	29685917	17	31358899	215726	213300	rs192112633	NC_000017.11:31358898:A:T
NM_001042492.3(NF1):c.731-6A>C	NF1		not specified|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2021)	criteria provided, conflicting interpretations	VCV000215725	17	29509520	17	31182502	215725	213246	rs369366499	NC_000017.11:31182501:A:C
NM_001042492.3(NF1):c.6921+10G>A	NF1		not specified|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2020)	criteria provided, conflicting interpretations	VCV000215724	17	29665833	17	31338815	215724	213292	rs767166725	NC_000017.11:31338814:G:A
NM_001042492.3(NF1):c.6870G>T (p.Leu2290=)	NF1		not provided|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000215723	17	29665772	17	31338754	215723	213291	rs773658814	NC_000017.11:31338753:G:T
NM_001042492.3(NF1):c.5910A>G (p.Arg1970=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000215722	17	29661953	17	31334935	215722	213288	rs777021090	NC_000017.11:31334934:A:G
NM_001042492.3(NF1):c.5865T>C (p.Asn1955=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000215721	17	29661908	17	31334890	215721	213286	rs863224356	NC_000017.11:31334889:T:C
NM_001042492.3(NF1):c.5812+8A>G	NF1		not specified|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215720	17	29657524	17	31330506	215720	213284	rs372075322	NC_000017.11:31330505:A:G
NM_001042492.3(NF1):c.5571C>T (p.Ile1857=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215719	17	29654819	17	31327801	215719	213282	rs771837192	NC_000017.11:31327800:C:T
NM_001042492.3(NF1):c.525T>C (p.His175=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215718	17	29496954	17	31169936	215718	213244	rs750358089	NC_000017.11:31169935:T:C
NM_001042492.3(NF1):c.5269-9A>G	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215717	17	29654508	17	31327490	215717	213281	rs544515671	NC_000017.11:31327489:A:G
NM_001042492.3(NF1):c.4977C>G (p.Leu1659=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215716	17	29652979	17	31325961	215716	213279	rs863224355	NC_000017.11:31325960:C:G
NM_001042492.3(NF1):c.468C>T (p.Arg156=)	NF1		Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000215715	17	29490383	17	31163365	215715	213243	rs779074793	NC_000017.11:31163364:C:T
NM_001042492.3(NF1):c.4020T>C (p.Leu1340=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215714	17	29576047	17	31249029	215714	213273	rs863224354	NC_000017.11:31249028:T:C
NM_001042492.3(NF1):c.3990G>A (p.Glu1330=)	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000215713	17	29576017	17	31248999	215713	213271	rs863224353	NC_000017.11:31248998:G:A
NM_001042492.3(NF1):c.2514C>T (p.Ile838=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000215712	17	29556147	17	31229129	215712	213261	rs863224352	NC_000017.11:31229128:C:T
NM_001042492.3(NF1):c.2358A>G (p.Gln786=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215711	17	29554573	17	31227555	215711	213260	rs762346437	NC_000017.11:31227554:A:G
NM_001042492.3(NF1):c.2061A>G (p.Leu687=)	NF1		not specified|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215710	17	29553512	17	31226494	215710	213254	rs143671377	NC_000017.11:31226493:A:G
NM_001042492.3(NF1):c.1548C>G (p.Pro516=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215709	17	29546043	17	31219025	215709	213250	rs768883989	NC_000017.11:31219024:C:G
NM_001042492.3(NF1):c.1528-10T>C	NF1		Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Apr 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000215708	17	29546013	17	31218995	215708	213249	rs376174484	NC_000017.11:31218994:T:C
NM_001042492.3(NF1):c.129A>C (p.Leu43=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000215707	17	29483069	17	31156051	215707	213242	rs759576680	NC_000017.11:31156050:A:C
NM_001042492.3(NF1):c.6147+8C>G	NF1		Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|not provided|not specified	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215465	17	29663499	17	31336481	215465	213289	rs182709912	NC_000017.11:31336480:C:G
NM_001042492.3(NF1):c.2252-34T>C	NF1		Neurofibromatosis, type 1|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215463	17	29554202	17	31227184	215463	213255	rs200937398	NC_000017.11:31227183:T:C
NM_001042492.3(NF1):c.2252-31A>T	NF1		Neurofibromatosis, type 1|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000215462	17	29554205	17	31227187	215462	213256	rs141082540	NC_000017.11:31227186:A:T
NM_001042492.3(NF1):c.5488C>G (p.Arg1830Gly)	NF1	R1809G, R1830G	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000208857	17	29654736	17	31327718	208857	205415	rs797045139	NC_000017.11:31327717:C:G
NM_001042492.3(NF1):c.5488C>A (p.Arg1830Ser)	NF1	R1809S, R1830S	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV000208856	17	29654736	17	31327718	208856	205414	rs797045139	NC_000017.11:31327717:C:A
NM_001042492.3(NF1):c.5489G>C (p.Arg1830Pro)	NF1	R1809P, R1830P	Neurofibromatosis, type 1	Pathogenic	no assertion criteria provided	VCV000208855	17	29654737	17	31327719	208855	205417	rs771529172	NC_000017.11:31327718:G:C
NM_001042492.3(NF1):c.5489G>T (p.Arg1830Leu)	NF1	R1809L, R1830L	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208854	17	29654737	17	31327719	208854	205418	rs771529172	NC_000017.11:31327718:G:T
NM_001042492.3(NF1):c.5488C>T (p.Arg1830Cys)	NF1	R1809C, R1830C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|not specified|Neurofibromatosis, type 1|Intellectual disability|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208853	17	29654736	17	31327718	208853	205416	rs797045139	NC_000017.11:31327717:C:T
NM_001042492.3(NF1):c.4729C>T (p.Gln1577Ter)	NF1	Q1556*, Q1577*	Inborn genetic diseases|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208766	17	29592251	17	31265233	208766	205301	rs797044942	NC_000017.11:31265232:C:T
NM_001042492.3(NF1):c.3500T>G (p.Leu1167Ter)	NF1	L1167*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000188394	17	29560023	17	31233005	188394	186251	rs786204253	NC_000017.11:31233004:T:G
NM_001042492.3(NF1):c.6373C>G (p.Leu2125Val)	NF1	L2104V, L2125V	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 27, 2015)	criteria provided, single submitter	VCV000188360	17	29663878	17	31336860	188360	186254	rs786204236	NC_000017.11:31336859:C:G
NM_001042492.3(NF1):c.3494T>A (p.Ile1165Lys)	NF1	I1165K	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000188312	17	29559897	17	31232879	188312	186250	rs786204211	NC_000017.11:31232878:T:A
NM_001042492.3(NF1):c.4332+2T>C	NF1		Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188306	17	29585522	17	31258504	188306	186252	rs786204207	NC_000017.11:31258503:T:C
NM_001042492.3(NF1):c.2041C>T (p.Arg681Ter)	NF1	R681*	not provided|Rhabdomyosarcoma|Neurofibromatosis, type 1|not specified|Optic nerve glioma|Axillary freckling|Cafe-au-lait spot|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188280	17	29553492	17	31226474	188280	186247	rs768638173	NC_000017.11:31226473:C:T
NM_001042492.3(NF1):c.4340A>G (p.Gln1447Arg)	NF1	Q1426R, Q1447R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000188220	17	29586057	17	31259039	188220	186253	rs786204157	NC_000017.11:31259038:A:G
NM_001042492.3(NF1):c.5793T>C (p.Ile1931=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187736	17	29657497	17	31330479	187736	184703	rs779114598	NC_000017.11:31330478:T:C
NM_001042492.3(NF1):c.910C>T (p.Arg304Ter)	NF1	R304*	Juvenile myelomonocytic leukemia|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000187722	17	29527461	17	31200443	187722	184531	rs786203950	NC_000017.11:31200442:C:T
NM_001042492.3(NF1):c.212T>C (p.Phe71Ser)	NF1	F71S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187703	17	29486035	17	31159017	187703	184502	rs752396270	NC_000017.11:31159016:T:C
NM_001042492.3(NF1):c.7087A>G (p.Ile2363Val)	NF1	I2342V, I2363V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187685	17	29670051	17	31343033	187685	184742	rs137966859	NC_000017.11:31343032:A:G
NM_001042492.3(NF1):c.5782G>T (p.Glu1928Ter)	NF1	E1907*, E1928*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187652	17	29657486	17	31330468	187652	184701	rs786203896	NC_000017.11:31330467:G:T
NM_001042492.3(NF1):c.3621A>G (p.Arg1207=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187649	17	29560144	17	31233126	187649	184631	rs141390152	NC_000017.11:31233125:A:G
NM_001042492.3(NF1):c.6955G>A (p.Ala2319Thr)	NF1	A2298T, A2319T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187632	17	29667556	17	31340538	187632	184737	rs786203881	NC_000017.11:31340537:G:A
NM_001042492.3(NF1):c.6900A>C (p.Lys2300Asn)	NF1	K2279N, K2300N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000187610	17	29665802	17	31338784	187610	184736	rs786203861	NC_000017.11:31338783:A:C
NM_001042492.3(NF1):c.1609C>T (p.His537Tyr)	NF1	H537Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187609	17	29546104	17	31219086	187609	184554	rs786203860	NC_000017.11:31219085:C:T
NM_001042492.3(NF1):c.7825G>A (p.Val2609Ile)	NF1	V2588I, V2609I	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187592	17	29684064	17	31357046	187592	184772	rs786203848	NC_000017.11:31357045:G:A
NM_001042492.3(NF1):c.6657T>G (p.Asp2219Glu)	NF1	D2198E, D2219E	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187569	17	29664851	17	31337833	187569	184728	rs786203831	NC_000017.11:31337832:T:G
NM_001042492.3(NF1):c.5768C>T (p.Thr1923Met)	NF1	T1902M, T1923M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187560	17	29657472	17	31330454	187560	184700	rs786203824	NC_000017.11:31330453:C:T
NM_001042492.3(NF1):c.1701A>G (p.Val567=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187554	17	29548927	17	31221909	187554	184557	rs786203819	NC_000017.11:31221908:A:G
NM_001042492.3(NF1):c.5381T>C (p.Val1794Ala)	NF1	V1773A, V1794A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187517	17	29654629	17	31327611	187517	184686	rs142867979	NC_000017.11:31327610:T:C
NM_001042492.3(NF1):c.7663A>G (p.Lys2555Glu)	NF1	K2534E, K2555E	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187512	17	29683525	17	31356507	187512	184766	rs786203792	NC_000017.11:31356506:A:G
NM_001042492.3(NF1):c.960T>A (p.Ala320=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187496	17	29527511	17	31200493	187496	184533	rs376447070	NC_000017.11:31200492:T:A
NM_001042492.3(NF1):c.2564G>C (p.Arg855Thr)	NF1	R855T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187414	17	29556197	17	31229179	187414	184602	rs786203716	NC_000017.11:31229178:G:C
NM_001042492.3(NF1):c.4252A>G (p.Ile1418Val)	NF1	I1397V, I1418V	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 29, 2020)	criteria provided, conflicting interpretations	VCV000187392	17	29585440	17	31258422	187392	184658	rs369345045	NC_000017.11:31258421:A:G
NM_001042492.3(NF1):c.8161-3C>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187374	17	29687502	17	31360484	187374	184782	rs786203684	NC_000017.11:31360483:C:T
NM_001042492.3(NF1):c.8000C>T (p.Thr2667Ile)	NF1	T2646I, T2667I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000187357	17	29685527	17	31358509	187357	184779	rs786203669	NC_000017.11:31358508:C:T
NM_001042492.3(NF1):c.3970A>G (p.Thr1324Ala)	NF1	T1324A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187350	17	29563035	17	31236017	187350	184648	rs189522993	NC_000017.11:31236016:A:G
NM_001042492.3(NF1):c.3538A>G (p.Met1180Val)	NF1	M1180V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187343	17	29560061	17	31233043	187343	184630	rs786203658	NC_000017.11:31233042:A:G
NM_001042492.3(NF1):c.2712T>C (p.Cys904=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187315	17	29556345	17	31229327	187315	184609	rs372963561	NC_000017.11:31229326:T:C
NM_001042492.3(NF1):c.624G>T (p.Ala208=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187312	17	29508477	17	31181459	187312	184515	rs370184932	NC_000017.11:31181458:G:T
NM_001042492.3(NF1):c.5961G>A (p.Gln1987=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2021)	criteria provided, conflicting interpretations	VCV000187307	17	29662004	17	31334986	187307	184708	rs757536610	NC_000017.11:31334985:G:A
NM_001042492.3(NF1):c.4385G>A (p.Arg1462Gln)	NF1	R1441Q, R1462Q	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187252	17	29586102	17	31259084	187252	184662	rs370852681	NC_000017.11:31259083:G:A
NM_001042492.3(NF1):c.3722G>A (p.Arg1241Gln)	NF1	R1241Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187226	17	29562642	17	31235624	187226	184635	rs543387071	NC_000017.11:31235623:G:A
NM_001042492.3(NF1):c.8490C>A (p.Phe2830Leu)	NF1	F2809L, F2830L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187205	17	29701143	17	31374125	187205	184792	rs760550772	NC_000017.11:31374124:C:A
NM_001042492.3(NF1):c.433C>G (p.Leu145Val)	NF1	L145V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187087	17	29490348	17	31163330	187087	184509	rs786203460	NC_000017.11:31163329:C:G
NM_001042492.3(NF1):c.625C>T (p.Gln209Ter)	NF1	Q209*	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000187069	17	29508478	17	31181460	187069	184516	rs786203448	NC_000017.11:31181459:C:T
NM_001042492.3(NF1):c.942G>A (p.Arg314=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187066	17	29527493	17	31200475	187066	184532	rs786203445	NC_000017.11:31200474:G:A
NM_001042492.3(NF1):c.2073G>C (p.Leu691=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187039	17	29553524	17	31226506	187039	184582	rs756988894	NC_000017.11:31226505:G:C
NM_001042492.3(NF1):c.7850C>T (p.Ala2617Val)	NF1	A2596V, A2617V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Dec 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187029	17	29684089	17	31357071	187029	184774	rs375990655	NC_000017.11:31357070:C:T
NM_001042492.3(NF1):c.5572G>A (p.Ala1858Thr)	NF1	A1837T, A1858T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187027	17	29654820	17	31327802	187027	184693	rs786203416	NC_000017.11:31327801:G:A
NM_001042492.3(NF1):c.512A>G (p.Asn171Ser)	NF1	N171S	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000187007	17	29496941	17	31169923	187007	184513	rs767500770	NC_000017.11:31169922:A:G
NM_001042492.3(NF1):c.7487C>G (p.Ser2496Cys)	NF1	S2475C, S2496C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186986	17	29679304	17	31352286	186986	184757	rs371773406	NC_000017.11:31352285:C:G
NM_001042492.3(NF1):c.705C>G (p.Tyr235Ter)	NF1	Y235*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2014)	criteria provided, single submitter	VCV000186943	17	29508778	17	31181760	186943	184519	rs769048538	NC_000017.11:31181759:C:G
NM_001042492.3(NF1):c.5619C>G (p.Ala1873=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2020)	criteria provided, conflicting interpretations	VCV000186934	17	29657323	17	31330305	186934	184695	rs786203335	NC_000017.11:31330304:C:G
NM_001042492.3(NF1):c.7298C>T (p.Thr2433Ile)	NF1	T2412I, T2433I	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000186928	17	29676246	17	31349228	186928	184746	rs755749772	NC_000017.11:31349227:C:T
NM_001042492.3(NF1):c.6315C>T (p.His2105=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186916	17	29663820	17	31336802	186916	184714	rs145732909	NC_000017.11:31336801:C:T
NM_001042492.3(NF1):c.5724T>C (p.Ile1908=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186905	17	29657428	17	31330410	186905	184696	rs786203312	NC_000017.11:31330409:T:C
NM_001042492.3(NF1):c.99A>G (p.Lys33=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186861	17	29483039	17	31156021	186861	184498	rs786203280	NC_000017.11:31156020:A:G
NM_001042492.3(NF1):c.1974C>T (p.Leu658=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186846	17	29552241	17	31225223	186846	184568	rs751318331	NC_000017.11:31225222:C:T
NM_001042492.3(NF1):c.5032T>C (p.Tyr1678His)	NF1	Y1657H, Y1678H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186815	17	29653034	17	31326016	186815	184680	rs786203241	NC_000017.11:31326015:T:C
NM_001042492.3(NF1):c.8446G>A (p.Gly2816Arg)	NF1	G2795R, G2816R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186814	17	29701099	17	31374081	186814	184789	rs778233452	NC_000017.11:31374080:G:A
NM_001042492.3(NF1):c.1775G>A (p.Ser592Asn)	NF1	S592N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2020)	criteria provided, conflicting interpretations	VCV000186812	17	29550515	17	31223497	186812	184560	rs760256377	NC_000017.11:31223496:G:A
NM_001042492.3(NF1):c.5753A>G (p.Asn1918Ser)	NF1	N1897S, N1918S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	VCV000186792	17	29657457	17	31330439	186792	184698	rs534249104	NC_000017.11:31330438:A:G
NM_001042492.3(NF1):c.3732T>A (p.Val1244=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186782	17	29562652	17	31235634	186782	184636	rs756653022	NC_000017.11:31235633:T:A
NM_001042492.3(NF1):c.4944C>T (p.Thr1648=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Dec 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186765	17	29652946	17	31325928	186765	184677	rs759291615	NC_000017.11:31325927:C:T
NM_001042492.3(NF1):c.5019C>T (p.Asn1673=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186756	17	29653021	17	31326003	186756	184679	rs767699634	NC_000017.11:31326002:C:T
NM_001042492.3(NF1):c.6555G>A (p.Arg2185=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000186748	17	29664513	17	31337495	186748	184724	rs786203189	NC_000017.11:31337494:G:A
NM_001042492.3(NF1):c.7536C>T (p.Gly2512=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000186746	17	29679353	17	31352335	186746	184761	rs786203187	NC_000017.11:31352334:C:T
NM_001042492.3(NF1):c.493A>G (p.Thr165Ala)	NF1	T165A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186745	17	29496922	17	31169904	186745	184511	rs786203186	NC_000017.11:31169903:A:G
NM_001042492.3(NF1):c.6666G>C (p.Thr2222=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186677	17	29664860	17	31337842	186677	184731	rs780247942	NC_000017.11:31337841:G:C
NM_001042492.3(NF1):c.3038C>T (p.Thr1013Met)	NF1	T1013M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186673	17	29557325	17	31230307	186673	184617	rs786203132	NC_000017.11:31230306:C:T
NM_001042492.3(NF1):c.7003A>G (p.Thr2335Ala)	NF1	T2314A, T2335A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186672	17	29667604	17	31340586	186672	184738	rs370209920	NC_000017.11:31340585:A:G
NM_001042492.3(NF1):c.4503C>T (p.Asp1501=)	NF1		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186666	17	29587459	17	31260441	186666	184666	rs577394398	NC_000017.11:31260440:C:T
NM_001042492.3(NF1):c.2188A>T (p.Asn730Tyr)	NF1	N730Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2020)	criteria provided, conflicting interpretations	VCV000186662	17	29553639	17	31226621	186662	184586	rs758893131	NC_000017.11:31226620:A:T
NM_001042492.3(NF1):c.3461A>G (p.Asn1154Ser)	NF1	N1154S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186659	17	29559864	17	31232846	186659	184626	rs371544233	NC_000017.11:31232845:A:G
NM_001042492.3(NF1):c.2032C>A (p.Pro678Thr)	NF1	P678T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186638	17	29553483	17	31226465	186638	184578	rs758691069	NC_000017.11:31226464:C:A
NM_001042492.3(NF1):c.1410A>C (p.Glu470Asp)	NF1	E470D	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186619	17	29541486	17	31214468	186619	184548	rs786203090	NC_000017.11:31214467:A:C
NM_001042492.3(NF1):c.2594C>T (p.Pro865Leu)	NF1	P865L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186610	17	29556227	17	31229209	186610	184604	rs786203084	NC_000017.11:31229208:C:T
NM_001042492.3(NF1):c.6387C>T (p.Ile2129=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186601	17	29663892	17	31336874	186601	184718	rs786203078	NC_000017.11:31336873:C:T
NM_001042492.3(NF1):c.1593A>G (p.Gln531=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Apr 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186578	17	29546088	17	31219070	186578	184552	rs773712266	NC_000017.11:31219069:A:G
NM_001042492.3(NF1):c.1587C>T (p.Leu529=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186560	17	29546082	17	31219064	186560	184551	rs786203041	NC_000017.11:31219063:C:T
NM_001042492.3(NF1):c.122A>C (p.Glu41Ala)	NF1	E41A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186556	17	29483062	17	31156044	186556	184500	rs786203038	NC_000017.11:31156043:A:C
NM_001042492.3(NF1):c.1620G>T (p.Glu540Asp)	NF1	E540D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186553	17	29546115	17	31219097	186553	184555	rs766748586	NC_000017.11:31219096:G:T
NM_001042492.3(NF1):c.6171A>T (p.Ile2057=)	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not specified|not provided|Neurofibromatosis-Noonan syndrome|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186545	17	29663676	17	31336658	186545	184711	rs140733963	NC_000017.11:31336657:A:T
NM_001042492.3(NF1):c.6033A>G (p.Leu2011=)	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|not provided	Benign/Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186544	17	29663377	17	31336359	186544	184710	rs147995863	NC_000017.11:31336358:A:G
NM_001042492.3(NF1):c.6665C>T (p.Thr2222Met)	NF1	T2201M, T2222M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186514	17	29664859	17	31337841	186514	184730	rs369803831	NC_000017.11:31337840:C:T
NM_001042492.3(NF1):c.3375G>A (p.Ala1125=)	NF1		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186480	17	29559778	17	31232760	186480	184623	rs112589561	NC_000017.11:31232759:G:A
NM_001042492.3(NF1):c.1999A>G (p.Met667Val)	NF1	M667V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186476	17	29552266	17	31225248	186476	184572	rs749833271	NC_000017.11:31225247:A:G
NM_001042492.3(NF1):c.7513G>C (p.Ala2505Pro)	NF1	A2484P, A2505P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186443	17	29679330	17	31352312	186443	184758	rs786202955	NC_000017.11:31352311:G:C
NM_001042492.3(NF1):c.8061T>C (p.Ser2687=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186419	17	29685588	17	31358570	186419	184780	rs786202936	NC_000017.11:31358569:T:C
NM_001042492.3(NF1):c.3690G>A (p.Val1230=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2020)	criteria provided, conflicting interpretations	VCV000186368	17	29560213	17	31233195	186368	184634	rs183296277	NC_000017.11:31233194:G:A
NM_001042492.3(NF1):c.239A>G (p.Tyr80Cys)	NF1	Y80C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000186333	17	29486062	17	31159044	186333	184503	rs4795581	NC_000017.11:31159043:A:G
NM_001042492.3(NF1):c.91C>T (p.His31Tyr)	NF1	H31Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186329	17	29483031	17	31156013	186329	184497	rs786202864	NC_000017.11:31156012:C:T
NM_001042492.3(NF1):c.8497A>C (p.Asn2833His)	NF1	N2812H, N2833H	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186327	17	29701150	17	31374132	186327	184793	rs786202863	NC_000017.11:31374131:A:C
NM_001042492.3(NF1):c.1806A>G (p.Glu602=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186321	17	29550546	17	31223528	186321	184562	rs370454753	NC_000017.11:31223527:A:G
NM_001042492.3(NF1):c.3024A>G (p.Ala1008=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186307	17	29557311	17	31230293	186307	184616	rs779490777	NC_000017.11:31230292:A:G
NM_001042492.3(NF1):c.876C>T (p.Asn292=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186258	17	29509671	17	31182653	186258	184527	rs786202811	NC_000017.11:31182652:C:T
NM_001042492.3(NF1):c.7742C>G (p.Thr2581Ser)	NF1	T2560S, T2581S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000186257	17	29683981	17	31356963	186257	184770	rs757632129	NC_000017.11:31356962:C:G
NM_001042492.3(NF1):c.2999G>T (p.Arg1000Leu)	NF1	R1000L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186250	17	29557286	17	31230268	186250	184614	rs753082620	NC_000017.11:31230267:G:T
NM_001042492.3(NF1):c.1370A>T (p.His457Leu)	NF1	H457L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186192	17	29533367	17	31206349	186192	184546	rs786202763	NC_000017.11:31206348:A:T
NM_001042492.3(NF1):c.905G>A (p.Ser302Asn)	NF1	S302N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2020)	criteria provided, conflicting interpretations	VCV000186172	17	29527456	17	31200438	186172	184530	rs786202746	NC_000017.11:31200437:G:A
NM_001042492.3(NF1):c.7213A>G (p.Ile2405Val)	NF1	I2384V, I2405V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|Juvenile myelomonocytic leukemia|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2021)	criteria provided, conflicting interpretations	VCV000186162	17	29676161	17	31349143	186162	184744	rs565708398	NC_000017.11:31349142:A:G
NM_001042492.3(NF1):c.1089A>G (p.Pro363=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186131	17	29528081	17	31201063	186131	184537	rs757508086	NC_000017.11:31201062:A:G
NM_001042492.3(NF1):c.100G>A (p.Val34Ile)	NF1	V34I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186105	17	29483040	17	31156022	186105	184499	rs772995929	NC_000017.11:31156021:G:A
NM_001042492.3(NF1):c.1392G>A (p.Pro464=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186095	17	29533389	17	31206371	186095	184547	rs201604273	NC_000017.11:31206370:G:A
NM_001042492.3(NF1):c.5087T>C (p.Leu1696Pro)	NF1	L1675P, L1696P	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186093	17	29653089	17	31326071	186093	184682	rs745489489	NC_000017.11:31326070:T:C
NM_001042492.3(NF1):c.4230C>T (p.Phe1410=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: May 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000186072	17	29585418	17	31258400	186072	184657	rs750213850	NC_000017.11:31258399:C:T
NM_001042492.3(NF1):c.2736A>G (p.Gln912=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186030	17	29556369	17	31229351	186030	184610	rs760097413	NC_000017.11:31229350:A:G
NM_001042492.3(NF1):c.2014G>A (p.Gly672Arg)	NF1	G672R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000186018	17	29553465	17	31226447	186018	184576	rs786202632	NC_000017.11:31226446:G:A
NM_001042492.3(NF1):c.7851G>A (p.Ala2617=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185979	17	29684090	17	31357072	185979	184775	rs751273275	NC_000017.11:31357071:G:A
NM_001042492.3(NF1):c.5787G>C (p.Glu1929Asp)	NF1	E1908D, E1929D	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000185958	17	29657491	17	31330473	185958	184702	rs786202591	NC_000017.11:31330472:G:C
NM_001042492.3(NF1):c.475A>C (p.Thr159Pro)	NF1	T159P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185947	17	29490390	17	31163372	185947	184510	rs371192107	NC_000017.11:31163371:A:C
NM_001042492.3(NF1):c.1182T>C (p.Phe394=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185943	17	29528174	17	31201156	185943	184541	rs786202581	NC_000017.11:31201155:T:C
NM_001042492.3(NF1):c.7988C>T (p.Ser2663Phe)	NF1	S2642F, S2663F	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185941	17	29685515	17	31358497	185941	184777	rs786202579	NC_000017.11:31358496:C:T
NM_001042492.3(NF1):c.2248A>G (p.Thr750Ala)	NF1	T750A	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185917	17	29553699	17	31226681	185917	184591	rs748064845	NC_000017.11:31226680:A:G
NM_001042492.3(NF1):c.5508C>T (p.Pro1836=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185914	17	29654756	17	31327738	185914	184690	rs786202557	NC_000017.11:31327737:C:T
NM_001042492.3(NF1):c.5906A>T (p.Gln1969Leu)	NF1	Q1948L, Q1969L	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000185913	17	29661949	17	31334931	185913	184705	rs143502927	NC_000017.11:31334930:A:T
NM_001042492.3(NF1):c.7693A>G (p.Thr2565Ala)	NF1	T2544A, T2565A	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185904	17	29683555	17	31356537	185904	184767	rs786202548	NC_000017.11:31356536:A:G
NM_001042492.3(NF1):c.2191C>T (p.Leu731Phe)	NF1	L731F	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000185893	17	29553642	17	31226624	185893	184587	rs185204667	NC_000017.11:31226623:C:T
NM_001042492.3(NF1):c.7442G>T (p.Gly2481Val)	NF1	G2460V, G2481V	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185891	17	29677321	17	31350303	185891	184754	rs786202540	NC_000017.11:31350302:G:T
NM_001042492.3(NF1):c.2281G>C (p.Ala761Pro)	NF1	A761P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000185850	17	29554265	17	31227247	185850	184593	rs786202504	NC_000017.11:31227246:G:C
NM_001042492.3(NF1):c.5925T>C (p.Leu1975=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185840	17	29661968	17	31334950	185840	184706	rs375776474	NC_000017.11:31334949:T:C
NM_001042492.3(NF1):c.4394A>G (p.Asn1465Ser)	NF1	N1444S, N1465S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185835	17	29586111	17	31259093	185835	184663	rs786202492	NC_000017.11:31259092:A:G
NM_001042492.3(NF1):c.6664A>G (p.Thr2222Ala)	NF1	T2201A, T2222A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2020)	criteria provided, conflicting interpretations	VCV000185829	17	29664858	17	31337840	185829	184729	rs745945481	NC_000017.11:31337839:A:G
NM_001042492.3(NF1):c.2244G>A (p.Met748Ile)	NF1	M748I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185815	17	29553695	17	31226677	185815	184590	rs786202478	NC_000017.11:31226676:G:A
NM_001042492.3(NF1):c.6704+3A>G	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000185805	17	29664901	17	31337883	185805	184732	rs375560135	NC_000017.11:31337882:A:G
NM_001042492.3(NF1):c.5458A>C (p.Ile1820Leu)	NF1	I1799L, I1820L	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185791	17	29654706	17	31327688	185791	184688	rs786202459	NC_000017.11:31327687:A:C
NM_001042492.3(NF1):c.7348C>T (p.Arg2450Ter)	NF1	R2429*, R2450*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Lisch nodules|Subcutaneous neurofibromas|not provided|not specified	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185789	17	29677227	17	31350209	185789	184747	rs786202457	NC_000017.11:31350208:C:T
NM_001042492.3(NF1):c.805C>T (p.Leu269=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185788	17	29509600	17	31182582	185788	184521	rs786202456	NC_000017.11:31182581:C:T
NM_001042492.3(NF1):c.3883A>G (p.Thr1295Ala)	NF1	T1295A	Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided|not specified|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2020)	criteria provided, conflicting interpretations	VCV000185777	17	29562948	17	31235930	185777	184644	rs143836226	NC_000017.11:31235929:A:G
NM_001042492.3(NF1):c.393A>C (p.Ala131=)	NF1		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Likely benign(Last reviewed: Apr 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185776	17	29490308	17	31163290	185776	184508	rs761086521	NC_000017.11:31163289:A:C
NM_001042492.3(NF1):c.7833T>C (p.Thr2611=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185773	17	29684072	17	31357054	185773	184773	rs786202445	NC_000017.11:31357053:T:C
NM_001042492.3(NF1):c.2640G>A (p.Val880=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185771	17	29556273	17	31229255	185771	184606	rs786202443	NC_000017.11:31229254:G:A
NM_001042492.3(NF1):c.2010A>G (p.Ala670=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185768	17	29553461	17	31226443	185768	184574	rs786202440	NC_000017.11:31226442:A:G
NM_001042492.3(NF1):c.1954C>T (p.Arg652Cys)	NF1	R652C	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185762	17	29552221	17	31225203	185762	184567	rs786202436	NC_000017.11:31225202:C:T
NM_001042492.3(NF1):c.2921A>G (p.Asn974Ser)	NF1	N974S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2020)	criteria provided, conflicting interpretations	VCV000185759	17	29556923	17	31229905	185759	184612	rs557875547	NC_000017.11:31229904:A:G
NM_001042492.3(NF1):c.1548C>T (p.Pro516=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185734	17	29546043	17	31219025	185734	184550	rs768883989	NC_000017.11:31219024:C:T
NM_001042492.3(NF1):c.4803T>C (p.Ala1601=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185617	17	29592325	17	31265307	185617	184670	rs148662566	NC_000017.11:31265306:T:C
NM_001042492.3(NF1):c.354C>T (p.Cys118=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|not specified|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000185589	17	29490269	17	31163251	185589	184505	rs768777585	NC_000017.11:31163250:C:T
NM_001042492.3(NF1):c.6264G>A (p.Leu2088=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185551	17	29663769	17	31336751	185551	184712	rs762751192	NC_000017.11:31336750:G:A
NM_001042492.3(NF1):c.5731A>G (p.Ile1911Val)	NF1	I1890V, I1911V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185542	17	29657435	17	31330417	185542	184697	rs146523293	NC_000017.11:31330416:A:G
NM_001042492.3(NF1):c.2032C>T (p.Pro678Ser)	NF1	P678S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185532	17	29553483	17	31226465	185532	184579	rs758691069	NC_000017.11:31226464:C:T
NM_001042492.3(NF1):c.4495A>G (p.Ile1499Val)	NF1	I1478V, I1499V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185497	17	29587451	17	31260433	185497	184664	rs764654925	NC_000017.11:31260432:A:G
NM_001042492.3(NF1):c.7415C>G (p.Pro2472Arg)	NF1	P2451R, P2472R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185455	17	29677294	17	31350276	185455	184753	rs786202184	NC_000017.11:31350275:C:G
NM_001042492.3(NF1):c.5139G>A (p.Gly1713=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185450	17	29653141	17	31326123	185450	184684	rs786202181	NC_000017.11:31326122:G:A
NM_001042492.3(NF1):c.7526C>T (p.Pro2509Leu)	NF1	P2488L, P2509L	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185402	17	29679343	17	31352325	185402	184759	rs786202146	NC_000017.11:31352324:C:T
NM_001042492.3(NF1):c.1264G>A (p.Ala422Thr)	NF1	A422T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Mar 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185401	17	29533261	17	31206243	185401	184543	rs786202145	NC_000017.11:31206242:G:A
NM_001042492.3(NF1):c.6428-3C>T	NF1		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2021)	criteria provided, conflicting interpretations	VCV000185376	17	29664383	17	31337365	185376	184720	rs374014162	NC_000017.11:31337364:C:T
NM_001042492.3(NF1):c.2573C>G (p.Ser858Cys)	NF1	S858C	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2021)	criteria provided, conflicting interpretations	VCV000185364	17	29556206	17	31229188	185364	184603	rs369493270	NC_000017.11:31229187:C:G
NM_001042492.3(NF1):c.5609G>A (p.Arg1870Gln)	NF1	R1849Q, R1870Q	Rhabdomyosarcoma|not provided|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185354	17	29654857	17	31327839	185354	184694	rs786202112	NC_000017.11:31327838:G:A
NM_001042492.3(NF1):c.3213A>G (p.Ala1071=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2020)	criteria provided, conflicting interpretations	VCV000185313	17	29559106	17	31232088	185313	184621	rs786202077	NC_000017.11:31232087:A:G
NM_001042492.3(NF1):c.6773G>A (p.Arg2258Gln)	NF1	R2237Q, R2258Q	Neurofibromatosis, type 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185248	17	29665111	17	31338093	185248	184733	rs786202030	NC_000017.11:31338092:G:A
NM_001042492.3(NF1):c.4263G>A (p.Pro1421=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185237	17	29585451	17	31258433	185237	184659	rs201648604	NC_000017.11:31258432:G:A
NM_001042492.3(NF1):c.7484C>T (p.Ser2495Phe)	NF1	S2474F, S2495F	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185223	17	29679301	17	31352283	185223	184756	rs757245615	NC_000017.11:31352282:C:T
NM_001042492.3(NF1):c.2458G>A (p.Val820Met)	NF1	V820M	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185170	17	29556091	17	31229073	185170	184598	rs761408020	NC_000017.11:31229072:G:A
NM_001042492.3(NF1):c.4120C>T (p.His1374Tyr)	NF1	H1374Y	not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000185155	17	29579965	17	31252947	185155	184654	rs764123241	NC_000017.11:31252946:C:T
NM_001042492.3(NF1):c.6552C>T (p.Asp2184=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Jan 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000185148	17	29664510	17	31337492	185148	184723	rs376808264	NC_000017.11:31337491:C:T
NM_001042492.3(NF1):c.2251+5A>G	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185107	17	29553707	17	31226689	185107	184592	rs786201934	NC_000017.11:31226688:A:G
NM_001042492.3(NF1):c.898C>T (p.Leu300=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185099	17	29527449	17	31200431	185099	184529	rs786201926	NC_000017.11:31200430:C:T
NM_001042492.3(NF1):c.3686A>G (p.Asn1229Ser)	NF1	N1229S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185096	17	29560209	17	31233191	185096	184633	rs140523180	NC_000017.11:31233190:A:G
NM_001042492.3(NF1):c.6345G>A (p.Pro2115=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185087	17	29663850	17	31336832	185087	184716	rs779475182	NC_000017.11:31336831:G:A
NM_000267.3(NF1):c.6792C>A (p.Tyr2264Ter)	NF1	Y2264*, Y2285*	Neurofibromatosis, type 1|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Ewing sarcoma|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185082	17	29665757	17	31338739	185082	184734	rs772295894	NC_000017.11:31338738:C:A
NM_001042492.3(NF1):c.378A>C (p.Glu126Asp)	NF1	E126D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000185081	17	29490293	17	31163275	185081	184507	rs786201914	NC_000017.11:31163274:A:C
NM_001042492.3(NF1):c.1308G>A (p.Ser436=)	NF1		Neurofibromatosis, familial spinal|not provided|Hereditary cancer-predisposing syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000185065	17	29533305	17	31206287	185065	184545	rs765425127	NC_000017.11:31206286:G:A
NM_001042492.3(NF1):c.6881C>T (p.Thr2294Ile)	NF1	T2273I, T2294I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185064	17	29665783	17	31338765	185064	184735	rs786201902	NC_000017.11:31338764:C:T
NM_001042492.3(NF1):c.4227G>C (p.Met1409Ile)	NF1	M1388I, M1409I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000185056	17	29585415	17	31258397	185056	184656	rs786201895	NC_000017.11:31258396:G:C
NM_001042492.3(NF1):c.7645T>C (p.Ser2549Pro)	NF1	S2528P, S2549P	Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000185037	17	29683507	17	31356489	185037	184765	rs767458044	NC_000017.11:31356488:T:C
NM_001042492.3(NF1):c.2233A>G (p.Ser745Gly)	NF1	S745G	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185011	17	29553684	17	31226666	185011	184589	rs786201865	NC_000017.11:31226665:A:G
NM_001042492.3(NF1):c.7461A>G (p.Thr2487=)	NF1		not provided|Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000185009	17	29679278	17	31352260	185009	184755	rs149924365	NC_000017.11:31352259:A:G
NM_001042492.3(NF1):c.582G>A (p.Leu194=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: May 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184989	17	29497011	17	31169993	184989	184514	rs786201846	NC_000017.11:31169992:G:A
NM_001042492.3(NF1):c.4043A>G (p.His1348Arg)	NF1	H1348R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184987	17	29576070	17	31249052	184987	184650	rs786201844	NC_000017.11:31249051:A:G
NM_001042492.3(NF1):c.2803A>C (p.Asn935His)	NF1	N935H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184962	17	29556436	17	31229418	184962	184611	rs786201823	NC_000017.11:31229417:A:C
NM_001042492.3(NF1):c.5424G>A (p.Thr1808=)	NF1		Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184959	17	29654672	17	31327654	184959	184687	rs765841113	NC_000017.11:31327653:G:A
NM_001042492.3(NF1):c.7528A>G (p.Thr2510Ala)	NF1	T2489A, T2510A	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184948	17	29679345	17	31352327	184948	184760	rs145794301	NC_000017.11:31352326:A:G
NM_001042492.3(NF1):c.3375G>T (p.Ala1125=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184927	17	29559778	17	31232760	184927	184624	rs112589561	NC_000017.11:31232759:G:T
NM_001042492.3(NF1):c.861C>T (p.Asp287=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Likely benign(Last reviewed: Dec 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184914	17	29509656	17	31182638	184914	184525	rs749949219	NC_000017.11:31182637:C:T
NM_001042492.3(NF1):c.8367G>A (p.Gln2789=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184905	17	29687711	17	31360693	184905	184786	rs786201780	NC_000017.11:31360692:G:A
NM_001042492.3(NF1):c.2042G>A (p.Arg681Gln)	NF1	R681Q	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184891	17	29553493	17	31226475	184891	184581	rs786201768	NC_000017.11:31226474:G:A
NM_001042492.3(NF1):c.2652G>A (p.Glu884=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 29, 2021)	criteria provided, conflicting interpretations	VCV000184887	17	29556285	17	31229267	184887	184607	rs757843283	NC_000017.11:31229266:G:A
NM_001042492.3(NF1):c.2019C>T (p.Cys673=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184886	17	29553470	17	31226452	184886	184577	rs146624509	NC_000017.11:31226451:C:T
NM_001042492.3(NF1):c.864G>C (p.Val288=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000184857	17	29509659	17	31182641	184857	184526	rs201181517	NC_000017.11:31182640:G:C
NM_001042492.3(NF1):c.6624T>C (p.Ala2208=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184846	17	29664582	17	31337564	184846	184726	rs746061888	NC_000017.11:31337563:T:C
NM_001042492.3(NF1):c.321G>A (p.Thr107=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184845	17	29490236	17	31163218	184845	184504	rs786201731	NC_000017.11:31163217:G:A
NM_001042492.3(NF1):c.1305C>T (p.His435=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184829	17	29533302	17	31206284	184829	184544	rs786201720	NC_000017.11:31206283:C:T
NM_001042492.3(NF1):c.3906T>G (p.Asp1302Glu)	NF1	D1302E	Neurofibromatosis, familial spinal|not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184818	17	29562971	17	31235953	184818	184647	rs549058591	NC_000017.11:31235952:T:G
NM_001042492.3(NF1):c.3111T>C (p.Phe1037=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Likely benign(Last reviewed: Jan 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184805	17	29557398	17	31230380	184805	184619	rs200240170	NC_000017.11:31230379:T:C
NM_001042492.3(NF1):c.2421C>T (p.Ser807=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184779	17	29556054	17	31229036	184779	184596	rs771345891	NC_000017.11:31229035:C:T
NM_001042492.3(NF1):c.4836-3T>C	NF1		not specified|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000184766	17	29652835	17	31325817	184766	184672	rs372460369	NC_000017.11:31325816:T:C
NM_001042492.3(NF1):c.6375G>A (p.Leu2125=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184762	17	29663880	17	31336862	184762	184717	rs773467465	NC_000017.11:31336861:G:A
NM_001042492.3(NF1):c.5931G>A (p.Lys1977=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184761	17	29661974	17	31334956	184761	184707	rs786201672	NC_000017.11:31334955:G:A
NM_001042492.3(NF1):c.1926A>G (p.Gln642=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184758	17	29552193	17	31225175	184758	184566	rs774806150	NC_000017.11:31225174:A:G
NM_001042492.3(NF1):c.1113A>C (p.Ala371=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184737	17	29528105	17	31201087	184737	184538	rs786201652	NC_000017.11:31201086:A:C
NM_001042492.3(NF1):c.3786T>C (p.Ser1262=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184727	17	29562706	17	31235688	184727	184639	rs786201645	NC_000017.11:31235687:T:C
NM_001042492.3(NF1):c.8484C>T (p.Gly2828=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184723	17	29701137	17	31374119	184723	184791	rs143289497	NC_000017.11:31374118:C:T
NM_001042492.3(NF1):c.5883G>A (p.Lys1961=)	NF1		not provided|Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184711	17	29661926	17	31334908	184711	184704	rs144808600	NC_000017.11:31334907:G:A
NM_001042492.3(NF1):c.5049C>T (p.Asn1683=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000184710	17	29653051	17	31326033	184710	184681	rs140994965	NC_000017.11:31326032:C:T
NM_001042492.3(NF1):c.4500T>C (p.Ser1500=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184707	17	29587456	17	31260438	184707	184665	rs775018971	NC_000017.11:31260437:T:C
NM_001042492.3(NF1):c.2490C>T (p.Asp830=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184700	17	29556123	17	31229105	184700	184599	rs786201629	NC_000017.11:31229104:C:T
NM_001042492.3(NF1):c.6558A>C (p.Ser2186=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184684	17	29664516	17	31337498	184684	184725	rs753509749	NC_000017.11:31337497:A:C
NM_001042492.3(NF1):c.6528T>C (p.Ile2176=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184643	17	29664486	17	31337468	184643	184722	rs147522129	NC_000017.11:31337467:T:C
NM_001042492.3(NF1):c.8223G>C (p.Thr2741=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184642	17	29687567	17	31360549	184642	184785	rs777755159	NC_000017.11:31360548:G:C
NM_001042492.3(NF1):c.1173C>T (p.Asn391=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184613	17	29528165	17	31201147	184613	184540	rs367986994	NC_000017.11:31201146:C:T
NM_001042492.3(NF1):c.7998C>T (p.Asn2666=)	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000184602	17	29685525	17	31358507	184602	184778	rs747307832	NC_000017.11:31358506:C:T
NM_001042492.3(NF1):c.4749A>G (p.Glu1583=)	NF1		Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2021)	criteria provided, conflicting interpretations	VCV000184594	17	29592271	17	31265253	184594	184669	rs144091165	NC_000017.11:31265252:A:G
NM_001042492.3(NF1):c.2658C>T (p.Asn886=)	NF1		not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184587	17	29556291	17	31229273	184587	184608	rs781549970	NC_000017.11:31229272:C:T
NM_001042492.3(NF1):c.1005T>C (p.Asn335=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184560	17	29527556	17	31200538	184560	184535	rs777369021	NC_000017.11:31200537:T:C
NM_001042492.3(NF1):c.2622G>A (p.Lys874=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000184534	17	29556255	17	31229237	184534	184605	rs77917884	NC_000017.11:31229236:G:A
NM_001042492.3(NF1):c.8499T>C (p.Asn2833=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided|not specified|Neurofibromatosis-Noonan syndrome	Benign/Likely benign(Last reviewed: Mar 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184533	17	29701152	17	31374134	184533	184794	rs142636150	NC_000017.11:31374133:T:C
NM_001042492.3(NF1):c.*4T>C	NF1		not specified|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|not provided	Benign/Likely benign(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184532	17	29701177	17	31374159	184532	184796	rs201044568	NC_000017.11:31374158:T:C
NM_001042492.3(NF1):c.1599C>G (p.Val533=)	NF1		Neurofibromatosis, type 1|not provided|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184523	17	29546094	17	31219076	184523	184553	rs369458366	NC_000017.11:31219075:C:G
NM_001042492.3(NF1):c.1495C>T (p.Leu499=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184522	17	29541571	17	31214553	184522	184549	rs764095472	NC_000017.11:31214552:C:T
NM_001042492.3(NF1):c.8451C>T (p.Ser2817=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184521	17	29701104	17	31374086	184521	184790	rs547090599	NC_000017.11:31374085:C:T
NM_001042492.3(NF1):c.4851A>G (p.Gln1617=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided	Benign/Likely benign(Last reviewed: Sep 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184492	17	29652853	17	31325835	184492	184673	rs150309802	NC_000017.11:31325834:A:G
NM_001042492.3(NF1):c.8395G>A (p.Val2799Ile)	NF1	V2778I, V2799I	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000184462	17	29701048	17	31374030	184462	184788	rs377393842	NC_000017.11:31374029:G:A
NM_001042492.3(NF1):c.7026G>A (p.Leu2342=)	NF1		not specified|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000184460	17	29667627	17	31340609	184460	184739	rs371581213	NC_000017.11:31340608:G:A
NM_001042492.3(NF1):c.7569C>T (p.Ser2523=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000184459	17	29679386	17	31352368	184459	184763	rs786201476	NC_000017.11:31352367:C:T
NM_001042492.3(NF1):c.1891G>A (p.Gly631Arg)	NF1	G631R	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2021)	criteria provided, conflicting interpretations	VCV000184452	17	29552158	17	31225140	184452	184565	rs757424379	NC_000017.11:31225139:G:A
NM_001042492.3(NF1):c.969C>T (p.Ala323=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Likely benign(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184436	17	29527520	17	31200502	184436	184534	rs786201462	NC_000017.11:31200501:C:T
NM_001042492.3(NF1):c.4321T>C (p.Leu1441=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000184429	17	29585509	17	31258491	184429	184661	rs786201458	NC_000017.11:31258490:T:C
NM_001042492.3(NF1):c.4665A>C (p.Ala1555=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184428	17	29588816	17	31261798	184428	184668	rs786201457	NC_000017.11:31261797:A:C
NM_001042492.3(NF1):c.2133C>T (p.Arg711=)	NF1		not specified|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184381	17	29553584	17	31226566	184381	184583	rs148085908	NC_000017.11:31226565:C:T
NM_001042492.3(NF1):c.3468C>T (p.Asn1156=)	NF1		not specified|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184364	17	29559871	17	31232853	184364	184627	rs147955381	NC_000017.11:31232852:C:T
NM_000267.3(NF1):c.1137C>T (p.Cys379=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184363	17	29528129	17	31201111	184363	184539	rs139648455	NC_000017.11:31201110:C:T
NM_001042492.3(NF1):c.7554C>G (p.Ala2518=)	NF1		none provided|not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Benign/Likely benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184332	17	29679371	17	31352353	184332	184762	rs141897690	NC_000017.11:31352352:C:G
NM_001042492.3(NF1):c.2547A>C (p.Gly849=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184331	17	29556180	17	31229162	184331	184601	rs748303121	NC_000017.11:31229161:A:C
NM_001042492.3(NF1):c.3867C>T (p.Phe1289=)	NF1		not specified|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|not provided|Hereditary cancer-predisposing syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2021)	criteria provided, conflicting interpretations	VCV000184320	17	29562787	17	31235769	184320	184643	rs138186428	NC_000017.11:31235768:C:T
NM_001042492.3(NF1):c.8394C>T (p.Asn2798=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Likely benign(Last reviewed: Jul 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184302	17	29701047	17	31374029	184302	184787	rs376136174	NC_000017.11:31374028:C:T
NM_001042492.3(NF1):c.3765A>G (p.Gln1255=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2021)	criteria provided, conflicting interpretations	VCV000184300	17	29562685	17	31235667	184300	184638	rs766896025	NC_000017.11:31235666:A:G
NM_001042492.3(NF1):c.8216T>C (p.Ile2739Thr)	NF1	I2718T, I2739T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184299	17	29687560	17	31360542	184299	184784	rs752541243	NC_000017.11:31360541:T:C
NM_001042492.3(NF1):c.2178G>C (p.Val726=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2021)	criteria provided, conflicting interpretations	VCV000184280	17	29553629	17	31226611	184280	184584	rs369590240	NC_000017.11:31226610:G:C
NM_001042492.3(NF1):c.696A>G (p.Thr232=)	NF1		Neurofibromatosis, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184279	17	29508769	17	31181751	184279	184517	rs368691517	NC_000017.11:31181750:A:G
NM_001042492.3(NF1):c.1987G>A (p.Gly663Arg)	NF1	G663R	not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Cafe-au-lait spot|Febrile seizures|Hyperactivity|Abnormal macular morphology|Abnormality of vision|EEG with generalized slow activity|Abnormal electroretinogram|Strabismus|Visual loss|Abnormality of macular pigmentation|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)	criteria provided, conflicting interpretations	VCV000184278	17	29552254	17	31225236	184278	184571	rs140653372	NC_000017.11:31225235:G:A
NM_001042492.3(NF1):c.3636C>A (p.Val1212=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184274	17	29560159	17	31233141	184274	184632	rs145126193	NC_000017.11:31233140:C:A
NM_001042492.3(NF1):c.7368A>G (p.Lys2456=)	NF1		Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184263	17	29677247	17	31350229	184263	184748	rs201287021	NC_000017.11:31350228:A:G
NM_001042492.3(NF1):c.369C>G (p.Thr123=)	NF1		not specified|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184262	17	29490284	17	31163266	184262	184506	rs146691765	NC_000017.11:31163265:C:G
NM_001042492.3(NF1):c.7909C>T (p.Arg2637Ter)	NF1	R2616*, R2637*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184261	17	29684326	17	31357308	184261	184776	rs786201367	NC_000017.11:31357307:C:T
NM_001042492.3(NF1):c.3801G>A (p.Leu1267=)	NF1		Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000184260	17	29562721	17	31235703	184260	184640	rs786201366	NC_000017.11:31235702:G:A
NM_001042492.3(NF1):c.3270A>C (p.Gly1090=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184233	17	29559163	17	31232145	184233	184622	rs150015024	NC_000017.11:31232144:A:C
NM_001042492.3(NF1):c.4269A>G (p.Glu1423=)	NF1		Hereditary cancer-predisposing syndrome|not provided|not specified|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184231	17	29585457	17	31258439	184231	184660	rs17886566	NC_000017.11:31258438:A:G
NM_001042492.3(NF1):c.7410T>C (p.Asn2470=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184229	17	29677289	17	31350271	184229	184752	rs17881903	NC_000017.11:31350270:T:C
NM_001042492.3(NF1):c.6393C>T (p.His2131=)	NF1		not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184228	17	29663898	17	31336880	184228	184719	rs17881788	NC_000017.11:31336879:C:T
NM_001042492.3(NF1):c.1975C>T (p.Arg659Trp)	NF1	R659W	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184227	17	29552242	17	31225224	184227	184569	rs757512142	NC_000017.11:31225223:C:T
NM_001042492.3(NF1):c.1976G>A (p.Arg659Gln)	NF1	R659Q	Neurofibromatosis, type 1|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2021)	criteria provided, conflicting interpretations	VCV000184221	17	29552243	17	31225225	184221	184570	rs151138158	NC_000017.11:31225224:G:A
NM_001042492.3(NF1):c.6628T>C (p.Leu2210=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184213	17	29664586	17	31337568	184213	184727	rs138265293	NC_000017.11:31337567:T:C
NM_001042492.3(NF1):c.1032A>G (p.Leu344=)	NF1		Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000184189	17	29527583	17	31200565	184189	184536	rs199832006	NC_000017.11:31200564:A:G
NM_001042492.3(NF1):c.5757G>A (p.Glu1919=)	NF1		Neurofibromatosis-Noonan syndrome|none provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000184188	17	29657461	17	31330443	184188	184699	rs141077224	NC_000017.11:31330442:G:A
NM_001042492.3(NF1):c.7755C>T (p.Ser2585=)	NF1		not specified|not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|none provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184185	17	29683994	17	31356976	184185	184771	rs17881980	NC_000017.11:31356975:C:T
NM_001042492.3(NF1):c.1884C>T (p.Tyr628=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184167	17	29552151	17	31225133	184167	184564	rs555635097	NC_000017.11:31225132:C:T
NM_001042492.3(NF1):c.7246C>T (p.Leu2416=)	NF1		Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000184165	17	29676194	17	31349176	184165	184745	rs786201310	NC_000017.11:31349175:C:T
NM_001042492.3(NF1):c.4835+5G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184157	17	29592362	17	31265344	184157	184671	rs786201306	NC_000017.11:31265343:G:C
NM_001042492.3(NF1):c.7584A>G (p.Gln2528=)	NF1		not specified|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184154	17	29679401	17	31352383	184154	184764	rs55865524	NC_000017.11:31352382:A:G
NM_001042492.3(NF1):c.4929G>A (p.Val1643=)	NF1		not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184149	17	29652931	17	31325913	184149	184676	rs17880521	NC_000017.11:31325912:G:A
NM_001042492.3(NF1):c.1810T>C (p.Leu604=)	NF1		Neurofibromatosis-Noonan syndrome|not specified|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Tumor susceptibility linked to germline BAP1 mutations|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jun 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184133	17	29550550	17	31223532	184133	184563	rs142712751	NC_000017.11:31223531:T:C
NM_001042492.3(NF1):c.5235G>A (p.Lys1745=)	NF1		not provided|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|not specified|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184131	17	29653237	17	31326219	184131	184685	rs17887014	NC_000017.11:31326218:G:A
NM_001042492.3(NF1):c.168C>T (p.Ser56=)	NF1		not provided|none provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|not specified|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184126	17	29483108	17	31156090	184126	184501	rs17881168	NC_000017.11:31156089:C:T
NM_001042492.3(NF1):c.846G>A (p.Gln282=)	NF1		not provided|not specified|Neurofibromatosis-Noonan syndrome|Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Myopathy, centronuclear, 5|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184123	17	29509641	17	31182623	184123	184524	rs138840528	NC_000017.11:31182622:G:A
NM_001042492.3(NF1):c.4882T>C (p.Leu1628=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|not specified|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184058	17	29652884	17	31325866	184058	184674	rs10512435	NC_000017.11:31325865:T:C
NM_001042492.3(NF1):c.2985G>C (p.Leu995=)	NF1		not specified|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Benign(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000184057	17	29556987	17	31229969	184057	184613	rs17881467	NC_000017.11:31229968:G:C
NM_001042492.3(NF1):c.2544G>A (p.Gly848=)	NF1		not provided|not specified|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Hereditary cancer-predisposing syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183949	17	29556177	17	31229159	183949	184600	rs17883704	NC_000017.11:31229158:G:A
NM_001042492.3(NF1):c.2034G>A (p.Pro678=)	NF1		not provided|Neurofibromatosis-Noonan syndrome|none provided|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183826	17	29553485	17	31226467	183826	184580	rs2285892	NC_000017.11:31226466:G:A
NM_001042492.3(NF1):c.702G>A (p.Leu234=)	NF1		none provided|Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|not provided	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183825	17	29508775	17	31181757	183825	184518	rs1801052	NC_000017.11:31181756:G:A
NM_001042492.3(NF1):c.3932C>T (p.Ser1311Phe)	NF1	S1311F	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Feb 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000143014	17	29562997	17	31235979	143014	152728	rs587782894	NC_000017.11:31235978:C:T
NM_001042492.3(NF1):c.8494C>T (p.Arg2832Cys)	NF1	R2811C, R2832C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143013	17	29701147	17	31374129	143013	152727	rs587782893	NC_000017.11:31374128:C:T
NM_001042492.3(NF1):c.241C>A (p.Leu81Ile)	NF1	L81I	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Apr 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142858	17	29486064	17	31159046	142858	152572	rs587782772	NC_000017.11:31159045:C:A
NM_001042492.3(NF1):c.5513C>G (p.Ser1838Cys)	NF1	S1817C, S1838C	Hereditary cancer-predisposing syndrome|not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Juvenile myelomonocytic leukemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)	criteria provided, conflicting interpretations	VCV000142804	17	29654761	17	31327743	142804	152518	rs368654378	NC_000017.11:31327742:C:G
NM_001042492.3(NF1):c.3402G>A (p.Met1134Ile)	NF1	M1134I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142761	17	29559805	17	31232787	142761	152475	rs587782701	NC_000017.11:31232786:G:A
NM_001042492.3(NF1):c.8378-4C>T	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000142759	17	29701027	17	31374009	142759	152473	rs587782700	NC_000017.11:31374008:C:T
NM_001042492.3(NF1):c.1553C>T (p.Thr518Ile)	NF1	T518I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142755	17	29546048	17	31219030	142755	152469	rs587782696	NC_000017.11:31219029:C:T
NM_001042492.3(NF1):c.6806G>A (p.Arg2269His)	NF1	R2248H, R2269H	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142753	17	29665144	17	31338126	142753	152467	rs562367786	NC_000017.11:31338125:G:A
NM_001042492.3(NF1):c.83A>C (p.Gln28Pro)	NF1	Q28P	Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Feb 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142742	17	29483023	17	31156005	142742	152456	rs587782686	NC_000017.11:31156004:A:C
NM_001042492.3(NF1):c.475A>G (p.Thr159Ala)	NF1	T159A	none provided|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 28, 2021)	criteria provided, conflicting interpretations	VCV000142741	17	29490390	17	31163372	142741	152455	rs371192107	NC_000017.11:31163371:A:G
NM_001042492.3(NF1):c.2015G>T (p.Gly672Val)	NF1	G672V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142707	17	29553466	17	31226448	142707	152421	rs371817372	NC_000017.11:31226447:G:T
NM_001042492.3(NF1):c.3198-5T>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142679	17	29559086	17	31232068	142679	152393	rs587782639	NC_000017.11:31232067:T:C
NM_001042492.3(NF1):c.1801C>T (p.Arg601Trp)	NF1	R601W	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142619	17	29550541	17	31223523	142619	152333	rs587782592	NC_000017.11:31223522:C:T
NM_001042492.3(NF1):c.1213A>G (p.Thr405Ala)	NF1	T405A	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142100	17	29528456	17	31201438	142100	151814	rs587782233	NC_000017.11:31201437:A:G
NM_001042492.3(NF1):c.5426C>T (p.Pro1809Leu)	NF1	P1788L, P1809L	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2020)	criteria provided, conflicting interpretations	VCV000142084	17	29654674	17	31327656	142084	151798	rs587782220	NC_000017.11:31327655:C:T
NM_001042492.3(NF1):c.3198-4T>C	NF1		not specified|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)	criteria provided, conflicting interpretations	VCV000142080	17	29559087	17	31232069	142080	151794	rs587782218	NC_000017.11:31232068:T:C
NM_001042492.3(NF1):c.4859G>A (p.Gly1620Asp)	NF1	G1599D, G1620D	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000142072	17	29652861	17	31325843	142072	151786	rs587782213	NC_000017.11:31325842:G:A
NM_001042492.3(NF1):c.3498C>T (p.Gly1166=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000142037	17	29560021	17	31233003	142037	151751	rs2066733	NC_000017.11:31233002:C:T
NM_001042492.3(NF1):c.7767G>C (p.Gln2589His)	NF1	Q2568H, Q2589H	Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141997	17	29684006	17	31356988	141997	151711	rs587782168	NC_000017.11:31356987:G:C
NM_001042492.3(NF1):c.1166A>G (p.His389Arg)	NF1	H389R	Hereditary cancer-predisposing syndrome|Inborn genetic diseases|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Midaortic syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2021)	criteria provided, conflicting interpretations	VCV000141982	17	29528158	17	31201140	141982	151696	rs149739570	NC_000017.11:31201139:A:G
NM_001042492.3(NF1):c.364C>T (p.His122Tyr)	NF1	H122Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141914	17	29490279	17	31163261	141914	151628	rs587782107	NC_000017.11:31163260:C:T
NM_001042492.3(NF1):c.8041A>G (p.Ile2681Val)	NF1	I2660V, I2681V	Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000141895	17	29685568	17	31358550	141895	151609	rs146315101	NC_000017.11:31358549:A:G
NM_001042492.3(NF1):c.5839G>T (p.Glu1947Ter)	NF1	E1926*, E1947*	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141892	17	29661882	17	31334864	141892	151606	rs587782088	NC_000017.11:31334863:G:T
NM_001042492.3(NF1):c.2553C>T (p.Cys851=)	NF1		not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Benign/Likely benign(Last reviewed: Feb 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141855	17	29556186	17	31229168	141855	151569	rs2230852	NC_000017.11:31229167:C:T
NM_001042492.3(NF1):c.7520C>T (p.Thr2507Ile)	NF1	T2486I, T2507I	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 14, 2020)	criteria provided, conflicting interpretations	VCV000141844	17	29679337	17	31352319	141844	151558	rs149055633	NC_000017.11:31352318:C:T
NM_001042492.3(NF1):c.5407A>G (p.Ile1803Val)	NF1	I1782V, I1803V	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Sep 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141837	17	29654655	17	31327637	141837	151551	rs559910904	NC_000017.11:31327636:A:G
NM_001042492.3(NF1):c.2022C>T (p.Ser674=)	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141819	17	29553473	17	31226455	141819	151533	rs2230851	NC_000017.11:31226454:C:T
NM_001042492.3(NF1):c.3604G>T (p.Ala1202Ser)	NF1	A1202S	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141747	17	29560127	17	31233109	141747	151461	rs146641724	NC_000017.11:31233108:G:T
NM_001042492.3(NF1):c.4207G>A (p.Gly1403Ser)	NF1	G1382S, G1403S	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141711	17	29585395	17	31258377	141711	151425	rs138227618	NC_000017.11:31258376:G:A
NM_001042492.3(NF1):c.4249G>T (p.Ala1417Ser)	NF1	A1396S, A1417S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141692	17	29585437	17	31258419	141692	151406	rs587781941	NC_000017.11:31258418:G:T
NM_001042492.3(NF1):c.2962A>G (p.Ile988Val)	NF1	I988V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141685	17	29556964	17	31229946	141685	151399	rs587781936	NC_000017.11:31229945:A:G
NM_001042492.3(NF1):c.2434A>C (p.Ile812Leu)	NF1	I812L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141640	17	29556067	17	31229049	141640	151354	rs587781899	NC_000017.11:31229048:A:C
NM_001042492.3(NF1):c.2224G>T (p.Ala742Ser)	NF1	A742S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141637	17	29553675	17	31226657	141637	151351	rs587781896	NC_000017.11:31226656:G:T
NM_001042492.3(NF1):c.734G>A (p.Cys245Tyr)	NF1	C245Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141601	17	29509529	17	31182511	141601	151315	rs587781869	NC_000017.11:31182510:G:A
NM_001042492.3(NF1):c.5257G>A (p.Val1753Ile)	NF1	V1732I, V1753I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided|none provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)	criteria provided, conflicting interpretations	VCV000141594	17	29653259	17	31326241	141594	151308	rs148540952	NC_000017.11:31326240:G:A
NM_001042492.3(NF1):c.4009C>T (p.Arg1337Trp)	NF1	R1337W	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141586	17	29576036	17	31249018	141586	151300	rs146306756	NC_000017.11:31249017:C:T
NM_001042492.3(NF1):c.1855A>G (p.Arg619Gly)	NF1	R619G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000141531	17	29552122	17	31225104	141531	151245	rs587781821	NC_000017.11:31225103:A:G
NM_001042492.3(NF1):c.7963C>A (p.Pro2655Thr)	NF1	P2634T, P2655T	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141493	17	29684380	17	31357362	141493	151207	rs587781791	NC_000017.11:31357361:C:A
NM_001042492.3(NF1):c.4417G>A (p.Asp1473Asn)	NF1	D1452N, D1473N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000141491	17	29586134	17	31259116	141491	151205	rs587781790	NC_000017.11:31259115:G:A
NM_001042492.3(NF1):c.367A>G (p.Thr123Ala)	NF1	T123A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141454	17	29490282	17	31163264	141454	151168	rs587781757	NC_000017.11:31163263:A:G
NM_001042492.3(NF1):c.3436G>A (p.Val1146Ile)	NF1	V1146I	Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000141451	17	29559839	17	31232821	141451	151165	rs201047812	NC_000017.11:31232820:G:A
NM_001042492.3(NF1):c.4219A>G (p.Ser1407Gly)	NF1	S1386G, S1407G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: May 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141448	17	29585407	17	31258389	141448	151162	rs587781755	NC_000017.11:31258388:A:G
NM_001042492.3(NF1):c.3394C>T (p.Arg1132Cys)	NF1	R1132C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141407	17	29559797	17	31232779	141407	151121	rs587781725	NC_000017.11:31232778:C:T
NM_001042492.3(NF1):c.5289A>G (p.Gln1763=)	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141393	17	29654537	17	31327519	141393	151107	rs199703296	NC_000017.11:31327518:A:G
NM_001042492.3(NF1):c.4110+4T>C	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141375	17	29576141	17	31249123	141375	151089	rs587781700	NC_000017.11:31249122:T:C
NM_001042492.3(NF1):c.1588G>A (p.Val530Ile)	NF1	V530I	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Acute monoblastic leukemia|Acute monocytic leukemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)	criteria provided, conflicting interpretations	VCV000141369	17	29546083	17	31219065	141369	151083	rs145191978	NC_000017.11:31219064:G:A
NM_001042492.3(NF1):c.6642+4T>C	NF1		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2020)	criteria provided, conflicting interpretations	VCV000141361	17	29664604	17	31337586	141361	151075	rs587781687	NC_000017.11:31337585:T:C
NM_001042492.3(NF1):c.575G>A (p.Arg192Gln)	NF1	R192Q	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)	criteria provided, conflicting interpretations	VCV000141341	17	29497004	17	31169986	141341	151055	rs587781670	NC_000017.11:31169985:G:A
NM_001042492.3(NF1):c.888+5G>A	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2021)	criteria provided, conflicting interpretations	VCV000141338	17	29509688	17	31182670	141338	151052	rs556444929	NC_000017.11:31182669:G:A
NM_001042492.3(NF1):c.4526G>A (p.Arg1509His)	NF1	R1488H, R1509H	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2021)	criteria provided, conflicting interpretations	VCV000141323	17	29587482	17	31260464	141323	151037	rs546073780	NC_000017.11:31260463:G:A
NM_001042492.3(NF1):c.340C>T (p.Leu114=)	NF1		Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|not provided|Hereditary cancer-predisposing syndrome|not specified	Benign/Likely benign(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141237	17	29490255	17	31163237	141237	150951	rs7207410	NC_000017.11:31163236:C:T
NM_001042492.3(NF1):c.2252-1G>C	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141209	17	29554235	17	31227217	141209	150923	rs587781577	NC_000017.11:31227216:G:C
NM_001042492.3(NF1):c.4421C>T (p.Ala1474Val)	NF1	A1453V	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2021)	criteria provided, conflicting interpretations	VCV000141176	17	29586138	17	31259120	141176	150890	rs587781553	NC_000017.11:31259119:C:T
NM_001042492.3(NF1):c.4579G>T (p.Asp1527Tyr)	NF1	D1506Y, D1527Y	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141164	17	29588730	17	31261712	141164	150878	rs587781542	NC_000017.11:31261711:G:T
NM_001042492.3(NF1):c.8495G>A (p.Arg2832His)	NF1	R2811H, R2832H	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141139	17	29701148	17	31374130	141139	150853	rs587781523	NC_000017.11:31374129:G:A
NM_001042492.3(NF1):c.7910G>A (p.Arg2637Gln)	NF1	R2616Q, R2637Q	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000141130	17	29684327	17	31357309	141130	150844	rs560262404	NC_000017.11:31357308:G:A
NM_001042492.3(NF1):c.231A>T (p.Lys77Asn)	NF1	K77N	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141116	17	29486054	17	31159036	141116	150830	rs373563053	NC_000017.11:31159035:A:T
NM_001042492.3(NF1):c.7841A>G (p.Lys2614Arg)	NF1	K2593R, K2614R	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000141112	17	29684080	17	31357062	141112	150826	rs587781502	NC_000017.11:31357061:A:G
NM_001042492.3(NF1):c.2902A>G (p.Met968Val)	NF1	M968V	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141107	17	29556904	17	31229886	141107	150821	rs587781499	NC_000017.11:31229885:A:G
NM_001042492.3(NF1):c.7108C>T (p.His2370Tyr)	NF1	H2349Y, H2370Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141081	17	29670072	17	31343054	141081	150795	rs587781479	NC_000017.11:31343053:C:T
NM_001042492.3(NF1):c.107C>G (p.Thr36Ser)	NF1	T36S	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2021)	criteria provided, conflicting interpretations	VCV000141048	17	29483047	17	31156029	141048	150762	rs199966218	NC_000017.11:31156028:C:G
NM_001042492.3(NF1):c.8151G>A (p.Pro2717=)	NF1		not specified|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141033	17	29686024	17	31359006	141033	150747	rs2285895	NC_000017.11:31359005:G:A
NM_001042492.3(NF1):c.4508A>G (p.Asn1503Ser)	NF1	N1482S, N1503S	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141029	17	29587464	17	31260446	141029	150743	rs587781445	NC_000017.11:31260445:A:G
NM_001042492.3(NF1):c.8479G>T (p.Ala2827Ser)	NF1	A2806S, A2827S	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141006	17	29701132	17	31374114	141006	150720	rs199878086	NC_000017.11:31374113:G:T
NM_001042492.3(NF1):c.7006G>A (p.Ala2336Thr)	NF1	A2315T, A2336T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141001	17	29667607	17	31340589	141001	150715	rs587781428	NC_000017.11:31340588:G:A
NM_001042492.3(NF1):c.8515G>A (p.Val2839Met)	NF1	V2818M, V2839M	not specified|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000134891	17	29701168	17	31374150	134891	138630	rs368149035	NC_000017.11:31374149:G:A
NM_001042492.3(NF1):c.7531G>C (p.Val2511Leu)	NF1	V2490L, V2511L	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134889	17	29679348	17	31352330	134889	138628	rs2230850	NC_000017.11:31352329:G:C
NM_001042492.3(NF1):c.584A>G (p.Lys195Arg)	NF1	K195R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified|not provided	Uncertain significance(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134888	17	29497013	17	31169995	134888	138627	rs587778552	NC_000017.11:31169994:A:G
NM_001042492.3(NF1):c.6172A>G (p.Ile2058Val)	NF1	I2037V, I2058V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)	criteria provided, conflicting interpretations	VCV000134887	17	29663677	17	31336659	134887	138626	rs201712827	NC_000017.11:31336658:A:G
NM_001042492.3(NF1):c.456A>G (p.Ala152=)	NF1		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Likely benign(Last reviewed: Dec 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134886	17	29490371	17	31163353	134886	138625	rs377481833	NC_000017.11:31163352:A:G
NM_001042492.3(NF1):c.1894T>A (p.Cys632Ser)	NF1	C632S	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not specified	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134883	17	29552161	17	31225143	134883	138622	rs370789267	NC_000017.11:31225142:T:A
NM_001042492.3(NF1):c.1955G>A (p.Arg652His)	NF1	R652H	not specified|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134882	17	29552222	17	31225204	134882	138621	rs587778549	NC_000017.11:31225203:G:A
NM_001042492.3(NF1):c.1994C>T (p.Ser665Phe)	NF1	S665F	not specified|not provided|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 5, 2021)	criteria provided, conflicting interpretations	VCV000134881	17	29552261	17	31225243	134881	138620	rs145891889	NC_000017.11:31225242:C:T
NM_001042492.3(NF1):c.1933A>G (p.Met645Val)	NF1	M645V	Hereditary cancer-predisposing syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|not specified|not provided	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134880	17	29552200	17	31225182	134880	138619	rs146051850	NC_000017.11:31225181:A:G
NM_001042492.3(NF1):c.1549G>A (p.Glu517Lys)	NF1	E517K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134879	17	29546044	17	31219026	134879	138618	rs587778548	NC_000017.11:31219025:G:A
NM_001042492.3(NF1):c.5551C>T (p.Pro1851Ser)	NF1	P1830S, P1851S	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000080405	17	29654799	17	31327781	80405	91296		NC_000017.11:31327780:C:T
NM_001042492.3(NF1):c.1392+1G>A	NF1		Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000080403	17	29533390	17	31206372	80403	91294	rs267604791	NC_000017.11:31206371:G:A
NM_001042492.3(NF1):c.970T>C (p.Cys324Arg)	NF1	C324R	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000068365	17	29527521	17	31200503	68365	79256	rs199474735	NC_000017.11:31200502:T:C
NM_001042492.3(NF1):c.92A>G (p.His31Arg)	NF1	H31R	Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000068364	17	29483032	17	31156014	68364	79255	rs199474725	NC_000017.11:31156013:A:G
NM_001042492.3(NF1):c.7891A>G (p.Thr2631Ala)	NF1	T2610A, T2631A	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: May 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068363	17	29684308	17	31357290	68363	79254	rs199474793	NC_000017.11:31357289:A:G
NM_001042492.3(NF1):c.7069G>A (p.Glu2357Lys)	NF1	E2336K, E2357K	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV000068362	17	29670033	17	31343015	68362	79253	rs199474784	NC_000017.11:31343014:G:A
NM_000267.3(NF1):c.647T>C (p.Leu216Pro)	NF1	L216P	none provided|not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 11, 2020)	criteria provided, conflicting interpretations	VCV000068360	17	29508500	17	31181482	68360	79251	rs199474756	NC_000017.11:31181481:T:C
NM_001042492.3(NF1):c.6001G>A (p.Gly2001Arg)	NF1	G1980R, G2001R	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Nov 4, 2014)	no assertion criteria provided	VCV000068358	17	29662044	17	31335026	68358	79249	rs199474751	NC_000017.11:31335025:G:A
NM_001042492.3(NF1):c.5854T>C (p.Trp1952Arg)	NF1	W1931R, W1952R	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068357	17	29661897	17	31334879	68357	79248	rs199474791	NC_000017.11:31334878:T:C
NM_001042492.3(NF1):c.4813A>G (p.Ile1605Val)	NF1	I1584V, I1605V	not specified|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068354	17	29592335	17	31265317	68354	79245	rs199474766	NC_000017.11:31265316:A:G
NM_001042492.3(NF1):c.479G>C (p.Arg160Thr)	NF1	R160T	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000068353	17	29490394	17	31163376	68353	79244	rs199474752	NC_000017.11:31163375:G:C
NM_001042492.3(NF1):c.470T>A (p.Ile157Asn)	NF1	I157N	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000068352	17	29490385	17	31163367	68352	79243	rs199474744	NC_000017.11:31163366:T:A
NM_001042492.3(NF1):c.4465A>G (p.Ser1489Gly)	NF1	S1468G, S1489G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068351	17	29587421	17	31260403	68351	79242	rs199474743	NC_000017.11:31260402:A:G
NM_001042492.3(NF1):c.4357G>C (p.Val1453Leu)	NF1	V1432L, V1453L	not provided|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000068349	17	29586074	17	31259056	68349	79240	rs199474755	NC_000017.11:31259055:G:C
NM_001042492.3(NF1):c.4352A>C (p.Asn1451Thr)	NF1	N1430T, N1451T	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	VCV000068348	17	29586069	17	31259051	68348	79239	rs199474754	NC_000017.11:31259050:A:C
NM_001042492.3(NF1):c.4337T>C (p.Leu1446Pro)	NF1	L1425P, L1446P	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2021)	criteria provided, conflicting interpretations	VCV000068346	17	29586054	17	31259036	68346	79237	rs199474733	NC_000017.11:31259035:T:C
NM_001042492.3(NF1):c.4331A>G (p.Lys1444Arg)	NF1	K1423R, K1444R	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068344	17	29585519	17	31258501	68344	79235	rs199474781	NC_000017.11:31258500:A:G
NM_001042492.3(NF1):c.4318A>C (p.Lys1440Gln)	NF1	K1419Q, K1440Q	not provided	Likely pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000068342	17	29585506	17	31258488	68342	79233	rs199474790	NC_000017.11:31258487:A:C
NM_001042492.3(NF1):c.3827G>A (p.Arg1276Gln)	NF1	R1276Q	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068341	17	29562747	17	31235729	68341	79232	rs137854556	NC_000017.11:31235728:G:A
NM_001042492.3(NF1):c.3826C>G (p.Arg1276Gly)	NF1	R1276G	Neurofibromatosis, type 1|not provided|not specified	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068340	17	29562746	17	31235728	68340	79231	rs199474742	NC_000017.11:31235727:C:G
NM_001042492.3(NF1):c.3610C>T (p.Arg1204Trp)	NF1	R1204W	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068338	17	29560133	17	31233115	68338	79229	rs199474732	NC_000017.11:31233114:C:T
NM_001042492.3(NF1):c.3610C>G (p.Arg1204Gly)	NF1	R1204G	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068337	17	29560133	17	31233115	68337	79228	rs199474732	NC_000017.11:31233114:C:G
NM_001042492.3(NF1):c.3587T>G (p.Leu1196Arg)	NF1	L1196R	not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000068336	17	29560110	17	31233092	68336	79227	rs199474741	NC_000017.11:31233091:T:G
NM_001042492.3(NF1):c.3578T>G (p.Phe1193Cys)	NF1	F1193C	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000068335	17	29560101	17	31233083	68335	79226	rs199474780	NC_000017.11:31233082:T:G
NM_001042492.3(NF1):c.3467A>G (p.Asn1156Ser)	NF1	N1156S	not specified|Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2020)	criteria provided, conflicting interpretations	VCV000068332	17	29559870	17	31232852	68332	79223	rs199474764	NC_000017.11:31232851:A:G
NM_001042492.3(NF1):c.3217A>G (p.Met1073Val)	NF1	M1073V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068330	17	29559110	17	31232092	68330	79221	rs199474740	NC_000017.11:31232091:A:G
NM_001042492.3(NF1):c.278G>A (p.Cys93Tyr)	NF1	C93Y	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2018)	criteria provided, conflicting interpretations	VCV000068328	17	29486101	17	31159083	68328	79219	rs199474728	NC_000017.11:31159082:G:A
NM_001042492.3(NF1):c.2693T>C (p.Leu898Pro)	NF1	L898P	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068326	17	29556326	17	31229308	68326	79217	rs199474786	NC_000017.11:31229307:T:C
NM_001042492.3(NF1):c.2617C>T (p.Arg873Cys)	NF1	R873C	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000068325	17	29556250	17	31229232	68325	79216	rs199474739	NC_000017.11:31229231:C:T
NM_001042492.3(NF1):c.2543G>A (p.Gly848Glu)	NF1	G848E	not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068324	17	29556176	17	31229158	68324	79215	rs199474748	NC_000017.11:31229157:G:A
NM_001042492.3(NF1):c.2540T>C (p.Leu847Pro)	NF1	L847P	not provided|not specified|Neurofibromatosis, type 1|Midaortic syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068323	17	29556173	17	31229155	68323	79214	rs199474747	NC_000017.11:31229154:T:C
NM_001042492.3(NF1):c.2531T>C (p.Leu844Pro)	NF1	L844P	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068322	17	29556164	17	31229146	68322	79213	rs137854566	NC_000017.11:31229145:T:C
NM_001042492.3(NF1):c.2530C>T (p.Leu844Phe)	NF1	L844F	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068321	17	29556163	17	31229145	68321	79212	rs199474785	NC_000017.11:31229144:C:T
NM_001042492.3(NF1):c.245C>T (p.Ser82Phe)	NF1	S82F	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000068320	17	29486068	17	31159050	68320	79211	rs199474729	NC_000017.11:31159049:C:T
NM_001042492.3(NF1):c.2350T>C (p.Trp784Arg)	NF1	W784R	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068318	17	29554565	17	31227547	68318	79209	rs199474730	NC_000017.11:31227546:T:C
NM_001042492.3(NF1):c.2339C>A (p.Thr780Lys)	NF1	T780K	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068316	17	29554554	17	31227536	68316	79207	rs199474746	NC_000017.11:31227535:C:A
NM_001042492.3(NF1):c.2330G>C (p.Trp777Ser)	NF1	W777S	Neurofibromatosis, type 1|not provided|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068315	17	29554545	17	31227527	68315	79206	rs199474745	NC_000017.11:31227526:G:C
NM_001042492.3(NF1):c.2294G>A (p.Arg765His)	NF1	R765H	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2020)	criteria provided, conflicting interpretations	VCV000068313	17	29554278	17	31227260	68313	79204	rs199474777	NC_000017.11:31227259:G:A
NM_001042492.3(NF1):c.2288T>C (p.Leu763Pro)	NF1	L763P	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068312	17	29554272	17	31227254	68312	79203	rs199474762	NC_000017.11:31227253:T:C
NM_001042492.3(NF1):c.2084T>C (p.Leu695Pro)	NF1	L695P	Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068309	17	29553535	17	31226517	68309	79200	rs199474761	NC_000017.11:31226516:T:C
NM_001042492.3(NF1):c.1885G>A (p.Gly629Arg)	NF1	G629R	Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1|not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000068308	17	29552152	17	31225134	68308	79199	rs199474738	NC_000017.11:31225133:G:A
NM_001042492.3(NF1):c.1748A>G (p.Lys583Arg)	NF1	K583R	Inborn genetic diseases|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068306	17	29550488	17	31223470	68306	79197	rs199474760	NC_000017.11:31223469:A:G
NM_001042492.3(NF1):c.1733T>G (p.Leu578Arg)	NF1	L578R	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000068304	17	29550473	17	31223455	68304	79195	rs199474774	NC_000017.11:31223454:T:G
NM_001042492.3(NF1):c.1646T>C (p.Leu549Pro)	NF1	L549P	not provided|Neurofibromatosis, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068303	17	29548872	17	31221854	68303	79194	rs199474758	NC_000017.11:31221853:T:C
NM_001042492.3(NF1):c.1595T>C (p.Leu532Pro)	NF1	L532P	Neurofibromatosis, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000068302	17	29546090	17	31219072	68302	79193	rs199474737	NC_000017.11:31219071:T:C
NM_001042492.3(NF1):c.1472A>G (p.Tyr491Cys)	NF1	Y491C	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068300	17	29541548	17	31214530	68300	79191	rs199474757	NC_000017.11:31214529:A:G
NM_001042492.3(NF1):c.1013A>G (p.Asp338Gly)	NF1	D338G	Neurofibromatosis, type 1|not provided	Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000068297	17	29527564	17	31200546	68297	79188	rs199474773	NC_000017.11:31200545:A:G
NM_001042492.3(NF1):c.847G>T (p.Asp283Tyr)	NF1	D283Y	Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041680	17	29509642	17	31182624	41680	50119	rs200572531	NC_000017.11:31182623:G:T
NM_001042492.3(NF1):c.8105A>T (p.Tyr2702Phe)	NF1	Y2681F, Y2702F	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000041679	17	29685632	17	31358614	41679	50118	rs201824349	NC_000017.11:31358613:A:T
NM_001042492.3(NF1):c.7595C>T (p.Ala2532Val)	NF1	A2511V, A2532V	Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041678	17	29679412	17	31352394	41678	50117	rs148154172	NC_000017.11:31352393:C:T
NM_001042492.3(NF1):c.7394A>G (p.Asp2465Gly)	NF1	D2444G, D2465G	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041677	17	29677273	17	31350255	41677	50116	rs143474365	NC_000017.11:31350254:A:G
NM_001042492.3(NF1):c.6929C>T (p.Pro2310Leu)	NF1	P2289L, P2310L	Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 1|not provided|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000041675	17	29667530	17	31340512	41675	50114	rs148736217	NC_000017.11:31340511:C:T
NM_001042492.3(NF1):c.6782A>G (p.His2261Arg)	NF1	H2240R, H2261R	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|not provided	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041674	17	29665120	17	31338102	41674	50113	rs201336602	NC_000017.11:31338101:A:G
NM_001042492.3(NF1):c.528T>A (p.Asp176Glu)	NF1	D176E	not provided|not specified|Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|none provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000041673	17	29496957	17	31169939	41673	50112	rs112306990	NC_000017.11:31169938:T:A
NM_001042492.3(NF1):c.5035A>G (p.Ile1679Val)	NF1	I1658V, I1679V	not specified|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041672	17	29653037	17	31326019	41672	50111	rs147327414	NC_000017.11:31326018:A:G
NM_001042492.3(NF1):c.3998A>G (p.Glu1333Gly)	NF1	E1333G	Neurofibromatosis, type 1|not provided	Uncertain significance(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000041671	17	29576025	17	31249007	41671	50110	rs200618072	NC_000017.11:31249006:A:G
NM_001042492.3(NF1):c.2585C>G (p.Thr862Ser)	NF1	T862S	not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome|Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Juvenile myelomonocytic leukemia|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000041670	17	29556218	17	31229200	41670	50109	rs200302954	NC_000017.11:31229199:C:G
NM_001042492.3(NF1):c.2033C>T (p.Pro678Leu)	NF1	P678L	not specified|not provided|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2021)	criteria provided, conflicting interpretations	VCV000041669	17	29553484	17	31226466	41669	50108	rs17881753	NC_000017.11:31226465:C:T
NM_001042492.3(NF1):c.574C>T (p.Arg192Ter)	NF1	R192*	Neurofibromatosis, type 1|not provided|Neurofibromatosis type 6|Focal T2 hyperintense basal ganglia lesion|Axillary freckling|Neurofibroma|Juvenile myelomonocytic leukemia|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040093	17	29497003	17	31169985	40093	48599	rs397514641	NC_000017.11:31169984:C:T
NM_001042492.3(NF1):c.4231C>T (p.Leu1411Phe)	NF1	L1390F, L1411F	Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030992	17	29585419	17	31258401	30992	39949	rs199474789	NC_000017.11:31258400:C:T
NM_001042492.3(NF1):c.4724+1G>C	NF1		Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000374	17	29588876	17	31261858	374	15413	rs1555619056	NC_000017.11:31261857:G:C
NM_001042492.3(NF1):c.2531T>G (p.Leu844Arg)	NF1	L844R	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000373	17	29556164	17	31229146	373	15412	rs137854566	NC_000017.11:31229145:T:G
NM_001042492.3(NF1):c.5773G>T (p.Glu1925Ter)	NF1	E1904*, E1925*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000000372	17	29657477	17	31330459	372	15411	rs137854565	NC_000017.11:31330458:G:T
NM_001042492.3(NF1):c.3728T>C (p.Leu1243Pro)	NF1	L1243P	not provided|Neurofibromatosis, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2019)	criteria provided, conflicting interpretations	VCV000000371	17	29562648	17	31235630	371	15410	rs137854564	NC_000017.11:31235629:T:C
NM_001042492.3(NF1):c.7189+3A>C	NF1		Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000000369	17	29670156	17	31343138	369	15408	rs267606610	NC_000017.11:31343137:A:C
NM_001042492.3(NF1):c.1070T>C (p.Leu357Pro)	NF1	L357P	Neurofibromatosis, familial spinal|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000000368	17	29528062	17	31201044	368	15407	rs137854563	NC_000017.11:31201043:T:C
NM_001042492.3(NF1):c.3721C>T (p.Arg1241Ter)	NF1	R1241*	not provided|Inborn genetic diseases|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000361	17	29562641	17	31235623	361	15400	rs137854562	NC_000017.11:31235622:C:T
NM_001042492.3(NF1):c.6007-5A>G	NF1		Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000359	17	29663346	17	31336328	359	15398	rs267606604	NC_000017.11:31336327:A:G
NM_001042492.3(NF1):c.6263T>C (p.Leu2088Pro)	NF1	L2067P, L2088P	Neurofibromatosis, familial spinal	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000000358	17	29663768	17	31336750	358	15397	rs137854561	NC_000017.11:31336749:T:C
NM_001042492.3(NF1):c.4021C>T (p.Gln1341Ter)	NF1	Q1341*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 2, 2015)	criteria provided, single submitter	VCV000000357	17	29576048	17	31249030	357	15396	rs137854559	NC_000017.11:31249029:C:T
NM_001042492.3(NF1):c.1260+1G>A	NF1		not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000356	17	29528504	17	31201486	356	15395	rs267606603	NC_000017.11:31201485:G:A
NM_001042492.3(NF1):c.1523T>C (p.Leu508Pro)	NF1	L508P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000000355	17	29541599	17	31214581	355	15394	rs137854558	NC_000017.11:31214580:T:C
NM_000267.3(NF1):c.1466A>G (p.Tyr489Cys)	NF1	Y489C	Neurofibromatosis, type 1|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Rhabdomyosarcoma|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000354	17	29541542	17	31214524	354	15393	rs137854557	NC_000017.11:31214523:A:G
NM_001042492.3(NF1):c.3827G>C (p.Arg1276Pro)	NF1	R1276P	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000353	17	29562747	17	31235729	353	15392	rs137854556	NC_000017.11:31235728:G:C
NM_001042492.3(NF1):c.1642-8A>G	NF1		Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000000352	17	29548860	17	31221842	352	15391	rs267606602	NC_000017.11:31221841:A:G
NM_001042492.3(NF1):c.4677G>A (p.Trp1559Ter)	NF1	W1538*, W1559*	not provided|Juvenile myelomonocytic leukemia|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000350	17	29588828	17	31261810	350	15389	rs137854555	NC_000017.11:31261809:G:A
NM_001042492.3(NF1):c.4236A>T (p.Arg1412Ser)	NF1	R1391S, R1412S	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000000348	17	29585424	17	31258406	348	15387	rs137854554	NC_000017.11:31258405:A:T
NM_001042492.3(NF1):c.3104T>G (p.Met1035Arg)	NF1	M1035R	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000000347	17	29557391	17	31230373	347	15386	rs137854553	NC_000017.11:31230372:T:G
NM_001042492.3(NF1):c.3113+1G>A	NF1		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000345	17	29557401	17	31230383	345	15384	rs267606599	NC_000017.11:31230382:G:A
NM_001042492.3(NF1):c.4084C>T (p.Arg1362Ter)	NF1	R1362*	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Aug 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000344	17	29576111	17	31249093	344	15383	rs137854560	NC_000017.11:31249092:C:T
NM_001042492.3(NF1):c.5902C>T (p.Arg1968Ter)	NF1	R1947*, R1968*	Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Neurofibromatosis-Noonan syndrome|Juvenile myelomonocytic leukemia|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1|Tibial pseudoarthrosis|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000343	17	29661945	17	31334927	343	15382	rs137854552	NC_000017.11:31334926:C:T
NM_001042492.3(NF1):c.6574T>A (p.Tyr2192Asn)	NF1	Y2171N, Y2192N	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000340	17	29664532	17	31337514	340	15379	rs267606598	NC_000017.11:31337513:T:A
NM_001042492.3(NF1):c.6490C>A (p.Leu2164Met)	NF1	L2143M, L2164M	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000000339	17	29664448	17	31337430	339	15378	rs137854551	NC_000017.11:31337429:C:A
NM_001042492.3(NF1):c.4330A>G (p.Lys1444Glu)	NF1	K1423E, K1444E	Neurofibromatosis type 6|Neurofibroma|Optic nerve glioma|Axillary freckling|not provided|Neurofibromatosis, type 1|Neurofibromatosis, familial spinal|Juvenile myelomonocytic leukemia|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000336	17	29585518	17	31258500	336	15375	rs137854550	NC_000017.11:31258499:A:G
NM_001042492.3(NF1):c.5908A>T (p.Arg1970Ter)	NF1	R1949*, R1970*	Neurofibromatosis, type 1	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000000335	17	29661951	17	31334933	335	15374	rs267606595	NC_000017.11:31334932:A:T
NM_001042492.3(NF1):c.5858T>C (p.Leu1953Pro)	NF1	L1932P, L1953P	not provided|Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000000334	17	29661901	17	31334883	334	15373	rs199474792	NC_000017.11:31334882:T:C
NM_000268.4(NF2):c.1738-19C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319665	22	30090722	22	29694733	1319665	1309916		NC_000022.11:29694732:C:A
NM_000268.4(NF2):c.448-1G>A	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319646	22	30050645	22	29654656	1319646	1309897		NC_000022.11:29654655:G:A
NM_000268.4(NF2):c.464C>T (p.Pro155Leu)	NF2	P113L, P114L, P155L, P72L	not provided	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001312631	22	30050662	22	29654673	1312631	1302892		NC_000022.11:29654672:C:T
NM_000268.4(NF2):c.1737+1420C>T	NF2	P497L, P538L, P539L, P580L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 27, 2021)	criteria provided, single submitter	VCV001172746	22	30079010	22	29683021	1172746	1161937		NC_000022.11:29683020:C:T
NM_000268.4(NF2):c.738T>C (p.Pro246=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001162035	22	30057256	22	29661267	1162035	1150038		NC_000022.11:29661266:T:C
NM_000268.4(NF2):c.1011G>A (p.Gln337=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV001161744	22	30067826	22	29671837	1161744	1150043		NC_000022.11:29671836:G:A
NM_000268.4(NF2):c.1574+10C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV001160833	22	30074322	22	29678333	1160833	1150055		NC_000022.11:29678332:C:T
NM_000268.4(NF2):c.1155T>C (p.Ala385=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001160414	22	30069290	22	29673301	1160414	1150045		NC_000022.11:29673300:T:C
NM_000268.4(NF2):c.36C>T (p.Ser12=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001157795	22	30000023	22	29604034	1157795	1150028		NC_000022.11:29604033:C:T
NM_000268.4(NF2):c.946T>C (p.Leu316=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001157501	22	30064382	22	29668393	1157501	1150041		NC_000022.11:29668392:T:C
NM_000268.4(NF2):c.1170C>T (p.Ile390=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, single submitter	VCV001157230	22	30069305	22	29673316	1157230	1150046		NC_000022.11:29673315:C:T
NM_000268.4(NF2):c.1743C>T (p.Thr581=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV001156629	22	30090746	22	29694757	1156629	1150056		NC_000022.11:29694756:C:T
NM_000268.4(NF2):c.501A>G (p.Glu167=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, single submitter	VCV001156568	22	30050699	22	29654710	1156568	1150034		NC_000022.11:29654709:A:G
NM_000268.4(NF2):c.1527C>T (p.Phe509=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV001156355	22	30074265	22	29678276	1156355	1150053		NC_000022.11:29678275:C:T
NM_000268.4(NF2):c.886-5C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV001155712	22	30064317	22	29668328	1155712	1150040		NC_000022.11:29668327:C:T
NM_000268.4(NF2):c.696G>A (p.Leu232=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV001155014	22	30057214	22	29661225	1155014	1150037		NC_000022.11:29661224:G:A
NM_000268.4(NF2):c.873T>C (p.Arg291=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001152466	22	30061041	22	29665052	1152466	1150039		NC_000022.11:29665051:T:C
NM_000268.4(NF2):c.1383A>G (p.Ala461=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV001151813	22	30070867	22	29674878	1151813	1150048		NC_000022.11:29674877:A:G
NM_000268.4(NF2):c.1419G>A (p.Leu473=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001151400	22	30070903	22	29674914	1151400	1150049		NC_000022.11:29674913:G:A
NM_000268.4(NF2):c.1383A>C (p.Ala461=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV001149315	22	30070867	22	29674878	1149315	1150047		NC_000022.11:29674877:A:C
NM_000268.4(NF2):c.363+7C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001149144	22	30035208	22	29639219	1149144	1150031		NC_000022.11:29639218:C:T
NM_000268.4(NF2):c.1518T>A (p.Ser506=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV001149119	22	30074256	22	29678267	1149119	1150052		NC_000022.11:29678266:T:A
NM_000268.4(NF2):c.447+10A>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001148287	22	30038284	22	29642295	1148287	1150033		NC_000022.11:29642294:A:G
NM_000268.4(NF2):c.531T>C (p.Tyr177=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001147317	22	30051597	22	29655608	1147317	1150035		NC_000022.11:29655607:T:C
NM_000268.4(NF2):c.999+7A>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV001147156	22	30064442	22	29668453	1147156	1150042		NC_000022.11:29668452:A:C
NM_000268.4(NF2):c.1509C>T (p.Asp503=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV001146932	22	30074247	22	29678258	1146932	1150051		NC_000022.11:29678257:C:T
NM_000268.4(NF2):c.676-9G>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV001145679	22	30057185	22	29661196	1145679	1150036		NC_000022.11:29661195:G:T
NM_000268.4(NF2):c.241-10A>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV001145326	22	30035069	22	29639080	1145326	1150029		NC_000022.11:29639079:A:G
NM_000268.4(NF2):c.1574+9C>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV001145197	22	30074321	22	29678332	1145197	1150054		NC_000022.11:29678331:C:A
NM_000268.4(NF2):c.402T>C (p.Pro134=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 22, 2020)	criteria provided, single submitter	VCV001143164	22	30038229	22	29642240	1143164	1150032		NC_000022.11:29642239:T:C
NM_000268.4(NF2):c.1443C>T (p.Tyr481=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV001142929	22	30070927	22	29674938	1142929	1150050		NC_000022.11:29674937:C:T
NM_000268.4(NF2):c.289T>C (p.Leu97=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV001142915	22	30035127	22	29639138	1142915	1150030		NC_000022.11:29639137:T:C
NM_000268.4(NF2):c.1017C>T (p.Leu339=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV001142310	22	30067832	22	29671843	1142310	1150044		NC_000022.11:29671842:C:T
NM_000268.4(NF2):c.339C>T (p.Ile113=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001139712	22	30035177	22	29639188	1139712	1129060		NC_000022.11:29639187:C:T
NM_000268.4(NF2):c.687C>A (p.Gly229=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001138852	22	30057205	22	29661216	1138852	1129066		NC_000022.11:29661215:C:A
NM_000268.4(NF2):c.811-10A>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001137085	22	30060969	22	29664980	1137085	1129067		NC_000022.11:29664979:A:G
NM_000268.4(NF2):c.546A>G (p.Glu182=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV001135008	22	30051612	22	29655623	1135008	1129064		NC_000022.11:29655622:A:G
NM_000268.4(NF2):c.1236C>T (p.Ile412=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001134878	22	30069371	22	29673382	1134878	1129069		NC_000022.11:29673381:C:T
NM_000268.4(NF2):c.69C>A (p.Thr23=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001134875	22	30000056	22	29604067	1134875	1129055		NC_000022.11:29604066:C:A
NM_000268.4(NF2):c.517-10T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV001134648	22	30051573	22	29655584	1134648	1129063		NC_000022.11:29655583:T:C
NM_000268.4(NF2):c.165G>A (p.Gly55=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001133921	22	30032790	22	29636801	1133921	1129056		NC_000022.11:29636800:G:A
NM_000268.4(NF2):c.1209A>C (p.Ala403=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV001132545	22	30069344	22	29673355	1132545	1129068		NC_000022.11:29673354:A:C
NM_000268.4(NF2):c.190C>T (p.Leu64=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001130491	22	30032815	22	29636826	1130491	1129057		NC_000022.11:29636825:C:T
NM_000268.4(NF2):c.1524C>T (p.Asp508=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001130320	22	30074262	22	29678273	1130320	1129075		NC_000022.11:29678272:C:T
NM_000268.4(NF2):c.1446+10G>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001128774	22	30070940	22	29674951	1128774	1129073		NC_000022.11:29674950:G:C
NM_000268.4(NF2):c.1470G>T (p.Pro490=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001128768	22	30074208	22	29678219	1128768	1129074		NC_000022.11:29678218:G:T
NM_000268.4(NF2):c.1353A>G (p.Ala451=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 11, 2020)	criteria provided, single submitter	VCV001128383	22	30070837	22	29674848	1128383	1129071		NC_000022.11:29674847:A:G
NM_000268.4(NF2):c.318A>G (p.Glu106=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV001127895	22	30035156	22	29639167	1127895	1129059		NC_000022.11:29639166:A:G
NM_000268.4(NF2):c.672C>T (p.Ile224=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001127176	22	30054250	22	29658261	1127176	1129065		NC_000022.11:29658260:C:T
NM_000268.4(NF2):c.438C>G (p.Val146=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001126498	22	30038265	22	29642276	1126498	1129062		NC_000022.11:29642275:C:G
NM_000268.4(NF2):c.240+8T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV001125683	22	30032873	22	29636884	1125683	1129058		NC_000022.11:29636883:T:C
NM_000268.4(NF2):c.1560G>A (p.Glu520=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001124131	22	30074298	22	29678309	1124131	1129076		NC_000022.11:29678308:G:A
NM_000268.4(NF2):c.1245A>G (p.Thr415=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001124121	22	30069380	22	29673391	1124121	1129070		NC_000022.11:29673390:A:G
NM_000268.4(NF2):c.1431C>A (p.Thr477=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV001122027	22	30070915	22	29674926	1122027	1129072		NC_000022.11:29674925:C:A
NM_000268.4(NF2):c.417G>A (p.Val139=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001120756	22	30038244	22	29642255	1120756	1129061		NC_000022.11:29642254:G:A
NM_000268.4(NF2):c.264G>A (p.Lys88=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001119920	22	30035102	22	29639113	1119920	1107639		NC_000022.11:29639112:G:A
NM_000268.4(NF2):c.726C>T (p.His242=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 14, 2020)	criteria provided, single submitter	VCV001119256	22	30057244	22	29661255	1119256	1107646		NC_000022.11:29661254:C:T
NM_000268.4(NF2):c.9G>A (p.Gly3=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV001118453	22	29999996	22	29604007	1118453	1107633		NC_000022.11:29604006:G:A
NM_000268.4(NF2):c.1005G>A (p.Glu335=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV001117827	22	30067820	22	29671831	1117827	1107649		NC_000022.11:29671830:G:A
NM_000268.4(NF2):c.241-4G>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001114004	22	30035075	22	29639086	1114004	1107638		NC_000022.11:29639085:G:C
NM_000268.4(NF2):c.363+9G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV001113852	22	30035210	22	29639221	1113852	1107641		NC_000022.11:29639220:G:A
NM_000268.4(NF2):c.78C>T (p.Ile26=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 3, 2020)	criteria provided, single submitter	VCV001113514	22	30000065	22	29604076	1113514	1107635		NC_000022.11:29604075:C:T
NM_000268.4(NF2):c.745A>C (p.Arg249=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 14, 2019)	criteria provided, single submitter	VCV001112874	22	30057263	22	29661274	1112874	1107647		NC_000022.11:29661273:A:C
NM_000268.4(NF2):c.1197C>T (p.Ala399=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV001112814	22	30069332	22	29673343	1112814	1107653		NC_000022.11:29673342:C:T
NM_000268.4(NF2):c.1521C>T (p.Phe507=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001112805	22	30074259	22	29678270	1112805	1107654		NC_000022.11:29678269:C:T
NM_000268.4(NF2):c.115-6T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001112646	22	30032734	22	29636745	1112646	1107636		NC_000022.11:29636744:T:C
NM_000268.4(NF2):c.1081C>T (p.Leu361=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 28, 2020)	criteria provided, single submitter	VCV001112377	22	30067896	22	29671907	1112377	1107651		NC_000022.11:29671906:C:T
NM_000268.4(NF2):c.826C>T (p.Leu276=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001110744	22	30060994	22	29665005	1110744	1107648		NC_000022.11:29665004:C:T
NM_000268.4(NF2):c.651C>T (p.Tyr217=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001110136	22	30054229	22	29658240	1110136	1107645		NC_000022.11:29658239:C:T
NM_000268.4(NF2):c.402T>G (p.Pro134=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV001110003	22	30038229	22	29642240	1110003	1107642		NC_000022.11:29642239:T:G
NM_000268.4(NF2):c.1122+10G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001109016	22	30067947	22	29671958	1109016	1107652		NC_000022.11:29671957:G:A
NM_000268.4(NF2):c.516+7G>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV001108536	22	30050721	22	29654732	1108536	1107643		NC_000022.11:29654731:G:T
NM_000268.4(NF2):c.1080G>C (p.Leu360=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV001106647	22	30067895	22	29671906	1106647	1107650		NC_000022.11:29671905:G:C
NM_000268.4(NF2):c.342A>G (p.Thr114=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV001104717	22	30035180	22	29639191	1104717	1107640		NC_000022.11:29639190:A:G
NM_000268.4(NF2):c.72G>A (p.Val24=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001104143	22	30000059	22	29604070	1104143	1107634		NC_000022.11:29604069:G:A
NM_000268.4(NF2):c.115-4G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV001102753	22	30032736	22	29636747	1102753	1107637		NC_000022.11:29636746:G:A
NM_000268.4(NF2):c.516+9T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001099208	22	30050723	22	29654734	1099208	1107644		NC_000022.11:29654733:T:C
NM_000268.4(NF2):c.336G>A (p.Glu112=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001095694	22	30035174	22	29639185	1095694	1085921		NC_000022.11:29639184:G:A
NM_000268.4(NF2):c.183C>T (p.Phe61=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV001094957	22	30032808	22	29636819	1094957	1085918		NC_000022.11:29636818:C:T
NM_000268.4(NF2):c.1218G>A (p.Glu406=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV001094785	22	30069353	22	29673364	1094785	1085931		NC_000022.11:29673363:G:A
NM_000268.4(NF2):c.676-4A>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV001092758	22	30057190	22	29661201	1092758	1085924		NC_000022.11:29661200:A:G
NM_000268.4(NF2):c.1785C>G (p.Leu595=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001092249	22	30090788	22	29694799	1092249	1085937		NC_000022.11:29694798:C:G
NM_000268.4(NF2):c.1428C>T (p.Ala476=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001091674	22	30070912	22	29674923	1091674	1085935		NC_000022.11:29674922:C:T
NM_000268.4(NF2):c.600-8C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV001088507	22	30054170	22	29658181	1088507	1085923		NC_000022.11:29658180:C:T
NM_000268.4(NF2):c.276C>T (p.Val92=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV001088386	22	30035114	22	29639125	1088386	1085920		NC_000022.11:29639124:C:T
NM_000268.4(NF2):c.1000-5C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001087029	22	30067810	22	29671821	1087029	1085928		NC_000022.11:29671820:C:T
NM_000268.4(NF2):c.810+7C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV001086556	22	30057335	22	29661346	1086556	1085926		NC_000022.11:29661345:C:T
NM_000268.4(NF2):c.1569A>G (p.Lys523=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001085957	22	30074307	22	29678318	1085957	1085936		NC_000022.11:29678317:A:G
NM_000268.4(NF2):c.6C>T (p.Ala2=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV001085863	22	29999993	22	29604004	1085863	1085915		NC_000022.11:29604003:C:T
NM_000268.4(NF2):c.1242C>T (p.Ala414=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV001085563	22	30069377	22	29673388	1085563	1085932		NC_000022.11:29673387:C:T
NM_000268.4(NF2):c.1059G>A (p.Arg353=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001084140	22	30067874	22	29671885	1084140	1085929		NC_000022.11:29671884:G:A
NM_000268.4(NF2):c.114+7G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001082160	22	30000108	22	29604119	1082160	1085917		NC_000022.11:29604118:G:A
NM_000268.4(NF2):c.219C>T (p.Ala73=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV001080536	22	30032844	22	29636855	1080536	1085919		NC_000022.11:29636854:C:T
NM_000268.4(NF2):c.693G>A (p.Glu231=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 13, 2019)	criteria provided, single submitter	VCV001080379	22	30057211	22	29661222	1080379	1085925		NC_000022.11:29661221:G:A
NM_000268.4(NF2):c.1299C>T (p.Ala433=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV001080206	22	30069434	22	29673445	1080206	1085933		NC_000022.11:29673444:C:T
NM_000268.4(NF2):c.57C>G (p.Pro19=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001078598	22	30000044	22	29604055	1078598	1085916		NC_000022.11:29604054:C:G
NM_000268.4(NF2):c.1078C>T (p.Leu360=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001078268	22	30067893	22	29671904	1078268	1085930		NC_000022.11:29671903:C:T
NM_000268.4(NF2):c.432C>T (p.Tyr144=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001077220	22	30038259	22	29642270	1077220	1085922		NC_000022.11:29642269:C:T
NM_000268.4(NF2):c.1198C>T (p.Gln400Ter)	NF2	Q317*, Q358*, Q359*, Q400*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001076273	22	30069333	22	29673344	1076273	1065013		NC_000022.11:29673343:C:T
NM_000268.4(NF2):c.1621G>T (p.Glu541Ter)	NF2	E458*, E499*, E500*, E541*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001075185	22	30077474	22	29681485	1075185	1065015		NC_000022.11:29681484:G:T
NM_000268.4(NF2):c.1606C>T (p.Gln536Ter)	NF2	Q453*, Q494*, Q495*, Q536*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV001075085	22	30077459	22	29681470	1075085	1065014		NC_000022.11:29681469:C:T
NM_000268.4(NF2):c.481G>T (p.Gly161Ter)	NF2	G119*, G120*, G161*, G78*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001074395	22	30050679	22	29654690	1074395	1065011		NC_000022.11:29654689:G:T
NM_000268.4(NF2):c.241-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001072590	22	30035077	22	29639088	1072590	1065006		NC_000022.11:29639087:A:G
NM_000268.4(NF2):c.240+2T>C	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001072589	22	30032867	22	29636878	1072589	1065005		NC_000022.11:29636877:T:C
NM_000268.4(NF2):c.114+1G>A	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001068058	22	30000102	22	29604113	1068058	1056673		NC_000022.11:29604112:G:A
NM_000268.4(NF2):c.363+2T>C	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001067623	22	30035203	22	29639214	1067623	1056674		NC_000022.11:29639213:T:C
NM_000268.4(NF2):c.872G>T (p.Arg291Leu)	NF2	R208L, R249L, R250L, R291L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001062752	22	30061040	22	29665051	1062752	1052067		NC_000022.11:29665050:G:T
NM_000268.4(NF2):c.1732A>G (p.Lys578Glu)	NF2	K495E, K536E, K537E, K578E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001061943	22	30077585	22	29681596	1061943	1052073		NC_000022.11:29681595:A:G
NM_000268.4(NF2):c.89A>G (p.Asp30Gly)	NF2	D30G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001061022	22	30000076	22	29604087	1061022	1052060		NC_000022.11:29604086:A:G
NM_000268.4(NF2):c.1685A>G (p.His562Arg)	NF2	H479R, H520R, H521R, H562R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001059809	22	30077538	22	29681549	1059809	1052072		NC_000022.11:29681548:A:G
NM_000268.4(NF2):c.376A>G (p.Ile126Val)	NF2	I126V, I43V, I84V, I85V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001058201	22	30038203	22	29642214	1058201	1052064		NC_000022.11:29642213:A:G
NM_000268.4(NF2):c.73A>G (p.Arg25Gly)	NF2	R25G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001057999	22	30000060	22	29604071	1057999	1052059		NC_000022.11:29604070:A:G
NM_000268.4(NF2):c.240+6G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001056984	22	30032871	22	29636882	1056984	1052063		NC_000022.11:29636881:G:A
NM_000268.4(NF2):c.50A>G (p.Lys17Arg)	NF2	K17R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001056444	22	30000037	22	29604048	1056444	1052058		NC_000022.11:29604047:A:G
NM_000268.4(NF2):c.100G>C (p.Glu34Gln)	NF2	E34Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001056223	22	30000087	22	29604098	1056223	1052061		NC_000022.11:29604097:G:C
NM_000268.4(NF2):c.789C>A (p.Asn263Lys)	NF2	N180K, N221K, N222K, N263K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001055359	22	30057307	22	29661318	1055359	1052066		NC_000022.11:29661317:C:A
NM_000268.4(NF2):c.1397G>T (p.Arg466Leu)	NF2	R383L, R424L, R425L, R466L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001053799	22	30070881	22	29674892	1053799	1052070		NC_000022.11:29674891:G:T
NM_000268.4(NF2):c.1243A>G (p.Thr415Ala)	NF2	T332A, T373A, T374A, T415A	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV001053758	22	30069378	22	29673389	1053758	1052068		NC_000022.11:29673388:A:G
NM_000268.4(NF2):c.1256C>T (p.Thr419Met)	NF2	T336M, T377M, T378M, T419M	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001051800	22	30069391	22	29673402	1051800	1052069		NC_000022.11:29673401:C:T
NM_000268.4(NF2):c.516G>A (p.Arg172=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001051726	22	30050714	22	29654725	1051726	1052065		NC_000022.11:29654724:G:A
NM_000268.4(NF2):c.223C>A (p.Leu75Ile)	NF2	L75I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001051271	22	30032848	22	29636859	1051271	1052062		NC_000022.11:29636858:C:A
NM_000268.4(NF2):c.1069G>A (p.Glu357Lys)	NF2	E274K, E315K, E316K, E357K	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jan 1, 2020)	no assertion criteria provided	VCV001048678	22	30067884	22	29671895	1048678	1036841		NC_000022.11:29671894:G:A
NM_000268.4(NF2):c.1630A>G (p.Thr544Ala)	NF2	T461A, T503A, T502A, T544A	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001047740	22	30077483	22	29681494	1047740	1035132		NC_000022.11:29681493:A:G
NM_000268.4(NF2):c.375G>C (p.Gln125His)	NF2	Q125H, Q42H, Q84H, Q83H	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001047733	22	30038202	22	29642213	1047733	1035114		NC_000022.11:29642212:G:C
NM_000268.4(NF2):c.598A>G (p.Arg200Gly)	NF2	R200G, R117G, R159G, R158G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001047674	22	30051664	22	29655675	1047674	1035117		NC_000022.11:29655674:A:G
NM_000268.4(NF2):c.1207G>T (p.Ala403Ser)	NF2	A361S, A362S, A403S, A320S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001047533	22	30069342	22	29673353	1047533	1035124		NC_000022.11:29673352:G:T
NM_000268.4(NF2):c.337A>C (p.Ile113Leu)	NF2	I113L, I71L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001047126	22	30035175	22	29639186	1047126	1035113		NC_000022.11:29639185:A:C
NM_000268.4(NF2):c.916C>G (p.Leu306Val)	NF2	L265V, L223V, L264V, L306V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV001046727	22	30064352	22	29668363	1046727	1035120		NC_000022.11:29668362:C:G
NM_000268.4(NF2):c.1540A>C (p.Met514Leu)	NF2	M514L, M431L, M473L, M472L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001046085	22	30074278	22	29678289	1046085	1035130		NC_000022.11:29678288:A:C
NM_000268.4(NF2):c.1737+5C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001045620	22	30077595	22	29681606	1045620	1035134		NC_000022.11:29681605:C:T
NM_000268.4(NF2):c.440A>C (p.Gln147Pro)	NF2	Q105P, Q106P, Q64P, Q147P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001045411	22	30038267	22	29642278	1045411	1035115		NC_000022.11:29642277:A:C
NM_000268.4(NF2):c.769C>T (p.Pro257Ser)	NF2	P215S, P216S, P257S, P174S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001045243	22	30057287	22	29661298	1045243	1035119		NC_000022.11:29661297:C:T
NM_000268.4(NF2):c.208G>C (p.Asp70His)	NF2	D70H	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001044974	22	30032833	22	29636844	1044974	1035112		NC_000022.11:29636843:G:C
NM_000268.4(NF2):c.1237A>G (p.Lys413Glu)	NF2	K330E, K371E, K413E, K372E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001043876	22	30069372	22	29673383	1043876	1035125		NC_000022.11:29673382:A:G
NM_000268.4(NF2):c.1721A>C (p.His574Pro)	NF2	H491P, H574P, H532P, H533P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001043762	22	30077574	22	29681585	1043762	1035133		NC_000022.11:29681584:A:C
NM_000268.4(NF2):c.1511G>T (p.Ser504Ile)	NF2	S462I, S463I, S421I, S504I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001043660	22	30074249	22	29678260	1043660	1035129		NC_000022.11:29678259:G:T
NM_000268.4(NF2):c.1585A>G (p.Met529Val)	NF2	M529V, M446V, M488V, M487V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001043361	22	30077438	22	29681449	1043361	1035131		NC_000022.11:29681448:A:G
NM_000268.4(NF2):c.1341G>A (p.Arg447=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 27, 2020)	criteria provided, single submitter	VCV001043072	22	30070825	22	29674836	1043072	1035126		NC_000022.11:29674835:G:A
NM_000268.4(NF2):c.922A>G (p.Met308Val)	NF2	M267V, M266V, M225V, M308V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001042782	22	30064358	22	29668369	1042782	1035121		NC_000022.11:29668368:A:G
NM_000268.4(NF2):c.506T>C (p.Leu169Pro)	NF2	L127P, L128P, L169P, L86P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001039707	22	30050704	22	29654715	1039707	1035116		NC_000022.11:29654714:T:C
NM_000268.4(NF2):c.1370A>T (p.Asp457Val)	NF2	D415V, D374V, D457V, D416V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001039580	22	30070854	22	29674865	1039580	1035127		NC_000022.11:29674864:A:T
NM_000268.4(NF2):c.602A>G (p.Asp201Gly)	NF2	D159G, D160G, D201G, D118G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, single submitter	VCV001039559	22	30054180	22	29658191	1039559	1035118		NC_000022.11:29658190:A:G
NM_000268.4(NF2):c.1021C>G (p.Arg341Gly)	NF2	R300G, R341G, R258G, R299G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001038092	22	30067836	22	29671847	1038092	1035123		NC_000022.11:29671846:C:G
NM_000268.4(NF2):c.1003G>A (p.Glu335Lys)	NF2	E335K, E293K, E294K, E252K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001037917	22	30067818	22	29671829	1037917	1035122		NC_000022.11:29671828:G:A
NM_000268.4(NF2):c.1384C>T (p.Arg462Cys)	NF2	R420C, R421C, R462C, R379C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001036137	22	30070868	22	29674879	1036137	1035128		NC_000022.11:29674878:C:T
NM_000268.4(NF2):c.22C>T (p.Arg8Cys)	NF2	R8C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001036118	22	30000009	22	29604020	1036118	1035109		NC_000022.11:29604019:C:T
NM_000268.4(NF2):c.67A>C (p.Thr23Pro)	NF2	T23P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001035608	22	30000054	22	29604065	1035608	1035111		NC_000022.11:29604064:A:C
NM_000268.4(NF2):c.32T>G (p.Phe11Cys)	NF2	F11C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001034701	22	30000019	22	29604030	1034701	1035110		NC_000022.11:29604029:T:G
NM_000268.4(NF2):c.675+5G>T	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Apr 30, 2020)	criteria provided, single submitter	VCV001030707	22	30054258	22	29658269	1030707	1018810		NC_000022.11:29658268:G:T
NM_000268.4(NF2):c.1066T>A (p.Leu356Met)	NF2	L273M, L314M, L315M, L356M	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV001027336	22	30067881	22	29671892	1027336	1014535		NC_000022.11:29671891:T:A
NM_000268.4(NF2):c.253G>C (p.Asp85His)	NF2	D43H, D85H	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001026668	22	30035091	22	29639102	1026668	1014533		NC_000022.11:29639101:G:C
NM_000268.4(NF2):c.1714A>C (p.Ser572Arg)	NF2	S489R, S530R, S531R, S572R	Neurofibromatosis, type 2|not provided	Uncertain significance(Last reviewed: Jun 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV001025043	22	30077567	22	29681578	1025043	1014539		NC_000022.11:29681577:A:C
NM_000268.4(NF2):c.1660A>T (p.Arg554Trp)	NF2	R471W, R512W, R513W, R554W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 31, 2018)	criteria provided, single submitter	VCV001024094	22	30077513	22	29681524	1024094	1014538		NC_000022.11:29681523:A:T
NM_000268.4(NF2):c.1165C>G (p.Gln389Glu)	NF2	Q306E, Q347E, Q348E, Q389E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001020897	22	30069300	22	29673311	1020897	1014536		NC_000022.11:29673310:C:G
NM_000268.4(NF2):c.1575A>C (p.Lys525Asn)	NF2	K442N, K483N, K484N, K525N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001020490	22	30077428	22	29681439	1020490	1014537		NC_000022.11:29681438:A:C
NM_000268.4(NF2):c.1720C>T (p.His574Tyr)	NF2	H491Y, H532Y, H533Y, H574Y	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 30, 2020)	criteria provided, single submitter	VCV001020349	22	30077573	22	29681584	1020349	1014540		NC_000022.11:29681583:C:T
NM_000268.4(NF2):c.245T>C (p.Leu82Pro)	NF2	L40P, L82P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001017607	22	30035083	22	29639094	1017607	1014531		NC_000022.11:29639093:T:C
NM_000268.4(NF2):c.133G>A (p.Asp45Asn)	NF2	D45N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001016914	22	30032758	22	29636769	1016914	1014530		NC_000022.11:29636768:G:A
NM_000268.4(NF2):c.652G>T (p.Gly218Cys)	NF2	G135C, G176C, G177C, G218C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001014785	22	30054230	22	29658241	1014785	1014534		NC_000022.11:29658240:G:T
NM_000268.4(NF2):c.251A>G (p.His84Arg)	NF2	H42R, H84R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001014551	22	30035089	22	29639100	1014551	1014532		NC_000022.11:29639099:A:G
NM_000268.4(NF2):c.524A>G (p.Asn175Ser)	NF2	N133S, N134S, N175S, N92S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001012002	22	30051590	22	29655601	1012002	999390		NC_000022.11:29655600:A:G
NM_000268.4(NF2):c.93C>A (p.Ala31=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001011330	22	30000080	22	29604091	1011330	999386		NC_000022.11:29604090:C:A
NM_000268.4(NF2):c.731A>G (p.Tyr244Cys)	NF2	Y161C, Y202C, Y203C, Y244C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV001010425	22	30057249	22	29661260	1010425	999392		NC_000022.11:29661259:A:G
NM_000268.4(NF2):c.1442A>G (p.Tyr481Cys)	NF2	Y398C, Y439C, Y440C, Y481C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001009711	22	30070926	22	29674937	1009711	999397		NC_000022.11:29674936:A:G
NM_000268.4(NF2):c.857A>G (p.Asn286Ser)	NF2	N203S, N244S, N245S, N286S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001008963	22	30061025	22	29665036	1008963	999393		NC_000022.11:29665035:A:G
NM_000268.4(NF2):c.1174G>A (p.Glu392Lys)	NF2	E309K, E350K, E351K, E392K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001007883	22	30069309	22	29673320	1007883	999394		NC_000022.11:29673319:G:A
NM_000268.4(NF2):c.191T>C (p.Leu64Pro)	NF2	L64P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001006297	22	30032816	22	29636827	1006297	999388		NC_000022.11:29636826:T:C
NM_000268.4(NF2):c.1297G>A (p.Ala433Thr)	NF2	A350T, A391T, A392T, A433T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 19, 2020)	criteria provided, single submitter	VCV001005805	22	30069432	22	29673443	1005805	999395		NC_000022.11:29673442:G:A
NM_000268.4(NF2):c.182T>C (p.Phe61Ser)	NF2	F61S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001002192	22	30032807	22	29636818	1002192	999387		NC_000022.11:29636817:T:C
NM_000268.4(NF2):c.1488A>C (p.Pro496=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001001423	22	30074226	22	29678237	1001423	999398		NC_000022.11:29678236:A:C
NM_000268.4(NF2):c.1735A>C (p.Lys579Gln)	NF2	K496Q, K537Q, K538Q, K579Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001001340	22	30077588	22	29681599	1001340	999400		NC_000022.11:29681598:A:C
NM_000268.4(NF2):c.1567A>G (p.Lys523Glu)	NF2	K440E, K481E, K482E, K523E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001000945	22	30074305	22	29678316	1000945	999399		NC_000022.11:29678315:A:G
NM_000268.4(NF2):c.319G>A (p.Glu107Lys)	NF2	E107K, E65K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV001000838	22	30035157	22	29639168	1000838	999389		NC_000022.11:29639167:G:A
NM_000268.4(NF2):c.709G>C (p.Asp237His)	NF2	D154H, D195H, D196H, D237H	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV000999978	22	30057227	22	29661238	999978	999391		NC_000022.11:29661237:G:C
NM_000268.4(NF2):c.1769C>T (p.Ala590Val)	NF2	A160V, A590V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000999620	22	30090772	22	29694783	999620	999401		NC_000022.11:29694782:C:T
NM_000268.4(NF2):c.1343C>G (p.Ala448Gly)	NF2	A365G, A406G, A407G, A448G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000999388	22	30070827	22	29674838	999388	999396		NC_000022.11:29674837:C:G
NM_000268.4(NF2):c.115-1G>A	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Feb 4, 2021)	criteria provided, single submitter	VCV000997868	22	30032739	22	29636750	997868	985661		NC_000022.11:29636749:G:A
NM_000268.4(NF2):c.1480G>C (p.Asp494His)	NF2	D452H, D411H, D494H, D453H	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000972026	22	30074218	22	29678229	972026	959068		NC_000022.11:29678228:G:C
NM_000268.4(NF2):c.675+6T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000971460	22	30054259	22	29658270	971460	960966		NC_000022.11:29658269:T:C
NM_000268.4(NF2):c.272C>G (p.Pro91Arg)	NF2	P91R, P49R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000971447	22	30035110	22	29639121	971447	959060		NC_000022.11:29639120:C:G
NM_000268.4(NF2):c.1088T>A (p.Met363Lys)	NF2	M280K, M322K, M363K, M321K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000969901	22	30067903	22	29671914	969901	959064		NC_000022.11:29671913:T:A
NM_000268.4(NF2):c.673C>T (p.Arg225Trp)	NF2	R142W, R183W, R184W, R225W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000969242	22	30054251	22	29658262	969242	959063		NC_000022.11:29658261:C:T
NM_000268.4(NF2):c.1762C>T (p.Arg588Ter)	NF2	R158*, R588*	Neurofibromatosis, type 2|not provided	Uncertain significance(Last reviewed: Mar 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000968444	22	30090765	22	29694776	968444	959069		NC_000022.11:29694775:C:T
NM_000268.4(NF2):c.1373T>G (p.Leu458Arg)	NF2	L375R, L417R, L416R, L458R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000967643	22	30070857	22	29674868	967643	959067		NC_000022.11:29674867:T:G
NM_000268.4(NF2):c.115A>G (p.Met39Val)	NF2	M39V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000966633	22	30032740	22	29636751	966633	959059		NC_000022.11:29636750:A:G
NM_000268.4(NF2):c.1105A>G (p.Met369Val)	NF2	M328V, M327V, M369V, M286V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000965974	22	30067920	22	29671931	965974	959065		NC_000022.11:29671930:A:G
NM_000268.4(NF2):c.1342G>A (p.Ala448Thr)	NF2	A406T, A448T, A365T, A407T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000965877	22	30070826	22	29674837	965877	959066		NC_000022.11:29674836:G:A
NM_000268.4(NF2):c.1446+5G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000965211	22	30070935	22	29674946	965211	960967		NC_000022.11:29674945:G:T
NM_000268.4(NF2):c.69C>G (p.Thr23=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000964500	22	30000056	22	29604067	964500	951408		NC_000022.11:29604066:C:G
NM_000268.4(NF2):c.1544A>G (p.Lys515Arg)	NF2	K515R, K473R, K432R, K474R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000963971	22	30074282	22	29678293	963971	951418		NC_000022.11:29678292:A:G
NM_000268.4(NF2):c.1712G>A (p.Ser571Asn)	NF2	S488N, S529N, S571N, S530N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000963835	22	30077565	22	29681576	963835	951420		NC_000022.11:29681575:G:A
NM_000268.4(NF2):c.240+1G>A	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000963818	22	30032866	22	29636877	963818	960340		NC_000022.11:29636876:G:A
NM_000268.4(NF2):c.1522G>T (p.Asp508Tyr)	NF2	D508Y, D425Y, D467Y, D466Y	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000961122	22	30074260	22	29678271	961122	951417		NC_000022.11:29678270:G:T
NM_000268.4(NF2):c.1661G>A (p.Arg554Lys)	NF2	R513K, R512K, R554K, R471K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000960618	22	30077514	22	29681525	960618	951419		NC_000022.11:29681524:G:A
NM_000268.4(NF2):c.992G>C (p.Arg331Thr)	NF2	R248T, R289T, R331T, R290T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000959850	22	30064428	22	29668439	959850	951412		NC_000022.11:29668438:G:C
NM_000268.4(NF2):c.647T>C (p.Met216Thr)	NF2	M133T, M175T, M174T, M216T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000959120	22	30054225	22	29658236	959120	951410		NC_000022.11:29658235:T:C
NM_000268.4(NF2):c.1575-6C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV000958949	22	30077422	22	29681433	958949	960344		NC_000022.11:29681432:C:G
NM_000268.4(NF2):c.1207G>A (p.Ala403Thr)	NF2	A362T, A403T, A320T, A361T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV000957711	22	30069342	22	29673353	957711	951414		NC_000022.11:29673352:G:A
NM_000268.4(NF2):c.952G>T (p.Val318Phe)	NF2	V276F, V277F, V318F, V235F	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000957677	22	30064388	22	29668399	957677	951411		NC_000022.11:29668398:G:T
NM_000268.4(NF2):c.364-3C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV000957062	22	30038188	22	29642199	957062	960341		NC_000022.11:29642198:C:T
NM_000268.4(NF2):c.1A>G (p.Met1Val)	NF2	M1V	not provided|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000956856	22	29999988	22	29603999	956856	951406		NC_000022.11:29603998:A:G
NM_000268.4(NF2):c.1264G>A (p.Glu422Lys)	NF2	E380K, E339K, E381K, E422K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000956748	22	30069399	22	29673410	956748	951415		NC_000022.11:29673409:G:A
NM_000268.4(NF2):c.1447-9C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000956632	22	30074176	22	29678187	956632	960343		NC_000022.11:29678186:C:G
NM_000268.4(NF2):c.1006C>T (p.Arg336Trp)	NF2	R336W, R253W, R295W, R294W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 12, 2020)	criteria provided, single submitter	VCV000956440	22	30067821	22	29671832	956440	951413		NC_000022.11:29671831:C:T
NM_000268.4(NF2):c.810+6A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000954417	22	30057334	22	29661345	954417	960342		NC_000022.11:29661344:A:G
NM_000268.4(NF2):c.1298C>T (p.Ala433Val)	NF2	A350V, A392V, A433V, A391V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000953775	22	30069433	22	29673444	953775	951416		NC_000022.11:29673443:C:T
NM_000268.4(NF2):c.162G>A (p.Leu54=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000952692	22	30032787	22	29636798	952692	929453		NC_000022.11:29636797:G:A
NM_000268.4(NF2):c.1126C>T (p.Arg376Trp)	NF2	R376W, R334W, R335W, R293W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000952483	22	30069261	22	29673272	952483	929459		NC_000022.11:29673271:C:T
NM_000268.4(NF2):c.17C>A (p.Ala6Asp)	NF2	A6D	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000950781	22	30000004	22	29604015	950781	929452		NC_000022.11:29604014:C:A
NM_000268.4(NF2):c.952G>A (p.Val318Ile)	NF2	V235I, V277I, V318I, V276I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000950659	22	30064388	22	29668399	950659	929458		NC_000022.11:29668398:G:A
NM_000268.4(NF2):c.733G>A (p.Asp245Asn)	NF2	D162N, D203N, D204N, D245N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000948122	22	30057251	22	29661262	948122	929456		NC_000022.11:29661261:G:A
NM_000268.4(NF2):c.531T>A (p.Tyr177Ter)	NF2	Y94*, Y135*, Y177*, Y136*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000945454	22	30051597	22	29655608	945454	929455		NC_000022.11:29655607:T:A
NM_000268.4(NF2):c.114+6C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, single submitter	VCV000945221	22	30000107	22	29604118	945221	941279		NC_000022.11:29604117:C:T
NM_000268.4(NF2):c.874G>A (p.Val292Ile)	NF2	V250I, V209I, V292I, V251I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000945202	22	30061042	22	29665053	945202	929457		NC_000022.11:29665052:G:A
NM_000268.4(NF2):c.263A>G (p.Lys88Arg)	NF2	K88R, K46R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000944347	22	30035101	22	29639112	944347	929454		NC_000022.11:29639111:A:G
NM_000268.4(NF2):c.599+6G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000943542	22	30051671	22	29655682	943542	940528		NC_000022.11:29655681:G:T
NM_000268.4(NF2):c.114+4A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000943289	22	30000105	22	29604116	943289	940527		NC_000022.11:29604115:A:G
NM_000268.4(NF2):c.558G>C (p.Glu186Asp)	NF2	E103D, E145D, E144D, E186D	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000940871	22	30051624	22	29655635	940871	939255		NC_000022.11:29655634:G:C
NM_000268.4(NF2):c.1660A>G (p.Arg554Gly)	NF2	R554G, R513G, R512G, R471G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000940455	22	30077513	22	29681524	940455	939265		NC_000022.11:29681523:A:G
NM_000268.4(NF2):c.974C>T (p.Ala325Val)	NF2	A284V, A242V, A325V, A283V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000939709	22	30064410	22	29668421	939709	939259		NC_000022.11:29668420:C:T
NM_000268.4(NF2):c.1234A>C (p.Ile412Leu)	NF2	I370L, I371L, I412L, I329L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000939634	22	30069369	22	29673380	939634	939261		NC_000022.11:29673379:A:C
NM_000268.4(NF2):c.1733A>G (p.Lys578Arg)	NF2	K536R, K537R, K578R, K495R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000939346	22	30077586	22	29681597	939346	939266		NC_000022.11:29681596:A:G
NM_000268.4(NF2):c.58A>T (p.Lys20Ter)	NF2	K20*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000938925	22	30000045	22	29604056	938925	939253		NC_000022.11:29604055:A:T
NM_000268.4(NF2):c.679A>T (p.Lys227Ter)	NF2	K144*, K186*, K185*, K227*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000937475	22	30057197	22	29661208	937475	939256		NC_000022.11:29661207:A:T
NM_000268.4(NF2):c.743A>G (p.Asn248Ser)	NF2	N248S, N165S, N207S, N206S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000936191	22	30057261	22	29661272	936191	939257		NC_000022.11:29661271:A:G
NM_000268.4(NF2):c.1366C>G (p.Gln456Glu)	NF2	Q414E, Q373E, Q456E, Q415E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000935884	22	30070850	22	29674861	935884	939263		NC_000022.11:29674860:C:G
NM_000268.4(NF2):c.820A>G (p.Lys274Glu)	NF2	K191E, K233E, K274E, K232E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000935647	22	30060988	22	29664999	935647	939258		NC_000022.11:29664998:A:G
NM_000268.4(NF2):c.1575-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000934838	22	30077426	22	29681437	934838	940529		NC_000022.11:29681436:A:G
NM_000268.4(NF2):c.222G>T (p.Trp74Cys)	NF2	W74C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV000934288	22	30032847	22	29636858	934288	939254		NC_000022.11:29636857:G:T
NM_000268.4(NF2):c.1753G>T (p.Ala585Ser)	NF2	A585S, A155S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000933328	22	30090756	22	29694767	933328	939267		NC_000022.11:29694766:G:T
NM_000268.4(NF2):c.*3645G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902994	22	30094436	22	29698447	902994	891076		NC_000022.11:29698446:G:A
NM_000268.4(NF2):c.*3644C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902993	22	30094435	22	29698446	902993	891075		NC_000022.11:29698445:C:T
NM_000268.4(NF2):c.*3313A>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902992	22	30094104	22	29698115	902992	891074		NC_000022.11:29698114:A:T
NM_000268.4(NF2):c.*2153T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902936	22	30092944	22	29696955	902936	891065		NC_000022.11:29696954:T:C
NM_000268.4(NF2):c.*2077C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902935	22	30092868	22	29696879	902935	891064		NC_000022.11:29696878:C:T
NM_000268.4(NF2):c.*860C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902871	22	30091651	22	29695662	902871	891050		NC_000022.11:29695661:C:T
NM_000268.4(NF2):c.*801A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902870	22	30091592	22	29695603	902870	891049		NC_000022.11:29695602:A:G
NM_000268.4(NF2):c.*758G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902869	22	30091549	22	29695560	902869	891048		NC_000022.11:29695559:G:A
NM_000268.4(NF2):c.*695C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902868	22	30091486	22	29695497	902868	891047		NC_000022.11:29695496:C:T
NM_000268.4(NF2):c.*3133A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902107	22	30093924	22	29697935	902107	891073		NC_000022.11:29697934:A:G
NM_000268.4(NF2):c.*3083C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902106	22	30093874	22	29697885	902106	891072		NC_000022.11:29697884:C:T
NM_000268.4(NF2):c.*2911C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902105	22	30093702	22	29697713	902105	891071		NC_000022.11:29697712:C:T
NM_000268.4(NF2):c.*1736T>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902050	22	30092527	22	29696538	902050	891063		NC_000022.11:29696537:T:A
NM_000268.4(NF2):c.*1668G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902049	22	30092459	22	29696470	902049	891062		NC_000022.11:29696469:G:T
NM_000268.4(NF2):c.*1624G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000902048	22	30092415	22	29696426	902048	891061		NC_000022.11:29696425:G:A
NM_000268.4(NF2):c.*1538C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000902047	22	30092329	22	29696340	902047	891060		NC_000022.11:29696339:C:G
NM_000268.4(NF2):c.*527G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000901971	22	30091318	22	29695329	901971	891046		NC_000022.11:29695328:G:T
NM_000268.4(NF2):c.*420C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901970	22	30091211	22	29695222	901970	891045		NC_000022.11:29695221:C:T
NM_000268.4(NF2):c.*397C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901969	22	30091188	22	29695199	901969	891044		NC_000022.11:29695198:C:T
NM_000268.4(NF2):c.*284C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901968	22	30091075	22	29695086	901968	891043		NC_000022.11:29695085:C:T
NM_000268.4(NF2):c.473A>G (p.His158Arg)	NF2	H158R, H116R, H75R, H117R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901907	22	30050671	22	29654682	901907	891038		NC_000022.11:29654681:A:G
NM_000268.4(NF2):c.*1418T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901480	22	30092209	22	29696220	901480	891059		NC_000022.11:29696219:T:C
NM_000268.4(NF2):c.*1287T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901479	22	30092078	22	29696089	901479	891058		NC_000022.11:29696088:T:C
NM_000268.4(NF2):c.*1159G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901478	22	30091950	22	29695961	901478	891057		NC_000022.11:29695960:G:A
NM_000268.4(NF2):c.*256T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901422	22	30091047	22	29695058	901422	891042		NC_000022.11:29695057:T:C
NM_000268.4(NF2):c.*204C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000901421	22	30090995	22	29695006	901421	891041		NC_000022.11:29695005:C:T
NM_000268.4(NF2):c.*189A>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000901420	22	30090980	22	29694991	901420	891040		NC_000022.11:29694990:A:C
NM_000268.4(NF2):c.-163C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901363	22	29999825	22	29603836	901363	891037		NC_000022.11:29603835:C:T
NM_000268.4(NF2):c.*2612T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900443	22	30093403	22	29697414	900443	891070		NC_000022.11:29697413:T:C
NM_000268.4(NF2):c.*2445G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000900442	22	30093236	22	29697247	900442	891069		NC_000022.11:29697246:G:A
NM_000268.4(NF2):c.*2332C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000900383	22	30093123	22	29697134	900383	891068		NC_000022.11:29697133:C:T
NM_000268.4(NF2):c.*2245C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900382	22	30093036	22	29697047	900382	891067		NC_000022.11:29697046:C:G
NM_000268.4(NF2):c.*2215A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000900381	22	30093006	22	29697017	900381	891066		NC_000022.11:29697016:A:G
NM_000268.4(NF2):c.*977C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000900324	22	30091768	22	29695779	900324	891056		NC_000022.11:29695778:C:T
NM_000268.4(NF2):c.*957C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900323	22	30091748	22	29695759	900323	891055		NC_000022.11:29695758:C:T
NM_000268.4(NF2):c.*944G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900322	22	30091735	22	29695746	900322	891054		NC_000022.11:29695745:G:A
NM_000268.4(NF2):c.*942C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900321	22	30091733	22	29695744	900321	891053		NC_000022.11:29695743:C:T
NM_000268.4(NF2):c.*937C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900320	22	30091728	22	29695739	900320	891052		NC_000022.11:29695738:C:T
NM_000268.4(NF2):c.*913C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000900319	22	30091704	22	29695715	900319	891051		NC_000022.11:29695714:C:T
NM_000268.4(NF2):c.1127G>T (p.Arg376Leu)	NF2	R334L, R293L, R335L, R376L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000900259	22	30069262	22	29673273	900259	891039		NC_000022.11:29673272:G:T
NM_000268.4(NF2):c.*3765G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899379	22	30094556	22	29698567	899379	891079		NC_000022.11:29698566:G:T
NM_000268.4(NF2):c.*3720C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899378	22	30094511	22	29698522	899378	891078		NC_000022.11:29698521:C:A
NM_000268.4(NF2):c.*3671G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000899377	22	30094462	22	29698473	899377	891077		NC_000022.11:29698472:G:A
NM_000268.4(NF2):c.863C>G (p.Ser288Ter)	NF2	S205*, S288*, S246*, S247*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV000870602	22	30061031	22	29665042	870602	858764		NC_000022.11:29665041:C:G
NM_000268.4(NF2):c.1745T>C (p.Leu582Ser)	NF2	L582S, L152S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000864027	22	30090748	22	29694759	864027	849215		NC_000022.11:29694758:T:C
NM_000268.4(NF2):c.193C>T (p.Gln65Ter)	NF2	Q65*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000864000	22	30032818	22	29636829	864000	849188		NC_000022.11:29636828:C:T
NM_000268.4(NF2):c.1737+2T>C	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000863067	22	30077592	22	29681603	863067	851916		NC_000022.11:29681602:T:C
NM_000268.4(NF2):c.1065G>C (p.Glu355Asp)	NF2	E313D, E314D, E355D, E272D	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000862788	22	30067880	22	29671891	862788	849206		NC_000022.11:29671890:G:C
NM_000268.4(NF2):c.1210G>T (p.Glu404Ter)	NF2	E321*, E363*, E404*, E362*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000862341	22	30069345	22	29673356	862341	849209		NC_000022.11:29673355:G:T
NM_000268.4(NF2):c.499G>C (p.Glu167Gln)	NF2	E125Q, E126Q, E167Q, E84Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000860795	22	30050697	22	29654708	860795	849195		NC_000022.11:29654707:G:C
NM_000268.4(NF2):c.352T>G (p.Phe118Val)	NF2	F118V, F76V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000859519	22	30035190	22	29639201	859519	849193		NC_000022.11:29639200:T:G
NM_000268.4(NF2):c.447+6C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000859445	22	30038280	22	29642291	859445	852432		NC_000022.11:29642290:C:T
NM_000268.4(NF2):c.240+6G>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 30, 2020)	criteria provided, single submitter	VCV000858557	22	30032871	22	29636882	858557	852924		NC_000022.11:29636881:G:C
NM_000268.4(NF2):c.311A>C (p.Asn104Thr)	NF2	N62T, N104T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000857538	22	30035149	22	29639160	857538	849191		NC_000022.11:29639159:A:C
NM_000268.4(NF2):c.1280A>C (p.Glu427Ala)	NF2	E385A, E386A, E344A, E427A	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000857191	22	30069415	22	29673426	857191	849210		NC_000022.11:29673425:A:C
NM_000268.4(NF2):c.940G>A (p.Asp314Asn)	NF2	D272N, D231N, D273N, D314N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000857149	22	30064376	22	29668387	857149	849202		NC_000022.11:29668386:G:A
NM_000268.4(NF2):c.886-3C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000856827	22	30064319	22	29668330	856827	852928		NC_000022.11:29668329:C:T
NM_000268.4(NF2):c.274G>A (p.Val92Ile)	NF2	V92I, V50I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000854677	22	30035112	22	29639123	854677	849190		NC_000022.11:29639122:G:A
NM_000268.4(NF2):c.1600C>T (p.His534Tyr)	NF2	H451Y, H493Y, H534Y, H492Y	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000854568	22	30077453	22	29681464	854568	849214		NC_000022.11:29681463:C:T
NM_000268.4(NF2):c.1336A>G (p.Arg446Gly)	NF2	R404G, R446G, R363G, R405G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000854233	22	30069471	22	29673482	854233	849211		NC_000022.11:29673481:A:G
NM_000268.4(NF2):c.896T>C (p.Leu299Pro)	NF2	L257P, L216P, L258P, L299P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000853586	22	30064332	22	29668343	853586	849201		NC_000022.11:29668342:T:C
NM_000268.4(NF2):c.78C>G (p.Ile26Met)	NF2	I26M	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000851328	22	30000065	22	29604076	851328	849184		NC_000022.11:29604075:C:G
NM_000268.4(NF2):c.1340G>T (p.Arg447Met)	NF2	R364M, R406M, R405M, R447M	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000850679	22	30069475	22	29673486	850679	849212		NC_000022.11:29673485:G:T
NM_000268.4(NF2):c.154C>T (p.Arg52Trp)	NF2	R52W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000849398	22	30032779	22	29636790	849398	849187		NC_000022.11:29636789:C:T
NM_000268.4(NF2):c.85A>G (p.Met29Val)	NF2	M29V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000848840	22	30000072	22	29604083	848840	849185		NC_000022.11:29604082:A:G
NM_000268.4(NF2):c.240+1G>C	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000848788	22	30032866	22	29636877	848788	851914		NC_000022.11:29636876:G:C
NM_000268.4(NF2):c.1088T>G (p.Met363Arg)	NF2	M321R, M363R, M322R, M280R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000848750	22	30067903	22	29671914	848750	849207		NC_000022.11:29671913:T:G
NM_000268.4(NF2):c.1447C>G (p.Pro483Ala)	NF2	P400A, P441A, P442A, P483A	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000847669	22	30074185	22	29678196	847669	849213		NC_000022.11:29678195:C:G
NM_000268.4(NF2):c.1446+6C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 5, 2020)	criteria provided, single submitter	VCV000847456	22	30070936	22	29674947	847456	852433		NC_000022.11:29674946:C:G
NM_000268.4(NF2):c.114+4A>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000847088	22	30000105	22	29604116	847088	852428		NC_000022.11:29604115:A:T
NM_000268.4(NF2):c.970C>G (p.Gln324Glu)	NF2	Q241E, Q282E, Q283E, Q324E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000846276	22	30064406	22	29668417	846276	849203		NC_000022.11:29668416:C:G
NM_000268.4(NF2):c.999G>C (p.Gln333His)	NF2	Q250H, Q292H, Q333H, Q291H	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000845567	22	30064435	22	29668446	845567	849204		NC_000022.11:29668445:G:C
NM_000268.4(NF2):c.142G>A (p.Asp48Asn)	NF2	D48N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000844896	22	30032767	22	29636778	844896	849186		NC_000022.11:29636777:G:A
NM_000268.4(NF2):c.545A>G (p.Glu182Gly)	NF2	E182G, E99G, E141G, E140G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000844334	22	30051611	22	29655622	844334	849198		NC_000022.11:29655621:A:G
NM_000268.4(NF2):c.566C>T (p.Thr189Ile)	NF2	T147I, T106I, T148I, T189I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 17, 2019)	criteria provided, single submitter	VCV000841718	22	30051632	22	29655643	841718	849199		NC_000022.11:29655642:C:T
NM_000268.4(NF2):c.542C>T (p.Pro181Leu)	NF2	P139L, P98L, P140L, P181L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV000841717	22	30051608	22	29655619	841717	849197		NC_000022.11:29655618:C:T
NM_000268.4(NF2):c.504G>C (p.Leu168Phe)	NF2	L85F, L168F, L126F, L127F	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000840078	22	30050702	22	29654713	840078	849196		NC_000022.11:29654712:G:C
NM_000268.4(NF2):c.73A>T (p.Arg25Trp)	NF2	R25W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000839589	22	30000060	22	29604071	839589	849183		NC_000022.11:29604070:A:T
NM_000268.4(NF2):c.785G>A (p.Arg262Gln)	NF2	R220Q, R221Q, R262Q, R179Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000838908	22	30057303	22	29661314	838908	849200		NC_000022.11:29661313:G:A
NM_000268.4(NF2):c.58A>C (p.Lys20Gln)	NF2	K20Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000838853	22	30000045	22	29604056	838853	849182		NC_000022.11:29604055:A:C
NM_000268.4(NF2):c.1112A>G (p.Asn371Ser)	NF2	N330S, N288S, N329S, N371S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000837125	22	30067927	22	29671938	837125	849208		NC_000022.11:29671937:A:G
NM_000268.4(NF2):c.1038G>T (p.Arg346Ser)	NF2	R304S, R263S, R305S, R346S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000836842	22	30067853	22	29671864	836842	849205		NC_000022.11:29671863:G:T
NM_000268.4(NF2):c.332A>C (p.Gln111Pro)	NF2	Q111P, Q69P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000835521	22	30035170	22	29639181	835521	849192		NC_000022.11:29639180:A:C
NM_000268.4(NF2):c.1763G>A (p.Arg588Gln)	NF2	R158Q, R588Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV000835220	22	30090766	22	29694777	835220	849216		NC_000022.11:29694776:G:A
NM_000268.4(NF2):c.599+5G>A	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826101	22	30051670	22	29655681	826101	815775	rs1601613749	NC_000022.11:29655680:G:A
NM_000268.4(NF2):c.587G>A (p.Arg196Gln)	NF2	R155Q, R113Q, R154Q, R196Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000826028	22	30051653	22	29655664	826028	815172	rs749176138	NC_000022.11:29655663:G:A
NM_000268.4(NF2):c.555G>A (p.Glu185=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000825828	22	30051621	22	29655632	825828	815171	rs1293410909	NC_000022.11:29655631:G:A
NM_000268.4(NF2):c.951A>G (p.Glu317=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2019)	criteria provided, conflicting interpretations	VCV000823304	22	30064387	22	29668398	823304	815181	rs1601636972	NC_000022.11:29668397:A:G
NM_000268.4(NF2):c.94G>A (p.Glu32Lys)	NF2	E32K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000823288	22	30000081	22	29604092	823288	815158	rs373337083	NC_000022.11:29604091:G:A
NM_000268.4(NF2):c.84C>T (p.Thr28=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000822515	22	30000071	22	29604082	822515	815156	rs1410448416	NC_000022.11:29604081:C:T
NM_000268.4(NF2):c.845T>C (p.Val282Ala)	NF2	V241A, V282A, V240A, V199A	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000822464	22	30061013	22	29665024	822464	815179	rs1601630493	NC_000022.11:29665023:T:C
NM_000268.4(NF2):c.831T>G (p.Asp277Glu)	NF2	D194E, D277E, D235E, D236E	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000822295	22	30060999	22	29665010	822295	815178	rs762883753	NC_000022.11:29665009:T:G
NM_000268.4(NF2):c.1051C>T (p.Arg351Cys)	NF2	R268C, R309C, R310C, R351C	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000822078	22	30067866	22	29671877	822078	815182	rs747756728	NC_000022.11:29671876:C:T
NM_000268.4(NF2):c.252T>C (p.His84=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000821440	22	30035090	22	29639101	821440	815163	rs374512699	NC_000022.11:29639100:T:C
NM_000268.4(NF2):c.1776T>C (p.Phe592=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000820053	22	30090779	22	29694790	820053	815204	rs1290530587	NC_000022.11:29694789:T:C
NM_000268.4(NF2):c.1726A>T (p.Thr576Ser)	NF2	T493S, T534S, T535S, T576S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819942	22	30077579	22	29681590	819942	815202	rs1601666549	NC_000022.11:29681589:A:T
NM_000268.4(NF2):c.1675G>T (p.Asp559Tyr)	NF2	D476Y, D517Y, D518Y, D559Y	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000819763	22	30077528	22	29681539	819763	815198	rs917012886	NC_000022.11:29681538:G:T
NM_000268.4(NF2):c.1533T>C (p.Asp511=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819482	22	30074271	22	29678282	819482	815197	rs1601659271	NC_000022.11:29678281:T:C
NM_000268.4(NF2):c.1522G>A (p.Asp508Asn)	NF2	D466N, D508N, D425N, D467N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000819446	22	30074260	22	29678271	819446	815196	rs749326764	NC_000022.11:29678270:G:A
NM_000268.4(NF2):c.150G>A (p.Val50=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 30, 2019)	criteria provided, conflicting interpretations	VCV000819417	22	30032775	22	29636786	819417	815161	rs1601578932	NC_000022.11:29636785:G:A
NM_000268.4(NF2):c.1459A>C (p.Ile487Leu)	NF2	I404L, I445L, I446L, I487L	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000819269	22	30074197	22	29678208	819269	815193	rs147506929	NC_000022.11:29678207:A:C
NM_000268.4(NF2):c.1453A>T (p.Asn485Tyr)	NF2	N444Y, N402Y, N443Y, N485Y	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000819254	22	30074191	22	29678202	819254	815192	rs1601658875	NC_000022.11:29678201:A:T
NM_000268.4(NF2):c.1303G>A (p.Val435Met)	NF2	V352M, V393M, V394M, V435M	Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000818855	22	30069438	22	29673449	818855	815190	rs772334382	NC_000022.11:29673448:G:A
NM_000268.4(NF2):c.1272C>A (p.Arg424=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818765	22	30069407	22	29673418	818765	815189	rs781241303	NC_000022.11:29673417:C:A
NM_000268.4(NF2):c.1257G>C (p.Thr419=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818613	22	30069392	22	29673403	818613	815188	rs375969005	NC_000022.11:29673402:G:C
NM_000268.4(NF2):c.105C>T (p.Phe35=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000818315	22	30000092	22	29604103	818315	815159	rs976153071	NC_000022.11:29604102:C:T
NM_000268.4(NF2):c.1271G>A (p.Arg424His)	NF2	R424H, R341H, R382H, R383H	not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000809347	22	30069406	22	29673417	809347	798083	rs751182657	NC_000022.11:29673416:G:A
NM_000268.4(NF2):c.1575-67G>A	NF2		not provided|Neurofibromatosis, type 2	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803676	22	30077361	22	29681372	803676	792051	rs140086	NC_000022.11:29681371:G:A
NM_000268.4(NF2):c.1340+2T>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803675	22	30069477	22	29673488	803675	792050	rs1601649049	NC_000022.11:29673487:T:G
NM_000268.4(NF2):c.999+15G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803672	22	30064450	22	29668461	803672	792047	rs367716680	NC_000022.11:29668460:G:A
NM_000268.4(NF2):c.810+2T>C	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803670	22	30057330	22	29661341	803670	792045	rs1601624296	NC_000022.11:29661340:T:C
NM_000268.4(NF2):c.600-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803668	22	30054176	22	29658187	803668	792043	rs1601618501	NC_000022.11:29658186:A:G
NM_000268.4(NF2):c.599+40C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803667	22	30051705	22	29655716	803667	792042	rs1292869497	NC_000022.11:29655715:C:T
NM_000268.4(NF2):c.493C>T (p.Gln165Ter)	NF2	Q123*, Q124*, Q82*, Q165*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803666	22	30050691	22	29654702	803666	792041	rs1601611973	NC_000022.11:29654701:C:T
NM_000268.4(NF2):c.363+9G>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803665	22	30035210	22	29639221	803665	792040	rs1601583861	NC_000022.11:29639220:G:T
NM_000268.4(NF2):c.1737+9G>A	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000799013	22	30077599	22	29681610	799013	788277	rs1601666607	NC_000022.11:29681609:G:A
NM_000268.4(NF2):c.1291C>T (p.Leu431=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000796984	22	30069426	22	29673437	796984	786576	rs1297186898	NC_000022.11:29673436:C:T
NM_000268.4(NF2):c.939C>A (p.Ala313=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000796722	22	30064375	22	29668386	796722	786574	rs747526252	NC_000022.11:29668385:C:A
NM_000268.4(NF2):c.993A>G (p.Arg331=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000794245	22	30064429	22	29668440	794245	786575	rs1601637132	NC_000022.11:29668439:A:G
NM_000268.4(NF2):c.930A>G (p.Arg310=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000788242	22	30064366	22	29668377	788242	717395	rs1408103989	NC_000022.11:29668376:A:G
NM_000268.4(NF2):c.132G>A (p.Lys44=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 9, 2020)	criteria provided, single submitter	VCV000772087	22	30032757	22	29636768	772087	705876	rs1224221346	NC_000022.11:29636767:G:A
NM_000268.4(NF2):c.699G>T (p.Leu233=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000771102	22	30057217	22	29661228	771102	705877	rs780003734	NC_000022.11:29661227:G:T
NM_000268.4(NF2):c.364-8C>T	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000771100	22	30038183	22	29642194	771100	778694	rs1601589373	NC_000022.11:29642193:C:T
NM_000268.4(NF2):c.216G>C (p.Val72=)	NF2		not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000766683	22	30032841	22	29636852	766683	773500	rs1601579272	NC_000022.11:29636851:G:C
NM_000268.4(NF2):c.1104A>G (p.Thr368=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV000766468	22	30067919	22	29671930	766468	773504	rs1601644321	NC_000022.11:29671929:A:G
NM_000268.4(NF2):c.915T>C (p.Asp305=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000766448	22	30064351	22	29668362	766448	773502	rs1601636823	NC_000022.11:29668361:T:C
NM_000268.4(NF2):c.1179G>A (p.Glu393=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000763572	22	30069314	22	29673325	763572	773505	rs1601648277	NC_000022.11:29673324:G:A
NM_000268.4(NF2):c.1574+7A>G	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: May 19, 2018)	criteria provided, single submitter	VCV000760335	22	30074319	22	29678330	760335	776846	rs1601659412	NC_000022.11:29678329:A:G
NM_000268.4(NF2):c.1447-7T>C	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Apr 22, 2018)	criteria provided, single submitter	VCV000758613	22	30074178	22	29678189	758613	776779	rs1182185192	NC_000022.11:29678188:T:C
NM_000268.4(NF2):c.414T>C (p.Ser138=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000758286	22	30038241	22	29642252	758286	773501	rs1601589507	NC_000022.11:29642251:T:C
NM_000268.4(NF2):c.1293G>A (p.Leu431=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000757851	22	30069428	22	29673439	757851	773506	rs1340711783	NC_000022.11:29673438:G:A
NM_000268.4(NF2):c.241-5T>C	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000757172	22	30035074	22	29639085	757172	776955	rs1378725834	NC_000022.11:29639084:T:C
NM_000268.4(NF2):c.978G>A (p.Arg326=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000756212	22	30064414	22	29668425	756212	773503	rs1601637089	NC_000022.11:29668424:G:A
NM_000268.4(NF2):c.1653G>A (p.Leu551=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000754773	22	30077506	22	29681517	754773	773507	rs1601666174	NC_000022.11:29681516:G:A
NM_000268.4(NF2):c.126A>G (p.Lys42=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000751421	22	30032751	22	29636762	751421	773499	rs1601578848	NC_000022.11:29636761:A:G
NM_000268.4(NF2):c.1446+9G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000750512	22	30070939	22	29674950	750512	760836	rs778709917	NC_000022.11:29674949:G:A
NM_000268.4(NF2):c.357C>T (p.Phe119=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000744198	22	30035195	22	29639206	744198	758034	rs1370689871	NC_000022.11:29639205:C:T
NM_000268.4(NF2):c.492C>T (p.Ala164=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000739244	22	30050690	22	29654701	739244	758035	rs1307586355	NC_000022.11:29654700:C:T
NM_000268.4(NF2):c.72G>C (p.Val24=)	NF2		not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000719886	22	30000059	22	29604070	719886	729132	rs761062232	NC_000022.11:29604069:G:C
NM_000268.4(NF2):c.186T>C (p.Phe62=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 22, 2018)	criteria provided, single submitter	VCV000719331	22	30032811	22	29636822	719331	729133	rs373178836	NC_000022.11:29636821:T:C
NM_000268.4(NF2):c.1350G>A (p.Glu450=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000715368	22	30070834	22	29674845	715368	729136	rs1231236846	NC_000022.11:29674844:G:A
NM_000268.4(NF2):c.516+10T>G	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Aug 5, 2018)	criteria provided, single submitter	VCV000715302	22	30050724	22	29654735	715302	731411	rs758073951	NC_000022.11:29654734:T:G
NM_000268.4(NF2):c.939C>T (p.Ala313=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000714194	22	30064375	22	29668386	714194	729135	rs747526252	NC_000022.11:29668385:C:T
NM_000268.4(NF2):c.720G>T (p.Gly240=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV000712241	22	30057238	22	29661249	712241	729134	rs769348972	NC_000022.11:29661248:G:T
NM_000268.4(NF2):c.1764A>C (p.Arg588=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000706341	22	30090767	22	29694778	706341	694706	rs1601688952	NC_000022.11:29694777:A:C
NM_000268.4(NF2):c.1440G>A (p.Thr480=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV000705582	22	30070924	22	29674935	705582	694704	rs774373946	NC_000022.11:29674934:G:A
NM_000268.4(NF2):c.1575-6C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000704891	22	30077422	22	29681433	704891	695872	rs1350177470	NC_000022.11:29681432:C:T
NM_000268.4(NF2):c.1257G>A (p.Thr419=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV000704053	22	30069392	22	29673403	704053	694703	rs375969005	NC_000022.11:29673402:G:A
NM_000268.4(NF2):c.795G>A (p.Ser265=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703503	22	30057313	22	29661324	703503	694701	rs376609988	NC_000022.11:29661323:G:A
NM_000268.4(NF2):c.1341-7C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Aug 31, 2019)	criteria provided, single submitter	VCV000703174	22	30070818	22	29674829	703174	695871	rs574718828	NC_000022.11:29674828:C:T
NM_000268.4(NF2):c.1173C>T (p.Thr391=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703071	22	30069308	22	29673319	703071	694702	rs769454739	NC_000022.11:29673318:C:T
NM_000268.4(NF2):c.279C>T (p.Thr93=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV000702958	22	30035117	22	29639128	702958	694700	rs758722464	NC_000022.11:29639127:C:T
NM_000268.4(NF2):c.810+9T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, single submitter	VCV000702947	22	30057337	22	29661348	702947	695870	rs143794864	NC_000022.11:29661347:T:C
NM_000268.4(NF2):c.1413G>A (p.Lys471=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000702017	22	30070897	22	29674908	702017	689275	rs1323009570	NC_000022.11:29674907:G:A
NM_000268.4(NF2):c.1455C>T (p.Asn485=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000701725	22	30074193	22	29678204	701725	689276	rs368966931	NC_000022.11:29678203:C:T
NM_000268.4(NF2):c.1212G>A (p.Glu404=)	NF2		Neurofibromatosis, type 2|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000700785	22	30069347	22	29673358	700785	689274	rs748403377	NC_000022.11:29673357:G:A
NM_000268.4(NF2):c.135C>T (p.Asp45=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000700743	22	30032760	22	29636771	700743	689273	rs752664255	NC_000022.11:29636770:C:T
NM_000268.4(NF2):c.641T>C (p.Leu214Pro)	NF2	L172P, L173P, L131P, L214P	Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2019)	criteria provided, conflicting interpretations	VCV000695095	22	30054219	22	29658230	695095	683212	rs1601618585	NC_000022.11:29658229:T:C
NM_000268.4(NF2):c.328G>C (p.Val110Leu)	NF2	V110L, V68L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV000666135	22	30035166	22	29639177	666135	649336	rs1601583759	NC_000022.11:29639176:G:C
NM_000268.4(NF2):c.1446+1G>A	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000664990	22	30070931	22	29674942	664990	653318	rs1601652425	NC_000022.11:29674941:G:A
NM_000268.4(NF2):c.1693A>T (p.Asn565Tyr)	NF2	N523Y, N565Y, N482Y, N524Y	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000664660	22	30077546	22	29681557	664660	649364	rs1601666359	NC_000022.11:29681556:A:T
NM_000268.4(NF2):c.726C>G (p.His242Gln)	NF2	H159Q, H200Q, H201Q, H242Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000662971	22	30057244	22	29661255	662971	649348	rs1480040681	NC_000022.11:29661254:C:G
NM_000268.4(NF2):c.1557G>A (p.Met519Ile)	NF2	M436I, M519I, M477I, M478I	Neurofibromatosis, type 2|not provided	Uncertain significance(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000662489	22	30074295	22	29678306	662489	649360	rs1601659358	NC_000022.11:29678305:G:A
NM_000268.4(NF2):c.305C>G (p.Pro102Arg)	NF2	P60R, P102R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 10, 2018)	criteria provided, single submitter	VCV000662380	22	30035143	22	29639154	662380	649334	rs1601583679	NC_000022.11:29639153:C:G
NM_000268.4(NF2):c.343C>G (p.Gln115Glu)	NF2	Q73E, Q115E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000662056	22	30035181	22	29639192	662056	649337	rs1350618734	NC_000022.11:29639191:C:G
NM_000268.4(NF2):c.1511G>A (p.Ser504Asn)	NF2	S504N, S462N, S463N, S421N	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000661260	22	30074249	22	29678260	661260	649359	rs756366940	NC_000022.11:29678259:G:A
NM_000268.4(NF2):c.1468C>T (p.Pro490Ser)	NF2	P407S, P490S, P448S, P449S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 22, 2018)	criteria provided, single submitter	VCV000660588	22	30074206	22	29678217	660588	649358	rs776076922	NC_000022.11:29678216:C:T
NM_000268.4(NF2):c.885+6T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000660535	22	30061059	22	29665070	660535	653619	rs1601630628	NC_000022.11:29665069:T:C
NM_000268.4(NF2):c.772T>G (p.Trp258Gly)	NF2	W216G, W217G, W175G, W258G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 23, 2018)	criteria provided, single submitter	VCV000659970	22	30057290	22	29661301	659970	649350	rs1601624186	NC_000022.11:29661300:T:G
NM_000268.4(NF2):c.1646T>A (p.Leu549Ter)	NF2	L508*, L466*, L549*, L507*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000659824	22	30077499	22	29681510	659824	649361	rs1601666156	NC_000022.11:29681509:T:A
NM_000268.4(NF2):c.479G>A (p.Arg160Gln)	NF2	R77Q, R118Q, R119Q, R160Q	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000657018	22	30050677	22	29654688	657018	649341	rs867595517	NC_000022.11:29654687:G:A
NM_000268.4(NF2):c.1270C>A (p.Arg424Ser)	NF2	R382S, R424S, R341S, R383S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000655363	22	30069405	22	29673416	655363	649352	rs763826793	NC_000022.11:29673415:C:A
NM_000268.4(NF2):c.347A>G (p.His116Arg)	NF2	H116R, H74R	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000655094	22	30035185	22	29639196	655094	649338	rs371373672	NC_000022.11:29639195:A:G
NM_000268.4(NF2):c.1400G>A (p.Arg467Lys)	NF2	R425K, R467K, R384K, R426K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000654279	22	30070884	22	29674895	654279	649356	rs1294032875	NC_000022.11:29674894:G:A
NM_000268.4(NF2):c.1340+6G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000653585	22	30069481	22	29673492	653585	653251	rs914659916	NC_000022.11:29673491:G:T
NM_000268.4(NF2):c.1460T>C (p.Ile487Thr)	NF2	I404T, I445T, I446T, I487T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000652338	22	30074198	22	29678209	652338	649357	rs1601658904	NC_000022.11:29678208:T:C
NM_000268.4(NF2):c.770C>T (p.Pro257Leu)	NF2	P174L, P215L, P216L, P257L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000651559	22	30057288	22	29661299	651559	649349	rs753300935	NC_000022.11:29661298:C:T
NM_000268.4(NF2):c.296A>G (p.Lys99Arg)	NF2	K99R, K57R	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000651188	22	30035134	22	29639145	651188	649333	rs181794923	NC_000022.11:29639144:A:G
NM_000268.4(NF2):c.676-10G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000648789	22	30057184	22	29661195	648789	653709	rs1601623842	NC_000022.11:29661194:G:A
NM_000268.4(NF2):c.157A>G (p.Thr53Ala)	NF2	T53A	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000647351	22	30032782	22	29636793	647351	649332	rs1601578990	NC_000022.11:29636792:A:G
NM_000268.4(NF2):c.516+1G>A	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000646675	22	30050715	22	29654726	646675	653312	rs1601612044	NC_000022.11:29654725:G:A
NM_000268.4(NF2):c.1301A>G (p.Glu434Gly)	NF2	E434G, E351G, E392G, E393G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000646364	22	30069436	22	29673447	646364	649354	rs1601648832	NC_000022.11:29673446:A:G
NM_000268.4(NF2):c.495A>G (p.Gln165=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000644065	22	30050693	22	29654704	644065	649342	rs1601611991	NC_000022.11:29654703:A:G
NM_000268.4(NF2):c.15C>G (p.Ile5Met)	NF2	I5M	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000643742	22	30000002	22	29604013	643742	649330	rs998779035	NC_000022.11:29604012:C:G
NM_000268.4(NF2):c.602A>T (p.Asp201Val)	NF2	D118V, D201V, D159V, D160V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000643206	22	30054180	22	29658191	643206	649344	rs1601618525	NC_000022.11:29658190:A:T
NM_000268.4(NF2):c.658A>T (p.Asn220Tyr)	NF2	N178Y, N220Y, N137Y, N179Y	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000643102	22	30054236	22	29658247	643102	649345	rs1601618646	NC_000022.11:29658246:A:T
NM_000268.4(NF2):c.515G>A (p.Arg172Lys)	NF2	R130K, R172K, R89K, R131K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000642873	22	30050713	22	29654724	642873	649343	rs752963731	NC_000022.11:29654723:G:A
NM_000268.4(NF2):c.370A>C (p.Lys124Gln)	NF2	K124Q, K41Q, K82Q, K83Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000642871	22	30038197	22	29642208	642871	649339	rs1601589425	NC_000022.11:29642207:A:C
NM_000268.4(NF2):c.1783C>T (p.Leu595Phe)	NF2	L165F, L595F	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000642286	22	30090786	22	29694797	642286	649367	rs1601689027	NC_000022.11:29694796:C:T
NM_000268.4(NF2):c.1270C>T (p.Arg424Cys)	NF2	R424C, R383C, R382C, R341C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 7, 2019)	criteria provided, single submitter	VCV000642120	22	30069405	22	29673416	642120	649353	rs763826793	NC_000022.11:29673415:C:T
NM_000268.4(NF2):c.685G>T (p.Gly229Cys)	NF2	G229C, G146C, G187C, G188C	Neurofibromatosis, type 2|not provided	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000641464	22	30057203	22	29661214	641464	649347	rs1028670573	NC_000022.11:29661213:G:T
NM_000268.4(NF2):c.1702A>G (p.Arg568Gly)	NF2	R527G, R568G, R485G, R526G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000640708	22	30077555	22	29681566	640708	649365	rs1318481716	NC_000022.11:29681565:A:G
NM_000268.4(NF2):c.1003G>T (p.Glu335Ter)	NF2	E252*, E293*, E294*, E335*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000640644	22	30067818	22	29671829	640644	649351	rs1601643866	NC_000022.11:29671828:G:T
NM_000268.4(NF2):c.457T>C (p.Tyr153His)	NF2	Y70H, Y112H, Y153H, Y111H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000640208	22	30050655	22	29654666	640208	649340	rs1374299963	NC_000022.11:29654665:T:C
NM_000268.4(NF2):c.326T>C (p.Leu109Pro)	NF2	L109P, L67P	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000639691	22	30035164	22	29639175	639691	649335	rs1601583740	NC_000022.11:29639174:T:C
NM_000268.4(NF2):c.1688A>G (p.Asn563Ser)	NF2	N521S, N522S, N563S, N480S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000639272	22	30077541	22	29681552	639272	649363	rs768303416	NC_000022.11:29681551:A:G
NM_000268.4(NF2):c.670A>G (p.Ile224Val)	NF2	I224V, I183V, I141V, I182V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 11, 2018)	criteria provided, single submitter	VCV000639228	22	30054248	22	29658259	639228	649346	rs1555994825	NC_000022.11:29658258:A:G
NM_000268.4(NF2):c.4G>T (p.Ala2Ser)	NF2	A2S	Schwannomatosis 1|Neurofibromatosis, type 2|Meningioma, familial	Uncertain significance(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638486	22	29999991	22	29604002	638486	626284	rs1601515682	NC_000022.11:29604001:G:T
NM_000268.4(NF2):c.1737+1432G>A	NF2	G584D, G543D, G501D, G542D	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000585003	22	30079022	22	29683033	585003	576059	rs746764835	NC_000022.11:29683032:G:A
NM_000268.4(NF2):c.1724A>G (p.Asn575Ser)	NF2	N575S, N492S, N533S, N534S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000585002	22	30077577	22	29681588	585002	576058	rs1569312127	NC_000022.11:29681587:A:G
NM_000268.4(NF2):c.1113C>G (p.Asn371Lys)	NF2	N371K, N288K, N329K, N330K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000585001	22	30067928	22	29671939	585001	576057	rs142459414	NC_000022.11:29671938:C:G
NM_000268.4(NF2):c.1059G>C (p.Arg353Ser)	NF2	R353S, R311S, R270S, R312S	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585000	22	30067874	22	29671885	585000	576056	rs1379674036	NC_000022.11:29671884:G:C
NM_000268.4(NF2):c.817A>G (p.Ile273Val)	NF2	I273V, I231V, I232V, I190V	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000584999	22	30060985	22	29664996	584999	576055	rs1368184325	NC_000022.11:29664995:A:G
NM_000268.4(NF2):c.610G>C (p.Glu204Gln)	NF2	E204Q, E162Q, E121Q, E163Q	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000584998	22	30054188	22	29658199	584998	576054	rs1569295916	NC_000022.11:29658198:G:C
NM_000268.4(NF2):c.349T>G (p.Leu117Val)	NF2	L117V, L75V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584997	22	30035187	22	29639198	584997	576053	rs1569281810	NC_000022.11:29639197:T:G
NM_000268.4(NF2):c.999+1G>A	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000583001	22	30064436	22	29668447	583001	573347	rs1569302393	NC_000022.11:29668446:G:A
NM_000268.4(NF2):c.1129T>G (p.Ser377Ala)	NF2	S377A, S294A, S335A, S336A	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000581638	22	30069264	22	29673275	581638	575248	rs1569305865	NC_000022.11:29673274:T:G
NM_000268.4(NF2):c.272C>A (p.Pro91Gln)	NF2	P91Q, P49Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000580632	22	30035110	22	29639121	580632	571858	rs1569281659	NC_000022.11:29639120:C:A
NM_000268.4(NF2):c.74G>A (p.Arg25Lys)	NF2	R25K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000580062	22	30000061	22	29604072	580062	574061	rs1569259813	NC_000022.11:29604071:G:A
NM_000268.4(NF2):c.713C>T (p.Ala238Val)	NF2	A238V, A155V, A197V, A196V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000578288	22	30057231	22	29661242	578288	573344	rs761195572	NC_000022.11:29661241:C:T
NM_000268.4(NF2):c.749T>A (p.Leu250Gln)	NF2	L250Q, L208Q, L167Q, L209Q	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000577903	22	30057267	22	29661278	577903	575245	rs1432132718	NC_000022.11:29661277:T:A
NM_000268.4(NF2):c.675+1G>A	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000577678	22	30054254	22	29658265	577678	574064	rs1555994854	NC_000022.11:29658264:G:A
NM_000268.4(NF2):c.736C>T (p.Pro246Ser)	NF2	P246S, P163S, P204S, P205S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000577558	22	30057254	22	29661265	577558	571891	rs1569297802	NC_000022.11:29661264:C:T
NM_000268.4(NF2):c.1053C>T (p.Arg351=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000577499	22	30067868	22	29671879	577499	573350	rs1179494821	NC_000022.11:29671878:C:T
NM_000268.4(NF2):c.1123-7C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000576029	22	30069251	22	29673262	576029	574075	rs559511611	NC_000022.11:29673261:C:G
NM_000268.4(NF2):c.1517C>G (p.Ser506Cys)	NF2	S506C, S423C, S464C, S465C	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000575367	22	30074255	22	29678266	575367	575250	rs970051210	NC_000022.11:29678265:C:G
NM_000268.4(NF2):c.675G>T (p.Arg225=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000574605	22	30054253	22	29658264	574605	571884	rs1569295986	NC_000022.11:29658263:G:T
NM_000268.4(NF2):c.1501A>G (p.Ile501Val)	NF2	I501V, I460V, I418V, I459V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000574302	22	30074239	22	29678250	574302	571905	rs1315864916	NC_000022.11:29678249:A:G
NM_000268.4(NF2):c.1678A>G (p.Ile560Val)	NF2	I560V, I519V, I518V, I477V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000574211	22	30077531	22	29681542	574211	574085	rs557347747	NC_000022.11:29681541:A:G
NM_000268.4(NF2):c.1547G>A (p.Arg516Gln)	NF2	R516Q, R475Q, R433Q, R474Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000574082	22	30074285	22	29678296	574082	571912	rs1569309694	NC_000022.11:29678295:G:A
NM_000268.4(NF2):c.436G>A (p.Val146Ile)	NF2	V146I, V105I, V104I, V63I	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000573553	22	30038263	22	29642274	573553	571860	rs771572024	NC_000022.11:29642273:G:A
NM_000268.4(NF2):c.662A>G (p.Tyr221Cys)	NF2	Y221C, Y179C, Y180C, Y138C	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000572959	22	30054240	22	29658251	572959	575244	rs746025177	NC_000022.11:29658250:A:G
NM_000268.4(NF2):c.521T>C (p.Ile174Thr)	NF2	I174T, I132T, I133T, I91T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000572737	22	30051587	22	29655598	572737	571879	rs1346860299	NC_000022.11:29655597:T:C
NM_000268.4(NF2):c.758A>G (p.Lys253Arg)	NF2	K253R, K170R, K212R, K211R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000572458	22	30057276	22	29661287	572458	571900	rs773573049	NC_000022.11:29661286:A:G
NM_000268.4(NF2):c.1737G>A (p.Lys579=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000571792	22	30077590	22	29681601	571792	571913	rs1569312133	NC_000022.11:29681600:G:A
NM_000268.4(NF2):c.1252C>T (p.Arg418Cys)	NF2	R418C, R335C, R377C, R376C	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000571182	22	30069387	22	29673398	571182	574077	rs765540111	NC_000022.11:29673397:C:T
NM_000268.4(NF2):c.1055C>T (p.Thr352Met)	NF2	T352M, T269M, T310M, T311M	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV000569661	22	30067870	22	29671881	569661	571901	rs764441073	NC_000022.11:29671880:C:T
NM_000268.4(NF2):c.215T>C (p.Val72Ala)	NF2	V72A	Hereditary cancer-predisposing syndrome|Schwannomatosis 1|Neurofibromatosis, type 2|Meningioma, familial|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000569354	22	30032840	22	29636851	569354	574062	rs1260510937	NC_000022.11:29636850:T:C
NM_000268.4(NF2):c.652G>A (p.Gly218Ser)	NF2	G218S, G176S, G135S, G177S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000569350	22	30054230	22	29658241	569350	574063	rs776818377	NC_000022.11:29658240:G:A
NM_000268.4(NF2):c.872G>A (p.Arg291His)	NF2	R291H, R249H, R250H, R208H	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000568655	22	30061040	22	29665051	568655	575247	rs755200117	NC_000022.11:29665050:G:A
NM_000268.4(NF2):c.1469C>T (p.Pro490Leu)	NF2	P490L, P449L, P407L, P448L	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000567951	22	30074207	22	29678218	567951	571904	rs765100922	NC_000022.11:29678217:C:T
NM_000268.4(NF2):c.1611G>T (p.Glu537Asp)	NF2	E537D, E496D, E495D, E454D	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000567902	22	30077464	22	29681475	567902	573351	rs946609084	NC_000022.11:29681474:G:T
NM_000268.4(NF2):c.1231C>T (p.Arg411Cys)	NF2	R411C, R328C, R369C, R370C	not specified|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000567682	22	30069366	22	29673377	567682	575249	rs773296925	NC_000022.11:29673376:C:T
NM_000268.4(NF2):c.1122+1G>A	NF2		Neurofibromatosis, type 2|not provided	Likely pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000567477	22	30067938	22	29671949	567477	574073	rs1569304774	NC_000022.11:29671948:G:A
NM_000268.4(NF2):c.904G>A (p.Gly302Arg)	NF2	G302R, G261R, G260R, G219R	not provided|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000567430	22	30064340	22	29668351	567430	574071	rs1255367068	NC_000022.11:29668350:G:A
NM_000268.4(NF2):c.497A>T (p.Glu166Val)	NF2	E166V, E125V, E124V, E83V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000567169	22	30050695	22	29654706	567169	575243	rs779353677	NC_000022.11:29654705:A:T
NM_000268.4(NF2):c.851A>G (p.Lys284Arg)	NF2	K284R, K201R, K243R, K242R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000566844	22	30061019	22	29665030	566844	573346	rs764034925	NC_000022.11:29665029:A:G
NM_000268.4(NF2):c.516+2T>G	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000565836	22	30050716	22	29654727	565836	571866	rs1569293488	NC_000022.11:29654726:T:G
NM_000268.4(NF2):c.1619A>G (p.Asn540Ser)	NF2	N540S, N457S, N498S, N499S	Schwannomatosis 1|Neurofibromatosis, type 2|Meningioma, familial|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000565467	22	30077472	22	29681483	565467	574080	rs774824164	NC_000022.11:29681482:A:G
NM_000268.4(NF2):c.1786T>C (p.Ter596Gln)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000561064	22	30090789	22	29694800	561064	552229	rs1569319775	NC_000022.11:29694799:T:C
NM_000268.4(NF2):c.1737+2T>A	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547710	22	30077592	22	29681603	547710	538260	rs1556003801	NC_000022.11:29681602:T:A
NM_000268.4(NF2):c.1550T>C (p.Leu517Pro)	NF2	L517P, L475P, L434P, L476P	Neurofibromatosis, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547709	22	30074288	22	29678299	547709	538259	rs1556002568	NC_000022.11:29678298:T:C
NM_000268.4(NF2):c.517-4G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000527724	22	30051579	22	29655590	527724	534699	rs1165155285	NC_000022.11:29655589:G:A
NM_000268.4(NF2):c.294C>G (p.Ala98=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000527723	22	30035132	22	29639143	527723	534691	rs1555987671	NC_000022.11:29639142:C:G
NM_000268.4(NF2):c.1698C>T (p.Ser566=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527722	22	30077551	22	29681562	527722	534320	rs751987156	NC_000022.11:29681561:C:T
NM_000268.4(NF2):c.1056G>A (p.Thr352=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527720	22	30067871	22	29671882	527720	534313	rs145427713	NC_000022.11:29671881:G:A
NM_000268.4(NF2):c.543G>A (p.Pro181=)	NF2		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527719	22	30051609	22	29655620	527719	534705	rs139838280	NC_000022.11:29655619:G:A
NM_000268.4(NF2):c.1617C>T (p.Leu539=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000527718	22	30077470	22	29681481	527718	534714	rs1556003665	NC_000022.11:29681480:C:T
NM_000268.4(NF2):c.861C>T (p.Ser287=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527717	22	30061029	22	29665040	527717	534177	rs143160499	NC_000022.11:29665039:C:T
NM_000268.4(NF2):c.459C>T (p.Tyr153=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527716	22	30050657	22	29654668	527716	534698	rs142972020	NC_000022.11:29654667:C:T
NM_000268.4(NF2):c.1209A>G (p.Ala403=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000527715	22	30069344	22	29673355	527715	534711	rs1026655770	NC_000022.11:29673354:A:G
NM_000268.4(NF2):c.966A>G (p.Lys322=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV000527714	22	30064402	22	29668413	527714	534185	rs746175548	NC_000022.11:29668412:A:G
NM_000268.4(NF2):c.885+10G>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527713	22	30061063	22	29665074	527713	534304	rs369317112	NC_000022.11:29665073:G:C
NM_000268.4(NF2):c.1020T>C (p.Ala340=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000527712	22	30067835	22	29671846	527712	534309	rs1556000130	NC_000022.11:29671845:T:C
NM_000268.4(NF2):c.771G>A (p.Pro257=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527711	22	30057289	22	29661300	527711	534300	rs759032771	NC_000022.11:29661299:G:A
NM_000268.4(NF2):c.1103C>T (p.Thr368Ile)	NF2	T368I, T285I, T326I, T327I	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000527710	22	30067918	22	29671929	527710	534191	rs1556000214	NC_000022.11:29671928:C:T
NM_000268.4(NF2):c.1037G>A (p.Arg346Lys)	NF2	R346K, R263K, R304K, R305K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000527709	22	30067852	22	29671863	527709	534189	rs1556000154	NC_000022.11:29671862:G:A
NM_000268.4(NF2):c.1018G>A (p.Ala340Thr)	NF2	A340T, A257T, A298T, A299T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527708	22	30067833	22	29671844	527708	534188	rs780430071	NC_000022.11:29671843:G:A
NM_000268.4(NF2):c.1013G>A (p.Arg338His)	NF2	R338H, R296H, R255H, R297H	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000527707	22	30067828	22	29671839	527707	534305	rs768053145	NC_000022.11:29671838:G:A
NM_000268.4(NF2):c.271C>A (p.Pro91Thr)	NF2	P91T, P49T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000527706	22	30035109	22	29639120	527706	534295	rs1555987645	NC_000022.11:29639119:C:A
NM_000268.4(NF2):c.111C>T (p.Cys37=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000527705	22	30000098	22	29604109	527705	534142	rs1302428933	NC_000022.11:29604108:C:T
NM_000268.4(NF2):c.1765G>A (p.Val589Met)	NF2	V589M, V159M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527704	22	30090768	22	29694779	527704	534325	rs1293851600	NC_000022.11:29694778:G:A
NM_000268.4(NF2):c.1502T>C (p.Ile501Thr)	NF2	I501T, I418T, I460T, I459T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527701	22	30074240	22	29678251	527701	534712	rs767682136	NC_000022.11:29678250:T:C
NM_000268.4(NF2):c.1300G>A (p.Glu434Lys)	NF2	E434K, E351K, E393K, E392K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527700	22	30069435	22	29673446	527700	534317	rs992662337	NC_000022.11:29673445:G:A
NM_000268.4(NF2):c.1450A>G (p.Met484Val)	NF2	M484V, M442V, M443V, M401V	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527699	22	30074188	22	29678199	527699	534197	rs1182896077	NC_000022.11:29678198:A:G
NM_000268.4(NF2):c.1357C>G (p.Gln453Glu)	NF2	Q453E, Q411E, Q412E, Q370E	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000527698	22	30070841	22	29674852	527698	534183	rs1556001358	NC_000022.11:29674851:C:G
NM_000268.4(NF2):c.599+3G>A	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000527696	22	30051668	22	29655679	527696	534164	rs768301915	NC_000022.11:29655678:G:A
NM_000268.4(NF2):c.1232G>A (p.Arg411His)	NF2	R411H, R328H, R369H, R370H	Neurofibromatosis, type 2|Schwannomatosis 1|Neurofibromatosis, type 2|Meningioma, familial|Hereditary cancer-predisposing syndrome|Meningioma, familial|not specified	Uncertain significance(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527695	22	30069367	22	29673378	527695	534181	rs201214090	NC_000022.11:29673377:G:A
NM_000268.4(NF2):c.1022G>A (p.Arg341Gln)	NF2	R341Q, R258Q, R300Q, R299Q	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527694	22	30067837	22	29671848	527694	534310	rs754087071	NC_000022.11:29671847:G:A
NM_000268.4(NF2):c.400C>T (p.Pro134Ser)	NF2	P134S, P92S, P51S, P93S	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000527693	22	30038227	22	29642238	527693	534692	rs1555988776	NC_000022.11:29642237:C:T
NM_000268.4(NF2):c.798C>G (p.Tyr266Ter)	NF2	Y266*, Y224*, Y225*, Y183*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000527692	22	30057316	22	29661327	527692	534168	rs917257652	NC_000022.11:29661326:C:G
NM_000268.4(NF2):c.683A>G (p.Lys228Arg)	NF2	K228R, K186R, K187R, K145R	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527691	22	30057201	22	29661212	527691	534180	rs145384260	NC_000022.11:29661211:A:G
NM_000268.4(NF2):c.1445C>T (p.Pro482Leu)	NF2	P482L, P399L, P440L, P441L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000527690	22	30070929	22	29674940	527690	534196	rs766339217	NC_000022.11:29674939:C:T
NM_000268.4(NF2):c.1364A>G (p.Lys455Arg)	NF2	K455R, K414R, K372R, K413R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000527689	22	30070848	22	29674859	527689	534199	rs1318882444	NC_000022.11:29674858:A:G
NM_000268.4(NF2):c.196T>A (p.Tyr66Asn)	NF2	Y66N	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000527688	22	30032821	22	29636832	527688	534688	rs772274240	NC_000022.11:29636831:T:A
NM_000268.4(NF2):c.759G>A (p.Lys253=)	NF2		Neurofibromatosis, type 2|not provided|not specified	Likely benign(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000509471	22	30057277	22	29661288	509471	507562	rs760272926	NC_000022.11:29661287:G:A
NM_000268.4(NF2):c.180G>A (p.Trp60Ter)	NF2	W60*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 29, 2016)	no assertion criteria provided	VCV000492893	22	30032805	22	29636816	492893	485797	rs780872661	NC_000022.11:29636815:G:A
NM_000268.4(NF2):c.43A>T (p.Lys15Ter)	NF2	K15*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 13, 2014)	no assertion criteria provided	VCV000492891	22	30000030	22	29604041	492891	485796	rs1555978356	NC_000022.11:29604040:A:T
NM_000268.4(NF2):c.1395G>A (p.Glu465=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485994	22	30070879	22	29674890	485994	480393	rs1556001388	NC_000022.11:29674889:G:A
NM_000268.4(NF2):c.1022G>T (p.Arg341Leu)	NF2	R341L, R299L, R300L, R258L	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485993	22	30067837	22	29671848	485993	480166	rs754087071	NC_000022.11:29671847:G:T
NM_000268.4(NF2):c.1445C>G (p.Pro482Arg)	NF2	P482R, P440R, P441R, P399R	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485992	22	30070929	22	29674940	485992	480394	rs766339217	NC_000022.11:29674939:C:G
NM_000268.4(NF2):c.504G>A (p.Leu168=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485991	22	30050702	22	29654713	485991	480170	rs182990439	NC_000022.11:29654712:G:A
NM_000268.4(NF2):c.770C>G (p.Pro257Arg)	NF2	P257R, P174R, P215R, P216R	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485989	22	30057288	22	29661299	485989	480197	rs753300935	NC_000022.11:29661298:C:G
NM_000268.4(NF2):c.1500C>T (p.Leu500=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485987	22	30074238	22	29678249	485987	480395	rs758182356	NC_000022.11:29678248:C:T
NM_000268.4(NF2):c.435C>T (p.Ala145=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485985	22	30038262	22	29642273	485985	480196	rs955424447	NC_000022.11:29642272:C:T
NM_000268.4(NF2):c.1127G>A (p.Arg376Gln)	NF2	R376Q, R293Q, R335Q, R334Q	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000485984	22	30069262	22	29673273	485984	480172	rs996964764	NC_000022.11:29673272:G:A
NM_000268.4(NF2):c.1586T>C (p.Met529Thr)	NF2	M529T, M488T, M446T, M487T	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485982	22	30077439	22	29681450	485982	480396	rs780818183	NC_000022.11:29681449:T:C
NM_000268.4(NF2):c.1699G>A (p.Asp567Asn)	NF2	D567N, D526N, D525N, D484N	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000485981	22	30077552	22	29681563	485981	480177	rs757586383	NC_000022.11:29681562:G:A
NM_000268.4(NF2):c.1206C>T (p.Ala402=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000485980	22	30069341	22	29673352	485980	480199	rs137953976	NC_000022.11:29673351:C:T
NM_000268.4(NF2):c.932G>A (p.Arg311Lys)	NF2	R311K, R269K, R228K, R270K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV000457932	22	30064368	22	29668379	457932	470118	rs1169276398	NC_000022.11:29668378:G:A
NM_000268.4(NF2):c.912T>C (p.His304=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457931	22	30064348	22	29668359	457931	471488	rs200272173	NC_000022.11:29668358:T:C
NM_000268.4(NF2):c.911A>G (p.His304Arg)	NF2	H304R, H263R, H221R, H262R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000457930	22	30064347	22	29668358	457930	471039	rs1555998800	NC_000022.11:29668357:A:G
NM_000268.4(NF2):c.882G>A (p.Lys294=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV000457929	22	30061050	22	29665061	457929	471037	rs146166875	NC_000022.11:29665060:G:A
NM_000268.4(NF2):c.879T>C (p.Asn293=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2020)	criteria provided, conflicting interpretations	VCV000457928	22	30061047	22	29665058	457928	471890	rs151198477	NC_000022.11:29665057:T:C
NM_000268.4(NF2):c.849C>T (p.Phe283=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000457927	22	30061017	22	29665028	457927	471032	rs1555997567	NC_000022.11:29665027:C:T
NM_000268.4(NF2):c.789C>T (p.Asn263=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV000457926	22	30057307	22	29661318	457926	471888	rs1555996218	NC_000022.11:29661317:C:T
NM_000268.4(NF2):c.595G>A (p.Ala199Thr)	NF2	A199T, A116T, A157T, A158T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457924	22	30051661	22	29655672	457924	470109	rs1261707371	NC_000022.11:29655671:G:A
NM_000268.4(NF2):c.599+1G>T	NF2		Neurofibromatosis, type 2	Likely pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000457923	22	30051666	22	29655677	457923	470113	rs1555993352	NC_000022.11:29655676:G:T
NM_000268.4(NF2):c.592C>T (p.Arg198Ter)	NF2	R198*, R156*, R115*, R157*	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457922	22	30051658	22	29655669	457922	470104	rs1555993345	NC_000022.11:29655668:C:T
NM_000268.4(NF2):c.586C>T (p.Arg196Ter)	NF2	R196*, R113*, R154*, R155*	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457921	22	30051652	22	29655663	457921	471030	rs1555993336	NC_000022.11:29655662:C:T
NM_000268.4(NF2):c.579A>G (p.Ala193=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000457920	22	30051645	22	29655656	457920	471485	rs1332985565	NC_000022.11:29655655:A:G
NM_000268.4(NF2):c.560G>A (p.Arg187Lys)	NF2	R187K, R104K, R145K, R146K	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000457919	22	30051626	22	29655637	457919	471887	rs1234052589	NC_000022.11:29655636:G:A
NM_000268.4(NF2):c.48G>A (p.Arg16=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457918	22	30000035	22	29604046	457918	470093	rs774973059	NC_000022.11:29604045:G:A
NM_000268.4(NF2):c.448-4C>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000457917	22	30050642	22	29654653	457917	471481	rs760733256	NC_000022.11:29654652:C:G
NM_000268.4(NF2):c.401C>T (p.Pro134Leu)	NF2	P134L, P51L, P92L, P93L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457916	22	30038228	22	29642239	457916	471478	rs1029716358	NC_000022.11:29642238:C:T
NM_000268.4(NF2):c.325C>T (p.Leu109=)	NF2		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457915	22	30035163	22	29639174	457915	471886	rs201603384	NC_000022.11:29639173:C:T
NM_000268.4(NF2):c.302A>T (p.Tyr101Phe)	NF2	Y101F, Y59F	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457914	22	30035140	22	29639151	457914	471028	rs1240469044	NC_000022.11:29639150:A:T
NM_000268.4(NF2):c.300T>A (p.Phe100Leu)	NF2	F100L, F58L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000457913	22	30035138	22	29639149	457913	470101	rs1555987677	NC_000022.11:29639148:T:A
NM_000268.4(NF2):c.364-9T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000457912	22	30038182	22	29642193	457912	470102	rs767658752	NC_000022.11:29642192:T:C
NM_000268.4(NF2):c.255T>C (p.Asp85=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2020)	criteria provided, conflicting interpretations	VCV000457910	22	30035093	22	29639104	457910	471476	rs375802248	NC_000022.11:29639103:T:C
NM_000268.4(NF2):c.1752C>T (p.Ser584=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Benign/Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457908	22	30090755	22	29694766	457908	470133	rs370999558	NC_000022.11:29694765:C:T
NM_000268.4(NF2):c.1737+1G>T	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV000457907	22	30077591	22	29681602	457907	471907	rs1556003799	NC_000022.11:29681601:G:T
NM_000268.4(NF2):c.1722C>T (p.His574=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000457906	22	30077575	22	29681586	457906	471056	rs1041539951	NC_000022.11:29681585:C:T
NM_000268.4(NF2):c.170G>A (p.Arg57Gln)	NF2	R57Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000457905	22	30032795	22	29636806	457905	470100	rs368773485	NC_000022.11:29636805:G:A
NM_000268.4(NF2):c.1701C>G (p.Asp567Glu)	NF2	D567E, D526E, D484E, D525E	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|Meningioma, familial|Schwannomatosis 1	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457904	22	30077554	22	29681565	457904	470130	rs1049732514	NC_000022.11:29681564:C:G
NM_000268.4(NF2):c.1639G>A (p.Glu547Lys)	NF2	E547K, E464K, E505K, E506K	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000457903	22	30077492	22	29681503	457903	471053	rs199669486	NC_000022.11:29681502:G:A
NM_000268.4(NF2):c.1491C>T (p.Ser497=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000457902	22	30074229	22	29678240	457902	471052	rs1556002514	NC_000022.11:29678239:C:T
NM_000268.4(NF2):c.1484T>G (p.Ile495Arg)	NF2	I495R, I412R, I454R, I453R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000457901	22	30074222	22	29678233	457901	471904	rs1556002511	NC_000022.11:29678232:T:G
NM_000268.4(NF2):c.1446+5G>A	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2020)	criteria provided, conflicting interpretations	VCV000457900	22	30070935	22	29674946	457900	471902	rs367829184	NC_000022.11:29674945:G:A
NM_000268.4(NF2):c.1397G>A (p.Arg466Gln)	NF2	R466Q, R383Q, R425Q, R424Q	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457899	22	30070881	22	29674892	457899	470129	rs866689896	NC_000022.11:29674891:G:A
NM_000268.4(NF2):c.1391C>T (p.Ala464Val)	NF2	A464V, A381V, A423V, A422V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000457898	22	30070875	22	29674886	457898	471901	rs776109136	NC_000022.11:29674885:C:T
NM_000268.4(NF2):c.1638C>T (p.Ile546=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457897	22	30077491	22	29681502	457897	471906	rs774264046	NC_000022.11:29681501:C:T
NM_000268.4(NF2):c.1323T>A (p.Ala441=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: May 27, 2017)	criteria provided, single submitter	VCV000457896	22	30069458	22	29673469	457896	470123	rs1556000942	NC_000022.11:29673468:T:A
NM_000268.4(NF2):c.1317G>A (p.Lys439=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000457895	22	30069452	22	29673463	457895	471042	rs1556000937	NC_000022.11:29673462:G:A
NM_000268.4(NF2):c.1303G>T (p.Val435Leu)	NF2	V435L, V393L, V394L, V352L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000457894	22	30069438	22	29673449	457894	471897	rs772334382	NC_000022.11:29673448:G:T
NM_000268.4(NF2):c.1288G>T (p.Val430Leu)	NF2	V430L, V347L, V388L, V389L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000457893	22	30069423	22	29673434	457893	470120	rs1361867592	NC_000022.11:29673433:G:T
NM_000268.4(NF2):c.1273C>T (p.Leu425=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457892	22	30069408	22	29673419	457892	471493	rs142446775	NC_000022.11:29673418:C:T
NM_000268.4(NF2):c.1271G>T (p.Arg424Leu)	NF2	R424L, R382L, R341L, R383L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV000457891	22	30069406	22	29673417	457891	471489	rs751182657	NC_000022.11:29673416:G:T
NM_000268.4(NF2):c.1128G>C (p.Arg376=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457890	22	30069263	22	29673274	457890	471895	rs757322524	NC_000022.11:29673273:G:C
NM_000268.4(NF2):c.1124T>C (p.Met375Thr)	NF2	M375T, M333T, M292T, M334T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000457889	22	30069259	22	29673270	457889	471894	rs1556000763	NC_000022.11:29673269:T:C
NM_000268.4(NF2):c.1000A>G (p.Met334Val)	NF2	M334V, M293V, M292V, M251V	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000457888	22	30067815	22	29671826	457888	471040	rs1556000094	NC_000022.11:29671825:A:G
NM_000268.4(NF2):c.1000-7C>G	NF2		Neurofibromatosis, type 2|not specified	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457887	22	30067808	22	29671819	457887	471892	rs776237839	NC_000022.11:29671818:C:G
NM_000268.4(NF2):c.1000-4G>A	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000457886	22	30067811	22	29671822	457886	471893	rs200113152	NC_000022.11:29671821:G:A
NM_000268.4(NF2):c.122G>A (p.Trp41Ter)	NF2	W41*	not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449433	22	30032747	22	29636758	449433	446394	rs1555986860	NC_000022.11:29636757:G:A
NM_000268.4(NF2):c.1635A>T (p.Glu545Asp)	NF2	E545D, E503D, E504D, E462D	Neurofibromatosis, type 2|not specified	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000435976	22	30077488	22	29681499	435976	430558	rs1556003698	NC_000022.11:29681498:A:T
NM_000268.4(NF2):c.1228C>T (p.Gln410Ter)	NF2	Q410*, Q368*, Q369*, Q327*	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000431979	22	30069363	22	29673374	431979	426372	rs1556000842	NC_000022.11:29673373:C:T
NM_000268.4(NF2):c.517-1G>A	NF2		Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Jun 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423789	22	30051582	22	29655593	423789	410982	rs1064796632	NC_000022.11:29655592:G:A
NM_000268.4(NF2):c.354C>T (p.Phe118=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417155	22	30035192	22	29639203	417155	404355	rs756564761	NC_000022.11:29639202:C:T
NM_000268.4(NF2):c.1311A>G (p.Ala437=)	NF2		not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417154	22	30069446	22	29673457	417154	403938	rs144628209	NC_000022.11:29673456:A:G
NM_000268.4(NF2):c.246G>A (p.Leu82=)	NF2		Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 2	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417153	22	30035084	22	29639095	417153	404353	rs371270318	NC_000022.11:29639094:G:A
NM_000268.4(NF2):c.798C>T (p.Tyr266=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV000417152	22	30057316	22	29661327	417152	404356	rs917257652	NC_000022.11:29661326:C:T
NM_000268.4(NF2):c.1548G>T (p.Arg516=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV000417151	22	30074286	22	29678297	417151	404391	rs534398531	NC_000022.11:29678296:G:T
NM_000268.4(NF2):c.1416C>T (p.Leu472=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not specified	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417150	22	30070900	22	29674911	417150	403939	rs148776784	NC_000022.11:29674910:C:T
NM_000268.4(NF2):c.1494C>T (p.Phe498=)	NF2		not provided|Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000417149	22	30074232	22	29678243	417149	404362	rs1060504990	NC_000022.11:29678242:C:T
NM_000268.4(NF2):c.1290G>A (p.Val430=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000417148	22	30069425	22	29673436	417148	403933	rs756041768	NC_000022.11:29673435:G:A
NM_000268.4(NF2):c.783C>T (p.Ile261=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000417147	22	30057301	22	29661312	417147	403925	rs765223726	NC_000022.11:29661311:C:T
NM_000268.4(NF2):c.600-6C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV000417146	22	30054172	22	29658183	417146	403908	rs749155274	NC_000022.11:29658182:C:T
NM_000268.4(NF2):c.1386C>T (p.Arg462=)	NF2		Hereditary cancer-predisposing syndrome|not specified|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000417145	22	30070870	22	29674881	417145	403946	rs138354622	NC_000022.11:29674880:C:T
NM_000268.4(NF2):c.1392G>A (p.Ala464=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2020)	criteria provided, conflicting interpretations	VCV000417144	22	30070876	22	29674887	417144	404357	rs375819833	NC_000022.11:29674886:G:A
NM_000268.4(NF2):c.1575-5G>A	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417143	22	30077423	22	29681434	417143	404364	rs199622889	NC_000022.11:29681433:G:A
NM_000268.4(NF2):c.1215T>G (p.Ala405=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417142	22	30069350	22	29673361	417142	403932	rs772219612	NC_000022.11:29673360:T:G
NM_000268.4(NF2):c.576C>T (p.Tyr192=)	NF2		Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417141	22	30051642	22	29655653	417141	403922	rs149803133	NC_000022.11:29655652:C:T
NM_000268.4(NF2):c.1018G>T (p.Ala340Ser)	NF2	A340S, A299S, A257S, A298S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000412217	22	30067833	22	29671844	412217	404389	rs780430071	NC_000022.11:29671843:G:T
NM_000268.4(NF2):c.1446G>A (p.Pro482=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000412215	22	30070930	22	29674941	412215	403949	rs753751373	NC_000022.11:29674940:G:A
NM_000268.4(NF2):c.1575A>G (p.Lys525=)	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000412214	22	30077428	22	29681439	412214	404366	rs1060503673	NC_000022.11:29681438:A:G
NM_000268.4(NF2):c.1774T>C (p.Phe592Leu)	NF2	F592L, F162L	Malignant tumor of breast|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)	criteria provided, conflicting interpretations	VCV000412213	22	30090777	22	29694788	412213	404368	rs764972504	NC_000022.11:29694787:T:C
NM_000268.4(NF2):c.1396C>G (p.Arg466Gly)	NF2	R466G, R383G, R425G, R424G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	VCV000412212	22	30070880	22	29674891	412212	404358	rs74315504	NC_000022.11:29674890:C:G
NM_000268.4(NF2):c.345A>T (p.Gln115His)	NF2	Q115H, Q73H	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412211	22	30035183	22	29639194	412211	403918	rs746369012	NC_000022.11:29639193:A:T
NM_000268.4(NF2):c.614T>C (p.Met205Thr)	NF2	M205T, M122T, M163T, M164T	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV000412210	22	30054192	22	29658203	412210	403927	rs747871414	NC_000022.11:29658202:T:C
NM_000268.4(NF2):c.114+6C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000412208	22	30000107	22	29604118	412208	403902	rs1060503671	NC_000022.11:29604117:C:G
NM_000268.4(NF2):c.517-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000412207	22	30051581	22	29655592	412207	403906	rs1060503670	NC_000022.11:29655591:A:G
NM_000268.4(NF2):c.1253G>A (p.Arg418His)	NF2	R418H, R376H, R335H, R377H	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412206	22	30069388	22	29673399	412206	403931	rs548217466	NC_000022.11:29673398:G:A
NM_000268.4(NF2):c.1052G>A (p.Arg351His)	NF2	R351H, R309H, R310H, R268H	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000412205	22	30067867	22	29671878	412205	403928	rs771675702	NC_000022.11:29671877:G:A
NM_000268.4(NF2):c.478C>T (p.Arg160Trp)	NF2	R160W, R77W, R119W, R118W	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV000412204	22	30050676	22	29654687	412204	403921	rs150667239	NC_000022.11:29654686:C:T
NM_000268.4(NF2):c.363+3A>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 2, 2016)	criteria provided, single submitter	VCV000412203	22	30035204	22	29639215	412203	404387	rs1060503669	NC_000022.11:29639214:A:T
NM_000268.4(NF2):c.293C>A (p.Ala98Asp)	NF2	A98D, A56D	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000412202	22	30035131	22	29639142	412202	403914	rs1060503668	NC_000022.11:29639141:C:A
NM_000268.4(NF2):c.432C>G (p.Tyr144Ter)	NF2	Y144*, Y102*, Y61*, Y103*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000412201	22	30038259	22	29642270	412201	403903	rs1060503667	NC_000022.11:29642269:C:G
NM_000268.4(NF2):c.676-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 25, 2016)	criteria provided, single submitter	VCV000412199	22	30057192	22	29661203	412199	403919	rs1060503666	NC_000022.11:29661202:A:G
NM_000268.4(NF2):c.1490G>C (p.Ser497Thr)	NF2	S497T, S455T, S414T, S456T	not specified|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000403231	22	30074228	22	29678239	403231	390486	rs900545157	NC_000022.11:29678238:G:C
NM_000268.4(NF2):c.1012C>T (p.Arg338Cys)	NF2	R338C, R297C, R255C, R296C	not provided|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000393183	22	30067827	22	29671838	393183	378781	rs761795291	NC_000022.11:29671837:C:T
NM_000268.4(NF2):c.705A>C (p.Gly235=)	NF2		not specified|Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000385259	22	30057223	22	29661234	385259	378776	rs749331641	NC_000022.11:29661233:A:C
NM_000268.4(NF2):c.947T>G (p.Leu316Trp)	NF2	L316W, L274W, L233W, L275W	Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000380975	22	30064383	22	29668394	380975	379846	rs750633919	NC_000022.11:29668393:T:G
NM_000268.4(NF2):c.*3783T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341178	22	30094574	22	29698585	341178	347405	rs886057393	NC_000022.11:29698584:T:C
NM_000268.4(NF2):c.*3715C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341177	22	30094506	22	29698517	341177	351347	rs886057392	NC_000022.11:29698516:C:A
NM_000268.4(NF2):c.*3670C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341176	22	30094461	22	29698472	341176	352380	rs886057391	NC_000022.11:29698471:C:T
NM_000268.4(NF2):c.*3646C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341175	22	30094437	22	29698448	341175	347398	rs886057390	NC_000022.11:29698447:C:T
NM_000268.4(NF2):c.*3603A>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341173	22	30094394	22	29698405	341173	352377	rs557359614	NC_000022.11:29698404:A:C
NM_000268.4(NF2):c.*3575G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341172	22	30094366	22	29698377	341172	352376	rs41278851	NC_000022.11:29698376:G:A
NM_000268.4(NF2):c.*3480T>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341171	22	30094271	22	29698282	341171	347396	rs886057388	NC_000022.11:29698281:T:G
NM_000268.4(NF2):c.*3443G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341170	22	30094234	22	29698245	341170	337804	rs886057387	NC_000022.11:29698244:G:T
NM_000268.4(NF2):c.*3298G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341168	22	30094089	22	29698100	341168	337798	rs886057385	NC_000022.11:29698099:G:T
NM_000268.4(NF2):c.*3274G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341167	22	30094065	22	29698076	341167	351343	rs11090576	NC_000022.11:29698075:G:A
NM_000268.4(NF2):c.*3266C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341166	22	30094057	22	29698068	341166	347395	rs886057384	NC_000022.11:29698067:C:A
NM_000268.4(NF2):c.*3208G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341165	22	30093999	22	29698010	341165	352373	rs117863523	NC_000022.11:29698009:G:A
NM_000268.4(NF2):c.*3189G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341164	22	30093980	22	29697991	341164	351342	rs886057383	NC_000022.11:29697990:G:T
NM_000268.4(NF2):c.*3140G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341163	22	30093931	22	29697942	341163	337790	rs886057382	NC_000022.11:29697941:G:T
NM_000268.4(NF2):c.*3107T>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341162	22	30093898	22	29697909	341162	352372	rs886057381	NC_000022.11:29697908:T:G
NM_000268.4(NF2):c.*3055C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341161	22	30093846	22	29697857	341161	352371	rs886057380	NC_000022.11:29697856:C:T
NM_000268.4(NF2):c.*3018C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341160	22	30093809	22	29697820	341160	347392	rs886057379	NC_000022.11:29697819:C:T
NM_000268.4(NF2):c.*2999G>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341159	22	30093790	22	29697801	341159	337787	rs886057378	NC_000022.11:29697800:G:C
NM_000268.4(NF2):c.*2922G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341158	22	30093713	22	29697724	341158	347391	rs112930471	NC_000022.11:29697723:G:A
NM_000268.4(NF2):c.*2876T>C	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341157	22	30093667	22	29697678	341157	352370	rs5763431	NC_000022.11:29697677:T:C
NM_000268.4(NF2):c.*2841C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341156	22	30093632	22	29697643	341156	352367	rs142797364	NC_000022.11:29697642:C:T
NM_000268.4(NF2):c.*2803C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341155	22	30093594	22	29697605	341155	351341	rs886057377	NC_000022.11:29697604:C:A
NM_000268.4(NF2):c.*2759G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341154	22	30093550	22	29697561	341154	337785	rs5763430	NC_000022.11:29697560:G:A
NM_000268.4(NF2):c.*2753A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341153	22	30093544	22	29697555	341153	351339	rs199805259	NC_000022.11:29697554:A:G
NM_000268.4(NF2):c.*2670C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341152	22	30093461	22	29697472	341152	337784	rs763727745	NC_000022.11:29697471:C:A
NM_000268.4(NF2):c.*2499C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341151	22	30093290	22	29697301	341151	337781	rs569992376	NC_000022.11:29697300:C:A
NM_000268.4(NF2):c.*2487A>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341150	22	30093278	22	29697289	341150	337775	rs550207111	NC_000022.11:29697288:A:G
NM_000268.4(NF2):c.*2468C>G	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341149	22	30093259	22	29697270	341149	347385	rs1034880	NC_000022.11:29697269:C:G
NM_000268.4(NF2):c.*2455T>C	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341148	22	30093246	22	29697257	341148	347383	rs73159090	NC_000022.11:29697256:T:C
NM_000268.4(NF2):c.*2408G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341147	22	30093199	22	29697210	341147	351334	rs114416141	NC_000022.11:29697209:G:A
NM_000268.4(NF2):c.*2396G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341146	22	30093187	22	29697198	341146	337773	rs886057376	NC_000022.11:29697197:G:T
NM_000268.4(NF2):c.*2373C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341145	22	30093164	22	29697175	341145	352366	rs886057375	NC_000022.11:29697174:C:A
NM_000268.4(NF2):c.*2369T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341144	22	30093160	22	29697171	341144	351331	rs150581809	NC_000022.11:29697170:T:C
NM_000268.4(NF2):c.*2365C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341143	22	30093156	22	29697167	341143	337770	rs765602116	NC_000022.11:29697166:C:T
NM_000268.4(NF2):c.*2311G>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341142	22	30093102	22	29697113	341142	352365	rs113956497	NC_000022.11:29697112:G:A
NM_000268.4(NF2):c.*2310C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341141	22	30093101	22	29697112	341141	352364	rs777037756	NC_000022.11:29697111:C:T
NM_000268.4(NF2):c.*2266C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341140	22	30093057	22	29697068	341140	347379	rs563567208	NC_000022.11:29697067:C:T
NM_000268.4(NF2):c.*2235G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341139	22	30093026	22	29697037	341139	351330	rs5997506	NC_000022.11:29697036:G:A
NM_000268.4(NF2):c.*2224A>G	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341138	22	30093015	22	29697026	341138	347374	rs112175950	NC_000022.11:29697025:A:G
NM_000268.4(NF2):c.*2206G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341137	22	30092997	22	29697008	341137	347370	rs886057374	NC_000022.11:29697007:G:A
NM_000268.4(NF2):c.*2205G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341136	22	30092996	22	29697007	341136	351329	rs886057373	NC_000022.11:29697006:G:A
NM_000268.4(NF2):c.*2113C>T	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341135	22	30092904	22	29696915	341135	347363	rs537244098	NC_000022.11:29696914:C:T
NM_000268.4(NF2):c.*2068G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341134	22	30092859	22	29696870	341134	347361	rs886057372	NC_000022.11:29696869:G:T
NM_000268.4(NF2):c.*2020C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341130	22	30092811	22	29696822	341130	352363	rs886057370	NC_000022.11:29696821:C:T
NM_000268.4(NF2):c.*2010G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341128	22	30092801	22	29696812	341128	347353	rs886057368	NC_000022.11:29696811:G:T
NM_000268.4(NF2):c.*2003T>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341127	22	30092794	22	29696805	341127	351317	rs886057367	NC_000022.11:29696804:T:G
NM_000268.4(NF2):c.*1904A>G	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341124	22	30092695	22	29696706	341124	352361	rs73390944	NC_000022.11:29696705:A:G
NM_000268.4(NF2):c.*1848C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341123	22	30092639	22	29696650	341123	351311	rs886057364	NC_000022.11:29696649:C:T
NM_000268.4(NF2):c.*1823C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341122	22	30092614	22	29696625	341122	337767	rs190590507	NC_000022.11:29696624:C:T
NM_000268.4(NF2):c.*1792G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341121	22	30092583	22	29696594	341121	351308	rs17462054	NC_000022.11:29696593:G:A
NM_000268.4(NF2):c.*1782T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341120	22	30092573	22	29696584	341120	352360	rs886057363	NC_000022.11:29696583:T:C
NM_000268.4(NF2):c.*1737C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341119	22	30092528	22	29696539	341119	337757	rs886057362	NC_000022.11:29696538:C:A
NM_000268.4(NF2):c.*1672C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341118	22	30092463	22	29696474	341118	337754	rs757272448	NC_000022.11:29696473:C:T
NM_000268.4(NF2):c.*1652G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341117	22	30092443	22	29696454	341117	347348	rs751068883	NC_000022.11:29696453:G:T
NM_000268.4(NF2):c.*1640A>C	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341116	22	30092431	22	29696442	341116	352357	rs138312881	NC_000022.11:29696441:A:C
NM_000268.4(NF2):c.*1618T>C	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341115	22	30092409	22	29696420	341115	351307	rs184477204	NC_000022.11:29696419:T:C
NM_000268.4(NF2):c.*1559C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341114	22	30092350	22	29696361	341114	347346	rs886057361	NC_000022.11:29696360:C:A
NM_000268.4(NF2):c.*1522C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341113	22	30092313	22	29696324	341113	352356	rs886057360	NC_000022.11:29696323:C:A
NM_000268.4(NF2):c.*1439T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341112	22	30092230	22	29696241	341112	352354	rs886057359	NC_000022.11:29696240:T:C
NM_000268.4(NF2):c.*1438A>G	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341111	22	30092229	22	29696240	341111	347344	rs376061969	NC_000022.11:29696239:A:G
NM_000268.4(NF2):c.*1326T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341110	22	30092117	22	29696128	341110	337749	rs886057358	NC_000022.11:29696127:T:C
NM_000268.4(NF2):c.*1297A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341108	22	30092088	22	29696099	341108	351303	rs886057356	NC_000022.11:29696098:A:G
NM_000268.4(NF2):c.*1294T>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341107	22	30092085	22	29696096	341107	347343	rs886057355	NC_000022.11:29696095:T:G
NM_000268.4(NF2):c.*1270T>C	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341106	22	30092061	22	29696072	341106	351300	rs542927614	NC_000022.11:29696071:T:C
NM_000268.4(NF2):c.*1264C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341105	22	30092055	22	29696066	341105	352353	rs879093980	NC_000022.11:29696065:C:T
NM_000268.4(NF2):c.*1208C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341101	22	30091999	22	29696010	341101	337748	rs2530680	NC_000022.11:29696009:C:T
NM_000268.4(NF2):c.*1111G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341100	22	30091902	22	29695913	341100	351295	rs886057351	NC_000022.11:29695912:G:T
NM_000268.4(NF2):c.*1087C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341099	22	30091878	22	29695889	341099	347329	rs148973148	NC_000022.11:29695888:C:T
NM_000268.4(NF2):c.*1007C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341098	22	30091798	22	29695809	341098	337746	rs886057350	NC_000022.11:29695808:C:A
NM_000268.4(NF2):c.*987C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341097	22	30091778	22	29695789	341097	347324	rs886057349	NC_000022.11:29695788:C:A
NM_000268.4(NF2):c.*974C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341096	22	30091765	22	29695776	341096	337745	rs8140096	NC_000022.11:29695775:C:T
NM_000268.4(NF2):c.*720G>A	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341094	22	30091511	22	29695522	341094	352350	rs184043147	NC_000022.11:29695521:G:A
NM_000268.4(NF2):c.*587G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341092	22	30091378	22	29695389	341092	347322	rs886057347	NC_000022.11:29695388:G:T
NM_000268.4(NF2):c.*573C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341091	22	30091364	22	29695375	341091	347319	rs543669369	NC_000022.11:29695374:C:T
NM_000268.4(NF2):c.*561C>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341090	22	30091352	22	29695363	341090	337744	rs776610927	NC_000022.11:29695362:C:G
NM_000268.4(NF2):c.*532G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341089	22	30091323	22	29695334	341089	352347	rs886057346	NC_000022.11:29695333:G:T
NM_000268.4(NF2):c.*503C>T	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341088	22	30091294	22	29695305	341088	337740	rs191509325	NC_000022.11:29695304:C:T
NM_000268.4(NF2):c.*388C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341087	22	30091179	22	29695190	341087	352346	rs777219109	NC_000022.11:29695189:C:T
NM_000268.4(NF2):c.*359G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341086	22	30091150	22	29695161	341086	337739	rs572307337	NC_000022.11:29695160:G:A
NM_000268.4(NF2):c.*354T>C	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341085	22	30091145	22	29695156	341085	337737	rs1008515	NC_000022.11:29695155:T:C
NM_000268.4(NF2):c.*335C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341084	22	30091126	22	29695137	341084	337730	rs886057345	NC_000022.11:29695136:C:T
NM_000268.4(NF2):c.*293C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341083	22	30091084	22	29695095	341083	351292	rs886057344	NC_000022.11:29695094:C:A
NM_000268.4(NF2):c.*266G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341082	22	30091057	22	29695068	341082	351290	rs886057343	NC_000022.11:29695067:G:T
NM_000268.4(NF2):c.*199C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341081	22	30090990	22	29695001	341081	352345	rs886057342	NC_000022.11:29695000:C:A
NM_000268.4(NF2):c.*158T>C	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341080	22	30090949	22	29694960	341080	352344	rs886057341	NC_000022.11:29694959:T:C
NM_000268.4(NF2):c.*136G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341079	22	30090927	22	29694938	341079	351289	rs886057340	NC_000022.11:29694937:G:A
NM_000268.4(NF2):c.*109G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341078	22	30090900	22	29694911	341078	347317	rs886057339	NC_000022.11:29694910:G:T
NM_000268.4(NF2):c.*106C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341077	22	30090897	22	29694908	341077	337728	rs886057338	NC_000022.11:29694907:C:T
NM_000268.4(NF2):c.*52C>A	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341076	22	30090843	22	29694854	341076	352341	rs370016332	NC_000022.11:29694853:C:A
NM_000268.4(NF2):c.*4G>A	NF2		not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000341075	22	30090795	22	29694806	341075	352340	rs141099051	NC_000022.11:29694805:G:A
NM_000268.4(NF2):c.1529A>G (p.Lys510Arg)	NF2	K510R, K427R, K468R, K469R	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341074	22	30074267	22	29678278	341074	351286	rs886057337	NC_000022.11:29678277:A:G
NM_000268.4(NF2):c.1439C>T (p.Thr480Met)	NF2	T480M, T397M, T438M, T439M	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000341073	22	30070923	22	29674934	341073	337726	rs145666157	NC_000022.11:29674933:C:T
NM_000268.4(NF2):c.1270C>G (p.Arg424Gly)	NF2	R424G, R341G, R382G, R383G	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341072	22	30069405	22	29673416	341072	347314	rs763826793	NC_000022.11:29673415:C:G
NM_000268.4(NF2):c.903C>T (p.Ile301=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000341071	22	30064339	22	29668350	341071	351285	rs199957176	NC_000022.11:29668349:C:T
NM_000268.4(NF2):c.886-15C>T	NF2		not specified|not provided|Neurofibromatosis, type 2	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000341070	22	30064307	22	29668318	341070	352337	rs200837904	NC_000022.11:29668317:C:T
NM_000268.4(NF2):c.676A>C (p.Asn226His)	NF2	N226H, N184H, N143H, N185H	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341069	22	30057194	22	29661205	341069	347302	rs886057336	NC_000022.11:29661204:A:C
NM_000268.4(NF2):c.600-13G>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341068	22	30054165	22	29658176	341068	351282	rs374509697	NC_000022.11:29658175:G:A
NM_000268.4(NF2):c.240+15C>T	NF2		not provided|not specified|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2020)	criteria provided, conflicting interpretations	VCV000341067	22	30032880	22	29636891	341067	352336	rs200701337	NC_000022.11:29636890:C:T
NM_000268.4(NF2):c.-110G>C	NF2		not provided|Neurofibromatosis, type 2	Benign(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341066	22	29999878	22	29603889	341066	352335	rs1800540	NC_000022.11:29603888:G:C
NM_000268.4(NF2):c.-204C>A	NF2		Neurofibromatosis, type 2|not provided	Benign(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341065	22	29999784	22	29603795	341065	337721	rs1800539	NC_000022.11:29603794:C:A
NM_000268.4(NF2):c.-245C>G	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341064	22	29999743	22	29603754	341064	352334	rs536438675	NC_000022.11:29603753:C:G
NM_000268.4(NF2):c.-246C>G	NF2		Neurofibromatosis, type 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341063	22	29999742	22	29603753	341063	337720	rs56733822	NC_000022.11:29603752:C:G
NM_000268.4(NF2):c.-268G>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341062	22	29999720	22	29603731	341062	351280	rs886057335	NC_000022.11:29603730:G:T
NM_000268.4(NF2):c.-284C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341061	22	29999704	22	29603715	341061	347300	rs886057334	NC_000022.11:29603714:C:A
NM_000268.4(NF2):c.-320C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341060	22	29999668	22	29603679	341060	347298	rs886057333	NC_000022.11:29603678:C:T
NM_016418.5(NF2):c.-397C>T	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341059	22	29999591	22	29603602	341059	337717	rs886057332	NC_000022.11:29603601:C:T
NM_016418.5(NF2):c.-402A>G	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341058	22	29999586	22	29603597	341058	347294	rs886057331	NC_000022.11:29603596:A:G
NM_000268.4(NF2):c.465C>T (p.Pro155=)	NF2		not specified|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262995	22	30050663	22	29654674	262995	257599	rs374911526	NC_000022.11:29654673:C:T
NM_000268.4(NF2):c.1470G>A (p.Pro490=)	NF2		Neurofibromatosis, type 2|not specified|not provided	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262992	22	30074208	22	29678219	262992	257600	rs373442542	NC_000022.11:29678218:G:A
NM_000268.4(NF2):c.-18G>A	NF2		Neurofibromatosis, type 2|not specified	Benign/Likely benign(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000262991	22	29999970	22	29603981	262991	257596	rs201591536	NC_000022.11:29603980:G:A
NM_000268.4(NF2):c.613A>G (p.Met205Val)	NF2	M205V, M163V, M122V, M164V	Hereditary cancer-predisposing syndrome|not specified|not provided|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000237626	22	30054191	22	29658202	237626	243692	rs141629512	NC_000022.11:29658201:A:G
NM_000268.4(NF2):c.448-5T>C	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000237625	22	30050641	22	29654652	237625	243691	rs878853928	NC_000022.11:29654651:T:C
NM_000268.4(NF2):c.391A>C (p.Ile131Leu)	NF2	I131L, I89L, I48L, I90L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000237624	22	30038218	22	29642229	237624	243690	rs878853927	NC_000022.11:29642228:A:C
NM_000268.4(NF2):c.1685A>T (p.His562Leu)	NF2	H562L, H520L, H479L, H521L	Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV000237623	22	30077538	22	29681549	237623	243703	rs878853926	NC_000022.11:29681548:A:T
NM_000268.4(NF2):c.1671T>C (p.Ala557=)	NF2		Neurofibromatosis, type 2|not provided	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000237622	22	30077524	22	29681535	237622	243702	rs759780271	NC_000022.11:29681534:T:C
NM_000268.4(NF2):c.1627A>T (p.Lys543Ter)	NF2	K543*, K501*, K460*, K502*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000237621	22	30077480	22	29681491	237621	243701	rs878853925	NC_000022.11:29681490:A:T
NM_000268.4(NF2):c.1446+6C>A	NF2		Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000237620	22	30070936	22	29674947	237620	243700	rs878853924	NC_000022.11:29674946:C:A
NM_000268.4(NF2):c.1387G>A (p.Glu463Lys)	NF2	E463K, E380K, E421K, E422K	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000237619	22	30070871	22	29674882	237619	243699	rs74315503	NC_000022.11:29674881:G:A
NM_000268.4(NF2):c.1385G>A (p.Arg462His)	NF2	R462H, R420H, R421H, R379H	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2021)	criteria provided, conflicting interpretations	VCV000237618	22	30070869	22	29674880	237618	243698	rs373650983	NC_000022.11:29674879:G:A
NM_000268.4(NF2):c.1340+8G>T	NF2		not specified|not provided|Neurofibromatosis, type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000237617	22	30069483	22	29673494	237617	243697	rs370604189	NC_000022.11:29673493:G:T
NM_000268.4(NF2):c.12C>T (p.Ala4=)	NF2		not provided|not specified|Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237616	22	29999999	22	29604010	237616	243689	rs144477078	NC_000022.11:29604009:C:T
NM_000268.4(NF2):c.1248G>A (p.Ala416=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237615	22	30069383	22	29673394	237615	243696	rs759993776	NC_000022.11:29673393:G:A
NM_000268.4(NF2):c.1123-6C>T	NF2		Neurofibromatosis, type 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2021)	criteria provided, conflicting interpretations	VCV000237614	22	30069252	22	29673263	237614	243695	rs147898623	NC_000022.11:29673262:C:T
NM_000268.4(NF2):c.1113C>T (p.Asn371=)	NF2		not provided|Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237613	22	30067928	22	29671939	237613	243694	rs142459414	NC_000022.11:29671938:C:T
NM_000268.4(NF2):c.1077G>A (p.Arg359=)	NF2		Neurofibromatosis, type 2	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000237612	22	30067892	22	29671903	237612	243693	rs878853923	NC_000022.11:29671902:G:A
NM_000268.4(NF2):c.1540A>G (p.Met514Val)	NF2	M514V, M473V, M431V, M472V	Neurofibromatosis, type 2|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000201125	22	30074278	22	29678289	201125	198037	rs201527155	NC_000022.11:29678288:A:G
NM_000268.4(NF2):c.1737+2098A>G	NF2		Neurofibromatosis, type 2|not specified	Uncertain significance(Last reviewed: Dec 19, 2015)	no assertion criteria provided	VCV000135570	22	30079688	22	29683699	135570	139309	rs75296199	NC_000022.11:29683698:A:G
NM_000268.4(NF2):c.1753G>A (p.Ala585Thr)	NF2	A585T, A155T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not specified	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000134897	22	30090756	22	29694767	134897	138636	rs145446060	NC_000022.11:29694766:G:A
NM_000268.4(NF2):c.1749G>A (p.Gln583=)	NF2		Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134896	22	30090752	22	29694763	134896	138635	rs201911915	NC_000022.11:29694762:G:A
NM_000268.4(NF2):c.1007G>A (p.Arg336Gln)	NF2	R336Q, R253Q, R295Q, R294Q	Neurofibromatosis, type 2|not specified|not provided	Uncertain significance(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000134895	22	30067822	22	29671833	134895	138634	rs587778554	NC_000022.11:29671832:G:A
NM_000268.4(NF2):c.1451T>C (p.Met484Thr)	NF2	M484T, M442T, M443T, M401T	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000134894	22	30074189	22	29678200	134894	138633	rs141538143	NC_000022.11:29678199:T:C
NM_000268.4(NF2):c.107A>G (p.Asn36Ser)	NF2	N36S	Hereditary cancer-predisposing syndrome|Neurofibromatosis, type 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 26, 2021)	criteria provided, conflicting interpretations	VCV000134892	22	30000094	22	29604105	134892	138631	rs372279458	NC_000022.11:29604104:A:G
NM_000268.4(NF2):c.983A>T (p.Glu328Val)	NF2	E328V, E286V, E287V, E245V	not provided|Neurofibromatosis, type 2	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000041681	22	30064419	22	29668430	41681	50120	rs200372028	NC_000022.11:29668429:A:T
NM_000268.4(NF2):c.185T>C (p.Phe62Ser)	NF2	F62S	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000003297	22	30032810	22	29636821	3297	18336	rs121434261	NC_000022.11:29636820:T:C
NM_000268.4(NF2):c.1579G>T (p.Glu527Ter)	NF2	E527*, E485*, E486*, E444*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003296	22	30077432	22	29681443	3296	18335	rs74315505	NC_000022.11:29681442:G:T
NM_000268.4(NF2):c.1396C>T (p.Arg466Ter)	NF2	R466*, R383*, R425*, R424*	not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003295	22	30070880	22	29674891	3295	18334	rs74315504	NC_000022.11:29674890:C:T
NM_000268.4(NF2):c.1387G>T (p.Glu463Ter)	NF2	E463*, E422*, E380*, E421*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000003294	22	30070871	22	29674882	3294	18333	rs74315503	NC_000022.11:29674881:G:T
NM_000268.4(NF2):c.1219C>T (p.Gln407Ter)	NF2	Q407*, Q365*, Q366*, Q324*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003293	22	30069354	22	29673365	3293	18332	rs74315501	NC_000022.11:29673364:C:T
NM_000268.4(NF2):c.1021C>T (p.Arg341Ter)	NF2	R341*, R300*, R258*, R299*	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003292	22	30067836	22	29671847	3292	18331	rs74315499	NC_000022.11:29671846:C:T
NM_000268.4(NF2):c.958C>T (p.Gln320Ter)	NF2	Q320*, Q278*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003291	22	30064394	22	29668405	3291	18330	rs74315497	NC_000022.11:29668404:C:T
NM_000268.4(NF2):c.784C>T (p.Arg262Ter)	NF2	R262*, R221*, R220*, R179*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000003290	22	30057302	22	29661313	3290	18329	rs74315496	NC_000022.11:29661312:C:T
NM_000268.4(NF2):c.544G>T (p.Glu182Ter)	NF2	E182*, E141*, E140*, E99*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003289	22	30051610	22	29655621	3289	18328	rs74315495	NC_000022.11:29655620:G:T
NM_000268.4(NF2):c.1613A>C (p.Gln538Pro)	NF2	Q538P, Q455P, Q496P, Q497P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000003287	22	30077466	22	29681477	3287	18326	rs74315494	NC_000022.11:29681476:A:C
NM_000268.4(NF2):c.1604T>C (p.Leu535Pro)	NF2	L535P, L494P, L452P, L493P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 1, 1995)	no assertion criteria provided	VCV000003286	22	30077457	22	29681468	3286	18325	rs74315493	NC_000022.11:29681467:T:C
NM_000268.4(NF2):c.169C>T (p.Arg57Ter)	NF2	R57*	not provided|Neurofibromatosis, type 2|Meningioma	Pathogenic(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003285	22	30032794	22	29636805	3285	18324	rs121434259	NC_000022.11:29636804:C:T
NM_000268.4(NF2):c.240+1G>T	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 10, 1993)	no assertion criteria provided	VCV000003283	22	30032866	22	29636877	3283	18322	rs587776562	NC_000022.11:29636876:G:T
NM_000268.4(NF2):c.1079T>C (p.Leu360Pro)	NF2	L360P, L277P, L318P, L319P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 10, 1993)	no assertion criteria provided	VCV000003282	22	30067894	22	29671905	3282	18321	rs74315492	NC_000022.11:29671904:T:C
NM_001368894.2(PAX6):c.112C>T (p.Arg38Trp)	PAX6	R38W, R119W, R39W	Aniridia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000040090	11	31824281	11	31802733	40090	48596	rs397514640	NC_000011.10:31802732:G:A
NM_001009944.3(PKD1):c.12465T>G (p.Phe4155Leu)	PKD1	F4154L, F4155L	Polycystic kidney disease, adult type	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2020)	criteria provided, conflicting interpretations	VCV000870597	16	2140175	16	2090174	870597	858759		NC_000016.10:2090173:A:C
NM_002834.5(PTPN11):c.782T>G (p.Leu261Arg)	PTPN11	L261R, L260R	Rasopathy|Neurofibromatosis-Noonan syndrome|not provided	Uncertain significance(Last reviewed: Mar 16, 2020)	reviewed by expert panel	VCV000280939	12	112910773	12	112472969	280939	264670	rs765642157	NC_000012.12:112472968:T:G
NM_002834.5(PTPN11):c.1658C>T (p.Thr553Met)	PTPN11	T553M, T557M, T552M	Rasopathy|Metachondromatosis|not provided|History of neurodevelopmental disorder|Primary dilated cardiomyopathy|Cardiomyopathy|Cardiovascular phenotype|not specified|Noonan syndrome|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome 1|Juvenile myelomonocytic leukemia	Benign(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040570	12	112940006	12	112502202	40570	49040	rs148176616	NC_000012.12:112502201:C:T
NM_002834.5(PTPN11):c.5C>T (p.Thr2Ile)	PTPN11	T2I	Noonan syndrome|Noonan syndrome 1|not provided|Rasopathy|Metachondromatosis	Pathogenic(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013349	12	112856920	12	112419116	13349	28388	rs267606990	NC_000012.12:112419115:C:T
NM_002834.5(PTPN11):c.1529A>G (p.Gln510Arg)	PTPN11	Q510R, Q514R, Q509R	Rasopathy|Noonan syndrome 1|none provided|not provided|LEOPARD syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013345	12	112926909	12	112489105	13345	28384	rs121918470	NC_000012.12:112489104:A:G
NM_020975.6(RET):c.2410G>A (p.Val804Met)	RET	V804M, V550M	not provided|Multiple endocrine neoplasia, type 2a|MEN2 phenotype: Unclassified|Congenital central hypoventilation|Hirschsprung disease 1|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|none provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000037102	10	43614996	10	43119548	37102	28984	rs79658334	NC_000010.11:43119547:G:A
NM_020975.6(RET):c.2753T>C (p.Met918Thr)	RET	M918T, M664T	Multiple endocrine neoplasia, type 2|Hirschsprung disease 1|Multiple endocrine neoplasia, type 2a|Pheochromocytoma|Multiple endocrine neoplasia, type 1|Neoplasm of the thyroid gland|Constipation|Hypothyroidism|Gingival enlargement|Short stature|Tetralogy of Fallot|Joint hypermobility|Thick vermilion border|Hypertelorism|Medullary thyroid carcinoma|not provided|Inborn genetic diseases|not specified|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Thyroid carcinoma, sporadic medullary	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013919	10	43617416	10	43121968	13919	28958	rs74799832	NC_000010.11:43121967:T:C
NM_032322.4(RNF135):c.575C>T (p.Thr192Ile)	RNF135	T192I	Chromosome 17q11.2 deletion syndrome, 1.4 MB	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV001032948	17	29315020	17	30988002	1032948	1021620		NC_000017.11:30988001:C:T
NM_001754.5(RUNX1):c.856C>A (p.Gln286Lys)	RUNX1	Q286K, Q259K	Familial platelet disorder with associated myeloid malignancy	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000575500	21	36171709	21	34799412	575500	573093	rs769966051	NC_000021.9:34799411:G:T
NM_002971.6(SATB1):c.1574A>G (p.Gln525Arg)	SATB1	Q525R, Q453R	Kohlschutter-Tonz syndrome-like	Pathogenic(Last reviewed: Apr 28, 2021)	no assertion criteria provided	VCV001043595	3	18419663	3	18378171	1043595	1035681		NC_000003.12:18378170:T:C
NM_003073.5(SMARCB1):c.34C>T (p.Gln12Ter)	SMARCB1	Q12*	Schwannomatosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000008026	22	24129390	22	23787203	8026	23065	rs74315513	NC_000022.11:23787202:C:T
NM_005633.4(SOS1):c.1352C>A (p.Thr451Lys)	SOS1	T451K, T444K	Neurofibromatosis type 6|Atrial septal defect	Uncertain significance(Last reviewed: Oct 15, 2014)	no assertion criteria provided	VCV000180531	2	39250217	2	39023076	180531	178504	rs730880218	NC_000002.12:39023075:G:T
NM_152594.3(SPRED1):c.354A>T (p.Arg118Ser)	SPRED1	R118S	Legius syndrome	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001319863	15	38614588	15	38322387	1319863	1310112		NC_000015.10:38322386:A:T
NM_152594.3(SPRED1):c.148C>T (p.Gln50Ter)	SPRED1	Q50*	Legius syndrome	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, single submitter	VCV001300146	15	38591689	15	38299488	1300146	82769	rs148646547	NC_000015.10:38299487:C:T
NM_152594.3(SPRED1):c.42T>C (p.Tyr14=)	SPRED1		not specified	Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, single submitter	VCV001177280	15	38591583	15	38299382	1177280	1166585		NC_000015.10:38299381:T:C
NM_152594.3(SPRED1):c.1080A>G (p.Lys360=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Mar 19, 2020)	criteria provided, single submitter	VCV001160125	15	38643610	15	38351409	1160125	1145153		NC_000015.10:38351408:A:G
NM_152594.3(SPRED1):c.939G>T (p.Thr313=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001156496	15	38643469	15	38351268	1156496	1145152		NC_000015.10:38351267:G:T
NM_152594.3(SPRED1):c.915C>G (p.Pro305=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV001152338	15	38643445	15	38351244	1152338	1145151		NC_000015.10:38351243:C:G
NM_152594.3(SPRED1):c.1260C>T (p.Tyr420=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001138594	15	38643790	15	38351589	1138594	1124294		NC_000015.10:38351588:C:T
NM_152594.3(SPRED1):c.208-10C>G	SPRED1		Legius syndrome	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001133880	15	38614432	15	38322231	1133880	1124292		NC_000015.10:38322230:C:G
NM_152594.3(SPRED1):c.348C>T (p.Ile116=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001132743	15	38614582	15	38322381	1132743	1124293		NC_000015.10:38322380:C:T
NM_152594.3(SPRED1):c.123C>T (p.Ser41=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001128752	15	38591664	15	38299463	1128752	1124291		NC_000015.10:38299462:C:T
NM_152594.3(SPRED1):c.9G>A (p.Glu3=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001122281	15	38545395	15	38253194	1122281	1124290		NC_000015.10:38253193:G:A
NM_152594.3(SPRED1):c.1278C>T (p.Cys426=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV001114729	15	38643808	15	38351607	1114729	1102864		NC_000015.10:38351606:C:T
NM_152594.3(SPRED1):c.376+10C>A	SPRED1		Legius syndrome	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001105215	15	38614620	15	38322419	1105215	1102861		NC_000015.10:38322418:C:A
NM_152594.3(SPRED1):c.510C>T (p.Ser170=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV001102540	15	38632024	15	38339823	1102540	1102862		NC_000015.10:38339822:C:T
NM_152594.3(SPRED1):c.1194C>T (p.Asp398=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001099293	15	38643724	15	38351523	1099293	1102863		NC_000015.10:38351522:C:T
NM_152594.3(SPRED1):c.552A>G (p.Arg184=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001096984	15	38632066	15	38339865	1096984	1081041		NC_000015.10:38339864:A:G
NM_152594.3(SPRED1):c.687C>A (p.Val229=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001094718	15	38643217	15	38351016	1094718	1081042		NC_000015.10:38351015:C:A
NM_152594.3(SPRED1):c.15G>C (p.Thr5=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV001092673	15	38545401	15	38253200	1092673	1081039		NC_000015.10:38253199:G:C
NM_152594.3(SPRED1):c.279G>A (p.Lys93=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV001087391	15	38614513	15	38322312	1087391	1081040		NC_000015.10:38322311:G:A
NM_152594.3(SPRED1):c.783C>A (p.Tyr261Ter)	SPRED1	Y261*	Legius syndrome	Pathogenic(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV001075013	15	38643313	15	38351112	1075013	1063231		NC_000015.10:38351111:C:A
NM_152594.3(SPRED1):c.841C>T (p.Gln281Ter)	SPRED1	Q281*	Legius syndrome	Pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001073547	15	38643371	15	38351170	1073547	1063233		NC_000015.10:38351169:C:T
NM_152594.3(SPRED1):c.385G>T (p.Glu129Ter)	SPRED1	E129*	Legius syndrome	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001072751	15	38616972	15	38324771	1072751	1063230		NC_000015.10:38324770:G:T
NM_152594.3(SPRED1):c.207+1G>T	SPRED1		Legius syndrome	Likely pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001068067	15	38591749	15	38299548	1068067	1056215		NC_000015.10:38299547:G:T
NM_152594.3(SPRED1):c.421C>A (p.Gln141Lys)	SPRED1	Q141K	Legius syndrome	Uncertain significance(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV001061484	15	38617008	15	38324807	1061484	1048901		NC_000015.10:38324806:C:A
NM_152594.3(SPRED1):c.1103G>C (p.Cys368Ser)	SPRED1	C368S	Legius syndrome	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001061139	15	38643633	15	38351432	1061139	1048904		NC_000015.10:38351431:G:C
NM_152594.3(SPRED1):c.583A>T (p.Ile195Leu)	SPRED1	I195L	Legius syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001057953	15	38641623	15	38349422	1057953	1048903		NC_000015.10:38349421:A:T
NM_152594.3(SPRED1):c.410C>T (p.Ala137Val)	SPRED1	A137V	Legius syndrome	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001053408	15	38616997	15	38324796	1053408	1048900		NC_000015.10:38324795:C:T
NM_152594.3(SPRED1):c.431A>G (p.Glu144Gly)	SPRED1	E144G	Legius syndrome	Uncertain significance(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001053137	15	38631945	15	38339744	1053137	1048902		NC_000015.10:38339743:A:G
NM_152594.3(SPRED1):c.1298G>A (p.Cys433Tyr)	SPRED1	C433Y	Legius syndrome	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001046000	15	38643828	15	38351627	1046000	1031974		NC_000015.10:38351626:G:A
NM_152594.3(SPRED1):c.770G>A (p.Arg257His)	SPRED1	R257H	Legius syndrome	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001045811	15	38643300	15	38351099	1045811	1031972		NC_000015.10:38351098:G:A
NM_152594.3(SPRED1):c.32+3A>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001038674	15	38545421	15	38253220	1038674	1031970		NC_000015.10:38253219:A:T
NM_152594.3(SPRED1):c.982G>A (p.Glu328Lys)	SPRED1	E328K	Legius syndrome	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001037119	15	38643512	15	38351311	1037119	1031973		NC_000015.10:38351310:G:A
NM_152594.3(SPRED1):c.382C>G (p.Pro128Ala)	SPRED1	P128A	Legius syndrome	Uncertain significance(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV001034322	15	38616969	15	38324768	1034322	1021308		NC_000015.10:38324767:C:G
NM_152594.3(SPRED1):c.1217C>T (p.Ala406Val)	SPRED1	A406V	Legius syndrome	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001022406	15	38643747	15	38351546	1022406	1011454		NC_000015.10:38351545:C:T
NM_152594.3(SPRED1):c.1189G>A (p.Asp397Asn)	SPRED1	D397N	Legius syndrome	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001022058	15	38643719	15	38351518	1022058	1011453		NC_000015.10:38351517:G:A
NM_152594.3(SPRED1):c.641G>A (p.Arg214Gln)	SPRED1	R214Q	Legius syndrome	Uncertain significance(Last reviewed: Jan 19, 2020)	criteria provided, single submitter	VCV001020173	15	38641681	15	38349480	1020173	1011451		NC_000015.10:38349479:G:A
NM_152594.3(SPRED1):c.487G>T (p.Val163Phe)	SPRED1	V163F	Legius syndrome	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001016965	15	38632001	15	38339800	1016965	1011450		NC_000015.10:38339799:G:T
NM_152594.3(SPRED1):c.423+5G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001015670	15	38617015	15	38324814	1015670	1011449		NC_000015.10:38324813:G:A
NM_152594.3(SPRED1):c.659G>A (p.Cys220Tyr)	SPRED1	C220Y	Legius syndrome	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001013780	15	38641699	15	38349498	1013780	1011452		NC_000015.10:38349497:G:A
NM_152594.3(SPRED1):c.451C>G (p.Leu151Val)	SPRED1	L151V	Legius syndrome	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001006489	15	38631965	15	38339764	1006489	996219		NC_000015.10:38339763:C:G
NM_152594.3(SPRED1):c.305C>A (p.Thr102Lys)	SPRED1	T102K	Legius syndrome	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001004532	15	38614539	15	38322338	1004532	996218		NC_000015.10:38322337:C:A
NM_152594.3(SPRED1):c.511T>C (p.Ser171Pro)	SPRED1	S171P	Legius syndrome	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001004068	15	38632025	15	38339824	1004068	996220		NC_000015.10:38339823:T:C
NM_152594.3(SPRED1):c.747C>G (p.Asn249Lys)	SPRED1	N249K	Legius syndrome	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV000999996	15	38643277	15	38351076	999996	996221		NC_000015.10:38351075:C:G
NM_152594.3(SPRED1):c.32+20C>T	SPRED1		Legius syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000984457	15	38545438	15	38253237	984457	972596		NC_000015.10:38253236:C:T
NM_152594.3(SPRED1):c.376+1G>A	SPRED1		Legius syndrome	Likely pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000972349	15	38614611	15	38322410	972349	960820		NC_000015.10:38322409:G:A
NM_152594.3(SPRED1):c.29A>G (p.Asn10Ser)	SPRED1	N10S	Legius syndrome	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000970869	15	38545415	15	38253214	970869	957397		NC_000015.10:38253213:A:G
NM_152594.3(SPRED1):c.1280A>G (p.His427Arg)	SPRED1	H427R	Legius syndrome	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV000970735	15	38643810	15	38351609	970735	957400		NC_000015.10:38351608:A:G
NM_152594.3(SPRED1):c.477A>T (p.Gln159His)	SPRED1	Q159H	Legius syndrome	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000967570	15	38631991	15	38339790	967570	957399		NC_000015.10:38339789:A:T
NM_152594.3(SPRED1):c.31G>A (p.Asp11Asn)	SPRED1	D11N	Legius syndrome	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000966373	15	38545417	15	38253216	966373	957398		NC_000015.10:38253215:G:A
NM_152594.3(SPRED1):c.6C>A (p.Ser2Arg)	SPRED1	S2R	Legius syndrome	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000965391	15	38545392	15	38253191	965391	957396		NC_000015.10:38253190:C:A
NM_152594.3(SPRED1):c.920A>G (p.Asp307Gly)	SPRED1	D307G	not provided|Legius syndrome	Uncertain significance(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000963626	15	38643450	15	38351249	963626	948857		NC_000015.10:38351248:A:G
NM_152594.3(SPRED1):c.535G>A (p.Glu179Lys)	SPRED1	E179K	Legius syndrome|Noonan syndrome	Uncertain significance(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000961884	15	38632049	15	38339848	961884	948853		NC_000015.10:38339847:G:A
NM_152594.3(SPRED1):c.922T>A (p.Ser308Thr)	SPRED1	S308T	Legius syndrome	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000961394	15	38643452	15	38351251	961394	948858		NC_000015.10:38351250:T:A
NM_152594.3(SPRED1):c.619A>T (p.Arg207Ter)	SPRED1	R207*	Legius syndrome	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000960145	15	38641659	15	38349458	960145	948854		NC_000015.10:38349457:A:T
NM_152594.3(SPRED1):c.640C>T (p.Arg214Trp)	SPRED1	R214W	Legius syndrome	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000956668	15	38641680	15	38349479	956668	948855		NC_000015.10:38349478:C:T
NM_152594.3(SPRED1):c.666C>A (p.Ser222Arg)	SPRED1	S222R	Legius syndrome	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000956543	15	38641706	15	38349505	956543	948856		NC_000015.10:38349504:C:A
NM_152594.3(SPRED1):c.49G>A (p.Val17Met)	SPRED1	V17M	Legius syndrome	Uncertain significance(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000954199	15	38591590	15	38299389	954199	948850		NC_000015.10:38299388:G:A
NM_152594.3(SPRED1):c.917A>G (p.Lys306Arg)	SPRED1	K306R	Legius syndrome	Uncertain significance(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000950640	15	38643447	15	38351246	950640	927300		NC_000015.10:38351245:A:G
NM_152594.3(SPRED1):c.161G>T (p.Gly54Val)	SPRED1	G54V	Legius syndrome	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000942930	15	38591702	15	38299501	942930	936899		NC_000015.10:38299500:G:T
NM_152594.3(SPRED1):c.1A>G (p.Met1Val)	SPRED1	M1V	Legius syndrome	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000930640	15	38545387	15	38253186	930640	919568		NC_000015.10:38253185:A:G
NM_152594.3(SPRED1):c.211G>A (p.Val71Ile)	SPRED1	V71I	not provided|Legius syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 20, 2020)	criteria provided, conflicting interpretations	VCV000918166	15	38614445	15	38322244	918166	915048		NC_000015.10:38322243:G:A
NM_152594.3(SPRED1):c.*5263C>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888520	15	38649128	15	38356927	888520	873341		NC_000015.10:38356926:C:A
NM_152594.3(SPRED1):c.*3543C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000888464	15	38647408	15	38355207	888464	873330		NC_000015.10:38355206:C:T
NM_152594.3(SPRED1):c.*3536C>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000888463	15	38647401	15	38355200	888463	873329		NC_000015.10:38355199:C:G
NM_152594.3(SPRED1):c.*3395G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888462	15	38647260	15	38355059	888462	873328		NC_000015.10:38355058:G:A
NM_152594.3(SPRED1):c.*3340G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888461	15	38647205	15	38355004	888461	873327		NC_000015.10:38355003:G:A
NM_152594.3(SPRED1):c.*3323C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888460	15	38647188	15	38354987	888460	873326		NC_000015.10:38354986:C:T
NM_152594.3(SPRED1):c.*3289C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888459	15	38647154	15	38354953	888459	873325		NC_000015.10:38354952:C:T
NM_152594.3(SPRED1):c.*1727G>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888406	15	38645592	15	38353391	888406	873308		NC_000015.10:38353390:G:T
NM_152594.3(SPRED1):c.*1095A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888405	15	38644960	15	38352759	888405	873307		NC_000015.10:38352758:A:G
NM_152594.3(SPRED1):c.*936C>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888404	15	38644801	15	38352600	888404	873306		NC_000015.10:38352599:C:A
NM_152594.3(SPRED1):c.371C>T (p.Ser124Phe)	SPRED1	S124F	Legius syndrome	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000888348	15	38614605	15	38322404	888348	873297		NC_000015.10:38322403:C:T
NM_152594.3(SPRED1):c.*4697G>A	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887267	15	38648562	15	38356361	887267	873340		NC_000015.10:38356360:G:A
NM_152594.3(SPRED1):c.*4471C>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887266	15	38648336	15	38356135	887266	873339		NC_000015.10:38356134:C:A
NM_152594.3(SPRED1):c.*4372A>G	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887265	15	38648237	15	38356036	887265	873338		NC_000015.10:38356035:A:G
NM_152594.3(SPRED1):c.*4304G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887264	15	38648169	15	38355968	887264	873337		NC_000015.10:38355967:G:A
NM_152594.3(SPRED1):c.*2990T>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887207	15	38646855	15	38354654	887207	873324		NC_000015.10:38354653:T:C
NM_152594.3(SPRED1):c.*2853A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887206	15	38646718	15	38354517	887206	873323		NC_000015.10:38354516:A:G
NM_152594.3(SPRED1):c.*2742G>T	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887205	15	38646607	15	38354406	887205	873322		NC_000015.10:38354405:G:T
NM_152594.3(SPRED1):c.*2611C>T	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887204	15	38646476	15	38354275	887204	873321		NC_000015.10:38354274:C:T
NM_152594.3(SPRED1):c.*633A>G	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887147	15	38644498	15	38352297	887147	873305		NC_000015.10:38352296:A:G
NM_152594.3(SPRED1):c.*632C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887146	15	38644497	15	38352296	887146	873304		NC_000015.10:38352295:C:T
NM_152594.3(SPRED1):c.*581T>C	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887145	15	38644446	15	38352245	887145	873303		NC_000015.10:38352244:T:C
NM_152594.3(SPRED1):c.*383G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887144	15	38644248	15	38352047	887144	873302		NC_000015.10:38352046:G:A
NM_152594.3(SPRED1):c.197G>C (p.Arg66Thr)	SPRED1	R66T	Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887071	15	38591738	15	38299537	887071	873296		NC_000015.10:38299536:G:C
NM_152594.3(SPRED1):c.170A>G (p.Asp57Gly)	SPRED1	D57G	Legius syndrome|not provided	Uncertain significance(Last reviewed: Sep 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000887070	15	38591711	15	38299510	887070	873295		NC_000015.10:38299509:A:G
NM_152594.3(SPRED1):c.-24A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887069	15	38545363	15	38253162	887069	873294		NC_000015.10:38253161:A:G
NM_152594.3(SPRED1):c.*3745A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886268	15	38647610	15	38355409	886268	873336		NC_000015.10:38355408:A:G
NM_152594.3(SPRED1):c.*3705A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886267	15	38647570	15	38355369	886267	873335		NC_000015.10:38355368:A:G
NM_152594.3(SPRED1):c.*3701A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886266	15	38647566	15	38355365	886266	873334		NC_000015.10:38355364:A:G
NM_152594.3(SPRED1):c.*2539A>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886205	15	38646404	15	38354203	886205	873320		NC_000015.10:38354202:A:T
NM_152594.3(SPRED1):c.*2444T>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886204	15	38646309	15	38354108	886204	873319		NC_000015.10:38354107:T:A
NM_152594.3(SPRED1):c.*2422A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886203	15	38646287	15	38354086	886203	873318		NC_000015.10:38354085:A:G
NM_152594.3(SPRED1):c.*2420T>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886202	15	38646285	15	38354084	886202	873317		NC_000015.10:38354083:T:C
NM_152594.3(SPRED1):c.*2398T>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886201	15	38646263	15	38354062	886201	873316		NC_000015.10:38354061:T:G
NM_152594.3(SPRED1):c.*2323T>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886200	15	38646188	15	38353987	886200	873315		NC_000015.10:38353986:T:C
NM_152594.3(SPRED1):c.*105A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000886134	15	38643970	15	38351769	886134	873301		NC_000015.10:38351768:A:G
NM_152594.3(SPRED1):c.1098T>G (p.Val366=)	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886133	15	38643628	15	38351427	886133	873300		NC_000015.10:38351426:T:G
NM_152594.3(SPRED1):c.1085G>A (p.Cys362Tyr)	SPRED1	C362Y	Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886132	15	38643615	15	38351414	886132	873299		NC_000015.10:38351413:G:A
NM_152594.3(SPRED1):c.-114G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886070	15	38545273	15	38253072	886070	873293		NC_000015.10:38253071:G:A
NM_152594.3(SPRED1):c.-175G>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000886069	15	38545212	15	38253011	886069	873292		NC_000015.10:38253010:G:T
NM_152594.3(SPRED1):c.*2251G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885300	15	38646116	15	38353915	885300	873314		NC_000015.10:38353914:G:A
NM_152594.3(SPRED1):c.*2247A>G	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885299	15	38646112	15	38353911	885299	873313		NC_000015.10:38353910:A:G
NM_152594.3(SPRED1):c.*2117A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885298	15	38645982	15	38353781	885298	873312		NC_000015.10:38353780:A:G
NM_152594.3(SPRED1):c.*2018T>G	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885297	15	38645883	15	38353682	885297	873311		NC_000015.10:38353681:T:G
NM_152594.3(SPRED1):c.*1967C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000885296	15	38645832	15	38353631	885296	873310		NC_000015.10:38353630:C:T
NM_152594.3(SPRED1):c.*1833A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885295	15	38645698	15	38353497	885295	873309		NC_000015.10:38353496:A:C
NM_152594.3(SPRED1):c.973C>G (p.Arg325Gly)	SPRED1	R325G	Legius syndrome	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000885239	15	38643503	15	38351302	885239	873298		NC_000015.10:38351301:C:G
NM_152594.3(SPRED1):c.*5540A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000884307	15	38649405	15	38357204	884307	873346		NC_000015.10:38357203:A:G
NM_152594.3(SPRED1):c.*5449A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884306	15	38649314	15	38357113	884306	873345		NC_000015.10:38357112:A:G
NM_152594.3(SPRED1):c.*5440T>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884305	15	38649305	15	38357104	884305	873344		NC_000015.10:38357103:T:C
NM_152594.3(SPRED1):c.*5418A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884304	15	38649283	15	38357082	884304	873343		NC_000015.10:38357081:A:G
NM_152594.3(SPRED1):c.*5398G>T	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884303	15	38649263	15	38357062	884303	873342		NC_000015.10:38357061:G:T
NM_152594.3(SPRED1):c.*3659A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884238	15	38647524	15	38355323	884238	873333		NC_000015.10:38355322:A:G
NM_152594.3(SPRED1):c.*3657C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884237	15	38647522	15	38355321	884237	873332		NC_000015.10:38355320:C:T
NM_152594.3(SPRED1):c.*3561G>A	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884236	15	38647426	15	38355225	884236	873331		NC_000015.10:38355224:G:A
NM_152594.3(SPRED1):c.1001G>A (p.Arg334His)	SPRED1	R334H	Legius syndrome	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000859841	15	38643531	15	38351330	859841	842244		NC_000015.10:38351329:G:A
NM_152594.3(SPRED1):c.892G>C (p.Asp298His)	SPRED1	D298H	Legius syndrome	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000856883	15	38643422	15	38351221	856883	842243		NC_000015.10:38351220:G:C
NM_152594.3(SPRED1):c.3G>A (p.Met1Ile)	SPRED1	M1I	Legius syndrome	Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000854050	15	38545389	15	38253188	854050	842240		NC_000015.10:38253187:G:A
NM_152594.3(SPRED1):c.1246T>C (p.Cys416Arg)	SPRED1	C416R	Legius syndrome	Uncertain significance(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000848886	15	38643776	15	38351575	848886	842245		NC_000015.10:38351574:T:C
NM_152594.3(SPRED1):c.353G>C (p.Arg118Thr)	SPRED1	R118T	Legius syndrome	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000846857	15	38614587	15	38322386	846857	842241		NC_000015.10:38322385:G:C
NM_152594.3(SPRED1):c.1324G>A (p.Ala442Thr)	SPRED1	A442T	Legius syndrome	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000842373	15	38643854	15	38351653	842373	842247		NC_000015.10:38351652:G:A
NM_152594.3(SPRED1):c.1313G>T (p.Gly438Val)	SPRED1	G438V	Legius syndrome	Uncertain significance(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000841757	15	38643843	15	38351642	841757	842246		NC_000015.10:38351641:G:T
NM_152594.3(SPRED1):c.948C>G (p.Ser316=)	SPRED1		Legius syndrome|not provided	Likely benign(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000759175	15	38643478	15	38351277	759175	770117	rs1595763720	NC_000015.10:38351276:C:G
NM_152594.3(SPRED1):c.174T>C (p.Phe58=)	SPRED1		Legius syndrome|not provided	Likely benign(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000758909	15	38591715	15	38299514	758909	770115	rs1595733589	NC_000015.10:38299513:T:C
NM_152594.3(SPRED1):c.1215A>G (p.Leu405=)	SPRED1		Legius syndrome|not provided	Likely benign(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000700705	15	38643745	15	38351544	700705	688402	rs1595764001	NC_000015.10:38351543:A:G
NM_152594.3(SPRED1):c.306G>A (p.Thr102=)	SPRED1		not specified|Legius syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000700598	15	38614540	15	38322339	700598	688401	rs372791883	NC_000015.10:38322338:G:A
NM_152594.3(SPRED1):c.403G>C (p.Glu135Gln)	SPRED1	E135Q	Legius syndrome	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000664866	15	38616990	15	38324789	664866	643121	rs1595748136	NC_000015.10:38324788:G:C
NM_152594.3(SPRED1):c.207+1G>A	SPRED1		Legius syndrome	Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000659240	15	38591749	15	38299548	659240	653035	rs1595733611	NC_000015.10:38299547:G:A
NM_152594.3(SPRED1):c.181C>T (p.Arg61Cys)	SPRED1	R61C	Legius syndrome	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000658760	15	38591722	15	38299521	658760	643115	rs765788978	NC_000015.10:38299520:C:T
NM_152594.3(SPRED1):c.135C>G (p.Phe45Leu)	SPRED1	F45L	Legius syndrome	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000656070	15	38591676	15	38299475	656070	643113	rs1595733562	NC_000015.10:38299474:C:G
NM_152594.3(SPRED1):c.401C>G (p.Ala134Gly)	SPRED1	A134G	Legius syndrome	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000655356	15	38616988	15	38324787	655356	643120	rs762633609	NC_000015.10:38324786:C:G
NM_152594.3(SPRED1):c.302T>C (p.Leu101Pro)	SPRED1	L101P	Legius syndrome	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000644593	15	38614536	15	38322335	644593	643116	rs1595746820	NC_000015.10:38322334:T:C
NM_152594.3(SPRED1):c.149A>T (p.Gln50Leu)	SPRED1	Q50L	Legius syndrome	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000641959	15	38591690	15	38299489	641959	643114	rs1475256958	NC_000015.10:38299488:A:T
NM_152594.3(SPRED1):c.800G>A (p.Trp267Ter)	SPRED1	W267*	Legius syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000641432	15	38643330	15	38351129	641432	643122	rs1595763557	NC_000015.10:38351128:G:A
NM_152594.3(SPRED1):c.302T>G (p.Leu101Arg)	SPRED1	L101R	Legius syndrome	Uncertain significance(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000640617	15	38614536	15	38322335	640617	643117	rs1595746820	NC_000015.10:38322334:T:G
NM_152594.3(SPRED1):c.395A>G (p.Asn132Ser)	SPRED1	N132S	Legius syndrome	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000640126	15	38616982	15	38324781	640126	643119	rs1595748117	NC_000015.10:38324780:A:G
NM_152594.3(SPRED1):c.1289G>C (p.Gly430Ala)	SPRED1	G430A	Legius syndrome	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000640062	15	38643819	15	38351618	640062	643126	rs749389617	NC_000015.10:38351617:G:C
NM_152594.3(SPRED1):c.315T>G (p.Ser105Arg)	SPRED1	S105R	Legius syndrome	Uncertain significance(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000576034	15	38614549	15	38322348	576034	566987	rs1566867263	NC_000015.10:38322347:T:G
NM_152594.3(SPRED1):c.683G>A (p.Arg228Lys)	SPRED1	R228K	Legius syndrome	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000575146	15	38641723	15	38349522	575146	566992	rs951963194	NC_000015.10:38349521:G:A
NM_152594.3(SPRED1):c.1283G>A (p.Arg428His)	SPRED1	R428H	not provided|Legius syndrome	Uncertain significance(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000569525	15	38643813	15	38351612	569525	569328	rs369492789	NC_000015.10:38351611:G:A
NM_152594.3(SPRED1):c.274T>C (p.Trp92Arg)	SPRED1	W92R	Legius syndrome	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000569345	15	38614508	15	38322307	569345	566978	rs1566867214	NC_000015.10:38322306:T:C
NM_152594.3(SPRED1):c.103G>T (p.Gly35Ter)	SPRED1	G35*	Legius syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547791	15	38591644	15	38299443	547791	538027	rs1555389690	NC_000015.10:38299442:G:T
NM_152594.3(SPRED1):c.1192G>A (p.Asp398Asn)	SPRED1	D398N	not provided|Legius syndrome|not specified	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000536698	15	38643722	15	38351521	536698	529116	rs771480941	NC_000015.10:38351520:G:A
NM_152594.3(SPRED1):c.208-6T>C	SPRED1		Legius syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000536696	15	38614436	15	38322235	536696	528724	rs1241478218	NC_000015.10:38322234:T:C
NM_152594.3(SPRED1):c.684+10G>A	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000536695	15	38641734	15	38349533	536695	529111	rs1555392611	NC_000015.10:38349532:G:A
NM_152594.3(SPRED1):c.1191C>T (p.Asp397=)	SPRED1		not provided|Legius syndrome	Likely benign(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000536694	15	38643721	15	38351520	536694	528728	rs749745659	NC_000015.10:38351519:C:T
NM_152594.3(SPRED1):c.52C>T (p.Arg18Ter)	SPRED1	R18*	Legius syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000536693	15	38591593	15	38299392	536693	529252	rs750777752	NC_000015.10:38299391:C:T
NM_152594.3(SPRED1):c.287A>G (p.Asp96Gly)	SPRED1	D96G	Legius syndrome	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000536692	15	38614521	15	38322320	536692	528782	rs1555391039	NC_000015.10:38322319:A:G
NM_152594.3(SPRED1):c.842A>G (p.Gln281Arg)	SPRED1	Q281R	Legius syndrome	Uncertain significance(Last reviewed: Jun 22, 2019)	criteria provided, single submitter	VCV000536691	15	38643372	15	38351171	536691	528785	rs1427402192	NC_000015.10:38351170:A:G
NM_152594.3(SPRED1):c.685G>T (p.Val229Phe)	SPRED1	V229F	Legius syndrome	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000536690	15	38643215	15	38351014	536690	529266	rs201837340	NC_000015.10:38351013:G:T
NM_152594.3(SPRED1):c.634G>A (p.Val212Ile)	SPRED1	V212I	Legius syndrome	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000536689	15	38641674	15	38349473	536689	528727	rs769630742	NC_000015.10:38349472:G:A
NM_152594.3(SPRED1):c.676C>T (p.Gln226Ter)	SPRED1	Q226*	Legius syndrome	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000536686	15	38641716	15	38349515	536686	529263	rs1555392609	NC_000015.10:38349514:C:T
NM_152594.3(SPRED1):c.305C>G (p.Thr102Arg)	SPRED1	T102R	Legius syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2018)	criteria provided, conflicting interpretations	VCV000520837	15	38614539	15	38322338	520837	512136	rs754706111	NC_000015.10:38322337:C:G
NM_152594.3(SPRED1):c.376+3A>T	SPRED1		not specified|Legius syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2020)	criteria provided, conflicting interpretations	VCV000516692	15	38614613	15	38322412	516692	504728	rs775985211	NC_000015.10:38322411:A:T
NM_152594.3(SPRED1):c.424-5A>G	SPRED1		not specified|Legius syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2019)	criteria provided, conflicting interpretations	VCV000506274	15	38631933	15	38339732	506274	497044	rs752656697	NC_000015.10:38339731:A:G
NM_152594.3(SPRED1):c.423+2T>C	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000505193	15	38617012	15	38324811	505193	497043	rs1555391161	NC_000015.10:38324810:T:C
NM_152594.3(SPRED1):c.449C>T (p.Ser150Phe)	SPRED1	S150F	Legius syndrome	Uncertain significance(Last reviewed: Dec 9, 2014)	no assertion criteria provided	VCV000492894	15	38631963	15	38339762	492894	485755	rs1555392025	NC_000015.10:38339761:C:T
NM_152594.3(SPRED1):c.299G>A (p.Gly100Asp)	SPRED1	G100D	Legius syndrome	Uncertain significance(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000492892	15	38614533	15	38322332	492892	485754	rs1555391048	NC_000015.10:38322331:G:A
NM_152594.3(SPRED1):c.974G>A (p.Arg325Gln)	SPRED1	R325Q	Legius syndrome	Uncertain significance(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000468802	15	38643504	15	38351303	468802	464717	rs1238094530	NC_000015.10:38351302:G:A
NM_152594.3(SPRED1):c.944C>T (p.Pro315Leu)	SPRED1	P315L	not provided|Legius syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 19, 2021)	criteria provided, conflicting interpretations	VCV000468801	15	38643474	15	38351273	468801	464715	rs115440602	NC_000015.10:38351272:C:T
NM_152594.3(SPRED1):c.538G>T (p.Asp180Tyr)	SPRED1	D180Y	Legius syndrome	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000468799	15	38632052	15	38339851	468799	464710	rs1375474473	NC_000015.10:38339850:G:T
NM_152594.3(SPRED1):c.446G>A (p.Ser149Asn)	SPRED1	S149N	not specified|Legius syndrome|not provided	Benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468798	15	38631960	15	38339759	468798	464708	rs373384814	NC_000015.10:38339758:G:A
NM_152594.3(SPRED1):c.406G>A (p.Gly136Arg)	SPRED1	G136R	Legius syndrome	Uncertain significance(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000468797	15	38616993	15	38324792	468797	464172	rs1555391158	NC_000015.10:38324791:G:A
NM_152594.3(SPRED1):c.376+9T>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000468796	15	38614619	15	38322418	468796	464168	rs1555391063	NC_000015.10:38322417:T:G
NM_152594.3(SPRED1):c.221G>T (p.Cys74Phe)	SPRED1	C74F	Legius syndrome	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000468795	15	38614455	15	38322254	468795	464706	rs1412213561	NC_000015.10:38322253:G:T
NM_152594.3(SPRED1):c.182G>A (p.Arg61His)	SPRED1	R61H	Legius syndrome	Uncertain significance(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000468794	15	38591723	15	38299522	468794	464975	rs750686148	NC_000015.10:38299521:G:A
NM_152594.3(SPRED1):c.178A>G (p.Ile60Val)	SPRED1	I60V	Legius syndrome	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000468793	15	38591719	15	38299518	468793	464697	rs761830220	NC_000015.10:38299517:A:G
NM_152594.3(SPRED1):c.1295C>T (p.Ala432Val)	SPRED1	A432V	Legius syndrome	Uncertain significance(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	VCV000468792	15	38643825	15	38351624	468792	464993	rs200871227	NC_000015.10:38351623:C:T
NM_152594.3(SPRED1):c.1202G>T (p.Cys401Phe)	SPRED1	C401F	Legius syndrome|not specified	Uncertain significance(Last reviewed: Aug 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000468791	15	38643732	15	38351531	468791	464176	rs779058019	NC_000015.10:38351530:G:T
NM_152594.3(SPRED1):c.115C>G (p.Leu39Val)	SPRED1	L39V	Legius syndrome	Uncertain significance(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000468789	15	38591656	15	38299455	468789	464153	rs1555389691	NC_000015.10:38299454:C:G
NM_152594.3(SPRED1):c.1076T>A (p.Ile359Asn)	SPRED1	I359N	Legius syndrome	Uncertain significance(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	VCV000468787	15	38643606	15	38351405	468787	464721	rs763738243	NC_000015.10:38351404:T:A
NM_152594.3(SPRED1):c.1008A>G (p.Val336=)	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000468786	15	38643538	15	38351337	468786	464720	rs1555392775	NC_000015.10:38351336:A:G
NM_152594.3(SPRED1):c.1006G>A (p.Val336Ile)	SPRED1	V336I	Legius syndrome|not provided	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429870	15	38643536	15	38351335	429870	422010	rs373477920	NC_000015.10:38351334:G:A
NM_152594.3(SPRED1):c.33-7A>G	SPRED1		not provided|Legius syndrome	Likely benign(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000415720	15	38591567	15	38299366	415720	400062	rs760850290	NC_000015.10:38299365:A:G
NM_152594.3(SPRED1):c.321T>C (p.Ala107=)	SPRED1		Legius syndrome|not provided	Likely benign(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000415719	15	38614555	15	38322354	415719	400064	rs770197803	NC_000015.10:38322353:T:C
NM_152594.3(SPRED1):c.30C>A (p.Asn10Lys)	SPRED1	N10K	not specified|not provided|Legius syndrome	Benign/Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000415718	15	38545416	15	38253215	415718	400554	rs201692618	NC_000015.10:38253214:C:A
NM_152594.3(SPRED1):c.1031A>G (p.His344Arg)	SPRED1	H344R	Legius syndrome	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000409628	15	38643561	15	38351360	409628	400558	rs376679136	NC_000015.10:38351359:A:G
NM_152594.3(SPRED1):c.421C>T (p.Gln141Ter)	SPRED1	Q141*	Legius syndrome	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000409627	15	38617008	15	38324807	409627	400555	rs1060502505	NC_000015.10:38324806:C:T
NM_152594.3(SPRED1):c.517A>G (p.Ile173Val)	SPRED1	I173V	Legius syndrome	Uncertain significance(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000409626	15	38632031	15	38339830	409626	400071	rs1060502504	NC_000015.10:38339829:A:G
NM_152594.3(SPRED1):c.281T>C (p.Ile94Thr)	SPRED1	I94T	not provided|Legius syndrome	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000392095	15	38614515	15	38322314	392095	373387	rs761473300	NC_000015.10:38322313:T:C
NM_152594.3(SPRED1):c.74A>G (p.Asp25Gly)	SPRED1	D25G	Legius syndrome|not provided	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391600	15	38591615	15	38299414	391600	373383	rs1057524159	NC_000015.10:38299413:A:G
NM_152594.3(SPRED1):c.1176G>A (p.Ser392=)	SPRED1		Legius syndrome|not provided	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000390623	15	38643706	15	38351505	390623	373395	rs755223172	NC_000015.10:38351504:G:A
NM_152594.3(SPRED1):c.594T>C (p.Gly198=)	SPRED1		Legius syndrome|not specified|not provided	Likely benign(Last reviewed: Jul 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000388363	15	38641634	15	38349433	388363	374480	rs756643495	NC_000015.10:38349432:T:C
NM_152594.3(SPRED1):c.879G>A (p.Leu293=)	SPRED1		not provided|not specified|Legius syndrome	Benign/Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386548	15	38643409	15	38351208	386548	373388	rs535687467	NC_000015.10:38351207:G:A
NM_152594.3(SPRED1):c.207+15A>G	SPRED1		not provided|not specified	Benign/Likely benign(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000385742	15	38591763	15	38299562	385742	373385	rs377288061	NC_000015.10:38299561:A:G
NM_152594.3(SPRED1):c.384C>T (p.Pro128=)	SPRED1		not provided|Legius syndrome	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000385514	15	38616971	15	38324770	385514	374479	rs761058615	NC_000015.10:38324769:C:T
NM_152594.3(SPRED1):c.973C>T (p.Arg325Ter)	SPRED1	R325*	Legius syndrome	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000374301	15	38643503	15	38351302	374301	361214	rs1057518683	NC_000015.10:38351301:C:T
NM_152594.3(SPRED1):c.46C>T (p.Arg16Ter)	SPRED1	R16*	not provided|Legius syndrome	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372718	15	38591587	15	38299386	372718	360244	rs1057517941	NC_000015.10:38299385:C:T
NM_152594.3(SPRED1):c.1282C>T (p.Arg428Cys)	SPRED1	R428C	Legius syndrome|not specified	Uncertain significance(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372629	15	38643812	15	38351611	372629	360252	rs941091989	NC_000015.10:38351610:C:T
NM_152594.3(SPRED1):c.*5346A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315792	15	38649211	15	38357010	315792	340373	rs886051125	NC_000015.10:38357009:A:C
NM_152594.3(SPRED1):c.*5232G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315791	15	38649097	15	38356896	315791	340372	rs886051124	NC_000015.10:38356895:G:A
NM_152594.3(SPRED1):c.*5202C>T	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315790	15	38649067	15	38356866	315790	340370	rs541213700	NC_000015.10:38356865:C:T
NM_152594.3(SPRED1):c.*5110C>T	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315789	15	38648975	15	38356774	315789	322393	rs8026118	NC_000015.10:38356773:C:T
NM_152594.3(SPRED1):c.*4987A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315787	15	38648852	15	38356651	315787	340367	rs886051123	NC_000015.10:38356650:A:C
NM_152594.3(SPRED1):c.*4932A>G	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315785	15	38648797	15	38356596	315785	338686	rs16966843	NC_000015.10:38356595:A:G
NM_152594.3(SPRED1):c.*4822A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315784	15	38648687	15	38356486	315784	331699	rs576136057	NC_000015.10:38356485:A:G
NM_152594.3(SPRED1):c.*4781C>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315783	15	38648646	15	38356445	315783	322386	rs886051121	NC_000015.10:38356444:C:A
NM_152594.3(SPRED1):c.*4744G>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315782	15	38648609	15	38356408	315782	338682	rs886051120	NC_000015.10:38356407:G:T
NM_152594.3(SPRED1):c.*4725A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315781	15	38648590	15	38356389	315781	340364	rs530058944	NC_000015.10:38356388:A:G
NM_152594.3(SPRED1):c.*4662T>A	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315780	15	38648527	15	38356326	315780	322372	rs10852019	NC_000015.10:38356325:T:A
NM_152594.3(SPRED1):c.*4472C>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315779	15	38648337	15	38356136	315779	331697	rs541556786	NC_000015.10:38356135:C:A
NM_152594.3(SPRED1):c.*4046G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315777	15	38647911	15	38355710	315777	340363	rs886051118	NC_000015.10:38355709:G:A
NM_152594.3(SPRED1):c.*3996G>A	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315776	15	38647861	15	38355660	315776	338680	rs72725364	NC_000015.10:38355659:G:A
NM_152594.3(SPRED1):c.*3946G>A	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315775	15	38647811	15	38355610	315775	340362	rs8039337	NC_000015.10:38355609:G:A
NM_152594.3(SPRED1):c.*3830G>A	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315774	15	38647695	15	38355494	315774	331693	rs8039150	NC_000015.10:38355493:G:A
NM_152594.3(SPRED1):c.*3698T>G	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315773	15	38647563	15	38355362	315773	331688	rs76527876	NC_000015.10:38355361:T:G
NM_152594.3(SPRED1):c.*3647T>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315772	15	38647512	15	38355311	315772	338678	rs186366365	NC_000015.10:38355310:T:G
NM_152594.3(SPRED1):c.*3623G>T	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315771	15	38647488	15	38355287	315771	338676	rs148525432	NC_000015.10:38355286:G:T
NM_152594.3(SPRED1):c.*3591C>T	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315770	15	38647456	15	38355255	315770	338674	rs147489619	NC_000015.10:38355254:C:T
NM_152594.3(SPRED1):c.*3584G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315769	15	38647449	15	38355248	315769	338669	rs886051117	NC_000015.10:38355247:G:A
NM_152594.3(SPRED1):c.*3544G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315768	15	38647409	15	38355208	315768	338666	rs886051116	NC_000015.10:38355207:G:A
NM_152594.3(SPRED1):c.*3521A>G	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315767	15	38647386	15	38355185	315767	340357	rs11634702	NC_000015.10:38355184:A:G
NM_152594.3(SPRED1):c.*3192G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315766	15	38647057	15	38354856	315766	322369	rs566065329	NC_000015.10:38354855:G:A
NM_152594.3(SPRED1):c.*3057A>G	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315765	15	38646922	15	38354721	315765	331687	rs72725362	NC_000015.10:38354720:A:G
NM_152594.3(SPRED1):c.*2885G>A	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315764	15	38646750	15	38354549	315764	331675	rs79309779	NC_000015.10:38354548:G:A
NM_152594.3(SPRED1):c.*2843A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315763	15	38646708	15	38354507	315763	338664	rs886051115	NC_000015.10:38354506:A:C
NM_152594.3(SPRED1):c.*2831G>A	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315762	15	38646696	15	38354495	315762	322368	rs35490364	NC_000015.10:38354494:G:A
NM_152594.3(SPRED1):c.*2570T>C	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315761	15	38646435	15	38354234	315761	322367	rs111997668	NC_000015.10:38354233:T:C
NM_152594.3(SPRED1):c.*2359G>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315758	15	38646224	15	38354023	315758	340355	rs886051112	NC_000015.10:38354022:G:C
NM_152594.3(SPRED1):c.*1897C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315757	15	38645762	15	38353561	315757	322362	rs776375597	NC_000015.10:38353560:C:T
NM_152594.3(SPRED1):c.*1798A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315756	15	38645663	15	38353462	315756	322356	rs886051111	NC_000015.10:38353461:A:C
NM_152594.3(SPRED1):c.*1747A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315755	15	38645612	15	38353411	315755	331666	rs561525888	NC_000015.10:38353410:A:C
NM_152594.3(SPRED1):c.*1724A>C	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315754	15	38645589	15	38353388	315754	338657	rs1554527	NC_000015.10:38353387:A:C
NM_152594.3(SPRED1):c.*1563C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000315752	15	38645428	15	38353227	315752	338654	rs886051110	NC_000015.10:38353226:C:T
NM_152594.3(SPRED1):c.*1400G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315751	15	38645265	15	38353064	315751	338652	rs886051109	NC_000015.10:38353063:G:A
NM_152594.3(SPRED1):c.*1337A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315750	15	38645202	15	38353001	315750	331655	rs570038934	NC_000015.10:38353000:A:C
NM_152594.3(SPRED1):c.*1040G>A	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315749	15	38644905	15	38352704	315749	340353	rs115568221	NC_000015.10:38352703:G:A
NM_152594.3(SPRED1):c.*810A>G	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315748	15	38644675	15	38352474	315748	338645	rs886051108	NC_000015.10:38352473:A:G
NM_152594.3(SPRED1):c.*565A>C	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315743	15	38644430	15	38352229	315743	322350	rs866578422	NC_000015.10:38352228:A:C
NM_152594.3(SPRED1):c.*427A>T	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315742	15	38644292	15	38352091	315742	340347	rs185290497	NC_000015.10:38352090:A:T
NM_152594.3(SPRED1):c.*256C>T	SPRED1		not provided|Legius syndrome	Benign/Likely benign(Last reviewed: Jun 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000315741	15	38644121	15	38351920	315741	338639	rs145373657	NC_000015.10:38351919:C:T
NM_152594.3(SPRED1):c.*248T>C	SPRED1		Legius syndrome|not provided	Benign(Last reviewed: Jun 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000315740	15	38644113	15	38351912	315740	340345	rs16966842	NC_000015.10:38351911:T:C
NM_152594.3(SPRED1):c.*149G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315739	15	38644014	15	38351813	315739	331651	rs776485386	NC_000015.10:38351812:G:A
NM_152594.3(SPRED1):c.1000C>T (p.Arg334Cys)	SPRED1	R334C	Legius syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000315738	15	38643530	15	38351329	315738	331649	rs765603808	NC_000015.10:38351328:C:T
NM_152594.3(SPRED1):c.963G>A (p.Lys321=)	SPRED1		not specified|not provided|Legius syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000315737	15	38643493	15	38351292	315737	338637	rs369711772	NC_000015.10:38351291:G:A
NM_152594.3(SPRED1):c.881A>T (p.Tyr294Phe)	SPRED1	Y294F	not specified|Legius syndrome	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000315736	15	38643411	15	38351210	315736	322347	rs886051105	NC_000015.10:38351209:A:T
NM_152594.3(SPRED1):c.707A>G (p.His236Arg)	SPRED1	H236R	Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315735	15	38643237	15	38351036	315735	322345	rs886051104	NC_000015.10:38351035:A:G
NM_152594.3(SPRED1):c.565C>A (p.Gln189Lys)	SPRED1	Q189K	Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315734	15	38632079	15	38339878	315734	322343	rs200142785	NC_000015.10:38339877:C:A
NM_152594.3(SPRED1):c.564G>A (p.Met188Ile)	SPRED1	M188I	Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315733	15	38632078	15	38339877	315733	338629	rs202092705	NC_000015.10:38339876:G:A
NM_152594.3(SPRED1):c.-87C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315732	15	38545300	15	38253099	315732	340344	rs886051103	NC_000015.10:38253098:C:T
NM_152594.3(SPRED1):c.-93C>T	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315731	15	38545294	15	38253093	315731	322338	rs192699510	NC_000015.10:38253092:C:T
NM_152594.3(SPRED1):c.-152C>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315730	15	38545235	15	38253034	315730	322334	rs886051102	NC_000015.10:38253033:C:A
NM_152594.3(SPRED1):c.-191C>T	SPRED1		Legius syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315728	15	38545196	15	38252995	315728	340339	rs556907443	NC_000015.10:38252994:C:T
NM_152594.3(SPRED1):c.-201G>A	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315727	15	38545186	15	38252985	315727	338625	rs770231868	NC_000015.10:38252984:G:A
NM_152594.3(SPRED1):c.-244T>C	SPRED1		Legius syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315726	15	38545143	15	38252942	315726	340338	rs138385793	NC_000015.10:38252941:T:C
NM_152594.3(SPRED1):c.-294C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000315725	15	38545093	15	38252892	315725	322328	rs886051100	NC_000015.10:38252891:C:T
NM_152594.3(SPRED1):c.-309C>T	SPRED1		Legius syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000315724	15	38545078	15	38252877	315724	322322	rs578173447	NC_000015.10:38252876:C:T
NM_152594.3(SPRED1):c.807T>G (p.Asn269Lys)	SPRED1	N269K	not provided|Legius syndrome	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280174	15	38643337	15	38351136	280174	264838	rs886041428	NC_000015.10:38351135:T:G
NM_152594.3(SPRED1):c.995G>A (p.Arg332His)	SPRED1	R332H	Legius syndrome	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000241993	15	38643525	15	38351324	241993	242036	rs779966392	NC_000015.10:38351323:G:A
NM_152594.3(SPRED1):c.939G>A (p.Thr313=)	SPRED1		Legius syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000241992	15	38643469	15	38351268	241992	242035	rs140644874	NC_000015.10:38351267:G:A
NM_152594.3(SPRED1):c.886T>C (p.Cys296Arg)	SPRED1	C296R	Neurofibromatosis-Noonan syndrome|Legius syndrome	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV000241991	15	38643416	15	38351215	241991	242034	rs554327738	NC_000015.10:38351214:T:C
NM_152594.3(SPRED1):c.685-8T>C	SPRED1		Legius syndrome|not provided	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV000241990	15	38643207	15	38351006	241990	242033	rs760690837	NC_000015.10:38351005:T:C
NM_152594.3(SPRED1):c.1005C>T (p.Cys335=)	SPRED1		not provided|Legius syndrome	Likely benign(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000241988	15	38643535	15	38351334	241988	242037	rs768937237	NC_000015.10:38351333:C:T
NM_152594.3(SPRED1):c.587C>T (p.Thr196Ile)	SPRED1	T196I	Legius syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2020)	criteria provided, conflicting interpretations	VCV000229269	15	38641627	15	38349426	229269	230561	rs147474792	NC_000015.10:38349425:C:T
NM_152594.3(SPRED1):c.51G>A (p.Val17=)	SPRED1		not provided|Legius syndrome	Likely benign(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000220213	15	38591592	15	38299391	220213	222417	rs864622421	NC_000015.10:38299390:G:A
NM_152594.3(SPRED1):c.926T>C (p.Val309Ala)	SPRED1	V309A	not provided|Legius syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2021)	criteria provided, conflicting interpretations	VCV000178134	15	38643456	15	38351255	178134	176103	rs114636635	NC_000015.10:38351254:T:C
NM_152594.3(SPRED1):c.702C>G (p.Ile234Met)	SPRED1	I234M	Legius syndrome|not specified	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000165293	15	38643232	15	38351031	165293	175959	rs138553244	NC_000015.10:38351030:C:G
NM_152594.3(SPRED1):c.675C>T (p.Ser225=)	SPRED1		Legius syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000047970	15	38641715	15	38349514	47970	57134	rs144764225	NC_000015.10:38349513:C:T
NM_152594.3(SPRED1):c.583-7A>G	SPRED1		not provided|Legius syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000047969	15	38641616	15	38349415	47969	57133	rs115970207	NC_000015.10:38349414:A:G
NM_152594.3(SPRED1):c.377-10A>G	SPRED1		not specified|not provided|Legius syndrome	Likely benign(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000047968	15	38616954	15	38324753	47968	57132	rs376134678	NC_000015.10:38324752:A:G
NM_152594.3(SPRED1):c.26A>T (p.Asp9Val)	SPRED1	D9V	not provided|Legius syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2020)	criteria provided, conflicting interpretations	VCV000047967	15	38545412	15	38253211	47967	57131	rs200157475	NC_000015.10:38253210:A:T
NM_152594.3(SPRED1):c.177T>C (p.Phe59=)	SPRED1		Legius syndrome|not provided|not specified	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000047966	15	38591718	15	38299517	47966	57130	rs397517871	NC_000015.10:38299516:T:C
NM_152594.3(SPRED1):c.124G>A (p.Val42Ile)	SPRED1	V42I	not specified|Legius syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000047965	15	38591665	15	38299464	47965	57129	rs147204964	NC_000015.10:38299463:G:A
NM_152594.3(SPRED1):c.424-8C>A	SPRED1		not provided|Legius syndrome|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041453	15	38631930	15	38339729	41453	49891	rs7180446	NC_000015.10:38339728:C:A
NM_152594.3(SPRED1):c.424-18G>A	SPRED1		not specified|not provided|Legius syndrome	Benign(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041452	15	38631920	15	38339719	41452	49890	rs7179118	NC_000015.10:38339718:G:A
NM_152594.3(SPRED1):c.424-98=	SPRED1		Legius syndrome	Benign(Last reviewed: Oct 14, 2010)	no assertion criteria provided	VCV000041373	15	38631840	15	38339639	41373	49797	rs7163339	NC_000015.10:38339638:T:T
NM_152594.3(SPRED1):c.424-8=	SPRED1		Legius syndrome	Benign(Last reviewed: Oct 14, 2010)	no assertion criteria provided	VCV000041372	15	38631930	15	38339729	41372	49796	rs7180446	NC_000015.10:38339728:C:C
NM_152594.3(SPRED1):c.291G>A (p.Lys97=)	SPRED1		not provided|Legius syndrome|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041371	15	38614525	15	38322324	41371	49795	rs7182445	NC_000015.10:38322323:G:A
NM_152594.3(SPRED1):c.1044T>C (p.Val348=)	SPRED1		not provided|Legius syndrome|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041370	15	38643574	15	38351373	41370	49794	rs3751526	NC_000015.10:38351372:T:C
NM_152594.3(SPRED1):c.131T>A (p.Val44Asp)	SPRED1	V44D	Legius syndrome	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000001816	15	38591672	15	38299471	1816	16855	rs121434318	NC_000015.10:38299470:T:A
NM_152594.3(SPRED1):c.784A>T (p.Arg262Ter)	SPRED1	R262*	Legius syndrome	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000001815	15	38643314	15	38351113	1815	16854	rs121434317	NC_000015.10:38351112:A:T
NM_152594.3(SPRED1):c.637C>T (p.Gln213Ter)	SPRED1	Q213*	Legius syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000001814	15	38641677	15	38349476	1814	16853	rs121434316	NC_000015.10:38349475:C:T
NM_152594.3(SPRED1):c.190C>T (p.Arg64Ter)	SPRED1	R64*	Legius syndrome	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001813	15	38591731	15	38299530	1813	16852	rs121434315	NC_000015.10:38299529:C:T
NM_152594.3(SPRED1):c.643C>T (p.Gln215Ter)	SPRED1	Q215*	Legius syndrome	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001812	15	38641683	15	38349482	1812	16851	rs121434314	NC_000015.10:38349481:C:T
NM_152594.3(SPRED1):c.423+1G>A	SPRED1		Legius syndrome	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001811	15	38617011	15	38324810	1811	16850	rs1566868058	NC_000015.10:38324809:G:A
NM_152594.3(SPRED1):c.70C>T (p.Arg24Ter)	SPRED1	R24*	not provided|Legius syndrome	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001810	15	38591611	15	38299410	1810	16849	rs121434313	NC_000015.10:38299409:C:T
NM_152594.3(SPRED1):c.349C>T (p.Arg117Ter)	SPRED1	R117*	Legius syndrome	Pathogenic(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV000001809	15	38614583	15	38322382	1809	16848	rs121434312	NC_000015.10:38322381:C:T
NM_000546.6(TP53):c.542G>A (p.Arg181His)	TP53	R142H, R181H, R49H, R22H	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Familial cancer of breast|Carcinoma of pancreas|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142320	17	7578388	17	7675070	142320	152034	rs397514495	NC_000017.11:7675069:C:T
NM_000546.6(TP53):c.877G>T (p.Gly293Trp)	TP53	G161W, G254W, G293W, G134W	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	Likely benign(Last reviewed: Aug 11, 2020)	reviewed by expert panel	VCV000127826	17	7577061	17	7673743	127826	133283	rs587780076	NC_000017.11:7673742:C:A
NM_000546.6(TP53):c.974G>T (p.Gly325Val)	TP53	G325V, G193V, G286V, G166V	Li-Fraumeni syndrome|not provided|Familial colorectal cancer|Hereditary cancer-predisposing syndrome|Non-Hodgkin lymphoma	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2021)	criteria provided, conflicting interpretations	VCV000012367	17	7576872	17	7673554	12367	27406	rs121912659	NC_000017.11:7673553:C:A
NM_000551.4(VHL):c.313A>C	VHL	T105P	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000496055	3	10183844	3	10142160	496055	486951	rs1553619461	NC_000003.12:10142159:A:C
